https://demo.pharmafocusasia.com/pressreleases/vertex-announces-casgevy-reimbursement-agreement-for-the-treatment 2026-05-07 09:10:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waiv-enters-collaboration-with-daiichi-sankyo 2026-05-07 09:04:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cartography-biosciences-announces-strategic-investment-from-samsung-ventures 2026-05-07 09:03:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taimei-technology-and-cr-research-announce-strategic-partnership 2026-05-07 08:56:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-launches-first-bio-based-solvent-portfolio 2026-05-07 08:48:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inmune-bio-and-anthony-nolan-announce-strategic 2026-05-06 06:39:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cleveland-clinic-riken-and-ibm-model-a-12635-atom-protein 2026-05-06 06:37:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellenkos-announces-fda-clearance-of-investigational 2026-05-05 06:32:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-ec-approves-henlius 2026-05-01 06:59:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ecolab-life-sciences-expands-global-bioprocessing 2026-05-01 06:52:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-reaches-three-settlement-agreements-for-vyndamax 2026-04-29 05:31:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-opens-us-flagship 2026-04-29 05:30:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-and-atlatl-sign-memorandum 2026-04-29 05:29:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xcovery-partners-with-eversana-to-commercialize 2026-04-28 07:08:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prothena-announces-novo-nordisk-obtains-fast-track 2026-04-28 07:07:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/img-pharma-enters-into-definitive-agreement 2026-04-28 07:05:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-signs-agreement-to-sell 2026-04-28 07:04:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-signs-definitive-agreement 2026-04-28 06:57:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-initiates-phase-iii-clinical-study-of-its-nectin-4-targeting 2026-04-24 06:14:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-receives-south-korea-mfds-gmp 2026-04-23 06:25:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-hanoi-2026-makes-its-debut-bringing 2026-04-22 05:11:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-acquire-kelonia-therapeutics-to-advance 2026-04-22 04:19:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adcendo-aps-provides-updates-on-pipeline-progress 2026-04-21 05:33:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-combination-therapy-for-advanced-small-cell-lung-cancer 2026-04-20 06:53:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/10x-genomics-introduces-atera 2026-04-20 06:53:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altathera-pharmaceuticals-to-engage-global-leaders 2026-04-17 05:42:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-applied-biosystems 2026-04-17 05:39:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-first-nmpa-accepts-ind-application-for-mabwells 2026-04-16 05:56:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-achieves-iso-13485-certification 2026-04-16 05:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-initiates-phase-1-clinical-trial 2026-04-15 10:30:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesa-expands-into-japan-appoints-senior-pharmaceutical 2026-04-15 05:00:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/haisco-enters-into-exclusive-license-agreement 2026-04-14 08:55:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genscript-and-mimulus-partner-to-industrialize 2026-04-14 08:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientifics-ppd-clinical-research 2026-04-14 08:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cartherics-and-catalent-expand-commercial-license-agreement 2026-04-10 03:15:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-global-biobank-leadership 2026-04-10 03:14:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nsg-bio-and-charles-river-sign-memorandum 2026-04-09 00:16:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trinetx-enhances-its-ability-to-federate 2026-04-09 00:14:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-signs-share-purchase-agreement-with-hasten-biopharmaceuticals-asia-limited 2026-04-09 00:13:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atlatl-announces-agreement-with-daiichi-sankyo 2026-04-09 00:10:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiji-pharma-asia-commences-operations 2026-04-08 03:23:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-begins-tender-offer-to-acquire 2026-04-08 03:22:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roosterbio-and-minebio-life-sciences-partner 2026-04-08 03:20:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-global-collaboration 2026-04-08 03:19:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-collaborates-with-trinetx-to-access-de-identified 2026-04-07 03:24:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofis-lunsekimig-met-primary-and-key-secondary 2026-04-07 03:22:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-propure-endotoxin-free-proteins 2026-04-02 01:36:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotus-pharmaceutical-announces-acquisition 2026-04-02 00:53:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-extends-tender-offer-to-acquire-arcellx 2026-04-02 00:52:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-completes-acquisition-of-all-rights 2026-04-02 00:51:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-integrated-platform 2026-04-02 00:48:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-acquire-centessa-pharmaceuticals-to-advance 2026-04-01 00:56:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-completes-acquisition-of-gsks 2026-04-01 00:54:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nj-bio-inc-and-ajinomoto-bio-pharma-services-partner 2026-04-01 00:53:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-thermo-scientific 2026-04-01 00:52:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matricelf-enters-strategic-collaboration-with-japans 2026-03-31 00:43:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shimadzu-scientific-instruments-inc-opens-new-laboratory 2026-03-31 00:42:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-grants-taisho-pharmaceutical-a-license 2026-03-31 00:40:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiji-seika-pharma-invests-in-centivax-to-develop 2026-03-31 00:39:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-announces-global-rd 2026-03-31 00:37:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioptimus-announces-stela-the-worlds-largest-clinically 2026-03-27 03:25:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alteogen-enters-into-a-license-agreement-with-biogen 2026-03-26 01:19:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-signs-a-large-scale-manufacturing-supply 2026-03-26 01:17:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-and-shl-medical-collaborate 2026-03-26 01:14:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/building-the-future-of-biotechnology 2026-03-26 00:05:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-reinforces-commitment-to-japan 2026-03-25 23:11:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vizai-partners-with-alnylam-pharmaceuticals-to-advance 2026-03-25 03:32:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-yoshindo-advance-domestic-biosimilar-manufacturing 2026-03-25 03:30:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/triple-agonist-ubt251-showed-a-mean-hba1c-reduction 2026-03-25 03:11:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-celebration-awards-2026 2026-03-25 00:13:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insitro-and-bristol-myers-squibb-collaboration-expanded 2026-03-24 01:18:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-inaugurates-new-research-home-for-the-institute 2026-03-24 01:16:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-launches-pandaclaw-empowering-biologists 2026-03-24 01:13:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-receives-10-m-milestone-from-bristol-myers-squibb 2026-03-23 05:45:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gi-innovation-announces-first-clinical-supply-agreement 2026-03-23 05:43:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunitybio-announces-approval-in-macau-sar-china 2026-03-23 05:41:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsks-b7-h3-targeted-antibody-drug-conjugate-risvutatug-rezetecan 2026-03-23 05:39:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/niper-raebareli-partners-with-roche-pharma 2026-03-20 04:26:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gi-innovation-announces-first-clinical-supply-agreement 2026-03-20 04:25:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-pharmteco-reaffirms-three-business-unit-strategy 2026-03-20 04:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellcarta-secures-global-exclusivity-for-biofidelitys-aspyre-lung 2026-03-20 04:23:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cpi-and-medicines-discovery-catapult-launch-project 2026-03-18 00:17:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zydus-and-lupin-sign-licensing-agreement 2026-03-18 00:12:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viva-biotech-accelerates-ai-driven-drug-discovery 2026-03-18 00:09:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-pharmteco-announces-successful-us-fda-inspection 2026-03-18 00:07:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innorna-announces-fda-clearance-of-ind-for-in026 2026-03-18 00:06:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-launches-next-generation-platform 2026-03-17 05:08:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurothera-labs-clearmind-medicine-collaboration 2026-03-17 03:47:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/australian-first-brain-cancer-study-to-test-hyperbaric 2026-03-17 03:43:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-global-first-in-class-trispecific-antibody 2026-03-17 03:42:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliber-honors-digital-transformation-leaders 2026-03-15 23:50:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genscript-strengthens-transatlantic-biotech-infrastructure 2026-03-13 00:30:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-earendil-labs-enter-strategic-collaboration 2026-03-13 00:29:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grunenthal-licenses-exclusive-south-korean-rights 2026-03-12 00:24:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/locus-cell-taiwan-based-cell-and-gene-therapy-cdmo 2026-03-12 00:13:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ixcells-reaches-ipsc-line-delivery-milestone 2026-03-12 00:12:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/george-medicines-signs-exclusive-licensing-agreement 2026-03-12 00:10:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curatis-and-neupharma-announce-exclusive-licensing 2026-03-12 00:09:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-acquires-cialis-tadalafil-from-lilly 2026-03-11 23:08:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-granted-priority-review-in-the-us-as-post-neoadjuvant 2026-03-11 01:27:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tsingke-biotech-and-igenetech-forge-strategic-partnership 2026-03-11 01:25:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-commercial-launch 2026-03-11 01:24:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/interphex-week-tokyo-2026-releases-conference 2026-03-11 01:19:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-005-eumg-breakthrough-how-sino-biological-propure 2026-03-09 23:40:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ramarketing-acquires-us-market-research-firm-isr 2026-03-09 23:37:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-and-genetix-biotherapeutics-extend-commercial 2026-03-09 23:35:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/a-vision-for-the-future-of-critical-medicines-in-ireland 2026-03-09 23:34:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/croda-expands-biopharma-capabilities-through-strategic-partnership 2026-03-06 05:40:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-immunodiagnostics-operations 2026-03-05 00:52:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-launches-rational-design-cho-host-cell-line 2026-03-05 00:37:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-blood-and-cell-technologies-introduces-apac 2026-03-05 00:36:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-biotechnologies-unveils-shunzymex-precision 2026-03-04 01:22:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senhwa-biosciences-signs-strategic-mou-with-y 2026-03-04 01:20:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-pilots-the-automated-ai-driven-partnering-system 2026-03-04 01:17:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advancing-influenza-vaccine-development-sino-biological 2026-03-03 04:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-pharma-announces-new-drug-discovery-collaboration 2026-03-03 03:40:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-rusfertide 2026-03-03 03:39:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jaypirca-pirtobrutinib-approved-in-china-for-the-treatment 2026-03-03 03:33:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-new-color-based 2026-03-03 03:31:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-idt-biologika-and-vaxxas-selected 2026-02-27 01:08:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sarepta-therapeutics-announces-commercial-launch 2026-02-27 01:13:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asahi-kasei-pharma-strengthens-preclinical-pipeline 2026-02-26 03:20:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brainlab-and-precision-neuromed-announce-strategic 2026-02-26 03:18:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-to-build-new-radioligand-therapy-site-in-denton 2026-02-26 03:17:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-unveils-roadmap-of-groundbreaking-novaseq-x 2026-02-26 03:16:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/steincares-and-shilpa-biologicals-strike-into-licensing 2026-02-26 03:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliber-commune-2026-india-edition-brings-pharma-leaders 2026-03-02 23:09:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-expands-fast-trak-process-development-and-validation 2026-02-25 07:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galderma-announces-triple-approval-of-new 2026-02-25 06:16:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-regenerons-dupixent-approved-in-the-united-states 2026-02-25 06:12:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansa-biopharmas-biologics-license-application-bla 2026-02-24 06:58:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-mhra-approval-in-uk-for-sugemalimab 2026-02-24 06:57:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/interphex-week-tokyo-to-expand-its-2026-showcase 2026-02-23 23:26:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-new-drug-application-for-genentechs 2026-02-21 00:26:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/savara-announces-the-us-food-and-drug-administration 2026-02-21 00:25:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zelluna-receives-uk-mhra-and-ethics-approval-to-initiate 2026-02-21 00:23:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asahi-kasei-pharma-selects-maia-pharmaceuticals 2026-02-20 00:46:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seqster-launches-1-click-data-refinery-to-power-scalable 2026-02-20 00:45:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puretech-announces-orphan-drug-designations-granted 2026-02-20 00:44:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deciphera-pharmaceuticals-announces-us-food 2026-02-20 00:42:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-expands-us-footprint 2026-02-19 00:06:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensei-biotherapeutics-announces-acquisition-of-faeth 2026-02-19 04:23:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tempus-announces-novel-pan-cancer-hrd-rna-algorithm 2026-02-19 00:02:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellares-and-university-of-wisconsin-school-of-medicine 2026-02-19 00:00:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-introduces-next-generation-microflow-lc-columns 2026-02-18 23:59:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmacelera-raises-eur6m-to-expand-in-us-and-build 2026-02-18 03:41:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-expands-antibody-discovery-offering 2026-02-18 03:40:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deciphera-pharmaceuticals-announces-us-food 2026-02-18 03:38:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-receives-european-commission-marketing-authorization 2026-02-18 03:37:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-announces-leadership-evolution-in-specialty 2026-02-17 23:19:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/6th-annual-pharma-gmp-quality-management-2026 2026-02-17 05:19:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyond-compliance-building-quality-maturity 2026-02-17 05:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-fda-clearance-of-ind-application 2026-02-16 23:54:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/niowave-and-novartis-enter-global-actinium-225-supply 2026-02-12 01:14:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evogene-systasy-and-lmu-university-hospital-munich 2026-02-12 01:13:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-receives-us-fda-clearance 2026-02-12 01:12:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-real-world-data-interoperability 2026-02-12 01:10:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gccl-and-medicover-integrated-clinical-services 2026-02-11 00:27:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ai-powered-rd-acceleration-insilico-medicine-and-cms 2026-02-11 00:26:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-completes-the-acquisition-of-dynavax 2026-02-11 00:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/17th-edition-strategic-alliance-management-for-pharma 2026-02-10 04:53:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaessentia-announces-plans-to-establish-new-us 2026-02-10 03:17:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kashiv-biosciences-and-intas-pharmaceuticals-sign 2026-02-10 03:15:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carterra-launches-industrys-first-48-channel-ht-spr-platform 2026-02-10 03:14:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-strategic-collaboration-with-lilly 2026-02-10 03:12:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-strengthens-consumer-healthcare-portfolio 2026-02-08 23:09:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-announces-ind-clearance-by-the-china 2026-02-06 00:14:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-exclusive-license-agreement 2026-02-06 00:11:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-enters-into-agreement-with-south-korea-based-sky 2026-02-06 00:09:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-henlius-enter-into-exclusive-commercial-license-agreement 2026-02-06 00:08:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asia-photonics-expo-2026-opens-in-singapore-cementing 2026-02-04 23:49:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cepi-and-samsung-biologics-collaborate-to-strengthen 2026-02-04 00:24:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zipbio-and-meiragtx-enter-into-exclusive-license-agreement 2026-02-04 00:22:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-seattle-site-now-certified-to-manufacture 2026-02-04 00:21:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cycle-pharmaceuticals-completes-acquisition 2026-02-04 00:18:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-introduces-tablet-in-capsule 2026-02-03 01:27:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/frontage-laboratories-expands-early-phase-clinical 2026-02-03 01:26:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-plans-to-invest-15-billion-in-china-through 2026-02-03 01:24:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanegenebio-announces-rnai-global-licensing 2026-02-03 01:22:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-vertex-sign-license-and-research 2026-02-03 01:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-pioneers-life-sciences-innovation 2026-02-01 23:38:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enveric-biosciences-expands-collaboration-with-totec 2026-01-30 00:41:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iqvia-and-boehringer-ingelheim-announce-strategic-long-term 2026-01-30 00:40:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuto-scientific-and-university-of-wisconsin-madison 2026-01-30 00:38:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-initiates-international-phase-12-clinical-trial 2026-01-30 00:37:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/whx-in-dubai-formerly-arab-health-to-debut-specialised 2026-01-29 05:12:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bora-biologics-celebrates-opening-of-30-million-san-diego 2026-01-29 05:14:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repare-announces-completion-of-acquisition-by-xeno 2026-01-29 01:16:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seamless-therapeutics-announces-global-research 2026-01-29 01:14:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/serina-therapeutics-announces-fda-clearance-of-ind 2026-01-29 01:12:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-expands-research-reagent-portfolio 2026-01-29 00:27:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ixcells-biotechnologies-and-rosebud-biosciences-partner 2026-01-28 00:09:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-first-daily-oral-glp1-treatment 2026-01-28 00:08:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-ibi3003-gprc5dbcmacd3-trispecific-antibody 2026-01-28 00:06:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/libevitug-approved-in-china-as-first-in-class-treatment 2026-01-28 00:04:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/whx-in-dubai-formerly-arab-health-to-bring-together-key 2026-01-27 03:58:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eclipsebio-acquires-terrain-bio-to-expand-its-end-to-end-ai 2026-01-27 03:18:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascletis-announces-first-participants-dosed-in-a-13-week-us 2026-01-27 03:17:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merz-therapeutics-submits-application-to-the-european 2026-01-27 03:16:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brazil-achieves-a-historic-milestone-blau-farmaceutica 2026-01-27 03:15:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/japan-tissue-engineering-wins-approval-for-insurance 2026-01-27 03:10:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-msd-and-hilleman-laboratories-advance-zaire-ebolavirus 2026-01-23 01:43:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crown-bioscience-san-diego-laboratory-achieves-cap-accreditation 2026-01-23 01:09:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuralight-and-teitur-trophics-announce-collaboration 2026-01-22 00:05:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elucidata-launches-ai-labs-to-solve-biomedical-agi 2026-01-22 00:04:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptinovo-biopharmas-targeted-cancer-drug-platform 2026-01-21 00:06:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biologicals-launch-of-swiftfluo-tr-fret 2026-01-21 00:04:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-solutions-and-pangea-laboratory-establish-strategic 2026-01-21 00:03:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-enters-agreement-to-acquire-rapt-therapeutics 2026-01-21 00:00:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-chemlex-sign-memorandum-of-understanding 2026-01-20 23:58:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biologicals-launch-of-swiftfluo-tr-fret-kits-pioneers 2026-01-20 23:21:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/healthcare-hospilog-asia-2026 2026-01-20 03:15:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-nmpa-acceptance-of-second-nda 2026-01-19 23:35:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinese-nmpa-accepts-new-drug-application-for-illuccix 2026-01-19 23:34:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abelzeta-announces-remaining-china-rights-to-gpc3 2026-01-19 23:33:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/myqorzo-and-redemplo-approved-in-china 2026-01-16 01:05:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-receives-swissmedic-approval-of-agamree 2026-01-16 01:04:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-drug-design-announces-further-in-vivo-validation 2026-01-15 23:31:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/interphex-week-tokyo-2026-expands-pharma-innovation 2026-01-13 03:41:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nmpa-accepts-the-nda-for-luye-pharmas-ruoxinlin 2026-01-09 04:16:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-biologics-receives-grant-for-ai-driven-optimization 2026-01-08 07:22:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arbele-receives-fda-orphan-drug-designation-for-arb1002 2026-01-08 07:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotech-receives-investigational-new-drug-approval 2026-01-06 03:13:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/geneditbio-receives-fda-clearance-of-ind-application 2026-01-06 03:11:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zydus-partners-with-bioeq-for-us-commercialisation 2025-12-24 03:30:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-secures-ind-approval-for-phase-1 2025-12-24 03:29:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-expands-rare-disease-presence-with-planned 2025-12-23 00:41:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-announces-approval-of-ustekinumab 2025-12-23 00:38:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-bioworks-partners-with-carnegie-mellon-university 2025-12-23 00:37:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orexo-enters-into-agreement-with-dexcel-pharma-usa 2025-12-23 00:35:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-as-wegovy-pill-approved-in-the-us 2025-12-23 00:33:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chitose-and-fujifilm-biosciences-form-strategic 2025-12-22 00:35:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiji-seika-pharma-partners-with-mbc-biolabs 2025-12-22 00:32:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-expands-us-manufacturing 2025-12-22 00:27:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medipost-announces-the-exclusive-commercialization 2025-12-19 01:05:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-announces-catalyze-agreement 2025-12-19 01:03:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revvity-introduces-signals-xynthetica 2025-12-18 23:20:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galux-announces-research-agreement-with-boehringer 2025-12-18 00:04:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-wins-2025-scientistcoms-supplier-recognition-award 2025-12-17 06:48:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repligen-introduces-next-generation-chromatography 2025-12-17 00:12:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-initiates-global-clinical-development 2025-12-17 00:11:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-enters-into-global-strategic-collaboration 2025-12-17 00:09:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-expands-xpovio-indications-in-malaysia 2025-12-17 00:08:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-expands-partnership-with-lundbeck 2025-12-16 03:19:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adel-signs-104-billion-global-license-agreement 2025-12-16 00:41:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/esco-aster-signs-exosome-clinical-cgmp-manufacturing 2025-12-16 00:40:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-gibco-bacto 2025-12-16 00:39:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gaelic-labs-acquisition-of-athlone-boosts-gaelics-leadership-in-the-beta 2025-12-11 23:47:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indupro-therapeutics-announces-strategic-investment-from-sanofi 2025-12-11 05:26:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk227-a-b7-h3-targeted-antibody-drug-conjugate 2025-12-11 05:25:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-opens-us-partnering-office-in-south-san-francisco 2025-12-11 05:21:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formation-bio-licenses-phase-1-ready-cns-penetrant-tyk2 2025-12-11 05:17:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-enters-into-exclusive-collaboration-and-license 2025-12-10 00:01:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bora-pharmaceuticals-and-corealis-pharma-forge-strategic 2025-12-10 00:00:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-fida-biosystems-collaborate-to-improve 2025-12-09 23:58:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pillar-biosciences-and-astrazeneca-expand-liquid-biopsy 2025-12-08 23:47:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-lecanemab-for-the-treatment-of-early 2025-12-08 23:46:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incytes-first-in-class-mutcalr-targeted-monoclonal 2025-12-08 23:38:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-ships-first-doses-of-worlds-first-recombinant 2025-12-08 23:36:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovation-and-partnership-take-centre-stage 2025-12-08 03:21:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ide034-a-bispecific-adc-licensed-by-biocytogen 2025-12-05 00:50:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hiropharmaconsulting-r-granted-patent-for-ai-enabled 2025-12-05 00:49:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-asia-pacific-expands-production-facilities 2025-12-05 00:47:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotech-and-crescent-biopharma-announce-strategic 2025-12-05 00:46:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xpovio-approved-in-hong-kong-for-two-additional-indications 2025-12-04 00:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-partners-with-atum-to-accelerate 2025-12-04 00:11:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baxdrostat-new-drug-application-accepted-under 2025-12-03 01:09:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pre-filled-syringe-presentation-of-byooviz-samsung 2025-12-03 01:07:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-deepens-investment-in-asias 2025-12-03 01:05:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanudis-replaces-fragmented-manual-lab-processes 2025-12-03 00:10:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axoltis-pharma-raises-eur18-million-to-accelerate-development 2025-12-02 07:58:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ajinomoto-cellist-korea-launches-cellisttm-aav 2025-12-02 07:56:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-celebrates-the-brightest-minds-in-science-at-merck 2025-12-02 06:11:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cosciens-announces-exclusive-distribution-agreement 2025-12-02 00:46:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-begins-review-of-mannkinds-supplemental 2025-12-02 00:44:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujitsu-develops-multi-ai-agent-collaboration-technology 2025-12-02 00:41:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynk-pharmaceuticals-announces-fda-ind-approval 2025-12-02 00:34:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diagnosearch-celebrates-30-years-of-excellence 2025-12-01 06:12:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/infant-bacterial-therapeutics-ab-secures-partnership 2025-12-01 04:42:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-announces-launch-of-denosumab-biosimilars 2025-12-01 01:30:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-unveils-state-of-the-art-clinical-trial-support 2025-11-30 23:18:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strategic-partnership-sanyou-bio-and-koreas-fatiabgen 2025-11-28 00:46:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-announces-bla-approval-of-fucaso 2025-11-28 00:45:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-receives-health-canada-approval-for-eydenzelt 2025-11-28 00:44:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-submits-new-drug-application-for-subcutaneous 2025-11-28 00:42:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cartherics-appoints-dr-ian-nisbet-as-chief-executive-officer 2025-11-28 00:08:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-achieves-regulatory-compliance 2025-11-26 23:53:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imugene-and-jw-therapeutics-announce-a-collaboration 2025-11-26 23:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maibe-and-leniobio-announce-a-new-strategic-collaboration 2025-11-26 23:49:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innova-therapeutics-to-advance-novel-cancer-treatment 2025-11-26 23:47:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-approved-in-the-us-as-first-and-only-perioperative 2025-11-26 03:53:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesa-launches-digital-platform-to-unlock-access 2025-11-25 23:14:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mettler-toledo-launches-x3-series-to-transform-bulk 2025-11-25 00:00:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omniab-enters-into-a-technology-license-and-services-agreement 2025-11-18 05:26:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-corevitas-clinical 2025-11-18 05:24:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-bispecific-antibody-targeting-ab-and-bbb-expressed 2025-11-18 05:23:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/msd-to-acquire-cidara-therapeutics-inc-diversifying 2025-11-15 03:24:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-completes-acquisition-of-alcyone-therapeutics 2025-11-15 03:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-presents-new-data-showing-mezagitamab 2025-11-14 23:48:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-approved-for-iv-maintenance-treatment 2025-11-14 00:28:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bostongene-and-kyoto-university-partner-to-accelerate 2025-11-13 00:47:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sarah-cannon-research-institute-and-bristol-myers 2025-11-13 00:45:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genezen-announces-manufacturing-partnership 2025-11-13 00:43:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-signs-global-license-agreement-to-commercialize 2025-11-13 00:41:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sophia-genetics-and-element-biosciences-unite 2025-11-12 01:29:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strategic-partnership-between-sanyou-bio 2025-11-12 01:28:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-boosts-lab-productivity-and-sample-throughput 2025-11-12 01:26:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revvity-to-acquire-acdlabs-to-expand-its-signals-software-capabilities 2025-11-11 00:24:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/primrose-bio-launches-prima-rnapols-extend-cap-au 2025-11-11 00:22:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-and-lilly-enter-a-research-licensing 2025-11-11 00:20:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-epis-holdings-announces-establishment 2025-11-11 00:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-announces-agreement-with-the-us 2025-11-07 00:45:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polyactiva-and-raresight-form-strategic-collaboration 2025-11-06 00:47:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avant-technologies-signs-joint-venture-to-advance 2025-11-06 00:46:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biodlink-congratulates-lepu-biopharma-on-securing 2025-11-06 00:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-subsidiary-ailux-announces-strategic-collaboration 2025-11-06 00:43:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ileukon-receives-fda-clearance-of-ind-application 2025-11-05 01:55:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-kygevvi-doxecitine-and-doxribtimine 2025-11-04 04:30:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milliporesigma-partners-with-promega-to-advance-3-d 2025-11-04 04:28:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-completes-spin-off-to-strengthen 2025-11-04 04:27:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-receives-a-manufacturing-approval 2025-11-01 00:16:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-acquires-exclusive-greater 2025-10-31 00:48:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotte-biologics-and-sk-pharmteco-sign-strategic 2025-10-30 00:40:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kazia-therapeutics-to-request-fda-type-c-meeting 2025-10-29 00:42:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kemwell-biopharmas-bangalore-plant-successfully 2025-10-29 00:41:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/raffles-medical-group-partners-gene-solutions-to-expand-access 2025-10-28 00:28:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/naobios-and-tokyo-metropolitan-institute-of-medical-science 2025-10-26 23:40:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alphamab-oncology-announces-the-first-patient-dosed 2025-10-26 23:37:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-manufacturing-automation-excellence-awards-2025 2025-10-23 03:56:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/7th-annual-pharma-manufacturing-automation-convention-2025 2025-10-23 03:54:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/api-china-strengthens-its-role-as-asias-pharma-powerhouse 2025-10-22 06:34:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/me-therapeutics-granted-licence-for-cd22-nanobody-asset 2025-10-17 03:18:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansoh-grants-roche-an-exclusive-license-to-novel-cdh17 2025-10-17 03:16:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adam-innovations-and-sophia-genetics-partner 2025-10-17 03:14:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-to-accelerate-life-science-breakthroughs 2025-10-17 03:12:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-fuels-the-future-of-multi-omics-research 2025-10-16 00:46:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jacobio-pharma-announces-strategic-partnership 2025-10-16 00:45:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-files-for-first-in-human-trial-of-universal 2025-10-16 00:44:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-opens-expanded-manufacturing-facility-in-texas 2025-10-16 00:43:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-the-chromatography-business-of-jsr-life-sciences 2025-10-16 00:42:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-fda-acceptance 2025-10-15 03:27:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-launches-charge-detection-mass-spectrometry-technology 2025-10-15 03:25:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-announces-positive-phase-i-clinical-data-for-rsv-hmpv-piv3-combination-vaccines-and-for-rsv-re-vaccination-in-older-adults 2025-10-15 03:24:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-secures-cmo-rights-for-shingles-vaccine 2025-10-14 00:01:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-hanoi-debuts-to-strengthen-vietnams-growing-laboratory 2025-10-13 00:22:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-secures-agreement-with-biomedica-for-the-distribution 2025-10-10 00:27:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-to-acquire-akero-therapeutics-and-its-promising 2025-10-10 00:22:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-plans-to-increase-investment-and-scope 2025-10-10 00:18:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chance-pharma-announces-commercialization-agreement 2025-10-10 00:17:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-introduces-optimized-manufacturing-framework 2025-10-10 00:16:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyteph-completes-recruitment-for-phase-i-clinical-trial-of-cyt-101 2025-10-09 03:44:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/croda-strengthens-commitment-to-help-customers-decarbonise 2025-10-08 03:11:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bbg-advanced-therapies-and-cellforcure-partner-to-provide 2025-10-07 06:59:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-ce-mark-for-ai-based-kidney-klinrisk-algorithm 2025-10-07 00:37:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eccogene-receives-us-fda-clearance-to-initiate-phase-2a 2025-10-06 07:24:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotus-enters-license-and-supply-agreement-with-adalvo 2025-10-06 07:23:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alto-neuroscience-receives-fda-fast-track-designation 2025-10-06 07:17:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genialis-and-cleveland-clinic-collaborate-to-develop-ai-powered-biomarkers 2025-10-03 02:02:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-announces-approval-in-canada-for-agamree 2025-10-03 02:01:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-tecentriq-plus-lurbinectedin-as-first-line-maintenance-therapy 2025-10-03 01:55:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tanner-pharma-group-and-ucb-pharma-initiate-partnership 2025-10-03 01:36:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veraxa-biotech-and-secarna-pharmaceuticals-initiate-antibody 2025-10-01 01:09:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-announces-ai-partnership-with-weave-bio-to-accelerate 2025-10-01 01:01:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/debiopharm-licenses-sunrock-biopharmas-anti-her3her2 2025-10-01 00:59:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hinge-bio-announces-license-and-collaboration-with-kyorin 2025-10-01 00:58:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/made-scientific-and-syenex-forge-technology-partnership 2025-10-01 00:56:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cell-therapies-and-teijin-announce-strategic-collaboration 2025-09-30 23:30:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-shows-major-improvement-in-invasive-disease-free-survival 2025-09-30 00:54:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pier-88-health-and-theranica-announce-china-nmpa-approval 2025-09-30 00:50:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/full-life-technologies-announces-us77-million-financing 2025-09-30 00:48:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-to-acquire-merus-expanding-late-stage-pipeline 2025-09-30 00:47:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/health-hope-pharma-enters-into-exclusive-licensing-agreement 2025-09-30 00:42:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-resolves-to-launch-innovative-quantum-computing-enabled 2025-09-26 00:34:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-immunotech-secures-patent-in-japan-through-2039 2025-09-26 00:33:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/respira-therapeutics-enters-into-agreement-with-gossamer-bio 2025-09-26 00:32:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crinetics-announces-fda-approval-of-palsonify-paltusotine 2025-09-26 00:28:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-launches-wuxia40-targeted-integration 2025-09-26 00:24:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-biotechnologies-celebrates-the-grand-opening 2025-09-25 00:41:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-launches-affordable-iron-sucrose-injection-for-treatment 2025-09-25 00:39:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hengrui-pharma-and-glenmark-pharmaceuticals-enter-exclusive 2025-09-25 00:36:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-park-cdmo-selects-thermo-fisher-scientific-to-equip-new-viral 2025-09-25 00:35:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-commits-an-additional-625-million-to-sanofi-ventures 2025-09-24 00:46:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-advances-personalized-cancer-care-with-new-pharma 2025-09-24 00:45:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/variational-ai-enters-collaboration-with-merck-to-apply-generative-ai 2025-09-24 00:43:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/branded-legacy-inc-unveils-cutting-edge-gmp-facility-to-accelerate 2025-09-24 00:41:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exmoor-pharma-and-siam-bioscience-form-strategic-partnership 2025-09-24 00:39:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rion-engages-lonza-to-scale-manufacturing-exosome-based-therapeutics 2025-09-24 00:37:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-expansion-of-idorsias-quviviq-continues-as-simcere 2025-09-23 00:19:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-first-company-to-advance-cell-therapy-as-well-as-gene-therapy 2025-09-23 00:16:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-recommends-marketing-authorization 2025-09-23 00:14:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galux-demonstrates-de-novo-antibody-design-with-structural 2025-09-23 00:12:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-submits-ind-application-for-phase-1-clinical-trial 2025-09-23 00:11:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-new-drug-application-for-its-novel-next-generation 2025-09-23 00:10:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/angelini-pharma-signs-exclusive-option-agreement-with-sovargen 2025-09-22 23:12:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intrinseque-health-secures-isoiec-270012022-certification-reinforcing-global 2025-09-21 23:35:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunflower-therapeutics-receives-first-milestone-payment-through 2025-09-19 00:36:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idorsias-jeraygo-aprocitentan-approved-in-switzerland 2025-09-19 00:35:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-casgevy-reimbursement-agreement 2025-09-19 00:33:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-pharmaceuticals-joins-alliance-for-genomic-discovery 2025-09-19 00:31:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novalgen-to-begin-worlds-first-clinical-trial-for-a-self-regulating 2025-09-18 01:03:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyluxvi-is-the-second-biosimilar-approved-for-alteogen-following 2025-09-18 01:01:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-bioscience-and-aditum-bio-announce-formation-of-kalexo 2025-09-18 01:00:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton 2025-09-17 00:41:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurexone-planning-to-establish-first-us-commercial-manufacturing 2025-09-17 00:40:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/berlin-institute-of-health-at-bih-and-probiogen-join-forces 2025-09-17 00:38:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-announces-plans-to-build-5-billion-manufacturing-facility-in-virginia 2025-09-17 00:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novocures-optune-lua-receives-approval-in-japan 2025-09-17 00:36:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-announces-adc-innovator-tubulis-has-signed-global-exclusive 2025-09-17 00:35:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eu-approval-makes-novo-nordisks-oral-semaglutide-the-first 2025-09-16 01:22:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-and-paradigm-health-partner-to-expand-access-and-efficiency 2025-09-16 01:21:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jointly-discovered-kat6i-molecule-originating-from-australian 2025-09-16 01:19:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-efficient-pro-medium-insulin 2025-09-16 01:18:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-neurodegeneration-research 2025-09-16 01:16:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/absci-accelerates-ai-driven-drug-discovery-with-oracle-and-amd 2025-09-12 01:36:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zhimeng-biopharmas-investigational-drug-approved-to-initiate-phase-2 2025-09-12 01:34:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioivt-expands-capacity-with-new-cutting-edge-facility 2025-09-11 00:48:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seattle-facility-achieves-regulatory-approvals-customer 2025-09-11 00:47:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innorna-completes-phase-ii-enrollment-and-vaccination 2025-09-11 00:45:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-whitelab-genomics-team-up-to-use-ai-to-accelerate 2025-09-11 00:44:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bee-sting-inspired-microneedles-from-chung-ang-university 2025-09-10 01:27:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tzield-approved-in-china-as-first-disease-modifying-therapy 2025-09-10 01:25:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-and-ethris-enter-strategic-partnership-to-expand-offerings 2025-09-10 01:22:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metabolon-partners-with-china-kadoorie-biobank-to-advance-precision-health 2025-09-10 01:20:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-ai-drug-discovery-collaboration-reaches-milestone 2025-09-10 01:18:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-generics-manufacturing-facility-to-open-in-southeast-asia 2025-09-10 00:17:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/introducing-an-advanced-ai-system-to-streamline-drug-discovery-in-asia 2025-09-10 00:17:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurexone-receives-us-patent-allowance-for-exosome-manufacturing 2025-09-09 01:14:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-reaches-agreement-with-regeneron-resolving 2025-09-09 01:12:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-announces-strategic-equity-investment-by-bloomage 2025-09-09 01:07:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-acquires-potential-treatment-for-fragile-x-syndrome 2025-09-09 01:06:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zydus-and-synthon-entered-into-exclusive-licensing-and-supply 2025-09-05 00:20:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-announces-partnership-with-pepfar-to-deliver-twice-yearly 2025-09-05 00:19:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c4-therapeutics-highlights-recent-achievement-in-biogen-collaboration 2025-09-05 00:14:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-enters-into-agreement-with-merck-kgaa-darmstadt 2025-09-05 00:12:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ori-biotechs-iro-platform-receives-fda-advanced-manufacturing 2025-09-04 00:20:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-clinical-trial-regulations-announced-in-india-to-accelerate-drug-development 2025-09-04 00:17:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-innovations-new-biologics-manufacturing-facility-opens-in-singapore 2025-09-04 00:17:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-shionogis-ensitrelvir-nda-for-review-as-the-first 2025-09-03 03:15:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-completes-acquisition-of-solventums 2025-09-03 03:12:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurophet-signs-mou-with-inrad-to-establish-global-standards 2025-09-03 01:59:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-submits-ind-for-phase-3-clinical-trial-of-2-dose 2025-09-03 01:58:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-completion-of-patient-enrollment-in-phase-iii-clinical 2025-09-03 01:57:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asian-supply-chain-consortium-formed-to-strengthen-pharmaceutical-logistics 2025-09-03 00:17:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/major-biotech-firm-initiates-clinical-trials-for-groundbreaking-gene-therapy-in-japan 2025-09-03 00:17:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-unveils-next-generation-pipettes-delivering-enhanced 2025-09-02 05:06:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regulatory-authority-in-asia-streamlines-approval-process-for-biosimilars 2025-09-02 00:38:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/major-biopharmaceutical-company-announces-collaborative-rd-agreement-with-leading-asian-university 2025-09-02 00:38:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-and-alnylam-advance-zilebesiran-into-global-phase-iii 2025-09-02 00:28:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringers-hernexeos-approved-in-china-as-first 2025-09-02 00:20:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotte-biologics-establishes-contract-manufacturing-partnership 2025-09-02 00:18:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaresearch-establishes-european-distribution-partnership 2025-08-30 00:35:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-supports-george-medicines-in-developing 2025-08-30 00:27:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofis-wayrilz-approved-in-us-as-first-btk-inhibitor-for-immune 2025-08-30 00:24:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accro-bioscience-and-fosun-pharma-announce-exclusive-license 2025-08-29 05:27:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/philippines-pharma-major-unilab-selects-tcs-for-cloud-led 2025-08-29 00:44:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-supports-groundbreaking-approval-of-anlotinib 2025-08-29 00:40:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/camurus-announces-approval-of-oczyesa-for-the-treatment-of-acromegaly 2025-08-29 00:39:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-enters-into-agreement-with-ikris-pharma-network 2025-08-29 00:37:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celaid-therapeutics-have-executed-a-collaborative-research 2025-08-29 00:35:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ms-pharma-establishes-menas-first-biologics-manufacturing-hub 2025-08-28 00:40:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/actinogen-trial-using-intended-commercial-xanamem-tablet-formulation 2025-08-28 00:39:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/digital-twin-technology-with-ai-to-boost-efficiency-and-reliability 2025-08-28 00:36:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acrobiosystems-and-daan-biotherapeutics-sign-strategic-mou 2025-08-28 00:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dhl-global-forwarding-adds-to-its-asia-pacifics-life-science 2025-08-27 23:39:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuneering-announces-clinical-supply-agreement-with-lilly 2025-08-26 00:39:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-and-stada-extend-biosimilars-alliance-to-tocilizumab 2025-08-26 00:38:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acceleration-in-clinical-development-leads-biolabs-lbl-034-dosed 2025-08-26 00:36:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novocure-announces-coverage-of-tumor-treating-fields-ttfields 2025-08-26 00:34:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-to-acquire-gilgamesh-pharmaceuticals-bretisilocin 2025-08-26 00:33:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxxas-secures-a90-million-in-funding-to-commercialise 2025-08-25 03:44:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-lecanemab-launched-in-the-eu-today 2025-08-25 03:41:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/austria-and-germany-to-become-the-first-markets-in-the-european-union 2025-08-25 03:38:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/datroway-approved-in-china-for-patients-with-previously-treated 2025-08-25 03:35:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyloris-signs-exclusive-licensing-agreement-with-huons-co 2025-08-22 01:12:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-discusses-further-collaboration-with-the-gates-foundation 2025-08-22 01:07:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/andelyn-biosciences-and-amplo-biotechnology-partner-to-manufacture 2025-08-22 01:06:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/smsbiotech-initiates-groundbreaking-phase-1-human-clinical-trial 2025-08-22 01:04:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-opens-manufacturing-center-of-excellence 2025-08-22 01:03:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eylea-hd-aflibercept-injection-8-mg-applications-for-expanded 2025-08-21 00:33:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/somiteai-announces-strategic-investment-from-amd-ventures 2025-08-21 00:28:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-datapoints-tangible-scientific-and-inductive-bio-partner 2025-08-21 00:27:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lspedia-and-spring-bio-solution-partner-to-advance-pharma 2025-08-21 00:25:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-secures-agreement-with-uniphar-for-the-distribution 2025-08-20 00:47:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-completes-patient-enrollment-of-sanovo-phase-iii-trial 2025-08-20 00:42:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwells-cdh17-targeting-adc-7mw4911-receives-ind-clearance 2025-08-20 00:39:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labconnect-launches-labconnector-to-streamline-lab-data 2025-08-20 00:38:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-signs-mou-with-dong-a-st-for-joint-research-and-development 2025-08-20 00:37:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qihan-biotech-announces-fda-clearance-of-ind-for-qt-019b 2025-08-19 00:52:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships 2025-08-19 00:50:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-signs-mou-with-thai-red-cross-society-to-strengthen 2025-08-19 00:48:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avixgen-a-subsidiary-of-dxvx-signs-a-licensing-out-agreement 2025-08-19 00:47:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyfortus-nirsevimab-approved-in-singapore-to-protect-all-infants 2025-08-19 00:47:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novel-gene-therapy-for-als-cleared-for-global-trials-in-china-and-the-us 2025-08-16 00:13:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hkbu-develops-microfluidic-flow-cytomolecular-analyser 2025-08-16 00:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leads-biolabs-announces-completion-of-patient-enrollment-in-pivotal 2025-08-16 00:10:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarivate-launches-ai-powered-regulatory-assistant-within-cortellis 2025-08-16 00:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etrasimod-receives-strong-recommendation-in-the-acg-clinical 2025-08-16 00:07:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofis-rilzabrutinib-earns-orphan-designation-in-the-eu-for-igg4-related 2025-08-14 01:25:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sarepta-therapeutics-announces-advancement-of-sirna-collaboration 2025-08-14 01:23:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shilpa-medicares-norudca-makes-history-as-first-approved-nafld 2025-08-14 01:10:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-acceptance-of-the-new-drug-application 2025-08-14 01:09:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-signs-agreement-with-gen-for-the-distribution 2025-08-13 01:14:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-brinsupri-brensocatib-as-the-first 2025-08-13 01:10:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-announces-195-million-investment-to-expand-active 2025-08-13 01:05:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-wuxiup-accomplishes-automated-continuous 2025-08-13 01:04:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-announces-first-patient-dosed-in-the-us-clinical-study 2025-08-13 01:02:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intas-accord-signs-agreement-to-acquire-prothya-biosolutions 2025-08-12 01:03:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-receives-fda-approval-for-ngs-based-companion 2025-08-12 01:02:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-launches-hek-293-stable-cell-line-platform 2025-08-12 01:00:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probio-launches-gmp-aav-manufacturing-services-at-hopewell 2025-08-12 00:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-and-nanotein-technologies-partner 2025-08-12 00:58:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minghui-pharmaceutical-announces-usd-131-million-pre-ipo 2025-08-08 00:30:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reshape-lifesciences-announces-shareholder-approval-of-merger 2025-08-08 00:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-nci-sponsors-senhwa-biosciences-second-program-ind 2025-08-08 00:27:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labconnect-partners-with-kits4life-to-reduce-kit-waste 2025-08-08 00:25:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intas-pharmaceuticals-and-accord-biopharma-become-one 2025-08-07 01:05:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virusure-launches-pioneering-first-in-class-viral-contamination 2025-08-07 01:02:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-expanded-indication-for-avtozma-tocilizumab-anoh 2025-08-07 01:01:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-full-approval-of-nefecon-in-taiwan 2025-08-07 00:47:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-and-dovetree-announce-landmark-6-billion-ai-drug 2025-08-07 00:46:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aboligo-closes-oversubscribed-round-to-accelerate-multiomic 2025-08-06 23:08:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kashiv-biosciences-and-ms-pharma-enter-into-mena-license 2025-08-06 00:39:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polpharma-biologics-and-fresenius-kabi-sign-licensing 2025-08-06 00:38:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-launches-broad-proprietary-pipeline-targeting-obesity 2025-08-06 00:37:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sophia-genetics-expands-collaboration-with-astrazeneca 2025-08-06 00:34:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fapon-biopharma-announces-the-enrollment-of-the-first-patient 2025-08-06 00:33:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nucleus-network-acquires-hammersmith-medicines-research 2025-08-05 00:59:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knight-therapeutics-and-incyte-amend-supply-and-distribution 2025-08-05 00:56:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kuros-biosciences-launches-magnetos-mis-delivery-system 2025-08-05 00:52:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minaris-advanced-therapies-opens-new-state-of-the-art 2025-08-05 00:49:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alveolus-bio-secures-strategic-investment-from-shilpa-medicare 2025-08-04 06:59:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anbogen-receives-fda-clearance-to-initiate-phase-12-trial 2025-08-04 06:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syvento-biotech-receives-mia-certification-first-in-poland 2025-08-02 00:59:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harrow-enters-into-commercialization-agreement-with-samsung 2025-08-01 23:58:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansa-biopharma-announces-supportive-data-from-treatment 2025-08-01 23:52:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-subsidiary-visirna-sells-rights-to-hypertriglyceridemia 2025-08-01 23:48:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-and-biotech-social-inc-pursue-crowdfunding-partnership 2025-08-01 00:49:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-expands-position-in-neuropsychiatric-care-through 2025-08-01 00:47:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azenta-life-sciences-partners-with-frenova-a-division 2025-08-01 00:44:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-twice-yearly-leqvio-inclisiran-receives 2025-08-01 00:42:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-clearmind-collaboration-leads-to-filing-of-international 2025-07-31 01:10:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vedtechbio-unveils-next-gen-drug-discovery-ai-partners 2025-07-31 01:08:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bon-launches-ai-powered-new-drug-research-and-development 2025-07-31 01:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-heidelberg-site-supplies-drug-substance 2025-07-31 01:06:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-completion-of-first-dosing-in-phase-iii 2025-07-31 01:05:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dxvx-signs-usd-220-million-co-development-and-license 2025-07-31 00:57:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incucyte-cx3-system-transforms-continuous-analysis-of-3d 2025-08-01 04:49:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ltz-therapeutics-announces-strategic-collaboration-with-eli-lilly 2025-07-30 00:08:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/concept-life-sciences-fios-genomics-partner-to-enhance 2025-07-30 00:07:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascellahealth-hub-partnership-with-abeona-therapeutics 2025-07-30 00:05:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tigermed-completes-acquisition-of-japanese-cro-micron 2025-07-29 00:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/entera-bio-receives-fda-agreement-on-bmd-as-primary 2025-07-29 00:31:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-bain-capital-create-new-company 2025-07-29 00:28:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-upgrades-preclinical-service-platform-and-launches 2025-07-29 00:27:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alphamab-oncology-announces-anti-her2-biparatopic-adc 2025-07-29 00:25:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nmpa-accepts-snda-for-ivonescimab-in-combination 2025-07-28 01:26:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shanton-receives-fast-track-designation-from-us-fda 2025-07-28 01:25:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biostate-ai-unlocks-molecular-doors-to-global-health 2025-07-25 01:31:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-washington-university-in-st-louis-sign-mou 2025-07-25 01:16:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tcg-labs-soleil-raises-an-additional-400-million-and-expands 2025-07-25 01:15:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cabometyx-approved-in-the-eu-for-previously-treated 2025-07-25 01:14:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-increases-accessibility 2025-07-25 01:12:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gnt-pharma-receives-regulatory-approval-to-initiate 2025-07-25 01:24:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/solvias-expands-us-capabilities-as-rtp-center-becomes-cgmp-ready 2025-07-24 23:26:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuraxpharm-continues-international-expansion-with-launch 2025-07-24 00:27:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenetic-biosciences-inc-expands-research-and-development 2025-07-24 00:26:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascellahealth-service-and-infrastructure-enhancements 2025-07-24 00:24:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-first-patient-enrollment-in-phase-iii-trial 2025-07-24 00:23:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/life-biosciences-announces-research-collaboration-with-singhealth 2025-07-23 01:15:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coriolis-pharma-opens-new-laboratory-at-spark-life-science 2025-07-23 01:13:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-announces-strategic-agreement 2025-07-23 01:12:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-england-biolabs-launches-nebnext-low-bias-small 2025-07-23 01:09:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-receives-positive-fda-feedback-on-pathway 2025-07-22 00:54:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/darolutamide-receives-eu-approval-in-third-indication 2025-07-22 00:52:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innobios-new-generation-her3-adc-db-1310-is-granted 2025-07-22 00:51:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-secures-fda-pli-approval-for-five-facilities 2025-07-22 00:49:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curocell-establishes-curolink-an-integrated-car-t-treatment-solution 2025-07-22 00:47:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-plans-to-invest-50-billion-in-america 2025-07-22 00:40:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-2-billion-manufacturing-investment 2025-07-21 07:10:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eqt-signs-definitive-agreement-to-acquire-adalvo 2025-07-19 00:21:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurneffy-adrenaline-nasal-spray-approved-in-the-uk 2025-07-19 00:19:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nkgen-biotech-and-hekabio-enter-strategic-partnership 2025-07-18 00:40:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-completes-acquisition-of-blueprint-medicines 2025-07-18 00:38:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-receives-marketing-authorization 2025-07-18 00:38:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-receives-approval-for-clinical-trials-of-21-valent 2025-07-18 00:37:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/from-legacy-to-leadership-csa-ai-agile-as-pharmas 2025-07-17 01:14:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-manufacturing-and-automation-excellence 2025-07-17 07:00:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/7th-annual-pharma-manufacturing-automation-convention-2025 2025-07-17 01:02:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-partnership-with-parkinsons-research-foundation 2025-07-17 00:18:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/partners-group-agrees-to-exit-from-its-initial-investment 2025-07-17 00:16:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandboxaq-and-ioncologi-partner-to-accelerate-brain-cancer 2025-07-17 00:14:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphix-bio-receives-fda-orphan-drug-designation 2025-07-17 00:13:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-and-sanofi-expand-strategic-partnership 2025-07-17 00:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elix-and-linc-become-the-first-in-the-world-to-commercialize 2025-07-16 00:56:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharma-bolsters-clinical-trial-capabilities-with-strategic 2025-07-16 00:55:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-biologics-expands-diabetes-portfolio-with-fda-approval 2025-07-16 00:53:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-first-patient-enrolled-in-the-phase-iii-trial 2025-07-16 00:52:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senhwa-biosciences-announces-first-patient-dosed 2025-07-16 00:51:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-introduces-the-oncomine-comprehensive 2025-07-15 00:16:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illimis-therapeutics-closes-58-billion-krw-42-million-series-b 2025-07-15 00:15:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/integrated-biosciences-unveils-first-of-its-kind-optogenetic 2025-07-15 00:13:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-sets-new-industry-standard-with-propure 2025-07-11 06:10:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/earendil-labs-announces-initiation-of-a-phase-1-study 2025-07-11 03:44:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-nmpa-approval-for-localized-manufacturing 2025-07-10 00:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repligen-corporation-univercells-technologies-partner 2025-07-10 00:33:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-and-servier-launch-first-xseed-labs-in-europe 2025-07-10 00:27:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-receives-orphan-drug-designation-from-the-ministry 2025-07-10 00:25:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medidata-and-the-university-of-sydneys-nhmrc-clinical-trials 2025-07-10 00:24:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indias-pharmacovigilance-momentum-takes-center-stage 2025-07-09 03:45:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veeda-lifesciences-announces-partnership-with-mango-sciences 2025-07-09 01:11:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breakthrough-in-ophthalmology-hengruis-heng-qin 2025-07-09 01:09:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioseeker-powers-development-of-a-first-of-its-kind 2025-07-09 01:08:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jcr-pharmaceuticals-enters-license-agreement-with-alexion 2025-07-09 01:06:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-and-conjugatebio-partner-to-develop-novel 2025-07-09 01:05:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-signs-exclusive-license-agreement-with-istituto-gentili 2025-07-09 01:03:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nybai-and-pnaseer-inc-announce-strategic-partnership 2025-07-08 00:10:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-usa-announces-us-launch-of-denosumab 2025-07-08 00:09:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/uk-mhra-approves-immunitybios-anktiva-plus-bcg 2025-07-08 00:08:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scg-cell-therapy-announces-clearance-of-investigational-new-drug 2025-07-08 00:06:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-launches-ipratropium-bromide-nasal-solution-nasal-spray 2025-07-04 23:41:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-approved-in-the-eu-as-first-and-only-perioperative 2025-07-04 23:38:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advancing-bone-health-european-commission-approves-biocon 2025-07-04 00:30:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ferring-adapt-1-trial-builds-on-dosing-evidence-for-follitropin-delta 2025-07-04 00:28:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transition-of-promotional-activities-for-allergen-immunotherapy 2025-07-04 00:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-pharmas-new-adc-innovative-drug-icp-b794 2025-07-04 00:23:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-first-bispecific-adc-trop2nectin4-adc-enters-clinical-trials 2025-07-04 00:22:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-announces-licensing-agreement-with-joincare 2025-07-04 00:21:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurizon-enters-into-global-license-with-elanco-to-accelerate 2025-07-03 00:30:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioversys-and-shionogi-enter-into-global-research 2025-07-03 00:29:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maat-pharma-announces-exclusive-commercialization-partnership 2025-07-03 00:25:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gwo-xi-stem-cell-company-powers-local-regenerative-medicine 2025-07-03 00:24:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-updated-positive-results 2025-07-03 00:22:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biological-e-limited-recbio-collaborate-to-produce-hpv9-vaccine 2025-07-02 00:18:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-xdc-announces-the-mechanical-completion 2025-07-02 00:16:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valgenesis-and-cai-partner-to-advance-ai-enabled-digital-validation 2025-07-02 00:14:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-and-advanz-pharma-enter-into-european-supply 2025-07-02 00:12:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rdp-pharma-ag-and-experimental-drug-development-centre-launch 2025-07-02 00:08:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hanchorbio-and-henlius-sign-major-licensing-deal-for-hcb101 2025-07-01 01:11:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alpha-fusion-inc-and-curadh-mtr-inc-to-enter-into-strategic-partnership 2025-07-01 01:10:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/klotho-neurosciences-moves-forward-with-manufacturing-gene-therapy 2025-07-01 01:08:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-to-acquire-capstan-therapeutics-further-strengthening-commitment 2025-07-01 01:07:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mesoblast-and-fda-align-on-key-items-for-revascor-biologic-license 2025-07-01 01:05:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-launches-next-generation-platform-wuxihigh20 2025-07-01 01:03:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aenova-expands-cold-chain-capabilities-with-new-state-of-the-art-warehouse 2025-06-30 07:15:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-mazdutide-first-dual-gcgglp-1-receptor-agonist 2025-06-30 01:14:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-marks-the-start-of-new-clinical-site-construction-with-groundbreaking 2025-06-30 01:09:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-and-pfizer-expand-strategic-collaboration-to-advance-ai-driven-drug 2025-06-30 01:08:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-celebrates-completion-of-new-vaccine-production-facility 2025-06-30 01:07:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-expands-bangalore-global-hub-in-india-with-166-crore 2025-06-27 00:20:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theravance-biopharma-announces-approval-of-yupelri-revefenacin 2025-06-27 00:19:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sineugenes-snug01-receives-fda-orphan-drug-designation-for-als 2025-06-27 00:17:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanced-and-eva-pharma-sign-mou-to-expand-car-t-cell 2025-06-27 00:15:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invetech-and-aicella-announce-strategic-collaboration-to-advance 2025-06-27 00:14:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-expands-cell-therapy-development-operations-to-asia 2025-06-26 00:31:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valneva-announces-exclusive-vaccine-marketing-and-distribution-agreement 2025-06-26 00:30:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-completes-acquisition-of-regulus-therapeutics 2025-06-26 00:28:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-becomes-secondary-commercialization-partner-for-formycons-stelara 2025-06-26 00:27:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lts-and-nualtis-announce-strategic-cooperation-to-expand-global 2025-06-26 00:22:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocitys-eta-selective-antagonist-sc0062-granted-breakthrough-therapy 2025-06-26 00:18:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-first-of-its-kind-donation-matching-program 2025-06-25 01:07:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortrea-emery-pharma-announce-strategic-collaboration-to-deliver 2025-06-25 01:06:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-pharmaceutical-and-vertex-announce-strategic-agreement-to-develop 2025-06-25 01:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-and-chico-pharmaceutical-sign-a-strategic-mou-for-oncology 2025-06-25 01:02:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axcelead-ddp-and-superluminal-announce-the-intent-to-collaborate 2025-06-24 00:50:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illuccix-approved-in-us-for-patient-selection-for-pre-taxane-rlt 2025-06-24 00:49:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revolution-medicines-announces-fda-breakthrough-therapy-designation 2025-06-24 00:47:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/libertas-bio-a-formation-bio-subsidiary-license-of-gusacitinib 2025-06-24 00:45:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-to-acquire-somalogic-accelerating-its-proteomics-business 2025-06-24 00:44:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-announces-zanzalintinib-in-combination-with-an-immune 2025-06-23 00:41:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quviviq-the-worlds-new-generation-anti-insomnia-drug-approved 2025-06-23 00:37:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-announces-strategic-collaboration-with-harvard-professor-gregory 2025-06-23 00:34:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-receives-positive-chmp-opinion-for-cabometyx-in-previously 2025-06-21 00:30:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-successful-release-of-first-clinical-batch 2025-06-21 00:21:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-solutions-strengthens-china-footprint-with-strategic-partnerships 2025-06-21 00:19:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuno-cure-and-pharmajet-announce-collaboration-to-advance 2025-06-19 23:38:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zemcelpro-um171-cell-therapy-receives-positive-chmp-opinion 2025-06-19 23:36:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanz-pharma-acquires-testoviron-rights-from-bayer-in-europe 2025-06-19 00:45:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avata-biosciences-and-oceanus-bio-agree-to-co-develop-oral-cannabidiol 2025-06-19 00:43:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nec-and-chugai-pharmaceutical-use-ai-to-potentially-enhance-cancer-treatment 2025-06-19 00:39:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-expands-manufacturing-and-rd-capacities-for-innovative 2025-06-19 00:38:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotte-biologics-signs-antibody-manufacturing-contract-with-ottimo-pharma 2025-06-19 00:37:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-medicovestors-first-in-class-adc 2025-06-18 03:39:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotte-biologics-signs-tripartite-mou 2025-06-18 03:30:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agenus-and-noetik-enter-collaboration-to-develop-ai-enabled-predictive 2025-06-18 03:28:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-acquire-verve-therapeutics-to-advance-one-time-treatments 2025-06-18 03:27:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/philips-future-health-index-2025-delayed-care-and-lost-clinical-time 2025-06-18 01:08:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emory-university-and-micron-biomedical-launch-first-in-human-clinical 2025-06-17 01:00:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaro-launches-panomiq-research-in-breakthrough-for-ai-driven-drug 2025-06-17 00:59:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/help-therapeutics-and-china-resources-sanjiu-announce-strategic 2025-06-17 00:57:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pierre-fabre-laboratories-strengthen-rd-portfolio-and-announce 2025-06-17 00:56:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/london-biotechnology-show-2025-gears-up-to-spotlight-industry-pioneers 2025-06-16 05:05:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hekabio-japan-based-biopharma-and-medtech-platform-enters-strategic 2025-06-16 03:18:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-completion-of-first-participant-dosed-in-the-seventh 2025-06-16 03:17:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-solutions-and-shenzhen-usk-bioscience-forge-strategic-partnership 2025-06-16 03:13:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-launches-drug-screening-services-samsung-organoids 2025-06-16 03:12:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vascarta-receives-fda-orphan-drug-designation-for-vasceptor 2025-06-13 00:18:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sumitomo-pharma-america-announces-that-nuvisertib-tp-3654 2025-06-13 00:16:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merry-life-launches-global-phase-ii-trial-of-tml-6-the-first-drug-targeted 2025-06-13 00:15:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mitsubishi-research-institute-and-astellas-announce-collaboration-to-support 2025-06-13 00:14:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/simtra-biopharma-solutions-and-milliporesigma-announce-strategic-alliance 2025-06-12 01:18:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deep-apple-therapeutics-announces-collaboration-with-novo-nordisk 2025-06-12 01:16:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-completing-16-billion-usd-in-strategic-investments-to-further-enhance 2025-06-12 01:15:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mesoblast-maintains-momentum-with-fda-on-accelerated-approval 2025-06-12 01:11:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-novel-cldn182-adc-skb315-ind-in-combination 2025-06-12 01:07:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/edetek-engages-capgemini-to-support-its-global-transformation-initiative 2025-06-11 01:13:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immvira-begins-dosing-in-phase-ii-trial-of-mvr-t3011 2025-06-11 01:11:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-launches-nach01-foundation-model-on-aws-marketplace 2025-06-11 01:09:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clavystbio-and-astar-partner-to-grow-medtech-ventures-in-singapore 2025-06-11 01:07:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indias-life-sciences-sector-leads-the-way-in-future-ready-lab-design 2025-06-11 00:58:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-enters-into-a-strategic-partnership-with-nipro 2025-06-10 00:42:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesis-biologics-launches-mastgut-a-breakthrough-supplement-that-uses 2025-06-10 00:41:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neowise-biotechnology-and-beone-medicines-enter-licensing-agreement 2025-06-10 00:40:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinas-center-for-drug-evaluation-accepts-mercks-application-for-marketing 2025-06-10 00:39:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formation-bio-announces-first-class-of-entrepreneurs-in-residence 2025-06-10 00:36:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/worlds-first-hla-g-targeted-exosome-therapy-for-cancer-enters-us 2025-06-10 00:35:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/improved-pharma-expands-footprint-at-kurz-purdue-technology-center 2025-06-07 00:45:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-sibeprenlimab-phase-3-data-show-a-statistically-significant 2025-06-07 00:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-geht-awk-zusammenarbeit-mit-tegmine-therapeutics 2025-06-07 00:29:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunoprecise-announces-ai-driven-breakthrough-in-universal-dengue-vaccine 2025-06-06 03:18:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-and-dr-reddys-enter-into-collaboration-to-co-develop-biosimilar 2025-06-06 03:15:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qurebio-ltd-completes-nearly-cny-100-million-series-c1-financing-led 2025-06-06 03:11:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mgi-tech-expands-partnership-with-fiocruz-to-accelerate-advances 2025-06-06 03:10:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-named-cargo-airline-of-the-year-global-at-the-2025-world 2025-06-05 00:32:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trilink-biotechnologies-and-quantoom-biosciences-sign-license 2025-06-04 00:52:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-rebrands-life-sciences-companies-to-strengthen-position 2025-06-04 00:50:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thinkcyte-unveils-morphoscan-cloud-a-versatile-cloud-based-platform 2025-06-04 00:49:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-manufacturing-solutions-tms-established-in-yokohama-japan 2025-06-04 00:49:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/venus-remedies-secures-ukrainian-gmp-renewal-strengthening 2025-06-03 07:15:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentechs-tecentriq-combined-with-lurbinectedin-shows-significant 2025-06-03 00:44:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-unveils-next-generation-mass-spectrometers 2025-06-03 00:37:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciex-and-evosep-expand-access-to-standardized-proteomics-for-pharma 2025-06-03 00:36:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asp-isotopes-and-isotopia-announce-supply-agreement-for-gadolinium-160 2025-06-03 00:34:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xellsmart-secures-fda-clearance-for-three-phase-i-inds-of-allogeneic 2025-06-03 00:33:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-launches-first-and-only-interchangeable-denosumab-biosimilars 2025-06-02 01:19:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zealand-pharma-submits-marketing-authorization-application 2025-06-02 01:11:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kura-oncology-and-kyowa-kirin-announce-fda-acceptance-and-priority 2025-06-02 01:09:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-zilovertamab-vedotin-shows-promising-results-in-phase-2-dlbcl-trial 2025-05-31 00:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-completes-its-acquisition-of-checkpoint-therapeutics 2025-05-31 00:21:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/circode-biomed-announces-fda-clearance-for-ind-application-of-hm2002 2025-05-31 00:13:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kexing-biopharms-gb18-project-received-clearance-of-ind-application 2025-05-30 00:07:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-unveils-the-next-generation-in-lc-mass-detection-the-infinitylab 2025-05-30 00:06:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-new-spectral-flow-cytometer-offering 2025-05-30 00:04:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dxvx-accelerates-development-of-universal-covid-19-vaccine 2025-05-30 00:02:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acceptance-of-a-new-drug-application-for-naldemedine-a-treatment 2025-05-30 00:01:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kilitch-drugs-limited-registers-yoy-remarkable-growth-and-revenue 2025-05-29 23:13:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuclera-and-cytiva-collaborate-to-accelerate-characterization-of-proteins 2025-05-29 00:33:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunitybio-saudi-arabias-ministry-of-investment-kfshrc 2025-05-29 00:33:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formosa-pharmaceuticals-and-adalvo-limited-announce-licensing-agreement 2025-05-29 00:31:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-introduces-bioresolve-protein-a-affinity-columns-to-accelerate-antibody 2025-05-29 00:30:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgens-satri-cel-granted-priority-review-by-the-nmpa 2025-05-29 00:29:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juri-biosciences-a-tcg-labs-soleil-portfolio-company-and-epimab 2025-05-28 00:55:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-subcutaneous-formulation-of-opdivo-approved-in-canada 2025-05-28 00:53:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-expand-its-pain-pipeline-with-acquisition-of-siteone-therapeutics 2025-05-28 00:47:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/drug-farm-and-xiamen-amoytop-biotech-co-ltd-enter-into-option 2025-05-28 00:45:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/remegen-telitacicept-for-the-treatment-of-generalized-myasthenia-gravis 2025-05-28 00:44:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-fda-grants-interchangeability-designation 2025-05-27 07:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/launch-of-radicava-for-the-treatment-of-als-in-australia 2025-05-27 00:26:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shanghai-pharma-holdings-and-novartis-china-reach-strategic-cooperation 2025-05-27 00:24:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aft-and-hikma-extend-us-maxigesic-cooperation 2025-05-27 00:19:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-launches-lillys-innovative-obesity-and-diabetes-medicine 2025-05-27 00:17:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huonslab-achieves-last-patient-in-lpi-in-phase-1-pivotal-study 2025-05-27 00:15:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-biologics-receives-mhra-uk-approval-for-yesintek-biosimilar 2025-05-26 07:08:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-pharma-solutions-ltd-conquers-complex-poc-project-through 2025-05-26 07:08:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/worlds-first-xellsmarts-allogeneic-ipsc-derived-regenerative 2025-05-26 07:06:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioplus-interphex-korea-2025 2025-05-23 00:29:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neogenomics-launches-c-met-cdx-assay-to-guide-treatment-decisions 2025-05-22 23:42:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-and-element-biosciences-expand-collaboration 2025-05-22 23:41:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bachem-expands-multi-site-production-capacities-to-meet-rising-demand 2025-05-22 06:20:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fourth-nda-for-kelun-biotechs-trop2-adc-sacituzumab-tirumotecan 2025-05-22 00:09:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrions-yuflyma-receives-fda-interchangeability-designation 2025-05-21 23:59:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-acquires-halo-labs 2025-05-21 23:56:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-and-boehringer-ingelheim-expand-joint-xseed-labs-incubator-in-the-us 2025-05-21 05:45:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idt-biologika-accelerates-global-growth-through-strategic-cdmo-partnership 2025-05-21 05:43:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-enters-into-a-global-clinical-collaboration-with-msd-to-evaluate-atg-022 2025-05-21 05:42:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minghui-pharmaceutical-announces-first-patient-dosed-in-the-phase 2025-05-21 05:41:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-enters-into-exclusive-licensing-agreement-with-3sbio 2025-05-20 00:43:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/basil-systems-launches-ai-powered-insights-tool-to-accelerate-pharma 2025-05-20 00:42:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-vaccines-next-gen-mrna-shingles-vaccine-secures-clinical-approvals 2025-05-20 00:40:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanced-announces-collaboration-with-hualong-biological 2025-05-20 00:39:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-obtains-first-regulatory-approval-in-japan-for-vabysmo-for-additional 2025-05-20 00:39:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brainstorm-receives-fda-clearance-to-initiate-phase-3b-trial-of-nurown 2025-05-20 00:37:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomarin-strengthens-enzyme-therapy-business-with-acquisition-of-inozyme 2025-05-17 00:05:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-solutions-and-newcl-forge-strategic-partnership-to-advance-genetic 2025-05-16 23:58:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmala-biotech-launches-phenesafe-ai-drug-discovery-platform 2025-05-16 00:21:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cansinobio-obtained-approval-for-clinical-trials-on-inhaled-tb-vaccine 2025-05-16 00:19:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aldevron-and-integrated-dna-technologies-manufacture-worlds 2025-05-16 00:15:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alamar-biosciences-expands-nulisaseq-cns-disease-120-panel 2025-05-16 00:13:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-provides-seven-years-of-orphan-drug-exclusive-approval-for-ryoncil 2025-05-15 00:31:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-partners-ubix-therapeutics-to-advance-transformative 2025-05-15 00:29:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty 2025-05-15 00:28:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-enters-into-an-agreement-with-terumo-on-leverkusen-dp-plant 2025-05-15 00:26:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-enters-into-definitive-agreement-for-the-divestiture 2025-05-13 00:31:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abtherx-and-spice-biotechnologies-announce-multi-program-antibody 2025-05-13 00:30:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-ltd-continues-to-invest-in-usa-90m-in-expansions 2025-05-13 00:29:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthego-introduces-gmp-spcas9-to-accelerate-gene-editing-for-therapeutic-advancement 2025-05-13 00:25:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trixeo-aerosphere-approved-in-the-uk-as-first-inhaled-respiratory-medicine 2025-05-13 00:24:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/engeneic-launches-groundbreaking-new-australian-trial-for-innovative 2025-05-13 00:22:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intrepid-labs-launches-to-transform-drug-formulation-with-ai 2025-05-13 00:21:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-and-genentech-announce-new-north-carolina-manufacturing-facility 2025-05-13 00:19:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novel-digital-labels-from-schreiner-medipharm-for-clinical-trials 2025-05-09 00:19:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-and-ginkgo-bioworks-revise-collaboration 2025-05-09 00:18:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zealand-pharma-announces-closing-of-collaboration-and-license-agreement 2025-05-09 00:15:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/colorcon-and-asha-cellulose-announce-new-partnership-to-support 2025-05-09 00:13:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgens-tepezza-teprotumumab-granted-marketing-authorisation 2025-05-08 01:04:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-followed-by-thp-significantly-improves-pathologic-complete 2025-05-08 01:02:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-upright-microscopes-for-enhanced-user-efficiency-and-comfort 2025-05-08 00:58:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-integrates-multi-angle-light-scattering-detectors-with-empower 2025-05-07 00:22:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-nmpa-full-approval-of-nefecon 2025-05-07 00:19:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formosa-pharmaceuticals-and-almac-discovery-announce-licensing 2025-05-07 00:17:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-prioritizes-continuity-and-action-in-its-sustainability-efforts 2025-05-06 07:53:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breakthrough-alzheimers-vaccine-duvax-secures-3-million-nih-grant 2025-05-06 00:12:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioivt-introduces-vivostart-cryopreserved-gmp-leukopaks 2025-05-06 00:11:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-partners-with-novelty-nobility-for-cell-line-development 2025-05-06 00:10:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-announces-significantly-improved-terms-for-collaboration 2025-05-06 00:09:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senores-pharmaceuticals-acquires-anda-for-topiramate-hcl-25-50-100 2025-05-05 06:55:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ichnos-glenmark-innovation-igi-receives-us-fda-fast-track-designation 2025-05-05 06:53:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ind-application-for-nts071-nutshell-therapeutics-p53-y220c 2025-05-05 06:51:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-filing-application-for-oral-semaglutide-25-mg-which-if-approved 2025-05-03 01:11:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bgm-group-announces-strategic-acquisition-of-hm-management 2025-05-03 01:04:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crown-bioscience-and-next-oncology-cement-partnership-extension 2025-05-02 00:49:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-to-submit-supplemental-biologics-license-application-sbla 2025-05-02 00:47:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocares-zurletrectinib-receives-priority-review-from-chinas-nmpa 2025-05-02 00:42:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rein-therapeutics-and-qureight-ltd-announce-planned-integration 2025-05-01 06:32:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symbiosis-completes-successful-mhra-audit-of-new-sterile-fillfinish 2025-05-01 01:25:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/licensing-agreed-for-optimer-as-novel-vaccine-adjuvant 2025-05-01 01:24:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/satsuma-pharmaceuticals-announces-us-fda-approval-for-atzumi 2025-05-01 01:23:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-announces-us-fda-clearance-of-ind-application 2025-05-01 01:20:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/se-bio-receives-koreas-first-approval-for-exosome-based-therapy 2025-05-01 01:18:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metabolon-launches-microbiome-research-solution-combining 2025-04-30 00:32:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-asimov-collaborate-on-next-generation-cell-line-design 2025-04-30 00:30:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roosterbio-announces-collaboration-with-thermo-fisher-scientific 2025-04-30 00:29:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-enters-global-collaboration-license-agreement-with-henlius 2025-04-30 00:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-new-drug-application-approval-of-velsipity 2025-04-30 00:20:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-secures-allowance-of-key-chinese-patent-application 2025-04-29 01:55:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telixs-illuccix-psma-pet-imaging-agent-approved-in-france 2025-04-29 01:53:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-leverages-integrated-solutions-to-accelerate 2025-04-29 01:51:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-members-in-eppendorfs-epmotion-family-4-channel-dispensing-tools 2025-04-29 01:34:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-us-biopharma-company-springworks-therapeutics 2025-04-28 07:02:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turbine-launches-the-worlds-first-virtual-lab-using-cell-simulations 2025-04-25 01:10:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syncell-launches-new-preferred-partner-network-expanding-commercial 2025-04-25 01:08:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isolere-bio-by-donaldson-passes-most-significant-milestone-to-date 2025-04-25 01:07:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/suvoda-and-greenphire-announce-completion-of-merger 2025-04-25 01:04:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-and-moebius-medical-announce-dual-publications-on-mm-iis 2025-04-25 01:03:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-invests-to-enhance-us-innovation-and-support 2025-04-25 00:57:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transforming-hospital-logistics-for-resilience-efficiency-and-innovation 2025-04-25 01:30:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioplus-interphex-korea-2025-uniting-visionaries-and-shaping 2025-04-25 00:23:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotte-biologics-begins-full-scale-operation-of-adc-manufacturing-facility 2025-04-24 00:24:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cn-bio-and-pharmaron-establish-long-term-strategic-partnership-to-develop 2025-04-24 00:23:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tempus-signs-expanded-strategic-agreements-with-astrazeneca-and-pathos 2025-04-24 00:22:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-completes-patient-enrollment-of-a-phase-ii-registration 2025-04-23 01:18:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-leverages-advanced-technology-to-expedite-oncology 2025-04-23 01:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-diosynth-biotechnologies-and-regeneron-sign-a-10-year-us 2025-04-23 01:10:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/docquity-and-astrazenecas-patient-support-program-educates-tens 2025-04-23 01:08:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-novel-adc-drug-skb518-has-been-granted-the-clearance 2025-04-22 00:45:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rona-therapeutics-announces-nmpa-approval-of-ind-application-for-rn1871 2025-04-22 00:44:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-completes-acquisition-of-chimerix 2025-04-22 00:43:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daan-biotherapeutics-and-gc-cell-sign-exclusive-technology 2025-04-21 04:52:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-completes-first-commercial-ppq-campaign-at-15000l 2025-04-18 23:35:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galmed-unveils-novel-pharmacodynamic-blood-markers-for-aramchol 2025-04-17 01:00:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-signs-high-volume-commercial-scale-copper-64-supply-agreement 2025-04-17 00:51:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanceds-end-to-end-cdmo-solutions-accelerates-ind-approval 2025-04-17 00:49:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-lecanemab-is-the-first-medicine-that-slows-progression 2025-04-16 00:47:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-the-acceptance-of-new-drug-application-for-pan-trk 2025-04-16 00:29:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xellsmarts-allogeneic-ipsc-derived-cell-therapies-for-parkinsons-disease 2025-04-16 00:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-interchangeable-designation-to-yuflyma-adalimumab-aaty 2025-04-15 00:35:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atmo-biosciences-strengthens-ip-portfolio-with-assignment-of-patents 2025-04-15 00:27:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-2025-concludes-with-record-breaking-attendance 2025-04-14 23:18:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pratia-in-partnership-with-essen-healthcare-is-bringing-clinical-trials 2025-04-14 23:13:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prism-biolab-and-elix-join-forces-to-accelerate-ai-driven-drug-discovery 2025-04-14 06:54:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dhl-supply-chain-strengthens-life-sciences-healthcare-infrastructure 2025-04-14 04:30:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-biologics-announces-us-fda-approval-for-jobevne-biosimilar 2025-04-10 23:42:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nona-biosciences-and-atossa-therapeutics-partner-to-discover-next-generation 2025-04-10 23:39:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/belief-biomed-and-takeda-china-jointly-announced-bbm-h901 2025-04-10 23:38:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-and-tulip-partner-to-drive-end-to-end-biomanufacturing 2025-04-10 00:52:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/worldwide-clinical-trials-adds-ai-driven-capability-for-patient-centric-enhanced 2025-04-10 00:51:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recursion-and-enamine-release-new-ai-enabled-targeted-compound-libraries 2025-04-09 06:55:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kalvista-pharmaceuticals-enters-into-licensing-agreement-with-kaken 2025-04-09 00:23:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kura-oncology-and-kyowa-kirin-announce-submission-of-new-drug 2025-04-09 00:21:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-receives-mfds-approval-for-worlds-first-recombinant 2025-04-09 00:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-nsg-bio-collaborate-to-strengthen-singapores 2025-04-09 00:18:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skycell-and-microsoft-announce-collaboration-to-bring-copilot-into-pharma 2025-04-08 00:28:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioduro-opens-new-rd-and-manufacturing-campuses-in-china-to-support 2025-04-08 00:24:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-strengthens-single-use-technology-network-adds-5000 2025-04-08 00:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-introduces-a-novel-class-of-drug-fexucluefexuprazan 2025-04-07 04:47:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/erbc-and-menarini-biotech-join-forces-to-accelerate-the-development 2025-04-05 00:27:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-announces-receipt-of-an-updated-non-binding-proposal 2025-04-04 01:15:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meitheal-pharmaceuticals-announces-approval-and-launch-of-liraglutide-injection 2025-04-04 01:13:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sai-life-sciences-sets-up-peptide-research-center-in-india 2025-04-03 04:40:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mycovia-pharmaceuticals-announces-partner-jiangsu-hengrui-pharmaceuticals 2025-04-03 01:07:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/productive-and-durable-protein-a-resins-bring-cost-efficiency-to-mab-capture 2025-04-03 01:04:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-announces-nmpa-approval-to-initiate-clinical-trial-of-novel-b7-h3 2025-04-03 01:02:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tci-biotech-expands-us-glass-bottling-capabilities 2025-04-03 01:01:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shin-etsu-chemical-to-actively-invest-in-pharmaceutical-cellulose-business 2025-04-02 00:18:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exclusive-licensing-agreement-with-link-healthcare-a-clinigen-company 2025-04-02 00:14:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-pfizers-rsv-vaccine-abrysvo 2025-04-02 00:11:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-launches-boruzu-first-ready-to-use-bortezomib-injection 2025-04-02 00:06:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-2025-opens-tomorrow-the-leading-laboratory-exhibition 2025-04-01 00:38:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/destiny-gastric05-phase-3-trial-of-enhertu-initiated-in-patients 2025-04-01 00:22:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharmas-rivastigmine-twice-weekly-transdermal-patch-approved 2025-04-01 00:07:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-exercised-the-option-for-the-global-rights-of-abbisko-therapeuticss 2025-04-01 00:05:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-radioligand-therapy-pluvicto-for-earlier 2025-03-28 23:57:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyonttra-acoramidis-the-first-near-complete-ttr-stabilizer-90 2025-03-28 00:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tivdak-tisotumab-vedotin-approved-by-japan-ministry-of-health-labour 2025-03-28 00:07:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrions-steqeyma-ustekinumab-stba-now-added-to-the-costco-member 2025-03-28 00:05:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-submits-supplemental-new-drug-application-for-ensitrelvir-in-japan 2025-03-27 00:45:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-and-dr-reddys-execute-exclusive-commercialization-agreement 2025-03-27 00:43:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-solutions-leads-the-way-in-cancer-early-detection-with-asias-first-clinical 2025-03-27 00:41:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nus-researchers-develop-microneedle-technology-to-accelerate-diabetic 2025-03-27 00:38:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-and-valo-health-identify-a-potential-therapeutic-for-lupus 2025-03-26 03:41:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xcellbio-announces-partnership-with-planet-innovation-to-develop 2025-03-26 00:06:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/complete-genomics-announces-partnership-with-bioturing-and-the-go-optical 2025-03-26 00:03:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sermonix-and-regor-announce-strategic-collaboration-to-optimize-regors 2025-03-25 00:30:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ractigens-rag-01-shows-promising-early-complete-responses-in-phase-i 2025-03-25 00:28:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alamar-biosciences-announces-the-launch-of-the-nulisaseq-mouse-panel-120 2025-03-25 00:27:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsks-omjjara-momelotinib-approved-in-singapore-as-the-first-treatment 2025-03-24 01:06:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-prostate-cancer-imaging-agent-gozellix 2025-03-21 00:20:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/registration-now-open-for-world-vaccine-congress-washington-2025 2025-03-21 03:47:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alamar-biosciences-announces-first-five-distribution-partners 2025-03-20 00:08:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanced-announces-collaboration-with-eureka-therapeutics 2025-03-20 00:07:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-partner-with-kyungpook-national-university-hospital-to-strengthen 2025-03-19 00:37:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bloomage-passes-gmp-audit-by-south-koreas-mfds-strengthening-its-global 2025-03-19 00:36:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipla-and-formosa-sign-multi-regional-licensing-deal-for-clobetasol-suspension 2025-03-19 00:34:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-hutchmed-jointly-announce-that-the-frusica-2-phase-23-study 2025-03-19 00:33:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chance-pharma-secures-new-funding-to-accelerate-development-of-innovative 2025-03-18 00:18:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rona-therapeutics-receives-ind-clearance-from-fda-to-initiate-phase-2 2025-03-18 00:15:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illuccix-approved-for-prostate-cancer-imaging-in-brazil-first-marketing 2025-03-18 00:14:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galux-unveils-a-study-in-ai-powered-de-novo-antibody-design-for-multiple 2025-03-18 00:13:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-to-acquire-esobiotec-to-advance-cell-therapy-ambition 2025-03-17 03:57:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioplus-interphex-korea-2025-pioneering-the-future-of-biopharma 2025-03-16 23:58:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-upgrades-its-4pl-model-enhancing-medicine-accessibility 2025-03-15 05:02:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polyrizon-signs-non-binding-loi-to-expand-its-innovative-intranasal 2025-03-15 04:56:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inovio-announces-promising-interim-results-from-ongoing 2025-03-14 00:54:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-adds-lead-212-isotope-production-capability 2025-03-13 01:46:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-cell-initiates-first-patient-dosing-in-phase-1-clinical-trial-for-gcc2005 2025-03-13 01:45:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliber-launches-analytics-and-ai-driven-solutions-to-revolutionize 2025-03-13 01:44:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/updates-on-influenza-vaccine-strain-recommended-by-who 2025-03-12 05:08:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gileads-capsid-revolution-meets-our-capsid-solutions 2025-03-12 04:40:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-boosts-pharmaceutical-storage-capacity-with-major-warehouse-expansion 2025-03-12 00:57:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptive-biotechnologies-launches-assay-enhancements-to-increase-clonoseq 2025-03-11 23:50:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-unveils-new-facility-to-increase-vaccine-production-capacity 2025-03-11 23:49:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sprim-global-investments-and-oneim-announce-joint-venture 2025-03-11 00:46:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-trop2-adc-sacituzumab-tirumotecan 2025-03-11 00:45:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-clearmind-collaboration-leads-to-publication-of-patent-application 2025-03-11 00:44:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/doer-biologics-completes-enrollment-of-the-phase-clinical-study-of-dr10624 2025-03-11 00:42:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-first-patient-dosed-with-evm16 2025-03-07 00:40:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genassist-ltd-announces-fda-clearance-new-drug-application-for-gen6050x 2025-03-07 00:35:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/india-and-belgium-unite-to-advance-rna-based-vaccines-mou-signed 2025-03-05 23:09:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-to-acquire-chimerix 2025-03-05 23:08:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indaptus-therapeutics-expands-patent-portfolio-in-china 2025-03-05 01:26:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-enhances-biopharmaceutical-contract-manufacturing 2025-03-05 01:24:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/raziel-and-fosun-pharma-initiate-phase-3-registration-trial-in-china 2025-03-05 01:22:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-first-patient-dosed-in-global-multicenter-phase-clinical-trial 2025-03-04 00:57:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avecho-and-sandoz-enter-exclusive-license-and-development-agreement 2025-03-04 00:55:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mastercontrol-acquires-qualer-to-transform-asset-management 2025-03-04 00:48:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ideaya-biosciences-announces-collaboration-with-attmos-to-accelerate 2025-03-03 07:00:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-dosed-in-the-first-pivotal-study 2025-03-03 06:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astar-and-mojiabio-to-develop-next-gen-sustainable-biomanufacturing 2025-02-28 23:48:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-secures-additional-paho-contract-to-supply-varicella-vaccines 2025-02-28 03:06:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-a-phase-iii-clinical-study-of-anti-her2-biparatopic-adc 2025-02-28 00:15:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-again-passed-gmp-inspection-by-japan-pmda 2025-02-28 00:13:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/a-southern-hemisphere-first-new-cutting-edge-radiotherapy-now-available 2025-02-28 00:11:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-assigns-japan-and-apac-ex-china-rights-to-cenerimod 2025-02-28 00:09:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilisium-signs-mou-with-iitm-pravartak-to-accelerate-life-sciences 2025-02-27 05:08:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/swissmedic-approves-csl-behrings-andembry-garadacimab 2025-02-27 00:28:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-licenses-rhb-102-for-commercialization-worldwide-excluding-north 2025-02-27 00:26:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazenecas-camizestrant-improves-progression-free-survival-in-first-line 2025-02-27 00:24:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kangpu-biopharmaceuticals-received-ind-approval-from-nmpa-for-kpg-818 2025-02-26 00:04:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgen-therapeutics-introduced-zhuhai-sb-xinchuang-to-accelerate-allogeneic 2025-02-26 00:03:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hbm-alpha-therapeutics-enters-strategic-collaboration-and-license-agreement 2025-02-26 00:02:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-announces-us-launch-of-pyzchiva-ustekinumab-ttwe 2025-02-25 00:26:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labconnect-and-australian-clinical-labs-specialised-trials-announce-strategic 2025-02-25 00:22:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-vaccines-mrna-shingles-vaccine-submits-clinical-application-to-the-us 2025-02-25 00:21:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-initiates-global-clinical-trials-of-mrna-japanese-encephalitis 2025-02-25 00:20:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioplus-interphex-korea-2025-the-ultimate-biopharma-innovation 2025-02-24 05:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-launches-biosimilar-pyzchiva-ustekinumab-ttwe-in-the-us 2025-02-24 01:53:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-receives-ec-approval-for-avtozma-ct-p47-a-biosimilar 2025-02-24 01:07:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-unveils-a-new-class-of-next-generation-sequencing-with-its-novel 2025-02-21 00:25:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-obtains-regulatory-approval-for-tecentriq-for-the-additional-indication 2025-02-21 00:24:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-partners-start-clinical-development-of-a-first-in-class 2025-02-21 00:22:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/informa-markets-unveils-whx-labs-dubai-marking-a-new-era-for-laboratory 2025-02-20 03:35:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nucala-mepolizumab-application-for-copd-accepted-for-review-in-china 2025-02-20 03:28:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parse-biosciences-launches-5-million-cell-evercode-wt-penta-kit-for-single-cell 2025-02-20 00:25:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hong-kong-to-host-landmark-international-symposium-on-genomic-medicine 2025-02-20 00:24:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brexogen-and-bmi-korea-enter-strategic-technology-transfer-agreement 2025-02-20 00:23:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sbti-verifies-genscript-biotech-corps-carbon-emission-reduction-goals 2025-02-19 00:31:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yemaachi-biotechnology-launches-the-african-cancer-atlas-in-partnership 2025-02-19 00:30:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocan-pharma-granted-first-patent-in-india-for-its-liposomal-cbd-injection 2025-02-19 00:29:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-expands-biosimilar-portfolio-in-the-european-union-following-european 2025-02-19 00:28:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nomination-period-opens-for-ihf-awards-and-i-to-i-innovation-hub-2025 2025-02-19 00:06:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cdmo-live-debuts-as-biopharma-manufacturing-sector-approaches-200-billion 2025-02-24 07:00:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taho-pharmaceuticals-reports-positive-results-from-pivotal-study 2025-02-18 00:08:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baltics-leading-pharmaceutical-company-grindeks-expands-to-new-export 2025-02-18 00:07:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rznomics-inc-liver-cancer-drug-candidate-secures-fast-track-designation 2025-02-18 00:05:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fosun-pharma-deeply-embraces-ai-self-developed-pharmaid-decision 2025-02-17 07:02:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-gains-european-commission-ec-approval-for-denosumab 2025-02-17 04:37:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-full-approval-of-decipheras-romvimza-vimseltinib 2025-02-17 01:36:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kexing-biopharm-obtained-ind-approval-for-its-self-developed-gb05 2025-02-17 01:30:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-announces-acceptance-of-new-drug-application-for-equecabtagene 2025-02-17 01:29:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-ind-acceptance-for-ak139 2025-02-14 03:24:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hanmi-pharmaceutical-introduces-new-automated-vial-dispensing-solution-in-canada 2025-02-14 03:23:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daan-biotherapeutics-signs-antibody-exclusive-licensing-agreement 2025-02-14 03:21:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trinetx-and-fujitsu-launch-joint-venture-to-increase-japanese-patients-access 2025-02-13 00:10:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncusp-therapeutics-receives-fda-fast-track-designation-for-cusp06 2025-02-13 00:09:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-vaccine-leverages-ai-to-advance-mrna-vaccine-development-mrna 2025-02-13 00:07:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-collaborates-with-who-to-strengthen-infectious-disease 2025-02-12 00:28:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyonttra-acoramidis-the-first-near-complete-ttr-stabilizer-90 2025-02-12 00:25:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-breast-cancer-therapy-to-reduce-risk-of-recurrence-and-improve 2025-02-12 00:24:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lion-tcrs-liocyx-m004-receives-fda-clearance-to-launch-global-multicenter 2025-02-12 00:21:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nls-pharmaceutics-and-kadimastem-unveil-multi-target-approach-to-diabetes 2025-02-11 00:48:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ena-respiratory-receives-us5m-investment-from-flu-lab-to-support 2025-02-11 00:46:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/olix-and-lilly-enter-global-licensing-agreement-for-mash-and-other 2025-02-11 00:44:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phc-and-ccrm-collaborate-to-develop-primary-t-cell-expansion 2025-02-11 00:43:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advancell-enters-into-strategic-collaboration-with-lilly-to-advance-novel 2025-02-11 00:42:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essential-pharma-and-clinigen-expand-collaboration-to-improve-patient-access 2025-02-07 00:21:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anti-her2-bispecific-adc-jskn003-received-approval-to-initiate 2025-02-07 00:19:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15 2025-02-07 00:17:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indegene-expands-footprint-in-europe-launches-new-entity-in-spain 2025-02-06 01:51:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lotus-pharmaceutical-becomes-strategic-partner-for-the-commercialization 2025-02-06 00:42:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/argent-biopharma-a-hidden-gem-traded-under-12m-edison-group-report 2025-02-06 00:38:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/actinogen-announces-new-and-unique-nonproprietary-name-of-emestedastat 2025-02-06 00:36:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/africa-and-europe-join-forces-to-revolutionize-rna-based-vaccines 2025-02-06 00:35:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bio-hdb-and-dndi-sign-mou-for-joint-development-of-xafty-based 2025-02-05 00:36:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-medical-university-and-healthcare-system-pioneers-ai-driven 2025-02-05 00:35:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trilink-biotechnologies-and-aldveron-enter-into-non-exclusive-license 2025-02-05 00:33:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eleva-and-3pbiovian-sign-strategic-gmp-manufacturing-and-technology 2025-02-05 00:31:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dd-pharmatech-completes-patient-enrollment-for-48-week-phase-2-trial 2025-02-04 01:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rsv-human-challenge-trial-contract-signed-with-new-client-inhalon-biopharma 2025-02-04 01:03:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tasso-and-arup-laboratories-announce-partnership-combined-offering 2025-02-04 00:59:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-completes-acquisition-of-biotheus 2025-02-03 06:46:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gv-research-platform-and-becytes-partner-to-enhance-access-to-certified 2025-02-03 06:44:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rystiggorozanolixizumab-for-generalized-myasthenia-gravis-gmg 2025-02-01 00:10:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiji-seika-pharma-receives-approval-for-adding-domestic-manufacturing 2025-02-01 00:08:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/datopotamab-deruxtecan-recommended-for-approval-in-the-eu-by-chmp 2025-02-01 00:06:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sarclisa-is-the-first-anti-cd38-treatment-approved-in-china-for-patients 2025-01-31 00:55:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cognizant-collaborates-with-medidata-to-provide-specialized-support-for-life-sciences-clients 2025-01-31 00:16:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-and-gsk-sign-collaboration-agreement-for-anti-dengue-virus-antibody 2025-01-31 00:14:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-celltrions-avtozma-tocilizumab-anoh-a-biosimilar 2025-01-31 00:12:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-completes-acquisition-of-next-generation-therapeutic-assets 2025-01-31 00:07:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vyluma-announces-acceptance-of-drug-application-for-nvk002-by-china 2025-01-30 00:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ose-immunotherapeutics-and-scienta-lab-establish-strategic-partnership 2025-01-30 00:34:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cpc-launches-industry-first-product-for-cell-and-gene-therapy-sterile-processing 2025-01-30 00:25:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fresenius-kabi-receives-fda-clearance-for-adaptive-nomogram 2025-01-29 01:48:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genialis-advances-biomarker-discovery-to-reduce-risk-in-cancer-drug 2025-01-29 01:46:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ryght-ai-and-crsa-partner-to-advance-cancer-trials-in-south-australia 2025-01-29 01:45:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inventia-life-science-launches-rastrum-allegro-to-revolutionize 2025-01-28 00:42:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thinkcyte-expands-product-portfolio-to-drive-innovation-in-drug-discovery 2025-01-28 00:40:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-completes-acquisition-of-rls-usa-inc 2025-01-28 00:39:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-announces-updated-data-from-phase-1b2-study-of-muzastotug 2025-01-27 07:09:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nippon-shinyaku-and-ab2-bio-enter-into-option-agreement-for-commercialization 2025-01-27 07:07:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-partners-with-steincares-to-market-sugemalimab-in-latin-america 2025-01-27 07:06:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veeva-and-zifo-partner-to-accelerate-quality-control-modernization 2025-01-24 01:00:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genethon-and-eukarys-announce-a-strategic-partnership-to-develop 2025-01-24 00:58:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-tagitanlimab-approved-for-second-line-npc-treatment 2025-01-24 00:58:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akkodis-acquires-raland-compliance-partners-and-expands-life-sciences 2025-01-24 00:54:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-and-sanofi-expand-partnership-to-target-the-domestic-market 2025-01-23 00:59:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellfe-announces-launch-of-first-in-class-t-rest-resting-t-cell-kit 2025-01-23 00:12:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kaist-develops-foundational-technology-to-revert-cancer-cells-to-normal-cells 2025-01-23 00:10:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-adm-unveils-a-new-paradigm-in-cancer-treatment-preclinical 2025-01-23 00:09:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-receives-grant-from-korean-government-to-develop-novel-antibody-based 2025-01-22 03:55:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biophytis-and-askhelpu-agreement-in-rare-neuromuscular-diseases 2025-01-22 00:50:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-establishes-smart-research-laboratory-in-san-diego 2025-01-22 00:45:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taho-pharmaceuticals-completes-pivotal-trial-of-tah3311-the-first-oral 2025-01-22 00:42:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lepu-biopharma-has-granted-arrivent-exclusive-license-for-mrg007 2025-01-22 00:40:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-quality-excellence-awards-2025 2025-01-21 01:20:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/5th-annual-pharma-gmp-and-quality-management-2025 2025-01-21 01:21:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-new-drug-material-compound-disclosure 2025-01-21 00:03:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgens-allogeneic-cd38-car-t-therapy-administers-first-dose 2025-01-20 23:58:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-and-keymed-jointly-announce-the-license-agreement-with-prolium 2025-01-20 23:57:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/golden-innovation-awards-digimedicine-marketing-innovation-summit-2025 2025-01-20 04:29:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tanvex-biopharma-completes-acquisition-of-bora-biologics-launching 2025-01-20 03:49:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-expands-jemperli-dostarlimab-plus-chemotherapy 2025-01-20 03:43:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gi-innovation-lanova-medicine-sign-mou-with-jpm-for-gi-102-adc-pancreatic 2025-01-19 23:50:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/datroway-approved-in-the-us-for-patients-with-previously-treated 2025-01-18 00:11:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-announces-toripalimabs-approval-in-australia 2025-01-18 00:07:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-sanofis-21-valent-pneumococcal-conjugate-vaccine 2025-01-17 03:41:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-and-google-cloud-expand-partnership-on-using-data-and-ai 2025-01-17 00:49:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senaparib-approved-by-nmpa-for-1l-maintenance-therapy-in-ovarian-cancer 2025-01-17 00:46:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-institute-launches-new-collaboration-with-daiichi-sankyo-in-cancer 2025-01-16 01:07:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyndra-therapeutics-announces-strategic-clinical-research-and-commercial 2025-01-16 01:05:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takara-bio-usa-holdings-inc-announces-the-acquisition-of-curio-bioscience 2025-01-16 01:04:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axcynsis-therapeutics-receives-fda-clearance-for-ind-application-of-at03-65 2025-01-15 04:07:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/touchlights-dbdna-manufacturing-facility-receives-world-first-gmp-license-from-mhra 2025-01-15 04:06:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aragen-secures-100-mn-investment-from-quadria-capital 2025-01-15 04:03:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-becomes-strategic-commercialization-partner-for-formycon 2025-01-15 04:01:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dxvx-presents-new-paradigm-for-next-generation-infectious-disease-response 2025-01-15 04:00:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sarclisa-obtains-first-approval-in-china-for-the-treatment-of-adult-patients 2025-01-13 01:45:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-to-acquire-next-generation-therapeutic-assets-and-innovative-biologic 2025-01-13 01:43:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gaelic-laboratories-announces-expansion-enabling-access-to-growing 2025-01-10 00:29:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ucb-partners-with-ailux-biologics-a-division-of-xtalpi-on-biologics-ai-platform 2025-01-10 00:26:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pandorum-partners-with-agc-biologics-to-support-clinical-manufacturing 2025-01-10 00:24:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientifics-olink-platform-selected-for-worlds-largest-human 2025-01-10 00:23:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biofidelity-and-cellcarta-partner-to-deploy-aspyre-lung-in-global-clinical-trials 2025-01-10 00:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alpha-cognition-announces-a-44-million-agreement-for-the-development 2025-01-09 00:36:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/araris-biotech-ag-announces-research-collaboration-and-option 2025-01-09 00:31:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dxvx-from-mrna-vaccines-to-nanoparticle-vaccines-era-of-next-generation 2025-01-09 00:29:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sutro-biopharma-and-boehringer-ingelheim-bioxcellence-collaboration 2025-01-08 07:39:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-and-acepodia-join-forces-to-advance-bispecific-antibody 2025-01-08 00:07:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quris-ais-bio-ai-platform-integrated-by-merck-kgaa-darmstadt-germany 2025-01-08 00:03:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alebund-pharmaceutical-announced-the-1st-closing-of-rmb-550-million 2025-01-08 00:01:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-received-positive-topline-results-from-two-phase-1-trials-of-ism5411 2025-01-08 00:00:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nus-researchers-boost-chemotherapy-uptake-in-breast-cancer-treatment 2025-01-07 00:54:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytomed-therapeutics-signs-business-research-collaboration-agreement 2025-01-07 00:51:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asieris-and-cdc-sign-investigational-product-supply-agreement 2025-01-07 00:46:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repligen-launches-the-ctech-solovpe-plus-system 2025-01-06 23:08:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-acquires-propan-from-adp-pharma-corporation-in-the-philippines 2025-01-06 23:04:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jcr-pharmaceuticals-and-modalis-therapeutics-announce-transition 2025-01-06 01:11:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/macsen-labs-group-commences-construction-of-new-api-manufacturing-facility 2025-01-06 01:08:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chime-biologics-and-mabgeek-achieve-mg-k10-ppq-milestone-advancing 2025-01-04 01:13:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nona-biosciences-announces-update-on-its-collaborator-dualitybios 2025-01-04 01:11:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-the-implementation-of-nefecon-national 2025-01-03 00:21:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tepoxx-tecovirimat-approved-in-japan-for-the-treatment-of-orthopoxviruses 2025-01-03 00:20:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmanovia-signs-in-licensing-deal-for-novel-osteoporosis-treatment 2025-01-02 06:03:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-announces-renewal-of-approval-by-israeli-medical-cannabis-agency 2025-01-02 00:37:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-micurxs-mrx-5-for-ntm-infections 2025-01-02 00:19:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-enters-into-exclusive-global-license-agreement-with-roche 2025-01-02 23:46:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dot-compliance-enhances-capabilities-to-transform-ai-powered 2024-12-31 00:07:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/radiopharm-announces-strategic-co-development-partnership-with-lantheus 2024-12-31 00:02:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huadong-medicine-co-and-synerk-reached-a-strategic-cooperation 2024-12-30 23:10:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microtech-announces-first-human-case-of-implantable-microsensor 2024-12-26 23:39:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ind-application-for-a-phase-iii-clinical-study-of-anti-her2-bispecific-adc 2024-12-26 23:38:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matwings-technology-raised-series-a-funding-of-tens-of-millions-usd 2024-12-26 00:07:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axcelead-ddp-enters-into-drug-discovery-service-agreement-with-astellas 2024-12-26 00:06:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-signs-definitive-agreement-to-sell-wuxi-advanced-therapies 2024-12-26 00:04:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujirebio-and-eisai-enter-into-memorandum-of-understanding-for-joint-research 2024-12-24 00:09:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent 2024-12-24 00:05:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-pharma-solutions-and-dragon-sail-pharmaceutical-form-strategic 2024-12-24 00:03:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptamer-developed-by-hkbu-for-treating-rare-bone-disease-x-linked 2024-12-23 04:27:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-enters-collaboration-with-glytech-to-expand-glycobi-enabling 2024-12-23 04:26:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-submission-of-clinical-trial-application-in-australia 2024-12-23 04:24:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytokinetics-announces-sanofi-acquired-rights-to-develop-and-commercialize 2024-12-21 00:40:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-receives-approval-of-dovbleron-taletrectinib-adipate-capsule 2024-12-21 00:38:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prenetics-im8-announces-collaboration-with-mayo-clinic-to-develop-new-line 2024-12-20 00:28:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bgm-group-and-jointown-deepen-cooperation-ushering-in-a-new-era 2024-12-20 00:26:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-sangamo-therapeutics-announce-agreement-for-neurological-diseases 2024-12-19 03:07:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-the-first-prescription-of-velsipity-in-the-greater 2024-12-19 00:40:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansoh-grants-msd-an-exclusive-global-license-rights-to-its-investigational 2024-12-19 00:39:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-expands-its-pipeline-with-a-novel-optimised-fap-targeted 2024-12-19 00:35:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juncell-therapeutics-opens-state-of-the-art-facility-for-til-production 2024-12-19 00:31:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scinai-immunotherapeutics-establishes-us-subsidiary-for-cdmo-business-unit 2024-12-18 01:04:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-acceptance-of-the-new-drug-application 2024-12-18 01:03:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-expands-partnership-with-steincares-in-latam 2024-12-17 00:10:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nona-biosciences-announces-discovery-collaboration-with-candid 2024-12-17 00:08:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-invests-dkk-85-billion-in-new-production-facility-in-odense 2024-12-16 01:40:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gileads-seladelpar-receives-positive-chmp-opinion-for-primary-biliary 2024-12-16 01:38:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nec-announces-interim-results-from-phase-1-clinical-trial-of-necvax-neo1 2024-12-13 01:10:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-receives-approval-for-global-clinical-trials-of-mrna-japanese 2024-12-13 00:36:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-pharma-solutions-and-aojin-life-sciences-announce-strategic 2024-12-13 00:34:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-expands-leadership-in-cll-at-ash-2024-with-new-data 2024-12-11 01:32:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-companion-diagnostic-assay-pd-l1-ihc-28-8-pharmdx-receives 2024-12-13 07:31:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nikon-and-elabnext-collaborate-to-integrate-the-nis-elements-imaging-platform 2024-12-10 01:12:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-receives-us-fda-approval-of-manufacturing-facility-in-indore-india 2024-12-10 01:07:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-ag-announces-kras-g12v-as-first-target-for-tcr-guided 2024-12-10 01:05:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nippon-shokubai-announces-shares-acquisition-of-lilac-pharmabecomes 2024-12-09 06:43:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/datopotamab-deruxtecan-demonstrated-meaningful-clinical-activity 2024-12-07 00:16:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-european-commission-approves-the-acquisition-of-catalent 2024-12-07 00:10:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-phase-iiib-data-shows-novartis-fabhalta-improved-hemoglobin-levels 2024-12-07 00:07:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-agreement-to-divest-teva-takeda-its-business-venture 2024-12-06 00:42:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-zhifei-revise-and-extend-strategic-vaccine-collaboration-in-china 2024-12-06 00:39:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-announces-update-to-national-comprehensive-cancer 2024-12-06 00:37:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alamar-biosciences-establishes-commercial-presence-in-apac-region 2024-12-06 00:32:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ep-dualfilter-tips-effective-protection-from-bio-aerosols 2024-12-05 23:34:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanz-pharma-acquires-the-rights-to-progynova-and-cyclo-progynova 2024-12-05 00:57:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/linaprazan-glurate-receives-marketing-approval-in-china 2024-12-05 00:56:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-lecanemab-approved-for-the-treatment-of-early-alzheimers 2024-12-05 00:54:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/treovir-and-matica-bio-forms-strategic-partnership-to-advance-innovative 2024-12-05 00:40:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/martin-pharmaceuticals-secures-exclusive-rights 2024-12-04 00:36:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyond-cancer-announces-approval 2024-12-04 00:35:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/duality-biologics-and-gsk-enter-exclusive-option-agreement 2024-12-04 00:33:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunshine-biopharma-announces-breakthrough-research-results 2024-12-03 00:36:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/olema-oncology-announces-new-clinical-trial-collaboration 2024-12-03 00:34:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ptc-therapeutics-collaboration-agreement-with-novartis 2024-12-03 00:32:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-and-novocure-announce-positive-topline-results-from-phase-panova-3 2024-12-03 00:30:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-se-and-datahow-ag-announce-strategic-collaboration 2024-12-02 23:17:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senkuteki-iyakuhin-pioneering-drug-designation-and-orphan-drug 2024-12-02 06:14:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mgi-tech-announces-partnership-with-universidad-de-san-martin-de-porres 2024-12-02 06:12:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zyme-biotech-and-valgenesis-partner 2024-11-29 23:50:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-launches-toripalimab-in-india-the-first-and-only-immuno-oncology 2024-11-29 03:13:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allink-biotherapeutics-raises-42m-series-a-financing-to-accelerate 2024-11-29 03:10:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-time-inclusion-of-sintbilo-and-new-indication 2024-11-28 00:16:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-announces-the-inclusion-of-augtyro-repotrectinib 2024-11-28 00:14:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kelun-biotechs-trop2-adc-sacituzumab-tirumotecan-sac-tmt-approved 2024-11-28 00:11:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/satsuma-pharmaceuticals-and-snbl-receive-fda-acceptance 2024-11-27 01:20:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maxscientific-enters-licensing-agreement-with-seragon-to-develop 2024-11-27 01:18:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-pharmaceuticals-announces-global-license-and-collaboration 2024-11-26 07:43:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monument-therapeutics-launches-first-clinical-study-of-mt1988 2024-11-26 05:17:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-and-novel-pharma-first-patient-dosed-in-global-phase 2024-11-26 00:37:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/duality-biologics-announces-expansion-of-adcendo-aps-collaboration 2024-11-26 00:35:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revir-therapeutics-and-kennedys-disease-association-partner-to-advance 2024-11-26 00:34:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arkbio-announces-successful-completion-of-enrollment-and-dosing-for-phase-1 2024-11-25 01:55:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/j-ints-bio-and-md-anderson-collaborate-on-the-development-of-brain-tumor-treatment 2024-11-25 01:54:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxxas-expands-global-intellectual-property-portfolio-for-exclusive-manufacture 2024-11-25 01:53:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-resubmits-dhe-autoinjector-new-drug-application-and-receives 2024-11-22 01:10:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-launch-by-takeda-of-fruzaqla-fruquintinib 2024-11-22 01:08:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-opens-new-center-for-bioprocess-innovation 2024-11-22 01:01:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/london-lab-live-2025-the-uks-premier-event-for-the-lab-community 2024-11-22 00:34:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularitys-strategic-partner-announces-groundbreaking-for-state-of-the-art 2024-11-21 01:03:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gbi-biomanufacturing-expands-capabilities-with-automated-aseptic-fill-finish 2024-11-21 01:01:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alloy-therapeutics-signs-collaboration-and-license-agreement-with-takeda 2024-11-21 00:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-digital-trust-centre-at-nanyang-technological-university-collaborate 2024-11-20 23:18:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-provides-update-on-sibeprenlimab-an-investigational-monoclonal 2024-11-20 01:58:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-biosciences-influenza-vaccine-skycellflu-receives-certification 2024-11-20 01:36:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-signs-manufacturing-deal-with-european-pharmaceutical 2024-11-20 01:15:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gigagen-doses-first-patient-in-phase-1-trial-of-recombinant-polyclonal-drug 2024-11-20 01:13:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-provides-update-on-izervayavacincaptad-pegol-intravitreal-solution 2024-11-20 01:12:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-nefecon-has-received-full-approval 2024-11-19 00:37:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosion-announces-exclusive-global-license-agreement-with-aclaris 2024-11-19 00:37:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-announces-a-new-drug-application-for-its-novel-bcl-2 2024-11-18 04:42:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trogenix-unveils-revolutionary-platform-to-transform-cancer-treatment-through 2024-11-18 04:41:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-receives-positive-chmp-opinion-for-opdivo-nivolumab 2024-11-16 00:49:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inflarx-receives-positive-chmp-opinion-for-gohibic-vilobelimab 2024-11-16 00:37:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-web-tool-for-easy-product-selection 2024-11-15 05:25:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-expands-rd-footprint-in-singapore-with-sgd42-million-investment 2024-11-15 01:11:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enlivex-announces-the-dosing-of-the-first-patient-in-a-phase-i-clinical-trial 2024-11-15 01:10:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-receives-positive-opinion-from-the-chmp-in-the-european-union 2024-11-15 01:08:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qps-launches-new-leukopak-and-cell-therapy-products-facility 2024-11-14 01:50:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-and-eckert-ziegler-to-partner-on-actinium-225-production-technology 2024-11-14 01:48:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mainz-biomed-and-thermo-fisher-scientific-sign-a-collaboration-agreement 2024-11-13 01:42:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enlivex-announces-the-enrollment-and-dosing-of-the-first-10-patient 2024-11-13 01:39:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-expands-for-2025-with-addition-of-new-hall 2024-11-12 01:53:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/can-fite-achieves-milestone-with-first-patient-dosing-in-pancreatic-cancer 2024-11-12 01:22:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ars-pharmaceuticals-announces-exclusive-agreement-with-global-allergy 2024-11-12 01:23:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-expand-bioconjugation-in-visp-ch-with-two-additional-manufacturing 2024-11-12 00:43:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genscript-biotech-sets-up-new-operations-and-logistics-hub-in-sydney 2024-11-11 06:31:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansoh-pharma-announces-positive-phase-1-clinical-trial-results 2024-11-11 06:29:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharmas-class-1-innovative-antidepressant-targeting-netdatgabaar 2024-11-11 06:26:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-submission-of-ind-application 2024-11-11 05:12:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-signs-mou-with-phase-to-advance-oncology-testing 2024-11-11 05:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbinger-health-announces-new-partnership-with-leading-cancer-center 2024-11-08 00:42:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avid-bioservices-to-be-acquired-by-gho-capital-partners-and-ampersand 2024-11-07 00:53:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioivt-llc-and-krishgen-biosystems-announce-exclusive 2024-11-07 00:51:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupixent-approved-in-the-eu-as-the-first-and-only-medicine-for-young-children 2024-11-06 01:14:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-collaborates-with-the-broad-institute-of-mit-and-harvard 2024-11-06 00:38:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/j-ints-bio-launches-ai-supercomputing-alliance-to-transform-cancer 2024-11-06 00:36:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/surrozen-and-tcgfb-inc-announce-strategic-research-collaboration 2024-11-05 01:34:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurobo-pharmaceuticals-completes-last-patient-last-visit-in-its-phase-2a 2024-11-05 01:32:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huidagene-therapeutics-receives-the-first-ever-fda-clearance 2024-11-05 01:31:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonzas-synaffix-collaborates-with-bighat-biosciences-on-the-development 2024-11-04 07:45:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lokon-pharma-announces-collaboration-to-combine-its-tme-gene 2024-11-04 06:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-semaglutide-demonstrates-superior-improvement 2024-11-02 03:39:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyell-immunopharma-completes-acquisition-of-immpact-bio 2024-11-01 00:50:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announces-first-patient-enrollment-in-phase-trial 2024-11-01 00:48:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/klockner-pentaplast-launches-kpnext-mdr1 2024-10-31 23:46:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atlatl-hong-kong-innovation-center-officially-opens-providing-one-stop 2024-10-30 01:05:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-invests-70-million-to-expand-adc-manufacturing-for-novel-cancer 2024-10-30 01:04:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-indonesia-recognized-as-the-best-places-to-work 2024-10-29 23:54:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardena-expands-bioanalytical-services-in-europe 2024-10-29 06:53:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-enters-agreement-to-acquire-cmg1a46-from-chimagen-biosciences 2024-10-29 06:51:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxxas-licenses-next-generation-vaccine-for-respiratory-syncytial-virus 2024-10-29 01:16:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-results-of-a-phase-2-study-of-picankibart 2024-10-29 01:15:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-announces-positive-clinical-data-for-rsv-vaccine-candidate-scb-1019 2024-10-29 01:12:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accelerate-antibody-capture-with-sartobind-rapid-a-lab-for-fast-flexible 2024-10-29 23:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/micurx-announces-the-successful-completion-of-phase-1-clinical-trial 2024-10-28 00:37:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corxel-and-lenz-therapeutics-announce-positive-topline-data-from-china 2024-10-28 00:36:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medera-announces-completion-of-cohort-a-and-initiation-of-dosing 2024-10-25 01:03:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epivax-and-cubrc-awarded-fda-contract-worth-2m-for-development 2024-10-25 01:02:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qurient-launches-clinical-trial-for-acute-myeloid-leukemia-treatment 2024-10-25 01:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliway-completed-cbl-514-phase-2b-study-cbl-0205-for-subcutaneous 2024-10-24 01:12:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/j-ints-bio-presents-interim-findings-from-phase-12-clinical-trial 2024-10-24 01:09:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/swri-celebrates-groundbreaking-of-new-21000-square-foot-clinical-supply 2024-10-24 01:06:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-receives-approval-of-quadrivalent-influenza-vaccine-in-indonesia 2024-10-23 00:54:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genelux-corporation-announces-first-patient-dosed-in-phase-2-trial-evaluating 2024-10-23 00:53:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/usp-acquires-stratix-labs-enhancing-its-microbiology-portfolio-with-innovative 2024-10-22 00:58:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-extends-collaboration-with-major-pharmaceutical-partner-for-integrated 2024-10-22 00:57:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujita-health-university-haneda-clinic-will-introduce-the-tumor-portrait 2024-10-22 00:56:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-ngs-based-companion-diagnostic-for-first-targeted-therapy 2024-10-22 00:54:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lanova-medicines-announces-initiation-of-phase-clinical-trial 2024-10-21 00:46:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-positive-chmp-opinion-for-kisqali-to-help-reduce-risk 2024-10-19 00:36:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/three-year-results-for-eylea-hd-aflibercept-injection-8-mg-demonstrate 2024-10-19 00:32:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/csl-vifor-and-travere-therapeutics-announce-swissmedic-approval 2024-10-18 01:00:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avacta-expands-its-pipeline-with-two-novel-assets-developed-using 2024-10-18 00:58:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ontada-collaborates-with-microsoft-to-transform-unstructured-oncology 2024-10-18 00:57:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-report-highlights-the-importance-of-a-strategic-roadmap-for-manufacturing 2024-10-17 03:05:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunbird-bio-raises-additional-14-million-to-advance-broadest-blood-based 2024-10-17 01:02:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-phase-2-clinical-study-of-picankibart-ibi112-in-chinese 2024-10-17 01:00:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ind-application-for-a-phase-clinical-study-of-kn026-combined 2024-10-17 00:57:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exscientia-achieves-milestones-for-two-programmes-in-sanofi-collaboration 2024-10-16 07:31:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lundbeck-to-acquire-longboard-pharmaceuticals-in-a-strategic-deal-significantly 2024-10-16 01:11:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-announces-toripalimab-obtained-approval-for-marketing 2024-10-16 00:56:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/urogen-announces-fda-acceptance-of-its-new-drug-application-for-ugn-102 2024-10-16 00:54:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardena-signs-agreement-to-expand-us-footprint-with-the-acquisition 2024-10-15 01:07:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-launches-high-concentration-formulation-platform 2024-10-15 01:06:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/positive-guidance-from-the-us-fda-on-64cu-sar-bispsma-phase-iii-trial 2024-10-15 01:02:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-announces-ongericimabs-nda-approval-in-china 2024-10-14 06:16:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-announces-positive-phase-iii-results-from-anchor-trials-for-depemokimab 2024-10-14 00:59:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ailux-biologics-enters-into-license-agreement-with-janssen-biotech 2024-10-11 00:53:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/keybioscience-announces-extension-of-strategic-collaboration-with-lilly 2024-10-11 00:49:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-can-fites-namodenoson-for-pancreatic 2024-10-10 01:47:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-unveils-innovative-drug-delivery-technologies 2024-10-10 01:45:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viatris-announces-positive-top-line-results-from-phase-3-study-of-effexor 2024-10-10 01:44:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-completes-acquisition-of-v-wave 2024-10-09 23:46:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-presents-positive-data-for-arexvy-its-respiratory-syncytial-virus-rsv-vaccine 2024-10-09 01:26:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pierre-fabre-scorpion-therapeutics-announce-new-phase-iii-clinical-trial 2024-10-09 01:08:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oragenics-inc-successfully-completes-key-fda-recognized-study-for-onp-002 2024-10-09 01:00:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-acquires-stake-in-us-biotech-fina-biosolutions 2024-10-08 04:54:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-aviadobio-announce-exclusive-option-and-license-agreement 2024-10-08 03:49:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medilink-announces-global-clinical-trial-collaboration-and-supply-agreement 2024-10-08 01:56:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-biopharmaceuticals-partner-eurofarma-submits-prioritized-nda 2024-10-08 01:49:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synexa-life-sciences-expands-bioanalysis-capabilities-with-the-acquisition 2024-10-08 01:48:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-strengthens-its-cardiovascular-pipeline-with-agreement 2024-10-07 04:33:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-supplemental-new-drug-application-submitted-in-japan 2024-10-05 01:12:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-expansion-of-global-collaboration-and-license-agreement 2024-10-05 01:08:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calquence-granted-priority-review-in-the-us-for-patients-with-untreated-mantle 2024-10-04 00:54:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ferring-bolsters-global-gene-therapy-supply-chain-with-european-manufacturing 2024-10-04 00:50:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-phase-ii-ca-nine-trial-of-tlx250-cdx-for-detection 2024-10-04 00:47:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-announces-new-45-billion-site-the-lilly-medicine-foundry 2024-10-03 01:32:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-and-philogen-enter-into-a-global-exclusive-commercialization 2024-10-03 01:29:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-the-first-and-only-generic-version-of-sandostatin 2024-10-03 01:21:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crown-bioscience-expands-singapore-facility-to-offer-advanced-tumor-models 2024-10-03 01:17:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curium-announces-strategic-partnership-with-peptidream-for-prostate-cancer 2024-10-01 06:34:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-co2-incubator-shaker-on-the-market-with-integrated-180-0c-sterilization-routine 2024-10-01 01:05:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/doer-biologics-announces-first-patient-dosed-in-phase-2-study-of-dr10624 2024-10-01 00:48:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-opens-its-first-innovation-hub-in-korea 2024-10-01 00:47:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ucb-announces-a-head-to-head-study-evaluating-bimzelxbimekizumab 2024-09-30 01:58:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alphamab-oncology-and-cspc-achieved-a-licensing-agreement 2024-09-30 01:55:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-cadonilimab-receives-second-indication-approval-from-nmpa 2024-09-30 01:52:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-partners-with-ncd-alliance-to-target-non-communicable 2024-09-30 03:05:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-submits-biologics-license-application-to-the-fda-for-telisotuzumab 2024-09-30 01:44:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ab-science-today-provides-an-update-on-the-microtubule-program-ab8939 2024-09-27 01:36:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arkbio-announces-publication-of-phase-3-clinical-trial-results-of-ziresovir 2024-09-27 01:29:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-oral-solid-dose-development-and-manufacturing 2024-09-27 01:28:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/outstanding-exhibitor-and-visitor-participation-synergistic-co-located-exhibitions 2024-09-26 04:46:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-launches-development-platforms-for-enhanced-therapeutic 2024-09-26 01:38:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/resync-bio-launches-to-automate-data-and-operations-in-drug-discovery 2024-09-26 01:35:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intrabio-announces-us-fda-approval-of-aqneursa-for-the-treatment 2024-09-26 01:33:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wheeler-bio-licenses-atums-mifuc-technology-to-expand-their-portable 2024-09-25 01:14:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-receives-approval-of-quviviq-daridorexant-25-and-50-mg 2024-09-25 01:12:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-receives-approval-for-fruzaqla-fruquintinib-in-japan 2024-09-25 01:04:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ten23-health-hosts-grand-opening-of-its-state-of-the-art-viva2-sterile-manufacturing 2024-09-24 03:31:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ten23-health-achieves-its-certification-a-b-corporation-recognizing-commitment 2024-09-24 03:23:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anticancer-agent-tasfygo-tablets-35mg-tasurgratinib-succinate-approved 2024-09-24 01:42:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuance-pharma-announces-expansion-bentrio-license-distribution-agreement 2024-09-24 01:37:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioatla-and-context-therapeutics-announce-exclusive-worldwide-license-agreement 2024-09-24 01:35:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-pharmaceutical-completes-acquisition-of-jnana-therapeutics-inc 2024-09-24 01:30:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-to-acquire-rls-to-expand-north-american-manufacturing-and-distribution 2024-09-23 00:35:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/henlius-receives-positive-chmp-opinion-for-hansizhuang-as-first-line-treatment 2024-09-21 04:22:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupixent-dupilumab-recommended-for-eu-approval-by-the-chmp 2024-09-21 01:02:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cd-suzhou-biopharma-announces-fda-clearance-for-phase-i-clinical-trial 2024-09-21 00:55:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-approval-of-clinical-trial-of-bcl2-inhibitor-icp-248 2024-09-20 23:41:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lifecore-biomedical-announces-high-speed-multi-purpose-5-head-isolator 2024-09-20 01:03:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-fast-track-designation-for-narmafotinib-in-advanced-pancreatic-cancer 2024-09-20 01:01:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galmed-announces-expansion-its-activities-cancer-major-cardiometabolic 2024-09-20 00:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/positive-phase-iii-results-show-xofluza-significantly-reduces-the-transmission-of-influenza-viruses 2024-09-20 00:55:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axcelead-ddp-and-lilly-enter-into-research-and-collaboration-agreement 2024-09-19 00:56:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-reports-positive-phase-iia-results-for-ism001-055 2024-09-19 00:55:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strides-receives-usfda-approval-for-fluoxetine-tabs-60-mg-expanding-the-products 2024-09-18 04:15:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sysmex-applies-for-manufacturing-and-marketing-approval-of-an-assay-kit 2024-09-18 03:12:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-kisqali-to-reduce-risk-of-recurrence-in-people 2024-09-18 03:05:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vectura-fertin-pharma-subsidiary-philip-morris-international-announces-agreement 2024-09-18 01:58:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metabolon-expands-integrated-bioinformatics-platform-to-include-advanced 2024-09-18 01:55:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-serialization-partnership-launched-by-advanco-and-arvato-systems 2024-09-17 06:36:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coya-therapeutics-announces-subcutaneously-administered-coya-302-elicits-direct-anti-inflammatory 2024-09-17 06:28:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rigaku-develops-new-electron-density-topology-technique-to-reveal-properties-of-biological 2024-09-17 06:25:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-presents-updated-phase-2-data-for-zanidatamab-demonstrating-increased 2024-09-17 06:23:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cumming-global-centre-for-pandemic-therapeutics-and-university-of-bonn-announce-partnership 2024-09-17 03:36:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-provides-update-on-contact-02-phase-iii-trial-in-metastatic-castration-resistant 2024-09-16 04:19:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizers-braftovi-mektovi-shows-long-term-clinically-meaningful 2024-09-16 04:11:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/japans-ministry-of-health-labor-and-welfare-approves-csl-and-arcturus 2024-09-16 03:52:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ntu-singapore-and-oxford-study-discover-new-process-for-cells-to-repair 2024-09-13 01:01:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turbine-achieves-key-milestone-in-collaboration-with-ono-pharmaceutical 2024-09-13 00:59:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-and-bristol-myers-squibb-kk-submit-supplemental-application-of-opdivo 2024-09-13 00:57:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-and-biogeometry-deepen-strategic-cooperation 2024-09-12 03:16:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-delivers-oral-presentation-on-phase-1-clinical-data-of-ibi363 2024-09-12 03:05:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bioscience-announces-xafty-a-groundbreaking-broad-spectrum 2024-09-12 01:41:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-cell-and-pt-bifarma-adiluhung-sign-a-licensing-agreement-for-immuncell-lc 2024-09-12 01:39:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carisma-and-moderna-expand-collaboration-to-develop-two-in-vivo-car-m-therapies 2024-09-11 01:08:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-designation 2024-09-11 01:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuance-pharma-completes-recruitment-for-enhance-china-the-phase-3-clinical 2024-09-11 00:59:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aft-adds-combogesic-tablets-to-hikma-agreement-in-us 2024-09-10 01:19:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seegene-expands-mpox-ruo-product-lineups-with-enhanced-detection-assays 2024-09-10 01:16:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-delivers-oral-presentation-of-updated-results-from-a-pivotal-phase-2 2024-09-10 01:04:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/next-generation-tff-cassette-vivaflow-su 2024-09-11 03:21:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rybrevant-plus-lazcluze-show-strong-favorable-overall-survival-trend-lung-cancer 2024-09-09 01:30:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-and-moebius-medical-announce-fast-track-designation-granted 2024-09-06 06:44:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rigel-announces-first-patient-enrolled-in-phase-1b2-triplet-therapy-trial 2024-09-06 01:16:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-unveils-new-life-sciences-center-in-cambridge-massachusetts 2024-09-06 01:09:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/6th-annual-pharma-manufacturing-automation-convention-2024 2024-09-06 00:33:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-manufacturing-automation-excellence-awards-2024 2024-09-06 00:32:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenity-biosciences-receives-regulatory-approval-for-collagen-dental-membrane 2024-09-05 01:31:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arsenalbio-announces-325-million-financing-to-advance-programmable-cell-therapy 2024-09-05 01:29:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rigel-expands-relationship-with-kissei-to-include-rezlidhia-olutasidenib 2024-09-04 03:19:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-hanmi-pharmaceutical-receives-clearance-phase-12-clinical-trial-the-us-fda 2024-09-04 03:24:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theolytics-awarded-significant-2m-transforming-cancer-therapeutics-grant 2024-09-03 01:10:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taiwan-food-drug-administration-approves-modernas-covid-19-mrna-vaccine 2024-09-03 01:13:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grit-biotechnology-receives-us-fda-clearance-of-investigational-new-drug-application 2024-09-02 04:53:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-to-receive-us35-million-from-neurocrine-biosciences-upon 2024-09-02 05:15:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-successfully-completes-first-scale-up-of-high-productivity-bioprocessing 2024-09-02 02:01:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-provides-update-on-fruquintinib-for-second-line-gastric-cancer 2024-08-31 01:09:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cancervax-flashpoint-therapeutics-nanotechnology-platform-universal-cancer-treatment 2024-08-31 01:04:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pierre-fabre-laboratories-receives-european-commission-approval-for-braftovi 2024-08-31 01:01:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-notes-positive-phase-2-data-for-partnered-schizophrenia-candidate-nbi-1117568 2024-08-30 02:01:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-starts-phase-iii-trial-in-non-small-cell-lung-cancer-nsclc 2024-08-30 01:08:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bioscience-to-conduct-phase-3-clinical-trial-for-high-risk-group-of-covid-19 2024-08-29 01:36:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-initiates-phase-3-clinical-study-of-fezolinetant-for-vms-in-women 2024-08-29 01:32:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/unique-international-collaboration-brings-breakthrough-oral-cholera-vaccine 2024-08-28 07:49:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-submits-nda-for-tlx101-cdx-pixclara-brain-cancer-imaging-agent 2024-08-28 01:28:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-celltrions-steqeyma-ct-p43-a-biosimilar-stelara 2024-08-28 01:27:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-receives-european-commission-approval-for-rsv-vaccine-mresviar 2024-08-27 07:36:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ucb-to-accelerate-innovation-and-strategic-partnerships-divesting-mature-product-portfolio 2024-08-27 01:17:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-announces-cde-approval-novel-nectin-targeting-initiate-phase-iii-clinical 2024-08-26 01:31:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iviva-biopharma-completes-enrollment-phase-1-clinical-trial-of-aiv007-age-related 2024-08-26 01:33:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-receive-us-fda-approval-authorization-for-omicron-kp 2024-08-23 01:27:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-initiation-investigator-initiated-clinical-cancer-vaccine-evm16 2024-08-22 01:31:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunesensor-therapeutics-receives-clearance-from-australian-regulators 2024-08-22 01:29:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/responding-to-mpox-global-outbreak-research-innovations-and-therapeutic-strategies 2024-08-21 03:46:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/west-pharmaceutical-services-expands-capabilities-in-asia 2024-08-21 01:56:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/life-molecular-imaging-and-pharmalogic-announce-neuraceq-availability 2024-08-21 01:02:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/st-pharm-and-quantoom-biosciences-announce-supply-agreement-smartcap-collaboration 2024-08-21 01:00:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgen-announces-enrollment-completion-in-china-gcgej-pivotal-phase-ii-clinical 2024-08-20 01:45:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-announces-enrollment-of-the-first-five-patients-in-the-clinical-trial-innovative 2024-08-20 01:42:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunoprecise-antibodies-successfully-engineers-in-silico-antibodies-to-elusive-tumor 2024-08-20 01:41:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-granted-breakthrough-therapy-designation-in-us 2024-08-19 06:32:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/noxopharm-targets-clinical-trial-for-first-in-class-drug 2024-08-19 06:25:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bitt-announced-cd40-otsuka-research-and-exclusivity-agreement 2024-08-16 23:59:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-finalizes-exclusive-global-out-licensing-agreemen-pain-therapy-at-3-million 2024-08-16 23:57:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-receives-the-iata-smart-facility-operational-capacity-certification-for-its-smartist-facility-at-istanbul-airport 2024-08-16 03:30:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ivonescimab-received-priority-chinas-nmpa-first-line-treatment-pd-l1-positive-nsclc 2024-08-16 03:13:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanoform-collaborates-with-takeda-their-plasma-derived-therapy-development 2024-08-16 03:10:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vimgreen-completes-enrollment-of-its-phase-2-clinical-trial-evaluating-vg081821ac 2024-08-16 03:16:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-receives-biopharma-innovation-of-the-year-award-2024 2024-08-16 02:01:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-precision-health-and-click-therapeutics-announce-launch-rejoyn-digital-therapeutic 2024-08-14 01:48:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teknova-introduces-proprietary-express-production-service-expanded-manufacturing 2024-08-14 01:26:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosyngens-brg01-receives-fda-approval-for-phase-ii-clinical-trial 2024-08-13 01:14:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/registrational-phase-iii-study-of-lisaftoclax-in-newly-diagnosed-patients 2024-08-13 01:13:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biochina-2025-chinas-largest-bio-convention 2024-08-12 23:51:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-acquire-investigational-b-cell-depletion-therapy-cn201curon-biopharmaceutical 2024-08-12 06:10:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c-paths-trxa-announces-250000-award-for-drug-development-project-in-als 2024-08-09 01:03:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/efficient-bridge-between-manual-and-automated-pipetting 2024-08-08 05:38:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kyowa-kirin-international-and-newbridge-pharmaceuticals-enter-into-agreement 2024-08-08 00:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parse-biosciences-partners-with-taiwan-based-prisma-biotech-to-extend-reach-in-asia 2024-08-08 00:48:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senhwa-biosciences-receives-us-fda-study-may-proceed-letter-for-the-phase 2024-08-07 03:25:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santen-and-cloudbreak-execute-a-new-licensing-agreement-for-cbt-001 2024-08-07 03:23:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-joins-the-pharmaceutical-supply-chain-initiative-as-supplier-partner 2024-08-07 03:20:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-hope-for-prostate-cancer-new-form-of-immunotherapy 2024-08-06 03:24:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-enrolled-in-the-us-phase-combination-therapy 2024-08-06 03:23:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obio-technology-congratulates-on-the-first-clinical-gene-editing 2024-08-06 03:22:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunovias-next-generation-test-to-be-included-in-large-study-of-pancreatic-cysts-funded-by-the-us-national-institutes-of-health 2024-08-05 07:10:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-receives-approval-from-us-fda-for-prednisolone-acetate-ophthalmic-suspension-usp 2024-08-05 07:06:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asymchem-inaugurates-its-first-european-small-molecule-development-and-api-pilot-plant-manufacturing-site-at-discovery-park-in-sandwich-kent-uk 2024-08-03 01:33:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/american-society-for-transplantation-and-cellular-therapy-applauds-fda-approval-of-tecelrar-for-synovial-sarcoma-treatment 2024-08-03 01:30:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-achei-alpha-1062-for-alzheimers-disease-treatment 2024-08-02 05:26:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepted-pd-l1-inhibitor-durvalumab-for-endometrial-cancer 2024-08-02 05:19:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurexone-announces-the-transfer-of-manufacturing-of-the-active-element-in-exopten-drug-to-a-commercial-gmp-manufacturer 2024-08-02 03:37:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/instil-bio-and-immuneonco-announce-license-and-collaboration-for-imm2510-and-imm27m-antibodies 2024-08-02 03:31:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitachi-high-tech-acquires-majority-interest-in-nabsys 2024-08-02 03:23:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-alecensa-approved-in-taiwan-as-an-adjuvant-treatment-for-early-stage-alk-positive-non-small-cell-lung-cancer-nsclc 2024-08-02 03:21:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boston-oncology-and-king-fahd-medical-city-kfmc-partner-to-advance-localized-cell-and-gene-therapies-in-saudi-arabia 2024-08-01 03:06:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-in-licenses-pi3k-inhibitor-inavolisib-for-breast-cancer-with-a-pik3ca-mutation 2024-08-01 01:58:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicilon-and-hengrui-pharma-deepen-strategic-collaboration-to-support-innovation-in-adcs-small-nucleic-acids-and-cgt-drugs 2024-08-01 01:47:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-advances-bioprocess-monitoring-and-analysis-with-the-launch 2024-07-31 07:28:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-singapore-clinical-research-institute-scri-launches-comprehensive-clinical-trials-portal 2024-07-31 03:10:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supercharging-queenslands-drug-discovery-pipeline 2024-07-31 01:49:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanced-and-geneseed-biotech-enter-into-strategic-collaboration-to-focus-on-advancing-circrna-innovative-therapeutics 2024-07-31 01:46:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/csafe-launches-reusable-silverpod-pallet-shipper-to-help-pharma-companies-save-on-disposal-costs-and-hit-sustainability-targets 2024-07-30 01:34:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-completion-of-enrollment-in-the-phase-2a-clinical-study-of-bbt-877-for-the-treatment-of-idiopathic-pulmonary-fibrosis 2024-07-30 01:32:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-receives-positive-recommendation-from-idmc-to-continue-developing-its-first-in-class-prs-inhibitor-bersiporocin 2024-07-30 01:31:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/almac-announces-investment-in-singapore-to-enhance-cold-chain-facility-for-global-pharmaceutical-sponsors-and-patients 2024-07-29 23:51:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/update-on-regulatory-review-of-lecanemab-for-early-alzheimers-disease-in-the-european-union 2024-07-29 07:01:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-european-commission-approval-of-sugemalimab-cejemly-as-first-line-treatment-for-non-small-cell-lung-cancer 2024-07-29 06:54:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obviohealth-announces-strategic-investment-by-guardant-health-to-accelerate-deployment-of-oncology-clinical-trials-globally 2024-07-26 01:39:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-wecomput-announce-strategic-partnership-to-advance-ai-driven-drug-discovery-and-development 2024-07-26 01:32:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-initiates-integrated-phase-i-phase-iii-clinical-trial-for-bat3306-a-proposed-biosimilar-of-keytruda-pembrolizumab 2024-07-26 01:29:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breakthrough-in-gene-therapy-brings-new-hope-to-glaucoma-patients 2024-07-25 23:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autobahn-therapeutics-completes-oversubscribed-100-million-series-c-financing-to-advance-pipeline-of-novel-therapeutics-for-depression-and-other-cns-disorders 2024-07-25 01:50:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/covid-is-here-to-stay-and-nv-387-is-a-much-needed-drug-against-it-reminds-nanoviricides 2024-07-25 01:43:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-announces-regulatory-filing-acceptance-for-bat2206-a-proposed-biosimilar-to-stelara-in-the-us-and-eu 2024-07-25 01:41:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-receives-us-fda-approval-of-investigational-new-drug-application-for-equecabtagene-autoleucel-for-multiple-sclerosis 2024-07-24 01:51:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/waters-new-rapid-screening-dsc-enables-up-to-24x-faster-thermal-stability-testing-at-ultra-low-sample-volumes-for-antibody-drugs 2024-07-24 01:42:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/triastek-announces-research-collaboration-and-platform-technology-license-agreement-with-biontech-to-advance-3d-printed-oral-rna-therapeutics 2024-07-24 01:38:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-cell-and-lukas-announce-strategic-cooperation-agreement-to-jointly-tap-into-the-innovative-cell-therapy-including-and-beyond-korean-and-taiwanese-market 2024-07-23 01:30:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qdx-announces-collaboration-with-prelude-therapeutics-on-novel-oncology-programs 2024-07-23 01:25:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-graduate-school-of-medicine-faculty-of-medicine-osaka-university-enter-into-research-collaboration-to-develop-pluripotent-stem-cell-derived-cartilage-organoid-cell-therapy 2024-07-22 06:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biophytis-deploys-its-partnership-strategy-and-signs-two-contracts-with-local-agents-in-asia 2024-07-22 06:39:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-first-phase-3-evidence-of-efficacy-and-safety-of-an-anti-cgrp-monoclonal-antibody-in-children-in-ajovy-fremanezumab-space-trial-for-prevention-of-episodic-migraine 2024-07-20 03:14:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizers-first-dual-indication-vaccine-for-respiratory-syncytial-virus-rsv-is-available-this-month-in-hong-kong 2024-07-19 03:51:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-goodrx-announce-exclusive-patient-affordability-initiative-for-adalimumab-adbm-injection-boehringers-biosimilar-to-humira 2024-07-19 03:47:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinus-pharmaceuticals-announces-ganaxolone-approved-in-china-as-first-treatment-for-seizures-associated-with-cdkl5-deficiency-disorder 2024-07-19 03:40:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nika-pharmaceuticals-inc-nika-signed-a-distribution-agreement-for-nigeria 2024-07-19 03:25:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-2025-set-to-be-the-biggest-yet-with-85-of-exhibition-halls-sold-out 2024-07-19 01:41:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renalys-pharma-announces-first-patient-dosed-in-registrational-phase-iii-clinical-trial-of-sparsentan-for-iga-nephropathy-in-japan 2024-07-18 03:47:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immutep-receives-regulatory-clearance-for-phase-i-study-of-first-in-class-lag-3-agonist-antibody-designed-to-treat-autoimmune-diseases 2024-07-18 03:48:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anixa-biosciences-announces-japanese-patent-on-breast-cancer-vaccine-technology 2024-07-18 03:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renalys-pharma-closes-60bn-series-a-financing-to-advance-kidney-disease-treatments-across-asia 2024-07-17 01:46:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanyou-bio-collaborates-on-adc-drug-development-entering-phase-i-clinical-trials 2024-07-17 01:42:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosyngens-brg01-enters-phase-ii-clinical-trial-a-first-in-kind-autologous-ebv-specific-car-t-therapy-for-solid-tumors-on-recurrentmetastatic-nasopharyngeal-carcinoma 2024-07-17 01:40:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acquisition-of-amolyt-pharma-completed 2024-07-16 03:10:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diakonos-oncology-receives-fda-fast-track-designation-for-pancreatic-cancer-dendritic-cell-vaccine-names-daniel-d-von-hoff-md-to-scientific-advisory-board 2024-07-16 01:55:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-type-1-diabetes-patient-enrolled-in-rise-therapeutics-latest-clinical-trial 2024-07-16 01:49:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-to-9mw2821-for-the-treatment-of-patients-with-locally-advanced-or-metastatic-nectin-4-positive-tnbc 2024-07-16 01:47:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/patent-rights-jointly-owned-by-the-national-cancer-center-and-the-university-of-pennsylvania-licensed-to-arc-therapies-inc 2024-07-12 01:21:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-phase-i-clinical-trial-of-yolt-201 2024-07-12 01:19:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mekanistic-therapeutics-incs-first-in-class-dual-egfr-and-pi3k-investigational-therapy-mtx-531-demonstrates-significant-tolerability-and-durable-tumor-regressions 2024-07-12 01:17:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approved-pde4-inhibitor-roflumilast-for-atopic-dermatitis 2024-07-11 05:44:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indegene-announces-strategic-collaboration-with-microsoft-to-help-life-sciences-companies-scale-up-generative-ai-adoption-and-accelerate-business-impact 2024-07-11 03:16:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athira-pharma-announces-last-patient-completed-lift-ad-clinical-trial-of-fosgonimeton-in-mild-to-moderate-alzheimers-disease 2024-07-11 03:09:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monopar-announces-first-patient-enrolled-in-first-in-human-phase-1-trial-for-its-novel-radiopharmaceutical-mnpr-101-zr 2024-07-11 01:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-to-acquire-chemaxon-to-strengthen-drug-discovery-software-portfolio 2024-07-11 01:55:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gearing-up-for-the-2nd-annual-pharma-impurities-conclave-2024 2024-07-11 01:45:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cracking-the-code-of-cleaning-validation-with-4th-annual-cleaning-validation-2024-a-practical-approach 2024-07-11 01:40:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-to-perform-plasmid-manufacturing-for-aavantgarde 2024-07-09 01:30:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/olverembatinib-approved-for-commercialization-in-macau-china 2024-07-09 01:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-mitsubishi-tanabe-pharma-corporation-enter-joint-agreement-to-promote-modernas-mrna-respiratory-vaccine-portfolio-in-japan-including-covid-19-vaccines 2024-07-09 01:24:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-j-star-and-enabling-technologies-consortium-collaboration-on-co-processing-platform-technology-development 2024-07-09 01:21:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recycled-materials-as-the-next-step-towards-increased-sustainability 2024-07-08 06:09:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xpovio-selinexor-approved-for-new-indication-in-dlbcl-in-china-bringing-a-new-treatment-option-to-patients-in-the-country 2024-07-06 00:58:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zhiyi-biotech-successfully-completes-phase-i-clinical-trial-of-sk10-for-the-treatment-of-chemotherapy-induced-diarrhea 2024-07-06 00:55:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/launch-of-phase-3-clinical-trial-with-nefecon-in-japan 2024-07-05 05:43:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zhejiang-doer-biologics-completes-enrollment-of-the-phase-1b2a-trial-evaluating-dr10624-in-obese-subjects-with-modest-hypertriglyceridemia 2024-07-05 05:33:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/going-global-chime-biologics-embraces-innovation-and-quality-with-partners 2024-07-05 05:32:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-received-us100-million-option-payment-from-takeda 2024-07-04 01:34:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-ag-expands-patent-portfolio-with-the-patent-grant-for-its-ny-eso-1lage-1a-targeted-t-cell-receptor-in-china 2024-07-04 01:30:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scinai-immunotherapeutics-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements 2024-07-04 01:27:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-expands-collaboration-and-license-agreement-for-development-of-cabometyx-in-advanced-neuroendocrine-tumors-based-on-positive-results-from-phase-iii-cabinet-trial 2024-07-03 06:09:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medsenic-biosenics-subsidiary-signed-a-new-set-of-licensing-and-commercialization-agreements-with-phebra-pty-ltd 2024-07-03 05:33:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-award-for-young-european-investigators-2024-goes-to-clemens-plaschka 2024-07-03 01:00:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/from-biotree-to-zeta-biosystem 2024-07-02 05:02:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altos-biologics-files-for-approval-of-aflibercept-biosimilar 2024-07-02 04:04:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/improvement-in-patient-with-decompensated-liver-cirrhosis-upon-treatment-with-namodenoson 2024-07-02 04:02:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anbogen-therapeutics-announces-completion-of-a-round-financing-to-advance-abt-301-phase-ii-clinical-trial 2024-07-02 03:59:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-announces-move-to-solo-development-and-commercialization-of-farletuzumab-ecteribulin-fzec-antibody-drug-conjugate-adc 2024-07-01 05:33:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cbc-backed-hasten-biopharmaceutical-announces-acquisition-of-14-celltrion-legacy-products 2024-07-01 05:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scg-cell-therapy-announces-fda-ind-clearance-of-scg142-a-next-generation-hpv-specific-tcr-t-cell-therapy-for-patients-with-hpv-associated-solid-tumor 2024-07-01 05:25:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-international-inc-and-proliant-health-and-biologicals-announce-recombinant-albumin-development-and-commercialization-partnership 2024-06-29 01:11:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-announces-completion-of-stp707-phase-i-clinical-study-with-strong-safety-profile-and-disease-activity-for-the-treatment-of-pancreatic-cancer-patients 2024-06-29 01:09:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchid-pharma-partners-with-cipla-to-launch-antibiotic-cefepime-enmetazobactam-in-india 2024-06-28 07:32:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leqembi-lecanemab-launched-in-china 2024-06-28 05:38:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dynavax-initiates-phase-12-study-of-novel-shingles-vaccine-program 2024-06-28 05:30:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fsd-pharma-receives-ethics-committee-approval-for-a-phase-1-multiple-ascending-doses-clinical-trial-for-lucid-21-302-lucid-ms-in-australia 2024-06-28 05:27:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-xpovio-selinexor-national-health-insurance-service-approval-for-reimbursement-in-south-korea 2024-06-27 01:19:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huadong-medicine-announces-positive-phase-i-results-for-innovative-oral-small-molecule-glp-1-receptor-agonist-hdm1002 2024-06-27 01:16:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-announces-plan-to-submit-ind-application-for-cid-103-an-anti-cd-38-antibody-in-antibody-mediated-rejection-and-receipt-of-a-non-binding-proposal-to-acquire-entire-china 2024-06-27 01:13:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bioscience-succeeds-in-developing-multi-treatment-for-mosquito-borne-viral-infections-including-dengue-fever 2024-06-26 03:51:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioai-and-genomic-testing-cooperative-announce-strategic-collaboration-to-provide-ai-powered-digital-pathology-solutions-for-clinical-research-and-diagnostic-applications 2024-06-26 03:49:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-laboratories-announces-strategic-lentiviral-vector-manufacturing-collaboration-with-gates-institute-at-university-of-colorado-anschutz-medical-campus 2024-06-26 03:46:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/capricor-therapeutics-announces-for-the-treatment-of-duchenne-muscular-dystrophy 2024-06-26 03:43:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/superlab-suisse-opens-state-of-the-art-facility-in-basel-fostering-new-spaces-for-scientific-breakthroughs 2024-06-25 06:27:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glyconex-enhances-global-intellectual-property-estate-for-gnx102-with-patent-approvals-in-japan-south-korea-russia-and-taiwan 2024-06-25 01:49:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enlivex-announces-the-dosing-of-the-first-patient-in-a-randomized-placebo-controlled-phase-iii-trial-evaluating-allocetratm-in-up-to-46-patients-with-thumb-osteoarthritis 2024-06-25 01:47:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-completes-taro-merger 2024-06-25 01:44:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bota-bios-biomanufacturing-technology-is-commercialized-at-nhu-with-a-successful-strategic-partnership-established 2024-06-25 01:42:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-approval-of-livtencity-maribavir-in-japan-for-post-transplant-cytomegalovirus-cmv-infectiondisease-that-is-refractory-to-existing-anti-cmv-therapies 2024-06-24 06:31:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pacific-northwest-research-institute-uncovers-hidden-dna-mechanisms-of-rare-genetic-diseases 2024-06-24 06:22:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/melodia-therapeutics-and-alivexis-sign-exclusive-license-agreement-for-cathepsin-c-inhibitor-program-mod-a 2024-06-24 06:18:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-announces-closing-of-us75-million-equity-investment-by-takeda 2024-06-21 01:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-submits-application-to-us-fda-seeking-approval-of-tremfya-guselkumab-for-the-treatment-of-moderately-to-severely-active-crohns-disease 2024-06-21 01:47:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cryoport-and-minaris-regenerative-medicine-form-strategic-partnership-to-support-advancement-of-cell-and-gene-therapies 2024-06-21 01:34:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-the-acceptance-of-biologics-license-application-for-tafasitamab-in-combination-with-lenalidomide-for-the-treatment-of-relapsed-in-adult-patients-in-china 2024-06-21 01:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-cell-signs-an-mou-with-pt-bifarma-adiluhung-an-affiliate-of-kalbe-group 2024-06-20 02:22:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diabetes-researchers-in-china-demonstrate-early-insulin-therapy-significant-benefits-cardiovascular-health 2024-06-20 02:19:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivir-selects-global-cro-partner-for-upcoming-phase-2b-study-in-hcc-with-fostrox-lenvima-and-initiates-study-feasibility 2024-06-20 02:12:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yoltech-and-kactus-join-forces-to-propel-innovative-dna-editing-system-in-greater-china 2024-06-19 01:23:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ability-biologics-announces-closing-of-us18-million-seed-funding-to-generate-novel-highly-targeted-immunomodulators 2024-06-19 01:21:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singleron-biotechnologies-partners-with-the-human-cell-atlas-hca-to-enhance-access-to-single-cell-analysis-globally 2024-06-19 01:11:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-asia-pacific-partners-with-pharmacosmos-to-expand-its-reach-of-monofer-to-singapore-and-malaysia 2024-06-19 01:08:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/primrose-bio-announces-investment-from-1315-capital-to-advance-manufacturing-solutions-for-next-generation-therapeutics 2024-06-18 03:21:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mozart-therapeutics-doses-first-cohort-of-participants-in-phase-1ab-clinical-trial-of-mtx-101-in-development-for-treatment-of-autoimmune-diseases 2024-06-18 03:16:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-launches-innovative-b2b-e-commerce-healthcare-purchasing-platform-ezrx-to-better-serve-pharmacies-and-clinics-in-asia 2024-06-17 23:48:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxcell-bio-secures-kddf-funding-to-develop-solid-tumor-dual-target-car-t-therapy 2024-06-17 06:17:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lixte-biotechnology-holdings-announces-collaboration-on-a-new-colon-cancer-clinical-trial 2024-06-15 03:05:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-submits-application-to-us-fda-for-updated-protein-based-2024-2025-formula-covid-19-vaccine 2024-06-15 03:03:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/record-numbers-expected-at-cphi-pmec-china-2024-as-asian-markets-boom 2024-06-14 05:38:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ethypharm-expands-its-mesalazine-etiasa-portfolio-in-china 2024-06-14 01:30:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vizai-collaborates-with-hypertrophic-cardiomyopathy-association-to-improve-care-for-hypertrophic-cardiomyopathy-patients 2024-06-14 01:26:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skan-research-trust-and-quadram-institute-bioscience-to-develop-novel-microbial-therapies 2024-06-14 01:27:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-demonstrates-strong-antitumor-activity-of-its-novel-oligonucleotide-chemodrug-conjugate-in-journal-of-oncology-research-and-therapy 2024-06-14 01:21:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-enters-into-a-multi-year-data-licence-agreement-with-ochre-bio-to-further-investigate-the-drivers-of-liver-disease 2024-06-13 03:50:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-announces-phase-12-study-initiation-for-obi-992-a-trop2-targeted-antibody-drug-conjugate-adc-for-cancer-therapy 2024-06-13 03:48:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sibylla-biotech-and-md-anderson-announce-strategic-collaboration-to-discover-and-develop-small-molecule-protein-degraders 2024-06-13 03:45:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/belite-bio-receives-sakigake-pioneer-drug-designation-of-tinlarebant-for-stargardt-disease-in-japan 2024-06-13 03:37:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bespak-reaches-key-milestone-in-the-expansion-of-its-manufacturing-capacity-with-further-expansion-plans-underway-to-meet-global-customer-demand-for-climate-friendly-inhalers 2024-06-12 01:50:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-ai-tool-finds-rare-variants-linked-to-heart-disease-in-17-genes 2024-06-12 01:47:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lokavant-launches-first-ai-clinical-trial-feasibility-solution-to-optimize-trials-from-strategic-planning-to-mid-study-re-forecasting 2024-06-12 01:41:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurexone-announces-expansion-of-exopten-patent-coverage-with-notice-of-allowance-for-japanese-patent-application 2024-06-12 01:38:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-registrational-phase-iii-study-of-olverembatinib-for-the-treatment-of-patients-with-sdh-deficient-gist-approved-by-the-china-cde 2024-06-11 03:43:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shaperon-and-dong-a-st-sign-mou-for-nanobody-based-new-drug-development 2024-06-11 03:37:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/j-ints-bio-asco-2024-jin-a02-showed-tumor-reductions-including-brain-metastasis-in-the-ongoing-first-in-human-dose-finding-phase-1-clinical-study 2024-06-10 05:13:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-to-gcbp-and-novel-pharmas-gc1130a 2024-06-10 05:11:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mlb-announces-ind-approval-by-us-fda-to-initiate-phase-1-trial-of-tml-6-a-new-era-multi-target-drug-for-the-treatment-of-alzheimers-disease 2024-06-10 05:03:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nagase-viita-launches-solbiotetm-a-new-brand-of-injectable-grade-saccharide-excipients-for-biopharmaceuticals 2024-06-10 05:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theralaser-successfully-destroys-lung-cancer 2024-06-07 04:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-initiates-phase-i-trial-of-menin-inhibitor-hmpl-506-in-patients-with-hematological-malignancies-in-china 2024-06-07 03:54:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scilex-holding-company-announces-the-us-fda-has-approved-the-snda-for-commercial-manufacturing-of-gloperba-which-will-be-launched-in-the-us-in-the-week-of-june-10th-2024 2024-06-07 03:44:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indevr-and-sino-biological-team-up-to-deliver-multiplexed-analytical-solutions 2024-06-06 03:38:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-announces-collaboration-with-bristol-myers-squibb-to-evaluate-givastomig-in-a-combination-study-for-newly-diagnosed-gastric-and-esophageal-cancers 2024-06-06 03:12:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approved-phase-iiiii-clinical-study-of-kpg-121-in-combination-with-abiraterone-as-a-first-line-treatment-for-mcrpc 2024-06-06 03:09:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genetype-and-stayhealthy-announce-landmark-distribution-agreement-for-revolutionary-multi-risk-test 2024-06-06 03:07:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aragen-bioscience-validates-getinges-single-use-production-reactor-supr 2024-06-05 04:40:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/champions-oncology-and-medicines-discovery-catapult-forge-partnership-to-accelerate-radiopharmaceutical-therapeutics-development 2024-06-05 04:37:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exevir-bio-announces-exceptional-virus-neutralization-potency-of-its-variant-proof-xvr013m-antibody-against-the-sars-cov-2-variant-jn1 2024-06-05 04:35:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zyus-life-sciences-receives-cannabis-drug-license-from-health-canada 2024-06-05 04:28:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inotiv-reaches-agreement-to-resolve-previously-announced-investigation-into-shuttered-cumberland-facility 2024-06-04 01:25:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/longeveron-announces-contract-development-and-manufacturing-business-and-first-contract 2024-06-04 01:22:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aurobac-therapeutics-presents-its-rd-strategy-pipeline-and-announces-new-development-program-in-partnership-with-boehringer-ingelheim 2024-06-04 01:21:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/highlife-receives-ide-approval-to-initiate-us-pivotal-clinical-study-for-treatment-of-mitral-regurgitation 2024-06-04 01:19:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-completes-tlx250-cdx-zircaix-bla-submission-for-kidney-cancer-imaging 2024-06-03 04:32:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grit-and-quangang-forge-strategic-partnership-to-accelerate-localization-of-interleukin-2 2024-06-03 04:29:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortrea-introduces-comprehensive-solution-to-improve-diversity-and-inclusion-in-clinical-research 2024-06-03 04:27:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kexing-biopharm-obtained-clinical-trial-approval-for-its-self-developed-class-i-innovative-drug-long-acting-growth-hormone 2024-05-31 02:14:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obio-technology-officially-launched-the-center-for-clinical-evaluation-and-translation-of-advanced-therapies-for-pediatric-rare-and-genetic-diseases 2024-05-31 02:09:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-and-burning-rock-collaborate-to-increase-patient-access-to-precision-cancer-medicines 2024-05-31 02:06:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gyre-pharmaceuticals-receives-ind-approval-from-chinas-nmpa-to-evaluate-f230-for-the-treatment-of-pulmonary-arterial-hypertension 2024-05-31 02:00:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heron-therapeutics-announces-prior-approval-supplement-submission-to-the-fda-for-zynrelef-vial-access-needle-van 2024-05-30 01:23:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/georgiamune-expands-cancer-treatment-pipeline-with-two-novel-drugs-within-five-months-of-launch 2024-05-30 01:20:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spinogenix-announces-fda-clearance-of-ind-application-for-spg302-a-novel-therapy-for-the-treatment-of-als 2024-05-30 01:19:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agios-announces-905-million-purchase-agreement-for-vorasidenib-royalty 2024-05-29 04:10:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monash-university-and-thermo-fisher-scientific-strengthen-strategic-collaboration 2024-05-29 04:07:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cormedix-inc-announces-commercial-agreement-with-top-tier-dialysis-provider 2024-05-29 03:39:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-ag-expands-its-end-to-end-platform-by-submitting-three-development-optimization-technology-patents-to-the-european-patent-office 2024-05-29 03:37:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/henlius-rituximab-receives-marketing-approval-in-peru 2024-05-28 01:30:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncocross-expands-collaboration-with-jw-pharmaceutical-to-develop-innovative-medicines-using-ai-in-anti-cancer-and-regenerative-medicine 2024-05-28 01:27:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fluoguide-selects-laser-system-for-photothermal-cancer-therapy-with-fg001 2024-05-28 01:25:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reddy-pharma-iberia-and-theranica-launch-nerivio-in-spain-offering-patients-who-suffer-from-migraine-a-non-pharmacological-treatment 2024-05-28 01:21:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bicycle-therapeutics-announces-555-million-private-placement-equity-financing 2024-05-24 01:33:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivirs-licensee-tango-therapeutics-has-discontinued-development-of-its-tng348-clinical-program 2024-05-24 01:30:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphastar-receives-fda-approval-for-albuterol-sulfate-inhalation-aerosol 2024-05-23 01:13:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metoject-subcutaneous-injection-pen-methotrexate-pen-type-autoinjector-launched-in-japan 2024-05-23 01:09:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-signs-definitive-agreement-to-acquire-life-science-company-mirus-bio-for-us-600-million 2024-05-23 01:00:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nus-scientists-discover-a-novel-way-of-activating-muscle-cells-natural-defences-against-cancer-using-magnetic-pulses 2024-05-22 01:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/remegen-completes-patient-enrollment-in-two-phase-iii-clinical-trials-using-telitacicept-for-treatment-of-iga-nephropathy-and-primary-sjogrens-syndrome 2024-05-22 01:31:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evergreen-theragnostics-announces-licensing-of-evg321-from-medical-university-of-innsbruck-and-enters-clinical-development-of-radioligand-therapies-in-small-cell-lung-cancer 2024-05-22 01:29:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-collaborates-with-dr-reddys-to-market-avt03-a-proposed-analogue-to-prolia-and-xgeva-in-the-us-and-europe 2024-05-22 01:23:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/limula-raises-68m-to-democratise-access-to-life-saving-cell-and-gene-therapies-with-swiss-made-manufacturing-platform 2024-05-21 05:26:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terran-biosciences-announces-development-of-terxt-a-combination-of-xanomeline-and-trospium-prodrugs-for-the-treatment-of-schizophrenia-and-intends-to-pursue-accelerated-505b2-approval 2024-05-21 01:24:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-plans-15-billion-manufacturing-facility-for-antibody-drug-conjugates-adcs-in-singapore 2024-05-21 01:15:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-completes-proof-of-concept-study-of-tlx592-targeted-alpha-therapy-in-prostate-cancer 2024-05-21 01:12:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-announces-a-collaboration-with-yaskawa-to-create-an-innovative-cell-therapy-ecosystem-through-the-integration-of-pharmaceutical-and-robotics-technologies 2024-05-21 01:08:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/treefrog-presents-data-from-its-parkinsons-disease-cell-therapy-program-at-iaprd 2024-05-20 07:54:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharmanovel-pharmas-sanfilippo-syndrome-treatment-obtains-fda-ind-approval 2024-05-20 07:52:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/introducing-proteinmentor-a-multi-attribute-platform-technology-for-the-biopharma-industry 2024-05-18 01:11:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virios-therapeutics-announces-proposed-public-offering-of-common-stock-to-commence-preparations-for-planned-imc-2-long-covid-phase-2b-study 2024-05-18 01:09:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-receives-anda-approval-for-brimonidine-tartrate-and-timolol-maleate-ophthalmic-solution-0205 2024-05-17 02:59:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axonics-receives-regulatory-approval-for-recharge-free-snm-system-in-australia 2024-05-17 02:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oragenics-inc-prepares-intranasal-pharmaceutical-onp-002-for-phase-ii-concussion-trial 2024-05-17 01:52:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advance-doe-workshop-2024-a-testament-to-the-power-of-collaboration-education-and-innovation 2024-05-16 06:25:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nitrosamine-advance-workshop-2024-a-comprehensive-post-show-review 2024-05-16 06:18:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scorpius-holdings-achieves-major-milestone-with-cgmp-facility-validation-for-microbial-manufacturing 2024-05-16 03:08:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evoq-bio-completes-successful-pre-investigational-new-drug-meeting-with-fda-for-development-of-inhaled-therapeutic-to-treat-pulmonary-infections 2024-05-16 02:00:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reviva-announces-enrollment-update-for-open-label-extension-study-evaluating-brilaroxazine-in-schizophrenia 2024-05-16 02:00:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascendis-pharma-announces-extension-of-us-food-and-drug-administration-review-period-for-transcon-pth-for-adults-with-hypoparathyroidism 2024-05-15 02:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ptc-therapeutics-announces-fda-acceptance-and-priority-review-of-the-bla-for-upstaza 2024-05-15 01:57:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tavros-therapeutics-achieves-two-milestone-payments-in-its-collaboration-with-vividion-therapeutics 2024-05-15 01:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senti-bio-announces-first-patient-dosed-in-phase-1-clinical-trial-of-senti-202-for-the-treatment-of-relapsed-or-refractory-hematologic-malignancies-including-acute-myeloid-leukemia 2024-05-14 01:32:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antiepileptic-drug-fycompa-approved-in-china-for-adjunctive-treatment-of-primary-generalized-tonic-clonic-seizures 2024-05-14 01:28:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imunon-announces-site-activation-for-imnn-101-phase-1-vaccine-study 2024-05-14 01:23:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-announces-approval-of-augtyro-repotrectinib-for-patients-with-ros1-positive-nsclc-by-chinas-nmpa 2024-05-13 07:56:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ribobay-pharma-boosts-crdmo-offerings-with-cytivas-first-flexfactory-platform-for-oligonucleotides 2024-05-13 07:53:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nika-pharmaceuticals-inc-nika-acquires-a-two-million-usd-production-building 2024-05-13 07:51:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/westgenes-therapeutic-mrna-cancer-vaccine-receives-fda-approval 2024-05-13 07:47:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-is-now-honored-with-two-awards-at-air-cargo-india-2024 2024-05-10 07:39:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-announces-us-patent-issue-notification-for-lipid-based-delivery-technology-for-annamycin 2024-05-10 03:19:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annovis-announces-unblinding-of-the-buntanetap-phase-iii-data-in-parkinsons-disease 2024-05-10 03:17:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formosa-pharmaceuticals-licenses-clobetasol-propionate-ophthalmic-suspension-to-tabuk-pharmaceuticals-for-post-ocular-surgery-treatment 2024-05-10 03:07:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approved-tivdak-targeting-tissue-factor-in-cervical-cancer 2024-05-10 02:03:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anaptys-to-receive-50-million-in-a-capped-non-recourse-monetization-from-amended-agreement-with-sagard-in-exchange-for-additional-jemperli-royalties 2024-05-10 01:55:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurocrine-biosciences-announces-initiation-of-phase-1-clinical-study-evaluating-effects-of-nbi-1117567-in-healthy-adults 2024-05-09 03:28:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avicenna-introduces-machine-learning-enhanced-medicinal-chemistry-platform-to-accelerate-the-last-mile-of-small-molecule-drug-discovery 2024-05-09 03:26:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neushen-therapeutics-initiates-first-in-human-trial-of-ns-136-a-novel-selective-m4-receptor-positive-allosteric-modulator-for-the-treatment-of-schizophrenia 2024-05-09 03:20:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arbor-biotechnologies-announces-acquisition-of-serendipity 2024-05-09 03:17:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4th-annual-pharma-gmp-quality-management-2024 2024-05-08 05:23:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-quality-excellence-awards-2024-a-night-of-elegance-and-triumph 2024-05-08 05:23:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kindeva-drug-delivery-and-syntegon-install-first-versynta-microbatch-in-north-america 2024-05-08 04:54:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mikart-and-nano-pharmasolutions-complete-key-milestones 2024-05-08 01:24:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciwind-biosciences-and-hk-innon-corporation-announce-licensing-and-partnership-agreement-for-ecnoglutide-injection-xw003-in-south-korea 2024-05-08 01:22:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellipont-bioservices-and-adva-biotechnology-collaborate-to-optimize-cell-therapy-manufacturing-with-the-adva-x3-platform 2024-05-08 01:19:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-receives-nmpa-breakthrough-therapy-designation-for-ibi343anti-claudin182-adcas-monotherapy-for-advanced-gastric-cancer 2024-05-07 01:34:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azurity-pharmaceuticals-inc-announces-fda-approval-of-myhibbin-mycophenolate-mofetil-oral-suspension 2024-05-07 01:25:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-immunotech-completes-cgmp-manufacturing-of-clinical-vials-of-ampligen 2024-05-07 01:23:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellectis-announces-completion-of-the-additional-equity-investment-by-astrazeneca 2024-05-06 06:38:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocartis-and-merck-to-collaborate-on-improving-patient-access-to-personalized-medicine-in-middle-east-and-north-africa-mea-region 2024-05-06 06:35:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curiox-biosystems-and-beckman-coulter-life-sciences-announce-a-partnership-combining-c-free-technology-with-dura-innovations-for-hands-free-washed-sample-preparation-for-flow-cytometry 2024-05-04 02:21:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parse-biosciences-launches-single-cell-immune-profiling-products 2024-05-03 05:24:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akoya-biosciences-and-shanghai-kr-pharmtech-announce-chinese-regulatory-agency-premarket-approval-for-kr-ht5-in-china-to-support-next-generation-pathology-clinical-workflows 2024-05-03 03:37:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/unleashing-the-power-of-mait-cells-pluri-launches-novel-immunotherapy-platform-for-solid-tumor-cancer-treatment 2024-05-03 03:34:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/guangzhou-bio-gene-technologies-announces-initiation-of-phase-i-clinical-trial-for-bg1805-a-car-t-targeting-cll-1 2024-05-03 03:32:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/national-medical-products-administration-nmpa-approves-chipscreen-biosciences-chidamide-epidaza-combined-with-r-chop-for-the-treatment-of-diffuse-large-b-cell-lymphoma 2024-05-02 05:19:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-announces-submission-to-fda-of-new-drug-application-for-et-400-hydrocortisone-oral-solution 2024-05-02 05:08:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-announces-first-subject-dosed-in-its-first-in-human-clinical-trial-of-fp-020 2024-05-02 04:45:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ingenium-therapeutics-novel-nk-cell-therapy-receives-orphan-drug-designation-from-fda 2024-05-02 04:42:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-techne-announces-new-distribution-agreement-with-thermo-fisher-scientific 2024-04-30 01:20:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ractigen-therapeutics-announces-fda-approval-for-rag-01-a-first-in-class-sarna-therapy-for-bcg-unresponsive-nmibc 2024-04-29 05:14:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-positive-chmp-opinion-for-fruquintinib-in-previously-treated-metastatic-colorectal-cancer-received-by-takeda 2024-04-29 05:10:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ena-respiratory-announces-fda-ind-clearance-for-its-prophylactic-intranasal-inna-051-a-first-in-class-antiviral-innate-immunomodulator 2024-04-29 04:53:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-finalizes-the-acquisition-of-signalchem-biotech 2024-04-28 23:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prism-biolab-enters-into-a-joint-research-and-licensing-agreement-with-ono 2024-04-26 03:14:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-medivirs-miv-711-rare-pediatric-disease-designation-and-orphan-drug-designation-for-the-treatment-of-legg-calve-perthes-disease 2024-04-26 03:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biobased-96-well-pcr-plates-now-also-semi-skirted 2024-04-25 23:59:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cullinan-therapeutics-to-present-phase-1-clinical-data-on-cln-619-a-novel-anti-micab-antibody-at-asco-2024 2024-04-25 01:29:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atom-bioscience-enrolling-patients-in-us-as-part-of-a-global-phase-2b3-clinical-trial-of-a-new-investigational-treatment-for-chronic-gout 2024-04-25 01:25:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alkermes-announces-initiation-of-vibrance-1-phase-2-study-evaluating-alks-2680-for-the-treatment-of-narcolepsy-type-1 2024-04-25 01:22:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lisata-therapeutics-and-qilu-pharmaceutical-announce-first-patient-treated-in-qilus-phase-2-trial-in-china-of-lsta1-in-patients-with-metastatic-pancreatic-ductal-adenocarcinoma 2024-04-24 01:26:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-gains-european-commission-approval-for-pyzchiva-a-biosimilar-to-stelara-ustekinumab 2024-04-24 01:23:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pillar-biosciences-oncoreveal-cdx-pan-cancer-solid-tumor-ivd-now-fda-approved-for-general-tumor-profiling-on-the-illumina-miseq-dx-system 2024-04-24 01:21:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-xtanditm-enzalutamide-granted-european-commission-approval-for-use-in-additional-recurrent-early-prostate-cancer-treatment-setting 2024-04-24 01:15:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocan-pharma-initiates-fda-approval-process-for-liposome-injection-therapy-for-chronic-pain 2024-04-23 01:56:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-receives-regulatory-approval-to-expand-harmonic-clinical-trial-for-non-small-cell-lung-cancer-in-never-smokers-into-japan-and-taiwan 2024-04-23 01:53:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-cellares-announce-a-380m-worldwide-capacity-reservation-and-supply-agreement-for-the-manufacture-of-car-t-cell-therapies-to-bring-the-promise-of-cell-therapy 2024-04-23 01:49:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gt20029-china-phase-ii-trial-for-aga-reached-primary-endpoint 2024-04-22 06:42:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kynos-therapeutics-announces-positive-top-line-results-from-the-first-in-human-phase-i-study-of-its-kmo-inhibitor-kns366-demonstrating-safety-tolerability-and-target-engagement 2024-04-22 06:37:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-contaminants-food-testing-more-analytica-convention-2024-focuses-on-vietnams-laboratory-needs 2024-04-22 04:02:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cormedix-inc-announces-cms-grants-tdapa-to-defencath 2024-04-20 03:16:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial 2024-04-20 03:11:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/la-jolla-institute-for-immunology-and-revolka-started-a-research-collaboration 2024-04-19 03:56:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ys-biopharma-granted-phase-i-clinical-trial-license-of-therapeutic-chronic-hepatitis-b-virus-vaccine 2024-04-19 03:52:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imunons-ind-application-cleared-to-begin-human-testing-of-imnn-101 2024-04-19 03:30:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diamedica-therapeutics-announces-first-patient-dosed-in-relaunch-of-its-pivotal-phase-23-remedy2-trial-of-dm199-for-the-treatment-of-acute-ischemic-stroke 2024-04-18 04:20:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clearmind-medicine-announces-exclusive-licensing-agreement-for-generation-30-psychedelic-compounds-for-the-treatment-of-mental-disorders 2024-04-18 04:10:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essential-pharma-announces-the-acquisition-of-reminyl-galantamine-hydrobromide-oral-capsules 2024-04-18 03:53:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/voyager-therapeutics-announces-selection-of-development-candidate-for-gba1-program-in-collaboration-with-neurocrine-biosciences-triggering-milestone-payment 2024-04-17 02:02:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gri-bio-expands-intellectual-property-protection-for-proprietary-natural-killer-t-nkt-cell-modulators-with-issuance-of-korea-patent 2024-04-17 01:58:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advance-doe-workshop-2024 2024-04-16 23:40:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-launches-first-all-in-one-genetic-stability-assay-to-accelerate-biosafety-testing 2024-04-16 23:27:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isospec-analytics-raises-19m-as-it-introduces-breakthrough-technology-to-rapidly-identify-unknown-molecules-at-scale 2024-04-16 05:06:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cormedix-inc-announces-us-inpatient-commercial-availability-of-defencath-taurolidine-and-heparin 2024-04-16 04:31:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dot-compliance-raises-a-175-million-up-round-in-series-b-extension-funding-to-advance-new-category-of-ai-driven-compliance 2024-04-15 07:42:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study 2024-04-15 07:38:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nxera-pharma-announces-exclusive-supply-and-distribution-agreement-with-handok-for-pivlaz-in-south-korea 2024-04-15 07:34:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanoform-enters-exclusive-partnership-with-cbc-to-bring-best-in-class-nanomedicine-technology-to-japan 2024-04-12 01:32:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boundless-bio-announces-first-patient-dosed-in-first-in-human-phase-12-clinical-trial-of-bbi-825-in-cancer-patients-with-resistance-gene-amplifications 2024-04-12 01:29:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-to-acquire-automax 2024-04-12 01:27:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gennao-bio-debuts-preclinical-data-for-first-in-class-antibody-drug-conjugate-from-gene-monoclonal-antibody-platform-gmab-adc 2024-04-10 04:58:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocity-announces-fda-clearance-of-the-investigational-new-drug-application-for-its-first-in-class-antibody-drug-conjugate-targeting-glypican-3 2024-04-10 04:56:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/world-orphan-drug-alliance-expands-to-japan-south-korea-and-the-african-subcontinent 2024-04-10 04:52:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cormedix-inc-announces-commercial-agreement-with-arc-dialysis-llc 2024-04-10 04:49:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicxi-and-starpharma-create-petalion-therapeutics-to-develop-novel-dendrimer-based-treatments-asx-announcement 2024-04-08 04:01:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renalys-pharma-submits-an-ind-application-for-a-phase-iii-clinical-trial-of-sparsentan-for-iga-nephropathy-in-japan 2024-04-08 03:50:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eilean-therapeutics-receives-clearance-to-initiate-rr-aml-trial-with-lomonitinib-a-selective-pan-flt3irak4-inhibitor 2024-04-05 01:41:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-and-mabxience-announce-strategic-global-licensing-agreement-for-oncology-biosimilar-candidate 2024-04-05 01:36:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biognosys-and-alamar-biosciences-forge-strategic-partnership-in-proteomics-to-advance-biopharma-and-precision-medicine-research 2024-04-05 01:34:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurocrine-biosciences-announces-first-patient-dosed-in-phase-2-clinical-study-evaluating-nbi-1070770-in-adults-with-major-depressive-disorder 2024-04-04 04:19:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tae-life-sciences-neutron-beam-system-receives-acceptance-enabling-the-start-of-bnct-clinical-trials-in-china 2024-04-04 04:14:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytomx-therapeutics-announces-nomination-of-second-clinical-candidate-in-broad-probody-t-cell-engaging-bispecific-tcb-collaboration-with-astellas 2024-04-04 04:09:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dd-pharmatech-granted-fast-track-designation-from-us-fda-for-dd01-for-the-treatment-of-nashmash 2024-04-03 04:43:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lygenesis-announces-first-patient-dosed-in-its-phase-2a-clinical-trial-of-a-first-in-class-regenerative-cell-therapy-for-patients-with-end-stage-liver-disease 2024-04-03 04:39:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tcbp-increasing-treatment-capacity-with-expanded-manufacturing-process 2024-04-03 04:08:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapeutic-potential-of-cd20-x-cd3-bispecific-antibodies 2024-04-03 03:22:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-astellas-supplemental-new-drug-application-for-izervay-avacincaptad-pegol-intravitreal-solution-for-geographic-atrophy 2024-04-02 05:15:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veolia-water-technologies-expands-mobile-water-services-capabilities-in-malaysia 2024-04-01 04:26:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-dosing-of-first-patient-in-clinical-study-of-the-combination-of-shp2-inhibitor-icp-189-and-egfr-inhibitor-furmonertinib 2024-03-30 01:42:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-announces-nmpas-ind-approval-for-equecabtagene-autoleucel-in-second-and-third-line-treatment-of-multiple-myeloma 2024-03-30 01:40:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/an-actriia-fusion-protein-got-fda-approved-for-pah-treatment 2024-03-30 01:26:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-is-the-first-generics-company-to-obtain-approval-for-diabetes-drug-liraglutide-in-the-uk 2024-03-28 03:16:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-the-launch-of-levofloxacin-oral-solution-usp 2024-03-28 01:43:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncopeptides-and-vector-pharma-fzco-announce-collaboration-to-provide-pepaxti-to-patients-in-the-middle-east-and-north-africa 2024-03-28 01:37:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-announces-nda-for-vamorolone-in-duchenne-muscular-dystrophy-accepted-and-granted-priority-review-by-chinas-nmpa 2024-03-28 01:32:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-dosed-first-participant-in-phase-3-clinical-study-neoshot-of-ibi310-anti-ctla-4-monoclonal-antibody-in-combination-with-sintilimab-for-msi-hdmmr-colon-cancer-neoadjuvant-therapy 2024-03-27 03:16:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tiumbio-submits-cta-for-phase-1b-clinical-trial-of-tu7710-a-long-acting-recombinant-activated-factor-vii-in-hemophilia-a-or-b-patients 2024-03-27 03:08:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-a-research-collaboration-with-the-university-of-colorado-school-of-medicine-to-explore-potential-of-bbt-877-for-immuno-oncology 2024-03-27 01:58:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptamer-sciences-inc-files-ind-application-for-innovative-liver-cancer-treatment-ast-201-a-promising-approach-to-address-under-medical-needs 2024-03-26 01:33:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocan-pharma-paves-its-way-to-lpt-cbd-chemistry-manufacturing-and-controls-cmc-key-milestones-for-fda-approval 2024-03-26 01:30:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-pharma-announces-enrollment-is-complete-for-the-first-arm-of-the-prospect-study-of-tirabrutinib-in-us-patients-with-relapsed-or-refractory-pcnsl 2024-03-26 01:27:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advancing-healthcare-innovation-juniper-biologics-recognized-as-the-best-novel-therapy-rd-and-commercialization-company-2024-by-apac-insider 2024-03-25 03:20:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-neuroscience-expands-clinical-research-in-braincomputer-interface 2024-03-25 03:11:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/belite-bio-announces-pmda-submission-of-tinlarebant-for-stargardt-disease-clinical-trial-in-japan 2024-03-25 01:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-announces-extension-of-gene-therapy-manufacturing-alliance-with-nus-yong-loo-lin-school-of-medicine 2024-03-22 01:35:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuexcell-therapeutics-announces-successful-dosing-of-first-patient-by-neurod1-gene-therapy 2024-03-22 01:31:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-cevidoplenib-for-itp 2024-03-22 01:30:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-announces-services-partnership-with-rapid-novor 2024-03-21 05:05:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-doses-first-subject-in-phase-1-trial-with-htl0033744-an-ep4-agonist-for-inflammatory-bowel-disease 2024-03-21 01:53:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-initiates-phase-ii-dose-expansion-study-of-claudin-182-adc-atg-022-in-china-and-australia 2024-03-21 01:46:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtl-to-aquire-the-social-proxy 2024-03-21 01:43:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genomics-focused-biomedical-research-secures-65-million-to-address-complex-health-challenges 2024-03-20 01:40:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carbogen-amcis-announces-successful-anvisa-audit-of-its-facility-in-china 2024-03-20 01:37:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lib-therapeutics-and-partner-hasten-biopharmaceuticals-announce-lerodalcibep-clinical-trial-acceptance-by-nmpa-in-china 2024-03-20 01:30:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clearmind-medicines-psychedelic-treatment-granted-divisional-patent-approval-in-china 2024-03-20 01:28:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/researchers-pinpoint-issue-that-could-be-hampering-common-chemotherapy-drug 2024-03-19 01:59:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-partners-with-steincares-to-market-two-biosimilars-in-latam 2024-03-19 01:55:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hope-for-autoinflammatory-disease-treatment 2024-03-19 01:51:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-invests-in-brickbio-to-develop-advanced-molecules-and-therapies-using-protein-engineering-technology-for-antibody-drug-conjugates-adc 2024-03-18 07:40:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/list-biotherapeutics-and-sacco-system-announce-lead-share-agreement 2024-03-16 01:50:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-announces-partnership-with-ginkgo-bioworks-and-joins-the-ginkgo-technology-network 2024-03-16 01:46:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galmed-announces-grant-of-new-patent-for-the-combination-of-aramchol-with-resmetirom-mgl-3196-rezdiffra-for-the-treatment-of-nash-and-liver-fibrosis 2024-03-16 01:47:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atsena-therapeutics-announces-initiation-of-dosing-in-second-cohort-of-phase-iii-clinical-trial-evaluating-atsn-201-gene-therapy-for-the-treatment-of-x-linked-retinoschisis-xlrs 2024-03-14 01:34:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-to-present-data-highlighting-zl-1310-a-novel-antibody-drug-conjugate-adc-for-treatment-of-solid-tumors 2024-03-14 01:31:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perspective-pharmacovigilance-inc-and-regdev-inc-announce-strategic-partnership-to-provide-best-in-class-molecule-to-market-services 2024-03-13 06:50:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanyou-biopharmaceuticals-launches-advanced-intelligent-rd-service-platform 2024-03-13 01:41:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocardia-announces-cms-approval-of-coverage-for-cardiamp-cell-therapy-confirmatory-phase-iii-heart-failure-study 2024-03-13 01:38:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-gets-green-light-for-clinical-trial-of-bcl2-inhibitor-icp-248-combo-with-orelabrutinib-for-cllsll-in-china 2024-03-13 01:36:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rigaku-opens-taiwan-branch-to-enhance-collaboration-and-innovation 2024-03-12 01:55:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/continued-strong-cresemba-isavuconazole-sales-in-asia-pacific-and-china-trigger-milestone-payment-to-basilea 2024-03-12 01:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ranok-therapeutics-expands-clinical-testing-of-champ-brd4-protein-degrader-rnk05047-to-china 2024-03-12 01:34:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-partner-calliditas-therapeutics-announces-us-fda-grants-an-additional-seven-year-orphan-drug-exclusivity-period-for-nefecon 2024-03-12 01:30:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-acceptance-of-velsipity-new-drug-application-in-macau 2024-03-11 01:32:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sellas-announces-executive-leadership-reorganization-and-prioritization-of-commercialization-partnerships 2024-03-11 01:25:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytek-biosciences-opens-new-facility-to-address-increasing-global-demand-for-cutting-edge-cell-analysis-solutions 2024-03-08 01:57:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/visen-announces-acceptance-of-a-biologics-license-application-for-lonapegsomatropin-in-china 2024-03-08 01:55:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/logipharma-asia-summit-2024 2024-03-08 00:30:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reflecting-on-the-success-of-drug-safety-symposium-2024 2024-03-07 03:50:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-enters-into-a-license-agreement-with-nex-i-to-develop-and-commercialize-nxi-101 2024-03-07 03:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-invests-in-c2n-to-support-simplifying-the-diagnosis-of-early-alzheimers-disease-to-better-serve-patients 2024-03-07 03:32:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-biomarker-data-add-further-evidence-supporting-the-potential-benefit-of-spinraza-nusinersen-in-infants-and-toddlers-with-unmet-clinical-needs-after-gene-therapy 2024-03-07 03:44:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-report-positive-interim-phase-1-data-for-bi-1206-in-the-treatment-of-relapsedrefractory-indolent-non-hodgkins-lymphoma-in-china 2024-03-06 01:48:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lipella-pharmaceuticals-announces-fda-clearance-of-ind-for-lp-410-for-oral-graft-versus-host-disease-advancing-clinical-pipeline 2024-03-06 01:44:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anew-medical-announces-key-patent-issued-in-china-to-protect-klotho-protein-and-gene-delivery-systems 2024-03-05 01:41:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortress-biotech-and-cyprium-therapeutics-announce-41-million-grant-from-ninds-to-further-development-of-aav-atp7a-gene-therapy-for-menkes-disease 2024-03-05 01:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-to-acquire-artms-inc-and-its-advanced-isotope-production-platform 2024-03-05 01:33:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nmpa-approves-the-nda-for-carsgens-bcma-car-t-therapy-zevorcabtagene-autoleucel-for-relapsed-or-refractory-multiple-myeloma 2024-03-02 01:41:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-participant-dosed-in-a-phase-i-study-of-ibi3002-an-anti-il-4ratslp-bispecific-antibody-in-australia 2024-03-01 01:37:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liscure-biosciences-announces-fda-clearance-of-ind-application-to-initiate-a-phase-2-study-of-lb-p8-for-primary-sclerosing-cholangitis-psc 2024-03-01 01:33:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sn-bioscience-received-us-fda-orphan-drug-designation-for-its-nano-anti-cancer-drug-snb-101-on-pancreatic-cancer 2024-03-01 01:31:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/andelyn-biosciences-chosen-for-fnih-amp-bgtc-gene-therapy-partnership 2024-02-29 01:47:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-ii-study-cadonilimab-shows-promise-in-cervical-cancer 2024-02-29 01:35:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intelligent-bio-solutions-partners-with-cliantha-research-to-conduct-clinical-study-as-part-of-fda-510k-pathway 2024-02-29 01:29:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-positive-results-from-clinical-pharmacokinetic-bridging-study-of-tonmya-to-support-development-and-partnering-in-japan-and-china 2024-02-28 04:32:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaegis-therapeutics-unveils-upcoming-clinical-study-of-gelsolin-an-immune-regulator-as-a-treatment-for-patients-with-acute-respiratory-distress-syndrome-ards 2024-02-28 04:19:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-to-9mw2821 2024-02-28 04:26:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/healis-therapeutics-asset-ckdb-501a-shares-phase-iii-topline-results-for-glabellar-injections-from-ckd-bio-in-south-korea 2024-02-28 04:02:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4th-annual-pharma-gmp-and-quality-management-2024 2024-02-27 06:59:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-quality-excellence-awards-2024 2024-02-27 06:55:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transthera-initiates-ind-enabling-studies-for-tt-02332-a-novel-highly-potent-and-cns-penetrating-nlrp3-inhibitor 2024-02-27 03:52:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milestone-pharmaceuticals-announces-plan-to-resubmit-nda-for-etripamil-for-the-treatment-of-psvt 2024-02-27 03:47:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bitterroot-bio-and-biotheus-announce-research-collaboration-to-develop-bispecific-proteins-in-cardio-immunology 2024-02-27 03:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocity-announces-enrollment-completion-of-the-iga-nephropathy-igan-cohort-in-the-randomized-placebo-controlled-phase-ii-clinical-trial-of-the-eta-receptor-antagonist-sc0062 2024-02-27 03:39:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pk-med-announces-fda-clearance-to-initiate-its-clinical-program-for-pkm-01-for-local-treatment-of-gout-flares-directly-by-a-phase-2-trial 2024-02-26 05:28:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oscotecadel-initiates-first-in-human-dosing-in-ph1-of-anti-mtbr-tau-antibody-adel-y01-in-alzheimers-disease 2024-02-26 04:41:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupixent-sbla-accepted-for-fda-priority-review-for-treatment-of-copd-with-type-2-inflammation 2024-02-26 04:38:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ovid-health-launches-2024-patient-partnership-index-showcasing-gold-standard-patient-centric-care 2024-02-23 07:48:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elevation-oncology-expands-ongoing-phase-1-clinical-trial-of-eo-3021-globally-dosing-first-patient-in-japan 2024-02-23 01:37:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gracell-biotechnologies-acquisition-completed 2024-02-23 01:29:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunofoco-announces-the-dual-approval-of-ind-applications-by-the-us-fda-and-china-cde-for-the-first-epcam-car-t-targeted-at-advanced-solid-tumors 2024-02-23 01:33:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-receives-regulatory-filing-acceptances-from-fda-and-ema-for-vorasidenib-in-the-treatment-of-idh-mutant-diffuse-glioma 2024-02-22 01:26:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-partner-pfizer-announces-european-commission-approves-velsipity-for-patients-with-moderately-to-severely-active-ulcerative-colitis 2024-02-22 01:23:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matinas-biopharma-successfully-reaches-agreement-with-fda-for-a-single-phase-3-registration-trial-to-support-an-nda-for-mat2203-for-the-treatment-of-invasive-aspergillosis 2024-02-21 00:44:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/venatorx-pharmaceuticals-partner-everest-medicines-announces-positive-findings-from-phase-3-certain-1-trial-of-cefepime-taniborbactam-in-new-england-journal-of-medicine 2024-02-21 00:39:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hox-therapeutics-and-vernalis-announce-a-drug-discovery-collaboration-in-oncology 2024-02-21 00:19:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurophth-announces-completion-of-patient-enrollment-for-opvika-phase-iii-clinical-trial-in-the-us 2024-02-20 01:10:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-and-gilead-enter-into-multi-target-antibody-collaboration-agreement 2024-02-19 05:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-termination-of-collaboration-agreements-with-providence 2024-02-19 05:29:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-announces-first-dosing-of-folotyn-in-china 2024-02-17 01:30:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azzur-group-expands-service-portfolio-with-analytical-services-for-advanced-therapeutics-enhancing-the-azzur-discovery-to-delivery-platform 2024-02-16 01:18:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vogenx-completes-enrollment-of-phase-2-trial-of-mizagliflozin-for-post-bariatric-hypoglycemia 2024-02-16 01:15:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iktos-opens-a-subsidiary-in-japan-and-entrusts-its-management-to-hideyoshi-fuji 2024-02-15 03:33:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-announces-agreement-to-acquire-vbis-ip-rights-in-brii-179-vbi-2601-and-plans-to-initiate-technology-transfer-to-expand-clinical-and-commercial-supplies 2024-02-15 03:17:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/egenesis-and-pormedtec-announce-successful-production-of-genetically-engineered-porcine-donors-in-japan 2024-02-15 03:15:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gid-bio-completes-enrollment-for-randomized-double-blinded-pivotal-phase-iii-cell-therapy-study-for-treatment-of-knee-osteoarthritis 2024-02-13 03:40:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nicox-and-kowa-enter-into-agreement-for-ncx-470-development-and-commercialization-in-japan 2024-02-13 03:37:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/auron-selects-first-development-candidate-for-its-portfolio-of-next-generation-targeted-cancer-treatments-from-its-novel-aurigin-platform 2024-02-13 03:34:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-in-human-dosed-in-clinical-trial-of-zma001-for-treatment-of-pulmonary-arterial-hypertension-pah 2024-02-08 01:56:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recce-pharmaceuticals-establishes-strategic-partnership-in-south-east-asia-to-accelerate-clinical-program 2024-02-08 01:54:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-partners-with-legochem-biosciences-for-adc-development-and-manufacturing 2024-02-08 01:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nordic-bioscience-to-make-its-precision-medicine-biomarker-pro-c3-available-in-china-for-research-use-only-ruo-in-the-first-quarter-of-2024 2024-02-08 01:48:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/empower-pharma-to-purchase-eugia-manufacturing-facility-in-new-jersey-for-large-scale-expansion-of-personalized-compounded-medicine 2024-02-06 03:22:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clearmind-medicine-receives-patent-approval-for-its-psychedelic-based-treatment-of-binge-behaviors-in-china 2024-02-06 03:20:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/showcase-on-lab-automation-instruments-and-consumables-on-display-at-slas2024-international-conference-and-exhibition 2024-02-05 23:57:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azenta-launches-the-bioarc-ultra-a-breakthrough-automated-solution-for-efficient-eco-friendly-ultracold-sample-management 2024-02-05 23:49:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/results-of-phase-ii-study-on-qilu-pharmaceuticals-novel-drug-ql1706-published-in-signal-transduction-and-targeted-therapy 2024-02-03 01:30:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rznomics-inc-secures-orphan-drug-designation-from-fda-for-rz-001-in-hepatocellular-carcinoma 2024-02-03 01:27:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-that-inmagene-exercises-option-to-license-two-drug-candidates-as-part-of-strategic-partnership 2024-02-02 05:34:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sai-life-sciences-augments-dmpk-capabilities-to-ace-large-scale-collaborations 2024-02-02 01:57:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amplifybio-celebrates-grand-opening-of-manufacturing-enablement-center-in-new-albany-ohio 2024-02-02 01:48:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosyngen-announces-fda-fast-track-designation-for-bst02-in-treatment-of-liver-cancer 2024-02-02 01:44:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kindeva-drug-delivery-launches-new-analytical-services-global-business-unit 2024-02-01 01:32:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/itm-and-alpha-9-oncology-announce-global-supply-agreement-to-support-alpha-9s-clinical-radiopharmaceutical-development-program 2024-01-31 04:37:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-xdc-enters-into-partnership-with-multitude-therapeutics-and-hyslink-therapeutics-novel-linker-payload-technology-enabling-clients-to-accelerate-adc-discovery-and-development 2024-01-31 03:57:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-expands-biologics-manufacturing-capacity-with-a-223-million-investment-in-singapore-manufacturing-site 2024-01-31 00:28:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jubilant-pharmovas-wholly-owned-subsidiary-to-sell-its-entire-258-stake-in-sofie-biosciences-inc-usa-for-aggregate-proceeds-of-about-usd-13943-million-including-preferred-returns 2024-01-30 23:43:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchid-pharmas-exblifep-granted-european-medicines-agency-approval-a-landmark-achievement-for-indias-pharmaceutical-industry 2024-01-30 23:55:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-now-offers-3-new-pharma-products 2024-01-30 03:19:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oricells-oricar-017-granted-fda-clearance-for-multiple-myeloma-car-t-therapy 2024-01-30 01:10:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/malaysian-patent-granted-for-cytomed-therapeutics-licensed-allogeneic-car-gamma-delta-t-cell-technology 2024-01-30 01:06:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-submits-new-drug-application-for-mecobalamin-ultrahigh-dose-formulation-in-japan-for-the-indication-of-amyotrophic-lateral-sclerosis 2024-01-29 03:47:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/processa-pharmaceuticals-announces-successful-completion-of-phase-1b-safety-evaluation-of-ngc-cap-in-patients-with-advanced-cancer-resulting-in-recommended-phase-2-doses 2024-01-29 03:11:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nus-mechanobiology-institute-receives-s49m-boost-to-develop-biomedical-innovations-for-age-related-conditions-such-as-infertility-muscle-loss-and-cancer 2024-01-25 04:46:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prism-biolab-raises-15-billion-yen-in-series-c-fundraising-to-advance-technologies-and-programs-targeting-protein-protein-interactions 2024-01-25 04:40:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-announces-renbiologics-sub-brand-focused-on-licensing-fully-human-antibodies-for-therapeutic-development 2024-01-25 01:25:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosion-announces-fda-clearance-of-ind-application-for-bsi-082-a-novel-anti-sirpa-monoclonal-antibody 2024-01-25 01:23:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-publishes-novel-mechanism-of-action-of-rnai-cancer-therapeutic-stp707-for-solid-tumors 2024-01-25 01:21:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-ind-clearance-for-hbm9027-in-the-us 2024-01-24 00:59:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-xdc-and-celltrion-sign-mou-for-integrated-services-for-antibody-drug-conjugates-adcs 2024-01-24 00:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-first-pediatric-patient-dosed-in-clinical-trial-of-pan-trk-inhibitor-zurletrectinib-in-china 2024-01-24 00:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bold-therapeutics-announces-positive-phase-2-safety-and-efficacy-results-for-bold-100-in-advanced-metastatic-colorectal-cancer-at-asco-gi-2024 2024-01-23 01:10:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gannexs-strategic-partner-sagimet-biosciences-announces-positive-topline-results-from-phase-2b-fascinate-2-clinical-trial-of-denifanstat-in-biopsy-confirmed-f2f3-nash 2024-01-23 01:06:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-prescribes-tafasitamab-combo-for-dlbcl-in-greater-bay-area-early-access-program 2024-01-22 06:11:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prilenia-announces-clinical-data-in-support-of-its-plans-to-initiate-global-phase-3-study-in-als 2024-01-20 03:07:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tempus-introduces-xm-to-assess-minimal-residual-disease-mrd-in-patients-with-colorectal-cancer-crc-for-research-use-only 2024-01-19 03:25:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/egenesis-and-organox-announce-successful-use-of-a-genetically-engineered-porcine-liver-with-a-human-donor 2024-01-19 03:27:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helio-genomics-collaborates-with-university-of-california-irvine-to-study-effectiveness-of-multimodal-epigenetic-sequencing-for-enhancing-early-cancer-detection 2024-01-19 03:11:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomica-successfully-completes-phase-i-trial-enrollment-for-microbiome-based-immuno-oncology-drug 2024-01-18 03:09:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-granted-us-patent-for-proprietary-bispecific-antibody-technology-platform-wuxibody 2024-01-18 01:59:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-and-sun-pharma-sign-marketing-and-distribution-agreement-for-second-brand-of-finerenone-in-india 2024-01-17 07:27:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kairos-pharma-doses-first-patients-in-phase-1-trial-of-lead-drug-candidate-env105-with-osimertinib-to-improve-therapy-sensitivity-for-egfr-driven-lung-cancer 2024-01-17 05:35:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delcath-systems-announces-us-launch-and-first-commercial-treatment-utilizing-hepzato-kit 2024-01-17 05:40:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chipscreen-newway-first-patient-dosed-in-phase-1-trial-of-the-bispecific-antibody-nwy001-a-next-generation-tumor-immunotherapy-in-patients-with-advanced-solid-tumors 2024-01-16 04:46:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/subject-enrollment-completed-for-international-multicenter-comparative-clinical-phase-3-study-of-boan-biotechs-denosumab 2024-01-16 04:38:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinchoice-acquires-csi-expanding-its-global-footprint-into-southeast-asia 2024-01-12 01:59:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-path-holdings-completes-first-dose-cohort-in-phase-1-trial-for-bp1002-in-lymphoma-and-cll 2024-01-12 01:56:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-silicon-biosystems-announces-publication-of-the-detect-iii-trial-results-highlighting-the-potential-clinical-utility-of-her2-testing-in-circulating-tumor-cells-with-cellsearch 2024-01-10 01:41:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/faron-announces-first-hma-failed-mds-patient-dosed-with-bexmarilimab-as-part-of-phase-2-of-bexmab-trial 2024-01-10 01:38:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-cells-promising-ab-201-cancer-treatment-to-begin-phase-1-trials-using-lunit-ai-platform 2024-01-09 00:49:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-triples-peptide-manufacturing-capacity-and-launches-the-new-taixing-api-manufacturing-site 2024-01-09 00:46:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/specialised-therapeutics-and-ascendis-pharma-sign-exclusive-deal-for-endocrinology-therapies-in-australia-and-se-asia 2024-01-08 04:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kexing-biopharm-introduces-eribulin-mesylate-injection-expanding-its-overseas-product-portfolio 2024-01-06 01:24:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supplemental-new-drug-application-for-akesos-cadonilimab-pd-1ctla-4-accepted-by-nmpa-for-first-line-treatment-of-gastric-cancer 2024-01-06 01:20:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jw-therapeutics-announces-nmpa-acceptance-of-the-supplemental-biological-license-application-for-carteyva-in-patients-with-relapsed-or-refractory-mantle-cell-lymphoma 2024-01-05 01:54:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/itm-announces-operational-readiness-for-nova-facility-the-worlds-largest-lutetium-177-production-site 2024-01-05 01:44:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turn-biotechnologies-expanded-eturna-delivery-platform-designed-to-solve-delivery-and-targeting-issues-that-challenge-industry 2024-01-04 01:53:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/belief-biomed-successfully-completed-dosing-of-first-subject-in-the-registrational-clinical-trial-for-hemophilia-a 2024-01-04 01:47:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gpn-vaccines-reports-positive-safety-and-immunogenicity-data-from-its-phase-1-trial-of-gamma-pn 2024-01-04 01:43:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allorion-therapeutics-announces-exclusive-option-and-global-license-agreement-for-novel-preclinical-stage-egfr-l858r-allosteric-inhibitor-program-with-astrazeneca 2024-01-03 01:52:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciwind-biosciences-reports-positive-phase-3-results-for-ecnoglutide-xw003-in-type-2-diabetes-in-china 2024-01-03 01:48:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-dosed-first-participant-in-phase-3-clinical-study-glory-2-of-mazdutide-ibi362-higher-dose-9-mg-in-chinese-adults-with-obesity 2024-01-02 07:08:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galapagos-signs-agreement-to-transfer-jyseleca-business-to-alfasigma 2024-01-02 06:58:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tiumbio-secures-krw-385-billion-in-anticipation-of-upcoming-clinical-data 2023-12-30 01:03:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-announces-positive-phase-results-for-scb-219m-for-treatment-of-chemotherapy-induced-thrombocytopenia-cit 2023-12-29 01:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heranova-lifesciences-debuts-with-135-million-seed-and-seed-round-funding-to-offer-integrated-clinical-solutions-to-womens-health 2023-12-29 00:56:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hightide-therapeutics-ipo-and-first-clinical-trial-for-nash-treatment-applauded-by-hkstp-boosting-hong-kongs-biotech-ecosystem 2023-12-28 07:54:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boan-biotechs-two-innovative-drugs-targeting-claudin-182-granted-odd-by-fda 2023-12-28 01:46:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliway-to-present-cbl-514-phase-2-study-results-for-subcutaneous-fat-reduction-at-imcas-2024 2023-12-28 01:41:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmablock-opens-hpapi-gmp-facility-at-zhejiang-manufacturing-site 2023-12-27 01:09:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/legochem-biosciences-announces-license-agreement-for-lcb84-trop2-targeted-adc 2023-12-26 05:05:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jemincare-announces-6-approvals-of-clinical-trials-for-its-innovative-drugs 2023-12-26 05:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncoshot-teams-up-with-zhejiang-ablaze-medicine-to-drive-data-powered-drug-development-in-china 2023-12-26 01:16:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arab-health-sells-out-as-international-exhibitors-hit-record-levels 2023-12-22 03:22:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arab-health-congress-confirms-partnership-with-dubai-health-authority 2023-12-22 03:22:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juniper-therapeutics-acquires-exclusive-rights-for-sar-registration-for-anti-viral-covid-19-drug-from-ping-an-shionogi-hong-kong-for-singapore 2023-12-22 01:33:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellorigin-announced-treatment-of-the-first-patient-with-car-m-in-china-and-reported-the-second-generation-of-car-m-for-solid-tumors 2023-12-22 01:10:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transthera-completes-first-patient-dosing-in-us-phase-3-trial-of-tinengotinib-for-cholangiocarcinoma 2023-12-22 01:06:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enlivex-announces-completion-of-enrollment-of-its-phase-ii-trial-evaluating-allocetra-in-patients-with-sepsis 2023-12-21 03:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocity-announces-the-first-patient-dosed-with-its-anti-tim-3-mab-bc3402-in-combination-with-imfinzi-for-the-treatment-of-advanced-hepatocellular-carcinoma-in-a-phase-ibii-trial 2023-12-21 01:56:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemdiv-helps-advance-virioms-influenza-treatment-to-successful-phase-i-clinical-trials-completion 2023-12-20 03:29:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huiadgene-announces-rare-pediatric-drug-designation-granted-to-hg302-a-novel-crispr-dna-editing-therapy-for-the-treatment-of-duchenne-muscular-dystrophy 2023-12-20 01:27:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-biologics-concludes-integration-of-acquired-biosimilars-business-in-120-countries 2023-12-19 01:18:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sub-license-agreement-for-ensitrelvir-fumaric-acid-in-covid-19-treatment-executed-by-ping-an-shionogi-hong-kong-to-juniper-therapeutics-with-sar-approval-in-singapore 2023-12-19 01:13:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalyst-pharmaceuticals-announces-firdapse-new-drug-application-submitted-in-japan-by-partner-dydo-pharma 2023-12-19 01:06:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carina-biotech-doses-first-patient-in-phase-12a-clinical-trial-of-lgr5-targeted-car-t-cell-therapy 2023-12-19 01:02:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-clinical-trial-of-yolt-201-for-the-treatment-of-hereditary-attr-cm 2023-12-18 03:30:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-receives-positive-chmp-opinion-for-hyqvia-as-maintenance-therapy-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy-cidp 2023-12-18 03:27:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-reports-cd47-antibody-ligufalimab-results-in-mds-and-aml-at-ash-2023 2023-12-18 03:12:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rezolute-initiates-phase-3-clinical-study-for-rz358-in-congenital-hyperinsulinism 2023-12-15 01:12:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-dna-announces-joint-development-agreement-to-integrate-linea-ivt-platform-into-cdmo-kudo-biotechnologys-mrna-manufacturing-workflow 2023-12-15 01:09:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/molecular-loop-biosciences-receives-18-million-to-expand-multi-pathogen-genomics-products-for-respiratory-infections 2023-12-14 01:28:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alebund-ap306-phase-ii-trial-update-in-hyperphosphatemia-patients-on-hemodialysis 2023-12-14 01:24:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/india-pharma-techs-next-big-opportunity-lies-in-the-sales-and-marketing-stack-reveals-bessemer-venture-partners 2023-12-13 03:12:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qilu-pharmaceutical-announces-results-from-phase-i-clinical-study-for-its-novel-bispecific-antibody-qls31905-at-esmo-immuno-oncology-congress 2023-12-13 01:23:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-initiates-phase-clinical-trial-for-rsv-vaccine-candidate 2023-12-13 01:15:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shinobi-therapeutics-launches-with-completion-of-51m-series-a-to-advance-hypoimmune-ips-t-cell-therapy-platform 2023-12-13 01:11:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzamend-neuro-granted-fda-approval-for-phase-iia-trial-of-al001-in-ptsd 2023-12-12 01:51:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hemab-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-study-investigating-hmb-001-for-the-treatment-of-glanzmann-thrombasthenia 2023-12-12 01:45:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-minapharm-sign-an-exclusive-agreement-for-localizing-the-manufacture-of-clexane 2023-12-11 04:57:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exegi-pharma-announces-first-patient-enrollment-in-the-prof-trial-of-exe-346 2023-12-11 04:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-group-announces-marketing-approval-for-pivlaz-clazosentan-sodium-150-mg-in-south-korea 2023-12-08 03:10:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regor-announces-positive-data-for-rgt-419b-in-hrher2-advanced-breast-cancer-after-cdk46-inhibitors 2023-12-08 01:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-reports-positive-phase-3-results-for-sintilimab-in-first-line-ggej-adenocarcinoma 2023-12-07 00:51:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cidara-therapeutics-announces-completion-of-enrollment-in-phase-3-restore-trial-of-rezafungin-in-china 2023-12-07 00:44:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytomed-therapeutics-signs-hoa-and-mou-to-advance-research-on-allogeneic-gamma-delta-t-cell-technology 2023-12-06 03:41:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-partner-jingxin-receives-approval-for-evt201-in-china 2023-12-06 03:29:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-announces-first-in-human-study-for-orally-phd-inhibitor-ism5411-for-inflammatory-bowel-disease-ibd 2023-12-06 01:46:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-announces-successful-completion-of-cohort-1-from-phase-i-clinical-study-of-galnac-based-rnai-therapeutic 2023-12-06 01:43:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kindeva-drug-delivery-and-orbia-fluorinated-solutions-announce-collaboration-for-low-gwp-propellant-conversion 2023-12-05 07:12:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vibcare-healthcare-opens-a-pharmaceutical-manufacturing-facility-with-rs-40-crore-investment-in-panchkula-haryana 2023-12-05 01:57:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/technoderma-medicines-completes-phase-1-dose-escalation-clinical-trial-of-tdm-180935-for-atopic-dermatitis 2023-12-05 01:33:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/granules-india-limited-received-anda-approval-for-sildenafil-for-oral-suspension 2023-12-04 03:45:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-alecensa-reduces-the-risk-of-disease-recurrence-or-death-by-more-than-60-in-asian-patients-with-alk-positive-early-stage-non-small-cell-lung-cancer 2023-12-04 03:50:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-establishes-mrna-production-facility-in-hwasun-korea 2023-12-04 03:14:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-reports-positive-phase-3-results-for-etrasimod-in-ulcerative-colitis 2023-12-04 03:09:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerecin-forges-strategic-partnership-with-astars-institute-of-molecular-and-cell-biology-imcb-in-singapore-to-advance-rd-in-neurological-disorders 2023-12-04 01:57:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujirebio-and-sysmex-expand-cdmo-partnership-into-the-field-of-neurodegenerative-diseases-under-their-immunoassay-collaboration 2023-11-30 04:27:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurexone-biologic-extends-spinal-cord-injury-therapy-portfolio-with-new-rna-sequences-promoting-healing-and-regeneration 2023-11-30 04:19:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polaris-group-announces-first-patient-successfully-dosed-with-adi-peg-20placebo-in-phase-2a-non-alcoholic-steatohepatitis-nash-study 2023-11-30 04:15:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medavail-announces-agreement-with-new-orleans-based-st-thomas-community-health-centers-for-deployment-of-two-m4-medcenters 2023-11-29 01:16:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-launches-construction-of-shanghai-global-rd-center-to-accelerate-its-innovation-globalization-strategy 2023-11-29 01:12:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neumora-therapeutics-announces-nmra-266-ind-clearance-and-initiation-of-phase-1-clinical-study 2023-11-28 01:08:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lexarias-technology-improves-the-oral-performance-of-the-rybelsusr-branded-glp-1-drug-semaglutide-in-human-pilot-study 2023-11-28 01:05:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-china-nmpas-approval-of-nefecon-for-the-treatment-of-primary-iga-nephropathy-in-adult-patients 2023-11-24 01:02:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-anhearts-taletrectinib-nda-accepted-by-chinas-nmpa 2023-11-24 00:54:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-successfully-implemented-a-fully-integrated-continuous-process-with-a-breakthrough-productivity-of-6-glday-at-pilot-scale 2023-11-23 01:29:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-receives-approval-from-us-fda-for-pitavastatin-tablets 2023-11-22 03:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-and-eddc-sign-new-collaboration-empowering-biomedical-innovation-with-robotics-and-large-language-models 2023-11-22 01:48:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/croda-singapore-expands-speciality-chemicals-manufacturing-with-new-pastillation-facility 2023-11-21 23:26:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chengdu-origen-and-vanotech-announce-first-patient-dosed-in-van-2201-phase-1-trial-of-gene-therapy-for-wet-age-related-macular-degeneration 2023-11-21 00:57:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-subject-enrolled-in-phase-1-study-of-mrx-5 2023-11-21 00:54:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acrometa-subsidiary-signs-two-mous-to-develop-co-working-laboratory-space-business-in-china 2023-11-20 06:33:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-launches-evinova-a-health-tech-business-to-accelerate-innovation-across-the-life-sciences-sector 2023-11-20 06:13:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/olverembatinib-approved-for-new-indicatation-allowing-more-patients-with-cml-to-benefit-from-the-drug 2023-11-20 06:06:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-now-ranks-the-3rd-among-the-global-air-cargo-carriers 2023-11-20 03:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adlai-nortye-completes-patient-enrollment-in-phase-iii-trial-of-buparlisib-an2025-paclitaxel-for-recurrent-hnscc 2023-11-18 01:03:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cg-pharmaceuticals-announces-the-commencement-of-phase-2-study-for-metastatic-pancreatic-cancer 2023-11-18 00:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/once-weekly-transcon-cnp-achieved-primary-efficacy-objective-in-accomplish-china-phase-2-trial 2023-11-17 01:11:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/university-of-tsukuba-and-astellas-confirm-a-strategic-partnership 2023-11-16 01:31:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orionis-biosciences-announces-first-patient-dosed-in-phase-1-clinical-trial-of-orb-011-in-patients-with-advanced-solid-tumors 2023-11-16 01:22:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aribio-co-ltd-announces-global-expansion-of-polaris-ad-a-phase-3-early-alzheimers-disease-registration-trial 2023-11-15 01:34:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axtria-introduces-ai-enabled-solution-for-emerging-biotech-and-pharmaceutical-companies 2023-11-15 01:31:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-phase-iii-prostact-global-study-of-antibody-based-prostate-cancer-therapy-candidate-tlx591 2023-11-14 04:46:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viatris-and-theravance-biopharma-report-positive-phase-iii-results-for-yupelri-in-copd-trial-in-china 2023-11-14 04:32:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioray-announces-the-incorporation-of-the-first-patient-to-the-phase-i-clinical-study-of-bry812 2023-11-14 04:15:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wollongong-hospital-a-world-leader-in-cancer-research 2023-11-13 23:41:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/take-the-lead-in-revolutionizing-pharma-regulation-be-part-of-the-2023-pda-asia-pacific-regulatory-conference-sponsored-workshop 2023-11-10 05:42:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senhwa-biosciences-announces-first-patient-successfully-dosed-in-taiwan-phase-ii-study-of-silmitasertib-in-hospitalized-adults-with-covid-19 2023-11-10 01:43:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabcine-advances-to-dose-level-2-in-clinical-trial-of-pmc-403-for-neovascular-amd 2023-11-10 01:40:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-and-wiik-pharma-sign-distribution-agreement-for-illuccix-in-the-nordic-region 2023-11-09 01:08:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flagship-pioneering-expands-into-asia-pacific-region-with-regional-hub-in-singapore 2023-11-09 01:01:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-cadonilimab-phase-iii-trial-shows-strong-survival-benefit-in-gastric-cancer-and-gejc-patients 2023-11-08 01:26:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-completes-bla-submission-for-seasonal-influenza-vaccine-in-brazil 2023-11-08 01:19:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kn026-was-granted-breakthrough-therapy-designation-by-cde 2023-11-08 01:15:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scinai-immunotherapeutics-announces-award-of-non-dilutive-grant-from-israel-innovation-authority 2023-11-07 06:20:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lerna-bio-unveils-its-first-in-class-solution-to-combat-liver-failure 2023-11-07 00:57:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-partner-pfizer-progresses-its-glp-1-receptor-agonist-pf-06954522-into-a-phase-1-trial 2023-11-06 03:04:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/17m-awarded-to-develop-globally-important-vaccine-hubs 2023-11-04 03:11:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-launches-diazepam-rectal-gel-in-the-united-states 2023-11-03 01:28:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-presents-new-data-that-show-blood-pressure-decreases-for-adults-treated-with-krystexxa-pegloticase 2023-11-03 01:20:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curocell-completes-koreas-first-phase-2-clinical-trial-for-next-generation-car-t 2023-11-02 01:05:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/resolian-acquires-china-based-bioanalytical-cro-denali-medpharma 2023-11-02 01:00:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-therapeutics-reports-positive-results-for-dextenza-in-post-cataract-surgery-patients-in-china 2023-11-01 01:24:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-initiation-of-phase-12-clinical-trial-of-bbt-207-in-egfr-mutant-nsclc 2023-11-01 01:19:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-enrolled-in-phase-iii-clinical-trial-of-boan-biotechs-nivolumab-injection 2023-10-31 01:20:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-initiation-of-phase-12-clinical-trial-of-bbt-207-in-egfr-mutant-nsclc 2023-10-31 01:15:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-and-zydus-sign-licensing-agreement-for-co-marketing-of-desidustat-a-critical-treatment-option 2023-10-30 05:43:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coherus-and-junshi-biosciences-fda-approve-loqtorzi-for-nasopharyngeal-carcinoma 2023-10-30 01:58:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fapon-lascco-abionic-formed-strategic-collaboration-for-psp-sepsis-diagnosis-in-china 2023-10-27 03:01:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-and-psi-kick-off-sar-bispsma-phase 2023-10-27 03:11:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skye-bioscience-announces-positive-phase-1-trial-results-for-sbi-100-ophthalmic-emulsion-its-first-in-class-cb1-agonist-being-developed-for-the-treatment-of-glaucoma 2023-10-26 01:39:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renibus-announces-first-patient-enrolled-in-protect-phase-3-study-of-rbt-1-to-reduce-post-operative-complications-after-cardiothoracic-surgery 2023-10-26 01:32:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-introduces-new-chapter-in-moisture-protection-with-launch-of-three-new-excipient-grades-at-cphi-barcelona 2023-10-25 05:35:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/citius-pharmaceuticals-executes-definitive-agreement-to-merge-wholly-owned-subsidiary-with-tenx-keane-acquisition 2023-10-25 00:55:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-completes-the-acquisition-of-qualicaps-and-reinforces-its-global-position-in-the-pharmaceutical-industry 2023-10-24 07:12:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obio-announces-strategic-partnership-with-refreshgene-to-realize-commercialization-of-gene-therapy 2023-10-24 03:19:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xingimaging-and-mitro-biotech-co-ltd-merge-to-deliver-full-service-cro-operations 2023-10-24 03:12:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/index-pharmaceuticals-has-been-granted-a-new-patent-for-cobitolimod-in-south-korea 2023-10-21 01:01:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sabin-vaccine-institute-begins-phase-2-clinical-trial-for-marburg-vaccine-in-uganda 2023-10-20 01:36:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-pd-1ctla-4-bispecific-antibody-shows-promise-in-refractory-solid-tumors-study-results-in-cell-reports-medicine 2023-10-20 01:30:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qilu-pharmaceutical-to-showcase-novel-anti-cancer-drug-ql1706-at-esmo 2023-10-20 01:12:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/australias-doherty-institute-joins-cepis-laboratory-network-to-speed-up-development-of-epidemic-and-pandemic-vaccines 2023-10-19 02:59:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/complete-genomics-partners-with-integrated-dna-technologies-to-establish-new-ecosystem-of-ngs-products 2023-10-19 02:54:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brise-pharma-announces-first-patient-dosed-with-br01t-in-phase-i-study-in-patients-with-chronic-low-back-pain 2023-10-19 01:57:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio4t2-announces-trial-evaluating-repeat-infusions-of-car-t-targeting-solid-tumors-without-lymphodepletion 2023-10-18 03:07:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunoforge-doses-first-patient-in-phase-2-clinical-trial-of-froniglutide-for-dermatomyositispolymyositis 2023-10-18 02:58:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-launches-new-high-productivity-bioprocessing-platform-wuxiui-for-cost-effective-commercial-manufacturing-and-desirable-product-quality 2023-10-17 01:42:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/canbridge-announces-full-enrollment-reached-in-the-core-part-of-the-can103-phase-2-trial-for-gaucher-disease-in-china 2023-10-17 01:36:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuvalent-reports-preliminary-phase-1-clinical-data-from-alkove-1-trial-that-support-best-in-class-potential-of-nvl-655-for-patients-with-alk-positive-nsclc 2023-10-17 01:31:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kronos-bio-presents-positive-preliminary-data-from-phase-1-dose-escalation-portion-of-phase-12-kb-0742-study-at-aacr-nci-eortc 2023-10-17 01:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-registrational-phase-iii-study-of-bcl-2-inhibitor-lisaftoclax-in-treatment-naive-patients-with-cllsll-approved-by-the-china-cde 2023-10-17 01:13:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/specialised-therapeutics-signs-exclusive-license-agreement-with-canariabio-for-new-ovarian-cancer-therapy 2023-10-17 00:58:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/purple-biotech-reports-potential-biomarker-data-support-cm24s-mechanism-of-action 2023-10-13 04:06:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-receives-tentative-approval-from-us-fda-for-tolvaptan-tablets 2023-10-13 04:03:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-new-picus-2-sets-a-new-standard-for-connected-electronic-pipettes 2023-10-13 04:44:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-tofidence-a-biosimilar-of-actemra-developed-by-bio-thera-solutions 2023-10-12 06:43:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mediwound-announces-collaboration-with-3m-on-escharex-phase-iii-study 2023-10-12 23:25:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharma-announces-the-approval-of-phase-ii-clinical-trial-of-hedgehogsmo-inhibitor-gt1708f-for-treatment-of-ipf-in-china 2023-10-12 23:27:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujirebio-and-sysmex-enter-into-basic-agreement-on-business-collaboration-in-the-field-of-immunoassay 2023-10-12 00:57:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-antibiotic-drug-developed-by-hku-chemistry-research-team-approved-for-clinical-trials-in-humans 2023-10-12 00:55:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-and-abl-bio-announce-latest-updates-of-pd-l1-and-4-1bb-bispecific-antibody-tj-l14b 2023-10-12 00:53:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taigen-enters-exclusive-license-agreement-with-ysp 2023-10-12 00:50:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gritgen-therapeutics-launches-commercial-gmp-facility-in-suzhou-china 2023-10-12 00:48:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-secures-iatas-ceiv-pharma-certificate 2023-10-11 23:22:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/creating-future-ready-organisations-5th-annual-pharma-manufacturing-and-automation-convention-2024 2023-10-10 23:58:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mediwound-deploys-nexobrid-for-emergency-supply 2023-10-10 04:08:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-biological-announces-the-opening-of-its-new-us-based-center-for-bioprocessing 2023-10-10 04:06:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-technologies-announces-licensing-of-evolux 2023-10-10 04:04:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/canariabio-and-hikma-announce-the-signing-of-distribution-and-license-agreement-for-oregovomab-in-mena-region 2023-10-10 04:01:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-griffith-university-site-for-the-translational-science-hub-brings-global-vaccine-research-and-development-to-the-gold-coast 2023-10-06 05:22:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-opens-new-manufacturing-facility-and-experience-center-in-india 2023-10-06 05:20:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/65lab-launches-in-partnership-with-evotec-se-and-backed-by-leading-global-investors-to-advance-drug-discovery-and-new-company-creation-in-singapore 2023-10-05 04:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncohosts-prophet-platform-to-support-henlius-us-based-phase-iii-trial-for-patients-with-extensive-stage-small-cell-lung-cancer 2023-10-04 01:27:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meitheal-pharmaceuticals-announces-expansion-of-portfolio-of-generic-injectable-products 2023-10-04 01:24:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lokavant-announces-8m-strategic-investment-from-mitsui-co-to-expand-ai-and-predictive-clinical-trial-intelligence-into-asia-pacific 2023-10-04 01:22:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-treated-with-cu-67-sar-bombesin-in-theranostic-prostate-cancer-trial 2023-10-04 01:07:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/a-stars-genome-institute-of-singapore-nanostring-and-next-level-genomics-establish-joint-lab 2023-10-04 01:02:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/granules-india-limited-received-anda-approval-for-losartan-and-hydrochlorothiazide-tablets 2023-10-03 03:22:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caliways-cbl-514-achieved-better-efficacy-than-liposuction 2023-10-03 01:01:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-provides-update-on-exkivity-mobocertinib 2023-10-03 00:56:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compugen-expands-intellectual-property-with-new-japanese-patent-for-the-triple-combination-of-any-anti-pvrig 2023-10-03 00:51:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-initiated-its-clinical-trial-with-sci-210-in-pediatrics-with-autism-spectrum-disorder 2023-09-30 04:50:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-and-remegen-collaborates-on-clinical-study-exploring-the-potential-of-pd-1-ctla-4-bispecific-antibody 2023-09-30 01:43:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-submission-of-new-drug-application-for-fruquintinib-for-previously-treated-metastatic-colorectal-cancer-in-japan 2023-09-30 01:40:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/germanys-merck-and-krisai-expand-collaboration 2023-09-29 07:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabwell-announces-first-patient-dosed-in-phase-trial-of-its-novel-nectin-4-targeting-adc-in-combination-with-pd-1-inhibitor 2023-09-29 07:39:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/paion-announces-submission-of-new-drug-application-for-remimazolam-by-its-licensee-mundipharma-in-japan 2023-09-29 07:32:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kriya-announces-exclusive-license-and-collaboration-agreement-with-everads-to-advance-gene-therapies-for-prevalent-diseases-in-ophthalmology-including-geographic-atrophy 2023-09-28 01:17:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akeso-announced-fda-clearance-of-ind-for-cd47-monoclonal-antibody-in-combination-with-azacitidine-in-myelodysplastic-syndromes 2023-09-28 01:14:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-approval-of-xerava-in-taiwan-for-the-treatment-of-complicated-intra-abdominal-infections-in-adult-patients 2023-09-28 01:13:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obio-has-launched-its-state-of-the-art-gmp-production-facility-intelli-m-to-expedite-innovative-and-advanced-therapies 2023-09-28 01:04:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elpiscience-announces-first-patient-dosed-for-phase-1-clinical-trial-of-anti-lilrb2-antibody-es009-in-australia 2023-09-27 01:00:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascletis-announces-completion-of-enrollment-of-120-patients-in-the-phase-iii-clinical-trial-of-fasn-inhibitor-asc40 2023-09-27 00:58:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abm-therapeutics-abm-1310-granted-fast-track-designation-by-the-fda-following-orphan-drug-designation 2023-09-27 00:56:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-vaccines-launches-its-first-vaccines-cdmo-site-in-china 2023-09-27 00:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/henlius-novel-anti-pd-1-mab-hansizhuang-approved-for-the-treatment-of-escc 2023-09-27 00:00:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/establishment-of-mgis-alab-at-hong-kong-science-park-to-expand-its-global-rd-footprint 2023-09-26 23:57:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-therapeutics-announces-clinical-trial-application-approval-in-mainland-china-for-risuteganib 2023-09-26 23:41:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kyowa-kirin-announces-approval-of-phozevel-for-improvement-of-hyperphosphatemia-in-chronic-kidney-disease-patients-on-dialysis-in-japan 2023-09-26 06:36:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-innovation-announces-collaboration-with-singapore-economic-development-board 2023-09-26 06:26:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-announces-approval-in-japan-of-avt04-a-biosimilar-to-stelara 2023-09-26 05:19:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/once-weekly-altuviiio-approved-in-japan-as-a-new-class-of-factor-viii-therapy-for-hemophilia-a 2023-09-26 04:43:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cara-therapeutics-announces-approval-of-korsuva-iv-injection-syringe-in-japan-for-the-treatment-of-pruritus-in-hemodialysis-patients 2023-09-26 04:29:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-pharmteco-to-expand-capabilities-with-acquisition-of-controlling-interest-in-center-for-breakthrough-medicines 2023-09-22 05:49:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-fda-acceptance-of-nda-resubmission-of-tak-721-for-the-short-term-treatment-of-eosinophilic-esophagitis 2023-09-22 05:48:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cepi-and-bio-farma-partnership-boosts-rapid-response-vaccine-manufacturing-for-the-global-south 2023-09-22 05:40:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/golidocitinib-granted-priority-review-by-china-nmpa-for-the-treatment-of-r-r-ptcl 2023-09-22 05:08:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-phase-i-study-of-anti-cd24-monoclonal-antibody-atg-031 2023-09-22 05:09:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polypid-announces-successful-completion-of-manufacturing-process-validation-for-d-plex1 2023-09-21 01:33:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurosense-granted-patents-in-europe-japan-and-israel-for-its-als-drug-primec 2023-09-21 01:28:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/1st-biotherapeutics-announces-clinical-trial-collaboration-and-supply-agreement-with-msd-to-evaluate-fb849-in-combination-with-keytruda 2023-09-21 01:19:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abu-dhabi-stem-cells-center-successfully-manufactures-uaes-first-car-t-cell-to-treat-an-11-year-old-leukemia-patient 2023-09-19 05:19:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-announces-expanded-strategic-agreement-with-bristol-myers-squibb-to-manufacture-antibody-cancer-drug-substance 2023-09-19 05:12:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iveric-bio-announces-positive-24-month-topline-results-from-phase-3-study-of-izervay 2023-09-19 04:33:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cure-genetics-and-frametact-reach-a-60-million-collaboration-and-licensing-agreement 2023-09-16 05:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-advanced-and-brl-medicine-build-strategic-partnership-to-accelerate-commercialization-of-gene-and-cell-therapies 2023-09-16 05:14:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aclipse-therapeutics-expands-drug-development-pipeline-with-signing-of-exclusiv 2023-09-16 05:12:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quizartinib-recommended-for-approval-in-eu-by-chmp-for-patients-with-newly-diagnosed-flt3-itd-positive-aml 2023-09-16 04:31:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ys-biopharma-granted-patent-in-the-us-for-immunotherapy-targeting-chronic-hepatitis-b-virus-infection 2023-09-16 03:52:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labasia-2023-pioneering-scientific-innovation-cultivating-partnerships-and-intellectual-exchange 2023-09-15 07:39:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hong-kong-science-park-invites-french-biotech-innovators-to-go-global-via-asias-booming-markets 2023-09-15 05:51:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-approval-of-clinical-trial-of-shp2-inhibitor-icp-189-in-combination-with-egfr-inhibitor-furmonertinib 2023-09-14 07:04:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovative-collaboration-buzzreach-and-oncoshot-spearhead-clinical-trial-advancements-in-japan 2023-09-14 07:02:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/south-korean-biotech-company-portrai-inc-adopts-infortrend-storage-to-enable-ai-data-analysis-for-pharmaceutical-drug-development 2023-09-13 00:46:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genetype-gianted-appioval-foi-pancieatic-cancei-melanoma-and-atiial-fibiillation-in-austialia 2023-09-13 00:42:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lib-therapeutics-and-hasten-biopharmaceutical-company-announce-325-million-strategic-collaboration 2023-09-13 00:37:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-asia-pacific-enters-into-an-exclusive-licensing-agreement-with-astellas-to-commercialize-smyraf-in-taiwan 2023-09-13 00:30:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-inaugural-program-on-pharma-impurities-setting-high-benchmarks-for-the-industry 2023-09-12 07:29:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/solving-the-challenges-and-setting-the-trend-with-the-3rd-annual-cleaning-validation-2023 2023-09-12 07:25:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-launches-quadrivalent-seasonal-influenza-vaccine-in-mainland-china 2023-09-12 01:15:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monrol-announces-investment-to-expand-its-nca-177-production-capacity 2023-09-12 01:11:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/treatment-with-rybrevant-and-lazertinib-plus-chemotherapy-showed-durable-progression-free-survival-in-patients 2023-09-12 01:07:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-completes-patient-enrollment-of-a-bridging-study-of-tazemetostat-in-patients 2023-09-12 01:01:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-partners-with-sandoz-to-commercialize-ustekinumab-biosimilar-candidate 2023-09-11 23:46:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-positive-topline-results-from-phase-2b-study-evaluating-tak-279 2023-09-11 23:45:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kubota-vision-announces-collaborative-research-agreement-with-china-medical-university-hsinchu-hospital 2023-09-08 03:12:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recce-pharmaceuticals-announces-recce-trademark-registered-in-vietnam 2023-09-08 01:58:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-opens-new-gmp-cell-culture-media-manufacturing-facility 2023-09-08 01:56:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ariceum-therapeutics-doses-first-patient-with-its-first-in-class-targeted-radiopharmaceutical-drug-satoreotide 2023-09-08 01:52:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cn-bio-and-lifenet-health-lifesciences-partner-to-supply-validated-primary-human-cells-for-microphysiological-systems 2023-09-08 01:48:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-receives-first-product-approval-in-china 2023-09-07 06:48:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-collaborates-with-mark-cuban-cost-plus-drug-company-and-copd-foundation-to-expand-access-to-medication-for-copd-patients 2023-09-07 06:49:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurophth-secures-australian-approval-for-ophthalmic-gene-therapy 2023-09-07 06:37:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-announces-topline-interim-results-of-phase-2-study-evaluating-brii-179 2023-09-06 07:21:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cell-impact-participates-in-the-stuttgart-hy-fcell-conference-and-exhibition 2023-09-06 07:14:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vitestro-starts-largest-scale-clinical-trial-globally-for-its-autonomous-blood-drawing-device 2023-09-06 04:34:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-application-for-genentechs-crovalimab-for-the-treatment-of-pnh-a-rare-life-threatening-blood-condition 2023-09-06 03:30:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heartseed-enters-into-induced-pluripotent-stem-cell-purification-patent-license-agreement-for-commercialization-of-cell-therapy 2023-09-06 03:00:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vistagen-and-fuji-enter-exclusive-negotiation-agreement-for-a-potential-license-to-develop-and-commercialize-vistagens 2023-09-06 02:53:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-alecensa-delivers-positive-phase-iii-results-for-people-with-alk-positive-early-stage-lung-cancer 2023-09-05 05:14:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-limited-announces-the-acquisition-of-a-manufacturing-facility-of-eywa-pharma-inc 2023-09-05 05:05:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ivi-and-cepi-renew-partnership-to-accelerate-development-of-vaccines-against-emerging-infectious-disease-threats 2023-09-05 03:33:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/5th-annual-pharma-manufacturing-and-automation-convention-2023 2023-09-04 01:56:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsks-regulatory-submission-accepted-for-review-by-japanese-regulator-for-use-of-nucala-in-adults 2023-09-01 23:40:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hiro-acquires-us-cro-courante-oncology-strengthens-global-footprint-and-operation-capabilities 2023-09-01 05:35:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-pharmaceutical-to-acquire-mindset-pharma 2023-09-01 05:40:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/highlights-from-the-2023-pda-pharmaceutical-manufacturing-quality-conference 2023-08-31 05:46:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epigenic-therapeutics-announces-32-million-in-series-a-funding-to-bring-breakthrough-epigenome-medicine-to-clinical-development 2023-08-31 01:38:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-and-bioventure-announce-approval-of-avt02-in-egypt 2023-08-31 01:36:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inxmed-receives-approval-to-initiate-phase-i-clinical-trial-in-china-for-omtx705 2023-08-31 01:36:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flomox-fine-granules-for-children-oral-cephem-antibiotic-agent-launched-in-china 2023-08-31 01:20:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strides-receives-usfda-approval-for-mycophenolate-mofetil-for-oral-suspension 2023-08-31 01:18:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-registrational-trial-of-sugemalimab-in-first-line-gastric 2023-08-29 06:09:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtalpi-inc-unveils-xtalpi-intelligent-automation-and-announces-new-automation-facility-in-shanghai 2023-08-29 06:03:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bionano-announces-second-oem-partner-has-received-china-nmpa-approval-for-dna-extraction-and-labeling-products 2023-08-29 06:00:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-participant-treated-at-the-highest-dose-level-in-claritys-theranostic-prostate-cancer-trial 2023-08-28 01:43:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/royalty-pharma-and-ferring-pharmaceuticals-enter-into-us-500-million-royalty-agreement-for-new-intravesical-gene-therapy-adstiladrin 2023-08-25 07:36:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-medical-system-gained-exclusive-license-of-an-anti-ischemic-stroke-class-1-innovative-drug 2023-08-25 07:34:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-new-drug-application-acceptance-by-the-pharmaceutical-administration-bureau-of-macao-for-nefecon 2023-08-25 07:32:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dizals-sunvozertinib-approved-by-china-nmpa-with-potential-for-best-in-class-therapy-in-nsclc-with-egfr-exon20ins-mutations 2023-08-24 01:43:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bostongene-nec-and-japan-industrial-partners-establish-joint-venture-to-promote-personalized-cancer-treatment 2023-08-24 01:40:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marksans-receives-usfda-approval-for-guaifenesin-extended-release-tablets 2023-08-23 00:18:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-gt20029 2023-08-22 23:55:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-signs-agreement-to-acquire-qualicaps 2023-08-22 05:51:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogens-project-integrum-achieves-milestone-progress-accelerating-antibody-business-growth 2023-08-22 01:58:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurophth-announces-first-patient-dosed-in-phase-clinical-trial-of-second-gene-thera 2023-08-22 01:55:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hofseth-biocare-asa-majority-owned-biotech-hbc-immunology-llc-raises-seed-capital-at-20m 2023-08-22 01:53:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/can-fite-submitted-to-fda-a-pediatric-plan-to-allow-registration-of-piclidenoson-for-the-treatment-of-adolescents-with-psoriasis 2023-08-22 01:50:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-holdings-participates-in-290m-strategic-financing-of-sangon-biotech 2023-08-22 01:49:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strategic-collaboration-agreements-in-the-field-of-artificial-intelligence 2023-08-22 01:46:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-that-the-sovleplenib-phase-iii-eslim-01-study-met-its-primary-endpoint-in-primary-immune-thrombocytopenia-in-china 2023-08-22 01:41:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hofseth-biocare-asa-majority-owned-biotech-hbc-immunology-llc-raises-seed-capital-at-20m-valuation 2023-08-17 06:10:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formosa-pharmaceuticals-announces-licensing-agreement-with-eyenovia-inc-for-the-commercialization-of-app13007 2023-08-17 05:26:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monash-university-and-moderna-form-partnership-to-advance-homegrown-mrna-medicines 2023-08-17 05:21:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impact-biotech-announces-research-collaboration-to-develop-a-treatment-to-arrest-pathologic-myopia 2023-08-15 09:38:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-receives-approval-from-us-fda-for-doxycycline-hyclate-delayed-release-tablets-usp 2023-08-15 09:32:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-and-cancer-research-uk-announce-the-dosing-of-the-first-patient 2023-08-11 07:14:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-announces-its-launch-of-saxagliptin-and-metformin-hydrochloride-extended-release-tablets-in-the-us 2023-08-11 07:02:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-therapeutics-announces-partner-vistagen-reports-positive-top-line-results-from-phase-3-palisade-2-trial 2023-08-11 06:23:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-ipax-2-study-of-tlx101-brain-cancer-therapy-candidate-in-patients 2023-08-08 06:17:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viatris-and-mapi-pharma-announce-fda-acceptance-of-new-drug-application-filing-for-ga-depot 2023-08-08 06:45:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-impurity-conclave-2023 2023-08-07 02:57:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteintech-accelerates-growth-with-expansions-in-the-us-and-china 2023-08-06 04:29:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recce-pharmaceuticals-granted-new-anti-viral-patent-in-australia-for-recce 2023-08-06 04:26:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lianbio-announces-first-patient-treated-in-phase-1-trial-of-shp2-inhibitor-bbp-398 2023-08-04 06:44:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/toyo-ink-group-invests-in-us-based-biotech-firm-vlp-therapeutics 2023-08-04 06:40:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapore-scientists-develop-gene-editing-technology-that-eliminates-ev-a71-rna-viruses 2023-08-04 06:37:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/molecular-targeting-technologies-inc-and-molecular-theranostics-center-of-singapore-receive-hsa-approval 2023-08-03 08:42:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daichirona-for-intramuscular-injection-mrna-covid-19-vaccine-approved 2023-08-03 08:43:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-lonsurf-in-combination-with-bevacizumab-in-3rd-line-refractory-metastatic-colorectal-cancer 2023-08-01 10:16:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-submits-a-new-drug-application-for-fexuprazan-in-china-challenging-the-worlds-largest-market-for-anti-ulcer-drugs 2023-08-01 10:14:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bertis-pan-omics-analysis-solution-and-systems-launched-in-the-us 2023-08-01 10:12:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-completion-of-patient-enrollment-in-nefecon-china-open-label-extension-study 2023-08-01 10:10:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qualicaps-welcomes-the-signature-of-an-agreement-to-join-roquette-group 2023-07-29 04:13:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gardp-and-bugworks-join-forces-to-accelerate-development-of-a-novel-antibiotic-to-treat-serious-bacterial-infections 2023-07-29 04:11:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-patient-dosed-in-chemotherapy-free-triple-combination-phase-ii-trial-targeting-soft-tissue-sarcoma 2023-07-29 04:03:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuno-cure-completed-us-12m-first-close-of-series-a-financing 2023-07-28 06:13:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acceptance-of-clinical-trial-application-for-the-recbios-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-china 2023-07-27 09:09:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabcine-announces-first-patient-dosed-in-the-phase-i-clinical-trial-of-its-novel-tie2-agonistic-antibody-in-namd 2023-07-27 09:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-commercial-launch-and-first-prescription-for-xerava-in-china 2023-07-27 09:01:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/griffith-university-and-gene-company-partner-to-create-exciting-rna-based-covid-anti-viral 2023-07-27 08:58:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immerse-yourself-in-the-future-of-pharmaceutical-manufacturing 2023-07-27 01:42:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuron-announces-first-patients-enrolled-in-travelan-clinical-study 2023-07-26 05:04:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-peptidream-enter-into-research-collaboration-and-license-agreement 2023-07-26 05:02:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-approval-of-clinical-trial-of-pan-trk-inhibitor-zurletrectinib 2023-07-26 04:46:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/industry-led-cell-and-gene-manufacturing-strategy-to-develop-australia-as-apac-hub-launched 2023-07-25 00:27:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kyowa-kirin-announces-application-for-partial-change-of-approved-indication-of-g-lasta-for-the-mobilization-of-hematopoietic-stem-cells 2023-07-25 00:20:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocon-biologics-announces-positive-chmp-opinion-for-yesafili-biosimilar-aflibercept 2023-07-24 23:54:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-medicine-nominates-preclinical-candidate-of-inhalation-solution-for-ism001-055 2023-07-24 04:39:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hkstp-partner-companies-hkrm-and-cordlife-sign-collaboration-agreement 2023-07-21 04:31:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-orphan-drug-designation-of-sn-biosciences-nano-anti-cancer-drug-snb-101 2023-07-21 04:17:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-acquires-global-intellectual-property-rights 2023-07-21 04:11:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scynexis-and-hansoh-pharma-announce-nmpa-acceptance-of-the-new-drug-application-for-ibrexafungerp-in-china 2023-07-21 04:06:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocity-announces-the-first-patient-dosed-with-its-first-in-class-cdh3-targeting-adc-bc3195-in-a-phase-1-trial 2023-07-20 23:44:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharma-announces-completion-of-first-patient-enrollment-in-kx-826-long-term-safety-phase-iii-trial-for-treatment-of-aga 2023-07-20 23:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-selects-er-kim-pharmaceuticals-as-commercial-partner-for-orladeyo-in-turkey 2023-07-20 23:37:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotheus-announces-strategic-research-collaboration-and-worldwide-license-agreement-with-biontech 2023-07-20 23:33:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-debuts-its-first-high-potency-sterile-injectable-manufacturing-line-at-wuxi-city-site 2023-07-19 06:28:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qihan-biotech-announces-nmpa-approval-of-investigational-new-drug-application-for-qn-019a 2023-07-19 06:25:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/out-licensing-agreement-and-asset-transfer-for-pharmaceutical-products-in-north-america 2023-07-19 06:19:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/duoning-biotech-acquires-prefluid-to-strengthen-fluid-management-solutions 2023-07-19 06:16:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yikaida-car-t-cell-therapy-approved-as-a-second-line-therapy-for-new-indication 2023-07-19 06:07:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-bioworks-and-sumitomo-chemical-announce-expanded-partnership 2023-07-19 05:57:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thinkcyte-and-fimm-establish-research-partnership-to-advance-understanding-and-treatment-of-blood-cancer 2023-07-18 03:00:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genequantum-and-inxmed-have-reached-a-technology-licensing-collaboration 2023-07-18 02:58:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/highfield-biopharmaceuticals-announces-first-patient-dosed-in-phase-trial-of-hf1k16 2023-07-18 02:57:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurostar-achieves-milestone-regulatory-clearance-in-south-korea 2023-07-18 02:49:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/3rd-annual-cleaning-validation-2023-a-practical-approach 2023-07-17 06:23:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-industry-strengtening-the-csv-and-csa-approach-with-the-3rd-annual-computer-software-assurance-2023 2023-07-16 23:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atlas-global-brands-announces-delay-in-annual-and-interim-filings-following-complex-reverse-takeover 2023-07-16 23:41:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-to-commence-its-clinical-trial-with-sci-210-in-children-with-autism-spectrum-disorder 2023-07-16 23:38:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/uae-to-launch-rare-disease-rd-project-nader-in-partnership-with-us 2023-07-16 23:35:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansoh-pharma-and-tiumbio-announce-clinical-trial-approval 2023-07-14 05:28:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recce-pharmaceuticals-receives-a-801-604-research-and-development-rebate-advance 2023-07-14 05:25:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/race-executes-agreement-with-ardena-for-gmp-manufacturing-of-rc220 2023-07-14 05:23:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardelyx-announces-acceptance-of-new-drug-application-for-tenapanor-for-hyperphosphatemia-in-china 2023-07-14 05:17:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-regulatory-conclave-2023-the-unique-inaugural-program-taking-bold-steps 2023-07-14 03:06:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kamada-announces-kedrion-exercised-its-option-for-two-year-extension-of-kedrab-distribution-agreement-in-the-us 2023-07-13 01:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-proposed-rituximab-biosimilar-application-accepted-for-review-by-usfda-ema-and-mhra 2023-07-13 01:08:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eitan-insights-platform-wins-award-for-best-new-technology-solution-in-drug-delivery 2023-07-13 01:04:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-recognise-young-scientists-in-india-with-2023-merck-young-scientist-award 2023-07-12 06:07:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gerresheimer-launches-open-innovation-program-for-the-development-of-home-therapy-solutions 2023-07-12 05:56:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-extends-partnership-with-peking-university-to-foster-pharmaceutical-innovation-in-china 2023-07-12 04:31:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ajanta-pharma-announces-strategic-partnership-with-credible-for-enhanced-esg-reporting-and-achieving-sustainable-goals 2023-07-12 04:13:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microsize-announces-a-strategic-investment-into-the-solubility-company 2023-07-11 02:59:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-announces-acceptance-by-chinas-nmpa-of-the-bla-for-efgartigimod-alfa-injection-for-patients 2023-07-11 02:54:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lifera-sanofi-and-arabio-sign-mou-to-manufacture-and-supply-vaccines-in-saudi-arabia 2023-07-10 22:50:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-pmec-china-2023-to-launch-international-roadshow-in-guangzhou 2023-07-10 05:13:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/south-rampart-pharma-further-expands-patent-portfolio-for-srp-001-with-composition-of-matter-patent-in-china 2023-07-10 04:29:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kazias-paxalisib-receives-fast-track-designation-from-fda-for-treatment-of-solid-tumor 2023-07-10 04:28:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mgis-dnbseq-t7-receives-approval-for-clinical-use-in-south-korea 2023-07-10 04:26:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shanghai-world-of-packaging-to-be-held-annually-starting-in-2024-for-desmoid-tumor-treatment 2023-07-06 23:36:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genprex-granted-chinese-patent-for-reqorsa-immunogene-therapy-in-combination-with-pd-1-antibodies 2023-07-06 05:55:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-key-registration-phase-iii-study-of-neriq-in-the-first-line-treatment-of-ph 2023-07-06 04:28:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impact-biotech-receives-fda-orphan-drug-designation-for-padeliporfin-vtp-in-pancreatic-cancer 2023-07-06 04:01:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-provides-latest-clinical-development-and-corporate-updates 2023-07-06 03:52:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-unveils-897-mln-manufacturing-deals-for-pfizer 2023-07-06 01:42:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/goserelin-microspheres-for-injection-approved-for-launch-in-china 2023-07-06 01:30:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alpro-jvs-with-sugi-holdings-to-introduce-japanese-style-drugstores-in-malaysia 2023-07-06 01:19:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-establishes-a-strategic-partnership-with-edirna-inc 2023-07-06 01:14:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baker-mckenzie-advises-prenetics-on-usd-200-million-joint-venture-with-globally-renowned-scientist-professor-dennis-lo 2023-07-03 23:47:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-establishes-a-us-center-of-excellence-for-targeted-copper-theranostics 2023-07-03 23:45:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/drug-farm-announces-ind-clearance-by-us-fda-enabling-phase-1-initiation 2023-07-03 23:43:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-invests-approximately-70-million-to-expand-reagent-manufacturing-in-china 2023-07-03 23:41:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jacobio-pharma-presents-clinical-results-of-glecirasib-in-colorectal-cancer 2023-07-03 23:40:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ambrosia-bio-leverages-ginkgo-enzyme-services-to-develop-a-more-scalable-enzymatic-process-for-allulose 2023-07-03 23:32:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strategic-partnership-with-pfizer-to-launch-local-brand-of-oral-antiviral-treatment-for-covid-19-in-china 2023-07-03 04:34:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioheart-announces-clinical-result-for-iberis-htn-at-cit-2023 2023-07-03 04:28:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-receives-approval-to-conduct-phase-iib-clinical-trial-for-sci-110-to-treat-tourette-syndrome-in-germany 2023-07-03 04:21:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microba-commences-phase-i-clinical-trial-for-ibd-therapeutic 2023-06-29 11:10:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanyou-forms-partnership-with-hangzhou-zhongmei-huadong-pharmaceutical 2023-06-29 11:03:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuance-pharmas-partner-verona-pharma-submits-new-drug-application-to-us-fda 2023-06-29 10:58:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inova-pharmaceuticals-expands-consumer-healthcare-platform-through-business-acquisition 2023-06-27 07:04:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-and-the-peter-doherty-institute-for-infection-and-immunity-join-forces-against-influenza 2023-06-27 06:16:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/japans-ministry-of-health-labour-and-welfare-approves-shingrix-for-the-prevention-of-shingles 2023-06-27 05:27:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-launches-a-newly-upgraded-version-of-opendel-a-self-service-screening-kit 2023-06-27 05:06:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/collplant-achieves-milestone-and-to-receive-10-million-from-abbvie 2023-06-27 04:41:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lianbio-announces-marketing-approval-of-camzyos-in-singapore 2023-06-27 04:32:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/point-biopharma-and-advancell-to-collaborate-in-the-development-of-lead-212-labeled-radioligands 2023-06-27 04:18:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-data-from-the-japanese-phase-iii-clinical-trial-of-hemlibra-for-acquired-hemophilia 2023-06-26 06:48:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taiho-pharmaceutical-obtains-approval-in-japan-to-manufacture-and-market-fgfr-inhibitor-lytgobi-tablets-4mg 2023-06-26 06:36:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seven-manufacturers-sign-sublicence-agreements-with-the-medicines-patent-pool-to-produce-generic-versions 2023-06-26 06:22:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-further-extends-infectious-disease-innovation-platform-with-planned-acquisition-of-qpex-biopharma 2023-06-26 06:10:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/psylo-announces-sponsored-research-agreement-with-daiichi-sankyo 2023-06-23 06:55:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-announces-completion-of-marketing-authorization-transfer-for-yescarta-car-t-cell-therapy 2023-06-23 06:50:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qatar-cancer-society-cure-brain-cancer-foundation-initiate-discussion-of-strategic-collaborative-partnership 2023-06-23 06:43:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/announcement-of-milestone-achievement-in-the-collaborative-research-with-sumitomo-pharma-co 2023-06-23 06:01:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ivi-exchanges-mou-with-seoul-national-university-on-cooperation-in-research-and-beyond 2023-06-22 11:52:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-announced-an-mou-with-bangladeshs-state-owned-pharmaceutical-company 2023-06-22 11:49:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-to-expand-late-stage-urologic-pipeline-with-acquisition-of-lightpoint-medical 2023-06-22 11:46:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-announces-irb-approval-to-conduct-its-phase-iib-trial-in-tourette-syndrome 2023-06-22 11:44:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anthem-biosciences-partners-with-veeva-to-drive-quality-excellence 2023-06-22 11:42:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocity-announces-initiation-of-a-phase-2-trial-for-sc0062 2023-06-22 11:40:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-partner-calliditas-therapeutics-makes-data-presentations-on-nefecon-at-european-renal-association 2023-06-22 01:20:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taisho-pharmaceutical-and-biolinq-announce-strategic-collaboration-and-exclusive-license-agreement-in-japan 2023-06-22 01:15:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immutep-granted-united-states-patent-for-imp761 2023-06-22 01:11:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-commences-combat-theranostic-prostate-cancer-trial-in-the-us 2023-06-22 01:06:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leading-the-charge-in-sustainable-science-first-electronic-pipette-awarded-act-label 2023-06-21 07:38:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/laurus-labs-signs-memorandum-of-agreement-with-iit-kanpur-for-novel-gene-therapy-assets 2023-06-20 10:19:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-advances-stp705-for-squamous-cell-carcinoma-in-situ-into-late-stage-clinical-development 2023-06-20 10:12:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-commits-to-science-based-targets-initiative-a-new-milestone-in-its-net-zero-journey 2023-06-20 10:13:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bachem-developed-easy-mass-spectrometry-methods-for-oligonucleotide-sequence 2023-06-20 03:22:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iaso-bio-receives-fda-approval-of-ind-application-for-iaso-782-for-treatment-of-autoimmune-disease 2023-06-19 05:49:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivirs-patent-application-for-fostrox-approved-in-china 2023-06-19 05:44:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-launches-thiamine-hydrochloride-injection-usp-in-the-united-states 2023-06-19 05:39:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novaccess-global-partners-with-ckn-ventures-to-expand-its-new-ai-driven-precision-medicine-division 2023-06-18 22:55:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-and-takeda-announce-publication-of-phase-iii-fresco-2-results-in-the-lancet 2023-06-18 22:52:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-expands-partnership-with-biomm-in-brazil-with-addition-of-bat2206 2023-06-18 22:46:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mindrank-announces-first-in-human-phase-1-study-of-mdr-001-in-china 2023-06-16 07:24:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c2-pharma-receives-approval-for-digoxin-china-dmf-becoming-chinas-only-european-supplier-of-this-api 2023-06-16 07:24:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wellthy-therapeutics-adds-beyond-next-ventures-as-an-investor-expands-into-japan 2023-06-16 07:19:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/culture-biosciences-and-cytiva-team-up-to-innovate-in-upstream-bioprocessing 2023-06-16 07:18:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/raysearch-laboratories-ab-is-pleased-to-announce-an-agreement-with-the-chinese-radiation-therapy-machine-manufacturer-shinva 2023-06-16 07:16:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quantiphi-partners-with-pharmarack-and-snowflake-to-revolutionize-indias-pharma-industry 2023-06-16 07:14:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/granules-india-limited-received-anda-approval-for-metoprolol-succinate-er-tablets 2023-06-16 07:13:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/can-fite-to-submit-ind-for-the-treatment-of-pancreatic-cancer-patients-with-namodenoson 2023-06-15 00:20:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salipro-biotech-expands-global-intellectual-property-portfolio-with-granted-patent-in-japan 2023-06-15 00:17:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharmas-first-published-clinical-data-of-nelix-in-the-treatment-of-children 2023-06-15 00:13:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/highfield-biopharmaceuticals-receives-us-fda-ind-clearance-for-phase-1-trial 2023-06-15 00:07:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-reaches-agreement-with-kentucky-to-settle-the-states-price-fixing-claims 2023-06-13 05:41:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocan-pharma-submits-new-patent-applications-for-advanced-pain-relief-technology 2023-06-13 05:06:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-recognised-by-the-australian-financial-review-as-australias-highest-achieving-company-for-international-growth 2023-06-13 04:40:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/super-trillion-common-light-chain-antibody-discovery-platform-launched 2023-06-12 23:02:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eccogene-raises-cny-180-million-in-series-b-equity-financing-propelling-its-pipeline-of-treatments-for-metabolic-diseases 2023-06-12 23:00:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alvotech-and-teva-secure-us-license-date-for-avt04-a-proposed-biosimilar-to-stelara 2023-06-12 22:58:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-confirms-unfavorable-district-court-decision-in-myrbetriq-us-patent-trial 2023-06-12 22:55:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-receives-us-fda-fast-track-designation-for-arct-810 2023-06-12 00:52:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amarin-partner-eddingpharm-receives-regulatory-approval-for-vascepa-in-mainland-china 2023-06-12 00:50:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-kite-oncology-demonstrate-growing-hematology-pipeline-and-strength-of-leading-cell-therapy-portfolio-at-eha 2023-06-12 00:48:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regulatory-authorities-in-china-and-japan-approve-clinical-trials-for-anthos-therapeutics 2023-06-11 23:05:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imbdx-expands-targeted-therapies-agreement-following-successful-evaluation-of-blood-based-genomic-profiling-assay-in-prostate-cancer 2023-06-11 23:02:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shineco-subsidiary-registered-as-a-member-of-pharmaceutical-chamber-of-commerce 2023-06-11 23:01:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-submits-new-drug-application-for-zolbetuximab-in-japan 2023-06-11 22:59:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-concludes-nationwide-opioids-settlement-agreement 2023-06-11 22:58:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acrobiosystems-expands-custom-gmp-grade-protein-services-to-drive-cgt-development-and-commercialization 2023-06-08 03:43:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/betalife-wins-cytivas-first-biochallenge-competition-in-southeast-asia 2023-06-08 03:41:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/livespo-represents-vietnam-to-announce-the-worlds-first-spore-probiotics-in-nasal-spray-form 2023-06-08 03:38:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-to-enhance-commercial-presence-in-asia-for-biologics-and-advanced-therapies-contract-services 2023-06-08 03:33:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jacobio-pharma-receives-ind-approval-for-parp7-inhibitor-jab-26766-in-china 2023-06-08 03:29:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-files-marketing-authorization-application-for-lecanemab-as-treatment-for-early-alzheimers-disease-in-south-korea 2023-06-08 03:26:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tianmaiyuanhe-announces-ind-approval-for-bispecific-antibody-drug-a-337 2023-06-07 04:07:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/konica-minolta-aist-bioprocess-technology-cooperative-research-laboratory-established 2023-06-07 04:05:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosyngens-cell-therapy-brg01-granted-orphan-drug-designation-by-the-us-fda 2023-06-07 04:02:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/commencement-of-deflexifol-trial-in-paediatric-brain-cancer 2023-06-07 04:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/implementation-of-generative-ai-across-the-ono-pharmaceutical-group 2023-06-07 03:59:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-accelerates-timeline-of-new-fifth-plant-to-be-operational-by-april-2025 2023-06-07 03:57:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxxas-announces-interim-results-from-phase-i-clinical-study-of-first-needle-free-covid-19-vaccine 2023-06-06 06:16:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ractigen-therapeutics-announces-dosing-of-first-patient-in-first-in-human-trial-of-rag-17 2023-06-06 06:13:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-regaining-rights-to-fexuprazan-in-the-united-states-and-canada 2023-06-06 06:11:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chimeric-announces-launch-of-new-phase-1b-glioblastoma-clinical-trial 2023-06-06 01:19:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-successfully-completes-phase-i-study-iv-route-of-drl-tc-a-proposed-biosimilar-of-tocilizumab 2023-06-06 01:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-steriles-manufacturing-and-research-capabilities 2023-06-05 05:27:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nmpa-accepted-akesos-ebronucimab-marketing-application-in-two-indications 2023-06-03 04:07:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaessentia-selects-pint-pharma-as-commercial-partner-for-besremi-in-latin-america 2023-06-03 04:03:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bruker-introduces-next-generation-automated-bioafm-for-quantification-of-molecular-forces 2023-05-31 23:38:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolight-announces-a-joint-cooperation-agreement-with-alexion-astrazeneca-rare-disease 2023-05-31 23:32:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seagen-stockholders-approve-acquisition-by-pfizer 2023-05-31 23:26:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/an-innovative-drug-ilumetri-tildrakizumab-injection-approved-for-marketing-in-china 2023-05-31 23:22:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-submits-supplemental-applications-for-approval-of-braftovi-capsule-and-mektovi-tablet 2023-05-31 23:14:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-investment-of-over-50-billion-yen-in-bio-manufacturing-facilities 2023-05-31 23:04:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xcode-life-forays-into-nutrigenomics-launching-a-comprehensive-gene-nutrition-test 2023-05-30 04:28:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shanghai-pharmaceutical-pyridostigmine-bromide-sustained-release-tablets-approved-for-clinical-trials 2023-05-30 01:41:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amp945-combined-with-folfirinox-enhances-treatment-effects-in-model-of-pancreatic-cancer 2023-05-30 01:40:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chengdu-hittor-opendel-series-products-help-ai-ml-realize-molecular-prediction 2023-05-30 01:40:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akanda-corp-announces-termination-of-loan-agreement 2023-05-30 01:39:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-receives-marketing-authorization-of-covid-19-vaccine-from-uk-mhra 2023-05-30 00:25:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrivax-awarded-2-million-grant-to-advance-innovative-vaccine-platform 2023-05-30 00:23:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lords-mark-industries-and-iit-bombay-partner-to-transform-sickle-cell-testing-in-india 2023-05-26 01:45:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanflyta-first-flt3-inhibitor-approved-in-japan-for-patients-with-newly-diagnosed-flt3-itd-positive-aml 2023-05-26 01:31:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-biotherapeutics-and-boehringer-ingelheim-agree-on-2-year-extension-to-their-second-multi-year-collaboration-in-cancer-immunology 2023-05-26 01:24:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-bioworks-and-centrient-pharmaceuticals-announce-expansion-of-partnership 2023-05-26 01:17:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyne-therapeutics-receives-european-medicines-agency-orphan-drug-designation-for-dyne-101 2023-05-26 01:13:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adamis-pharmaceuticals-announces-closing-of-the-merger-with-dmk-pharmaceuticals 2023-05-26 01:08:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisais-initiatives-for-developing-new-medicines-for-neglected-tropical-diseases-and-malaria-and-commitment-for-funding-to-the-3rd-phase-of-global-health-innovative-technology-fund-activities 2023-05-26 01:04:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/keytruda-plus-lenvima-demonstrates-long-term-durable-survival-benefit-versus-sunitinib 2023-05-26 00:59:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-adds-new-cryogenic-capabilities-at-shiga-japan-facility-to-support-clinical-supply-demand 2023-05-26 00:55:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-usa-announces-us-fda-approval-of-yuflyma-a-high-concentration-and-citrate-free-formulation-of-humira 2023-05-25 02:02:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/10x-genomics-launches-visium-cytassist-gene-and-protein-expression-assay 2023-05-25 01:36:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mainz-biomed-processes-first-patients-from-colorectal-cancer-screening-campaign-through-its-corporate-health-portal-in-partnership-with-zoller-kipper 2023-05-25 01:26:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accelerating-drug-discovery-with-screening-technologies-of-the-future 2023-05-25 01:22:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-announces-the-intended-decision-to-transfer-its-manufacturing-plant-and-business-based-in-meppel 2023-05-25 01:19:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-announces-agreement-with-maia-pharmaceuticals-to-distribute-bivalirudin-injection-in-ready-to-use-vials 2023-05-25 01:06:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cumberland-pharmaceuticals-announces-fda-clearance-of-ind-for-new-treatment-of-idiopathic-pulmonary-fibrosis 2023-05-24 03:22:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-presents-solution-for-equitable-access-of-vaccine 2023-05-24 03:18:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-for-pneumonia-caused-by-certain-difficult-to-treat-bacteria 2023-05-24 03:15:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenxbio-receives-fda-regenerative-medicine-advanced-therapy 2023-05-24 03:09:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/societal-cdmo-enters-agreement-with-atossa-therapeutics-to-provide-clinical-trial-services 2023-05-24 03:07:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mustgrow-and-janssen-pmp-a-division-of-janssen-pharmaceutica-nv-extend-exclusive-global-partnership 2023-05-24 03:04:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nhi-drug-price-listing-and-launch-of-nexobrid-gel-5g-for-the-removal-of-burn-eschar 2023-05-24 01:46:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-claudin-antibody-drug-conjugate-atg-022-granted-orphan-drug-designations 2023-05-24 01:30:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-regulatory-conclave-2023 2023-05-24 00:37:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mate-launches-trial-of-australian-first-flu-vaccine 2023-05-23 06:08:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/freenome-acquires-global-immunodiagnostics-developer-oncimmune-ltd 2023-05-23 04:43:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opentrons-flex-lab-robot-launches-to-accelerate-bioautomation-across-thousands-of-life-science-experiments 2023-05-23 04:41:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yaral-pharma-partners-with-eversana-to-support-the-commercialization-of-its-expanded-generics-portfolio 2023-05-23 04:35:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-prescription-nasal-spray-to-reverse-opioid-overdose 2023-05-23 04:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-ag-expands-patent-portfolio-for-its-end-to-end-platform 2023-05-23 04:25:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-and-genpharm-announce-collaboration-to-provide-imcivree-to-patients 2023-05-23 04:16:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avronio-announces-agreement-to-sell-cystinosis-gene-therapy-program 2023-05-23 04:06:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-clinical-proof-of-concept-study-of-tnx-1900 2023-05-22 07:54:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avantor-and-labguru-collaborate-to-drive-more-efficient-lab-buying-experience 2023-05-22 07:51:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzecure-is-granted-european-patent-for-neurorestore-acd856 2023-05-22 07:49:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thousand-oaks-biologics-and-genequantum-healthcare-signed-a-strategic-partnership-agreement 2023-05-22 07:46:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmenable-closes-7-million-financing-led-by-mp-healthcare 2023-05-22 07:43:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-topical-gene-therapy-for-treatment-of-wounds-in-patients 2023-05-20 00:45:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imcd-malaysia-acquires-euro-chemo-pharma-to-accelerate-growth-in-life-science-markets 2023-05-20 00:41:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-initiates-phase-3-clinical-trial-of-mutant-strain-covid-19-vaccine-in-japan 2023-05-20 00:37:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-steriles-manufacturing-and-research-capabilities 2023-05-19 04:32:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ajinomoto-bio-pharma-services-announces-leadership-changes-at-us-facility 2023-05-19 01:00:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biodexa-pharmaceuticals-enters-into-non-binding-letter-of-intent-for-proposed-acquisition 2023-05-19 00:59:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mustang-bio-announces-strategic-manufacturing-partnership-and-portfolio-updates 2023-05-19 00:54:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phio-pharmaceuticals-presents-preclinical-study-showing-intasyl-treatment-of-nk-cells 2023-05-19 00:51:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alimera-acquires-us-commercial-rights-to-yutiq 2023-05-19 00:47:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lucy-scientific-discovery-inc-accelerates-psilocybin-access-and-product-launch 2023-05-19 00:44:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/myeloid-therapeutics-announces-73-million-financing 2023-05-19 00:41:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intelgenx-receives-amended-del-license-to-conduct-third-party-testing 2023-05-18 01:31:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zendal-and-iavi-announce-expanded-agreement-to-partner-on-development-of-tb-vaccine 2023-05-18 01:28:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-menarini-silicon-biosystems-partnership-with-alivio-health-expands-patient-access-to-cellsearch-liquid-biopsy-tests 2023-05-18 01:21:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lobe-sciences-announces-commercial-distribution-agreement-with-pentec-health 2023-05-18 01:16:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellectis-presents-clinical-data-on-ameli-01-and-preclinical-data-on-multiplex-engineering 2023-05-18 01:07:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shorla-oncology-eversana-announce-commercial-launch-of-recent-fda-approved-nelarabine-injection 2023-05-17 01:12:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perrigo-announces-us-fda-approval-for-nicotine-coated-mint-lozenge 2023-05-17 01:08:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arisglobal-acquires-leading-regulatory-data-solution-sporify 2023-05-17 01:05:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenxbio-announces-nav-technology-platform-will-support-bespoke-gene-therapy 2023-05-17 01:01:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ideaya-expands-clinical-trial-collaboration-and-supply-agreements-with-pfizer-to-support-registrational-trial 2023-05-17 00:57:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phio-pharmaceuticals-announces-fda-clearance-to-initiate-clinical-trial-of-ph-762 2023-05-17 00:50:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intercept-pharmaceuticals-recieves-fda-orphan-drug-designation 2023-05-17 00:43:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-responds-to-ftc-action-re-proposed-acquisition-of-horizon-therapeutics 2023-05-17 00:38:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-expands-renewable-energy-through-virtual-power-purchase-agreement 2023-05-16 00:26:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/melinta-therapeutics-and-xediton-pharmaceuticals-announce-licensing-agreement 2023-05-15 23:59:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bavarian-nordic-completes-acquisition-of-travel-vaccine-portfolio 2023-05-15 23:56:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-receives-nmpa-breakthrough-designation-fo-ibi351-as-monotherapy 2023-05-15 23:52:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hummingbird-bioscience-and-merck-enter-collaboration-to-evaluate-hmbd-001 2023-05-15 23:46:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announce-fda-approval-and-commercialization-of-two-andas 2023-05-15 23:43:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/3rd-annual-computer-software-assurance-2023 2023-05-15 05:46:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellular-origins-partners-with-scaleready-to-simplify-standardise-and-automate 2023-05-12 03:36:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-drug-to-treat-agitation-symptoms 2023-05-12 03:30:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthego-opens-state-of-the-art-gmp-guide-rna-manufacturing-facility 2023-05-12 03:27:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-small-business-administration-announces-2023-exporter-of-the-year 2023-05-12 00:27:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codexis-unveils-eco-synthesis-platform-for-large-scale-rnai-therapeutics-production 2023-05-11 05:15:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chiesi-global-rare-diseases-and-protalix-bi-therapeutics-announc-fda-approva-of-elfabri 2023-05-11 05:13:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microba-partners-with-mainz-biomed-for-the-development-of-pancalert 2023-05-11 05:10:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-techne-announces-launch-of-kappa-and-lambda 2023-05-11 05:08:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-and-cainiao-extend-partnership-with-new-space-and-service-commitment-agreement 2023-05-10 23:14:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-pmec-china-2023-to-see-surge-from-pent-up-international-ingredients-demand 2023-05-09 03:06:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bruker-announces-acquisition-of-zontal-to-advance-the-digital-laboratory-transformation-and-integrated-biopharma-data-solutions 2023-05-09 01:02:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bliss-biopharmaceutical-enters-into-a-clinical-trial-collaboration-agreement 2023-05-08 03:52:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genetiks-and-veritas-announce-a-collaboration-to-completes-the-turkish-laboratory 2023-05-08 03:43:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/golden-biotech-announces-positive-results-with-longer-survival-compared 2023-05-05 22:26:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xnk-therapeutics-enters-into-research-agreement-with-global-pharma-company 2023-05-04 06:33:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/a-novel-treatment-crb091-effectively-reduces-cancer-cell-proliferation 2023-05-04 06:32:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trellis-bioscience-announces-positive-interim-phase-1-results-for-trl1068 2023-05-04 06:32:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mekonos-announces-research-collaboration-with-bitbio-to-advance-cell-engineering 2023-05-04 03:43:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hasten-biopharma-acquires-commercial-rights-in-china-for-roches-antibiotic-rocephin 2023-05-04 03:43:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/formus-labs-pioneering-developer-of-ai-powered-3d-orthopedic-surgery 2023-05-04 03:41:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grand-success-of-the-6th-annual-pharma-project-portfolio-management-2023 2023-05-04 01:37:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-pmec-china-2023-to-see-surge-from-pent-up-international-ingredients-demand 2023-05-03 22:29:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fusion-pharmaceuticals-announces-opening-of-radiopharmaceutical-manufacturing-facility 2023-05-03 02:54:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule 2023-05-03 02:53:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brightpath-biotherapeutics-and-artisan-bio-announce-research-and-licensing-agreement 2023-05-03 02:52:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bioscience-announced-positive-phase-2-clinical-study-results 2023-05-03 02:51:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-pall-life-sciences-complete-integration-to-create-global-innovation 2023-05-02 03:10:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovation-and-development-of-generic-pharmaceuticals 2023-04-29 01:45:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juno-pharmaceuticals-canada-rosemont-joint-partnership-announcement 2023-04-26 23:53:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mina-therapeutics-enters-research-collaboration-with-biomarin-pharmaceutical 2023-04-26 23:52:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/infusystem-announces-distribution-agreement-with-genadyne 2023-04-26 23:50:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-announces-positive-outcome-in-arbitration-relating-to-agreements-with-tracon 2023-04-26 23:49:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/difgen-pharmaceuticals-acquires-aveva-drug-delivery-services-inc 2023-04-24 23:28:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salix-partners-with-the-colorectal-cancer-alliance-on-community-screening-program 2023-04-24 23:26:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-presents-final-phase-i-data-of-tcr-t-cell-therapy-mdg1011-in-patients 2023-04-24 23:25:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-millburn-facility-for-us-commercial-production-of-pluvicto 2023-04-24 23:24:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cbc-group-and-mubadala-co-lead-fundraising-round-for-hasten-biopharma 2023-04-21 05:54:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tubulis-announces-strategic-license-agreement-with-bristol-myers-squibb 2023-04-20 22:51:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-announces-positive-phase-3-tislelizumab-trial-in-advanced-gastric 2023-04-20 22:48:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qosina-teams-up-with-dupont-liveo-healthcare-solutions-to-market 2023-04-20 22:46:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sai-life-sciences-opens-ssrl-a-dedicated-research-facility-for-schrodinger 2023-04-20 06:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-diosynth-biotechnologies-acquires-additional-41-acres-of-land-in-rtp 2023-04-19 23:48:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-wins-patent-appeal-on-otezla 2023-04-19 23:47:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asahi-kasei-bioprocess-america-and-geminibio-enter-strategic-partnership-to-advance 2023-04-19 23:46:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-cuts-ribbon-on-25-million-pharmaceutical-innovation-center-in-the-united-states 2023-04-19 23:24:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosenic-receives-key-european-patent-from-epo-for-further-therapeutic-development 2023-04-19 03:04:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-nda-acceptance-in-china-for-fruquintinib-in-second-line-gastric-cancer 2023-04-19 03:00:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-receives-us-patent-for-manufacturing-seasonal-and-pandemic-influenza-vaccines 2023-04-19 02:58:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-biopharma-announces-issuance-of-us-patent-covering-xerisol-formulations 2023-04-19 02:57:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sygnature-discovery-and-daewoong-pharma-announce-research-collaboration 2023-04-19 02:56:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-wuxi-xdc-congratulate-dualitybio-on-entering-global-licensing 2023-04-18 01:46:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-bioworks-and-syngenta-seeds-announce-collaboration-to-develop-new-traits 2023-04-18 01:43:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acadia-pharmaceuticals-announces-daybue-is-now-available 2023-04-18 01:42:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lipella-pharmaceuticals-enters-manufacturing-collaboration-agreement 2023-04-18 01:41:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/snbl-to-acquire-satsuma-pharmaceuticals 2023-04-18 01:40:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-make-record-breaking-investment-in-indiana-manufacturing-facilities 2023-04-18 01:39:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/radiopharm-theranostics-enters-into-supply-agreement-with-terthera 2023-04-17 06:43:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-announces-launch-of-argatroban-injection-through-premier 2023-04-17 06:42:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sysmex-inostics-and-genomic-testing-cooperative-form-partnership-to-accelerate 2023-04-15 00:33:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-xtalpi-collaboration-optimizes-drug-formulations-with-ai-powered-techniques 2023-04-15 00:32:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sona-nanotech-secures-bentley-biomedical-as-regulatory-affairs-advisor-for-its-tht 2023-04-15 00:30:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-genomics-collaborates-with-element-biosciences-to-optimize-cytogenomics 2023-04-15 00:29:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-announces-expanded-licensing-agreement-to-develop-and-commercialize 2023-04-13 00:39:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mitsui-acquires-convertible-bonds-issued-by-alvotech 2023-04-13 00:37:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imaginab-executes-new-license-and-supply-agreement-for-cd8-immunopet 2023-04-13 00:36:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-significant-investment-in-the-worlds-largest-integrated-specialty 2023-04-13 00:35:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-exercises-option-with-denali-to-develop-and-commercialize-antibody-transport 2023-04-13 00:34:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lygenesis-and-imagine-pharma-announce-joint-research-collaboration 2023-04-12 01:51:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discovery-life-sciences-acquires-reachbio-research-labs 2023-04-12 01:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fulgent-genetics-launches-mission-bio-platform-to-broaden-accessibility-of-single-cell 2023-04-12 01:49:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenetic-biosciences-inc-announces-research-and-development-collaboration 2023-04-12 01:47:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karius-and-egenesis-partner-to-help-accelerate-xenotransplantation 2023-04-12 01:46:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quadriga-biosciences-announces-dosing-of-first-subject-in-phase-2-study 2023-04-12 01:45:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ctrl-therapeutics-launches-with-10m-seed-financing-to-advance-next-generation-cell-therapy 2023-04-10 23:33:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aviceda-therapeutics-announces-strategic-partnership 2023-04-10 23:28:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bora-pharmaceuticals-and-celltrion-partners-to-expand-osd-capabilities-in-apac-market 2023-04-10 23:14:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nona-biosciences-enters-into-collaboration-agreement-with-exevir-bio 2023-04-06 01:09:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/simcha-therapeutics-announces-clinical-trial-collaboration-with-merck-to-evaluate-st-067 2023-04-06 01:08:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proxygen-announces-collaboration-and-license-agreement-with-msd 2023-04-06 01:07:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opgens-subsidiary-curetis-signs-expansion-of-rd-collaboration-with-find 2023-04-06 01:06:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anabios-acquires-cell-systems-expands-human-cell-portfolio-for-drug-discovery 2023-04-05 03:26:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beactica-therapeutics-and-oscotec-mutually-agree-to-conclude-oncology-collaboration 2023-04-05 03:13:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forcefield-therapeutics-signs-exclusive-patent-and-know-how-license-agreement 2023-04-05 03:05:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scorpion-therapeutics-and-pierre-fabre-announce-collaboration-and-license-agreement 2023-04-05 03:04:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diamyd-medical-partners-with-jdrf-to-advance-the-diagnode-3 2023-04-05 02:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridgewest-group-launches-novacina-new-sterile-injectable-cdmo 2023-04-05 02:52:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigene-enters-cooperative-research-and-development-agreement 2023-04-04 03:40:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/histogen-announces-exclusive-intellectual-property-license-agreement 2023-04-04 03:38:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innate-pharma-announces-exclusive-license-of-antibodies-to-takeda 2023-04-04 03:31:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclerion-therapeutics-enters-into-exclusive-negotiation-period 2023-04-04 03:26:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultomiris-recommended-for-approval-in-the-eu-by-chmp-for-the-treatment-of-adults 2023-04-04 03:25:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cabaletta-bio-receives-fda-clearance-of-ind-application-for-caba-201 2023-04-01 03:26:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renovion-receives-fda-fast-track-designation 2023-03-31 03:15:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gandeeva-and-moderna-enter-into-cryo-em-research-collaboration 2023-03-31 03:14:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/decibel-therapeutics-receives-european-orphan-drug-designation 2023-03-31 03:13:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eip-pharma-and-diffusion-pharmaceuticals-announce-merger-agreement 2023-03-31 03:12:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-biopharma-announces-research-evaluation-collaboration-and-option-agreement 2023-03-31 02:57:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-over-the-counter-naloxone-nasal-spray 2023-03-30 00:50:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bgi-genomics-partners-with-zentya-to-launch-fecal-dna-test-for-colorectal-cancer 2023-03-30 00:48:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-completes-clinical-and-commercial-drug-product-manufacturing-line-in-visp-ch 2023-03-30 00:47:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/simulations-plus-enters-new-strategic-collaboration-to-discover-anticancer-therapies 2023-03-29 03:01:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-announces-establishment-of-joint-venture-with-rxilient-biotech-to-jointly-develop-and-commercialize-toripalimab-in-southeast-asia 2023-03-29 02:59:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ratio-therapeutics-announces-licensing-agreement 2023-03-29 02:58:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-announces-agreement-with-ad-ports-group-for-exclusive-product-distribution 2023-03-29 02:57:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-announces-first-patient-dosed-in-the-phase-2-study-harmonic 2023-03-29 02:55:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclerion-therapeutics-receives-us-fda-orphan-drug-designation-for-zagociguat 2023-03-27 23:56:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurosense-therapeutics-massachusetts-general-hospitals-neuroepigenetics-lab 2023-03-27 23:55:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-expanded-partnership-with-beyond-benign 2023-03-27 23:53:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-approved-in-japan-as-the-first-her2-directed-therapy-for-patients-with-her2 2023-03-27 23:51:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellusion-announces-first-patient-transplanted-ipsc-derived-corneal 2023-03-27 05:34:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-at-interim 2023-03-27 05:58:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyne-therapeutics-receives-fda-orphan-drug-and-rare-pediatric-designations-for-dyne-251 2023-03-24 00:04:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tela-bio-announces-510k-clearance-for-ovitex-prs-long-term 2023-03-23 23:54:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sona-nanotech-closes-acquisition-of-siva-therapeutics 2023-03-23 23:53:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pionyr-immunotherapeutics-and-gilead-change-exclusive-option-agreement 2023-03-23 23:52:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcenta-announces-first-patient-dosed-in-the-us-study-of-its-first-in-class 2023-03-23 23:51:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabiome-and-roquette-collaborate-on-the-development-of-tailored-fibers 2023-03-23 05:33:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcellera-and-rq-bio-partner-to-accelerate-the-advancement 2023-03-23 00:16:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/macrogenics-earns-15-million-milestone-following-us-fda-approval-of-zynyz 2023-03-23 00:14:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/truveta-and-alpine-immune-sciences-announce-strategic-partnership 2023-03-23 00:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aziyo-biologics-and-sientra-announce-simpliderm-partnership 2023-03-23 00:03:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-acquires-essex-management 2023-03-23 00:00:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-receives-fda-fast-track-designation-for-pbp1510 2023-03-21 01:28:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-receives-fda-fast-track-designation-for-aro-apoc3 2023-03-21 01:27:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/icosagen-acquires-the-carterra-lsa-instrument-to-significantly-enhance 2023-03-21 01:25:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/northwest-biotherapeutics-and-advent-bioservices-announce-receipt-of-license 2023-03-21 01:21:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nubeqa-darolutamide-approved-for-additional-prostate-cancer-indication-in-china 2023-03-21 01:13:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-exercises-option-to-license-nurixs-irak4-targeted-protein-degrader 2023-03-21 01:11:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-medias-gmp-and-quality-management-programs-success 2023-03-20 05:34:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupont-liveo-healthcare-exhibits-at-2023-ebc-biopharma 2023-03-19 22:16:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leucid-bio-and-great-ormond-street-hospital-enter-commercial-agreement 2023-03-17 01:09:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthego-introduces-crispr-discovery-partners-to-streamline-crispr-driven 2023-03-17 00:59:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enzo-biochem-agrees-to-sell-clinical-laboratory-to-labcorp 2023-03-17 00:36:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/successful-fda-inspection-at-gerresheimer-peachtree-city-usa 2023-03-16 05:01:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inspire-biotherapeutics-launches-with-pre-seed-investment-to-target-monogenic 2023-03-16 03:05:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/miltenyi-biotec-acquires-biosensor-company-lino-biotech 2023-03-16 03:04:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-fda-has-approved-the-csf-1r-inhibitor-pimicotinib-of-abbisko-therapeutics 2023-03-15 23:51:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-and-nsg-biolabs-announce-albatroz-therapeutics-as-winner-of-first-amgen 2023-03-15 23:42:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perspective-therapeutics-and-pharmalogic-announce-collaboration-for-the-development 2023-03-15 00:57:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synaffix-announces-expansion-of-adc-collaboration-with-macrogenics 2023-03-15 00:54:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cambrian-bio-unveils-new-pipeline-company-amplifier-therapeutics 2023-03-15 00:53:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyeganics-organic-tears-the-only-usda-certified-organic-lubricant-eye-drop 2023-03-15 00:51:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-japan-2023-depreciated-yen-attracting-renewed-international-interest 2023-03-13 23:35:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gensight-biologics-confirms-sustained-efficacy-and-safety-of-bilateral-lumevoq 2023-03-13 22:20:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biorestorative-therapies-to-seek-fda-approval-to-expand 2023-03-13 22:14:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gtp-bioways-and-texcell-announce-a-business-partnership-to-provide-extended-services 2023-03-10 04:41:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hikma-expands-impact-in-canada-with-launches-of-new-sterile-injectable-medicines 2023-03-10 04:41:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-signs-memorandum-of-understanding-to-build-new-biologics-plant-in-slovenia 2023-03-10 04:40:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tessa-therapeutics-enters-into-cooperative-research-and-development-agreement 2023-03-09 00:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aribio-co-and-fujirebio-diagnostics-announce-strategic-partnership 2023-03-09 00:48:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-simplifies-trace 2023-03-09 00:46:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qsam-biosciences-receives-clearance-from-fda-to-expand-enrollment-criteria 2023-03-09 00:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carisma-therapeutics-closes-merger-with-sesen-bio 2023-03-08 01:01:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytek-biosciences-introduces-new-20-color-aml-panel 2023-03-08 01:00:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-announces-the-release-of-simcyp-pbpk-simulator-version-22 2023-03-08 00:57:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-biomarins-supplemental-new-drug-application-to-expand-use-of-voxzogo 2023-03-08 00:55:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/danaher-partners-with-the-university-of-pennsylvanias-center 2023-03-08 00:52:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phanes-therapeutics-entered-into-a-research-collaboration-with-xyphos-biosciences 2023-03-07 01:24:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viecure-and-exact-sciences-enter-strategic-collaboration-aimed-at-improving 2023-03-07 01:24:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolinerx-announces-clinical-trial-collaboration-with-washington-university-school-of-medicine 2023-03-07 01:23:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amarin-highlights-new-evidence-of-therapeutic-value-of-epa 2023-03-07 01:21:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/update-on-us-regulatory-review-of-lynparza-in-combination-with-abiraterone 2023-03-03 01:06:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/colorcon-inc-completes-acquisition-of-controlled-atmosphere-packaging-specialist 2023-03-03 01:05:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/confo-therapeutics-announces-global-licensing-agreement-with-lilly 2023-03-03 00:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-launches-health-equity-campaign-in-partnership-with-award-winning 2023-03-03 00:58:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-completes-fda-filing-for-approval-of-millburn-facility-to-support-pluvicto-launch 2023-03-03 00:57:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celanese-announces-collaboration-with-alessa-therapeutics 2023-03-02 01:36:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/3p-biopharmaceuticals-increases-its-microbial-production-capacity 2023-03-02 01:31:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vivos-expands-revenue-potential-with-acquisition-of-product-rights 2023-03-02 01:30:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nephros-and-donastar-announce-strategic-partnership 2023-03-02 01:29:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clean-cells-launches-activities-at-new-biopharmaceutical-quality-control-facility 2023-03-01 06:29:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-centrifuge-5910-ri-is-the-first-centrifuge-in-the-market 2023-03-01 06:25:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tilt-holdings-enters-into-licensing-agreement-to-bring-thredz 2023-03-01 00:39:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aravive-announces-fda-orphan-drug-designation-granted-to-batiraxcept 2023-03-01 00:37:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunshine-biopharma-signs-exclusive-worldwide-license-with-university-of-arizona 2023-03-01 00:35:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/awakn-life-sciences-signs-its-fourth-licensing-partnership-agreement-in-north-america 2023-03-01 00:33:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcode-therapeutics-announces-orphan-drug-designation-status-for-ttx-mc138 2023-03-01 00:30:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-japan-2023-deprecated-yen-attracting-renewed-international 2023-03-01 00:24:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peter-maccallum-cancer-centre-and-cartherics-announce-collaboration 2023-02-28 22:11:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerba-research-and-teddy-lab-sign-memorandum-of-understanding 2023-02-28 22:07:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-signs-agreement-for-the-supply-of-cbd-rich-cannabis-oil-for-its-clinical-trial 2023-02-28 00:37:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-biopharma-signs-agreement-with-catalyst-biosciences-for-the-acquisition 2023-02-28 00:36:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biologics-license-application-for-lecanemab-designated-for-priority-review 2023-02-28 00:35:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/askbio-receives-european-commission-orphan-drug-designation-through-its-eu-based 2023-02-28 00:33:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-unveils-the-new-automation-generation-at-the-slas-conference 2023-02-27 03:45:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shuttle-pharmaceuticals-expands-laboratory-space-to-advance-drug-development 2023-02-26 22:51:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wcg-collaborates-with-leading-multiple-sclerosis-kol-to-launch 2023-02-26 22:50:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aviadobio-signs-exclusive-license-agreement-with-neurgain-technologies 2023-02-26 22:49:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/predictive-oncology-and-cvergenx-announce-partnership-to-develop 2023-02-26 22:48:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mei-pharma-and-infinity-pharmaceuticals-announce-definitive-merger-agreement 2023-02-26 22:47:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vbl-therapeutics-and-notable-labs-announce-definitive-merger-agreement 2023-02-26 22:45:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lepu-biopharma-and-keymed-jointly-announces-global-exclusive-licence-agreement-with-astrazeneca 2023-02-26 22:41:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heron-therapeutics-enters-into-cooperation-agreement 2023-02-23 01:11:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/primordial-genetics-launches-high-performance-rna-polymerases 2023-02-23 01:09:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcode-therapeutics-and-brain-biotech-join-forces-to-develop 2023-02-23 01:09:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cognition-therapeutics-and-actc-receive-fda-clearance-for-phase-2-start-study 2023-02-23 01:08:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cue-biopharma-enters-into-a-strategic-collaboration-and-option-agreement 2023-02-23 01:06:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relation-therapeutics-announces-launch-of-flagship-integrated-wetdry-laboratory 2023-02-23 01:05:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genscript-probio-and-rvac-medicines-announce-strategic-partnership-for-gmp 2023-02-23 01:05:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcheck-announces-collaboration-to-apply-microfluidics-technology 2023-02-22 03:46:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thewell-bioscience-announces-launch-of-vitrogel-organoid-recovery-solution 2023-02-22 03:45:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosenic-receives-eur-1-million-from-pregene-in-accordance 2023-02-22 03:44:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemomab-announces-fda-clearance-of-investigational-new-drug-application 2023-02-22 03:42:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pediatric-research-at-resvinet-2023-underscores-beyfortus 2023-02-22 03:41:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-provides-update-on-phase-3-move-ahead-trial-evaluating-lagevrio 2023-02-22 03:40:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivir-has-determined-the-recommended-phase-2-dose-for-fostrox 2023-02-20 23:51:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-and-liscure-biosciences-announce-strategic-collaboration-to-develop 2023-02-20 23:50:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bachem-partners-with-simplynano-project-to-inspire-young-people-with-nanotechnology 2023-02-23 04:19:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oliver-healthcare-packaging-to-set-up-manufacturing-facility-in-malaysia 2023-02-20 00:52:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/resilience-signs-multi-year-strategic-biomanufacturing-partnership-with-leading-pharmaceutical-company 2023-02-17 03:55:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-announces-positive-talzenna-and-xtandi-combination 2023-02-17 03:54:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-astrazeneca-present-final-results-of-key-secondary-overall-survival-endpoint 2023-02-17 03:50:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-keytruda-pembrolizumab-plus-chemotherapy-significantly-improved 2023-02-17 03:45:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iveric-bio-announces-fda-accepts-new-drug-application-and-grants-priority-review 2023-02-17 03:35:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-completes-expansion-of-conjugation-facility-in-visp-ch 2023-02-17 03:25:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enflex-expands-its-pharma-healthcare-solutions-portfolio-with-stick-pack-technology 2023-02-16 03:35:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/igis-asia-investment-management-partners-with-cha-bio-group 2023-02-16 03:32:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coya-therapeutics-expansion-licensing-agreement-with-arscience-biotherapeutics 2023-02-16 02:57:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celanese-announces-a-research-agreement-with-johns-hopkins-university 2023-02-16 02:55:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbio-announces-positive-data-from-phase-2-trial-of-bemcentinib-in-combination 2023-02-16 02:02:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-dosed-in-a-phase-3-clinical-trial-of-picankibart-in-patients 2023-02-16 01:21:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurofins-discovery-collaborating-with-invasight-on-cancer-therapies 2023-02-15 00:26:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delix-therapeutics-partners-with-cellectricon 2023-02-15 00:23:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endomimetics-announces-a-research-collaboration-agreement-with-bisco 2023-02-15 00:22:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vizai-collaborates-with-johns-hopkins-to-expedite-patient-enrollment-in-brain-injury-trial 2023-02-15 00:21:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-expand-early-development-services-offering-into-north-america 2023-02-14 01:25:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocuphire-announces-fda-acceptance-of-new-drug-application-and-pdufa 2023-02-14 00:24:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fusion-pharmaceuticals-to-acquire-phase-2-program 2023-02-14 00:21:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sophia-genetics-expands-partnership-with-astrazeneca 2023-02-14 00:00:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ironwood-pharmaceuticals-announces-fda-filing-acceptance-and-priority-review 2023-02-13 23:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/completion-of-the-first-batch-of-subject-enrollment-for-the-phase-i-clinical-trial 2023-02-13 03:17:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuvectis-pharma-announces-publication-in-the-journal-of-experimental-medicine 2023-02-10 01:41:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ensoma-announces-closing-of-twelve-bio-acquisition 2023-02-10 01:39:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revir-therapeutics-and-asieris-pharmaceuticals-enter-into-agreement 2023-02-09 00:37:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adrestia-therapeutics-partners-with-leading-patient-advocacy-groups-to-form-ataxia-telangiectasia-research-consortium 2023-02-09 00:35:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adma-biocenters-receives-fda-approval-for-its-eighth-plasma-collection-center 2023-02-09 00:33:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lineage-provides-update-on-auditory-neuronal-cell-transplant-program 2023-02-09 00:27:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gerresheimer-and-corning-announce-joint-venture-to-meet-growing-demand-for-velocity-vials 2023-02-08 04:39:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elektrofi-announces-collaboration-with-thermo-fisher-scientific 2023-02-08 01:14:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arima-genomics-and-velsera-announce-partnership-to-enable-broad-adoption 2023-02-08 01:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opiant-pharmaceuticals-announces-cfius-approval-for-proposed-acquisition-by-indivior-plc 2023-02-08 01:13:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ankyra-therapeutics-announces-collaboration-to-evaluate 2023-02-08 00:56:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opiant-pharmaceuticals-announces-expiration-of-hart-scott-rodino-waiting-period 2023-02-06 23:36:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/presage-announces-collaboration-with-pure-biologics-to-investigate-oncology 2023-02-06 23:34:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singular-genomics-launches-max-read-kits-for-single-cell-sequencing 2023-02-06 23:33:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-and-healthcare-royalty-agree-to-extinguish-all-redhills-debt 2023-02-06 23:32:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultima-genomics-partners-with-new-england-biolabs 2023-02-06 23:31:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deepcell-releases-first-of-its-kind-single-cell-morphology-data-sets 2023-02-06 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-pharmaceutical-begins-the-first-administration-of-the-bersiporocin 2023-02-06 06:55:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ground-breaking-results-in-phase-2-scleroderma-study-by-certa-therapeutics 2023-02-06 06:55:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qurient-co-ltd-and-tb-alliance-announce-exclusive-license-agreement-for-telacebec 2023-02-03 23:27:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azenta-announces-the-acquisition-of-ziath 2023-02-03 23:26:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accutar-biotechnology-announces-fda-clearance-of-ind-application-for-phase-trial 2023-02-03 23:25:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/center-for-breakthrough-medicines-launches-precision-plasmids 2023-02-02 23:36:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-strengthens-manufacturing-capabilities-with-first-in-house-plasmid 2023-02-02 23:35:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/y-mabs-and-the-european-medicines-agency-reach-agreement 2023-02-02 23:33:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karuna-therapeutics-announces-exclusive-global-license-agreement-for-goldfinch-bios 2023-02-02 23:31:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carbogen-amcis-opens-new-state-of-the-art-facility-dedicated-to-sterile-liquid 2023-02-02 22:31:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ellipses-pharma-announces-fda-approval-of-ind-application-for-ep0042-for-patients 2023-02-02 00:28:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blue-water-vaccines-announces-partnership-with-abvacc-for-joint-development-of-novel 2023-02-02 00:27:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orbit-discovery-and-endevica-bio-enter-multi-target-collaboration 2023-02-02 00:26:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beactica-therapeutics-receives-fda-orphan-drug-designation-for-bea-17 2023-02-02 00:25:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-label-expansion-of-roches-hemlibra-to-include-people 2023-02-02 00:24:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenlight-biosciences-receives-approval-to-initiate-phase-clinical-trial 2023-02-01 23:53:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coeptis-therapeutics-enters-into-sponsored-research-agreement 2023-02-01 01:48:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/benchsci-announces-launch-of-ascend 2023-02-01 01:47:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inovio-announces-strategic-reorganization 2023-02-01 01:45:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reneo-pharmaceuticals-receives-fast-track-designation-from-the-fda-for-mavodelpar 2023-02-01 01:44:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciwind-biosciences-announces-initiation-of-patient-dosing-in-phase-clinical-trials 2023-01-31 22:28:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-enters-exclusive-licensing-agreement-with-cs-pharmaceuticals 2023-01-31 22:26:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanoscope-therapeutics-receives-fast-track-designation-by-the-fda-for-mco-010 2023-01-30 23:24:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ribon-therapeutics-announces-equity-investment-from-pfizer 2023-01-30 23:23:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genedx-makes-significant-industry-wide-contributions-to-new-disease-gene-discovery 2023-01-30 23:23:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lecanemab-receives-priority-review-status-in-japan 2023-01-30 06:24:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teijin-pharma-to-launch-japan-market-sales-of-abaloparatide-acetate-for-osteoporos 2023-01-30 06:21:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-receives-positive-chmp-opinion-for-citrate-free-high-concentration 2023-01-30 06:18:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaegis-therapeutics-announces-fda-clearance-of-ind-for-its-inflammation-regulator-protein 2023-01-26 23:16:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centessa-pharmaceuticals-announces-fda-clearance-of-ind-application-for-phase 2023-01-26 23:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-commercial-launch-of-briumvi 2023-01-26 23:14:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sona-nanotech-to-acquire-cancer-therapy-developer-siva-therapeutics 2023-01-26 23:13:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-supports-direct-reliefs-efforts-to-expand-access 2023-01-26 23:12:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-approved-in-the-eu-as-the-first-her2-directed-therapy-for-patients 2023-01-26 23:11:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/poxel-receives-orphan-drug-designation-from-the-european-commission 2023-01-26 22:11:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innate-pharma-announces-hsr-clearance-regarding-expansion-of-its-collaboration-with-sanofi 2023-01-26 22:10:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-to-commercial-manufacture-provention-bio-diabetes-therapy 2023-01-26 22:09:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/psyence-and-eden-labs-announce-extraction-and-product-development-collaboration 2023-01-26 22:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stevanato-group-collaborates-with-transcoject 2023-01-24 23:38:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atum-announces-leap-in-transposase-licensing-agreement-with-codiak-biosciences 2023-01-24 23:37:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amolyt-pharma-announces-research-agreement-and-licensing-option-with-xoma 2023-01-24 23:36:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essent-biologics-launches-revolutionary-human-native-tissue-derived-type-i-collagen 2023-01-24 23:35:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immpact-bio-announces-fda-clearance-of-ind-for-novel-bispecific-car 2023-01-24 23:34:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-plans-to-invest-additional-at-manufacturing-site-in-research-triangle-park 2023-01-24 06:50:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-and-immedica-enter-exclusive-partnership-for-commercialisation 2023-01-24 06:49:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyloris-announces-commercial-partnership-for-maxigesic-iv-in-9-european-countries 2023-01-24 06:47:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intelgenx-and-arwan-enter-into-a-supply-agreement-for-rizaport-in-mena-countries 2023-01-24 06:46:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioasis-technologies-announces-termination-agreement-with-midatech-pharma 2023-01-24 06:45:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-announces-agreement-to-acquire-leading-antifungal-agent-mycamine 2023-01-24 06:44:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellectis-amends-20-million-convertible-note-under-collaboration-agreement 2023-01-20 23:28:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microbiome-connect-asia-a-must-attend-event-for-advancing-microbiome-research 2023-01-20 22:53:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brukinsa-approved-in-the-us-for-chronic-lymphocytic-leukemia 2023-01-19 23:27:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/editas-medicine-and-shoreline-biosciences-enter-into-definitive-agreement 2023-01-19 23:25:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evaxion-receives-fda-fast-track-designation-for-personalized-cancer-immunotherapy 2023-01-19 23:24:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-doses-first-patient-in-aurelio-05-phase-trial-of-nanrilkefusp-alfa 2023-01-19 22:28:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teon-therapeutics-announces-clinical-trial-collaboration-with-merck 2023-01-18 22:59:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kaneka-expands-gmp-manufacturing-capacity-for-mrna-in-kaneka-eurogentec 2023-01-18 22:58:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cambrex-completes-acquisition-of-snapdragon-chemistry 2023-01-18 22:56:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-agreement-with-nhsa-for-inclusion-of-orpathys 2023-01-18 22:55:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inscripta-acquires-infinome-biosciences-and-sestina-bio 2023-01-18 22:53:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogens-vaccine-production-cell-line-age1crpix-used-for-clinical-production 2023-01-18 22:39:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ceruvia-lifesciences-announces-first-participant-dosed-in-bol-148-phase-clinical-trial 2023-01-18 01:08:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-biomath-llc-presents-model-informed-drug-discovery-and-development 2023-01-18 01:07:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matinas-biopharma-announces-collaboration-with-national-resilience-to-explore 2023-01-12 23:28:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-acquires-us-based-cbr-international 2023-01-12 22:42:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-acquires-european-cro-strengthens-global-operations 2023-01-12 22:41:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-and-ch-trading-group-announce-product-distribution-agreement 2023-01-12 22:23:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arbor-biotechnologies-announces-expanded-strategic-partnership-with-vertex 2023-01-12 22:21:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zeon-corporation-acquires-edge-manufactures-and-sells-prototypes 2023-01-10 23:16:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosig-executes-agreement-with-bellin-health 2023-01-10 23:13:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-to-acquire-instadeep-to-strengthen-pioneering-position-in-the-field 2023-01-10 23:12:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-anima-biotech-announce-collaboration-for-the-discovery-and-development 2023-01-10 23:10:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kronos-bio-announces-discovery-collaboration-with-genentech 2023-01-09 23:55:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenlight-biosciences-and-epivax-therapeutics-sign-exclusive-collaboration-agreement 2023-01-09 23:54:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bt-beamedical-technologies-and-shina-systems-enter-into-definitive-agreement 2023-01-09 23:53:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-to-acquire-albireo-accelerating-growth-in-rare-disease-with-treatment 2023-01-09 23:52:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-and-lundbeck-announce-fda-acceptance-and-priority-review-of-snda 2023-01-09 23:48:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coherus-agrees-to-acquire-exclusive-us-commercial-rights-to-eylea 2023-01-09 23:45:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-to-roches-bispecific-antibody-glofitamab 2023-01-06 23:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-for-priority-review-the-supplemental-biologics-license-application-for-pfizer 2023-01-06 23:52:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ns-pharma-opens-new-us-drug-discovery-center-in-cambridge-ma 2023-01-06 23:50:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-year-and-two-new-zones-at-pharmapack-europe-in-2024 2023-01-06 05:37:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imunon-enters-into-collaborative-research-agreement-with-the-wistar-institute 2023-01-05 23:56:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/duality-biologics-announces-license-agreement-of-its-next-generation 2023-01-05 23:55:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxcytes-vax-24-granted-fda-breakthrough-therapy-designation 2023-01-05 23:54:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/frontier-medicines-announces-advancement-of-second-and-third-programs 2023-01-05 23:53:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bellerophon-therapeutics-announces-license-agreement 2023-01-05 23:53:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytomx-and-moderna-announce-strategic-research-collaboration 2023-01-05 23:52:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-announces-strategic-partnership-with-uk-government 2023-01-05 23:49:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-alcyone-therapeutics-announce-license-and-collaboration-agreement 2023-01-04 23:20:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncorus-announces-research-collaboration-with-daewoong-pharmaceutical 2023-01-04 23:19:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-acquires-vyasa-an-artificial-intelligence-company 2023-01-04 23:17:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/capsida-biotherapeutics-announces-strategic-collaboration-with-prevail 2023-01-04 23:16:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/belharra-therapeutics-announces-broad-collaboration-with-genentech-to-discover 2023-01-04 23:15:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-launches-first-continuous-manufacturing-line-for-oral-solids 2023-01-04 01:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-and-hansoh-pharma-announce-an-antibody-license-agreement 2023-01-04 01:02:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-completes-acquisition-of-the-binding-site-group 2023-01-04 01:01:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-fda-approval-of-briumvi 2022-12-28 23:28:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acer-therapeutics-and-relief-therapeutics-announce-us-fda-approval-of-olpruva 2022-12-28 22:16:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-enters-into-a-global-clinical-collaboration-with-msd-to-evaluate-atg-037 2022-12-28 22:08:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nova-mentis-receives-health-canada-approval-for-first-of-its-kind-psilocybin-clinical-trial 2022-12-22 23:14:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mersana-therapeutics-announces-research-collaboration-agreement-with-merck-kgaa 2022-12-22 23:13:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hataali-and-reef-group-announce-strategic-partnership-for-atmp-smart-labs 2022-12-22 01:27:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inflarx-announces-amendment-of-co-development-agreement 2022-12-22 00:35:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oric-pharmaceuticals-announces-clinical-development-collaboration-with-pfizer 2022-12-22 00:33:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-eisai-daiichi-sankyo-and-takeda-agree-to-collaborate 2022-12-22 00:31:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/point-biopharma-announces-closing-of-agreements-with-lantheus-holdings 2022-12-20 23:16:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sutro-biopharma-and-vaxcyte-enter-into-option-grant-agreement 2022-12-20 23:15:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relief-therapeutics-holding-and-nrx-pharmaceuticals-announce-close-of-definitive-settlement 2022-12-20 23:13:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/car-t-cell-therapy-breyanzi-approved-as-relapsed-or-refractory-large-b-cell 2022-12-20 23:11:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-the-fda-approval-and-launch-of-levocarnitine-tablets-usp 2022-12-20 00:38:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-receives-fda-approval-for-additional-indication-for-pemfexy 2022-12-20 00:37:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-reaches-agreement-with-genentech 2022-12-20 00:36:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-click-therapeutics-expand-their-existing-collaboration 2022-12-20 00:34:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nykode-therapeutics-and-richter-helm-biologics-announce-strategic 2022-12-19 23:01:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/swanbio-therapeutics-initiates-first-in-human-study-of-aav 2022-12-15 23:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-designates-alexis-bios-realskin-as-regenerative-medicine-advanced-therapy 2022-12-15 23:52:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-washington-university-school-of-medicine-in-st-louis 2022-12-14 23:35:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-us-collaboration-with-pfizer-to-help-patients 2022-12-14 23:32:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vallon-pharmaceuticals-and-gri-bio-enter-into-merger-agreement 2022-12-13 23:19:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-to-acquire-late-stage-potential-best-in-class-oral-allosteric 2022-12-13 23:18:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-wave-life-sciences-announce-collaboration-to-drive-discovery-and-development 2022-12-13 23:16:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/titan-pharmaceuticals-announces-licensing-agreement-with-ocular-therapeutix 2022-12-12 23:07:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-reaches-settlement-agreement-with-accord-healthcare 2022-12-12 23:05:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-investigational-new-drug-ind-application-for-vx-522 2022-12-12 23:04:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-announces-research-agreement-with-nitrase-therapeutics-focused 2022-12-12 23:03:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-enters-rd-agreements-with-the-university-of-oxford 2022-12-08 23:42:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-and-entrada-therapeutics-establish-collaboration-to-discover-and-develop 2022-12-08 23:41:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-for-priority-review-the-biologics-license-application-for-pfizer 2022-12-07 23:21:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/replimune-enters-into-clinical-collaboration-agreement-with-roche-for-the-development 2022-12-07 23:19:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revolution-medicines-to-regain-global-rights-to-rmc-4630-following-sanofi 2022-12-07 23:19:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-therapeutics-has-received-fda-clearance-to-initiate-clinical-trials 2022-12-07 00:31:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evaxion-and-expres2ion-initiate-research-collaboration-on-a-novel-cytomegalovirus 2022-12-07 00:30:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-gains-leading-perfusion-micro-bioreactor-with-erbi-biosystems-acquisition 2022-12-07 00:29:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/csl-opens-new-australian-plasma-fractionation-facility 2022-12-07 00:27:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-launches-industry-first-public-database-listing-companys-science-collaborations 2022-12-07 00:26:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syndax-announces-us-fda-breakthrough-therapy-designation-granted-for-revumenib 2022-12-05 23:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/respirerx-pharmaceuticals-enters-a-collaboration-with-national-institute-for-neurological 2022-12-05 23:19:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-national-partnership-with-habitat-for-humanity-international 2022-12-05 23:18:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anaptysbio-and-gsk-partnered-immuno-oncology-agent-jemperli 2022-12-03 00:37:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reaction-biology-acquires-bioassay-gmbh-increasing-large-molecule-capabilities 2022-12-03 00:37:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alcami-builds-cgmp-biostorage-facility-in-north-carolina 2022-12-02 22:59:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/integra-lifesciences-announces-definitive-agreement-to-acquire-surgical-innovation-associates 2022-12-02 22:58:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-completes-acquisition-of-akouos-expanding-efforts 2022-12-02 22:57:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-consulting-agreement 2022-12-01 01:53:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipas-subsidiary-biostrand-and-briacell-announce-artificial-intelligence-collaboration 2022-12-01 01:52:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immutep-enters-into-second-clinical-trial-collaboration-agreement-with-merck-kgaa-darmstadt-germany-and-pfizer 2022-11-30 01:54:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-exercises-option-for-novel-antibody-drug-conjugate-program-under-agreement-with-legochem 2022-11-30 01:51:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipla-announces-launch-of-leuprolide-acetate-injection-depot-225mg 2022-11-29 23:58:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eikonoklastes-therapeutics-and-forge-biologics-announce-viral-vector 2022-11-29 23:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-to-acquire-neogene-therapeutics 2022-11-29 23:56:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioventure-minapharm-pharmaceuticals-and-migentra-sign-an-exclusive-agreement 2022-11-29 04:22:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tenaya-therapeutics-receives-orphan-drug-designation 2022-11-29 04:00:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enlivex-receives-allocetra-ind-clearance-from-the-us-food-and-drug-administration 2022-11-29 03:58:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azelis-strengthens-pharmaceutical-offering-in-india-through-distribution-partnership 2022-11-28 23:49:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-major-regulatory-updates-in-taiwan-and-south-korea-for-nefecon-for-the-treatment-of-primary-iga-nephropathy 2022-11-27 22:43:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-biopharma-announces-research-collaboration-and-option-agreement 2022-11-24 01:55:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-announces-european-commission-approval-of-skyrizi 2022-11-24 01:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imaginab-executes-new-license-and-supply-agreement-for-cd8-immunopet 2022-11-22 23:31:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biological-dynamics-collaborates-on-clinical-utility-studies-to-examine 2022-11-22 23:29:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-invests-in-expansion-of-clinical-manufacturing-facilities 2022-11-22 23:29:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/umoja-biopharma-and-iaso-biotherapeutics-announce-research-collaboration 2022-11-22 01:12:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensei-biotherapeutics-announces-collaboration-with-washington-university 2022-11-22 01:11:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blue-water-vaccines-announces-exclusive-global-license-agreement 2022-11-22 01:09:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/legend-biotech-announces-fda-clearance-of-ind-application-for-lb2102 2022-11-22 01:08:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/paxmedica-inc-enters-into-committed-equity-investment-agreement 2022-11-17 23:57:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invivyd-announces-partnership-with-population-health-partners 2022-11-17 23:55:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bavarian-nordic-enters-joint-procurement-agreement-with-the-european 2022-11-17 23:54:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idorsia-and-simcere-enter-into-a-licensing-agreement-for-daridorexant-in-china 2022-11-16 23:18:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metoject-subcutaneous-injection-syringe-launched-in-japan 2022-11-16 00:23:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nextcure-and-legochem-biosciences-enter-into-collaboration 2022-11-15 23:14:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotheus-has-entered-into-a-license-and-collaboration-agreement-with-hansoh-pharma 2022-11-15 23:13:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elevatebio-and-affini-t-therapeutics-announce-partnership-to-advance-affini 2022-11-15 23:12:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-diosynth-biotechnologies-expands-strategic-partnership-with-nc-state 2022-11-15 23:11:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-reaches-agreement-in-principle-with-hcr 2022-11-15 00:54:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantheus-and-point-biopharma-announce-strategic-collaboration 2022-11-15 00:53:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-recommended-for-approval-in-the-eu-by-chmp-for-patients-with-previously 2022-11-15 00:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-biopharmaceuticals-receives-korea-drug-development-fund-investment-grant 2022-11-13 23:12:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daewoong-and-hitgen-announce-research-collaboration 2022-11-13 23:11:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaccinex-and-its-collaborators-present-two-abstracts-related-to-pepinemab 2022-11-11 00:29:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imunon-enters-into-technology-evaluation-agreement-with-acuitas-therapeutics 2022-11-11 00:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirona-biochem-signs-research-collaboration-agreement-with-international-centre 2022-11-11 00:27:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skye-bioscience-closes-acquisition-of-emerald-health-therapeutics 2022-11-11 00:25:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/angus-acquires-expression-systems 2022-11-09 23:47:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medison-pharma-announces-expansion-of-the-multi-territorial-agreement 2022-11-09 23:46:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oryzon-announces-fda-clearance-of-ind-to-initiate-collaborative-phase-ii 2022-11-09 23:45:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/awakn-life-sciences-signs-its-third-licensing-partnership-agreement-in-north-america 2022-11-09 23:43:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/libtayo-in-combination-with-chemotherapy-approved 2022-11-08 23:43:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iti-receives-fda-fast-track-designation-for-iti-3000-a-pdna-vaccine 2022-11-08 23:40:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avenue-therapeutics-completes-the-acquisition-of-baergic-bio-and-its-selective 2022-11-08 23:39:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocuphire-pharma-enters-into-a-global-license-agreement-for-development 2022-11-08 01:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-announces-cell-therapy-manufacturing-capacity-expansion 2022-11-08 01:51:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-divest-rights-for-muscle-relaxant-myonal 2022-11-06 23:11:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/research-on-neural-dynamics-wins-2022-eppendorf-science-prize 2022-11-04 06:02:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affimed-and-artiva-biotherapeutics-announce-partnership-to-advance-combination-therapy 2022-11-03 23:25:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/io-biotech-announces-new-clinical-collaboration-with-merck-to-evaluate-neoadjuvant 2022-11-03 23:24:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reaction-biology-and-vyant-bio-announce-closing-of-definitive-agreement-to-acquire 2022-11-03 23:22:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovative-processes-transforming-oligonucleotide-manufacturing 2022-11-14 22:29:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jounce-therapeutics-earns-clinical-milestone-payment-under-the-ccr8 2022-11-02 23:20:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocuphire-announces-peer-reviewed-publication-in-bmc-ophthalmology-for-nyxol 2022-11-02 23:18:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/igm-biosciences-and-adc-therapeutics-announce-clinical-collaboration-agreement 2022-11-02 23:18:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-vemlidy-for-treatment 2022-11-02 23:15:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-and-sairopa-establish-exclusive-collaboration-and-option-agreement 2022-11-02 00:36:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-setmelanotide-granted-breakthrough 2022-11-02 00:33:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmather-enters-into-exclusive-option-agreement 2022-11-02 00:31:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hilleman-laboratories-to-develop-a-thermostable-second-generation 2022-10-31 23:36:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alx-oncology-enters-100-million-loan-facility-agreement-with-oxford-finance 2022-10-31 23:21:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mosaic-immunoengineerings-academic-collaborators-awarded-grants 2022-10-31 23:20:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-overland-biopharm-completes-buildout-of-cgmp-manufacturing 2022-10-31 23:18:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardelyx-collaboration-partner-kyowa-kirin-announces-submission 2022-10-31 23:17:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/preclinical-data-demonstrates-sonotran-increased-delivery 2022-10-31 03:56:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-commits-to-purdue-to-establish-an-innovative-pharmaceutical 2022-10-28 03:51:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-diosynth-biotechnologies-enters-into-an-agreement-with-argenx 2022-10-28 03:50:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/castle-biosciences-presents-new-data-from-collaboration 2022-10-28 03:49:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-bioscience-and-hilleman-laboratories-to-co-develop-new-vaccine-platforms 2022-10-27 23:42:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/candel-therapeutics-partners-with-the-university-of-pennsylvania 2022-10-27 22:55:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medavail-announces-technology-partnership-with-progressive-care-inc 2022-10-27 22:53:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sema4-genedx-collaborates-on-new-research-demonstrating-genome 2022-10-27 22:52:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opgen-subsidiary-curetis-and-bioversys-sign-collaboration-agreement 2022-10-26 03:13:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-enters-partnership-with-hannover-medical-school-to-create-molecular 2022-10-26 03:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/csl-enters-into-strategic-option-and-license-agreement-with-translational-sciences 2022-10-26 03:10:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/limmatech-enters-exclusive-license-and-collaboration-agreement-with-griffith-university 2022-10-24 23:38:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mjudo-in-combination-with-imfinzi-approved-in-the-us-for-patients 2022-10-24 23:36:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hookipa-announces-strategic-collaboration-and-license-agreement-with-roche 2022-10-20 22:58:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunshine-biopharma-announces-the-acquisition-of-nora-pharma 2022-10-20 22:55:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-and-refuge-biotechnologies-announce-exclusive-license-agreement 2022-10-20 22:54:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/triumvira-immunologics-announces-expansion-of-cell-therapy-manufacturing-capabilities 2022-10-20 00:37:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-and-zymeworks-announce-exclusive-license-agreement 2022-10-20 00:36:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-to-present-the-aurelio-04-phase-2-study-design-and-findings-from-boxr-research-at-the-sitc-annual-meeting 2022-10-19 01:39:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanobiotix-executes-definitive-agreement-to-restructure-existing-loan-with-the-european-investment-bank 2022-10-18 23:58:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-aesthetics-and-girls-inc-partner-to-bridge-the-gender-gap-in-stem 2022-10-18 23:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-the-bill-melinda-gates-medical-research-institute-licensing-agreement 2022-10-18 23:56:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/at-cphi-2022-telstar-will-present-a-new-predictive-maintenance-platform 2022-10-20 00:40:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oculis-sa-and-european-biotech-acquisition-corp-announce-business-combination 2022-10-18 03:31:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nkgen-biotech-receives-ind-clearance-from-fda-for-snk02-allogeneic-natural-killer 2022-10-18 03:28:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kineta-announces-clinical-collaboration-with-merck-to-evaluate-kva12123 2022-10-18 03:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ferring-pharmaceuticals-and-blackstone-life-sciences-restructure 2022-10-18 03:26:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mettler-toledo-launches-new-combination-checkweighing-and-serialization-system 2022-10-17 03:08:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galectin-therapeutics-receives-fda-approval-to-proceed 2022-10-13 00:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-immunotech-announces-fda-clearance-of-ind-application-to-evaluate-ampligen 2022-10-13 00:52:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vbi-vaccines-and-agenus-announce-collaboration-to-evaluate-vbi-1901-in-combination 2022-10-13 00:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jacobio-pharma-to-collaborate-with-merck 2022-10-13 00:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/t10-indian-pharma-champions-trophy-2022 2022-10-12 03:15:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hanalls-licensed-partner-in-china-enters-sublicense-agreement-with-cspc 2022-10-12 03:12:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cabaletta-bio-and-iaso-biotherapeutics-announce-exclusive-license-agreement 2022-10-12 03:11:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mikart-and-nano-pharmasolutions-have-entered-into-a-collaboration-agreement 2022-10-12 03:09:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atyr-pharma-announces-research-collaboration-with-dualsystems-biotech-ag 2022-10-12 03:07:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-digital-data-enters-the-metaverse-with-immersive-user-journey 2022-10-12 01:10:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/malaysian-genomics-signs-agreement-with-national-institutes-of-health 2022-10-12 01:03:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scpharmaceuticals-announces-fda-approval-of-furoscix-furosemide-injection 2022-10-11 01:32:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-launches-naavigation-vector-platform 2022-10-11 01:30:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vincov-19-an-antidote-and-a-cure-against-covid-19 2022-10-11 01:25:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/surrozen-announces-strategic-partnership-with-boehringer-ingelheim-to-develop 2022-10-07 00:29:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neximmune-announces-research-collaboration-with-national-institute-of-neurological-disorders 2022-10-07 00:28:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-receives-us-fda-fast-track-designation-for-tirzepatide-for-the-treatment 2022-10-07 00:25:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-selected-as-scrip-awards-finalist-for-best-full-service-cro 2022-10-06 22:06:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/msd-launches-new-manufacturing-facilities-in-singapore 2022-10-06 22:03:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-announces-new-cryo-tem-with-expansive-automation 2022-10-06 01:08:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nfl-biosciences-partners-with-themis-medicare-for-the-development-of-nfl-101-in-india 2022-10-06 01:03:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenlight-biosciences-and-queensland-university-of-technology-partner 2022-10-06 00:47:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-farma-secures-multi-year-purchase-contract-from-unicef 2022-10-03 23:27:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-and-enalare-therapeutics-announce-fda-orphan-drug-designation 2022-10-03 23:24:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-announces-agreement-to-acquire-medicxi-backed-villaris-therapeutics 2022-10-03 23:22:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calithera-receives-fda-fast-track-designation-for-sapanisertib-for-the-treatment 2022-10-03 23:20:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanda-pharmaceuticals-and-olipass-announce-strategic-partnership 2022-09-29 23:53:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genfit-announces-signature-of-the-share-purchase-agreement 2022-09-29 23:51:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrea-bioseparations-introduces-nereus-lentihero 2022-09-29 23:49:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-adds-the-1500-series-biological-safety-cabinet-to-bsc-portfolio 2022-09-29 23:22:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmaus-life-sciences-announces-collaboration-with-kier-spates 2022-09-29 03:11:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kbio-announces-strategic-collaboration-with-leaf-expression-systems 2022-09-29 03:10:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idera-pharmaceuticals-acquires-aceragen 2022-09-29 03:08:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crispr-therapeutics-announces-fda-regenerative-medicine-advanced-therapy 2022-09-29 03:06:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-signs-agreement-with-iata-to-work-on-its-ceiv-pharma-certification 2022-09-29 01:52:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-microcnx-connectors-a-first-for-small-volume-aseptic-processing-true-alternative 2022-09-28 05:32:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blue-earth-diagnostics-announces-fda-acceptance-of-new-drug-application 2022-09-28 00:32:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-keytruda-pembrolizumab-receives-four-new-approvals-in-japan 2022-09-28 00:30:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prosoma-digital-therapeutics-and-eversana-announce-commercialisation-partnership 2022-09-27 02:57:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-exercises-the-exclusive-worldwide-license-option-of-their-collaboration-program 2022-09-27 02:55:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corvus-pharmaceuticals-announces-partner-angel-pharmaceuticals-received-ind-approval 2022-09-27 02:54:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergent-biosolutions-completes-acquisition-of-exclusive-worldwide-rights-to-tembexa 2022-09-27 02:53:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-opens-first-high-potency-oral-drug-product-manufacturing-facility 2022-09-26 22:33:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-metoject-subcutaneous-injection-syringe-methotrexate-approved-in-japan 2022-09-26 22:31:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navigo-and-mannin-sign-agreement-to-develop-innovative-affinity-ligand 2022-09-26 01:36:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/citius-pharmaceuticals-announces-clinical-collaboration-with-the-university-of-pittsburgh 2022-09-23 03:06:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virax-biolabs-group-limited-announces-distribution-agreement-to-market-monkeypox-virus 2022-09-23 03:04:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tezspire-approved-in-the-eu-for-the-treatment-of-severe-asthma 2022-09-22 00:07:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inventiva-and-sino-biopharm-announce-licensing-and-collaboration-agreement 2022-09-22 00:04:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avrobio-receives-rare-pediatric-disease-designation 2022-09-21 02:02:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/covalab-cimcure-and-partners-receive-106m-eureka-eurostars-grant 2022-09-21 01:58:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-blood-and-cell-technologies-launches-quantum-flex-bioreactor-platform 2022-09-21 01:42:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-enters-into-pre-paid-advance-agreement-with-yorkville 2022-09-16 01:15:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurobo-pharmaceuticals-and-dong-a-st-co-ltd-announce-strategic-collaboration 2022-09-16 01:14:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-announces-collaboration-with-fineimmune-to-develop 2022-09-16 01:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-announces-collaboration-with-fineimmune-to-develop-tcr-mimic 2022-09-15 00:50:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-launches-cdpath-personalized-prognostic-tool-advancing-innovation-for-patients 2022-09-15 00:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-selects-new-partners-for-global-corporate-social-responsibility-program 2022-09-13 23:01:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akouos-receives-fda-clearance-of-its-ind-application-for-ak-otof 2022-09-13 22:59:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicenna-announces-clinical-collaboration-with-merck-to-evaluate-mdna11 2022-09-13 22:58:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-announces-acquisition-of-fda-approved-rare-disease-product 2022-09-13 22:56:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bora-expands-its-cdmo-capabilities-acquisition-of-twi-pharmaceuticals 2022-09-13 05:40:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/awakn-life-sciences-signs-drug-development-agreement-with-catalent 2022-09-13 03:37:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanobiotix-announces-agreement-in-principle-to-restructure-existing-loan-agreement 2022-09-13 03:30:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-and-microsoft-collaborate-to-accelerate-drug-discovery 2022-09-13 03:28:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ayala-pharmaceuticals-presents-positive-interim-data-from-ringside-pivotal-phase-trial 2022-09-13 03:01:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioivt-acquires-xenotech-leading-provider-of-products-and-services 2022-09-12 23:18:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-opens-new-sterile-lipid-nanoparticle-formulation-facility 2022-09-12 01:28:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-presents-results-of-post-hoc-analysis-of-eribulin-mesylate-at-the-european-society 2022-09-12 01:04:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncoresponse-announces-clinical-supply-agreement-with-regeneron 2022-09-07 23:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zealand-pharma-announces-global-license-and-development-agreement-with-novo-nordisk 2022-09-07 23:23:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcutis-announces-acquisition-of-ducentis-biotherapeutics-ltd 2022-09-07 23:22:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellbox-solutions-expands-to-israeli-market-via-partnership-with-biogate-ltd 2022-09-07 02:51:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-expands-singapore-clinical-supply-facility-for-increased-temperature 2022-09-07 02:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tenaya-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2022-09-07 00:24:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synlogic-achieves-research-milestone-in-collaboration-with-roche-for-development 2022-09-07 00:21:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-launches-fencovis-a-new-vaccine-to-prevent-calf-diarrhea 2022-09-07 00:20:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leica-biosystems-announces-partnership-with-indica-labs 2022-09-05 23:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forxiga-approved-in-china-for-the-treatment-of-chronic-kidney-disease 2022-09-05 23:47:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-presents-new-data-from-its-oncology-portfolio-and-pipeline-at-esmo-congress-2022 2022-09-05 23:44:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-receives-fda-tentative-approval-for-libervant 2022-09-01 00:56:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenpozymetm-olipudase-alfa-rpcp-approved-by-fda-as-first-disease-specific-treatment 2022-09-01 00:55:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/next-sunday-launch-of-the-9th-edition-of-pharmaconex-conference-exhibition 2022-08-31 23:07:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ideaya-announces-achievement-of-first-milestone-in-ongoing-collaboration-with-gsk 2022-08-30 00:18:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mydecine-innovations-group-announces-common-share-subscription-agreement 2022-08-30 00:01:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asc-announces-the-expansion-of-its-cgmp-manufacturing-facility 2022-08-30 00:00:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tagrisso-approved-in-japan-for-the-adjuvant-treatment-of-patients 2022-08-25 23:17:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aslan-pharmaceuticals-signs-license-agreement-with-belleai 2022-08-25 23:16:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arbor-biotechnologies-enters-into-agreement-with-acuitas-therapeutics 2022-08-25 23:14:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocardia-enters-agreement-with-bluerock-therapeutics-to-provide-enabling-catheter 2022-08-24 23:45:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-ltd-announces-additional-positive-results-for-the-cocaine-addiction-treatment 2022-08-24 23:44:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bavarian-nordic-enters-supply-agreement-with-paho 2022-08-24 23:43:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-obtains-regulatory-approval-for-polivy-for-additional-indication 2022-08-24 23:42:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/5-factors-that-will-drive-growth-in-the-indian-pharma-sector-in-2023 2022-08-24 07:21:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c2n-and-eisai-collaborate-to-build-awareness-and-real-world-evidence 2022-08-23 23:36:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-receives-fast-track-designation-from-the-us-fda-for-mk-2060 2022-08-23 23:34:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pillar-biosciences-receives-china-national-medical-products-administration-approval 2022-08-22 22:27:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/geron-announces-first-patient-dosed-in-improvemf-phase-1-combination-study 2022-08-22 22:25:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-nuvaxovid-covid-19-vaccine-granted-expanded-provisional-approval 2022-08-19 00:47:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-announces-approval-of-orladeyo-in-saudi-arabia 2022-08-19 00:42:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-krystal-biotechs-biologics-license-application 2022-08-19 00:40:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/awakn-life-sciences-signs-second-licensing-partnership-agreement 2022-08-19 00:38:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mirena-from-bayer-approved-in-the-us-for-extended-duration-of-use-in-contraception 2022-08-19 00:37:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scilex-holding-company-a-sorrento-company-announces-exclusive-agreement-with-ch-trading-group-llc 2022-08-17 22:56:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pan-tb-collaboration-to-advance-investigational-tuberculosis 2022-08-17 22:53:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-chemical-business-of-mecaro 2022-08-17 22:52:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-announces-collaboration-with-morehouse-school-of-medicine 2022-08-17 22:51:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-fda-approval-and-imminent-launch-of-dexamethasone 2022-08-16 22:56:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphastar-pharmaceuticals-receives-fda-approval-for-epinephrine-pre-filled-syringes 2022-08-16 22:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicinova-reaches-agreement-to-participate-in-grant-funded-clinical-trial-to-evaluate 2022-08-16 22:53:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-supplemental-biologics-license-application-for-roches-polivy-combination 2022-08-16 00:34:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-new-diagnostic-test-for-the-better-understanding 2022-08-16 00:00:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/q32-bio-and-horizon-therapeutics-announce-collaboration-in-autoimmune-diseases 2022-08-15 23:59:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/awakn-life-sciences-expands-commercial-operations-into-the-us 2022-08-15 23:57:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-obtains-regulatory-approval-for-osteoporosis-treatment-edirol-tablet 2022-08-15 23:56:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-approved-in-the-us-as-the-first-her2-directed-therapy-for-patients 2022-08-12 01:03:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ceapro-inc-expands-collaborative-research-program-with-mcmaster-university-to-develop 2022-08-12 01:00:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acquisition-of-teneotwo-for-its-clinical-stage-t-cell-engager-completed 2022-08-12 00:59:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caladrius-biosciences-prospective-merger-partner-cend-therapeutics-announces-collaboration-agreement 2022-08-10 23:57:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gemini-therapeutics-and-disc-medicine-announce-merger-agreement 2022-08-10 23:55:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-regulatory-update-and-strategic-partnership 2022-08-10 23:54:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/starpharma-signs-new-dep-agreement-with-msd 2022-08-10 23:49:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hemoshear-develops-new-human-tissue-based-model-of-rare-liver-disease 2022-08-10 23:48:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relmada-therapeutics-receives-fda-fast-track-designation-for-rel-1017 2022-08-09 23:40:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-takes-equity-stake-in-with-option-to-acquire-enalare-therapeutics 2022-08-09 23:39:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-the-european-commission-ec-amend-covid-19-vaccine-agreement 2022-08-09 23:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-lifenet-enter-into-capital-and-business-alliance-agreement 2022-08-09 23:36:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-becomes-one-of-the-first-cdmos-to-provide-full-viral-vector 2022-08-09 23:33:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mersana-therapeutics-announces-option-agreement-with-gsk 2022-08-09 01:24:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioivt-acquires-cypex 2022-08-09 01:23:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-to-acquire-albumedix 2022-08-09 01:23:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maruho-launched-in-japan-the-anti-il-31-receptor 2022-08-09 01:22:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-additional-indication-of-darolutamide-in-combination-with-docetaxel 2022-08-09 01:21:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaconex-9th-edition-to-launch-next-september 2022-08-05 04:12:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/societal-cdmo-adds-three-new-customers 2022-08-04 23:52:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-to-acquire-chemocentryx-for-4-billion-in-cash 2022-08-04 23:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anheart-therapeutics-receives-fda-breakthrough-therapy-designation 2022-08-04 23:03:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintara-therapeutics-enters-into-equity-purchase-agreement 2022-08-04 23:02:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/poseida-therapeutics-announces-strategic-global-collaboration-with-roche 2022-08-04 23:01:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/context-therapeutics-and-the-menarini-group-announce-clinical-trial-collaboration-and-supply-agreement 2022-08-02 23:18:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salarius-pharmaceuticals-and-volitionrx-enter-into-rd-collaboration-agreement 2022-08-02 23:16:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codexis-and-molecular-assemblies-announce-execution-of-commercial-license-and-enzyme-supply-agreement 2022-08-02 23:15:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-coherus-cimerli-ranibizumab-eqrn 2022-08-02 23:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caris-life-sciences-and-xencor-enter-target-discovery-collaboration-and-license-agreement-for-novel-xmab-bispecific-antibodies 2022-08-02 23:11:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-and-abbvie-enter-new-multi-target-collaboration 2022-08-02 23:10:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eledon-pharmaceuticals-receives-fda-clearance-of-ind-application-to-evaluate-tegoprubart 2022-08-01 22:57:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-opens-new-site-in-singapore 2022-08-01 05:14:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-posts-record-mid-year-revenue 2022-08-01 05:10:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veolia-marks-20-years-of-reliable-proven-purified-water-technology-with-orion 2022-08-01 00:16:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-omeros-masp-3-inhibitor 2022-07-31 22:43:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-enters-into-a-licensing-agreement-with-slayback-pharma 2022-07-31 22:41:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astria-therapeutics-announces-fda-clearance-of-ind-application-for-star-0215 2022-07-29 01:28:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-collaboration-with-kenya-medical-research-institute 2022-07-29 01:27:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunshine-biopharma-increases-support-for-anti-coronavirus-collaborative-research-with-the-university-of-arizona 2022-07-29 01:26:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinus-pharmaceuticals-announces-us-commercial-launch-of-ztalmy 2022-07-29 01:25:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-editing-market-to-reach-usd-199-billion-by-2030 2022-07-26 23:20:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-biogens-new-drug-application-and-grants-priority-review-of-tofersen-for-a-rare 2022-07-26 23:15:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cosmo-and-sun-pharma-announce-territory-expansion-of-license-and-supply-agreements-for-winlevi 2022-07-26 23:14:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/somalogic-acquires-dna-nanotechnology-leader-palamedrix 2022-07-26 23:11:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oryzon-collaborates-with-the-cmt-research-foundation-in-the-us 2022-07-26 23:10:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opgen-subsidiary-ares-genetics-gmbh-enters-into-collaboration-agreement 2022-07-26 23:09:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-biomedica-signs-licence-supply-agreement-with-new-partner-for-lentivector-platform 2022-07-26 23:08:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/developing-a-variant-proof-sars-cov-2-vaccine 2022-07-26 22:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sram-mram-partners-with-medmokk-enterprises-to-diversify-its-healthcare-portfolio 2022-07-26 00:30:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polpharma-biologics-announces-fda-file-acceptance-for-review-of-natalizumab 2022-07-25 06:25:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-granted-priority-review-in-the-us-for-patients-with-her2-low-metastatic-breast-cancer 2022-07-25 06:13:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applications-for-proposed-first-of-a-kind-multiple-sclerosis-biosimilar 2022-07-25 06:09:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/at-achema-2022-telstar-breakthrough-innovations-in-freeze-drying 2022-07-25 01:22:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-announces-first-patient-dosed-in-phase-clinical-trial-of-claudin 2022-07-24 22:53:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-advances-vx-548-in-acute-and-neuropathic-pain 2022-07-24 22:52:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-plans-to-builda-comprehensive-crdmo-center-in-singapore 2022-07-22 04:40:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/partial-revision-of-the-basic-alliance-agreement-with-roche 2022-07-21 23:03:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zynerba-pharmaceuticals-enters-into-equity-purchase-agreement 2022-07-21 23:02:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-supplemental-biologics-license-application-accepted-by-us-fda 2022-07-21 23:01:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine 2022-07-21 22:59:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nexusbioag-and-mustgrow-biologics-announce-exclusive-marketing-and-distribution 2022-07-21 00:29:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/portage-biotech-acquires-outstanding-minority-interest-of-invariant-natural-killer 2022-07-21 00:27:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blue-water-vaccines-announces-signing-agreement-with-cincinnati-childrens-hospital-medical 2022-07-21 00:26:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-and-verve-therapeutics-establish-collaboration-to-discover-and-develop 2022-07-21 00:24:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indegene-joins-the-metaverse-standards-forum-to-foster-interoperability 2022-07-20 05:49:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navigo-proteins-successfully-develops-affinity-resin-against-ferritin 2022-07-20 05:41:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-opens-a-new-large-scale-continuous-manufacturing-plant 2022-07-19 23:32:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-research-collaboration-with-celularity 2022-07-19 23:30:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-announces-expanded-agreement-with-sk-bioscience-to-manufacture-covid-19 2022-07-19 23:28:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-bio-announces-strategic-partnership-with-china-resources-pharmaceutical-commercial-group 2022-07-19 23:26:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pmv-pharmaceuticals-announces-clinical-trial-collaboration-with-merck 2022-07-19 03:05:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/erasca-announces-clinical-trial-collaboration-and-supply-agreement-with-eli-lilly-and-company 2022-07-19 03:03:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-european-commission-grants-approval-of-kinpeygo 2022-07-19 03:02:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/escend-pharmaceuticals-receives-ind-clearance-from-the-fda-for-es-3000-phase-i-study 2022-07-15 23:20:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omega-therapeutics-announces-fda-clearance-of-ind-application-for-otx-2002 2022-07-15 01:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repertoire-immune-medicines-enters-new-research-collaboration 2022-07-15 01:50:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neximmune-announces-ind-clearance-by-the-us-fda-for-nexi-003 2022-07-15 01:49:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-emergency-use-authorization-for-novavax-covid-19-vaccine 2022-07-14 04:06:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avrobio-receives-orphan-drug-designation-from-the-us-food-and-drug-administration 2022-07-14 04:05:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-orion-announce-global-collaboration-for-the-development 2022-07-14 04:03:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-client-sk-bioscience-achieves-skycovionetm-covid-19-vaccine-approval-in-korea 2022-07-13 03:03:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/societal-cdmo-announces-signing-of-amendment-to-license-and-supply-agreement-with-lannett 2022-07-13 00:31:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omnipathology-announces-the-launch-of-its-oropharyngeal-hpv-pcr-test 2022-07-13 00:30:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-reaches-agreement-with-san-francisco-to-settle-opioid-related-claims 2022-07-13 00:29:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioventus-completes-cartiheal-acquisition 2022-07-13 00:28:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/provepharm-receives-fda-marketing-approval-in-us-for-bludigo 2022-07-12 22:24:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-byondis-biologics-license-application-fortrastuzumab 2022-07-12 22:21:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-teams-up-with-granite-bio-for-cell-line-development 2022-07-12 06:36:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telstar-develops-real-time-sublimation-front-monitoring-system-for-gmp-freeze-dryers 2022-07-12 04:44:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-korea-at-the-heart-of-pharma 2022-07-12 04:38:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innoviva-completes-acquisition-of-entasis-therapeutics 2022-07-11 23:34:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/t2-biosystems-receives-fda-breakthrough-device-designation-for-the-t2lyme-panel 2022-07-11 23:33:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medipharm-labs-enters-purchase-agreement-for-the-sale-of-australian-facility 2022-07-11 23:32:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/primary-analysis-of-japanese-phase-iii-clinical-trial-of-hemlibra-for-acquired-hemophilia 2022-07-11 23:30:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labcorp-forms-strategic-partnership-with-md-anderson-cancer-center 2022-07-11 22:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lanxess-completes-acquisition-of-iffs-microbial-control-business 2022-07-11 22:14:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dksh-and-pharmanovia-partner-to-respond-to-therapeutic-needs-in-southeast-asia 2022-07-11 03:16:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyenovia-strategic-partner-arctic-vision-enrolls-first-patient-in-phase-iii-clinical-trial-of-arvn003 2022-07-06 23:32:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/betterlife-secures-additional-mitacs-funding-in-collaboration 2022-07-06 23:30:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qualigen-therapeutics-announces-partnership-with-hande-sciences-to-scale-up 2022-07-06 23:26:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cepi-partners-with-codiak-biosciences-to-develop-broadly-protective-betacoronavirus-vaccine 2022-07-05 23:02:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-us-fda-accepts-and-grants-priority-review-for-eisais-biologics-license-application-of-lecanemab 2022-07-05 23:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mogrify-and-astellas-announce-collaboration-to-conduct-research 2022-07-05 22:54:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-exercises-option-for-vir-biotechnologys-vir-3434 2022-07-05 05:38:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stimlabs-llc-announces-growing-portfolio-with-new-product-enverse 2022-07-05 05:36:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inceptor-bio-announces-strategic-collaboration 2022-06-30 23:23:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akebia-therapeutics-regaining-rights-to-vadadustat-in-the-united-states-europe-china 2022-06-30 23:22:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurix-therapeutics-announces-clearance-of-investigational-new-drug-application 2022-06-30 23:21:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocuphire-granted-new-us-patent-for-late-stage-oral-drug-candidate-apx3330 2022-06-30 00:26:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eylea-aflibercept-injection-sbla-for-every-16-week-dosing-regimen-in-patients 2022-06-30 00:25:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apnimed-granted-fda-fast-track-designation-for-ad109-a-novel-first-in-class 2022-06-29 00:42:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evofem-reaches-agreement-with-one-of-the-largest 2022-06-29 00:41:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyond-airs-lungfit-ph-receives-fda-approval-to-treat-term 2022-06-29 00:40:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prophase-labs-announces-formation-of-prophase-biopharma 2022-06-29 00:38:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-newest-clinical-manufacturing-site-successfully 2022-06-28 22:18:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-opens-a-high-potency-api-plant 2022-06-28 22:16:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-clinical-trial-collaboration-with-beigene 2022-06-27 23:34:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-sutro-biopharma-announce-worldwide-strategic-collaboration 2022-06-27 23:32:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cullinan-oncology-and-taiho-pharmaceutical-complete-agreement 2022-06-23 23:22:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chimerix-announces-93-million-international-tembexa-procurement-agreement 2022-06-23 23:20:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-signs-the-public-private-partnership-kigali-declaration 2022-06-23 23:19:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aveo-oncology-announces-clinical-trial-collaboration-and-supply-agreement-with-eli-lilly 2022-06-22 23:39:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ikena-oncology-receives-fda-fast-track-designation-for-novel-tead 2022-06-22 23:36:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-happify-health-collaborate-to-support-multiple-sclerosis-patients-on-digital-platform 2022-06-22 23:35:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-mercks-vaxneuvance 2022-06-22 23:34:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-to-offer-3-new-services-for-shipment 2022-06-22 06:05:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jupiter-wellness-acquires-the-assets-of-applied-biology-inc 2022-06-21 23:04:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-submits-supplemental-new-drug-application-to-us-fda-for-atogepant 2022-06-21 23:03:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-lilly-jointly-announce-the-approval-of-tyvyt-by-china 2022-06-20 23:17:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hepion-pharmaceuticals-receives-fda-orphan-drug-status-designation-for-rencofilstat 2022-06-20 23:15:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-receives-mfds-approval-in-south-korea-for-companion-diagnostic 2022-06-18 02:21:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nordic-bioscience-and-roche-diagnostics-strengthen-collaboration-for-development 2022-06-17 04:01:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/newly-created-automatic-vial-format-change-system-for-freeze-drying 2022-06-16 03:17:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zomedica-to-acquire-assets-of-innovative-veterinary-imaging-company-revo-squared 2022-06-15 23:32:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quoin-pharmaceuticals-announces-licensing-and-distribution-agreement 2022-06-15 23:31:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coya-therapeutics-secures-option-agreement-for-exclusive-worldwide-rights 2022-06-15 23:30:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptamer-group-signs-deal-with-flip-gene-therapeutics-to-support-the-development-of-inducible-gene-therapies 2022-06-15 05:03:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-announces-licensing-of-its-2g-unic-technology-platform 2022-06-15 01:25:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scilex-holding-company-agreement-for-exclusive-license-romeg-therapeutics 2022-06-14 23:19:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharma-and-etanas-collaboration-on-pruxelutamides-covid-19-project 2022-06-14 23:17:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avid-bioservices-announces-launch-of-analytical-and-process-development-suites 2022-06-14 23:14:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-collaboration-with-agilent-technologies 2022-06-14 23:13:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-signs-mou-for-sustainable-pharmaceutical-transportation-solutions 2022-06-14 04:07:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-pharmaceutical-solutions-offers-pre-fillable-syringe-solutions-for-demanding 2022-06-14 23:14:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/a-new-dpi-device-for-the-generic-drugs-market 2022-06-14 02:21:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirona-biochem-announces-exclusive-global-licensing-agreement-with-allergan-aesthetics 2022-06-14 23:15:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurobio-scientific-expands-into-benelux-by-acquiring 2022-06-14 23:15:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/organon-enters-into-global-license-agreement 2022-06-14 23:15:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/si-bone-inc-announces-fda-clearance 2022-06-14 23:15:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cordenpharma-increases-xrna-based-capabilities-with-a-strategic-investment 2022-06-13 06:27:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-commences-new-arbitration-under-license-agreement-with-janssen 2022-06-10 04:10:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-completes-acquisition-of-acacia-pharma 2022-06-10 04:08:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eledon-pharmaceuticals-announces-orphan-drug 2022-06-10 04:01:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-completes-acquisition-of-reviral 2022-06-10 03:56:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-expands-production-capacity-of-tegosoft-mm-mb-to-shanghai 2022-06-09 23:21:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oryzon-announces-fda-orphan-drug-designation-granted 2022-06-09 03:20:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/passage-bio-receives-fda-clearance-of-ind-application-for-pbml04-for-treatment-of-metachromatic-leukodystrophy 2022-06-09 03:23:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-inaxaplin-vx-147-granted-breakthrough-therapy 2022-06-09 03:31:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-announces-the-fda-granted-regenerative 2022-06-09 03:37:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-commercial-launch-of-tlando 2022-06-08 01:58:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skye-bioscience-expands-cannabinoid-pharmaceutical-innovation-program-with-leading-cannabinoid 2022-06-08 01:57:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-dupixent-dupilumab-as-first-biologic-medicine-for-children 2022-06-08 01:55:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immatics-and-editas-medicine-enter-strategic-research-collaboration-and-licensing-agreement 2022-06-08 01:54:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ginkgo-bioworks-acquires-bitome-an-integrated-metabolite-monitoring-platform 2022-06-07 01:07:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yumanity-therapeutics-announces-definitive-agreements-for-two-strategic-transactions 2022-06-07 01:06:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-alectos-therapeutics-announce-license-and-collaboration-agreement 2022-06-07 01:04:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bluestar-genomics-receives-clia-certification-for-its-clinical-laboratory 2022-06-07 00:00:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valent-biosciences-announces-major-expansion-at-its-osage-facility 2022-06-06 23:59:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qualigen-therapeutics-acquires-majority-stake-in-infectious-disease-diagnostics-technology 2022-06-03 00:13:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alterity-therapeutics-launches-ath434-phase-2-clinical-trial 2022-06-03 00:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-strengthens-commitment-to-oncology-through-purchase-of-sanofis-stake 2022-06-03 00:10:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-partnership-with-the-american-society-of-hematology-to-fight-sickle-cell-disease-in-sub-saharan-africa 2022-06-03 00:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cocrystal-pharma-expands-collaboration-with-the-national-institute-of-allergy 2022-06-01 23:19:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sana-biotechnology-announces-plan-to-relocate-manufacturing-to-bothell-washington 2022-06-01 23:15:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-the-fda-approval-and-imminent-launch-of-fludrocortisone-acetate-tablets-usp 2022-06-01 23:14:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kymera-therapeutics-receives-fda-orphan-drug-designation-for-kt-333 2022-06-01 23:13:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asher-bio-announces-clinical-trial-collaboration-with-merck-to-evaluate 2022-06-01 23:12:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blue-water-vaccines-announces-sponsored-research-agreement-amendment-to-continue 2022-06-01 04:41:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/launch-of-dysval-capsules-40mg-for-treatment-of-tardive-dyskinesia-in-japan 2022-06-01 04:36:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-completes-acquisition-of-checkmate-pharmaceuticals 2022-06-01 04:32:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-adds-cell-therapy-manufacturing-facility-with-acquisition-of-rigenerand 2022-05-31 22:32:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carerx-completes-acquisition-of-hogan-long-term-care-pharmacy 2022-06-01 04:46:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupont-opens-new-biopharma-tubing-manufacturing-site-in-the-united-states 2022-06-01 04:28:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perrigo-announces-us-fda-approval-for-omeprazole-magnesium 2022-05-27 03:39:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-acquires-uractivtm-portfolio-from-fiterman-pharma-in-romania 2022-05-27 03:38:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eugiapharma-receives-usfda-approval-for-pemetrexed-for-injection 2022-05-26 23:43:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/data-from-sotios-phase-11b-aurelio-03-trial-of-sot101-demonstrate-clinical 2022-05-26 23:40:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dfe-pharma-opens-its-new-center-of-excellence-in-india 2022-05-26 23:35:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cleveland-clinic-announces-details-of-expansion-projects-to-meet-increased-demand-for-healthcare-services-from-the-us-and-abroad 2022-05-26 23:49:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/freya-pharma-solutions-establishes-scientific-advisory-board-with-leading-european-experts 2022-05-26 23:54:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phathom-pharmaceuticals-announces-fda-acceptance-for-filing-of-vonoprazan-nda 2022-05-26 23:58:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elevation-oncology-announces-fda-fast-track-designation-granted-to-seribantumab 2022-05-26 00:54:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-launches-vabysmo-intravitreal-injection 2022-05-26 00:52:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-enters-into-sublicense-agreement-with-tianshi-pharmaceuticals 2022-05-25 00:53:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaron-acquires-commercial-api-manufacturing-facility-in-the-united-states 2022-05-25 00:52:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuronascent-receives-fda-rare-pediatric-drug-designation-for-nni-351-treatment 2022-05-25 01:58:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-and-israel-biotech-fund-collaboration-framework-agreement-to-support-biologics 2022-05-25 00:47:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-expand-inhalation-capabilities-at-tampa-site 2022-05-25 00:50:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-has-been-selected-as-the-best-air-cargo-brand-in-europe-in-the-field-of-sustainability 2022-05-25 00:54:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxzevria-approved-in-the-eu-as-third-dose-booster-against-covid-19 2022-05-24 01:15:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kalivir-immunotherapeutics-enters-into-global-exclusive-licensing-agreement-with-roche 2022-05-24 01:13:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kala-announces-entry-into-definitive-agreement-to-sell-eysuvis 2022-05-24 01:10:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunitybio-submits-biologics-license-application-for-n-803-plus-bcg 2022-05-24 01:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/depymed-receives-fda-orphan-drug-designation-for-clinical-candidate 2022-05-24 00:58:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telstar-to-promote-new-aseptic-process-integrated-systems-at-pharma-congress-2022 2022-05-23 03:50:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomoti-collaborates-with-global-pharmaceutical-company 2022-05-23 03:46:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brim-biotechnology-inc-and-ora-inc-announce-new-partnership 2022-05-20 00:47:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indaptus-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2022-05-20 00:45:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mersana-therapeutics-announces-fda-grant-of-orphan-drug-designation-to-xmt-2056 2022-05-20 00:41:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siga-receives-approval-from-the-fda-for-intravenous 2022-05-20 00:00:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-to-launch-brillo-first-in-class-oral-lipid-lowering-drug-in-india 2022-05-19 04:33:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jiangsu-hengrui-pharmaceuticals-launches-luzsana-biotechnology 2022-05-19 04:29:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luca-science-and-kyowa-kirin-announce-joint-research-agreement 2022-05-19 04:26:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-and-sernova-announce-exclusive-strategic-partnership 2022-05-18 01:43:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mannkind-corporation-announces-agreement-to-acquire-v-go-insulin-delivery 2022-05-18 01:39:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-and-kallyope-enter-collaboration 2022-05-18 01:32:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-further-expansion-in-the-boston-seaport 2022-05-18 01:24:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/travere-therapeutics-announces-fda-acceptance-and-priority-review 2022-05-17 01:33:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scpharmaceuticals-inc-announces-fda-acceptance-of-furoscix-new-drug-application 2022-05-17 01:32:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-announces-clinical-collaboration-with-merck 2022-05-17 01:29:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergent-biosolutions-to-acquire-from-chimerix 2022-05-17 01:08:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-cugene-announce-collaboration-in-autoimmune-diseases 2022-05-17 01:07:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb 2022-05-13 01:49:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skye-bioscience-signs-arrangement-agreement-with-emerald-health-therapeutics 2022-05-16 23:58:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/editas-medicine-receives-fda-orphan-drug-designation-for-edit-301 2022-05-16 23:54:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-announces-us-fda-approval-for-generic-mesalamine 2022-05-16 23:52:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-enters-partnership-with-the-global-fund-to-support 2022-05-16 23:48:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crown-bioscience-and-mbl-enter-joint-venture-to-provide-advanced-preclinical-services 2022-05-12 23:19:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuronetics-and-transformations-care-network-announce-extended 2022-05-12 01:49:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cue-biopharma-receives-fda-acceptance-of-investigational-new-drug-application 2022-05-12 01:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arisglobal-acquires-boehringer-ingelheims-signal-analytics-engine 2022-05-12 01:40:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-lilly-and-incytes-olumiant 2022-05-12 01:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tetra-bio-pharma-announces-licensing-agreement-with-true-north 2022-05-11 00:22:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-biopharmaceuticals-and-anges-announce-exclusive-partnership 2022-05-11 00:21:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scisparc-and-clearmind-medicine-collaboration-yields-new-patent-application 2022-05-11 00:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/castle-biosciences-collaborates-with-the-sun-bus-to-provide-free-skin 2022-05-11 00:01:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-and-flagship-pioneering-announce-a-strategic-collaboration 2022-05-12 02:00:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-and-alsa-ventures-collaborate 2022-05-10 23:07:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avantor-and-cytovance-biologics-collaborate-to-accelerate-plasmid-dna 2022-05-10 23:13:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-enters-license-agreement-with-astellas 2022-05-10 00:41:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acer-therapeutics-announces-agreement-with-fda-on-special-protocol-assessment 2022-05-10 00:35:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cumberland-pharmaceuticals-announces-key-co-promotion-agreement 2022-05-10 00:32:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transasia-supports-timeless-pankaj-udhas-musical-concert-in-aid-of-thalassemia-children 2022-05-10 00:45:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/societal-cdmo-signs-three-year-manufacturing-and-supply-agreement-with-infectopharm 2022-05-09 00:31:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nabriva-extends-exclusive-agreement-to-promote-and-distribute-sivextro 2022-05-09 00:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prime-therapeutics-is-acquiring-magellan-rx 2022-05-08 23:54:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-european-commission-approval-for-jakavi 2022-05-08 23:44:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juniper-biologics-signs-exclusive-license-agreement-with-helsinn 2022-05-05 04:20:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-announces-the-approval-in-china-of-blincyto-for-injection-for-pediatric 2022-05-05 04:16:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pressure-biosciences-announces-first-nanoemulsions-manufacturing-agreement 2022-05-05 01:50:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyepoint-pharmaceuticals-announces-agreement-with-betta-pharmaceuticals 2022-05-05 01:42:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coriolis-pharma-appoints-silvia-steyrer-gruber-as-new-chief-executive-officer 2022-05-04 22:32:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rousselot-biomedical-announces-the-launch-of-quali-pure-hgp-2000 2022-05-04 22:26:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oryzon-starts-preclinical-collaboration-on-kabuki-syndrome 2022-05-05 01:14:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qualigen-therapeutics-to-acquire-majority-stake 2022-05-05 22:42:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cenexel-acquires-iresearch 2022-05-05 22:38:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phathom-pharmaceuticals-announces-fda-approval-of-voquezna-triple-pak 2022-05-05 22:33:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/x-therma-receives-fda-breakthrough-device-designation-for-xt-vivo 2022-05-05 04:41:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-supplemental-new-drug-application-and-grants-priority-review 2022-05-05 04:38:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astorg-to-acquire-leading-pharmaceutical-cordenpharma-from-icig 2022-05-03 23:57:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mimetas-expands-adult-stem-cell-organoid-license-to-all-organs 2022-05-03 23:47:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intravacc-signs-an-exclusive-license-agreement-with-zhifei-lvzhu-biopharmaceutical 2022-05-02 23:51:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-receives-fda-complete-response-letter 2022-05-02 23:46:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ikena-oncology-and-vall-dhebron-institute-of-oncology 2022-05-02 23:40:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harpoon-therapeutics-and-roche-to-collaborate-on-clinical-trials 2022-05-02 23:34:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-dragonfly-announce-strategic-research-collaboration-to-develop-natural-killer 2022-05-02 23:27:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milestone-pharmaceuticals-announces-presentation-of-data-from-phase 2022-05-02 04:06:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recipharm-offers-services-to-enable-switch-to-next-generation-pmdi-propellants 2022-05-02 04:10:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mgi-announces-partnership-with-nalagenetics-to-advance-personalised-medicine 2022-05-02 04:27:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clearpoint-neuro-announces-fda-clearance-of-the-smartframe-array-version 2022-04-29 00:00:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eversana-and-vector-pharma-fzco-announce-strategic-partnership 2022-04-29 00:23:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skye-bioscience-engages-clinical-trial-site-for-phase-study-in-agreement 2022-04-29 00:31:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenetic-biosciences-expands-oncology-pipeline-with-in-licensing-of-dnase-based 2022-04-28 23:47:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fennec-pharmaceuticals-announces-fda-acceptance-for-filing-of-new-drug-application 2022-04-28 23:51:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caladrius-biosciences-and-cend-therapeutics-announce-definitive-merger-agreement 2022-04-28 23:54:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-receives-fda-orphan-drug-designation-for-allo-605 2022-04-28 23:57:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vigeneron-announces-follow-on-collaboration-with-daiichi-sankyo 2022-04-28 23:42:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neximmune-announces-preclinical-research-collaboration-with-columbia-university-irving 2022-04-28 23:40:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/petros-pharmaceuticals-engages-massachusetts-general-hospital-in-research-agreement 2022-04-28 23:35:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gamida-cell-announces-fda-clearance-of-ind-and-removal 2022-04-28 23:31:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-to-embed-agile-operating-model 2022-04-28 23:26:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-and-necstgen-establish-partnership-to-improve-viral-vector-manufacturing 2022-04-26 00:57:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quoin-pharmaceuticals-announces-fda-clearance-of-ind-for-its-lead-asset 2022-04-26 00:52:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sol-gel-technologies-and-galderma-announce-fda-approval-of-epsolay 2022-04-26 00:48:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intra-cellular-therapies-announces-fda-approval-of-new-dosage-strengths-for-caplyta 2022-04-26 00:46:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/erytech-sells-us-manufacturing-facility 2022-04-25 23:35:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-completes-the-acquisition-of-biotest 2022-04-26 00:38:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/university-of-tokyo-astellas-enter-second-phase-of-strategic-partnership 2022-04-26 00:31:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-early-development-services-and-integral-molecular 2022-04-26 00:28:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syneos-health-strengthens-asia-pacific-leadership 2022-04-25 23:38:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/northx-biologics-signs-gmp-manufacturing-collaboration-agreement-with-abera-bioscience 2022-04-23 01:00:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zambon-receives-us-fda-breakthrough-therapy-designation-for-cms-i-neb-in-patients 2022-04-22 04:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pacbio-and-childrens-mercy-kansas-city-expand-collaboration 2022-04-22 03:53:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/legend-biotech-achieves-milestone-under-collaboration-agreement-with-janssen-biotech 2022-04-22 03:43:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heat-biologics-completes-acquisition-of-elusys-therapeutics 2022-04-22 00:52:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-regenerative-medicine-advanced-therapy-designation-to-allovirs-posoleucel 2022-04-22 00:57:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seagen-announces-plans-to-expand-pacific-northwest-biomanufacturing-capacity 2022-04-22 01:01:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bora-pharmaceuticals-to-expand-operations-with-10m-investment 2022-04-22 01:03:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/springworks-therapeutics-announces-collaboration-agreement-with-regeneron 2022-04-19 23:40:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-receives-us-fda-approval-car-t-cell-therapy-manufacturing-facility 2022-04-19 23:36:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coeptis-therapeutics-and-bull-horn-holdings-corp-announce-merger-agreement 2022-04-19 23:32:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-new-drug-application-for-daprodustat 2022-04-19 23:29:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-joins-the-national-institute-for-innovation-in-manufacturing-to-advance-biomanufacturing 2022-04-19 23:26:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fulgent-genetics-agrees-to-acquire-inform-diagnostics 2022-04-19 04:37:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amoydx-enters-into-master-collaboration-agreement-with-astrazeneca 2022-04-19 04:24:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-and-nec-enter-into-strategic-research-collaboration 2022-04-19 04:16:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-enters-agreement-with-ctm-bio-to-co-develop 2022-04-19 04:11:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-biotherapeutics-grants-third-exclusive-license-to-boehringer-ingelheim 2022-04-19 05:39:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/longeveron-enters-into-cooperative-research-and-development-agreement 2022-04-19 05:29:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-receives-approval-for-precision-oncology-treatment-vitrakvi-in-china 2022-04-19 05:24:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-sierra-oncology 2022-04-19 05:16:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rousselot-biomedical-announces-the-worlds-first-gelma-produced-under-gmp 2022-04-14 00:54:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lixte-biotechnology-announces-preclinical-results-of-its-collaboration 2022-04-13 03:21:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lysogene-enters-into-an-exclusive-worldwide-license-agreement-with-yeda 2022-04-13 03:15:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codexis-and-molecular-assemblies-announce-results-of-first-collaboration 2022-04-13 03:09:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/actinium-pharmaceuticals-and-immedica-announce-commercialization-agreement 2022-04-13 03:04:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reactor-ready-filter-lab-reactor-for-synthesis-and-filtration-in-one-compact-system 2022-04-12 22:49:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-and-matinas-biopharma-announce-exclusive-research-collaboration 2022-04-12 03:39:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/artiva-biotherapeutics-announces-agreement-with-merck 2022-04-12 03:32:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-the-launch-of-misoprostol-tablets 2022-04-12 03:25:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-announces-fda-approval-of-cysteine-hydrochloride-injection 2022-04-12 03:18:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sequence-bio-announces-discovery-collaboration-agreement-with-leo-pharma 2022-04-07 23:42:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/propella-therapeutics-announces-licensing-agreement-with-jiangsu-aosaikang-pharmaceutical 2022-04-07 23:40:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-enters-into-an-mou-for-partnership-with-china-resources 2022-04-07 23:36:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-to-acquire-reviral-and-its-respiratory-syncytial-virus-therapeutic-candidates 2022-04-07 23:30:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-announces-fda-approval-of-igalmi 2022-04-07 06:23:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-ind-clearance-for-tnx-102-sl-potential-treatment 2022-04-07 06:15:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-extends-collaboration-agreement-to-drive-cutting-edge-digital-solutions 2022-04-07 06:12:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-carried-335-million-doses-of-covid-19-vaccine-to-61-countries-during-2021 2022-04-06 22:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plus-therapeutics-and-medidata-announce-expanded-clinical-trial-partnership 2022-04-05 23:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-extension-of-sponsored-research-agreement 2022-04-05 23:58:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinook-therapeutics-iga-nephropathy-foundation-and-komodo-health-collaborate 2022-04-06 00:25:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-vijoice-as-first-and-only-treatment-for-select-patients 2022-04-06 00:31:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-advances-bioprocessing-capabilities-with-acquisition-of-mast-platform-from-lonza 2022-04-06 00:34:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microba-life-sciences-and-ginkgo-bioworks-announce-partnership 2022-04-05 01:22:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atara-biotherapeutics-announces-the-completion-of-the-acquisition-of-its-cell-therapy 2022-04-05 02:59:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/castle-biosciences-to-acquire-altheadx 2022-04-05 02:00:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-priority-review-to-chugais-actemra-roactemra 2022-04-05 01:53:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-dupixent-for-priority-review-in-patients 2022-04-05 01:46:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virginia-manufacturing-facility-to-further-increase-mercks-hpv-vaccine-supply 2022-04-05 01:41:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-priority-review-to-genentechs-actemra 2022-04-05 01:27:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accutar-biotechnology-receives-nmpa-clearance-of-ind-application-for-ac0682 2022-04-05 03:04:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-worldmeds-and-adamis-pharmaceuticals-announce-us-launch 2022-04-05 04:25:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jaguar-health-enters-license-agreement-with-quadri-pharmaceuticals 2022-04-05 04:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-announces-acquisition-of-arteryex-shares 2022-04-05 03:17:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/distribution-agreement-signed-with-vector-pharma-for-alkindi 2022-03-30 23:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/universe-pharmaceuticals-inc-announces-strategic-partnership-with-lian-ou-health 2022-03-31 00:00:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/collegium-announces-master-settlement-agreement-resolving 2022-03-31 04:09:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-reaches-agreement-with-florida-to-settle-the-states-opioid-related-claims 2022-03-31 04:14:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-bio-announces-strategic-partnership-with-sinopharm-to-advance-commercialization 2022-03-30 05:21:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vyant-bio-and-organotherapeutics-announce-strategic-collaboration 2022-03-30 02:52:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-selects-veeva-development-cloud-worldwide 2022-03-30 03:02:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-igm-biosciences-announce-collaboration-agreement-for-oncology 2022-03-30 03:04:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-receive-expanded-us-emergency-use-authorization 2022-03-30 05:12:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/artelo-expands-collaboration-with-trinity-college-dublin-to-investigate-cellular 2022-03-29 03:15:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stealth-biotherapeutics-receives-orphan-drug-designation-from-fda 2022-03-29 03:20:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-obtains-regulatory-approval-for-vabysmo 2022-03-29 03:25:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xipere-is-the-first-and-only-fda-approved-therapy-for-delivery 2022-03-29 03:33:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-fintepla-oral-solution-for-treatment-of-seizures 2022-03-29 03:36:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ozempic-20-mg-approved-in-the-us-for-the-treatment-of-type-2-diabetes 2022-03-29 03:40:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biondvax-signs-definitive-collaboration-agreement-for-the-development-of-pipeline 2022-03-25 06:42:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclo-therapeutics-collaboration-agreement-with-wits-commercial-enterprise 2022-03-25 06:37:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-granted-fda-breakthrough-therapy-designation-for-respiratory-syncytial-virus 2022-03-25 06:33:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celonic-to-become-long-term-partner-of-the-federal-republic-of-germany 2022-03-25 02:56:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huma-and-astrazeneca-partner-to-accelerate-innovation-for-digital-first-patient-care 2022-03-24 05:26:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nutra-pharma-announces-first-manufacturing-agreement 2022-03-24 05:22:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-pluvicto-approved-by-fda-as-first-targeted-radioligand-therapy 2022-03-24 01:45:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4d-pharma-announces-positive-interim-results-from-the-phase-study-of-the-combination 2022-03-23 05:27:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/philochem-and-bracco-imaging-announce-collaboration-on-the-development 2022-03-23 05:49:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-to-acquire-shenandoah-biotechnology 2022-03-23 05:41:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipher-pharmaceuticals-announces-partner-moberg-pharmas-regulatory-submission 2022-03-23 05:37:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocardia-announces-new-center-for-medicare-and-medicaid-services-reimbursement 2022-03-23 05:34:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/srl-diagnostics-and-roche-diagnostics-india-partner-to-unveil-laboratory-of-the-future 2022-03-22 23:53:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pear-therapeutics-announces-agreement-with-softbank-corp 2022-03-22 03:10:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-launches-synthetic-rna-positive-controls-for-sars-cov-2 2022-03-22 03:05:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chimeron-bio-enters-into-an-agreement-with-the-niaid 2022-03-22 03:00:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-radiopharmaceutical-production-facility-buildout-commences 2022-03-22 02:54:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcenta-announces-global-clinical-collaboration-with-bristol-myers-squibb-to-evaluate 2022-03-22 01:56:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/volastra-therapeutics-announces-drug-discovery-collaboration-with-bristol-myers-squibb 2022-03-21 23:32:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-receives-anda-approval-for-lacosamide-tablets 2022-03-21 23:36:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bavarian-nordic-announces-license-and-supply-agreement-with-nuance-pharma 2022-03-21 23:43:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inivata-and-collaborators-publish-clinical-validation 2022-03-18 01:53:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-receives-fda-fast-track-designation-for-aqst-109 2022-03-18 01:57:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nutra-pharma-expands-manufacturing-capabilities 2022-03-18 02:57:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-reaches-settlement-agreement-resolving-patent-litigation-related-to-ultomiris 2022-03-18 03:03:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siemens-and-akesobio-join-forces-to-drive-forward-the-development-of-bio-pharma 2022-03-17 23:35:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coriolis-pharma-and-u-medico-announce-a-strategic-alliance 2022-03-17 22:25:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viatris-inc-announces-receipt-of-the-first-fda-approval-for-generic-version 2022-03-16 23:49:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-immunotech-receives-ind-clearance-from-the-us-fda-to-advance-its-phase 2022-03-17 00:20:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-seagen-announce-collaboration-to-develop-and-commercialize-multiple 2022-03-17 00:27:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/linkinvax-announces-a-collaboration-with-gtp-bioways-for-the-development 2022-03-16 00:46:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relief-therapeutics-wholly-owned-subsidiary-apr-applied-pharma-research-signs 2022-03-16 01:35:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-announces-collaboration-with-blackstone-life-sciences-to-advance 2022-03-16 01:40:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nosopharm-signs-partnership-with-inrae 2022-03-15 06:41:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-eisai-amend-collaboration-agreements-on-alzheimers-disease-treatments 2022-03-15 07:00:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arch-therapeutics-partners-with-centurion-therapeutics-to-expand-access 2022-03-15 06:00:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenlight-biosciences-holdings-pbc-enters-into-multitarget-licensing-agreement-with-serum-institute 2022-03-15 06:07:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neximmune-announces-melanoma-research-collaboration 2022-03-15 06:15:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corium-receives-fda-approval-of-adlarity 2022-03-15 06:25:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-and-xgen-pharmaceuticals-djb-announce-launch-of-rezipres 2022-03-15 06:33:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/expansion-of-everest-medicines-licence-agreement-to-include-south-korea 2022-03-15 06:36:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omya-strengthens-its-growth-in-asia-pacific-with-the-acquisition-of-prima-inter-chem 2022-03-13 22:30:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-acquires-casimir-its-fourth-major-acquisition 2022-03-11 00:36:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ceapro-signs-exclusive-long-term-supply-and-distribution-agreement 2022-03-11 00:39:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-that-licensing-partner-venatorx-pharmaceuticals 2022-03-11 00:54:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-receives-fda-fast-track-designation 2022-03-11 00:57:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-xembify-receives-european-approvals 2022-03-11 01:08:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellevolve-announces-expansive-global-collaboration 2022-03-10 00:25:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tataa-biocenter-is-partnering-with-olink-and-illumina 2022-03-10 00:32:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-therapeutics-receives-us-fda-orphan-drug-designation-for-ntla-5001 2022-03-10 00:34:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-unveils-new-genetic-analyzer-to-bring-advanced-capabilities-to-sanger-sequencing-and-fragment-analysis 2022-03-08 23:02:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-collaboration-with-massachusetts 2022-03-08 23:29:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-announces-closing-of-acquisition-of-serenity-pharmaceuticals 2022-03-08 23:35:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/targovax-asa-and-agenus-announce-collaboration-on-mutant-kras-cancer 2022-03-08 23:50:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-biotechnology-leader-amgen-breaks 2022-03-08 23:56:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-fda-orphan-drug-designation-for-tnx-2900 2022-03-04 04:21:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-and-haisco-pharmaceutical-group-enter-licensing-and-supply-agreement 2022-03-04 04:31:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurostar-advanced-therapy-launches-new-tap-into-new-possibility 2022-03-04 04:34:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cure-pharmaceutical-and-milagro-pharmaceuticals-collaborate 2022-03-04 05:44:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vapotherm-launches-strategic-partnership-with-carnegie-mellon-university 2022-03-04 05:49:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-receives-fda-orphan-drug-designation-for-its-novel-claudin 2022-03-04 05:54:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exclusive-license-for-croda-to-commercialise-ssis-caf-vaccine-adjuvants 2022-03-04 05:58:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nicoxs-partner-fera-pharmaceuticals-obtains-orphan-drug-designation 2022-03-03 00:35:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aceto-acquires-biotron-laboratories-and-talus-mineral-company 2022-03-03 00:33:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-announces-safebody-multi-target-collaboration-with-sanofi 2022-03-03 00:33:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-granted-fda-breakthrough-therapy-designation-for-respiratory-syncytial 2022-03-03 00:32:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tff-pharmaceuticals-and-catalent-announce-new-inhalation-dry-powder-development 2022-03-02 23:13:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stevanato-group-announces-agreement-with-barda-for-the-expansion-of-vials-production 2022-03-02 23:24:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quoin-pharmaceuticals-extends-exclusive-distribution-agreement 2022-03-02 23:35:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-and-neurimmune-close-exclusive-global-collaboration 2022-03-02 23:42:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-acquires-syndesi-therapeutics 2022-03-02 23:49:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-xpovio-regulatory-approval-in-singapore 2022-03-02 00:02:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sgd-pharma-launches-industry-first-ready-to-use-sterile-100ml-molded-glass-vials 2022-03-01 23:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lifebit-and-boehringer-ingelheim-announce-partnership-to-capture 2022-03-01 23:58:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-announces-definitive-agreement-to-acquire-serenity-llc 2022-02-28 23:50:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crinetics-pharmaceuticals-and-sanwa-kagaku-kenkyusho-enter-into-exclusive 2022-03-01 00:01:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/design-therapeutics-announces-fda-clearance-of-investigational 2022-03-01 00:24:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-for-priority-review-bristol-myers-squibb 2022-03-01 00:31:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynk-pharmaceuticals-announces-first-patient-dosed-in-phase-ii-clinical-study 2022-03-01 00:36:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-biologics-and-anheart-therapeutics-receive-nmpa-breakthrough-designation 2022-03-01 00:44:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/better-therapeutics-announces-new-cms-hcpcs-code 2022-03-01 00:50:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arla-food-ingredients-and-zerion-pharma-complete-long-term 2022-02-24 00:55:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclerion-therapeutics-and-ariana-pharma-announce-an-artificial-intelligence-driven-precision-medicine-collaboration 2022-02-24 02:52:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-therapeutics-enters-lease-agreement-to-build-manufacturing 2022-02-24 02:56:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-completes-acquisition-of-exelead-and-plans-to-invest 2022-02-24 03:06:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recipharm-invests-in-new-high-speed-filling-line-to-meet-demand-for-aseptic-products 2022-02-24 03:14:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plus-therapeutics-partners-with-medidata-to-apply-innovative-synthetic-control 2022-02-23 00:42:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/panbela-therapeutics-inc-to-acquire-cancer-prevention-pharmaceuticals-inc 2022-02-23 00:44:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-enters-license-agreement-with-odeon-therapeutics-for-the-rights 2022-02-23 00:51:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cosette-pharmaceuticals-launches-first-injectable-product-prochlorperazine-edisylate-injection-in-the-us 2022-02-23 00:57:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/code-biotherapeutics-announces-collaboration-with-takeda-to-use-proprietary-3dna 2022-02-23 01:01:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orapharma-launches-orafit-custom-clear-dental-aligner-system 2022-02-23 01:03:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-progresses-ambition-zero-carbon-programme-with-honeywell 2022-02-23 01:14:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4d-pharma-announces-fda-clearance-of-ind-application-for-live-biotherapeutics 2022-02-23 01:20:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strides-receives-usfda-approval-for-amantadine-hydrochloride-softgel-capsules 2022-02-22 06:39:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azelis-strengthens-its-pharmaceutical-presence-in-india 2022-02-22 06:47:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lumiradx-receives-uk-mhra-approval-for-sars-cov-2-rna-star-complete 2022-02-22 06:49:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-and-medigene-announce-global-collaboration-to-advance-t-cell-receptor-immunotherapies 2022-02-22 06:57:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peli-biothermal-releases-new-credo-cargo-shipper 2022-02-20 23:06:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quotient-sciences-completes-integration-of-drug-substance-into-translational-pharmaceutics-platform 2022-02-17 23:53:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discovery-life-sciences-streamlines-cell-and-gene-therapy-manufacturing 2022-02-17 23:59:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repertoire-immune-medicines-enters-research-collaboration-with-umass-chan-medical 2022-02-18 00:08:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-announces-that-it-has-acquired-a-majority-ownership-in-diagnostic-manufacturer-zhengzhou-fortune-bioscience 2022-02-18 00:32:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/remix-therapeutics-enters-collaboration-with-janssen 2022-02-18 00:52:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-rovi-expand-long-term-collaboration-for-the-manufacture 2022-02-17 03:29:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-introduces-first-modular-mrna-manufacturing-facility-to-promote-scalable 2022-02-17 03:17:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curve-therapeutics-announces-collaboration-with-msd-for-next-generation-drug-discovery-platform 2022-02-17 03:05:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/an2-therapeutics-announces-epetraborole-granted-orphan-drug-designation 2022-02-17 02:57:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-expands-into-additional-pediatric-cancers-through-collaboration 2022-02-16 01:04:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-and-onk-therapeutics-announce-collaboration-to-advance-allogeneic 2022-02-16 00:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hookipa-and-gilead-amend-collaboration-and-license-agreement 2022-02-16 00:38:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-therapeutics-announces-ind-clearance-by-us-fda-for-am712 2022-02-16 00:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-enters-commercial-distribution-agreement-for-illuccix-in-australia 2022-02-15 23:57:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-waters-to-collaborate-on-extractables-and-leachables-reference-library 2022-02-15 23:38:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aion-labs-powered-by-biomed-x-launches-third-global-call-for-application 2022-02-15 03:10:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/collegium-to-acquire-biodelivery-sciences-broadening-pain-portfolio 2022-02-15 03:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cidara-therapeutics-announces-fda-acceptance-of-its-investigational-new-drug-application 2022-02-15 03:32:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaceutical-manufacturing-and-packaging-congress-2022-connects-pharma-leaders 2022-02-15 03:38:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-orphan-drug-designation-to-bcma-car-t-cell-therapy 2022-02-15 03:51:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inivata-and-collaborators-publish-positive-results-from-prospective-clinical-study-of-radar-in-head-and-neck-squamous-cell-carcinoma 2022-02-12 04:43:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcellera-discovered-antibody-bebtelovimab-receives-us-fda-emergency-use-authorization 2022-02-12 04:39:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapore-study-sheds-light-on-antibiotics-associated-diarrhea 2022-02-11 06:01:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-valens-company-begins-manufacturing-cannabis-infused-beverages 2022-02-11 05:02:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theramex-announces-licensing-agreement-with-obseva-for-the-commercialisation 2022-02-11 05:18:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/havn-life-enters-into-distribution-agreement-with-mycrodose-therapeutics-for-us-market 2022-02-11 05:47:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-england-biolabs-launches-lyoprime-luna-rt-qpcr-master-mix 2022-02-10 01:50:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huadong-medicine-and-akso-announce-strategic-collaboration-to-develop 2022-02-10 01:46:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharma-launches-herotracker-sense 2022-02-10 01:30:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-juvederm-volbella-xc-for-undereye-hollows 2022-02-08 23:12:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-completes-acquisition-of-novaseps-chromatography-division 2022-02-10 02:58:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sengine-precision-medicine-and-oncodesign-announce-collaboration-agreement 2022-02-10 02:12:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthetic-biologics-announces-vcn-biosciences-vcn-01-receives 2022-02-10 02:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ngm-bios-ngm621-receives-fast-track-designation-from-the-fda-for-the-treatment 2022-02-08 02:23:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-rapid-environmental-pcr-testing 2022-02-08 02:27:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-xbrane-announce-commercialization-and-license-agreement 2022-02-08 03:05:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regio-biosciences-enters-into-license-agreement-with-astrazeneca 2022-02-04 04:16:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-partners-with-centers-across-france 2022-02-04 04:13:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-and-plexium-announce-multi-year-drug-discovery-collaboration 2022-02-04 04:05:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-supports-new-collaboration-to-accelerate-covid-19-research-for-children 2022-02-04 03:53:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brickell-biotech-acquires-exclusive-global-rights-to-portfolio-of-novel-sting-inhibitors 2022-02-03 23:40:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/unicef-and-lilly-collaborate-to-help-improve-health-outcomes 2022-02-03 23:34:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veru-enters-into-clinical-trial-collaboration-and-supply-agreement-with-eli-lilly 2022-02-03 23:43:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-completes-acquisition-of-virex-health 2022-02-03 23:54:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cordenpharma-completes-acquisition-of-three-manufacturing-facilities-from-vifor-pharma 2022-02-03 23:48:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-collaborates-with-twist-bioscience-to-enhance-antibody-discovery 2022-02-02 06:54:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polyplus-acquires-e-zyvec-to-expand-expertise-in-plasmid-dna-vector-engineering 2022-02-02 00:11:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-receives-full-us-fda-approval-for-covid-19-vaccine-spikevax 2022-02-02 00:32:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-new-label-update-for-car-t-cell-therapy-yescarta 2022-02-02 00:29:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-vabysmo-the-first-bispecific-antibody 2022-02-02 00:23:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-expands-its-portfolio-to-address-customers-separation-needs 2022-02-02 00:19:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/construction-works-launch-at-new-fill-finish-facility-in-morocco 2022-01-28 22:57:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calliditas-therapeutics-announces-commercial-availability-and-initial-sales-of-tarpeyo 2022-01-28 03:22:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atai-life-sciences-launches-invyxis-to-accelerate-discovery 2022-01-28 00:57:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurosense-therapeutics-extends-als-biomarker-collaboration-with-massachusetts 2022-01-28 01:01:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocugen-signs-letter-of-intent-to-acquire-vaccine-manufacturing-rd-hub 2022-01-28 01:03:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alx-oncology-receives-us-fda-orphan-drug-designation-for-evorpacept 2022-01-28 01:07:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hillstream-biopharma-and-university-of-massachusetts-chan-medical-school-announce-research-collaboration 2022-01-27 23:47:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunocore-announces-fda-approval-of-kimmtrak 2022-01-27 23:52:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evaxion-biotech-announces-publication-of-clinical-data-of-evx-01 2022-01-28 00:01:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quoin-pharmaceuticals-signs-exclusive-distribution-agreement-with-orphandc 2022-01-28 00:52:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-receives-rare-pediatric-disease-and-orphan-drug-designations-for-lp-184 2022-01-25 03:00:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyell-immunopharma-announces-fda-clearance-of-ind-for-lyl132 2022-01-25 03:09:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sqz-biotechnologies-announces-fda-clearance-sqz-eapc-hpv 2022-01-25 03:14:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tango-therapeutics-announces-clearance-of-tng908-ind-by-fda 2022-01-25 03:20:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beckley-psytech-announces-first-cohort-of-psychotherapists-have-begun 2022-01-24 06:11:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maat-pharma-announces-positive-interim-engraftment-data 2022-01-24 06:14:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fermenta-biotech-limited-exclusively-licenses-its-proprietary 2022-01-24 00:11:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-launches-its-first-parenteral-formulation-manufacturing-line 2022-01-24 00:12:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-second-indication-for-skyrizi 2022-01-24 00:17:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turning-point-therapeutics-announces-fda-clearance-of-investigational-new-drug 2022-01-21 23:07:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptorum-group-receives-fda-orphan-drug-designation-for-its-sact-1-repurposed-drug 2022-01-21 23:18:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sonoma-pharmaceuticals-announces-expansion-of-its-partner-network-for-oral-and-dental-products-in-the-us-and-china 2022-01-21 23:24:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compass-therapeutics-announces-us-fda-clearance-of-investigational 2022-01-21 23:35:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-new-clinical-manufacturing-site-now-officially-authorized 2022-01-20 07:10:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siteone-therapeutics-announces-collaboration-and-license-agreement-with-vertex-pharmaceuticals-to-advance-nav17-inhibitors-for-the-treatment-for-pain 2022-01-20 07:07:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytomx-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-cx-904-for-the-treatment-of-advanced-solid-tumors 2022-01-20 07:01:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/engitix-announces-54m-series-a-financing-and-a-strategic-collaboration-with-dompe-farmaceutici-using-exscalates 2022-01-20 06:58:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ucb-to-acquire-zogenix 2022-01-20 06:54:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-announces-collaboration-research-agreement-with-the-danish-cancer-society-research-center 2022-01-19 04:07:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-therapeutics-announces-exclusive-license-with-mitsubishi-tanabe-pharma-corporation-to-develop-and-commercialize-zynlonta-loncastuximab-tesirine-lpyl-in-japan 2022-01-19 04:14:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-ridgeback-announce-supply-agreement-with-unicef-for-molnupiravir 2022-01-19 04:17:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ono-expands-drug-discovery-collaboration-with-neurimmune 2022-01-18 02:00:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascletis-announces-us-ind-approval-of-asc22-envafolimab 2022-01-18 02:03:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensorion-updates-on-sens-401-phase-2-trial-in-sudden-sensorineural-hearing-loss 2022-01-18 02:18:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/engineering-usa-acquires-movilitas 2022-01-17 01:16:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rousselot-announces-partnership-with-terasaki-institute-for-biomedical-innovation 2022-01-12 05:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aligos-therapeutics-expands-collaboration-with-merck-to-develop-oligonucleotide-therapies-for-nash 2022-01-12 00:53:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-announces-exclusive-collaboration-and-global-license-agreement 2022-01-12 01:01:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-expands-neuroscience-collaboration-with-bristol-myers-squibb 2022-01-12 01:05:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-vir-biotechnology-announce-united-states-government 2022-01-12 01:12:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/international-freezer-challenge-2022-optimizing-your-cold-storage-practices 2022-01-12 01:20:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-announces-innovent-as-a-new-partner-signing-license-of-glymaxx-technology 2022-01-12 01:25:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioatla-announces-clinical-collaboration-with-bristol-myers-squibb 2022-01-11 01:55:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sana-biotechnology-iaso-biotherapeutics-and-innovent-biologics-announce-license-agreement 2022-01-11 01:51:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-out-licensing-agreement-for-osteoarthritis-asset-sprifermin 2022-01-11 01:09:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-announces-clinical-trial-collaborations-with-merck 2022-01-11 01:25:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-beam-enter-exclusive-multi-target-research-collaboration 2022-01-11 01:34:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-enters-exclusive-license-and-research-collaboration-agreement-with-ku 2022-01-10 23:04:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaron-acquires-commercial-api-manufacturing-facility 2022-01-10 23:33:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recipharm-announces-sale-of-fontaine-les-dijon-site-to-astrea 2022-01-10 23:37:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autism-clinical-trials-now-open-on-the-trialwire-platform 2022-01-10 04:46:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/b-cell-lymphoma-clinical-trials-now-open-on-the-trialwire-platform 2022-01-10 04:48:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atyr-pharma-announces-fda-orphan-drug-designation-for-atyr1923-for-treatment-of-sarcoidosis 2022-01-07 03:16:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxcyte-announces-fda-clearance-of-investigational-new-drug-application-for-vax-24 2022-01-07 03:11:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-and-verily-will-collaborate-to-generate-novel-drug-candidates 2022-01-07 03:07:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-and-gaelan-medical-enter-into-license-agreement-for-talicia 2022-01-07 03:00:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-entos-pharmaceuticals-enter-into-research-and-collaboration-agreement 2022-01-07 02:56:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/definitive-agreement-to-acquire-exelead-will-strengthen-mercks-cdmo-offering-for-mrna 2022-01-07 02:01:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pci-biotech-and-mdimune-announce-research-collaboration-agreement 2022-01-06 01:33:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-therapeutics-and-kyverna-therapeutics-announce-collaboration 2022-01-06 01:38:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cue-biopharma-and-lg-chem-life-sciences-announce-development-milestone 2022-01-06 01:47:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pacbio-and-care4rare-consortium-collaborate-on-rare-disease-research-study 2022-01-06 01:52:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-acquires-saol-therapeutics-baclofen-franchise 2022-01-06 02:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-enters-into-exclusive-licensing-agreement-with-roivant-concerning 2022-01-06 02:56:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolife-solutions-collaborates-with-seattle-childrens-to-improve-viral-vector 2022-01-05 00:51:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-exclusive-option-and-research-collaboration-with-kansas-state-university 2022-01-05 00:44:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-and-synaffix-enter-into-license-agreement-for-adc-technology 2022-01-05 00:36:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-enters-into-exclusive-license-agreement-with-sperogenix-for-vamorolone 2022-01-05 00:32:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncternal-therapeutics-announces-agreement-with-fda-on-phase-registrational-study 2022-01-05 00:24:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-launches-first-generic-version-of-cuvposa-glycopyrrolate-oral-solution 2022-01-05 00:18:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-acquires-its-first-plasma-donation-center-in-canada 2022-01-04 23:55:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-acquires-institut-dr-schauerte 2022-01-04 23:48:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genprex-receives-us-fda-fast-track-designation-for-reqorsa 2022-01-04 01:44:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansa-biopharma-enters-into-agreement-with-askbio-to-evaluate-feasibility-of-imlifidase 2022-01-04 01:51:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-immix-biopharma-rare-pediatric-disease-designation-for-imx-110 2022-01-04 01:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-announces-fda-acceptance-of-new-drug-application 2022-01-04 02:59:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-drug-molnupiravir-get-dcgi-approval 2022-01-04 03:11:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-us-government-contract-award-for-new-lateral-flow 2021-12-29 23:45:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oramed-subsidiary-oravax-medical-signs-cooperation-and-purchase-agreement 2021-12-29 23:44:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aditxt-signs-amendment-to-extend-worldwide-licensing-agreement 2021-12-29 23:37:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aditxt-signs-share-exchange-agreement-to-acquire-aipharma 2021-12-29 03:25:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-receives-fast-track-designation-from-us-fda-for-its-nk-cell-therapy 2021-12-29 03:30:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sutro-biopharma-and-tasly-biopharmaceuticals-enter-into-exclusive-license-agreement 2021-12-29 03:37:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regor-therapeutics-announces-us-fda-authorization-to-conduct-regor 2021-12-29 03:43:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-ridgebacks-molnupiravir-an-investigational-oral-antiviral-covid-19-treatment 2021-12-27 00:41:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-announces-antitrust-clearance-of-license-agreement 2021-12-23 23:44:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-ridgebacks-molnupiravir-receives-us-fda-emergency 2021-12-23 23:42:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biondvax-signs-definitive-agreements-for-development-and-commercialization 2021-12-22 23:58:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-achieves-key-milestone-in-collaboration-with-exelixis 2021-12-22 23:57:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-leqvio 2021-12-22 23:56:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-first-to-market-generic-version-of-narcan 2021-12-22 23:55:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karyopharm-and-menarini-group-enter-into-exclusive-license-agreement-to-commercialize-nexpovio-selinexor-in-europe-and-other-key-global-territories 2021-12-22 07:07:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heat-biologics-announces-planned-acquisition-of-elusys-therapeutics 2021-12-22 07:02:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hepion-pharmaceuticals-announces-fda-clearance-of-ind-application 2021-12-22 06:45:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-xarelto-to-treat-venous-thromboembolism 2021-12-22 06:24:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-to-acquire-amunix-immuno-oncology-pipeline 2021-12-22 06:19:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lineage-establishes-exclusive-worldwide-collaboration-with-genentech 2021-12-20 23:05:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-expands-collaboration-with-novartis-to-develop-and-commercialize-beigene 2021-12-20 23:04:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-research-plus-is-the-first-pipette-to-receive-my-green-lab-act-label 2021-12-17 06:30:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-enters-antibody-discovery-agreement-with-twist-bioscience 2021-12-16 23:04:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nkarta-receives-us-fda-orphan-drug-designation-for-nkx101 2021-12-16 23:03:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyell-immunopharma-announces-fda-clearance-of-its-ind-for-lyl797 2021-12-16 23:02:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-aesthetics-completes-acquisition-of-soliton 2021-12-16 23:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-and-hof-sonderanlagenbau-partnership-creates-streamlined-offering 2021-12-16 05:42:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gerresheimer-enters-into-agreement-with-major-american-biotech 2021-12-16 04:16:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codexis-launches-codex-hitemp-reverse-transcriptase-to-address-key-challenges 2021-12-16 00:27:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verrica-pharmaceuticals-announces-acceptance-by-fda-of-nda 2021-12-15 23:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-pfizers-xeljanz 2021-12-15 01:04:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ukrainian-satellite-sich-2-30-started-its-journey-towards-space-with-turkish-cargo 2021-12-15 01:00:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akoya-biosciences-announces-a-groundbreaking-collaboration-with-pathai 2021-12-13 23:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-xbiotechs-ind-in-rheumatology 2021-12-13 23:48:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-foghorn-announce-strategic-collaboration-for-novel-oncology 2021-12-13 23:46:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-australia-announce-collaboration-to-bring-mrna-manufacturing-to-australia 2021-12-13 23:45:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-the-avenio-edge-system 2021-12-13 23:43:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atmps-and-assurea-llc-launch-strategic-collaboration-for-advanced-therapy-supply-chain 2021-12-12 23:30:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aerogen-and-cansinobio-agree-on-landmark-development-partnership 2021-12-10 01:39:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-announces-the-launch-of-valsartan-tablets 2021-12-10 01:35:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qiagen-and-denovo-biopharma-partner-to-develop-companion-diagnostic-test 2021-12-10 01:32:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hoth-therapeutics-sign-api-and-drug-product-contracts-with-wuxi-sta 2021-12-10 01:29:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abu-dhabi-to-strengthen-its-capabilities-as-life-sciences-hub 2021-12-09 03:18:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/doer-biologics-signs-licensing-agreement-with-lonza 2021-12-09 00:27:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-announces-clinical-collaboration-with-msd-to-evaluate-il-15-superagonist 2021-12-09 00:23:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valneva-signs-advance-purchase-agreement-with-bahrain 2021-12-09 00:18:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuvation-bio-announces-fda-clearance-of-investigational-new-drug-application 2021-12-08 23:23:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/igm-biosciences-to-collaborate-on-the-study-of-igm-and-iga-antibodies 2021-12-08 23:22:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hansa-biopharma-and-medison-pharma-announce-multiregional-commercialization-partnership 2021-12-08 00:01:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinas-largest-commercial-gmp-plasmid-manufacturing-facility-is-put-into-operation 2021-12-07 23:59:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arbutus-biopharma-x-chem-and-proteros-biostructures-achieve-first-milestone 2021-12-07 23:57:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aerie-concludes-exclusive-license-agreement-with-santen-for-rhopressa-and-rocklatan 2021-12-07 23:56:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-and-rarestone-announce-exclusive-licensing-agreement 2021-12-06 23:44:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ngm-bio-announces-clinical-trial-collaboration-with-merck 2021-12-06 23:42:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/longeveron-granted-orphan-drug-designation-by-fda-for-lomecel-b 2021-12-06 23:38:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kaleido-biosciences-announces-expansion-of-collaboration-with-janssen 2021-12-06 23:37:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-to-launch-sars-cov-2-flu-ab-rapid-antigen-test-in-countries-accepting 2021-12-06 06:36:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xphyto-completes-strategic-acquisition-of-3a-diagnostics-gmbh 2021-12-06 06:34:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cbdmd-therapeutics-announces-human-clinical-study-in-collaboration 2021-12-05 22:50:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-and-cardinal-health-enter-into-agreement-for-targeted-copper-theranostics 2021-12-02 23:56:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemomab-announces-fda-clearance-of-its-ind-application-for-cm-101 2021-12-02 23:55:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/itm-and-navigo-proteins-announce-research-collaboration-to-develop-fap-targeting 2021-12-02 05:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-forms-strategic-partnership-with-coherent-biopharma 2021-12-02 00:36:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/surface-oncology-announces-fda-clearance-of-ind-application-for-gsk4381562 2021-12-01 23:50:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaxart-announces-acquisition-of-second-gmp-manufacturing-facility 2021-12-01 23:47:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-an-authorized-generic-of-epiduo-forte-gel 2021-12-01 23:45:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-completes-purchase-agreement-with-long-term-partner-tib-molbiol-to-expand-pcr-test 2021-12-01 23:43:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allakos-announces-expansion-of-lirentelimab-development-into-atopic-dermatitis 2021-12-01 23:37:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atyr-pharma-and-fujifilm-diosynth-biotechnologies-announce-manufacturing-agreement 2021-12-01 23:36:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/treadwell-therapeutics-announces-us-fda-clearance-of-ind-application-for-phase-2-study 2021-12-01 23:34:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oriciro-genomics-launches-new-enzymatic-dna-synthesis-tool-for-commonly-used-vectors 2021-11-29 23:14:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/todos-medical-enters-into-binding-agreement-to-acquire-all-3cl-protease 2021-11-29 23:13:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valneva-and-idt-biologika-announce-collaboration-for-production-of-inactivated-covid-19-vaccine-vla2001 2021-11-29 23:11:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-announces-fda-clearance-of-investigational-new-drug-application-for-natural-killer-cell-therapy-cynk-101 2021-11-29 23:10:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avacta-announces-fda-approval-of-its-investigational-new-drug 2021-11-29 23:06:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relief-reports-that-its-us-collaboration-partner-has-identified-a-significantly-higher-likelihood-of-surviving-and-recovering 2021-11-29 23:05:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-announces-completion-of-third-actt-clinical-trial-for-covid-19 2021-11-29 22:30:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-pharmaceuticals-completes-acquisition-of-adamas-pharmaceuticals 2021-11-24 23:47:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/philogen-announces-new-collaboration-with-janssen 2021-11-24 23:46:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takedas-livtencitytm-maribavir-approved-by-us-fda-as-the-first-and-only-treatment 2021-11-23 23:52:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-fda-clearance-of-the-ind 2021-11-23 23:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-donates-to-the-embl-to-promote-women-working-in-science 2021-11-23 00:58:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurocrine-biosciences-and-sosei-heptares-announce-collaboration 2021-11-22 23:34:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/decibel-therapeutics-announces-extension-of-research-term-under-strategic-collaboration-with-regeneron 2021-11-22 23:32:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocorrx-acquires-intellectual-property-for-drug-delivery 2021-11-22 23:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verrica-pharmaceuticals-announces-fda-acceptance-of-its-ind-application-for-ltx-315 2021-11-19 04:42:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytovia-and-cellectis-expand-their-talen-gene-edited-ink-partnership 2021-11-19 04:39:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-mercks-keytruda-as-adjuvant-therapy-for-certain-patients 2021-11-19 04:37:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bivictrix-and-abzena-collaborate-to-manufacture-antibody-drug-conjugates 2021-11-19 00:21:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hoth-therapeutics-announces-a-sponsored-research-agreement-to-further-develop-novel-mrna-cancer-therapeutic-ht-kit 2021-11-16 23:55:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rakovina-therapeutics-partners-with-st-baldricks-foundation-to-research-and-develop-new-treatments-for-childhood-bone-cancer 2021-11-16 23:54:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inovio-collaborates-with-guardrx-and-geneva-university-hospitals-for-heterologous 2021-11-16 23:52:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-blood-and-cell-technologies-and-immunicom-establish-agreement 2021-11-16 23:13:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-launches-colorwheel-flow-cytometry-antibodies-and-dyes 2021-11-16 23:10:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-and-medgenome-launch-genomics-strategic-partnership-focused 2021-11-16 06:38:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-participated-in-logitrans-2021-fair 2021-11-16 04:47:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-announces-co-promotion-agreement-with-tolmar-pharmaceuticals 2021-11-16 04:04:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-fda-acceptance-for-filing-and-priority-review 2021-11-16 04:02:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kala-pharmaceuticals-acquires-combangio-expanding-its-pipeline-with-a-clinical-stage-novel-biologic-for-the-treatment-of-persistent-corneal-epithelial-defect 2021-11-16 03:58:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-pantherna-enter-into-technology-evaluation-agreement 2021-11-16 03:54:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-awarded-with-air-cargo-excellence-by-wof-expo 2021-11-15 05:24:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-hope-for-bowel-cancer-patients-as-fresh-partnership-between-carina-biotech 2021-11-15 03:15:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sot101-shows-clinical-benefit-in-patients-with-advanced-solid-tumors 2021-11-14 23:24:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-acquire-codiak-biosciences-exosomes-manufacturing-facility-and-establish-a-long-term-strategic-collaboration 2021-11-15 06:07:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-acquire-exosomics-service-unit-to-expand-exosomes-service-offering 2021-11-15 06:06:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-receives-clearance-from-us-federal-trade-commission-for-the-acquisition-of-novitium-pharma 2021-11-11 23:37:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncorus-announces-exclusive-licensing-agreement 2021-11-11 23:34:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zipline-pfizer-and-biontech-collaboration 2021-11-11 23:27:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meridian-bioscience-receives-fda-emergency-use-authorization 2021-11-10 23:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-university-of-chicago-extend-research-collaboration 2021-11-10 23:29:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbio-receives-fda-fast-track-designation-for-bemcentinib-in-stk11-mutated-advancedmetastatic-non-small-cell-lung-cancer-nsclc 2021-11-10 00:06:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inovio-receives-us-fda-authorization-to-proceed-with-innovate-phase-3-segment-for-its-covid-19-vaccine-candidate-ino-4800-in-the-us 2021-11-09 23:46:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-completes-acquisition-of-kadmon 2021-11-09 23:40:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-and-pfizer-enter-strategic-collaboration-for-the-commercialization-of-rimegepant-outside-the-united-states 2021-11-09 23:38:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/talis-biomedical-granted-fda-emergency-use-authorization-eua-for-covid-19 2021-11-09 01:12:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kronos-bio-and-tempus-announce-multi-year-collaboration-to-provide-kronos-bio 2021-11-09 01:11:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amyris-announces-jv-partnership-with-immunitybio-for-next-generation 2021-11-09 01:06:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-receipt-of-antitrust-clearance-in-germany-and-austria-relating 2021-11-09 00:58:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascletis-and-suzhou-alphamab-expand-their-partnership-into-worldwide-license-agreement-for-asc22 2021-11-08 22:50:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moberg-pharma-enters-into-collaboration-with-allderma-for-launch-in-scandinavia 2021-11-08 22:49:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/burning-rock-collaborates-with-impact-therapeutics-to-provide-testing-services 2021-11-05 02:58:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptose-enters-into-exclusive-worldwide-license-agreement-with-hanmi-pharmaceutical 2021-11-05 02:52:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases 2021-11-05 02:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-receives-fda-orphan-drug-designation-for-sel24men1703 2021-11-05 01:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grao-direto-and-bayer-collaborate-to-expand-the-reach-and-impact-of-sustainable-practices-in-grain-trading 2021-11-05 01:33:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogens-presentation-shows-how-the-directedluck-transpose-system 2021-11-03 03:39:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nautilus-and-abcam-announce-strategic-partnership 2021-11-03 01:59:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-nova-mentis-orphan-drug-application 2021-11-03 01:56:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galecto-announces-clinical-collaboration-with-roche-for-phase-2-trial-of-gb1211 2021-11-03 01:55:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/australian-tga-approves-illuccix-for-prostate-cancer-imaging 2021-11-01 23:55:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imugene-and-eureka-therapeutics-announce-strategic-collaboration 2021-11-01 23:52:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-receives-fda-approval-of-ind-for-phase-1-trial-of-atg-101 2021-11-01 23:51:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sio-gene-therapies-announces-granting-of-fda-fast-track-designation-for-investigational 2021-11-01 23:49:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-adds-macau-to-its-expanding-cargo-flight-network 2021-11-01 06:56:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-fda-approval-of-purified-cortrophin-gel 2021-11-01 05:20:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyloris-announces-fda-acceptance-of-new-drug-application-for-maxigesic 2021-11-01 05:18:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-further-expands-clinical-supply-network-with-new-facility-in-san-diego 2021-10-29 02:51:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-submits-new-drug-application-to-us-fda-for-tebipenem-hbr 2021-10-28 23:42:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xbiotech-to-launch-novel-candidate-therapy-for-stroke 2021-10-28 23:40:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siemens-and-merck-collaborate-to-boost-machine-to-machine-trust-in-industrial-value-chains 2021-10-28 23:39:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-launches-millicell-dci-digital-cell-imager-for-fast 2021-10-28 23:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recro-enters-into-master-commercial-supply-and-services-agreement-with-otsuka 2021-10-27 23:39:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-establishes-collaboration-for-clinical-trial-of-adg106-in-combination-with-nivolumab-in-patients-with-non-small-cell-lung-cancer-in-singapore 2021-10-27 23:38:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/silo-pharma-enters-into-sponsored-research-agreement-with-columbia-university 2021-10-27 23:36:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corvus-pharmaceuticals-announces-partner-angel-pharmaceuticals-received-ind-approval 2021-10-27 23:34:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-to-acquire-gammadelta-therapeutics-to-accelerate-development-of-allogeneic 2021-10-27 23:33:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/solasia-and-nippon-kayaku-announce-license-agreement-in-japan 2021-10-27 04:16:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trillium-securityholders-approve-acquisition-by-pfizer 2021-10-27 04:15:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/berkeley-lights-announces-gsk-acquires-third-beacon-optofluidic-system 2021-10-27 04:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selecta-biosciences-and-ginkgo-bioworks-announce-partnership-to-advance-treatments-for-orphan-and-rare-diseases 2021-10-27 04:10:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-and-mammoth-biosciences-announce-collaboration 2021-10-27 04:09:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-nasally-administered-pharmaceutical-treatment-for-dry-eye-disease-approved-by-us 2021-10-26 01:19:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/canbridge-pharmaceuticals-enters-into-research-collaboration-agreement-with-scriptr-global 2021-10-26 01:09:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinus-pharmaceuticals-joins-the-loulou-foundation-in-collaboration-on-candid 2021-10-26 01:05:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evaxion-biotech-announces-clinical-collaboration-to-evaluate-lead-product-candidate 2021-10-25 05:13:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-comprehensive-genomic-profiling-kit-to-expand-access 2021-10-25 05:10:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/specialised-therapeutics-enters-into-a-new-supply-and-distribution-agreement 2021-10-22 04:02:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atreca-enters-into-licensing-agreement-with-bill-melinda-gates-medical-research 2021-10-22 04:00:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-enters-into-research-collaboration-license-option-agreement 2021-10-22 03:58:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ferrer-and-treeway-enter-into-licence-agreement-for-the-development 2021-10-22 01:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-has-been-carrying-cancer-medicine-for-25-years 2021-10-20 06:33:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plus-therapeutics-announces-fda-clearance-of-investigational-new-drug-application 2021-10-19 23:34:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akero-therapeutics-receives-fda-fast-track-designation-for-efruxifermin 2021-10-19 23:32:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antios-therapeutics-and-assembly-biosciences-announce-clinical-collaboration-agreement 2021-10-19 23:31:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-partners-to-accelerate-development 2021-10-19 23:28:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kedrion-grows-in-north-america-as-it-completes-acquisition-of-prometic 2021-10-18 23:49:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matica-bio-announces-joint-research-agreement-with-sartorius 2021-10-18 23:48:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takara-bio-usa-launches-automated-full-length-single-cell-rna-seq-solution 2021-10-18 23:41:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunocore-and-medison-pharma-partner-for-future-commercialization 2021-10-18 23:40:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wave-life-sciences-and-takeda-amend-cns-collaboration 2021-10-18 23:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oyster-point-pharma-announces-fda-approval-of-tyrvaya 2021-10-18 05:53:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/som-biotech-granted-orphan-drug-designation-by-the-fda-for-som3355 2021-10-18 05:51:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-roches-tecentriq-as-adjuvant-treatment 2021-10-17 23:04:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-biomath-llc-announces-collaboration-with-byomass-for-systems-pharmacology 2021-10-17 23:02:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sal-signs-cargo-ground-handling-agreement-with-qatar-airways-cargo 2021-10-14 03:19:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lixte-biotechnology-announces-collaboration-with-netherlands-cancer-institute-amsterdam 2021-10-13 23:47:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-receives-fda-clearance-to-proceed-with-clinical-trial-for-anti-trop-2-antibody-drug-conjugate 2021-10-13 23:45:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turning-point-therapeutics-and-eqrx-announce-clinical-collaboration-to-evaluate-elzovantinib-in-combination-with-aumolertinib 2021-10-13 23:45:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relief-reports-that-its-us-collaboration-partner-has-announced-progress-on-worldwide 2021-10-13 23:43:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inmed-pharmaceuticals-completes-acquisition-of-baymedica-creating-a-market-leader 2021-10-13 23:40:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellumed-and-artes-sign-development-and-license-agreement 2021-10-13 06:34:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bd-launches-plunger-stopper-in-partnership-with-aptar-pharma 2021-10-13 02:56:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/krystal-biotech-and-genedx-announce-collaboration-to-provide-no-charge-genetic-testing-for-patients 2021-10-12 23:17:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/albireo-announces-exclusive-licensing-agreement-with-jadeite-medicines-for-bylvay 2021-10-12 23:16:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-and-fosun-pharma-sign-exclusive-license-and-distribution-agreements-for-aloxi 2021-10-12 23:14:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gensight-biologics-announces-fda-grant-of-fast-track-designation 2021-10-12 23:12:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-launches-university-of-medicine-excellence 2021-10-12 23:11:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tracon-pharmaceuticals-and-eucure-biopharma-a-subsidiary-of-biocytogen-announce-partnership 2021-10-12 03:45:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pasithea-therapeutics-and-evotec-se-enter-into-drug-development-agreement 2021-10-12 03:43:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiromic-biopharma-announces-strategic-collaboration-with-gemelli-teaching-hospital 2021-10-12 03:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/landos-biopharma-announces-fda-clearance-of-its-ind-for-labp-104-for-the-treatment 2021-10-11 05:44:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-completes-acquisition-of-gsks-cephalosporin-business 2021-10-11 05:43:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-launches-the-cosmetic-active-ingredient-ronacare 2021-10-11 05:42:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-opens-new-full-service-clinical-supply-facility-in-shiga-japan 2021-10-10 23:35:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/msd-announces-supply-purchase-agreement-with-singapore-government-for-molnupiravir 2021-10-10 23:31:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mirati-therapeutics-to-collaborate-with-sanofi-on-phase-12-study 2021-10-08 00:43:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meridian-launches-new-air-dryable-qpcr-mix-enabling 2021-10-08 00:42:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enzolytics-inc-and-samsung-biologics-announce-development-and-manufacturing-agreement 2021-10-08 00:41:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lendlease-to-build-a-large-vaccine-facility-in-support-of-singapores-growth-as-a-life-sciences-hub 2021-10-07 22:48:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4d-molecular-therapeutics-announces-fda-clearance-of-ind-application-for-4d-150 2021-10-07 00:25:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/voyager-therapeutics-announces-license-option-agreement-with-pfizer 2021-10-07 00:24:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acer-therapeutics-and-relief-therapeutics-announce-fda-acceptance 2021-10-07 00:22:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navigo-proteins-gmbh-announces-extension-of-partnership-with-itm 2021-10-07 00:02:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegon-and-vetter-win-pda-drug-delivery-innovation-award-for-versynta-microbatch 2021-10-06 03:03:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peli-biothermal-relocates-us-headquarters 2021-10-06 01:14:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/t-cure-bioscience-and-atlas-antibodies-ab-enter-collaboration-agreement 2021-10-06 01:06:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mindmed-announces-strategic-research-collaboration-with-sphere-health 2021-10-06 00:48:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-completes-acquisition-of-pinnacle-21 2021-10-05 01:13:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selecta-biosciences-announces-strategic-licensing-agreement-with-takeda 2021-10-05 01:12:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/snaptec-single-handed-operation-for-fast-and-safe-sample-handling 2021-10-04 23:43:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-award-2022-call-for-entries 2021-10-04 23:36:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-wins-coveted-airline-of-the-year-asia-award-at-acn-awards-2021 2021-10-04 22:37:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xencor-enters-global-collaboration-and-license-agreement-with-janssen-to-advance-plamotamab 2021-10-04 06:08:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immixbio-announces-fda-orphan-drug-designation-for-imx-110-for-the-treatment 2021-09-30 23:00:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptive-biotechnologies-launches-enhanced-clonoseq-assay-reports-for-patients 2021-09-30 22:58:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-to-commercialize-next-generation-through-collaboration-with-jcr-pharmaceuticals 2021-09-30 22:56:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prime-therapeutics-and-pear-therapeutics-announce-first-comprehensive-value-based-agreement-for-prescription-digital-therapeutics 2021-09-30 00:01:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-livmarli-maralixibat-as-the-first-and-only-approved-medication-for-the-treatment-of-cholestatic 2021-09-29 23:59:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-abbotts-amplatzer-talisman-system-for-pfo-closure 2021-09-29 23:58:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantern-pharma-enters-into-strategic-collaboration-with-deep-lens 2021-09-29 00:32:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-qulipta-the-first-and-only-oral-cgrp-receptor-antagonist 2021-09-29 00:30:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-catalyst-biosciences-orphan-drug-designation-for-marzaa 2021-09-29 00:28:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemomab-therapeutics-announces-collaboration-with-leeds-university-to-further-elucidate-the-role-of-ccl24 2021-09-27 23:13:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-invetx-announce-strategic-collaboration 2021-09-27 23:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syndax-pharmaceuticals-and-incyte-announce-global-collaboration-to-develop 2021-09-27 05:27:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hikma-strengthens-us-injectables-business-through-acquisition-of-custopharm 2021-09-27 05:23:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-water-preservation-cell-promotes-elimination-of-water-borne-contaminants 2021-09-27 03:53:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knight-therapeutics-enters-into-exclusive-supply-and-distribution-agreement-with-incyte 2021-09-24 02:03:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quell-therapeutics-significantly-expands-clinical-manufacturing-capacity 2021-09-24 02:00:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-expands-research-collaboration-to-develop-precision-medicine 2021-09-24 01:59:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-to-discover-and-develop-self-amplifying-rna-therapeutics 2021-09-24 01:58:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-approval-of-investigational-new-drug-application-by-china 2021-09-24 01:22:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carisma-therapeutics-announces-us-food-and-drug-administration-grants-fast-track-designation-to-ct-0508-for-the-treatment-of-patients-with-solid-tumors 2021-09-22 23:57:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-announces-fda-approval-of-jakafi-for-treatment-of-chronic-graft-versus-host-disease 2021-09-22 23:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-launches-first-and-only-generic-version-of-chantix-tablets-in-the-united-states 2021-09-22 23:52:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-three-respiratory-test-panels-on-cobas-68008800-systems 2021-09-22 23:50:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-announces-us-fda-approval-of-opzelura-cream 2021-09-22 00:23:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/black-diamond-therapeutics-and-openeye-scientific-announce-collaboration 2021-09-22 00:21:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medexus-announces-expanded-availability-of-trecondyv-treosulfan-in-canada 2021-09-22 00:03:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-acquires-abexxa-biologics-to-further-expand-its-research-efforts 2021-09-22 00:02:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-announces-procurement-agreement-with-european-commission 2021-09-22 00:01:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-contribution-to-climate-protection-corporate-sites-around-the-world-are-co2-neutral 2021-09-21 22:53:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-samsung-bioepis-and-biogens-byooviz 2021-09-21 02:05:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/barda-and-partner-therapeutics-foster-a-new-partnership-around-their-fda-approved-drug 2021-09-21 02:02:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncternal-therapeutics-and-celularity-enter-into-research-collaboration 2021-09-21 02:00:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glaukos-announces-licensing-agreement-with-attillaps-holdings 2021-09-20 06:19:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/landos-biopharma-to-collaborate-on-phase-study-of-omilancor-in-crohns-disease 2021-09-20 06:18:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deciphera-announces-positive-chmp-opinion-for-qinlock 2021-09-20 01:07:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-therapeutics-announces-us-fda-acceptance-of-investigational 2021-09-16 23:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/repligen-announces-agreement-to-acquire-avitide 2021-09-16 23:37:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-sinovent-and-sinomab-announce-licensing-agreement 2021-09-16 23:35:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-in-the-us 2021-09-16 23:34:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-enters-clinical-collaboration-with-amgen-to-study-bi-1701963 2021-09-16 23:32:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emmes-standardizes-on-veeva-development-cloud-to-streamline-product-development 2021-09-16 23:18:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmapack-report-2021-us-leads-on-drug-device-innovation-but-trails-europe 2021-09-16 22:43:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptorum-group-limited-has-received-ind-clearance-from-the-us-fda 2021-09-16 01:27:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vifor-pharma-and-travere-therapeutics-announce-licensing-agreement-for-the-commercialization-of-sparsentan-in-europe-australia-and-new-zealand 2021-09-16 01:26:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obseva-announces-submission-of-new-drug-application-to-us-fda 2021-09-16 01:17:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takedas-exkivity-approved-by-us-fda-as-the-first-oral-therapy 2021-09-16 01:11:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-new-us-government-agreement-to-purchase-additional-doses 2021-09-14 22:58:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-announces-fda-acceptance-of-new-drug-application-for-axs-07 2021-09-14 22:55:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-techne-launches-excellerate-ipsc-expansion-medium 2021-09-14 22:54:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inmed-pharmaceuticals-signs-definitive-agreement-to-acquire-baymedica 2021-09-14 00:22:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-enters-into-comprehensive-agreements-with-providence-therapeutics 2021-09-14 00:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dynavax-provides-update-on-its-covid-19-collaboration-with-valneva 2021-09-14 00:19:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adicet-bio-collaborates-with-twist-bioscience-to-accelerate-discovery-of-gamma-delta 2021-09-14 00:01:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sal-and-bahrains-gulf-air-sign-7-year-cargo-logistics-partnership-agreement 2021-09-13 23:24:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-and-radius-sign-italian-distribution-agreement-for-prostate-cancer-imaging 2021-09-13 03:32:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-eisai-and-ea-pharma-launch-humira-support-tool-ordering-service-for-patients 2021-09-13 03:31:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/retrobrain-announces-strategic-cooperation-with-schenker-technologies 2021-09-08 22:46:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/healthcare-why-focus-on-digitalization 2021-09-08 04:25:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alpha-cognition-announces-the-acceptance-of-its-us-fda-investigational-new-drug 2021-09-08 03:12:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avantor-to-acquire-masterflex-expands-proprietary-single-use-offering-for-bioproduction 2021-09-08 03:11:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptimmune-enters-into-a-strategic-collaboration-with-genentech-to-research 2021-09-08 03:05:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-the-institute-for-life-changing-medicines-announce-new-collaboration 2021-09-08 02:55:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/newron-receives-fourth-tranche-from-financing-agreement 2021-09-07 03:14:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tiziana-life-science-tlsa-to-host-call-to-discuss-exclusive-license 2021-09-07 03:12:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/versantis-receives-us-fda-orphan-drug-designation-for-vs-01 2021-09-07 03:05:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affamed-therapeutics-enters-into-strategic-partnership-agreement-with-beijing-tiantan-hospital 2021-09-05 23:00:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avidity-science-announces-agreement-to-divest-lab-products-harford-systems 2021-09-05 22:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-announces-us-fda-approval-of-trudhesa 2021-09-05 22:57:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-announces-qelbree-snda-for-adult-indication-accepted-for-review-by-fda 2021-09-02 23:31:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-and-tiziana-life-sciences-announce-exclusive-license-agreement 2021-09-02 23:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovion-and-bial-enter-european-licensing-agreement-for-apomorphine-sublingual-film 2021-09-02 23:18:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stemcell-technologies-launches-human-pluripotent-stem-cell-characterization-and-banking-services 2021-09-02 02:55:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bellicum-and-md-anderson-announce-additional-license-agreement 2021-09-02 02:52:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lumen-bioscience-launches-phase-trial-of-oral-biologic-drug 2021-09-02 02:50:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-and-astrazeneca-to-co-develop-ngs-based-companion-diagnostics 2021-09-02 02:49:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-fda-acceptance-of-purified-cortrophin 2021-09-01 03:58:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verily-completes-acquisition-of-signalpath 2021-09-01 03:54:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-and-medincell-announce-fda-acceptance-of-new-drug-application-for-tv-46000 2021-09-01 03:53:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-fuji-yakuhin-conclude-license-agreement-concerning-the-development 2021-08-31 23:24:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/springworks-therapeutics-enters-into-research-collaboration-with-leading-cancer-institute 2021-08-30 05:29:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xphyto-launches-first-commercial-biosensor-for-oral-disease 2021-08-30 05:21:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-and-hikma-pharmaceuticals-announce-exclusive-commercialization 2021-08-29 23:37:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immixbio-announces-clinical-trial-and-supply-agreement-with-beigene 2021-08-29 23:35:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-genes-launches-rare-patient-identification-and-inclusion-initiative 2021-08-27 00:03:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/landos-biopharma-announces-research-collaboration-into-the-nlrx1-pathway 2021-08-27 00:02:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bolt-biotherapeutics-and-innovent-biologics-announce-collaboration 2021-08-27 00:01:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilex-biolabs-partners-with-endpoints-news-for-the-first-webinar-on-rapid-vaccine-development-in-australia 2021-08-26 06:40:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blade-therapeutics-announces-fda-activation-of-ind-application 2021-08-25 23:30:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharma-collaborates-with-etana-to-commercialize-proxalutamide 2021-08-25 23:29:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-lycia-therapeutics-enter-into-strategic-collaboration-to-discover 2021-08-25 23:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptamer-group-and-bio-works-technologies-partner-to-enable-improved-solutions 2021-08-25 04:13:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-establish-drug-product-manufacturing-services-in-guangzhou 2021-08-25 01:45:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-therapeutics-announces-entry-into-option-agreement-to-exclusively-license-mpro 2021-08-25 00:34:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cardiol-therapeutics-receives-fda-clearance-of-investigational-new-drug-application 2021-08-25 00:33:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-and-arbor-biotechnologies-establish-new-partnership-to-develop 2021-08-25 00:31:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-expansion-of-the-peripheral-artery-disease 2021-08-25 00:30:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogenes-and-fyonibio-combine-their-scientific-expertise-and-cooperate 2021-08-24 06:45:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medigen-vaccine-biologics-announces-launch-of-its-covid-19-vaccine 2021-08-24 00:22:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ceapro-enters-into-research-collaboration-with-the-angiogenesis-foundation 2021-08-24 00:19:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cara-therapeutics-and-vifor-pharma-announce-us-fda-approval-of-korsuva 2021-08-24 00:08:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-for-priority-review-bristol-myers 2021-08-23 06:30:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cronos-group-and-ginkgo-bioworks-announce-achievement-of-equity-milestone-in-partnership 2021-08-23 06:28:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zydus-receives-eua-from-dcgi-for-zycov-d 2021-08-22 23:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coeptis-therapeutics-partners-with-vygen-bio-inc-to-co-develop-two-assets-designed 2021-08-20 01:27:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amyris-launches-terasana-clinical-clean-skincare-brand 2021-08-20 01:26:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delsitech-announces-an-exclusive-licensing-and-collaboration-agreement 2021-08-20 01:25:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-announces-the-third-clinical-trial-collaboration-with-merck 2021-08-20 01:24:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-celebrates-the-60th-birthday-of-a-pipetting-masterstroke 2021-08-19 01:07:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mydecine-innovations-strikes-five-year-research-agreement 2021-08-19 00:54:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-jardiance-to-treat-adults-living-with-heart-failure 2021-08-19 00:54:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aequus-and-revision-to-collaborate-on-stargardt-disease-program 2021-08-18 01:44:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinus-pharmaceuticals-reports-topline-ganaxolone-phase-2-open-label-results 2021-08-18 01:43:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agios-announces-fda-acceptance-and-priority-review-of-new-drug-application-for-mitapivat 2021-08-18 01:43:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gritstone-and-cepi-announce-agreement-to-advance-second-generation-covid-19 2021-08-18 01:33:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-vision-to-pioneer-integrated-eye-health-ecosystem-in-singapore 2021-08-17 06:14:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/edgewise-receives-us-fda-fast-track-designation-for-edg-5506-for-the-treatment 2021-08-17 00:29:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-and-innocare-announce-collaboration-and-license-agreement 2021-08-17 00:28:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gracell-biotechnologies-signs-exclusive-license-agreement-with-futuregen-biopharm 2021-08-17 00:25:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hdt-bio-announces-agreement-with-koreas-quratis 2021-08-16 06:52:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-fda-lifts-clinical-hold-on-danon-disease-trial-of-rp-a501 2021-08-16 06:51:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivir-strengthens-the-business-development-potential-of-remetinostat 2021-08-16 06:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-capacity-helps-eliminate-bottleneck-for-covid-19-vaccines 2021-08-16 06:34:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anticancer-agent-tazverik-tablets-200mg-launched-in-japan 2021-08-15 22:45:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/facelift-for-reusable-pipette-tip-boxes 2021-08-13 22:58:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fusion-pharmaceuticals-and-triumf-announce-expanded-rd-collaboration-for-actinium-supply-production 2021-08-13 01:46:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-announces-us-fda-approval-of-xywav 2021-08-13 01:45:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-receives-fda-orphan-drug-designation-for-allo-715 2021-08-13 01:43:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugai-launches-evrysdi-dry-syrup-60-mg-for-the-treatment-of-spinal-muscular-atrophy 2021-08-13 01:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vtx-801-receives-us-fda-fast-track-designation-for-the-treatment-of-wilson-disease 2021-08-13 01:40:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nobelpharma-signs-a-license-agreement-for-probiogens-vaccine-manufacturing 2021-08-12 06:53:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-pharmaceuticals-announces-fda-acceptance-of-its-ind-application-for-xerisol 2021-08-11 23:47:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avicanna-enters-partnership-with-heritage-cannabis-holdings-corp-to-commercialize 2021-08-11 23:46:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-lantern-pharma-orphan-drug-designation-for-drug-candidate-lp-184 2021-08-11 23:44:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenlight-biosciences-announces-business-agreement-with-environmental-impact-acquisition-corp 2021-08-11 03:50:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dermavant-announces-fda-acceptance-for-filing-of-new-drug-application-nda-for-tapinarof-cream 2021-08-11 03:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-application-for-mercks-keytrud-as-single-agent-for-certain-patients 2021-08-11 03:47:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veraxa-biotech-and-indivumed-cooperate-on-the-development-of-precision-oncology-antibody 2021-08-10 06:40:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seagen-and-remegen-announce-exclusive-worldwide-license-agreement 2021-08-10 06:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-announces-licensing-agreement-with-aop-orphan 2021-08-10 06:36:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/algernon-pharmaceuticals-announces-exclusive-licensing-agreement 2021-08-10 06:35:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acer-therapeutics-and-relief-therapeutics-announce-submission-of-a-new-drug-application 2021-08-10 06:33:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mission-and-abbvie-collaboration-in-alzheimers-and-parkinsons-diseases-reaches-next-milestone 2021-08-09 23:04:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-and-mindrank-ai-enter-into-collaboration-to-advance-the-development 2021-08-09 23:02:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apexigen-receives-orphan-drug-designation-from-the-fda-for-sotigalimab 2021-08-06 05:24:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oyster-point-pharma-announces-exclusive-license-agreement-with-ji-xing 2021-08-06 05:17:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-strengthens-drug-discovery-platform-through-acquisition-of-vividion-therapeutics 2021-08-06 05:13:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bd-and-certest-biotec-announce-ce-mark-for-molecular-test-to-detect 2021-08-06 05:11:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-receives-award-for-excellence-in-corporate-communications 2021-08-05 00:36:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imugene-and-celularity-announce-an-exclusive-strategic-partnership 2021-08-05 00:32:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biodelivery-sciences-announces-agreement-to-acquire-us-and-canadian-rights 2021-08-05 00:29:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmather-granted-fda-orphan-drug-designation-for-ketamine 2021-08-05 00:27:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-comprehensive-expansion-of-clinical-development 2021-08-04 02:00:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tachyon-and-abcellera-collaborate-to-develop-novel-antibody-therapeutic-targeting 2021-08-04 01:55:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-berinert-c1-esterase-inhibitor 2021-08-04 01:53:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monopar-announces-fda-clearance-to-proceed-with-camsirubicin-clinical-trial 2021-08-04 01:20:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clintex-cti-launches-cti-oem-blockchain-clinical-trial-app 2021-08-03 06:32:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-completes-acquisition-of-bristol-myers-squibb-manufacturing-facility-in-couvet 2021-08-03 06:20:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epygenix-therapeutics-receives-us-fda-orphan-drug-designation-for-epx-200 2021-08-03 03:00:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-collaborates-with-vingroup 2021-08-03 02:59:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-receives-fda-authorization-to-start-phase-1-clinical-trial-of-proprietary 2021-08-03 02:57:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autolus-and-moderna-sign-option-and-license-agreement-for-access 2021-08-03 02:55:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-acquires-german-biotech-company-jenacell-to-expand-biomaterials-portfolio 2021-08-02 23:18:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharma-enters-distribution-agreement-with-zuellig-pharma-for-seroquel 2021-08-02 04:36:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-and-exicure-enter-into-exclusive-collaboration-targeting 2021-08-02 04:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-institute-today-announces-two-new-research-groups-in-autoimmunity 2021-08-02 03:07:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisais-anti-epileptic-drug-fycompa-approved-in-china-as-monotherapy 2021-08-01 23:55:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-and-pall-corporation-investing-over-two-years-to-meet-growing-demand 2021-08-03 03:01:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scipher-medicine-increases-patient-access-for-prismra 2021-07-30 01:04:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-vico-therapeutics-orphan-drug-designation-for-vo659 2021-07-30 00:59:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-kumquat-biosciences-announce-collaboration-to-discover-and-develop 2021-07-30 00:56:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-minovia-therapeutics-announce-strategic-collaboration 2021-07-30 00:51:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-expanded-botox-label 2021-07-30 00:50:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-application-for-roches-faricimab-for-the-treatment-of-neovascular-age-related 2021-07-30 00:48:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-has-been-carrying-turkish-rose-products-to-all-over-the-world 2021-07-29 22:46:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tillotts-pharma-ag-announces-launch-of-asacol-800-mg-tablets 2021-07-29 00:56:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagonist-therapeutics-announces-amendment-of-agreement-with-janssen-biotech 2021-07-29 00:53:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-collaborative-research-agreement 2021-07-29 00:52:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fusion-pharmaceuticals-announces-fda-clearance-of-ind-for-fpi-1966 2021-07-29 00:48:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fermenta-biotech-limited-is-among-indias-best-workplaces 2021-07-28 06:32:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metriopharm-selected-by-european-commission-for-funding 2021-07-28 03:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegon-wins-german-packaging-award-for-sustainable-tablet-packaging 2021-07-28 03:53:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valenzabio-partners-with-probiogen-to-maximize-cell-line-productivity 2021-07-28 01:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-agreement-to-acquire-infectious-disease-rd-facility 2021-07-28 00:23:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oragenics-enters-into-licensing-agreement-with-the-national-research-council 2021-07-28 00:22:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-calico-announce-second-extension-of-collaboration 2021-07-28 00:21:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kronos-bio-announces-fda-clearance-of-investigational-new-drug-application 2021-07-28 00:20:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/byondis-and-glycotope-enter-platform-access-agreement-for-discovery-and-development 2021-07-27 03:35:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-announces-additional-licensing-agreements-for-tirbanibulin 2021-07-27 01:24:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codexis-and-kalsec-announce-expanded-collaboration-for-supply-of-novel-enzyme-to-sustainably-produce-natural-clean-label-beverage-ingredient 2021-07-27 01:23:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inhibikase-therapeutics-receives-fda-clearance-to-begin-evaluation-of-ikt-148009 2021-07-27 01:19:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aadi-bioscience-announces-fda-acceptance-and-priority-review-for-the-new-drug-application 2021-07-27 01:18:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allarity-therapeutics-and-lantern-pharma-enter-into-agreement-for-future-clinical 2021-07-26 06:09:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fidia-announces-the-fda-orphan-drug-designation-for-oncofid-p 2021-07-26 06:08:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saniona-receives-us-fda-orphan-drug-designation-for-tesomet-in-hypothalamic-obesity 2021-07-26 06:07:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dalvance-receives-fda-approval-to-treat-acute-bacterial-skin-and-skin-structure 2021-07-26 00:30:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-cryocube-f440-ult-freezers-now-all-green 2021-07-23 05:32:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-fda-approves-lenvima-plus-keytruda-combination-for-patients 2021-07-23 03:37:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-and-medison-pharma-partner-to-commercialize-imcivree 2021-07-23 03:18:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arvinas-and-pfizer-announce-global-collaboration-to-develop-and-commercialize 2021-07-23 03:16:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adagene-announces-clinical-trial-collaboration-with-merck 2021-07-23 03:10:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antares-pharma-announces-fda-acceptance-of-ind-application 2021-07-23 03:08:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-new-clinical-manufacturing-site-now-fully-integrated 2021-07-22 23:08:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/organicell-announces-fda-approval-of-ind-application-for-the-use-of-zofin 2021-07-22 00:06:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viracta-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1b2-trial 2021-07-22 00:05:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minaris-will-be-the-commercial-manufacturer-in-europe-for-skysona 2021-07-21 06:39:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/good-advice-for-good-breathing-during-monsoon 2021-07-21 01:26:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-for-venclexta-in-combination-with-azacitidine 2021-07-21 01:24:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kineta-and-samsung-biologics-announce-development-and-manufacturing-agreement 2021-07-21 01:23:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/albireo-announces-fda-approval-of-bylvay-the-first-drug-treatment 2021-07-21 01:22:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skyepharma-partners-with-veratrak-to-guarantee-data-integrity-for-batch-manufacturing-records 2021-07-20 01:38:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/todos-medical-to-launch-eua-authorized-cpass-sars-cov-2-neutralizing-antibody-kit 2021-07-20 01:13:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-pharmaceuticals-enters-into-an-exclusive-license-agreement-with-tetris-pharma 2021-07-20 01:03:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ligands-partner-merck-receives-fda-approval-for-vaxneuvance 2021-07-20 01:02:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-announces-fda-acceptance-of-new-drug-application 2021-07-20 01:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-extends-collaboration-with-major-biopharmaceutical-partner-for-large-scale 2021-07-16 02:57:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foundation-medicine-expands-indication-for-foundationone-liquid-cdx 2021-07-16 02:55:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xoma-acquires-royalty-and-milestone-interest-in-checkmate 2021-07-16 02:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-rebrands-to-peli-biothermal 2021-07-15 22:53:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-extends-collaboration-with-genedata 2021-07-15 02:01:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-alkeus-pharmaceuticals-breakthrough-therapy-designation-for-alk-001 2021-07-15 02:00:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/direct-biologics-announces-fda-acceptance-of-ind-application-for-a-phase 2021-07-15 01:59:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idifarma-launches-accelerated-pathway-for-complex-drugs 2021-07-14 22:33:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-strategic-collaboration-with-medbanks-health-technology 2021-07-14 00:33:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recro-enters-development-and-manufacturing-agreement-with-new-client 2021-07-14 00:32:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/palisade-bio-enters-into-worldwide-in-licensing-agreement 2021-07-14 00:31:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heat-biologics-enters-into-research-license-agreement-for-probiogen 2021-07-13 06:43:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gerresheimer-accelerates-revenue-growth 2021-07-13 03:19:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bormioli-pharma-accelerates-on-sustainability 2021-07-13 00:29:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-janssen-receives-us-fda-approval-of-darzalex-faspro 2021-07-13 00:25:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enochian-biosciences-announces-fda-acceptance-of-pre-ind-request 2021-07-13 00:23:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-and-nymirum-announce-strategic-collaboration-to-discover-and-develop 2021-07-13 00:21:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hummingbird-bioscience-and-md-anderson-announce-strategic-research-collaboration 2021-07-12 05:10:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-the-first-patient-dosed-in-the-phase-study-of-ibi323 2021-07-11 23:25:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stallergenes-greer-and-alyatec-announce-research-collaboration-to-advance-precision 2021-07-10 01:19:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-finerenone-for-the-treatment-of-patients-with-chronic-kidney-disease 2021-07-10 01:16:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immutep-receives-fda-and-irb-approval-in-the-us-for-phase-iib-tacti-003-trial-in-hnscc 2021-07-09 02:32:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-updated-aduhelm-prescribing-information 2021-07-09 02:29:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tezepelumab-regulatory-submission-accepted-and-granted-fda-priority-review-in-the-us-for-the-treatment-of-patients-with-asthma 2021-07-09 02:27:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mimetas-and-roche-enter-into-a-collaboration-to-develop-human-disease 2021-07-06 02:31:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-acceptance-of-ind-application-in-china-for-the-phase-ii 2021-07-05 23:36:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/guo-chao-packaging-design-week-makes-its-surprise-debut-at-swop-2021 2021-07-05 04:53:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-and-merck-kgaa-darmstadt-germany-launch-new-research-program-in-oncology 2021-07-05 04:38:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-results-from-the-landmark-prospective-circulate-trial-expand-clinical-utility 2021-07-03 00:03:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-alector-announce-global-collaboration-in-immuno-neurology 2021-07-03 00:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lipidor-ab-licence-agreement-grants-menarini-group-company-relife-srl-exclusive-rights-to-register-promote-distribute-and-market-two-new-psoriasis-drug 2021-07-02 04:21:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-completes-divestment-of-specialty-ingredients-business 2021-07-02 04:09:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-and-pharming-group-announce-collaboration-to-develop-and-commercialize-ex-vivo 2021-07-02 02:25:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunic-inc-announces-fda-clearance-to-begin-imu-838-phase-3-ensure-studies 2021-07-02 02:22:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogx-receives-fda-eua-for-a-novel-high-throughput 2021-07-02 02:25:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-carried-100-million-vaccine-doses-to-all-around-the-world 2021-07-01 04:03:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-announces-equity-investment-from-pfizer-inc 2021-07-01 01:56:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-granted-fda-fast-track-designation-for-allo-605 2021-07-01 01:55:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-announces-us-fda-approval-of-rylaze 2021-07-01 01:53:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmap-2021-navigation-map-through-the-pharma-trends 2021-06-30 06:30:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-expands-production-of-highly-complex-antibodies-at-german-site 2021-06-30 06:28:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-invests-chf-20-million-to-expand-api-development 2021-06-29 03:23:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-enspryng-approved-by-european-commission-as-first-and-only-at-home 2021-06-29 02:22:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-license-agreement-with-synaffix-in-an-adc-technology-deal 2021-06-29 02:19:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/askbio-receives-fda-fast-track-designation-for-lion-101-a-novel-investigational-aav-gene-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2ir9-lgmd2ir9 2021-06-29 02:15:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atsena-therapeutics-receives-orphan-drug-designation-from-the-fda 2021-06-29 02:01:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynparza-approved-in-china-for-the-treatment-of-brca-mutated-metastatic-castration-resistant-prostate-cancer 2021-06-25 23:45:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lillys-donanemab-receives-us-fdas-breakthrough-therapy-designation 2021-06-25 23:43:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-report-predicts-supercharged-partnering-in-usa-pharma-sector-over-the-next-18-months 2021-06-24 06:49:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rivaroxaban-application-submitted-to-us-fda-for-approval 2021-06-24 00:27:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-joint-venture-fosun-kite-gains-the-first-car-t-cell-therapy-approval-in-china 2021-06-24 00:28:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-and-hewlett-packard-enterprise-join-forces-to-advance-novartis-global-health-efforts 2021-06-24 00:25:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-increase-of-vaccines-production-boosts-the-demand-of-eto-sterilization-chambers 2021-06-23 03:16:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shimadzu-launches-labsolutions-bix 2021-06-23 01:58:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-its-launch-of-the-first-generic-perforomist 2021-06-23 00:41:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fennec-pharmaceuticals-announces-fda-acceptance-of-new-drug-application 2021-06-23 00:39:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hutchmed-announces-savolitinib-approved-in-china 2021-06-23 00:37:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-lava-therapeutics-nv-sign-agreement-for-cell-line-development 2021-06-22 07:04:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/power-voice-system-the-first-isolator-with-integrated-voice-commands 2021-06-20 23:50:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-sars-cov-2-molecular-test-granted-first-fda-emergency-use-authorization-for-pcr-testing 2021-06-19 04:51:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turning-point-therapeutics-granted-fda-orphan-drug-designation 2021-06-18 01:33:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-therapeutics-granted-fast-track-designation-by-fda-for-at-007-for-galactosemia 2021-06-18 01:32:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lumen-bioscience-and-novo-nordisk-enter-into-research-collaboration 2021-06-17 01:01:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cndap-partners-with-takeda-to-develop-new-therapies-for-alzheimers-disease 2021-06-17 00:56:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-topline-results-from-phase-study-of-gosuranemab 2021-06-17 00:55:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-announces-planned-nda-submission-for-axs-14 2021-06-16 05:33:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampio-pharmaceuticals-receives-approval-to-expand-enrollment-of-its-ap-019-phase-ii-study-to-india 2021-06-16 05:31:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scipher-medicine-presents-new-data-at-the-european-league-against-rheumatism 2021-06-15 06:54:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/digital-pharma-manufacturing-revolution-in-cases 2021-06-15 06:16:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-announces-discontinuation-of-development-of-nafamostat-inhalation-formulation 2021-06-15 02:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avenue-therapeutics-receives-complete-response-letter-from-the-fda-for-iv-tramadol 2021-06-15 02:26:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-announces-clinical-trial-collaboration-and-supply-agreement-with-bristol-myers-squibb 2021-06-15 02:25:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-topline-results-from-phase-3-gene-therapy-study-in-choroideremia 2021-06-15 02:10:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-iteos-therapeutics-announce-development-and-commercialisation-collaboration 2021-06-15 02:08:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-divest-rights-for-zonegran-in-europe-and-other-regions-to-advanz-pharma 2021-06-15 02:05:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inceptor-bio-launches-next-generation-car-t-car-m-and-nknkt-platform 2021-06-14 23:21:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genincode-announces-major-us-commercialisation-partnership-with-eversana 2021-06-14 23:20:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yposkesi-launches-construction-of-its-second-commercial-bioproduction-site 2021-06-14 04:37:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veraxa-biotech-and-quadira-biosciences-enter-partnership-on-adc-development 2021-06-14 01:36:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-investigational-oral-therapy-iptacopan-shows-benefit-as-monotherapy 2021-06-14 00:23:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veru-enrolls-first-patient-in-phase-2-clinical-trial-of-veru-100-novel-long-acting-gnrh 2021-06-11 03:54:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-new-formulation-of-epclusa 2021-06-11 03:09:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-provides-update-on-aubagio-submission-for-children-and-adolescents 2021-06-11 04:10:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-entresto-indicated-for-treatment-of-hypertension-in-china 2021-06-11 03:05:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verona-pharma-and-nuance-pharma-announce-219-million-strategic-collaboration 2021-06-10 02:16:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-supply-agreement-with-us-government-for-molnupiravir 2021-06-10 02:14:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revolo-biotherapeutics-enters-into-partnership-agreement-with-northway-biotech 2021-06-10 02:13:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hummingbird-bioscience-and-novogene-enter-into-strategic-partnership-to-expand 2021-06-10 02:11:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rockwell-medical-and-drogsan-pharmaceuticals-enter-into-exclusive-license-agreement 2021-06-09 04:38:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-to-advance-two-first-of-its-kind-cell-and-gene-therapies-for-parkinsons-disease 2021-06-09 04:36:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-obtains-ce-mark-for-the-sars-cov-2-antigen-self-test-nasal 2021-06-09 04:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbio-receives-fda-fast-track-designation-for-bemcentinib 2021-06-09 03:57:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scipher-medicine-and-leading-medical-researchers-in-network-and-data-science 2021-06-08 07:07:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symbiosis-affirms-commitment-to-growth-with-new-business-development-manager 2021-06-08 04:47:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegons-gkf-60-sets-new-standards-in-capsule-filling-for-laboratories 2021-06-08 03:17:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indo-irish-biotech-startup-cygenica-secures-funding-from-sosv-to-accelerate-cancer 2021-06-08 02:49:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cullinan-oncology-receives-investigational-new-drug-ind-clearance-from-the-fda 2021-06-08 00:01:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-launches-ion-ampliseq-sars-cov-2-insight-research-assay 2021-06-08 00:00:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-new-interim-analysis-phase-ii-data-for-iptacopan-in-rare-kidney-disease 2021-06-07 23:58:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-accelerated-approval-for-aduhelm-as-the-first-and-only-alzheimer 2021-06-07 23:56:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-affiliate-cilag-gmbh-international-discontinues-collaboration-and-license-agreement-with-argenx 2021-06-07 06:26:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/springworks-therapeutics-announces-clinical-collaboration-with-seagen 2021-06-07 06:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-anheart-release-preliminary-results-from-the-phase-ii-trust-trial 2021-06-06 22:43:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aragen-formerly-gvk-bio-to-partner-with-global-biopharma-with-a-renewed-brand-promise 2021-06-05 01:47:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/surface-oncology-to-collaborate-with-roche 2021-06-05 01:44:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liminal-biosciences-announces-fda-approval-for-its-biologics-license-application 2021-06-05 01:42:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-177lu-psma-617-significantly-improves-overall-survival 2021-06-04 03:12:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sihuan-pharmaceutical-obtained-the-exclusive-distribution-right-for-lipivage 2021-06-04 02:35:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-zealand-pharma-receive-fda-fast-track-designation 2021-06-03 06:33:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates 2021-06-03 06:31:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-and-kahr-medical-announce-development-and-manufacturing-agreement-for-cancer-immunotherapy-drug-candidate 2021-06-03 06:11:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirios-nutra-innovation-team-tackles-global-surge-in-demand-for-novel-mood 2021-06-01 06:46:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleac-announces-us-fda-approval-of-ind-application-for-phase-1-study-of-mlc1501 2021-06-01 06:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-and-kyowa-kirin-to-jointly-develop-and-commercialize-khk4083 2021-06-01 06:42:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akebia-and-otsuka-announce-fda-acceptance-for-filing-of-new-drug-application 2021-06-01 06:41:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-biologics-and-anheart-therapeutics-jointly-announce-exclusive-license-agreement 2021-06-01 00:28:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-the-first-in-class-registrational-clinical-trial-of-sugemalimab-met 2021-05-28 00:51:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-biohavens-nurtec-odt-rimegepant-for-prevention 2021-05-28 00:49:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dynavax-announces-agreement-with-bavarian-nordic 2021-05-28 00:45:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-minapharm-pharmaceuticals-incorporate-migentra-gmbh 2021-05-27 03:58:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transthera-announces-collaboration-with-roche-to-evaluate-tt-00420 2021-05-27 02:05:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-announces-fda-approval-of-camcevi 2021-05-27 02:03:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senti-bio-and-bluerock-therapeutics-enter-collaboration-to-develop-gene-circuit-engineered-cell-therapies 2021-05-27 02:02:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-once-again-wins-axia-best-managed-companies-award 2021-05-27 01:59:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-and-pharmapack-europe-given-the-all-clear-by-host-country-governments 2021-05-26 07:30:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-fda-acceptance-of-biologics-license-application-for-ublituximab 2021-05-26 02:56:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/askbio-announces-ind-for-lion-101 2021-05-26 02:51:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-venclyxto-based-combinations-for-adults 2021-05-26 02:49:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sharp-purchases-new-land-as-part-of-17-million-capacity-expansion 2021-05-25 03:36:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharmas-innovative-alzheimers-disease-therapy-rivastigmine-multi-day 2021-05-24 06:46:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akesos-penpulimab-monoclonal-antibody-submitted-bla-in-the-united-states 2021-05-24 06:40:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/myriad-genetics-signs-definitive-agreement-to-sell-myriad-rbm-to-q2-solutions 2021-05-24 06:39:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enveric-biosciences-announces-definitive-agreement-to-acquire-magicmed-industries 2021-05-24 06:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-dates-for-medical-fair-thailand-with-move-to-2022-monday-may-24-2021 2021-05-24 00:46:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sparrow-pharmaceuticals-presents-data-on-spi-62-at-the-european-congress 2021-05-24 00:20:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-targeted-therapy-for-subset-of-non-small-cell-lung-cancer 2021-05-21 23:06:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilex-biolabs-partners-with-endpoints-news-on-deconvoluting 2021-05-21 03:32:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-positive-topline-results-from-pneu-direction 2021-05-21 03:29:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-announces-lag-3-blocking-antibody-relatlimab-and-nivolumab 2021-05-20 02:18:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-seagen-announce-updated-results-from-two-trials-of-padcev 2021-05-20 02:12:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-announces-fda-acceptance-for-filing-of-nda-for-bxcl501 2021-05-20 02:09:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/island-pharmaceuticals-granted-key-patent-for-isla-101-in-the-united-states 2021-05-20 02:07:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-announces-that-the-third-novel-drug-candidate 2021-05-19 07:00:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-announces-first-patient-dosed-in-china-phase-2-combination-trial 2021-05-19 06:56:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-chopra-foundation-and-mindmed-enter-into-letter-of-intent-to-partner-on-the-future 2021-05-19 06:54:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bd-to-build-new-165-million-manufacturing-facility-in-zaragoza-spain 2021-05-18 05:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sharp-appoints-new-leader-to-its-global-clinical-services-business 2021-05-18 05:20:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmather-announces-fda-approval-of-ketamine-ind-in-the-treatment 2021-05-18 03:33:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liminal-biosciences-enters-into-agreement-with-kedrion-to-divest-its-plasma-collection 2021-05-18 03:30:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zeus-scientific-announces-fda-emergency-use-authorization-approval-for-our-elisa 2021-05-18 03:28:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-the-completion-of-the-quantitative-and-systems-pharmacology 2021-05-17 06:53:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-university-and-oracle-partner-to-speed-identification-of-covid-19-variants 2021-05-17 06:52:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-china-nmpa-has-accepted-biologics-license 2021-05-17 06:51:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/icanomab-announces-novel-il-18-signaling-blocker-ready-for-development 2021-05-17 02:17:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-submits-application-for-additional-indication-of-mirogabalin-in-japan 2021-05-15 03:51:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-envisagenics-announce-collaboration-to-advance-rna-splicing-research 2021-05-15 03:46:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regulus-therapeutics-to-present-at-the-oppenheimer-rare-orphan-disease-summit 2021-05-14 23:47:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascendis-pharma-as-announces-expansion-of-global-clinical-reach-for-transcon-pth-with-filing-of-the-clinical-trial-notification-for-phase-3-clinical-trial-in-adults 2021-05-13 00:15:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-receives-uk-approval-of-orladeyo 2021-05-13 00:12:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-exercise-of-option-to-acquire-the-investigational-drug-tms-007 2021-05-13 00:10:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-ind-approval-in-china-for-a-global-phase-iii-trial-of-selinexor 2021-05-13 00:09:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-to-cerc-002-for-treatment-of-hospitalized-patients 2021-05-12 05:22:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gene-editing-expands-to-new-types-of-immune-cells 2021-05-12 05:21:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-mina-therapeutics-announce-sarna-research-collaboration 2021-05-12 05:05:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navigo-proteins-and-mdimune-enter-into-research-collaboration 2021-05-11 02:43:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-capsigen-announce-collaboration-to-discover-and-develop-novel-aav-capsids-for-targeted 2021-05-10 23:53:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampio-pharmaceuticals-receives-investigational-review-board-approval-for-its-phase-i-long 2021-05-10 23:52:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compugen-announces-expansion-of-research-collaboration-with-johns-hopkins-university 2021-05-10 23:51:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-announces-tezepelumab-biologics-license-application-submitted 2021-05-10 23:49:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bionomics-bnc210-expansion-into-social-anxiety-disorder 2021-05-10 05:27:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-commences-phase-iii-clinical-trial-of-prostate-cancer-therapy 2021-05-10 05:07:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antibe-therapeutics-announces-agreement-to-unify-intellectual-property-ownership 2021-05-10 00:16:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-vir-biotechnology-announce-the-start-of-the-ema-rolling-review-of-vir-7831 2021-05-08 00:11:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-initiate-rolling-submission-of-biologics-license-application 2021-05-08 00:08:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-nmpa-approves-parp-inhibitor-pamiparib-for-patients-with-previously-treated-advanced-ovarian-cancer 2021-05-06 23:58:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-establishes-three-year-collaboration-with-stanford-medicine 2021-05-06 23:55:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptorum-group-enters-into-an-agreement-with-exeltis 2021-05-06 23:54:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-amgens-supplemental-new-drug-application-for-otezla 2021-05-06 00:03:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-benlysta-for-adult-patients-with-active-lupus-nephritis 2021-05-05 23:48:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-tecentriq-approved-by-european-commission-as-first-line-monotherapy-treatment 2021-05-05 23:46:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-announces-fda-filing-acceptance-and-priority-review-for-tibsovo 2021-05-05 23:43:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qsam-biosciences-announces-submission-of-ind-application-for-cyclosam-with-fda 2021-05-05 04:32:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tarsus-pharmaceuticals-announces-fda-acceptance-of-investigational 2021-05-05 04:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/uppthera-and-cominnex-sign-research-collaboration 2021-05-05 04:30:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valisure-and-medly-pharmacy-announce-partnership-to-expand-distribution 2021-05-05 04:28:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-xtandi-enzalutamide-approved-by-european-commission-for-men 2021-05-05 04:26:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scipher-applies-spectra-platform-to-discover-drugs-targeting-autoimmune-patients 2021-05-04 07:05:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-enters-into-research-agreement-with-ucsf 2021-05-04 01:42:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ichnos-sciences-presents-positive-data-from-ongoing-phase-2b-study-of-telazorlimab 2021-05-04 01:33:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galmed-announces-approval-of-ind-application-in-china 2021-05-04 01:28:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-launches-ryaltris-az-nasal-spray 2021-05-03 06:01:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genfit-announces-the-launch-by-labcorp-of-nashnext-a-novel-noninvasive-diagnostic 2021-05-03 05:59:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphastar-pharmaceuticals-receives-fda-approval-for-morphine-sulfate-injection 2021-05-03 05:57:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rousselot-reinforces-its-application-sciences-leadership 2021-05-03 05:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dishman-carbogen-amcis-announces-that-its-subsidiary-carbogen-amcis-ag-has-entered-into-a-co-investment-agreement 2021-05-03 01:43:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilex-biolabs-and-b2s-life-sciences-on-immunoassay-bioanalysis-for-clinical-trials 2021-05-03 01:41:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veolia-to-address-pharma-industrys-agility-continuity-needs 2021-05-03 01:39:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-expands-patent-portfolio 2021-05-02 23:31:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-receives-european-commission-approval-of-orladeyo 2021-05-01 00:42:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hikma-announces-us-fda-approval-of-kloxxado 2021-05-01 00:40:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mereo-biopharma-and-cancer-focus-fund-announce-partnership-for-phase 2021-05-01 00:39:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/farxiga-approved-in-the-us-for-the-treatment-of-chronic-kidney-disease-in-patients 2021-05-01 00:38:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-taps-digital-air-cargo-offering-forwarders-ebookings-on-webcargo 2021-04-30 23:43:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hikma-announces-us-fda-approval-of-kloxxado-tm-naloxone-hydrochloride-nasal-spray-8mg 2021-04-30 06:51:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atea-pharmaceuticals-announces-first-patient-dosed-in-global-phase-3-morningsky-trial-of-at-527-for-treatment-of-covid-19 2021-04-30 06:48:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/core-one-labs-reaches-definitive-agreement-to-acquire-akome-biotech 2021-04-30 06:47:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-the-launch-of-the-first-generic-version-of-absorica-isotretinoin-capsules-for-the-treatment-of-severe-recalcitrant-nodular-acne 2021-04-30 06:32:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/melinta-therapeutics-and-hikma-sign-exclusive-licensing-agreement-for-two-novel-anti-infectives-for-the-middle-east-and-north-africa-region 2021-04-29 22:44:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adcendo-raises-eur-51-million-in-series-a-financing-to-advance-novel-antibody-drug-conjugates-for-treatment-of-cancers 2021-04-29 22:42:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akari-therapeutics-receives-fda-fast-track-designation-for-nomacopan-for-the-treatment-of-bullous-pemphigoid 2021-04-29 01:25:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protalix-biotherapeutics-provides-update-on-complete-response-letter-for-pegunigalsidase-alfa-from-the-fda 2021-04-29 01:28:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-provides-regulatory-update-on-the-supplemental-biologic-license-application-sbla-for-subcutaneous-administration-of-tysabri-natalizumab 2021-04-29 01:14:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-dosed-in-the-phase-2-clinical-trial-of-ibi302-a-first-in-class-ophthalmic-anti-vegf-and-anti-complement-bispecific-fusion-protein 2021-04-29 01:11:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-and-rentschler-biopharma-further-strengthen-their-strategic-alliance 2021-04-29 01:03:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-takes-action-for-failure-to-submit-required-clinical-trial-results-information-to-clinicaltrialsgov 2021-04-28 22:56:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clearpoint-neuro-inc-congratulates-voyager-therapeutics-on-fda-clearance-of-ind-application-for-gene-therapy-candidate-vy-htt01-for-treatment-of-huntingtons-disease 2021-04-28 22:54:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amid-humanitarian-crisis-in-india-merck-announces-voluntary-licensing-agreements-with-five-indian-generics-manufacturers-to-accelerate-and-expand-global-access-to-molnupiravir 2021-04-28 07:11:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/logicbio-therapeutics-announces-research-collaboration-with-daiichi-sankyo 2021-04-28 07:09:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brickell-biotech-completes-patient-enrollment-in-us-phase-3-pivotal-cardigan-i-study-of-sofpironium-bromide-gel-15-for-the-treatment-of-primary-axillary-hyperhidrosis 2021-04-28 07:09:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurofins-transplant-diagnostics-group-receives-new-york-state-clep-approval-for-novel-rejection-biomarker-assays 2021-04-28 07:08:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-files-for-fda-orphan-drug-designation-for-psilocybin-in-traumatic-brain-injury 2021-04-27 22:40:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-receives-fda-clearance-to-proceed-with-phase-2-study-for-sti-3031-an-anti-pd-l1-antibody-for-advanced-urothelial-carcinoma 2021-04-27 22:38:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asher-biotherapeutics-contracts-probiogen-to-develop-and-manufacture-their-lead-candidate 2021-04-27 01:06:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hilco-industrial-acquires-all-machinery-equipment-from-legacy-pharmaceutical-switzerland 2021-04-27 01:02:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-announces-agreement-with-sanofi-for-fillfinish-manufacturing-of-the-moderna-covid-19-vaccine-in-the-us 2021-04-26 23:01:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reata-announces-fda-accepted-for-filing-the-nda-for-bardoxolone-for-the-treatment-of-patients-with-chronic-kidney-disease-caused-by-alport-syndrome 2021-04-26 22:59:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-announces-construction-of-a-new-small-molecule-manufacturing-complex-in-visp 2021-04-26 00:05:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fermenta-biotech-limited-develops-enzymatic-synthesis-of-molnupiravir 2021-04-25 23:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-initiates-phase-2b-study-using-stp705-for-treatment-of-squamous-cell-skin-cancer 2021-04-25 22:27:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-accelerated-approval-for-gsks-jemperli-dostarlimab-gxly-for-women-with-recurrent-or-advanced-dmmr-endometrial-cancer 2021-04-23 01:23:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-fda-approval-for-first-companion-diagnostic-to-identify-endometrial-cancer-patients-eligible-for-immunotherapy 2021-04-23 01:26:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-submits-new-drug-application-in-japan-for-filgotinib-for-the-treatment-of-ulcerative-colitis-with-an-inadequate-response-to-conventional-therapies 2021-04-23 01:05:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vyant-bio-inc-ordaos-bio-and-cellaria-inc-announce-collaboration-to-design-and-qualify-biomarker-specific-small-protein-therapeutics 2021-04-23 01:00:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosplice-licenses-rights-to-lorecivivint-a-novel-phase-3-osteoarthritis-drug-candidate-to-samil-for-the-republic-of-korea 2021-04-23 00:56:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-nda-of-the-novel-anti-pd-1-mab-serplulimab-of-henlius-accepted-by-nmpa-and-proposed-to-be-granted-priority-review 2021-04-23 00:53:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brii-biosciences-via-biotechnology-and-vbi-vaccines-start-phase-2-clinical-trials-to-investigate-combined-therapy 2021-04-22 22:49:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-immunotherapy-for-endometrial-cancer-with-specific-biomarker 2021-04-22 22:27:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rdif-and-minapharm-agree-to-produce-over-40-million-doses-of-the-sputnik-v-vaccine 2021-04-22 04:10:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allogene-therapeutics-announces-fda-regenerative-medicine-advanced-therapy-rmat-designation-granted-to-allo-715 2021-04-22 01:29:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-to-initiate-phase-3a-development-in-obesity-with-oral-semaglutide 2021-04-22 01:22:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valneva-initiates-pivotal-phase-3-clinical-trial-for-its-inactivated-covid-19-vaccine-candidate-using-dynavaxs-cpg-1018-adjuvant 2021-04-22 01:20:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hemoshear-therapeutics-advances-second-novel-drug-target-into-horizon-therapeutics-plc-early-discovery-pipeline-for-gout 2021-04-22 01:14:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharvaris-announces-fda-acceptance-of-ind-application-for-prophylactic-treatment-of-hae-using-phvs416 2021-04-21 22:35:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcenta-received-ind-clearance-from-us-fda-for-initiating-phase-i-clinical-trial 2021-04-20 23:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vincerx-pharma-announces-fda-clearance-of-ind-for-phase-1b-study-of-vip152 2021-04-20 23:57:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-pharmaceuticals-and-crispr-therapeutics-amend-collaboration 2021-04-20 23:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kindred-biosciences-unveils-positive-results-from-its-long-acting-interleukin 2021-04-20 23:52:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclo-therapeutics-to-proceed-with-ind-filing-for-phase-2-trial 2021-04-20 23:51:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-seagen-announce-us-fda-acceptance-of-two-supplemental-biologics-license-applications-for-padcev-enfortumab-vedotin-ejfv-in-locally-advanced-or-metastatic-urothelial-cancer 2021-04-20 01:20:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgens-investigational-targeted-treatment-bemarituzumab-granted-breakthrough-therapy-designation 2021-04-20 01:18:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-announces-submission-of-tyvaso-dpi-new-drug-application-to-fda 2021-04-20 01:16:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prenetics-signs-multi-million-dollar-collaboration-with-oxford-university-for-advanced-molecular-diagnostics 2021-04-20 01:11:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abzena-announces-location-of-new-biologics-gmp-manufacturing-site 2021-04-19 23:51:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-to-supply-the-european-union-with-100-million-additional-doses-of-comirnaty 2021-04-19 22:36:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curis-receives-fda-orphan-drug-designation-for-ca-4948-for-the-treatment-of-aml-and-mds 2021-04-19 22:27:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyndra-therapeutics-presents-promising-phase-2-data-on-once-weekly-oral-risperidone-treatment-lyn-005-in-development-for-schizophrenia 2021-04-19 06:21:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-second-indication-of-sarclisa-isatuximab-for-relapsed-multiple-myeloma 2021-04-19 06:19:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prothena-presents-phase-1-study-results-of-prx004-in-oral-presentation-at-aan-2021 2021-04-19 06:16:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avadel-presents-new-data-from-its-pivotal-rest-on-phase-3-trial-of-ft218-once-nightly-sodium-oxybate-at-the-2021-american-academy-of-neurology-annual-meeting 2021-04-19 06:14:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-initiates-phase-2-study-using-stp705-for-keloid-scar-prevention 2021-04-18 22:18:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-receives-us-clearance-of-proposed-acquisition-of-alexion 2021-04-17 00:57:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-opdivo-nivolumab-in-combination-with-chemotherapy-for-patients-with-advanced-or-metastatic-gastric-cancer 2021-04-17 00:55:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-requests-revocation-of-emergency-use-authorization-for-bamlanivimab-alone-to-complete-transition-to-bamlanivimab-and-etesevimab-together 2021-04-17 00:48:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qilu-pharmaceutical-and-peptron-sign-license-agreement-for-anti-muc1-adc 2021-04-17 00:42:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-successfully-completes-acquisition-of-five-prime-therapeutics 2021-04-16 22:43:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kintor-pharmaceuticals-announced-successful-dosing-of-the-first-batch-of-patients-for-acne-vulgaris-phase-iii-clinical-trial-of-pyrilutamide 2021-04-16 22:21:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-and-immunitas-therapeutics-announce-manufacturing-agreement 2021-04-16 02:55:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-expands-in-the-uk-by-relocating-to-new-facility 2021-04-16 01:53:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-and-veeva-partner-to-accelerate-clinical-trials 2021-04-16 01:35:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-signs-initial-agreement-to-reserve-capacity-and-implement-the-technology-transfer-for-the-production-of-the-active-pharmaceutical-ingredient-for-roches-actemraroactemra 2021-04-16 01:26:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-grows-presence-in-china-with-the-approval-of-tecfidera-dimethyl-fumarate-for-the-treatment-of-relapsing-multiple-sclerosis 2021-04-16 01:18:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alligator-bioscience-and-macrogenics-enter-into-a-research-collaboration-to-develop-a-novel-immunotherapy 2021-04-16 01:14:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-evrysdi-continues-to-improve-motor-function-and-survival-in-babies-with-type-1-spinal-muscular-atrophy-sma 2021-04-15 22:23:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-ridgeback-biotherapeutics-provide-update-on-progress-of-clinical-development-program-for-molnupiravir 2021-04-15 22:15:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-md-anderson-expand-collaboration-to-accelerate-development-of-kras-and-trailr2-compounds-in-lung-cancer 2021-04-15 00:33:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tagrisso-approved-in-china-in-early-lung-cancer 2021-04-15 00:30:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-receives-european-commission-approval-for-opdivo-nivolumab-in-combination-with-cabometyx-cabozantinib-as-first-line-treatment-for-patients 2021-04-15 00:01:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-extends-partnership-with-takeda 2021-04-14 23:56:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/claritas-announces-letter-of-intent-to-acquire-exclusive-worldwide-rights-to-develop-r-107-for-pah 2021-04-14 23:55:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adlai-nortye-announces-first-patient-dosed-in-global-phase-iii-clinical-trial-of-buparlisib-an2025-in-combination-with-paclitaxel 2021-04-14 23:50:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncosec-receives-ce-mark-certification-for-its-commercial-electroporation-device-genpulse-for-the-treatment-of-solid-tumors 2021-04-14 23:49:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleac-announces-us-fda-approval-of-ind-application-for-phase-1-study-of-mlc1501-programme-in-post-traumatic-brain-injury-recovery 2021-04-14 22:24:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atyr-pharma-and-lonza-announce-manufacturing-agreement-for-atyrs-anti-nrp2-antibody-atyr2810 2021-04-14 22:23:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/actimed-therapeutics-and-faraday-pharmaceuticals-announce-license-agreement-for-s-oxprenolol 2021-04-14 00:52:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-and-lundbeck-announce-decision-to-continue-phase-iii-clinical-trial-evaluating-brexpiprazole-for-treatment-of-agitation-in-patients-with-alzheimers-type-dementia 2021-04-14 00:46:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-accelerated-approval-to-trodelvy-for-the-treatment-of-metastatic-urothelial-cancer 2021-04-14 00:44:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-xolair-omalizumab-prefilled-syringe-for-self-injection-across-all-indications 2021-04-14 00:41:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kibow-biotech-announces-fda-approval-of-ind-to-initiate-phase-ii-clinical-trial-of-us-apr2020-to-treat-chronic-kidney-disease-stage-iv 2021-04-14 00:38:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-renews-partnership-with-cielo-to-strengthen-its-talent-acquisition-strategy 2021-04-14 00:21:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-receives-orphan-drug-designation-for-natural-killer-cell-therapy-cynk-001-in-the-treatment-of-malignant-gliomas 2021-04-13 22:27:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vtv-therapeutics-receives-fda-breakthrough-therapy-designation-for-ttp399-for-the-treatment-of-type-1-diabetes 2021-04-13 22:22:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cosmo-announces-fda-approval-of-gi-genius-intelligent-endoscopy-module-its-revolutionary-artificial-intelligence-device-for-lesion-detection-during-colonoscopy 2021-04-12 05:19:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genscript-parkway-laboratories-and-diagnostics-development-dxd-hub-collaborate-to-provide-cpass-sars-cov-2-neutralizing-antibody-testing-service-in-singapore 2021-04-12 05:15:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharmas-phase-23-covid-19-study-of-opaganib-passes-fourth-dsmb-review-with-unanimous-recommendation-to-continue 2021-04-11 22:30:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medolife-rx-announces-positive-pre-clinical-results-showing-up-to-95-percent-cancer-cell-apoptosis-with-introduction-of-lead-cancer-drug-candidate 2021-04-09 03:06:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-initiatesphase-2trial-to-evaluatepexidartinib-in-japanese-patients-with-tgct 2021-04-09 03:15:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-bio-thera-solutions-announce-commercialization-and-license-agreement-for-proposed-biosimilar-currently-in-phase-3 2021-04-09 02:57:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-that-licensing-partner-gilead-sciences-inc-has-received-full-us-fda-approval-of-trodelvy-for-the-treatment-of-previously-treated-unresectable-locally-advanced 2021-04-09 02:51:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-keytruda-pembrolizumab-demonstrated-superior-disease-free-survival-dfs-compared-with-placebo-as-adjuvant-therapy-in-patients-with-renal-cell-carcinoma-rcc-following-surgery 2021-04-09 01:59:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-incyte-announce-results-from-the-phase-3-cov-barrier-study-of-baricitinib-in-hospitalized-covid-19-patients 2021-04-08 22:39:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aprea-therapeutics-receives-fda-orphan-drug-designation-for-eprenetapopt-for-the-treatment-of-acute-myeloid-leukemia-aml 2021-04-08 22:22:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilex-biolabs-buys-leading-biolab-tetraq-as-part-of-apac-expansion-plans 2021-04-08 00:50:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ortho-regenerative-technologies-announces-submission-of-investigational-new-drug-applicationfor-ortho-r 2021-04-07 22:54:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inotiv-inc-announces-partnership-with-phoenixbio-co-ltd-to-expand-discovery-pharmacology-offering 2021-04-07 22:47:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cell-biotech-acquire-a-european-patent-for-anticancer-protein-p8-originated-from-lactobacillus-rhamnosus 2021-04-07 22:42:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gan-lee-receives-ema-orphan-drug-designation-for-phase-i-drug-candidate-glr2007-for-the-treatment-of-glioma 2021-04-07 22:55:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-announces-extension-of-review-of-new-drug-application-of-abrocitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis 2021-04-07 22:34:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioniz-therapeutics-receives-orphan-drug-designation-from-the-european-commission-for-bnz-1-for-treatment-of-cutaneous-t-cell-lymphoma 2021-04-07 22:30:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/even-more-efficient-pipetting-between-different-vessel-formats 2021-04-06 05:14:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-and-bioage-announce-research-progress-in-dna-encoded-library-based-drug-discovery-research-collaboration 2021-04-06 01:09:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invitae-to-acquire-genosity-to-accelerate-access-to-personalized-oncology-testing-worldwide 2021-04-06 01:07:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acadia-pharmaceuticals-receives-complete-response-letter-from-us-fda-for-supplemental-new-drug-application-for-pimavanserin-for-the-treatment-of-hallucinations-and-delusions 2021-04-06 01:05:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-joins-unicef-humanitarian-initiative 2021-04-05 23:30:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-nmpa-approval-of-ind-application-for-atg-019-in-patients-with-advanced-solid-tumors-or-non-hodgkins-lymphoma 2021-04-05 22:33:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-announces-us-fda-accepts-investigational-new-drug-application-for-xb002-in-patients-with-advanced-solid-tumors 2021-04-05 22:22:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-compassionate-special-permit-csp-patient-in-philippines-improved-significantly-35-hours-after-first-injection-of-leronlimab-and-released-3-days-later 2021-04-05 06:10:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ionis-initiates-phase-3-trial-of-novel-antisense-medicine-to-treat-leading-cause-of-juvenile-onset-als 2021-04-05 06:05:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-toa-eiyo-announce-termination-of-distribution-agreement 2021-04-05 06:01:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allarity-therapeutics-submits-premarket-approval-application-to-us-fda-for-drp-companion-diagnostic-for-dovitinib 2021-04-04 22:47:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crystec-launch-new-rd-centre-in-haimen 2021-04-02 23:24:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanoform-and-nacuity-pharmaceuticals-sign-technology-proof-of-concept-poc-agreement-for-two-ophthalmic-drug-candidates 2021-04-01 01:50:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-mabxiences-bevacizumab-for-the-treatment-of-certain-types-of-cancer 2021-04-01 01:47:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-laboratories-acquires-retrogenix 2021-04-01 01:44:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-nmpa-approves-qinlock-ripretinib-for-treatment-of-advanced-gastrointestinal-stromal-tumors-gist 2021-04-01 01:39:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-sarclisa-isatuximab-irfc-in-combination-with-carfilzomib-and-dexamethasone-for-patients-with-relapsed-or-refractory-multiple-myeloma 2021-04-01 01:57:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-discover-connecting-global-pharma-pre-qualifying-partners-ahead-of-in-person-events 2021-03-31 23:27:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affimed-and-nkmax-america-announce-fda-clearance-of-ind-application-to-study-the-combination-of-afm24-an-egfr-targeted-innate-cell-engager 2021-03-31 22:48:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-biontech-announce-positive-topline-results-of-pivotal-covid-19-vaccine-study-in-adolescents 2021-03-31 22:39:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-to-acquire-rodeo-therapeutics-corporation 2021-03-31 01:18:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-abbvies-new-drug-application-for-atogepant-for-the-preventive-treatment-of-migraine 2021-03-31 01:16:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-eu-approval-for-kesimpta-ofatumumab-the-first-and-only-self-administered-targeted-b-cell-therapy-for-adult-patients-with-relapsing-multiple-sclerosis 2021-03-31 01:09:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-receives-positive-eu-chmp-opinion-for-updated-label-of-keytruda-pembrolizumab-to-include-results-of-phase-3-keynote-361-trial-in 2021-03-31 01:05:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-evrysdi-approved-by-european-commission-as-first-and-only-at-home-treatment-for-spinal-muscular-atrophy 2021-03-31 00:58:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-tb-alliance-enter-into-a-new-collaborative-research-agreement-to-identify-lead-compounds-for-the-treatment-of-tuberculosis 2021-03-31 00:54:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-and-abl-bio-receive-us-fda-approval-to-initiate-phase-1-trial-of-bispecific-antibody-tj-cd4babl111-in-patients-with-advanced-or-metastatic-solid-tumors 2021-03-30 22:32:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biom-therapeutics-receives-orphan-drug-status-for-bio017-from-the-us-fda-for-the-treatment-of-angelman-syndrome 2021-03-30 22:30:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celonic-and-curevac-announce-agreement-to-manufacture-curevac-covid-19-vaccine 2021-03-30 06:53:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-announces-launch-of-asia-pacific-rainbow-grant-2021 2021-03-30 01:50:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valeo-pharma-inc-enters-into-an-agreement-forenerzairbreezhalerand-atecturabreezhalerin-canada 2021-03-30 01:11:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kazia-licenses-rights-to-paxalisib-in-greater-china-tosimcere-a-leading-chinesepharmaceutical-company 2021-03-30 00:53:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karyopharm-receives-conditional-marketing-authorization-from-the-european-commission-for-nexpovio-selinexor 2021-03-30 00:34:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurorx-announces-zyesami-aviptadil-rlf-100-met-the-primary-endpoint-of-its-phase-2b3-clinical-trial-and-also-demonstrated-a-meaningful-benefit-in-survival-from-critical-covid-19 2021-03-30 00:27:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-xospata-gilteritinib-meets-overall-survival-endpoint-in-commodore-trial-of-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-with-a-flt3-mutation 2021-03-30 00:25:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-receives-complete-response-letter-from-us-fda-for-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab 2021-03-30 00:20:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-accepts-the-marketing-authorisation-applications 2021-03-30 00:00:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cordenpharma-enters-into-a-technology-alliance-agreement-with-nanos-of-south-korea 2021-03-29 22:45:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-vir-biotechnology-and-gsk-announce-positive-topline-data-from-the-phase-2-blaze-4-trial-evaluating-bamlanivimab-with-vir-7831-in-low-risk-adults-with-covid-19 2021-03-29 22:43:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-institute-launches-new-global-call-collaboration-with-boehringer-ingelheim 2021-03-29 02:49:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/henlius-plans-to-file-the-nda-of-novel-anti-pd-1-mab-hlx10-for-the-treatment-of-msi-h-solid-tumours-the-phase-2-clinical-trial-has-met-the-primary-endpoint 2021-03-29 00:01:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mezzion-announces-re-submission-of-new-drug-application-for-its-orphan-drug-udenafil-to-treat-patients-who-have-undergone-the-fontan-operation-for-single-ventricle-heart-disease 2021-03-28 23:59:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orphazyme-announces-topline-results-from-pivotal-trial-of-arimoclomol-for-inclusion-body-myositis-ibm 2021-03-28 23:42:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/state-of-the-art-clean-rooms-processing-of-cannabis-in-denmark 2021-03-26 06:10:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-reaches-covid-19-milestone-vials-for-1-billion-vaccine-doses-delivered 2021-03-26 06:04:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-cryocube-f570-ult-freezers-now-all-green 2021-03-26 06:01:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isotopia-molecular-imaging-and-molecular-targeting-technologies-have-signed-a-clinical-supply-agreement-for-lu177-nca 2021-03-26 01:18:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sophia-genetics-and-hitachi-announce-collaboration-to-advance-data-driven-precision-medicine 2021-03-26 01:17:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-validates-marketing-authorization-application-for-sacituzumab-govitecan-hziy-for-the-treatment-of-metastatic-triple-negative-breast-cancer 2021-03-26 01:15:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-announces-relativity-047-a-trial-evaluating-anti-lag-3-antibody-relatlimab-and-opdivo-nivolumab-in-patients-with-previously-untreated-metastatic 2021-03-26 01:11:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/111-signs-strategic-cooperation-agreement-with-jianming-pharmaceutical-to-develop-chronic-disease-management-platform 2021-03-25 23:24:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/goliver-therapeutics-to-launch-its-2m-industrial-manufacturing-platform-project-aimed-at-developing-a-liver-biomedicine-from-pluripotent-stem-cells 2021-03-25 23:05:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fishawack-health-expands-with-the-acquisition-of-prma-consulting 2021-03-25 06:42:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-two-new-breakthrough-device-designations-for-nateras-signatera-mrd-test 2021-03-25 00:28:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akebia-therapeutics-announces-approval-for-additional-indication-of-riona-ferric-citrate-hydrate-for-the-treatment-of-iron-deficiency-anemia-in-adult-patients-in-japan 2021-03-25 00:27:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-and-biotia-receive-us-fda-emergency-use-authorization-for-first-hybridization-capture-based-next-generation-sequencing-sars-cov-2-assay 2021-03-25 00:21:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocean-genomics-partners-with-geninus-to-co-develop-rna-based-biomarkers-and-advance-research 2021-03-24 23:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-provides-update-on-fda-phase-3-clinical-trial-for-bucillamine-in-covid-19 2021-03-24 23:44:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-enters-into-agreement-with-nobelpharma-for-manufacturing-process 2021-03-24 22:58:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-mercks-keytruda-pembrolizumab-plus-platinum-and-fluoropyrimidine-based-chemotherapy 2021-03-24 03:04:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-receives-approval-for-vitrakvi-in-japan 2021-03-24 01:59:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breakthrough-immunotherapy-earns-first-regulatory-approval-for-triple-negative-breast-cancer-tnbc 2021-03-24 01:58:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-positive-result-of-phase-iii-study-with-radioligand-therapy-177lu-psma-617-in-patients-with-advanced-prostate-cancer 2021-03-24 01:57:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ge-healthcare-announces-510k-clearance-of-new-3d-surgical-imaging-system-enabling-more-precise-and-efficient-care 2021-03-24 01:53:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellmax-life-and-sebela-pharmaceuticals-enter-strategic-development-and-commercialization-partnership-for-firstsight-blood-test-for-detection-of-colorectal-cancer-and-pre-cancer 2021-03-23 23:50:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-initiates-phase-1-study-of-novel-oral-antiviral-therapeutic-agent-against-sars-cov-2 2021-03-23 23:49:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stelis-concludes-us-195m-series-b-and-series-c-fund-raise 2021-03-23 23:31:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-partners-with-summit-biosciences-to-produce-a-multidose-nasal-spray-presentation-of-its-adcovid-vaccine-candidate 2021-03-23 00:20:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-and-medytox-to-develop-vaccines-against-covid-19-variants 2021-03-22 23:57:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sesen-bio-and-qilu-pharmaceutical-announce-approval-of-ind-application-in-china-for-vicineum 2021-03-22 23:52:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-results-of-pre-ind-meeting-with-fda-on-tnx-601-cr-for-the-treatment-of-major-depressive-disorder 2021-03-22 23:50:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pacira-announces-fda-approval-of-supplemental-new-drug-application-for-exparel-bupivacaine-liposome-injectable-suspension-in-pediatric-patients 2021-03-22 23:49:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pivotal-phase-iii-study-shows-roches-tecentriq-helped-people-with-early-lung-cancer-live-longer-without-their-disease-returning 2021-03-22 23:45:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rdif-and-stelis-biopharma-partner-to-supply-200-million-doses-of-the-sputnik-v-vaccine 2021-03-22 23:36:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eucure-biopharma-announces-groundbreaking-phase-i-results-for-anti-ctla-4-therapy-in-combination-with-anti-pd-1-from-junshi-biosciences 2021-03-22 23:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/laboratories-in-times-of-social-distancing-and-remote-work 2021-03-22 06:45:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-and-bausch-health-join-together-to-commercialize-ryaltris-nasal-spray-in-canada 2021-03-22 06:16:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/israel-and-new-zealand-permit-sale-of-sanotizes-breakthrough-anti-viral-nasal-spray 2021-03-22 06:13:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-initiates-phase-12-clinical-trial-for-mrna-covid-19-vaccine-in-japan 2021-03-22 06:11:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanoform-launches-next-generation-starmap-v20-the-ai-based-drug-candidate-selection-tool-for-cess 2021-03-22 05:57:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xylonix-reveals-new-drug-compound-for-combating-cancer-and-abnormal-macrophages 2021-03-22 04:06:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-begins-construction-of-its-new-injectionresearch-building-at-kawashima-industrial-park-in-japan 2021-03-22 01:46:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-dosing-of-first-patient-in-phase-i-clinical-study-of-its-next-generation-anti-ctla-4-antibody-in-china 2021-03-21 23:22:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-fda-accepts-bristol-myers-squibbs-application-for-mavacamten-in-symptomatic-obstructive-hypertrophic-cardiomyopathy-ohcm-in-patients 2021-03-20 03:16:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/keytruda-pembrolizumab-plus-lenvima-lenvatinib-significantly-improved-progression-free-survival-and-overall-survival-versus-chemotherapy 2021-03-20 03:13:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oramed-forms-a-joint-venture-oravax-medical-inc-for-the-development-of-novel-oral-covid-19-vaccines 2021-03-20 03:05:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-announces-us-fda-approval-of-ponvory-ponesimod-an-oral-treatment-for-adults-with-relapsing-multiple-sclerosis-proven-superior-to-aubagio-teriflunomide 2021-03-20 03:04:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/purple-biotech-announces-initiation-of-phase-1b2-clinical-trial-of-cm24-for-treatment-of-multiple-advanced-cancers 2021-03-19 23:46:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/onk-therapeutics-strengthens-its-cell-therapy-manufacturing-process-with-license-for-ebv-lcl-feeder-cell-line-from-nih-to-enhance-nk-cell-expansion 2021-03-19 00:44:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idera-pharmaceuticals-announces-results-from-illuminate-301-trial-of-tilsotolimod-ipilimumab-in-anti-pd-1-refractory-advanced-melanoma 2021-03-19 00:28:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiniksa-announces-fda-approval-of-arcalyst-rilonacept-for-recurrent-pericarditis 2021-03-19 00:25:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-novo-nordisk-expand-nash-clinical-collaboration 2021-03-19 00:20:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-starts-the-first-phase-3-study-with-a-long-acting-anti-il-5-treatment-for-patients-with-severe-asthma 2021-03-19 00:00:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orgenesis-enters-into-collaboration-agreement-with-mida-to-deploy-ompuls-for-point-of-care-research-and-development-of-promising-cell-and-gene-therapies 2021-03-18 23:59:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ds-biopharma-and-nuvothera-enter-option-and-license-agreement-for-epadilin 2021-03-18 23:57:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precigen-receives-fda-orphan-drug-designation-for-prgn-2012-adenoverse-immunotherapy-in-patients-with-recurrent-respiratory-papillomatosis-rrp 2021-03-18 23:34:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-cellular-dynamics-and-sana-biotechnology-announce-license-agreement 2021-03-18 04:24:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-to-acquire-cmab-and-form-strategic-partnership-with-cbc-group 2021-03-18 04:23:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-expanded-indication-for-mercks-keytruda 2021-03-18 04:21:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-cobas-pure-integrated-solutions-analyser 2021-03-18 04:16:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilex-biolabs-showcases-advanced-immunoassay-and-immunobiology-services 2021-03-18 01:40:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujitsu-embarks-on-joint-research-with-national-cancer-center-japan-to-create 2021-03-18 01:37:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-licenses-glymaxx-technology-to-sanofi 2021-03-17 22:52:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurix-therapeutics-announces-collaboration-for-the-discovery-of-novel-drugs-to-treat-pediatric-cancers 2021-03-17 00:41:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-the-lieber-institute-for-brain-development-to-collaborate-to-develop-centrally-acting-comt-inhibitors-for-treatment-of-neuropsychiatric-disorders 2021-03-17 00:38:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicago-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate 2021-03-17 00:35:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-receives-priority-review-from-fda-for-new-drug-application-for-hif-2a-inhibitor-belzutifan-mk-6482 2021-03-17 00:33:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brain-scientific-announces-collaboration-with-jelikalite-in-new-clinical-trial 2021-03-17 00:31:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brightinsight-and-astrazeneca-collaborate-to-enhance-disease-management 2021-03-17 00:34:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-sars-cov-2-variant-test-to-help-monitor-emerging-coronavirus-mutations 2021-03-17 00:27:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dzne-and-eisai-enter-into-research-collaboration-agreement 2021-03-17 00:01:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemomab-completes-merger-with-anchiano-therapeutics 2021-03-16 23:39:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytocom-receives-fda-clearance-of-ind-for-phase-2-clinical-trial-of-cyto-205-as-treatment-for-covid-19 2021-03-16 23:28:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navigo-proteins-and-eleva-announce-successful-development-of-an-affinity 2021-03-16 03:35:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atyr-pharma-announces-positive-biomarker-data-from-phase-2-clinical-trial-of-atyr1923-demonstrating-anti-inflammatory-effects-in-covid-19-patients 2021-03-16 00:28:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mateon-announces-initiation-of-phase-1b-clinical-trial-on-ot-101il-2-combination-therapy-for-solid-tumors 2021-03-16 00:26:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intec-pharma-and-decoy-biosystems-announce-merger-agreement 2021-03-16 00:24:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-signs-definitive-merger-agreement-with-genmark-diagnostics-inc-to-access-novel-technology-to-test-for-broad-range-of-pathogens-with-one-patient-sample 2021-03-16 00:32:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calliditas-announces-submission-of-new-drug-application-to-us-fda-for-nefecon-in-patients-with-primary-iga-nephropathy 2021-03-16 00:19:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-expands-adcovid-manufacturing-collaboration-with-lonza 2021-03-15 23:18:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-enters-into-a-major-bioproduction-agreement-with-wuxi-biologics-hong-kong-ltd 2021-03-15 22:42:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-receives-fda-breakthrough-therapy-designation-for-bxcl501-for-the-acute-treatment-of-agitation-associated-with-dementia 2021-03-15 22:37:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tilt-biotherapeutics-advances-cancer-immunotherapy-clinical-trial-achieving-primary-end-point-in-the-first-cohort 2021-03-15 06:14:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atossa-therapeutics-announces-final-results-from-phase-1-clinical-study 2021-03-12 02:54:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuvation-bio-granted-orphan-drug-designation-for-nuv-422-for-the-treatment-of-patients-with-malignant-gliomas 2021-03-12 00:31:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alkermes-announces-fda-orphan-drug-designation-for-nemvaleukin-alfa-for-treatment-of-mucosal-melanoma 2021-03-12 00:29:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohavens-nurtec-odt-approved-in-united-arab-emirates-for-acute-treatment-of-migraine 2021-03-12 00:27:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-submits-new-drug-application-for-enfortumab-vedotin-in-japan 2021-03-12 00:21:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-to-spectrum-pharmaceuticals-poziotinib 2021-03-12 00:19:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-announces-its-single-dose-covid-19-vaccine-candidate-received-favorable-opinion-from-chmp 2021-03-11 23:51:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adicet-bio-announces-initiation-of-its-first-in-human-phase-1-trial-of-adi-001-for-the-treatment-of-b-cell-non-hodgkins-lymphoma 2021-03-10 23:08:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/circ-biosciences-announces-orphan-drug-designation-for-treatment-of-retinitis-pigmentosa-rp 2021-03-10 22:57:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegon-presents-versynta-ffp-the-modular-small-batch-solution-for-liquid-pharmaceuticals 2021-03-10 04:02:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-announces-final-approval-of-its-anda-for-everolimus-tablets-generic-for-afinitor 2021-03-09 01:14:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomarin-announces-fda-regenerative-medicine-advanced-therapy-rmat-designation-granted-to-valoctocogene-roxaparvovec-investigational-gene-therapy-for-hemophilia-a 2021-03-09 01:13:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-first-generic-version-of-azopt-brinzolamide-ophthalmic-suspension-1-used-to-treat-high-pressure-inside-the-eye-in-the-united-states 2021-03-09 01:08:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amryt-and-medison-pharma-sign-distribution-agreement-for-myalepta-metreleptin-in-canada 2021-03-09 01:04:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baxter-biopharma-solutions-and-moderna-announce-agreement-for-fillfinish-manufacturing-of-the-moderna-covid-19-vaccine-in-the-us 2021-03-09 01:03:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-introduces-connected-electronic-pipettes 2021-03-08 23:35:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/psivac-and-lonza-enter-a-strategic-agreement 2021-03-08 23:31:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-establishes-office-in-china-to-better-serve-the-needs-of-its-growing-customer-base-worldwide 2021-03-08 23:28:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultragenyx-announces-fda-clearance-of-investigational-new-drug-ind-application-for-ux053-an-mrna-for-the-treatment-of-glycogen-storage-disease-type-iii 2021-03-08 23:07:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-presents-results-from-phase-1-trial-evaluating-investigational-islatravir-subdermal-implant-for-the-prevention-of-hiv-1-infection-at-croi-2021 2021-03-08 23:06:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-announces-supply-agreement-to-provide-13-million-doses-of-covid-19-vaccine-moderna-to-the-philippines 2021-03-07 23:09:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elekta-and-iba-strengthen-partnership-to-help-cancer-centers-integrate-proton-therapy 2021-03-06 01:22:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abclonal-biotechnology-acquires-yurogen-biosystems-to-better-serve-diagnostic-and-pharmaceutical-researchers-worldwide 2021-03-06 01:21:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-yescarta-for-relapsed-or-refractory-follicular-lymphoma-after-two-or-more-lines-of-systemic-therapy 2021-03-06 01:19:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proxalutamide-phase-iii-clinical-trial-for-the-treatment-of-covid-19-patients-approved-by-fda 2021-03-06 01:14:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-actemraroactemra-becomes-the-first-biologic-therapy-approved-by-the-fda-for-slowing-the-rate-of-decline-in-pulmonary-function 2021-03-06 01:13:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sigilon-therapeutics-receives-orphan-drug-designation-for-sig-007-for-the-treatment-of-fabry-disease 2021-03-05 23:31:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptamer-group-extends-collaboration-with-leading-biopharmaceutical-company 2021-03-05 23:06:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-intas-pharmaceuticals-for-commercialization-in-the-united-states 2021-03-05 03:10:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-plans-to-build-a-new-state-of-the-art-gene-therapy-manufacturing-facility-in-research-triangle-park-north-carolina 2021-03-05 03:06:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tirzepatide-achieved-superior-a1c-and-body-weight-reductions-across-all-three-doses-compared-to-injectable-semaglutide-in-adults-with-type-2-diabetes 2021-03-05 03:02:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-completes-acquisition-of-myr-gmbh 2021-03-05 02:55:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-signs-initial-agreement-with-curevac-to-manufacture-covid-19-vaccine-candidate 2021-03-05 02:54:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sharp-appoints-eu-qualified-person 2021-03-05 01:29:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enzyre-announces-strategic-partnership-with-takeda-to-accelerate-development-of-pioneering-diagnostic-technology-platform-for-hemophilia-patients 2021-03-04 23:29:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dicerna-announces-roches-initiation-of-galxc-rnai-candidate-rg6346-in-phase-2-combination-trial-for-treatment-of-chronic-hepatitis-b-virus-infection 2021-03-04 23:20:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/partner-therapeutics-announces-partnership-with-sirs-therapeutics-and-f4-pharma-to-explore-potential-uses-for-fx06-in-biodefense-applications 2021-03-04 01:54:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adma-biologics-expands-global-regulatory-approval-presence-and-announces-fda-approval-to-commence-hepatitis-b-plasma-collections 2021-03-04 01:52:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-and-coherus-biosciences-announce-initiation-of-rolling-submission-of-bla-for-toripalimab-to-the-us-fda-for-the-treatment-of-nasopharyngeal-carcinoma 2021-03-04 01:51:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-secures-global-rights-from-ovid-therapeutics-to-develop-and-commercialize-soticlestat-for-the-treatment-of-children-and-adults-with-dravet-syndrome-and-lennox-gastaut-syndrome 2021-03-04 01:49:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-novel-once-daily-capsuleazstarystm-serdexmethylphenidate-and-dexmethylphenidate 2021-03-04 01:44:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medalliance-receives-fourth-fda-breakthrough-device-designation-for-sirolimus-drug-eluting-balloon-in-treatment-of-de-novo-coronary-lesions 2021-03-04 01:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exithera-pharmaceuticals-announces-fda-acceptance-of-ind-application-for-phase-2-trial-of-ep-7041-for-thrombosis-prevention-in-covid-19-patients 2021-03-03 23:30:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-expands-approval-of-pfizers-lorbrena-as-first-line-treatment-for-alk-positive-metastatic-lung-cancer 2021-03-03 23:29:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-submits-marketing-authorization-application-for-uk-approval-of-orladeyo-an-oral-once-daily-therapy-to-prevent-attacks-in-patients-with-hereditary-angioedema 2021-03-03 03:03:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oyster-point-pharma-announces-fda-acceptance-for-filing-new-drug-application-for-oc-01-varenicline-nasal-spray-for-the-treatment-of-signs-and-symptoms-of-dry-eye-disease 2021-03-03 03:01:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strongbridge-biopharma-plc-announces-submission-of-new-drug-application-for-recorlev-levoketoconazole-for-the-treatment-of-endogenous-cushings-syndrome 2021-03-03 02:59:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipla-gulf-expands-partnership-with-alvotech-for-commercialization-of-biosimilars-in-australia-and-new-zealand 2021-03-03 02:56:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-help-produce-johnson-johnsons-covid-19-vaccine-barda-to-provide-merck-with-funding-to-expand-mercks-manufacturing-capacity-for-covid-19-vaccines-and-medicines 2021-03-03 02:55:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kempharm-announces-fda-approval-of-azstarys-serdexmethylphenidate-and-dexmethylphenidate-capsules-for-oral-use-cii-a-new-once-daily-treatment-for-adhd 2021-03-03 02:54:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyenovia-announces-fda-acceptance-of-the-mydcombi-nda 2021-03-02 23:08:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-receives-fda-clearance-to-start-clinical-trial-of-anti-cd47-antibody-discovered-from-fully-human-g-mab-library-for-treatment-of-multiple-malignancies 2021-03-02 23:06:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kazia-licenses-cantrixil-a-clinical-stage-first-in-class-ovarian-cancer-drug-candidate-to-oasmia-pharmacetical-ab 2021-03-02 01:26:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tissuetech-receives-us-food-and-drug-administration-clearance-to-proceed-with-clinical-study-using-investigational-new-drug-ttbt01 2021-03-02 01:24:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plx-pharma-receives-fda-approval-of-sndas-for-both-vazalore-325-mg-and-81-mg 2021-03-02 01:22:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-and-astrazeneca-announce-strategic-collaboration-to-commercialize-toripalimab-in-china 2021-03-02 01:21:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/riots-under-vacuum-conti-tds-in-practice 2021-03-01 23:45:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-drug-approval-for-in-house-developed-anti-insomnia-drug-dayvigo 2021-03-01 23:35:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flexion-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-fx301-a-novel-formulation-of-a-locally-administered-nav17-inhibitor-for-post-operative-pain 2021-03-01 23:14:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcline-investment-management-acquires-chargepoint-technology 2021-03-01 22:41:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-outside-china-dosed-in-the-phase-clinical-trial 2021-02-28 23:12:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-covid-19-vaccine-authorized-by-us-fda-for-emergency-use 2021-02-28 23:12:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-pandion-therapeutics 2021-02-26 01:18:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tabmelt-granted-patent-rights-in-russia-expanding-vivera-global-licensing 2021-02-26 01:15:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essa-pharma-announces-clinical-collaboration-with-astellasto-evaluate-the-combination-of-epi-7386-and-enzalutamide-forpatients-with-metastatic-castration-resistant-prostate-cancer 2021-02-26 01:13:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-nmpa-approval-of-ind-for-combination-therapy-of-next-gen-anti-ctla-4-antibody-for-treatment-of-nsclc-and-solid-tumors 2021-02-26 01:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/welldoc-and-lilly-collaborate-to-integrate-bluestar-app-capabilities-into-lillys-connected-insulin-solutions 2021-02-26 01:13:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-an-abbvie-company-submits-new-drug-application-for-investigational-agn-190584-for-the-treatment-of-presbyopia 2021-02-26 01:03:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zentalis-pharmaceuticals-and-tempus-announce-strategic-collaboration-to-advance-research-and-development-capabilities 2021-02-25 23:05:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amri-joins-network-of-approved-manufacturers-of-lipid-excipients-for-pfizer-biontech-covid-19-vaccine 2021-02-25 23:03:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/humira-adalimumab-receives-fda-approval-to-treat-pediatric-patients-living-with-moderately-to-severely-active-ulcerative-colitis 2021-02-25 00:21:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertice-launches-thyquidity-levothyroxine-sodium-oral-solution 2021-02-24 23:53:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milestone-scientific-inc-announces-breakthrough-compupulse-system-and-receives-notice-of-allowance-for-us-patent 2021-02-24 23:50:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/locate-bios-chondro3-granted-fda-breakthrough-device-designation 2021-02-24 23:50:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ctsi-oncology-solutions-a-varian-company-to-provide-technology-enabled-services-for-radiation-oncology-at-christus-health 2021-02-24 23:48:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orna-therapeutics-launches-with-over-100m-raised-to-develop-a-new-class-of-fully-engineered-circular-rna-therapies 2021-02-24 22:55:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seven-bridges-selected-by-pfizer-to-support-data-management-solution-for-single-cell-rna-sequencing-data 2021-02-24 22:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elicio-therapeutics-announces-fda-clearance-of-ind-application-for-eli-002-a-therapeutic-vaccine-targeting-mutated-kras-cancers 2021-02-24 01:21:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-endoclot-hemostat-to-manage-gi-bleeding 2021-02-24 01:20:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-nda-for-atg-010-selinexor-granted-priority-review-by-chinas-nmpa 2021-02-24 01:19:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veru-submits-new-drug-application-for-proprietary-tadfin-for-bph 2021-02-24 01:17:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-announces-latest-distributor-partnerships 2021-02-23 22:51:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-bcma-car-t-co-developed-by-iaso-biotherapeutics-and-innovent-was-granted-breakthrough-therapy-designation-by-the-nmpa-for-the-treatment-of-relapsedrefractory-multiple-myeloma 2021-02-23 22:46:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/soleno-therapeutics-announces-collaboration-with-vanderbilt-university-to-discover-and-develop-next-generation-katp-channel-activators-for-the-treatment-of-rare-diseases 2021-02-23 22:41:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmaceutical-packaging-and-manufacturing-trends-to-be-covered-by-pharmap-2021 2021-02-24 06:07:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-libtayo-cemiplimab-rwlc-monotherapy-for-patients-with-first-line-advanced-non-small-cell-lung-cancer-with-pd-l1-expression-of-50 2021-02-23 03:12:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tris-pharma-and-athena-bioscience-announce-exclusive-license-agreement-to-commercialize-near-to-market-long-acting-antihypertensive-product-in-the-us 2021-02-23 01:38:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mhlw-grants-orphan-drug-designation-in-japan-to-novel-fibroblast-growth-factor-fgf-receptor-selective-tyrosine-kinase-inhibitor-e7090 2021-02-23 01:37:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-gsk-initiate-new-phase-2-study-of-their-adjuvanted-recombinant-protein-based-covid-19-vaccine-candidate 2021-02-23 01:34:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-submits-supplemental-new-drug-application-for-otezla-apremilast-for-adults-with-mild-to-moderate-plaque-psoriasis 2021-02-23 01:41:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novalgen-enters-strategic-partnership-with-halix 2021-02-22 23:25:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mhlw-grants-orphan-drug-designation-in-japan-to-novel-fgf-receptor-selective 2021-02-22 23:19:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maxivax-and-minaris-regenerative-medicine-enter-into-manufacturing-partnership 2021-02-22 23:15:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-receives-corporate-philanthropy-award-for-its-efforts-to-realize-human 2021-02-22 23:05:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intra-cellular-therapies-applies-for-fda-approval-of-caplyta-lumateperone-for-the-treatment-of-bipolar-depression 2021-02-22 22:35:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncology-pharma-extends-licensing-agreement-with-nanosmart-pharmaceuticals-inc-for-veterinary-oncology 2021-02-22 22:30:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-and-berry-gene-reached-a-strategic-cooperation-the-two-parties-will-jointly-develop-a-new-portfolio-of-ngs-products 2021-02-21 23:00:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunocores-tebentafusp-granted-breakthrough-therapy-designation-for-unresectable-or-metastatic-uveal-melanoma-from-fda 2021-02-20 00:47:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dynavax-announces-european-commission-marketing-authorization-for-heplisav-b-a-2-dose-adult-hepatitis-b-adjuvanted-vaccine 2021-02-20 00:46:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-announces-acceptance-and-granting-of-priority-review-status-to-its-new-drug-application-nda-for-ruxolitinib-cream-for-the-treatment-of-atopic-dermatitis 2021-02-19 22:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blackfynn-builds-therapeutic-pipeline-with-option-to-a-phase-3-ready-drug-for-parkinsons 2021-02-19 01:09:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-announces-acceptance-by-the-nmpa-of-supplemental-new-drug-application-for-toripalimab-combined-with-chemotherapy-for-the-first-line-treatment 2021-02-19 01:08:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-and-bioelpida-sign-term-sheet-for-clinical-grade-bvx-0918a-bio-production 2021-02-19 01:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mindmed-reaches-agreement-to-acquire-healthmode-a-leading-machine-learning-digital-medicine-company 2021-02-19 01:05:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-announces-positive-topline-results-from-two-phase-3-pivotal-global-trials-of-fezolinetant-for-the-nonhormonal-treatment-of-vasomotor-symptoms-in-postmenopausal-women 2021-02-19 01:02:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurofins-scientific-announces-the-acquisition-of-beacon-discovery-to-significantly-strengthen-its-capabilities-and-expertise-in-drug-discovery 2021-02-18 23:23:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-continues-its-successful-performance-at-the-2021-cmo-leadership-awards 2021-02-18 23:18:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scynexis-announces-licensing-agreement-and-strategic-partnership-with-hansoh-pharma-for-rights-to-ibrexafungerp-in-greater-china 2021-02-18 00:49:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verrica-pharmaceuticals-announces-fda-filing-acceptance-of-resubmitted-new-drug-application-for-vp-102-for-the-treatment-of-molluscum-contagiosum 2021-02-18 00:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-and-the-bill-melinda-gates-foundation-collaborate-to-discover-and-develop-an-accessible-in-vivo-gene-therapy-for-sickle-cell-disease 2021-02-18 00:30:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-initiates-pivotal-phase-2-magnetismm-3-trial-of-bcma-cd3-bispecific-antibody-elranatamab-pf-06863135-in-multiple-myeloma 2021-02-18 00:26:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-announces-us-fda-acceptance-of-supplemental-new-drug-application-for-brukinsa-zanubrutinib-in-waldenstroms-macroglobulinemia 2021-02-17 23:17:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emercell-signs-strategic-partnership-with-onward-therapeutics-for-the-development-of-its-nk-cell-therapy-technology 2021-02-17 23:14:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/almirall-and-mc2-therapeutics-enter-license-collaboration 2021-02-17 03:12:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-launches-posaconazole-delayed-release-tablets 2021-02-17 02:59:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/signature-cord-prime-receives-investigational-new-drug-ind-approval-from-fda-for-phase-1-study-in-patients-with-symptomatic-osteoarthritis-of-the-knee 2021-02-17 00:54:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-sotorasib-priority-review-designation-for-the-treatment-of-patients-with-kras-g12c-mutated-locally-advanced-or-metastatic-non-small-cell-lung-cancer 2021-02-17 00:50:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-completes-submission-of-supplemental-new-drug-application-for-xywav-oral-solution-for-idiopathic-hypersomnia 2021-02-17 00:48:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-entresto-granted-expanded-indication-in-chronic-heart-failure-by-fda 2021-02-17 00:43:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forge-biologics-receives-fda-fast-track-orphan-drug-and-rare-pediatric-disease-designations-for-fbx-101-gene-therapy-for-patients-with-krabbe-disease 2021-02-16 23:06:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-solid-form-services-for-small-molecule-drugs 2021-02-16 23:01:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centrient-pharmaceuticals-to-acquire-astral-steritech-expanding-its-product-portfolio-with-sterile-injectable-antibiotic-finished-dosage-forms 2021-02-16 01:00:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-covid-19-vaccine-authorised-for-emergency-use-by-the-world-health-organization 2021-02-16 00:59:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cortexyme-provides-regulatory-update-on-development-program-for-atuzaginstat-in-alzheimers-disease 2021-02-16 00:29:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gyroscope-therapeutics-announces-positive-interim-data-from-phase-iii-focus-trial-of-investigational-gene-therapy-gt005 2021-02-16 00:24:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/targovax-receives-fast-track-designation-for-oncos-102 2021-02-15 06:45:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nicoxs-us-licensee-eyevance-expands-us-promotion-of-zerviate-in-agreement-with-hikma 2021-02-15 06:38:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/voluntis-announces-issuance-of-european-patent-for-drug-dosing-support-with-its-theraxium-digital-therapeutic-platform 2021-02-15 06:36:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellink-has-entered-into-an-agreement-to-acquire-the-advanced-robotics 2021-02-15 02:57:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-pharmaceuticals-receives-approval-from-the-european-commission-for-ogluo-glucagon-injection-for-the-treatment-of-severe-hypoglycemia-in-adults 2021-02-14 22:34:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medpharm-former-cso-marc-brown-champions-company-innovation-in-new-role 2021-02-12 05:32:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-strengthens-strategic-partnership-with-biontech-on-covid-19-vaccine 2021-02-12 02:49:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-sxt-pharmaceuticals-inc-enters-into-non-binding-loi-to-acquire-jiangsu-renji-pharmaceutical-chain-co-ltd 2021-02-12 01:14:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protalix-biotherapeutics-enters-into-an-exclusive-partnership-with-sarcomed-usa-to-develop-alidornase-alfa-for-the-treatment-of-pulmonary-sarcoidosis-and-related-respiratory-diseases 2021-02-12 01:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-in-class-evkeeza-evinacumab-dgnb-for-patients-with-ultra-rare-inherited-form-of-high-cholesterol 2021-02-12 01:03:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/expanding-car-t-manufacturing-in-australia 2021-02-12 00:53:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-announces-agreement-to-acquire-gsks-cephalosporin-antibiotics-business-reinforcing-its-leading-global-position-in-antibiotics 2021-02-12 00:51:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-develops-neutralizing-antibody-combination-treatment-with-ct-p59-to-address-the-spread-of-covid-19-variants-using-its-antibody-development-platform 2021-02-11 22:37:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-first-fda-clearance-for-urine-sample-type-for-bk-virus-quantitative-test-to-aid-in-the-improvement-of-care-for-transplant-patients 2021-02-11 22:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/targovax-and-papyrus-therapeutics-enter-research-collaboration-to-develop-novel-oncos-viruses-with-receptor-tyrosine-kinase-rtk-inhibitor-functionality 2021-02-11 00:53:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapeutic-solutions-international-acquires-stem-cell-therapy-that-successfully-completed-fda-double-blind-placebo-controlled-efficacy-study-for-lung-disease 2021-02-11 00:51:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astrazeneca-and-idt-biologika-sign-letter-of-intent-to-increase-covid-19-vaccine-manufacturing-in-europe-and-secure-long-term-supply-capacity 2021-02-11 00:49:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-announces-new-zuma-1-cohort-analysis-evaluating-prophylactic-corticosteroid-use-with-yescarta-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma 2021-02-11 00:48:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-caribou-biosciences-announce-collaboration-and-license-agreement-for-car-t-cell-products 2021-02-11 00:45:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcellera-discovered-antibody-bamlanivimab-administered-with-etesevimab-receives-fda-emergency-use-authorization-for-covid-19 2021-02-10 22:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-submits-new-drug-application-to-manufacture-and-market-darvadstrocel-in-japan-for-treatment-of-complex-perianal-fistulas-in-adult-patients-with-crohns-disease 2021-02-10 22:33:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lees-pharmaceutical-announces-its-anti-pd-l1-antibody-socazolimab-licensed-from-sorrento-therapeutics-receives-breakthrough-therapy-designation-in-china-for-the-treatment 2021-02-10 00:08:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-partners-with-mindray-on-clinical-chemistry-analyzers-for-use-with-drugs-of-abuse-immunoassays 2021-02-10 00:06:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-libtayo-cemiplimab-rwlc-as-first-immunotherapy-indicated-for-patients-with-advanced-basal-cell-carcinoma 2021-02-10 00:04:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-ida-foundation-partner-to-expand-access-to-essential-cancer-treatments-in-70-low-and-lower-middle-income-countries 2021-02-09 23:56:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-mcquade-center-for-strategic-research-and-development-and-eikonizo-therapeutics-enter-agreement-to-develop-treatments-for-patients-with-rare-diseases 2021-02-09 22:33:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncology-pharma-renews-licensing-agreement-with-ribera-solutions-llc-for-its-connect2med-clinical-trials-platform 2021-02-09 22:30:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lineage-enters-into-exclusive-agreement-with-neurgain-technologies-to-evaluate-novel-delivery-system-for-opc1-to-treat-spinal-cord-injury 2021-02-09 02:57:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elevar-therapeutics-announces-orphan-drug-designation-for-rivoceranib-apatinib-for-the-treatment-of-adenoid-cystic-carcinoma-acc 2021-02-09 02:48:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/longevity-acquisition-corporation-announces-4d-pharma-clinical-trial-collaboration-and-supply-agreement-for-the-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma 2021-02-09 01:53:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hoth-therapeutics-partners-with-camargo-pharmaceutical-services-for-the-ht-001-ind-a-treatment-for-cancer-patients 2021-02-09 01:48:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adjuvant-treatment-with-opdivo-nivolumab-demonstrates-statistically-significant-and-clinically-meaningful-improvement-in-disease-free-survival 2021-02-09 01:46:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/riots-under-vacuum-association-of-powder-and-liquid 2021-02-09 06:46:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-announces-treatment-with-erleada-apalutamide-significantly-improved-overall-survival-in-patients-with-metastatic-castration-sensitive-prostate-cancer 2021-02-08 23:12:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catapult-therapeutics-receives-fda-clearance-of-investigational-new-drug-ind-application-for-cap-100-an-innovative-first-in-class-humanized-anti-ccr7-antibody 2021-02-08 22:38:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spravato-esketamine-nasal-spray-authorised-in-europe-for-the-rapid-reduction-of-depressive-symptoms-in-a-psychiatric-emergency-for-patients-with-major-depressive-disorder 2021-02-08 06:11:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-device-designation-for-roches-elecsys-growth-differentiation-factor-15-gdf-15-assay-to-help-identify-patients-suitable 2021-02-08 06:05:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-fda-breakthrough-therapy-designations-for-investigational-stamp-inhibitor-asciminib-abl001-in-chronic-myeloid-leukemia 2021-02-08 06:20:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-enters-into-outsourcing-agreement-to-manufactureastrazeneca-covid-19-vaccine-in-japan 2021-02-06 04:06:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-confirms-us-patent-term-extension-for-ibrance-palbociclib-until-march-2027 2021-02-06 04:03:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrions-covid-19-treatment-candidate-receives-korean-mfds-conditional-marketing-authorisation 2021-02-06 04:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-fda-accelerated-approval-of-ukoniq-umbralisib 2021-02-06 04:09:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innocare-announces-approval-of-orelabrutinib-in-combination-with-r-chop-as-first-line-therapy-for-mantle-cell-lymphoma-in-china 2021-02-05 22:25:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forxiga-approved-in-china-for-heart-failure 2021-02-05 01:18:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-xospata-gilteritinib-receives-conditional-approval-by-chinas-national-medical-products-administration-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-flt3-mutation 2021-02-05 01:13:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-announces-submission-of-application-to-the-us-fda-for-emergency-use-authorization-of-its-investigational-single-shot-janssen-covid-19-vaccine-candidate 2021-02-05 01:07:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karyopharm-announces-xpovio-selinexor-receives-regulatory-approval-in-israel-for-the-treatment-of-patients-with-multiple-myeloma-and-diffuse-large-b-cell-lymphoma 2021-02-05 01:05:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diamond-therapeutics-signs-agreement-with-mcgill-university-for-research-on-low-dose-lsd 2021-02-05 00:50:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/petros-pharmaceuticals-establishes-steering-committee-to-expand-into-non-rx-status-for-stendra-avanafil 2021-02-04 22:43:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthetic-bryostatin-available-to-expand-neurodegenerative-indication-trials 2021-02-04 22:39:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lodige-named-top-10-pharma-tech-solution-provider-in-europe 2021-02-04 06:17:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-receives-approval-for-nubeqa-in-china-for-the-treatment-of-men-with-non-metastatic-castration-resistant-prostate-cancer-nmcrpc 2021-02-04 02:48:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-the-rockefeller-university-announce-license-agreement-for-sars-cov-2-neutralizing-monoclonal-antibody-combination-for-the-treatment-of-covid-19 2021-02-04 01:56:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-curevac-to-develop-next-generation-mrna-covid-19-vaccines 2021-02-04 01:52:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-announces-fda-approval-of-supplemental-new-drug-application-for-rapivab-expanding-patient-population-to-include-children-six-months-and-older 2021-02-04 02:50:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-tepmetko-as-the-first-and-only-once-daily-oral-met-inhibitor-for-patients-with-metastatic-nsclc-with-metex14-skipping-alterations 2021-02-04 01:42:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asana-biosciences-gusacitinib-granted-fda-fast-track-designation-for-moderate-to-severe-chronic-hand-eczema 2021-02-03 22:22:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eucure-biopharma-announces-encouraging-antitumor-activity-of-its-anti-cd40-antibody-in-refractory-pd-1-ocular-melanoma 2021-02-03 22:21:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mynd-life-sciences-inc-announces-collaborative-research-agreement-with-the-university-of-british-columbia-on-major-depressive-disorder 2021-02-03 06:17:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medexus-pharmaceuticals-and-medac-gmbh-enter-into-a-license-agreement-for-first-in-class-conditioning-agent 2021-02-03 06:06:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-to-purchase-bristol-myers-squibb-manufacturing-facility-in-couvet 2021-02-03 05:52:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-lilly-jointly-announce-the-approval-of-tyvyt-sintilimab-injection-by-china-nmpa 2021-02-03 05:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegon-validates-first-ai-equipped-visual-inspection-system-in-production-line 2021-02-02 23:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocugen-and-bharat-biotech-announce-execution-of-definitive-agreement-for-the-commercialization-of-covaxin-in-the-us-market 2021-02-02 22:30:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-positive-assessment-of-dsmb-futility-for-phase-23-study-of-opaganib-for-covid-19 2021-02-02 22:28:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-syringe-label-with-first-opening-indication-from-schreiner-medipharm 2021-02-02 03:56:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scenic-biotech-appoints-dr-philippe-dro-as-independent-chairman 2021-02-02 03:23:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-and-probiogen-agree-on-a-glymaxx-license-to-fast-track-cell 2021-02-02 02:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-announces-fda-approval-of-plegridy-peginterferon-beta-1a-intramuscular-administration-for-multiple-sclerosis 2021-02-02 00:34:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-partners-with-area-health-systems-to-help-enable-access-to-important-antibody-infusion-therapies-for-covid-19-patients 2021-02-02 00:31:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-application-for-zeposia-ozanimod-for-the-treatment-of-ulcerative-colitis-accepted-for-filing-with-priority-review-by-us-food-and-drug-administration 2021-02-02 00:29:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-the-upcoming-launch-of-the-sars-cov-2-rapid-antigen-test-nasal-allowing-for-patient-self-collection 2021-02-02 00:24:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recipharm-and-medspray-launch-resyca-joint-venture 2021-02-01 23:05:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curevac-and-rentschler-biopharma-ramp-up-manufacturing-of-covid-19-vaccine-cvncov 2021-02-01 23:02:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-and-dynavax-announce-planned-global-phase-23-efficacy-trial-of-adjuvanted-covid-19-vaccine-candidate 2021-02-02 02:53:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iterum-therapeutics-announces-collaboration-with-eversana-to-support-oral-sulopenem-launch 2021-02-01 22:35:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-completes-sale-of-tachosil-to-corza-health 2021-02-01 06:26:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coherus-biosciences-to-expand-late-stage-pipeline-to-immuno-oncology-with-in-license-of-junshi-biosciences-pd-1-toripalimab-in-united-states-and-canada 2021-02-01 06:22:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-receives-approval-in-the-uk-for-xarelto-rivaroxaban-to-treat-children-with-venous-thromboembolism-vte-and-to-prevent-vte-recurrence 2021-02-01 06:15:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-to-explore-structure-based-drug-discovery-sbdd-approaches-to-ion-channels-through-strategic-technology-collaboration-with-metrion-biosciences 2021-02-01 06:12:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zogenixs-fintepla-fenfluramine-oral-solution-now-available-in-germany-for-the-treatment-of-seizures-in-dravet-syndrome 2021-02-01 06:10:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-launch-parkinsons-disease-treatment-equfina-in-south-korea 2021-01-31 22:54:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-announces-breakthrough-therapy-designation-granted-for-sotorasib-in-china 2021-01-29 22:23:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ose-immunotherapeutics-expands-its-collaboration-with-mabsilico 2021-01-29 03:23:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-fda-clearance-of-investigational-new-drug-application-for-vx-880 2021-01-29 03:17:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omniseq-and-upmc-collaborate-to-launch-novel-phase-ii-prospective-head-and-neck-cancer-clinical-study 2021-01-29 03:15:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-presents-positive-results-for-mobocertinib-in-patients 2021-01-29 03:10:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-announces-fda-accepts-biologics-license-application 2021-01-28 22:53:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/almirall-and-happify-health-enter-into-strategic-partnership-to-develop 2021-01-28 22:52:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanz-pharma-corp-limited-announces-agreement-of-terms-to-be-acquired-by-nordic-capital 2021-01-27 23:53:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-the-acceptance-of-atg-010-selinexor-nda-by-the-nmpa-for-the-treatment-of-rrmm 2021-01-27 23:47:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/q-biomeds-uttroside-b-receives-us-fda-orphan-drug-designation-in-the-treatment-of-liver-cancer 2021-01-27 23:48:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-vir-biotechnology-and-gsk-announce-first-patient-dosed-in-expanded-blaze-4-trial-evaluating-bamlanivimab-ly-cov555-with-vir-7831-gsk4182136-for-covid-19 2021-01-27 23:48:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioarctic-receives-european-patent-for-new-antibodies-targeting-alzheimers-disease 2021-01-27 23:40:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nrichdx-launches-revolution-sample-prep-semi-automated-workflow 2021-01-27 23:40:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zymeworks-advances-her2-bispecific-antibody-drug-conjugate-zw49-into-expansion-cohort-stage-of-clinical-development 2021-01-27 22:23:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shimadzu-changi-general-hospital-jointly-launch-centre-to-conduct-mass-spectrometry 2021-01-27 23:52:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-science-prize-for-neurobiology-2021 2021-01-27 06:08:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symbicort-turbuhaler-approved-in-china-as-an-anti-inflammatory-reliever-in-mild-asthma 2021-01-27 01:37:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiragtx-announces-aav-cnga3-granted-fast-track-designation-by-us-fda-for-treatment-of-achromatopsia-or-mismatch-repair-deficient-dmmr-colorectal-cancer 2021-01-27 01:32:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-keytruda-pembrolizumab-as-first-line-treatment-in-patients-with-metastatic-microsatellite-instability-high-msi-h 2021-01-27 01:57:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-national-oncoventure-and-eutilex-obtains-ind-approval-from-fda 2021-01-27 01:18:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-p-mec-china-gives-a-glimpse-of-the-success-returning-pharma-events 2021-01-26 22:56:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-institute-starts-new-research-project-in-drug-delivery-in-collaboration-with-janssen 2021-01-26 22:45:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-partnership-with-asiana-airlines-announced 2021-01-26 22:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veralox-therapeutics-announces-fda-orphan-drug-designation-for-vlx-1005 2021-01-26 22:37:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orphan-drug-designation-granted-to-rezafungin-in-eu-for-the-treatment-of-invasive-candidiasis 2021-01-26 22:32:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calquence-approved-in-japan-for-the-treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukaemia 2021-01-25 04:40:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quercis-pharma-licenses-key-patents-for-thromboembolism-platform-across-cancer-and-covid-19-indications 2021-01-25 04:39:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-renews-partnership-with-sysmex-to-deliver-haematology-testing-solutions 2021-01-25 04:38:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-bavencio-avelumab-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma 2021-01-25 04:36:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-toripalimab-fast-track-designation-for-mucosal-melanoma 2021-01-24 22:23:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-announces-us-fda-approval-of-cabenuva-rilpivirine-and-cabotegravir-the-first-long-acting-regimen-for-the-treatment-of-hiv 2021-01-22 01:30:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menarini-receives-european-commission-approval-of-elzonris-tagraxofusp-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn 2021-01-22 01:30:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fluidigm-receives-ce-ivd-mark-for-its-saliva-based-advanta-dx-sars-cov-2-rt-pcr-assay-for-covid-19 2021-01-22 01:30:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-licenses-glymaxx-technology-to-abbvie 2021-01-21 23:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultragenyx-announces-fda-clearance-of-investigational-new-drug-ind-application-for-ux701-a-new-gene-therapy-for-the-treatment-of-wilson-disease 2021-01-21 22:40:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/providegx-partners-with-pfizer-inc-to-secure-the-supply-of-five-essential-medications 2021-01-21 22:38:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-approved-in-the-eu-for-the-treatment-of-her2-positive-metastatic-breast-cancer 2021-01-21 03:48:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-announces-us-food-drug-administration-acceptance-of-new-drug-application-for-inp104-for-the-acute-treatment-of-migraine 2021-01-21 03:32:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-vericiguat-for-patients-with-symptomatic-chronic-heart-failure 2021-01-21 03:30:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/approval-based-on-destiny-breast01-phase-ii-trial-which-showed-clinically-meaningful-and-durable-responses-in-patients-with-previously-treated-disease 2021-01-21 03:28:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-for-priority-review-application-for-opdivo-nivolumab-combined-with-chemotherapy-as-first-line-treatment-in-metastatic-gastric-cancer 2021-01-21 03:46:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-us-fda-approval-of-verquvo-vericiguat 2021-01-21 03:23:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-reports-50-y-o-y-rise-in-pharma-shipments 2021-01-21 00:26:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-announces-us-food-drug-administration-acceptance 2021-01-20 23:52:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biologics-license-application-for-narsoplimab-in-hsct-tma-accepted-for-priority-review-by-us-fda 2021-01-20 22:48:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jemincare-initiates-phase-i-clinical-trial-of-anti-sars-cov-2-neutralizing-antibody-jmb2002 2021-01-20 22:30:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-to-acquire-point-of-care-molecular-diagnostics-provider-mesa-biotech 2021-01-20 03:20:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytosorbents-announces-approval-of-cytosorb-in-korea-in-collaboration-with-partner-fresenius-medical-care 2021-01-20 03:10:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ppmd-invests-1-million-in-satellos-bioscience-to-support-new-regenerative-medicine-technology 2021-01-20 03:06:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gracell-biotechnologies-receives-ind-approval-from-china-nmpa-for-gc019f-a-fastcar-enabled-car-t-therapy-for-the-treatment-of-relapsed-or-refractory-adult-b-all 2021-01-20 02:59:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-and-gsk-announce-collaboration-to-support-scientific-research-into-genetic-diversity-in-africa 2021-01-20 02:54:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c4-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-cft7455-an-orally-bioavailable-monodac-for-hematologic-malignancies 2021-01-19 22:40:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incarda-therapeutics-announces-enrollment-of-first-us-patient-in-phase-2-instant-trial-of-inrhythm-for-treatment-of-atrial-fibrillation 2021-01-19 22:39:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-begins-clinical-trial-of-a-new-treatment-that-would-provide-immediate-immunity-against-covid-19 2021-01-19 01:29:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-an-out-license-agreement-with-pt-etana-biotechnologies-indonesia-to-launch-byvasda-bevacizumab-biosimilar-in-indonesia 2021-01-19 01:28:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hanmi-pharmaceutical-expects-us-fda-approval-for-2-new-drugs 2021-01-19 01:27:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lipidor-and-cannassure-enter-exclusive-licensing-agreement-regarding-topical-medical-cannabis-products-based-on-lipidors-akvano-technology 2021-01-19 01:25:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-amended-agreement-with-spero-therapeutics 2021-01-19 01:24:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-announces-first-patient-dosed-in-phase-2a-study-of-stp705-for-treatment-of-cutaneous-basal-cell-carcinoma 2021-01-18 23:19:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tessa-therapeutics-receives-prime-designation-from-european-medicines-agency-for-cd30-car-t-therapy 2021-01-18 23:20:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-announces-that-janssen-has-been-granted-us-fda-approval-for-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-for-patients-with-newly-diagnosed-light-chain-al-amyloidosis 2021-01-15 23:21:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-announces-a-research-collaboration-with-actinium-for-molecular-targeted-radiotherapy 2021-01-15 00:20:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-for-patients-with-chronic-spontaneous-urticaria-csu 2021-01-15 00:19:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-medicine-group-significantly-expands-cell-and-gene-therapy-expertise-with-acquisition-of-project-farma 2021-01-15 00:11:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizers-xalkori-crizotinib-approved-by-fda-for-alk-positive-anaplastic-large-cell-lymphoma-in-children-and-young-adults 2021-01-15 00:10:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-announces-research-collaboration-with-north-carolina-state-university-for-natural-biosynthesis-enzymatic-platform-to-develop-psilocybin 2021-01-14 22:36:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knopp-biosciences-announces-positive-top-line-results-from-the-phase-2-exhale-trial-of-oral-dexpramipexole-in-moderate-to-severe-eosinophilic-asthma 2021-01-14 22:28:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-2021-postponed-from-april-to-october 2021-01-13 05:26:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-aesthetics-enters-into-option-to-acquire-cypris-medical 2021-01-13 00:25:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/la-jolla-pharmaceutical-company-announces-exclusive-licensing-agreement-for-giaprezatm-angiotensin-ii-and-xeravatm-eravacycline-in-europe 2021-01-13 00:24:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-vir-biotechnology-establish-clinical-collaboration-to-explore-combination-strategies-for-functional-cure-for-chronic-hepatitis-b-virus 2021-01-13 00:21:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/timber-pharmaceuticals-receives-orphan-drug-designation-from-us-fda-for-tmb-003-for-the-treatment-of-systemic-sclerosis 2021-01-13 00:16:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-invests-120-million-in-biotechnology-innovation-through-the-pfizer-breakthrough-growth-initiative 2021-01-12 22:43:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-announces-us-fda-accepts-new-drug-application-and-grants-priority-review-for-investigational-drug-finerenone-for-patients-with-chronic-kidney-disease-and-type-2-diabetes 2021-01-12 22:42:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-accepts-supplemental-new-drug-application-for-jardiance-empagliflozin-for-adults-with-heart-failure-with-reduced-ejection-fraction 2021-01-12 01:24:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytokinetics-granted-orphan-drug-designation-for-ck-3773274-for-the-treatment-of-hypertrophic-cardiomyopathy 2021-01-12 01:10:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivir-enters-into-exclusive-licensing-agreement-with-igm-biosciences-for-birinapant 2021-01-12 01:04:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quantum-computing-boehringer-ingelheim-and-google-partner-for-pharma-rd 2021-01-12 01:03:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/illumina-announces-new-and-expanded-oncology-partnerships-with-bristol-myers-squibb-kura-oncology-myriad-genetics-and-merck-to-advance-comprehensive-genomic-profiling 2021-01-12 00:58:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/international-freezer-challenge-2021-optimizing-your-cold-storage-practices 2021-01-11 23:54:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cohbar-announces-preclinical-collaboration-with-niaid-to-evaluate-potential-of-cb5064-analogs-for-treatment-of-covid-19-ards 2021-01-11 22:15:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/irisys-awarded-850000-nih-contract-for-the-formulation-of-drinabant-a-drug-in-development-for-treatment-of-acute-cannabinoid-overdose 2021-01-11 22:12:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurorx-relief-and-quantum-leap-announce-the-inclusion-of-zyesami-rlf-100-aviptadil-in-the-i-spy-covid-19-trial 2021-01-11 06:18:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pivotal-phase-iii-clinical-trial-ind-submission-of-the-original-innovative-anticancer-drug-chiauranib 2021-01-11 06:02:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-xofluza-approved-by-the-european-commission-for-the-treatment-of-influenza-the-first-new-influenza-antiviral-for-patients-in-almost-20-years 2021-01-11 05:58:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunodiagnostics-and-vaccine-development-at-viravaxx-ag-gain-momentum 2021-01-11 03:38:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sino-american-crown-division-further-expands-genomics-and-next-generation-sequencing-ngs-capabilities-to-optimize-the-workflow-of-transformation-biomarker-discovery 2021-01-10 22:33:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-doses-first-participant-in-phase-3-study-for-duchenne-muscular-dystrophy-investigational-gene-therapy 2021-01-08 03:19:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nurix-therapeutics-announces-expansion-of-its-strategic-collaboration-with-sanofi-to-develop-novel-targeted-protein-degradation-therapies 2021-01-08 03:17:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-and-medincell-announce-positive-results-for-registration-trial-of-investigational-extended-release-subcutaneous-injectable-risperidone 2021-01-08 03:15:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bluerock-therapeutics-in-collaboration-with-memorial-sloan-kettering-cancer-center-receives-ind-clearance-for-da01-in-parkinsons-disease 2021-01-08 03:05:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/integral-molecular-and-optimeos-partner-to-deliver-long-acting-therapeutic-antibodies-using-nanoparticle-formulation-technology 2021-01-07 22:26:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merus-granted-fda-fast-track-designation-of-zenocutuzumab-for-the-treatment-of-patients-with-neuregulin-1-fusion-cancers 2021-01-07 22:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/farxiga-granted-priority-review-in-the-us-for-the-treatment-of-patients-with-chronic-kidney-disease 2021-01-07 06:57:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-and-oxford-biotherapeutics-establish-cell-therapy-research-collaboration-in-blood-cancers-and-solid-tumors 2021-01-07 06:56:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-to-invest-over-200-billion-yen-2-billion-usd-to-establish-new-large-scale-cell-culture-manufacturing-site-for-biopharmaceuticals-in-the-usa 2021-01-07 06:48:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation-for-ntm-disease 2021-01-07 06:43:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-stas-integrated-cmc-platform-supports-innocare-orelabrutinib-approved-by-nmpa 2021-01-06 23:27:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-announces-closing-of-lactel-absorbable-polymers 2021-01-06 23:25:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intravacc-and-cristal-therapeutics-announce-strategic-collaboration 2021-01-06 23:22:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-receives-approval-for-sulfamethoxazole-and-trimethoprim-oral-suspension-usp 2021-01-06 23:20:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aker-biomarine-collaborates-with-university-of-illinois-chicago 2021-01-06 23:17:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/servier-and-x-chem-announce-drug-discovery-collaboration-in-neurological-diseases 2021-01-06 22:35:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genesis-drug-discovery-and-development-expands-its-presence-in-the-clinical-space-by-acquiring-statking-clinical-services 2021-01-06 22:33:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-for-priority-review-the-new-drug-application-for-mirabegron-for-oral-suspension-and-supplemental-new-drug-application-for-myrbetriq-mirabegron-tablets-in-pediatric-patients 2021-01-06 01:51:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-novel-anti-tigit-tiragolumab-granted-fda-breakthrough-therapy-designation-in-combination-with-tecentriq-for-pd-l1-high-non-small-cell-lung-cancer 2021-01-06 01:46:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inhibrx-announces-phase-1-dose-escalation-results-of-inbrx-106-a-novel-hexavalent-ox40-agonist 2021-01-06 01:43:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sebela-pharmaceuticals-announces-us-launch-of-sutab-tablets-an-alternative-to-liquid-colonoscopy-preparation 2021-01-06 01:41:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aro-biotherapeutics-announces-88-million-series-a-financing-to-advance-development-of-centyrin-targeted-genetic-medicines 2021-01-05 22:23:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentechs-novel-anti-tigit-tiragolumab-granted-fda-breakthrough-therapy-designation-in-combination-with-tecentriq-for-pd-l1-high-non-small-cell-lung-cancer 2021-01-05 22:22:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-receives-fda-allowance-to-proceed-with-phase-2-study-of-arct-021-lunar-cov19-vaccine-candidate-in-the-united-states 2021-01-05 02:16:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-to-invest-40-million-to-establish-a-new-state-of-the-art-viral-vector-and-advanced-therapy-process-development-and-manufacturing-facility 2021-01-05 02:14:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-submission-of-ind-application-in-china-for-a-global-phase-3-trial-of-atg-010-selinexor-in-advanced-or-recurrent-endometrial-cancer 2021-01-05 02:12:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-arx788-fast-track-designation-for-her2-positive-metastatic-breast-cancer 2021-01-05 02:11:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/icon-supports-pfizer-and-biontech-on-the-investigational-covid-19-vaccine-trial 2021-01-04 22:34:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/y-biologics-signed-license-agreement-with-3d-medicines-for-t-cell-bispecific 2021-01-04 22:19:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inovio-and-advaccine-announce-exclusive-partnership-to-commercialize 2021-01-04 22:18:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/generex-and-nugenerex-immuno-oncology-provide-update-on-ii-key-covid-19-vaccine-development-program-and-files-trademark-application-for-the-complete-vaccine 2021-01-03 22:48:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recipharm-and-moderna-finalize-agreement-for-aseptic-drug-product-manufacturing-and-fill-finish-for-supply-to-countries-outside-the-us 2020-12-31 01:17:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centene-completes-acquisition-of-pantherx-rare-pharmacy-pantherx 2020-12-31 01:10:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chi-med-announces-the-nmpa-approval-of-surufatinib-sulanda-in-china-for-non-pancreatic-neuroendocrine-tumors 2020-12-31 01:05:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-begins-multinational-phase-2-clinical-trial-of-heptcelltm-a-novel-immunotherapeutic-for-the-treatment-of-chronic-hepatitis-b 2020-12-31 00:56:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-to-advance-arct-032-an-aerosolized-lunar-mrna-based-therapeutic-as-a-development-candidate-for-cystic-fibrosis-lung-disease 2020-12-30 23:25:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/propanc-biopharma-advances-pop1-joint-research-and-drug-discovery-program-for-projected-us1112b-global-metastatic-cancer-market 2020-12-30 23:23:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-becomes-the-first-company-to-launch-remogliflozin-vildagliptin-fixed-dose-combination-at-an-affordable-price-for-adults-with-type-2-diabetes-in-india 2020-12-30 00:21:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphastar-announces-approval-for-glucagon-for-injection-kit-1mg 2020-12-30 00:18:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clovis-oncology-submits-investigational-new-drug-applications-for-novel-peptide-targeted-radionuclide-fap-2286-for-therapeutic-and-imaging-clinical-trial 2020-12-30 00:16:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyenovia-submits-new-drug-application-to-fda-for-pharmacologic-mydriasis-with-mydcombi-targeting-80-million-patient-encounters-in-the-us-annually 2020-12-30 00:14:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-announces-annamycin-receives-fda-orphan-drug-designation-for-soft-tissue-sarcomas 2020-12-29 23:58:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-announces-agreement-to-acquire-priority-review-voucher 2020-12-29 00:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-received-approval-from-singapore-health-sciences-authority-to-proceed-with-phase-2-study-of-arct-021-lunar-cov19-vaccine-candidate 2020-12-29 00:41:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quanterix-receives-fda-emergency-use-authorization-for-semi-quantitative-antibody-test 2020-12-29 00:27:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-announces-new-drug-submission-for-investigational-triple-combination-medicine-for-the-treatment-of-cystic-fibrosis-has-been-accepted 2020-12-29 00:26:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lorbrena-lorlatinib-snda-in-previously-untreated-alk-positive-lung-cancer-accepted-for-priority-review-by-us-fda 2020-12-28 23:43:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-launches-meloxicam-capsules 2020-12-28 23:41:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-generic-of-drug-used-to-treat-severe-hypoglycemia 2020-12-28 23:29:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elevar-therapeutics-announces-licensing-agreement-with-inceptua-group-for-commercialization-of-apealea-paclitaxel-micellar-in-europe 2020-12-28 01:06:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-subject-dosed-with-gannexs-fxr-agonist-asc42-in-a-us-phase-i-trial 2020-12-27 23:38:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-supply-agreement-with-us-government-for-initial-doses-of-investigational-biological-therapy-for-the-treatment-of-patients-with-severe-and-critical-covid-19 2020-12-24 05:12:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-announces-cnct19-cd19-car-t-receives-china-breakthrough-therapy-designation 2020-12-24 05:04:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compugen-announcesfirst-development-milestone-in-license-agreement-with-astrazeneca-for-the-development-of-bispecific-and-multi-specific-antibody-products 2020-12-24 05:02:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-roche-receives-european-commission-approval-for-phesgo-fixed-dose-combination-of-perjeta-and-herceptin 2020-12-24 05:04:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-roches-phesgo-fixed-dose-combination-of-perjeta-and-herceptin-for-subcutaneous-injection-for-people-with-her2-positive-breast-cancer 2020-12-24 04:41:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/urovant-sciences-announces-us-fda-approval-of-gemtesa-vibegron-75-mg-tablets-for-the-treatment-of-patients-with-overactive-bladder-oab 2020-12-24 04:37:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amryt-granted-orphan-drug-designation-by-the-fda-for-ap103 2020-12-23 23:58:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/senhwa-biosciences-receives-us-fda-study-may-proceed-letter-to-treat-brca2-or-palb2-solid-tumors-with-cx-5461 2020-12-23 23:50:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monopar-announces-issuance-of-us-patent-covering-compositions-of-matter-for-a-novel-family-of-camsirubicin-analogs 2020-12-23 05:30:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kempharm-files-ind-for-kp879-for-the-treatment-of-stimulant-use-disorder 2020-12-23 05:28:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-licenses-amg-634-an-investigational-treatment-for-tuberculosis-and-leprosy-to-medicines-development-for-global-health 2020-12-23 05:27:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-nmpa-granted-new-indication-approvals-for-sulinno-adalimumab-injection 2020-12-23 05:23:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-and-veracyte-announce-precision-oncology-collaboration-in-thyroid-cancer 2020-12-23 05:19:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fibrogen-advances-phase-3-clinical-development-of-pamrevlumab-for-the-treatment-of-idiopathic-pulmonary-fibrosis-with-initiation-of-zephyrus-2 2020-12-22 23:36:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyundai-bioscience-develops-injection-drug-for-potential-treatment-of-severe-cases-of-covid-19 2020-12-22 23:28:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-european-commission-grants-marketing-authorization-for-plegridy-peginterferon-beta-1a-intramuscular-administration 2020-12-22 04:32:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ligand-and-gsk-enter-global-collaboration-and-license-agreement-leveraging-icagens-discovery-technology-to-target-neurological-disorders 2020-12-22 03:21:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-announces-license-agreement-with-merck-co-inc-kenilworth-nj-usa-to-access-compounds-for-potential-development-of-a-novel-class-of-drugs 2020-12-22 03:17:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-sells-a-facility-at-its-wuppertal-site-to-wuxi-biologics 2020-12-22 03:14:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-urthers-innovation-focused-strategy-in-china-with-sale-of-select-non-core-assets-to-hasten-for-322-million-usd 2020-12-22 03:10:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-announces-loi-to-acquire-pharmathers-psilocybin-program 2020-12-21 23:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-conjugation-facility-with-two-additional-manufacturing-suites 2020-12-21 23:33:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-receive-authorization-in-the-european-union-for-covid-19-vaccine 2020-12-21 23:31:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomedion-ag-announces-the-acquisition-of-the-compliance-division-of-arivis-ag 2020-12-21 23:30:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioinvent-and-transgene-receive-cta-approval-for-phase-llla-trial-of-oncolytic-virus-bt-001-in-solid-tumors 2020-12-21 07:33:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autobahn-labs-and-ucsf-announce-strategic-drug-discovery-collaboration 2020-12-21 07:21:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-ind-approval-for-phase-2-clinical-trial-of-innovation-pharmaceuticals-brilacidin-for-treating-covid-19 2020-12-21 07:19:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-reports-positive-data-from-phase-2a-study-of-stp705-for-treatment-of-squamous-cell-skin-cancer 2020-12-21 00:08:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-supplemental-new-drug-application-for-takedas-iclusig-ponatinib-for-adult-patients-with-resistant-or-intolerant-chronic-phase-cml 2020-12-19 03:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karyopharm-announces-fda-approval-of-xpovio-selinexor-as-a-treatment-for-patients-with-multiple-myeloma-after-at-least-one-prior-therapy 2020-12-19 03:35:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-to-begin-pragmatic-study-of-neutralizing-antibody-bamlanivimab-ly-cov555-for-covid-19-in-new-mexico 2020-12-19 03:22:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-ahren-announce-co-led-series-a-investment-in-adrestia-and-multi-project-discovery-collaboration 2020-12-19 01:58:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-takes-additional-action-in-fight-against-covid-19-by-issuing-emergency-use-authorization-for-second-covid-19-vaccine 2020-12-18 23:53:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allovir-announces-fda-clearance-of-investigational-new-drug-application-for-alvr106 2020-12-18 04:39:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-amgens-riabni-rituximab-arrx-a-biosimilar-to-rituxan-rituximab 2020-12-18 04:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-approval-and-launch-of-aminocaproic-acid-tablets 2020-12-18 03:52:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blueprint-medicines-submits-supplemental-new-drug-application-to-fda-for-ayvakit-avapritinib-for-the-treatment-of-advanced-systemic-mastocytosis 2020-12-18 03:46:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/suez-unveils-new-sievers-toc-analyzers-for-online-ultrapure-water-monitoring 2020-12-18 00:11:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vir-biotechnology-and-gsk-announce-start-of-nih-sponsored-activ-3-trial-evaluating-vir-7831-in-hospitalized-adults-with-covid-19 2020-12-17 23:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cns-pharmaceuticals-announces-fda-approval-of-ind-application-for-its-brain-cancer-drug-candidate-berubicin 2020-12-17 23:47:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avadel-pharmaceuticals-announces-submission-of-new-drug-application-for-ft218-to-the-fda 2020-12-17 03:39:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/durect-corporation-announces-dur-928-granted-fda-fast-track-designation-for-treatment-of-alcoholic-hepatitis 2020-12-17 03:32:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-investigational-oral-therapy-iptacopan-lnp023-receives-fda-breakthrough-therapy-designation-for-pnh-and-rare-pediatric-disease-designation-for-c3g 2020-12-17 03:29:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-submits-sotorasib-new-drug-application-to-us-fda-for-advanced-or-metastatic-non-small-cell-lung-cancer-with-kras-g12c-mutation 2020-12-17 03:26:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kites-tecartus-kte-x19-granted-conditional-marketing-authorization-for-the-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma-in-europe 2020-12-17 03:24:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valgenesis-collaborates-with-biocon-biologics-for-digital-validation-across-multiple-sites 2020-12-17 03:07:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-regulation-appoints-new-chairman-and-builds-out-senior-management-team 2020-12-17 02:51:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relaxera-and-cbl-patras-announce-exclusive-agreement-on-manufacturing-and-sales 2020-12-16 23:48:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-launches-school-of-cool-for-customers-and-distributors 2020-12-16 23:45:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lipidor-signs-cooperation-agreement-with-contract-manufacturer-to-offer-licensees-the-opportunity-for-gmp-production 2020-12-16 23:39:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-partner-macrogenics-announces-fda-approval-of-margenza-for-patients-with-pretreated-metastatic-her2-positive-breast-cancer 2020-12-16 23:34:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-cobas-pik3ca-mutation-test-for-patients-with-advanced-or-metastatic-breast-cancer-in-countries-accepting-the-ce-mark 2020-12-16 03:56:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-new-drug-application-for-review-grants-priority-review-for-takedas-tak-721-budesonide-oral-suspension 2020-12-16 03:51:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aurinia-and-lonza-announce-exclusive-agreement-for-dedicated-voclosporin-manufacturing-capacity 2020-12-16 03:42:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/expansion-of-the-domestic-logistics-platform-for-pharmaceuticals 2020-12-16 03:38:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-reports-positive-topline-results-from-second-phase-iii-trial-of-beovu-in-patients-with-diabetic-macular-edema 2020-12-16 03:32:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-galapagos-announce-new-commercialization-and-development-agreement-for-jyseleca-filgotinib 2020-12-16 03:27:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/greenwich-lifesciences-announces-option-agreement-for-pre-clinical-coronavirus-vaccine-candidates 2020-12-15 23:23:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortress-biotech-announces-breakthrough-therapy-designation-for-cutx-101-copper-histidinate-for-the-treatment-of-menkes-disease 2020-12-15 23:17:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/legend-biotech-announces-fda-clearance-of-the-ind-for-lb1901-an-investigational-autologous-anti-cd4-car-t-therapy-for-relapsed-or-refractory-t-cell-lymphoma 2020-12-15 05:10:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/unicycive-therapeutics-acquires-renazorb-lanthanum-dioxycarbonate-from-spectrum-pharmaceuticals-for-the-treatment-of-hyperphosphatemia-in-patients-with-chronic-kidney-disease 2020-12-15 04:41:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-therapeutics-and-overland-pharmaceuticals-announce-formation-of-overland-adct-biopharma 2020-12-15 04:32:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avelas-receives-fda-breakthrough-therapy-designation-for-pegloprastide-avb-620-for-use-during-breast-cancer-surgery 2020-12-15 04:18:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-ocrevus-ocrelizumab-shorter-2-hour-infusion-for-relapsing-and-primary-progressive-multiple-sclerosis 2020-12-15 04:15:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-esperare-foundation-and-pierre-fabre-join-forces-to-develop-and-market-a-pioneering-treatment-for-xlhed 2020-12-15 03:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-announces-final-approval-of-its-anda-for-asenapine-sublingual-tablets-25-and-10mg-strengths-generic-for-saphris 2020-12-15 03:50:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relay-therapeutics-announces-a-worldwide-license-and-collaboration-agreement-with-genentech-for-rly-1971 2020-12-15 03:44:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trastuzumab-deruxtecan-recommended-for-approval-in-the-eu-by-chmp-for-her2-positive-metastatic-breast-cancer 2020-12-15 03:41:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mediwound-continues-global-expansion-with-distribution-agreement-for-nexobrid-in-united-arab-emirates-with-ghassan-aboud-group 2020-12-14 23:47:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eleusis-launches-clinical-development-of-psychedelic-infusion-therapies-for-major-depressive-disorder-and-acquires-kalypso-wellness-centers 2020-12-14 23:29:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gannex-received-us-fda-fast-track-designation-for-its-nash-drug-candidate-asc42an-fxr-agonist 2020-12-13 23:54:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/passage-bio-receives-mhra-clinical-trial-authorization-for-pbgm01 2020-12-11 03:13:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/x4-pharmaceuticals-receives-rare-pediatric-disease-designation 2020-12-11 03:11:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crescendo-biologics-expands-its-ongoing-collaboration-with-takeda 2020-12-11 03:09:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/entera-bio-announces-fda-approval-of-ind-application-for-eb613 2020-12-11 03:07:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-expands-gene-product-line 2020-12-11 00:31:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-to-acquire-labor-dr-merk-kollegen-to-strengthen-its-next-generation-cancer-immunology-program 2020-12-10 07:10:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-partners-with-moderna-to-include-sars-cov-2-antibody-test-in-ongoing-covid-19-vaccine-trials 2020-12-10 06:58:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-enspryng-approved-in-taiwan-as-first-approved-medicine-for-neuromyelitis-optica-spectrum-disorder-nmosd 2020-12-10 06:52:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-receives-fda-orphan-drug-designation-for-treprostinil-for-the-treatment-of-idiopathic-pulmonary-fibrosis 2020-12-10 06:35:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sinovac-announces-product-license-for-23-valent-pneumococcal-polysaccharide-vaccine 2020-12-10 06:32:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-further-expands-global-footprint-for-drug-product-development-and-commercial-manufacturing 2020-12-10 00:00:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultragenyx-announces-orphan-drug-designation-for-ux701-for-the-treatment-of-wilson-disease 2020-12-09 23:44:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptidream-announces-strategic-partnership-and-license-option-agreement-with-amolyt-pharma 2020-12-09 04:58:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/procyon-technologies-llc-and-novo-nordisk-as-to-collaborate-on-the-development-of-a-stem-cell-based-therapy-for-type-1-diabetes 2020-12-09 04:57:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-approval-of-takhzyro-lanadelumab-subcutaneous-injection-in-china-for-the-treatment-of-hereditary-angioedema 2020-12-09 04:54:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-gsks-filing-of-nucala-mepolizumab-for-use-in-chronic-rhinosinusitis-with-nasal-polyps 2020-12-09 04:48:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgens-sotorasib-granted-breakthrough-therapy-designation-for-advanced-or-metastatic-non-small-cell-lung-cancer-patients-with-kras-g12c-mutation 2020-12-09 04:41:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halix-signs-agreement-with-astrazeneca-for-commercial-manufacture-of-covid-19-vaccine 2020-12-08 08:01:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-viatris-announce-termination-of-co-promotion-succession-of-manufacturing-and-marketing-approval-and-transfer-of-distribution-for-celecox-tablets 2020-12-08 06:05:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-collaborates-with-proxygen-to-explore-molecular-glue-degraders-a-novel-approach-to-fight-cancer 2020-12-08 06:00:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-and-novartis-partner-with-karamo-brown-to-support-and-empower-people-living-with-migraine 2020-12-08 05:58:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-reports-positive-clinical-data-for-bcma-cd3-bispecific-antibody-pf-06863135-in-multiple-myeloma 2020-12-08 05:53:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orexo-enters-exclusive-license-and-supply-agreement-with-accord-healthcare-for-zubsolv-in-europe 2020-12-08 05:51:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fermenta-biotech-usa-llc-acquires-52-interest-in-agd-nutrition-llc 2020-12-08 03:57:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kronos-bio-announces-fda-clearance-of-investigational-new-drug-ind-application-for-kb-0742-an-oral-cdk9-inhibitor-targeting-myc-amplified-cancers 2020-12-07 23:55:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocytogen-enters-into-renmab-renlite-license-agreement-with-xencor 2020-12-07 23:46:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kalivir-immunotherapeutics-and-astellas-enter-worldwide-exclusive-licensing-agreement-for-development-and-commercialization-of-vet2-l2-novel-oncolytic-virus 2020-12-07 02:06:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yescarta-shows-positive-results-as-a-first-line-treatment-for-patients-with-high-risk-large-b-cell-lymphoma 2020-12-07 01:10:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sinovac-secures-approximately-500-million-in-funding-for-covid-19-vaccine-development 2020-12-07 00:56:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corvus-presents-new-data-on-its-investigational-itk-inhibitor-cpi-818-at-the-american-society-of-hematology-ash-annual-meeting-exposition 2020-12-07 00:53:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antengene-announces-acceptance-of-ind-application-in-china-for-atg-010-selinexor-in-combination-with-r-gdp-sr-gdp-for-the-treatment-of-rrdlbcl-in-a-global-phase-23-study 2020-12-06 23:25:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phagomed-selected-leading-biotech-in-europe 2020-12-05 04:25:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-unitedhealth-group-partner-on-pragmatic-study-of-neutralizing-antibody-bamlanivimab-ly-cov555-for-covid-19 2020-12-05 04:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-first-data-from-reach3-trial-showing-jakavi-ruxolitinib-significantly-improved-outcomes-in-patients-with-steroid-resistantdependent-chronic-gvhd 2020-12-05 04:02:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-saxenda-for-the-treatment-of-obesity-in-adolescents-aged-12-17 2020-12-05 03:52:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ptc-announces-translarna-approval-in-russia-for-the-treatment-of-duchenne-muscular-dystrophy 2020-12-05 03:38:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-accelerates-clinical-development-of-anti-cd47-monoclonal-antibody-lemzoparlimab-in-the-us-and-china 2020-12-04 23:43:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-to-present-phase-1b2-trial-results-of-tg4001-in-combination-with-avelumab-in-advanced-hpv-positive-cancers-at-esmo-io-2020 2020-12-04 04:58:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-submits-application-to-us-fda-seeking-approval-of-amivantamab-for-the-treatment-of-patients 2020-12-04 04:55:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocryst-announces-fda-approval-of-orladeyo-berotralstat-first-oral-once-daily-therapy-to-prevent-attacks-in-hereditary-angioedema-patients 2020-12-04 04:51:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/engene-receives-fast-track-designation-for-eg-70-for-the-treatment-of-non-muscle-invasive-bladder-cancer 2020-12-04 04:49:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inmed-licenses-midrops-delivery-technology-from-eyecro-for-the-delivery-of-therapeutic-cannabinoids 2020-12-04 05:01:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i2o-therapeutics-receives-strategic-investment-from-colorcon-ventures-and-enters-into-research-collaboration-with-colorcon 2020-12-03 23:48:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/realta-life-sciences-announces-ema-orphan-drug-designation-for-rls-0071-for-the-treatment-of-neonatal-encephalopathy 2020-12-03 23:36:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obiltoxaximab-receives-marketing-authorization-from-european-commission-for-the-treatment-of-inhalation-anthrax 2020-12-03 04:20:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-acquires-rights-to-novel-gene-therapypioneering-treatmentsolutions-forlate-stageage-related-macular-degeneration 2020-12-03 04:18:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-establishes-cell-and-gene-therapy-platform-to-accelerate-pharmaceutical-innovation 2020-12-03 04:12:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bd-to-invest-12-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-four-years 2020-12-03 04:11:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalyst-biosciences-receives-fda-fast-track-designation-for-subcutaneous-marzaa-for-the-treatment-of-episodic-bleeding-in-hemophilia-a-or-b-with-inhibitors 2020-12-02 23:58:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-frontier-medicines-establish-global-partnership-to-discover-and-develop-novel-therapies-and-e3-degraders-against-difficult-to-drug-targets 2020-12-02 23:56:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-and-pfizer-achieve-first-authorization-in-the-world-for-a-vaccine-to-combat-covid-19 2020-12-02 04:26:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-announces-positive-efficacy-and-safety-results-from-phase-3-comet-long-term-trial-and-comet-au-trial-of-axs-05-in-major-depressive-disorder 2020-12-02 04:10:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-and-biohaven-enter-global-collaboration-and-license-agreement-to-advance-novel-small-molecule-cgrp-antagonist-portfolio 2020-12-02 04:14:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casma-therapeutics-and-vipergen-enter-into-drug-discovery-agreement 2020-12-02 03:59:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-announces-fda-approval-of-gavreto-pralsetinib-for-people-with-advanced-or-metastatic-ret-mutant-and-ret-fusion-positive-thyroid-cancers 2020-12-02 03:56:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-launches-malaysia-office-to-strengthen-presence-in-southeast-asia 2020-12-02 03:54:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-xolair-omalizumab-for-adults-with-nasal-polyps 2020-12-02 03:52:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-announces-fda-approves-3-rare-pediatric-disease-designations-for-wp1066 2020-12-02 00:15:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/health-decisions-and-oncobay-clinical-partner-to-provide-specialized-clinical-development-services-in-womens-oncology 2020-12-02 00:14:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-provides-viral-vaccine-platform-program-update 2020-12-01 05:33:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/macrogenics-and-eversana-announce-agreement-to-support-the-potential-launch-and-commercialization-of-margetuximab 2020-12-01 05:11:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prevail-therapeutics-receives-european-commission-orphan-designation-for-pr006-for-the-treatment-of-frontotemporal-dementia 2020-12-01 05:05:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forxiga-approved-in-japan-for-chronic-heart-failure 2020-12-01 05:02:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zymeworks-receives-fda-breakthrough-therapy-designation-for-her2-targeted-bispecific-antibody-zanidatamab-in-patients-with-biliary-tract-cancer 2020-12-01 04:55:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-receives-fda-fast-track-designation-for-investigational-irinotecan-liposome-injection-onivyde-as-a-second-line-monotherapy-treatment-for-small-cell-lung-cancer-sclc 2020-12-01 04:53:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/air-france-klm-martinair-cargo-ready-to-distribute-covid-19-vaccines 2020-12-01 00:32:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luminultra-expands-testing-capacity-including-range-of-covid-19-offerings-with-acquisition-of-source-molecular-corporation 2020-11-30 23:34:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aprea-therapeutics-receives-fda-fast-track-designation-for-eprenetapopt-in-the-treatment-of-tp53-mutant-acute-myeloid-leukemia-aml 2020-11-30 23:33:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foxx-life-sciences-announces-opening-of-new-asia-headquarters-in-india 2020-12-02 00:52:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaccine-nationalism-cdmo-expansion-amr-and-dual-sourcing-predicted-in-2021-according-to-new-cphi-report 2020-11-30 07:49:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-present-latest-data-on-perampanel-at-the-74th-american-epilepsy-society-annual-meeting 2020-11-30 01:12:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-wren-therapeutics-enter-into-research-collaboration-agreement-for-drug-discovery-for-synucleinopathies 2020-11-30 00:10:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/veritas-offers-genome-analysis-to-predict-a-persons-response-to-covid-19 2020-11-29 23:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-receives-approval-of-evrenzo-roxadustat-in-japan-for-the-treatment-of-anemia-of-chronic-kidney-disease-in-adult-patients-not-on-dialysis 2020-11-27 08:09:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protalix-biotherapeutics-and-chiesi-global-rare-diseases-announce-extension-of-pdufa-date-for-pegunigalsidase-alfa-for-the-proposed-treatment-of-fabry-disease 2020-11-27 07:57:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breakthrough-in-aml-treatment-goldenbiotech-reports-new-drug-trial-of-antroquinonol-outperforms-listing-drugs-in-relapsed-acute-myeloid-leukemia 2020-11-27 07:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-fda-approval-of-imcivree-setmelanotide-as-first-ever-therapy-for-chronic-weight-management-in-patients-with-obesity-due-to-pomc-pcsk1-or-lepr-deficiency 2020-11-27 07:53:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-smartblock-for-cell-thawing-reproducible-and-reliable-process 2020-11-27 07:09:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sal-unveils-new-pharma-and-perishable-facilities-in-riyadh 2020-11-27 01:41:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/postera-and-neurolucent-collaborate-on-identifying-small-molecule-therapeutics-for-alzheimers-disease 2020-11-26 06:22:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polaryx-therapeutics-receives-both-rare-pediatric-disease 2020-11-25 05:13:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhovacs-prostate-cancer-drug-candidate-rv001 2020-11-25 05:11:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-receives-european-commission-approval 2020-11-25 05:10:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lokelma-label-update-approved-in-china 2020-11-25 05:05:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-fda-approval-of-xofluza-for-the-prevention-of-influenza-following-contact-with-an-infected-person 2020-11-25 05:01:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-and-fosun-pharma-announce-the-start-of-phase-clinical-trial 2020-11-25 04:58:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiniksa-announces-us-fda-acceptance-of-sbla-and-priority-review-for-rilonacept-in-recurrent-pericarditis 2020-11-24 04:56:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-doses-first-participant-in-phase-3-study-evaluating-anti-tfpi-investigational-therapy-marstacimab-for-people-with-severe-hemophilia-a-and-b-with-or-without-inhibitors 2020-11-24 04:35:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-submits-applications-for-licensure-of-v114-the-companys-investigational-15-valent-pneumococcal-conjugate-vaccine-for-use-in-adults 2020-11-24 04:33:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-oncoimmune 2020-11-24 04:31:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-starts-phase-3-study-of-rsv-maternal-candidate-vaccine 2020-11-24 04:30:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-menquadfi-the-latest-innovation-in-meningococcal-menacwy-vaccination-for-individuals-12-months-of-age-and-older 2020-11-24 04:28:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viatris-inc-announces-fda-tentative-approval-of-a-pediatric-formulation-of-dolutegravir-dtg-under-pepfar 2020-11-24 04:23:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-drug-to-treat-rare-metabolic-disorder 2020-11-24 04:22:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-expands-approval-of-influenza-treatment-to-post-exposure-prevention 2020-11-24 04:20:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ab201-development-as-a-potential-treatment-for-covid-19-receives-us-fda-fast-track-designation 2020-11-24 04:07:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytodyn-announces-partnership-with-amfar-to-accelerate-hiv-cure-research 2020-11-24 04:03:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/panaxia-and-neuraxpharm-expand-strategic-collaboration-to-france-with-medical-cannabis 2020-11-23 23:42:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isd-immunotech-a-novo-seeds-portfolio-company-enters-strategic-research-collaboration-for-the-development-of-a-novel-lupus-treatment 2020-11-23 23:38:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pierre-fabre-and-y-biologics-are-jointly-researching-new-immunotherapies-based-on-monoclonal-antibodies 2020-11-23 07:56:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-receives-approvals-for-two-phase-ibii-clinical-studies-of-the-bcl-2-inhibitor-apg-2575 2020-11-23 07:53:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telstar-consolidates-a-new-high-standard-process-rd-laboratory-service-in-china 2020-11-23 06:51:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azd1222-vaccine-met-primary-efficacy-endpoint-in-preventing-covid-19 2020-11-23 03:31:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-for-treatment-of-covid-19 2020-11-23 03:30:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-ever-treatment-for-rare-rapid-aging-disease-progeria-receives-us-fda-approval 2020-11-23 03:29:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenerons-regen-cov2-is-first-antibody-cocktail-for-covid-19-to-receive-fda-emergency-use-authorization 2020-11-23 03:27:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glycostem-initiates-phase-iiia-pivotal-trial-to-evaluate-the-safety-and-efficacy-of-onkord-in-patients-with-acute-myeloid-leukemia-aml 2020-11-22 23:50:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcellera-discovered-antibody-granted-interim-authorization-by-health-canada-as-a-treatment-for-covid-19 2020-11-20 23:15:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-fda-clearance-of-ind-application-for-otl-200-for-metachromatic-leukodystrophy-mld 2020-11-20 07:58:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cue-biopharma-extends-research-collaboration-for-the-development-of-immuno-stat-biologics-for-the-treatment-of-defined-autoimmune-diseases-with-merck 2020-11-20 07:56:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-scientific-tundra-cryo-tem-democratizes-cryo-electron-microscopy-extends-to-users-of-any-experience-level 2020-11-20 07:54:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jardiance-reduced-the-risk-of-first-plus-recurrent-cardiovascular-events-in-adults-with-type-2-diabetes-and-established-cardiovascular-disease 2020-11-20 07:51:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-ypsomed-collaborate-to-advance-an-automated-insulin-delivery-system-for-people-with-diabetes 2020-11-20 07:38:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baricitinib-receives-emergency-use-authorization-from-the-fda-for-the-treatment-of-hospitalized-patients-with-covid-19 2020-11-20 07:36:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/results-from-phase-3-crown-trial-of-pfizers-lorbrena-lorlatinib-in-previously-untreated-alk-positive-lung-cancer 2020-11-20 07:22:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-mmv-present-positive-data-on-treatment-for-plasmodium-vivax-malaria-in-children-from-6-months-up-to-15-years-of-age 2020-11-20 07:14:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-approved-in-the-us-for-less-frequent-fixed-dose-use 2020-11-20 07:11:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vfmcrp-and-fresenius-kabi-expand-collaboration-in-nephrology-in-china-with-veltassa-agreement 2020-11-19 23:43:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/askbio-and-selecta-biosciences-receive-orphan-drug-designation-for-mma-101-to-treat-methylmalonic-acidemia 2020-11-19 23:35:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-carries-covid-19-vaccines-via-its-cross-continental-air-bridge 2020-11-19 03:26:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biontech-and-pfizer-conclude-phase-3-study-of-covid-19-vaccine-candidate 2020-11-19 03:20:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ucbs-vimpat-lacosamide-cv-now-approved-by-fda-for-primary-generalized-tonic-clonic-seizures-and-expanded-pediatric-use-for-people-living-with-epilepsy 2020-11-19 03:20:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-designation-to-4d-path-for-novel-cancer-diagnostic-solution 2020-11-19 03:10:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kempharm-and-corium-to-co-host-kp415-market-opportunity-and-commercialization-strategy-investor-event 2020-11-19 03:08:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jardiance-reduced-the-risk-of-first-plus-recurrent-cardiovascular-events-in-adults-with-type-2-diabetes-and-established-cardiovascular-disease-in-new-analysis 2020-11-19 03:04:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rilzabrutinib-granted-fda-fast-track-designation-for-treatment-of-immune-thrombocytopenia 2020-11-19 02:50:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-for-avalglucosidase-alfa-a-potential-new-therapy-for-pompe-disease 2020-11-19 02:48:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-and-biogen-announce-fda-filing-acceptance-of-sb11-a-proposed-biosimilar-referencing-lucentis-ranibizumab 2020-11-19 02:46:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipla-launches-covi-g-for-covid-19-rapid-antibody-detection 2020-11-19 02:41:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qbiotics-stelfonta-receives-fda-approval-for-canine-mast-cell-tumours 2020-11-19 02:39:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmather-enters-into-research-collaboration-with-revive-therapeutics-for-psilocybin-and-panaceai-psychedelic-discovery-ai-platform 2020-11-18 23:42:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qiagen-collaborates-with-biontech-on-companion-diagnostics-development-for-hpv-associated-squamous-cell-carcinoma-of-the-head-and-neck 2020-11-18 23:35:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/covis-group-completes-acquisition-of-amag-pharmaceuticals 2020-11-18 04:35:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/value-based-agreement-between-prime-therapeutics-and-biohaven-aims-to-bring-nurtec-odt-acute-migraine-treatment-financial-protection-to-health-plans 2020-11-18 04:34:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiniksa-announces-breakthrough-therapy-designation-granted-to-vixarelimab-for-the-treatment-of-pruritus-associated-with-prurigo-nodularis 2020-11-18 04:27:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apellis-announces-fda-acceptance-and-priority-review-of-the-new-drug-application-for-pegcetacoplan-for-the-treatment-of-pnh 2020-11-18 04:06:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medexus-reaches-50-enrollment-in-ixinity-phase-4-clinical-trial-targeting-label-expansion-for-pediatric-hemophilia-b-patients 2020-11-18 04:05:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocuphire-pharma-announces-expansion-of-global-patents-for-nyxol-and-17-million-nih-grants-for-apx3330-program 2020-11-18 04:03:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-advances-phase-3-trial-to-evaluate-investigational-islatravir-as-once-monthly-oral-prep-for-women-at-high-risk-for-acquiring-hiv-1 2020-11-18 04:02:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/late-breaking-data-from-subgroup-analysis-of-phase-iii-fidelio-dkd-study-presented-at-the-american-heart-association-aha-scientific-sessions-2020 2020-11-18 03:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ptc-therapeutics-announces-that-ptc518-has-entered-into-a-phase-1-clinical-trial-for-the-huntingtons-disease-program 2020-11-17 23:42:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-announces-supply-agreement-with-united-kingdom-government-to-supply-mrna-vaccine-against-covid-19-mrna-1273-if-approved-for-use 2020-11-17 23:37:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bone-therapeutics-announces-completion-of-the-acquisition-of-its-cell-therapy-manufacturing-subsidiary-scts-by-catalent 2020-11-16 23:36:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaegis-therapeutics-expands-phase-2-covid-19-treatment-clinical-trial-in-eu-for-inflammation-regulator 2020-11-16 23:35:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chmp-accepted-a-positive-opinion-for-elzonris-tagraxofusp-for-the-treatment-of-blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn 2020-11-16 06:01:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calypso-biotech-announces-successful-dosing-of-first-phase 2020-11-16 05:14:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bone-therapeutics-announces-completion-of-the-acquisition-of-its-cell-therapy-manufacturing-subsidiary-scts-by-catalent 2020-11-16 05:04:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lead-pharma-enters-into-a-research-collaboration-and-license-agreement-with-roche 2020-11-16 02:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/contract-for-innovative-delivery-system-for-covid-19-vaccine 2020-11-16 01:26:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-p-mec-china-2020-adapts-to-customer-needs-with-hybrid-pharma-event 2020-11-15 23:36:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-receives-approval-for-indication-expansion-of-anti-epileptic-agent-fycompa 2020-11-15 23:24:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaegis-therapeutics-expands-phase-2-covid-19-treatment-clinical-trial-in-eu-for-inflammation-regulator 2020-11-15 23:11:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valeo-pharma-announces-amikacin-approval-in-canada-and-us-launch-of-ethacrynate-sodium 2020-11-13 05:15:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wize-pharma-announces-positive-topline-results-in-phase-iv-study-of-lo2a-for-the-treatment-of-dry-eye-syndrome-in-patients-with-sjogrens-syndrome 2020-11-13 05:08:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuronasal-inc-announces-completion-of-pilot-study-receives-ind-clearance-to-continue-into-phase-i-trials-of-mtbi-therapeutic 2020-11-13 05:04:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sumitovant-biopharma-and-urovant-sciences-announce-sumitovants-acquisition-of-remaining-stake-in-urovant 2020-11-13 05:00:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/angelini-pharma-and-sunovion-pharmaceutical-europe-receive-ema-approval-for-latuda-the-first-atypical-antipsychotic-for-the-treatment-of-adolescent-schizophrenia 2020-11-13 04:48:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agios-announces-fda-orphan-drug-designation-granted-to-mitapivat-for-treatment-of-sickle-cell-disease 2020-11-13 04:40:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akers-biosciences-and-mymd-pharmaceuticals-sign-definitive-merger-agreement 2020-11-12 23:57:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicago-and-gsk-announce-phase-23-clinical-trials-begin-on-covid-19-adjuvanted-vaccine-candidate 2020-11-12 23:43:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tcr2-therapeutics-announces-partnership-with-elevatebio-to-expand-tc-210-manufacturing-capacity 2020-11-12 07:48:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/angiocrine-bioscience-announces-fda-regenerative-medicine-advanced-therapy-rmat-designation-granted-to-ab-205-universal-e-cel-cell-therapy 2020-11-12 07:46:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-announces-completion-of-pre-nda-meeting-with-fda-for-bxcl501-for-the-acute-treatment-of-agitation-in-patients-with-schizophrenia-and-bipolar-disorders 2020-11-12 07:41:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/update-on-calavi-phase-ii-trials-for-calquence-in-patients-hospitalised-with-respiratory-symptoms-of-covid-19 2020-11-12 07:39:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzecure-receives-approval-to-start-clinical-phase-i-trial-with-acd856-in-alzheimers-disease 2020-11-12 07:37:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valeo-pharma-announces-amikacin-approval-in-canada-and-us-launch-of-ethacrynate-sodium 2020-11-12 07:32:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellia-therapeutics-receives-grant-to-develop-curative-crisprcas9-in-vivo-sickle-cell-disease-treatments 2020-11-11 23:45:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vapogenix-awarded-15m-phase-ii-sbir-grant-to-develop-groundbreaking-topical-therapy-for-painful-inflammatory-conditions 2020-11-11 23:44:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-announces-positive-antibody-immune-response-results 2020-11-11 06:45:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sebela-pharmaceuticals-receives-fda-approval-for-sutab-tablets-for-colonoscopy-preparation 2020-11-11 06:15:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-provides-regulatory-updates-for-spn-812-and-spn-830 2020-11-11 06:04:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-provides-regulatory-updates-for-spn-812-and-spn-830 2020-11-11 05:45:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-covid-19-vaccine-granted-fast-track-designation-by-us-fda 2020-11-11 05:28:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cpasstm-sars-cov-2-neutralization-antibody-kit-is-the-first-eua-authorized-test-that-detects-neutralizing-antibodies-within-one-hour 2020-11-11 05:24:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-rare-pediatric-disease-designation-to-amo-pharma-for-amo-02-for-treatment-of-congenital-myotonic-dystrophy 2020-11-11 05:21:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tcr2-therapeutics-announces-partnership-with-elevatebio-to-expand-tc-210-manufacturing-capacity 2020-11-10 23:40:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rafael-pharmaceuticals-receives-fda-fast-track-designation-for-cpi-613-devimistat-for-the-treatment-of-pancreatic-cancer 2020-11-10 23:38:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tezepelumab-navigator-phase-iii-trial-met-primary-endpoint-of-a-statistically-significant-and-clinically-meaningful-reduction-in-exacerbations 2020-11-10 06:44:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-submits-marketing-authorization-applications-for-finerenone-in-the-us-and-the-eu-for-patients-with-chronic-kidney-disease-and-type-2-diabetes 2020-11-10 05:25:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-receives-fda-emergency-use-authorization-for-the-treatment-of-recently-diagnosed-covid-19 2020-11-10 05:12:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-presents-late-breaking-phase-2-data-demonstrating-the-safety-and-efficacy-of-deucravacitinib-bms-986165-in-patients-with-psoriatic-arthritis 2020-11-10 05:05:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calquence-approved-in-the-eu-for-the-treatment-of-chronic-lymphocytic-leukaemia 2020-11-10 04:52:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apeiron-biologics-ag-and-domainex-ltd-announce-the-expansion-of-their-partnership 2020-11-10 03:23:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-adds-lonza-as-a-manufacturing-partner-for-supply-of-adcovid 2020-11-10 03:20:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-announce-vaccine-candidate-against-covid-19 2020-11-10 03:14:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-out-licensing-agreement-for-investigational-atacicept-with-vera-therapeutics 2020-11-10 03:11:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/insilico-announces-a-multi-target-ai-powered-drug-discovery-collaboration-with-janssen 2020-11-10 02:07:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-announces-fda-submission-of-new-drug-application-for-inp104-for-the-acute-treatment-of-migraine 2020-11-10 00:04:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-rare-pediatric-disease-designation-to-amo-pharma-for-amo-02-for-treatment-of-congenital-myotonic-dystrophy 2020-11-09 23:15:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taigen-partners-with-gpcr-to-develop-burixafor-taigexyn 2020-11-09 07:32:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synact-pharma-announces-positive-interim-phase-2-data-of-ap1189-in-rheumatoid-arthritis 2020-11-09 07:06:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vifor-pharma-and-angion-sign-license-agreement-for-ang-3777-in-nephrology-indications 2020-11-09 07:04:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novo-nordisk-to-acquire-emisphere-technologies-and-obtain-ownership-of-the-eligen-snac-oral-delivery-technology 2020-11-09 07:01:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-institute-announces-expansion-of-their-strategic-collaboration-with-janssen-in-immunology-research 2020-11-09 07:01:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-receives-european-commission-approval-for-opdivo-nivolumab-plus-yervoy-ipilimumab-with-two-cycles-of-chemotherapy 2020-11-09 06:48:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brilinta-approved-in-the-us-to-reduce-the-risk-of-stroke-in-patients-with-an-acute-ischaemic-stroke-or-high-risk-transient-ischaemic-attack 2020-11-09 06:42:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liminal-biosciences-announces-fda-extension-of-review-period-for-ryplazimplasminogen-bla 2020-11-09 05:14:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ligands-partner-sedor-pharmaceuticals-receives-fda-approval-for-sesquient-for-the-treatment-of-status-epilepticus-in-adult-and-pediatric-patients 2020-11-07 00:27:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jubilant-radiopharma-and-sofie-biosciences-ink-strategic-partnership-deal-to-further-advance-the-field-of-molecular-imaging-therapeutics 2020-11-06 05:35:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atg-pharma-enters-the-european-market 2020-11-06 05:31:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-drug-for-gastrointestinal-stromal-tumours-gist-to-be-launched-in-australia-new-zealand-and-south-east-asia-following-distribution-agreement 2020-11-06 05:18:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynparza-approved-in-the-eu-as-1st-line-maintenance-treatment-with-bevacizumab-for-hrd-positive-advanced-ovarian-cancer 2020-11-06 05:10:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forxiga-approved-in-the-eu-for-heart-failure 2020-11-06 04:55:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-to-acquire-velosbio 2020-11-06 04:52:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-announces-licensing-of-its-2g-unic-technology-platform-for-production-of-biologics-to-gilead-sciences 2020-11-05 23:54:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synthace-and-ipsen-partner-to-accelerate-novel-therapeutic-development-through-automation 2020-11-05 23:34:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-announces-licensing-of-its-unic-technology-platform 2020-11-05 05:35:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imcd-completes-the-acquisition-of-signet-excipients-private-limited 2020-11-05 04:29:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acg-acquires-significant-stake-in-mumbai-based-iqgen-x 2020-11-05 04:27:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/betterlife-pharma-signs-etmf-partner-to-help-accelerate 2020-11-05 04:25:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-cosentyx-shows-early-synovitis-reduction-in-patients-with-psoriatic-arthritis 2020-11-05 04:24:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-myokardia-announce-expiration-of-hsr-act-waiting-period 2020-11-05 00:31:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomx-announces-dosing-of-first-subject-in-phase-study-of-bx002-phage-therapy 2020-11-05 00:29:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-announces-collaboration-with-northeastern-university 2020-11-05 00:21:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzinova-ab-announces-the-study-design-for-the-first-clinical-study 2020-11-05 00:19:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/engene-announces-fda-clearance-of-ind-application-for-eg-70-an-intravesical-dual-immune-modulator-for-the-treatment-of-non-muscle-invasive-bladder-cancer 2020-11-04 01:08:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salvia-bioelectronics-receives-fda-breakthrough-device-designation-for-innovative-neurostimulation-solution 2020-11-04 00:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/food-and-drug-administration-accepts-biomarins-new-drug-application-for-vosoritide-to-treat-children-with-achondroplasia 2020-11-04 00:54:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boston-scientific-receives-fda-approval-for-the-ranger-drug-coated-balloon 2020-11-04 00:51:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chiesi-usa-inc-announces-fda-approval-of-bronchitol-mannitol-inhalation-powder 2020-11-04 00:49:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxford-biodynamics-announces-strategic-partnership-with-boca-biolistics-in-order-to-advance-episwitch-disease-severity-program-for-covid-19 2020-11-04 00:33:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ionis-and-akcea-announce-that-pfizer-has-initiated-a-phase-2b-clinical-study-of-vupanorsen-akcea-angptl3-lrx 2020-11-04 00:31:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-offers-to-acquire-kiadis-for-308-million 2020-11-03 03:07:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biovaxys-files-patent-application-for-novel-covid-19-diagnostic-for-t-cell-immunity 2020-11-03 03:00:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taigen-announces-fda-approval-of-ind-for-its-flu-antiviral-tg-1000 2020-11-03 02:55:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-roches-tecentriq-in-combination-with-avastin-for-the-treatment-of-people-with-the-most-common-form-of-liver-cancer 2020-11-03 02:09:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/automatic-vial-filling-system-integrated-with-containment-lyophilization-processes 2020-11-03 01:55:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gritstone-oncology-advances-into-phase-2-expansion-cohorts-for-its-personalized-neoantigen-immunotherapy-granite-and-its-off-the-shelf-neoantigen-immunotherapy-slate 2020-11-02 23:36:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tempus-announces-strategic-collaboration-with-janssen-applying-data-science-to-enhance-therapeutic-development 2020-11-02 23:34:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-air-cargo-brand-turkish-cargo-chosen-as-the-best-air-cargo-brand 2020-11-02 02:03:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minaris-regenerative-medicine-to-expand-manufacturing-capacity 2020-11-02 01:57:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-announces-agreement-to-manufacture-astrazenecas-covid 2020-11-02 00:03:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/everest-medicines-announces-approval-of-clinical-trial-application-by-china-national-medical-products-administration-for-phase-3-registration-trial-of-trodelvy 2020-11-01 23:59:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genmab-and-adc-therapeutics-announce-expanded-agreement-for-camidanlumab-tesirine-cami 2020-10-30 23:48:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-rafael-pharmaceuticals-orphan-drug-designation-for-cpi-613-devimistat-for-treatment-of-soft-tissue-sarcoma 2020-10-30 06:10:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-for-priority-review-libtayo-cemiplimab-rwlc-for-advanced-non-small-cell-lung-cancer-with-pd-l1-expression-of-50 2020-10-30 06:08:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/somalogic-announces-new-collaboration-with-fda-to-advance-biosimilar-development 2020-10-30 06:03:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-expands-kymriah-manufacturing-footprint-with-first-ever-approved-site-for-commercial-car-t-cell-therapy-manufacturing-in-asia 2020-10-30 05:55:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-fda-approval-for-the-cobas-egfr-mutation-test-v2-as-the-first-companion-diagnostic-test-for-expanded-egfr-tki-therapies-in-patients-with-non-small-cell-lung-cancer 2020-10-30 05:47:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/equillium-receives-fda-clearance-of-covid-19-ind-for-phase-3-trial 2020-10-30 05:32:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-announces-asia-award-win-for-excellence 2020-10-30 00:08:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-extends-collaboration-to-advance 2020-10-30 00:05:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genprex-receives-conditional-fda-acceptance-of-proprietary-name-reqorsa-for-lead-drug-candidate-for-treatment-of-non-small-cell-lung-cancer 2020-10-29 23:54:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-biologics-and-horizon-therapeutics-plc-expand-partnership 2020-10-29 23:52:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-its-capsule-manufacturing-capacity 2020-10-29 06:20:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prevail-therapeutics-receives-us-fda-fast-track-designation-for-pr001-for-the-treatment-of-neuronopathic-gaucher-disease 2020-10-29 05:39:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/passage-bios-pbkr03-receives-orphan-drug-and-rare-pediatric-disease-designations-from-fda-for-treatment-of-krabbe-disease 2020-10-29 05:31:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revision-therapeutics-announces-us-fda-grant-of-rare-pediatric-disease-and-orphan-drug-designation-for-rev-0100-for-the-treatment-of-stargardt-disease 2020-10-29 05:26:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qualigen-therapeutics-receives-positive-pre-ind-response-from-fda-for-the-clinical-development-of-as1411-as-a-treatment-for-covid-19 2020-10-29 05:24:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-and-legochem-biosciences-enter-into-global-licensing-agreement 2020-10-28 23:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santen-and-aerie-conclude-exclusive-license-agreement-for-rhopressa-and-rocklatan-in-japan-and-several-other-asian-countries 2020-10-28 23:42:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhertu-granted-priority-review-in-the-us-for-treatment 2020-10-28 04:50:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evonik-launches-eudragit-ready-to-use-powder-premix 2020-10-28 03:42:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-present-latest-data-on-pipeline-assets-in-the-area-of-alzheimers-disease 2020-10-28 00:19:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogens-productivity-increasing-pathway-modulator-technology 2020-10-28 00:15:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensorion-and-novasep-announce-signature-of-a-gene-therapy-product-development-and-manufacturing-agreement 2020-10-27 23:55:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taysha-gene-therapies-receives-rare-pediatric-disease-designation-and-orphan-drug-designation-for-tsha-104-to-treat-surf1-associated-leigh-syndrome 2020-10-27 23:33:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aeglea-biotherapeutics-announces-us-and-eu-orphan-drug-designations-for-acn00177-for-the-treatment-of-homocystinuria 2020-10-27 07:24:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/y-mabs-announces-fda-clearance-of-ind-for-lutetium-177-labeled-omburtamab-antibody-for-adult-indications 2020-10-27 07:22:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanda-pharmaceuticals-receives-fda-approval-to-proceed-with-investigational-new-drug-vsj-110-for-allergic-conjunctivitis 2020-10-27 07:24:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-presents-promising-interim-phase-ii-data-of-potential-first-in-class-oral-therapy-iptacopan-lnp023 2020-10-27 07:18:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-cogstate-expand-agreement-for-global-development-and-commercialization 2020-10-27 01:38:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tff-pharmaceuticals-expands-its-cgmp-manufacturing-capabilities-with-experic 2020-10-26 23:41:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tracon-announces-fda-orphan-drug-designation-for-trc102-in-malignant-glioma-including-glioblastoma 2020-10-26 23:35:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/passage-bios-pbgm01-receives-orphan-drug-designation-from-ema-for-treatment-of-gm1-gangliosidosis 2020-10-26 08:02:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-receives-fda-clearance-of-ind-for-phase-2-trial-with-bxcl501-for-the-treatment-of-agitation-associated-with-delirium 2020-10-26 08:00:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-acquires-springworks-therapeutics-faah-inhibitor-program 2020-10-26 07:59:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sai-life-sciences-to-significantly-expand-biology-capabilities-at-its-integrated-rd-campus 2020-10-26 07:54:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nbe-therapeutics-commences-first-clinical-study-of-anti-ror1-antibody-drug-conjugate-for-patients-with-solid-tumors 2020-10-26 03:49:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galera-therapeutics-announces-positive-interim-data-from-first-cohort-of-patients-in-pilot-phase-12-clinical-trial-of-gc4419-in-pancreatic-cancer 2020-10-23 23:44:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telstars-centre-in-the-united-kingdom-moves-into-new-premises 2020-10-23 00:33:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invitae-and-pacific-biosciences-collaborate-to-develop-whole-genome-sequencing-based-assays-for-pediatric-epilepsy-diagnostics 2020-10-22 23:34:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galera-therapeutics-announces-dosing-of-first-patient-in-the-phase-12-greco-1-clinical-trial-of-gc4711-in-combination-with-sbrt-for-non-small-cell-lung-cancer 2020-10-22 23:32:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adicet-announces-fda-clearance-of-ind-application-for-first-in-class-allogeneic-car-gamma-delta-t-cell-therapy 2020-10-22 07:24:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anika-announces-fda-510k-clearance-for-its-wristmotion-total-arthroplasty-system-for-the-replacement-of-painful-wrist-joints 2020-10-22 07:26:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aidoc-granted-ai-industry-first-fda-clearance-for-triage-of-incidental-pulmonary-embolism 2020-10-22 07:27:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-fast-track-designation-granted-by-the-fda-to-ublituximab-in-combination-with-umbralisib-for-the-treatment-of-adult-patients-with-chronic-lymphocytic 2020-10-22 07:18:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nevakar-announces-fda-approval-for-ephedrine-sulfate-injection-as-ready-to-use-vials 2020-10-22 07:12:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valicare-extends-gxp-expertise 2020-10-22 00:11:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteintech-acquires-chromotek-expanding-its-portfolio-of-next-generation-antibody-based-instruments 2020-10-21 23:18:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagonist-therapeutics-receives-orphan-drug-designation-from-the-european-medicines-agency-for-ptg-300-in-polycythemia-vera 2020-10-21 23:14:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth 2020-10-21 07:57:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-festival-asia-new-all-encompassing-ecosystem-comprising-events 2020-10-21 03:50:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selecta-biosciences-and-askbio-receive-fda-rare-pediatric-disease-designation-for-their-gene-therapy-for-methylmalonic-acidemia 2020-10-20 23:35:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-fast-track-designation-for-asp0367ma-0211-a-selective-ppard-modulator-being-developed-for-the-treatment-of-primary-mitochondrial-myopathies 2020-10-20 23:31:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sigyn-therapeutics-announces-completion-of-merger-with-reign-resources 2020-10-20 05:09:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-receives-fda-emergency-use-authorization-for-sars-cov-2-rt-pcr-assay-for-individuals-without-symptoms-or-other-reasons-to-suspect-covid-19 2020-10-20 05:01:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inventiva-receives-fda-fast-track-designation-in-mps-vi-for-its-clinical-stage-asset-odiparci 2020-10-20 04:56:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-receives-anda-approval-for-sirolimus-tablets-05-mg-1-mg-and-2-mg 2020-10-20 04:51:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-full-fda-approval-for-venclexta-combinations-for-acute-myeloid-leukaemia 2020-10-20 04:50:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-for-priority-review-applications-for-opdivo-nivolumab-in-combination 2020-10-20 04:45:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-submits-regulatory-applications-to-fda-and-ema-for-rinvoq-upadacitinib-in-atopic-dermatitis 2020-10-19 23:48:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orgenesis-completes-acquisition-of-koligo-therapeutics-and-announces-additional-acquisition-of-icellator-technology-from-tissue-genesis-in-related-transaction 2020-10-19 23:37:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/versantis-receives-fda-rare-pediatric-disease-designation-for-vs-01-for-the-treatment-of-urea-cycle-disorders 2020-10-19 04:49:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aimmune-receives-positive-chmp-opinion-on-palforzia-for-the-treatment-of-patients-with-peanut-allergy-in-europe 2020-10-17 00:00:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zogenix-receives-positive-chmp-opinion-for-fintepla-fenfluramine-oral-solution-for-the-treatment-of-seizures-in-patients-with-dravet-syndrome 2020-10-16 23:39:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-translate-bio-mrna-covid-19-vaccine-candidate-induced-high-antibody-levels-in-preclinical-studies 2020-10-16 07:18:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anges-and-er-kim-enter-into-an-agreement-for-the-commercialization-of-collategene-in-turkey 2020-10-15 23:47:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-expanded-indication-for-mercks-keytruda-pembrolizumab-in-adult-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma-chl 2020-10-15 23:40:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-and-atum-announce-leap-in-transposase-licensing-agreement-for-development-of-robust-manufacturing-processes-for-complex-therapeutic-proteins 2020-10-14 23:52:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-launches-post-exposure-prophylaxis-clinical-trial-of-anti-covid-19-monoclonal-antibody-treatment-candidate-ct-p59 2020-10-14 23:41:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-new-virusexpress-platform-speeds-development-of-cell-and-gene-therapies 2020-10-14 22:36:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-genes-and-rady-childrens-institute-for-genomic-medicine-partner-to-develop 2020-10-14 22:08:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/combination-of-copanlisib-and-rituximab-significantly-prolonged-progression-free-survival-of-patients-with-relapsed-indolent-non-hodgkins-lymphoma 2020-10-14 06:55:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-accelerates-digital-transformation-with-accenture-and-aws 2020-10-14 06:05:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dupixent-dupilumab-significantly-reduced-severe-asthma-attacks-in-children-and-is-the-only-biologic-to-demonstrate-improvement-in-childrens-lung-function-in-a-randomized-phase-3-trial 2020-10-14 06:01:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-to-launch-laboratory-sars-cov-2-antigen-test-to-support-high-volume-testing-of-suspected-covid-19-patients 2020-10-14 05:57:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/windmil-therapeutics-and-stephenson-cancer-center-announce-collaboration-to-collect-bone-marrow-from-patients-with-renal-and-urothelial-carcinomas 2020-10-14 00:12:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iksuda-therapeutics-enters-license-agreement-with-university-of-goettingen-to-develop-a-new-generation-of-antibody-drug-conjugates 2020-10-14 00:11:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-strategic-project-portfolio-management-for-pharma 2020-10-13 01:29:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxular-receives-rare-paediatric-disease-and-orphan-drug-designations-for-retinoblastoma-treatment 2020-10-12 23:32:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/auravax-therapeutics-enters-into-exclusive-license-option-agreement-with-the-university-of-houston-for-intranasal-vaccine-platform 2020-10-12 23:30:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saniona-receives-pre-ind-feedback-from-fda-on-regulatory-path-for-tesomet 2020-10-12 06:36:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/safety-and-efficacy-of-subcutaneous-entyvio-vedolizumab-sustained-during-long-term-maintenance-therapy-in-adults-with-moderately 2020-10-12 06:35:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/covid-19-long-acting-antibody-laab-combination-azd7442-rapidly-advances-into-phase-iii-clinical-trials 2020-10-12 06:31:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-received-european-medicines-agency-ema-prime-designation-for-iptacopan-lnp-in-c3-glomerulopathy-c3g 2020-10-12 06:29:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eli-lillys-and-regenerons-eua-applications-for-their-covid-19-mab-therapies 2020-10-11 23:58:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virtrial-partners-with-betterlife-to-launch-covid-19-clinical-trials 2020-10-09 23:45:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sumitomo-dainippon-pharma-oncology-announces-first-patient-dosed-with-tp-1454-in-patients-with-advanced-solid-tumors 2020-10-09 23:41:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nec-oncoimmunity-as-and-oslo-university-hospital-team-up-to-develop-a-diagnostic 2020-10-09 04:12:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinomed-biotech-ag-develops-first-medicinal-product-for-autoimmune-gastritis 2020-10-08 04:59:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pluristem-expands-its-phase-ii-covid-19-european-clinical-trial-to-israel 2020-10-08 04:38:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arca-biopharma-announces-fda-approval-of-ind-application-for-ab201-as-a-potential-treatment-for-covid-19 2020-10-08 04:35:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-sangamo-dose-first-participant-in-phase-3-study-evaluating-hemophilia-a-gene-therapy-treatment 2020-10-08 04:30:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-signs-joint-procurement-agreement-with-the-european-commission-for-veklury-remdesivir 2020-10-08 04:25:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opdivo-nivolumab-plus-chemotherapy-shows-statistically-significant-improvement-in-pathologic-complete-response-as-neoadjuvant-treatment 2020-10-08 04:23:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-contributes-to-manufacturing-of-covid-19-mrna-vaccine 2020-10-08 05:08:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/research-on-thirst-wins-2020-eppendorf-science-prize 2020-10-07 23:37:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karolinska-developments-portfolio-company-aprea-therapeutics-receives-fda-clearance-to-initiate-phase-1-study-of-apr-548 2020-10-07 23:36:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sri-international-awarded-43m-from-darpa-to-create-rapid-response-therapeutic-manufacturing-system 2020-10-07 23:31:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amphastar-pharmaceuticals-receives-fda-approval-for-atropine-sulfate-injection 2020-10-07 02:24:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aegle-therapeutics-receives-rare-pediatric-disease-designation-from-the-food-and-drug-administration-fda 2020-10-07 02:23:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vir-biotechnology-and-gsk-announce-global-expansion-to-phase-3-of-comet-ice-study-evaluating-vir-7831-for-the-treatment-of-covid-19 2020-10-07 02:18:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reyvow-lasmiditan-c-v-demonstrated-superior-pain-freedom-at-2-hours-in-at-least-2-of-3-migraine-attacks-in-new-phase-3-consistency-of-effect-study 2020-10-07 02:29:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-out-licensing-agreement-for-phase-ii-ready 2020-10-07 00:19:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-submits-new-drug-application-to-the-fda-for-topiramate-oral-solution-et-101 2020-10-06 23:20:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-phase-iii-analysis-demonstrates-novartis-beovu-showed-improvement 2020-10-06 04:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-announces-positive-topline-phase-2-results 2020-10-06 03:59:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-to-acquire-myokardia 2020-10-06 03:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-blood-and-cell-technologies-announces-advanced-therapy-manufacturing 2020-10-20 04:07:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bone-therapeutics-link-health-and-pregene-to-develop-and-commercialize-the-allob 2020-10-06 03:02:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-expands-emprove-program-to-include-cellvento-cho-cell-culture-media 2020-10-06 02:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/noble-and-aptar-pharma-launch-adhereit-connected-medical-device-solution 2020-10-06 02:56:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-biotech-services-and-national-institute-for-viral-disease-control-and-prevention 2020-10-06 02:52:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-nec-and-bostongene-announce-strategic-collaboration 2020-10-06 02:01:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zenith-epigenetics-announces-collaboration-with-nci-in-developing-zen-3694-for-multiple-oncology-indications 2020-10-06 02:00:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arch-oncology-advances-anti-cd47-antibody-ao-176-into-chemotherapy-combination-phase-12-trial-in-solid-tumors 2020-10-06 02:00:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impact-biomedical-to-begin-efficacy-testing-of-pan-coronavirus-vaccine 2020-10-05 01:51:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegon-goes-live-at-pack-expo-connects-2020 2020-10-05 00:17:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teneobio-announces-us-fda-clearance-of-investigational-new-drug-application-for-tnb-486-and-the-initiation-of-phase-i-clinical-studies-in-patients-with-b-cell-malignancies 2020-10-02 23:38:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-receives-fda-fast-track-designation-for-duchenne-muscular-dystrophy-investigational-gene-therapy 2020-10-01 08:09:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-pfizers-xeljanz-tofacitinib-for-the-treatment-of-active-polyarticular-course-juvenile-idiopathic-arthritis 2020-10-01 08:08:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/skinmedica-launches-tns-advanced-pro-infusion-serum-for-diamondglow 2020-10-01 07:59:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-fraunhofer-ime-launch-collaboration 2020-10-01 07:56:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/irisys-llc-signs-a-third-contract-with-tff-pharma-to-produce-medication-to-treat-lung-conditions-including-covid-19 2020-10-01 01:51:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurorx-and-relief-therapeutics-establish-supply-and-distribution-agreements-for-rlf-100-aviptadil 2020-09-30 23:51:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-biomath-llc-announces-collaboration-with-cullinan-oncology 2020-09-29 23:44:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jellagen-ltd-announces-a-collaboration-with-the-mayo-clinic 2020-09-29 23:40:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-approves-haegarda-for-prevention-of-hereditary-angioedema-hae-attacks 2020-09-29 04:34:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quotient-limited-announces-receipt-of-us-fda-emergency-use-authorization-eua-for-mosaiq-covid-19-antibody-test 2020-09-29 04:21:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-receives-orphan-drug-and-fast-track-designations-from-the-us-food-and-drug-administration 2020-09-29 04:14:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-completes-principia-biopharma-inc-acquisition 2020-09-29 04:08:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-pfizers-xeljanz-tofacitinib 2020-09-29 04:04:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huya-bioscience-international-announces-orphan-drug-designation-for-hbi-8000-monotherapy-adult-t-cell-leukemia-lymphoma-atl-in-japan 2020-09-29 04:44:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-ind-approval-for-phase-ii-clinical-trial-using-stemedicas-itmsc-therapy 2020-09-29 04:33:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-reinforces-pharmaceutical-shipment-expertise-with-pharmalife-launch 2020-09-28 03:37:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syntegons-schiedam-site-celebrates-anniversary-and-long-heritage 2020-09-28 03:29:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-nucala-as-the-first-and-only-biologic-treatment-for-hypereosinophilic-syndrome-hes 2020-09-25 23:38:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/millendo-therapeutics-announces-initiation-of-first-in-human-clinical-trial-of-mle-301-a-selective-nk3r-antagonist 2020-09-24 23:50:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-at-007-pediatric-rare-disease-designation-and-orphan-designation-for-treatment-of-pmm2-cdg 2020-09-24 23:31:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-initiates-pivotal-global-phase-clinical-trial 2020-09-23 23:48:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vivet-therapeutics-and-pfizer-inc-enter-into-manufacturing-agreement 2020-09-23 23:46:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genetics-research-and-oxford-nanopore-technologies-sign-non-exclusive-licensing-agreement-for-genetics-researchs-patented-dna-negative-enrichment-technology-platform 2020-09-22 23:24:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gyroscope-therapeutics-granted-fda-fast-track-designation-for-gt005-an-investigational-gene-therapy-for-dry-age-related-macular-degeneration 2020-09-22 23:23:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genocea-announces-fda-acceptance-of-gen-011-ind-application 2020-09-22 07:41:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-completes-acquisition-of-forbius 2020-09-22 07:40:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabcine-expands-partnership-with-samsung-biologics-for-pmc-403 2020-09-22 00:13:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/city-of-hope-enters-licensing-agreement-with-chimeric-to-develop-its-pioneering-chlorotoxin-car-t-cell-therapy 2020-09-22 00:11:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-kisqali-receives-the-highest-rating-of-any-cdk46-inhibitor-on-the-esmo-magnitude-of-clinical-benefit-scale 2020-09-21 08:12:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-and-springworks-therapeutics-announce-clinical-collaboration-to-evaluate-pbcar269a 2020-09-21 08:09:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verzenio-significantly-reduced-the-risk-of-cancer-recurrence-by-25-for-people-with-hr-her2-high-risk-early-breast-cancer 2020-09-21 08:06:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-announces-expedited-development-of-axs-12 2020-09-21 08:03:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crinetics-pharmaceuticals-receives-rare-pediatric-disease-designation-from-fda-for-crn04777-for-the-treatment-of-congenital-hyperinsulinism 2020-09-21 08:01:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/preparation-products-of-yiling-pharma-approved-by-fda-for-launch-in-the-us-market 2020-09-21 04:54:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-establishes-new-cell-drug-manufacturing-facility-for-research-and-development-to-support-expansion-of-next-generation-clinical-programs 2020-09-18 23:53:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zynerba-pharmaceuticals-receives-orphan-drug-designation-for-cannabidiol-for-the-treatment-of-22q112-deletion-syndrome 2020-09-18 07:41:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allovir-announces-the-fda-clearance-of-investigational-new-drug-application-ind-for-alvr109-for-the-treatment-of-high-risk-covid-19-patients 2020-09-18 07:39:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-receives-orphan-drug-designation-from-the-us-fda-for-toripalimab-for-the-treatment-of-soft-tissue-sarcoma 2020-09-18 07:36:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dyadic-announces-collaboration-with-jiangsu-hengrui-medicine-for-biologic-drug-development 2020-09-18 00:09:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lamkap-bio-group-and-lonza-collaborate-to-manufacture-bispecific-antibodies-for-cancer-treatment 2020-09-18 00:07:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zynerba-pharmaceuticals-receives-orphan-drug-designation-for-cannabidiol-for-the-treatment-of-22q112-deletion-syndrome 2020-09-17 23:30:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elicio-therapeutics-and-moffitt-collaborate-to-study-amp-cd19-in-combination-with-cd19-car-t-cells 2020-09-17 23:21:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-chiesi-group-establish-collaboration-to-discover-and-develop-mrna-therapeutics-for-pulmonary-arterial-hypertension-pah 2020-09-16 23:21:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-vertex-establish-new-collaboration-to-treat-cystic-fibrosis-using-gene-editing 2020-09-16 23:18:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-fda-approval-for-expanded-use-of-the-cintec-plus-cytology 2020-09-16 01:45:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-fast-track-designation-to-jardiance 2020-09-16 01:46:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytiva-invests-for-global-capacity-expansion 2020-09-16 00:35:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/juvenescence-announces-licensing-agreement-with-evgen-pharma-plc 2020-09-15 23:23:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plus-therapeutics-receives-fast-track-designation-from-fda-for-its-novel-glioblastoma-treatment 2020-09-15 23:32:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-dupixent-dupilumab-breakthrough-therapy-designation-for-eosinophilic-esophagitis 2020-09-15 07:38:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-ema-approves-safety-label-update-for-novartis-beovu 2020-09-15 07:35:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-reports-positive-topline-results-from-the-first-phase-iii-trial-of-beovu-versus-aflibercept 2020-09-15 07:21:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telstar-consultancy-service-eu-gmp-annex 2020-09-15 07:10:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hifibio-therapeutics-announces-a-global-strategic-partnership-with-abl-bio-for-the-co-development-of-a-sars-cov-2-neutralizing-antibody 2020-09-14 23:51:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sorrento-secures-exclusive-license-from-mayo-clinic-for-antibody-drug-nanoparticle-albumin-bound-immune-complex-adnic-platform 2020-09-14 23:44:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ziopharm-oncology-granted-rare-pediatric-disease-designation-for-controlled-il-12-for-the-treatment-of-dipg 2020-09-14 07:58:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essa-pharma-announces-fast-track-designation-granted-by-the-fda-to-epi-7386 2020-09-14 07:56:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharmas-mdm2-p53-inhibitor-apg-115-granted-orphan-drug-designation-by-the-fda-for-the-treatment-of-gastric-cancer 2020-09-14 07:55:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-dupixent-dupilumab-breakthrough-therapy-designation-for-eosinophilic-esophagitis 2020-09-14 07:54:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiadis-announces-us-fda-approval-of-the-abigail-wexner-research-institute-at-nationwide-childrens-hospitals-ind 2020-09-14 07:50:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-propose-expansion-of-pivotal-covid-19-vaccine-trial 2020-09-13 23:48:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-submits-application-seeking-us-fda-approval-of-darzalex-faspro 2020-09-13 23:17:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-to-present-new-data-from-abstracts-at-the-international-congress-of-parkinson 2020-09-13 23:13:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-data-further-reinforce-roches-ocrevus 2020-09-13 23:10:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/junshi-biosciences-receives-fda-breakthrough-therapy-designation-for-toripalimab-for-the-treatment-of-nasopharyngeal-carcinoma 2020-09-12 04:05:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fasenra-met-both-co-primary-endpoints-of-reduced-nasal-polyp-size-and-blockage-in-the-ostro-phase-iii-trial-for-patients-with-chronic-rhinosinusitis-with-nasal-polyps 2020-09-12 04:04:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-trelegy-ellipta-as-the-first-once-daily-single-inhaler-triple-therapy-for-the-treatment-of-both-asthma-and-copd-in-the-us 2020-09-12 03:40:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/know-bio-announces-breakthrough-nitric-oxide-discovery-to-combat-covid-19 2020-09-12 00:15:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-biopharmaceuticals-initiates-clinical-development-program-for-cenobamate-in-asia 2020-09-11 23:54:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gain-therapeutics-announces-research-collaboration-with-sumitomo-dainippon-pharma-co-ltd-to-advance-gains-lysosomal-enzyme-allosteric-regulator-program 2020-09-10 23:36:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brink-biologics-announces-license-agreement-with-global-healthcare-company-fresenius-kabi-swissbiosim-gmbh 2020-09-10 23:33:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-athena-biosciences-new-drug-application-nda-for-qdolo-tramadol-hydrochloride-oral-solution 2020-09-10 07:44:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clarity-pharmaceuticals-announces-the-us-fda-grants-rare-paediatric-disease-designation 2020-09-10 07:33:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-premier-otology-focused-event-in-the-middle-east-virtual-edition 2020-09-09 23:54:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-59-million-expansion-in-antibody-drug-conjugate-manufacturing 2020-09-09 23:23:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-to-potentially-supply-the-eu-with-200-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2 2020-09-09 23:21:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-expands-its-multiple-sclerosis-portfolio-with-investigational-btk-inhibitor-fenebrutinib-and-initiates-novel-clinical-trials 2020-09-09 08:02:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-receives-fast-track-designation-from-us-food-and-drug-administration-for-pbcar269a 2020-09-09 07:57:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptilogics-receives-fda-orphan-drug-designation-for-novel-peptide-therapy-for-the-treatment-of-prosthetic-joint-infections 2020-09-09 07:55:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-collaborates-with-recursion-to-strengthen-digital-drug-discovery-and-advance-new-therapies-for-fibrotic-diseases 2020-09-09 07:53:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-non-profit-to-advance-science-education-joins-president-obamas-educate-to-innovate-campaign 2020-09-09 07:52:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sheba-medical-center-treats-first-patient-with-car-t-cell-immunotherapy 2020-09-08 23:57:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astex-pharmaceuticals-and-md-anderson-announce-strategic-collaboration-to-accelerate-clinical-evaluation-of-therapies-for-patients-with-leukemia 2020-09-08 23:00:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aridis-announces-agreement-with-the-fda-on-updated-phase-2-clinical-trial-design-for-ar-501 2020-09-08 22:58:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-ngs-based-companion-diagnostic-for-ret-fusion-positive-non-small-cell-lung-cancer 2020-09-08 07:51:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/radiomedix-and-curium-announce-fda-approval-of-detectnet-in-the-us 2020-09-08 07:49:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beyondspring-receives-breakthrough-therapy-designations-from-both-us-fda-and-china-nmpa-for-plinabulin-in-chemotherapy-induced-neutropenia-indication 2020-09-08 07:44:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wellcome-and-ripeta-partner-to-assess-dataset-availability-in-funded-research 2020-09-08 07:40:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomica-announces-positive-pre-clinical-results-in-its-immuno-oncology-program 2020-09-08 06:24:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-announces-fda-approval-of-gavreto-pralsetinib-for-the-treatment-of-adults-with-metastatic-ret-fusion-positive-non-small-cell-lung-cancer 2020-09-07 23:57:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-post-hoc-analysis-shows-high-dose-enerzair-breezhaler-reduces-asthma-exacerbations-versus-medium-dose-complementing-key-pivotal-iridium-study-findings 2020-09-07 07:36:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-fda-approval-of-gavreto-pralsetinib-for-the-treatment-of-adults-with-metastatic-ret-fusion-positive-non-small-cell-lung-cancer 2020-09-07 07:28:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharmas-bcl-2-inhibitor-apg-2575-granted-orphan-drug-designation-by-the-fda-for-the-treatment-of-chronic-lymphocytic-leukemia 2020-09-07 07:22:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-announces-fda-approval-of-gavreto-pralsetinib-for-the-treatment-of-adults-with-metastatic-ret-fusion-positive-non-small-cell-lung-cancer 2020-09-05 00:07:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascendis-pharma-as-announces-us-food-and-drug-administration-fda-accepts-biologics-license-application-bla 2020-09-04 07:39:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-i-mab-enter-into-global-strategic-partnership-for-differentiated-immuno-oncology-therapy 2020-09-04 07:31:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-fda-emergency-use-authorization-for-the-cobas-sars-cov-2-influenza-ab-test 2020-09-04 07:39:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-additional-doses-of-trulicity-dulaglutide-for-the-treatment-of-type-2-diabetes 2020-09-04 07:24:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xencor-and-md-anderson-enter-strategic-collaboration-to-advance-investigational-xmab-drug-candidates 2020-09-04 00:11:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relay-therapeutics-announces-dosing-of-first-patient-in-first-in-human-clinical-trial-of-rly-4008-a-highly-selective-fgfr2-inhibitor 2020-09-04 00:07:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lodo-therapeutics-acquires-hibiskus-biopharma 2020-09-03 07:26:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aeon-biopharma-announces-fda-acceptance-of-ind-for-abp-450-as-a-treatment 2020-09-03 07:25:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-gsk-initiate-phase-clinical-trial-of-covid-19 2020-09-03 07:24:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avexis-renamed-novartis-gene-therapies-signifying-the-growing-importance 2020-09-03 07:18:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-nejm-publication-of-pivotal-study-of-tabrecta 2020-09-03 07:17:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-and-hifibio-therapeutics-partner-to-discover-novel-targets 2020-09-03 07:15:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabcine-signs-a-cmo-contract-with-binex-so-binex-can-produce-olinvacimab-at-its-new-5000l-production-line 2020-09-02 23:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rain-therapeutics-announces-exclusive-license-to-the-clinical-stage-mdm2-inhibitor-ds-3032-milademetan-from-daiichi-sankyo 2020-09-02 23:29:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/northwest-biotherapeutics-acquires-flaskworks 2020-09-01 23:37:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hdt-bio-receives-nih-contract-to-advance-novel-rnalion-covid-19-vaccine-into-clinical-trials 2020-09-01 23:28:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-approved-in-the-eu-for-the-treatment-of-extensive-stage-small-cell-lung-cancer 2020-09-01 07:58:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-and-jounce-therapeutics-announce-exclusive-license-agreement-for-novel-immunotherapy-program 2020-09-01 07:56:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-receives-fda-approval-for-first-hiv-1hiv-2-qualitative-test-on-the-cobas-systems 2020-09-01 07:54:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-ambitious-esg-targets-to-increase-access-to-medicines 2020-09-01 07:51:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-collaboration-between-novartis-and-africa-medical-supplies-platform 2020-09-01 07:50:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-provides-update-on-kevzara-phase-3-trial-in-severe-and-critically 2020-09-01 07:48:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luina-bio-announces-new-bio-manufacturing-gmp-and-development-facility-expansion 2020-09-01 00:35:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/my-personal-therapeutics-and-medivizor-announce-a-collaboration-agreement 2020-08-31 23:53:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/velosbio-announces-fda-fast-track-and-orphan-drug-designations-for-vls-101-in-patients-with-mantle-cell-lymphoma 2020-08-31 23:51:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/farxiga-demonstrated-unprecedented-reduction-in-the-risk-of-kidney-failure 2020-08-31 07:20:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vir-biotechnology-and-gsk-start-phase-23-study-of-covid-19-antibody-treatment 2020-08-31 07:09:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-positive-results-from-phase-ii-study-of-lnp023-in-patients 2020-08-31 07:07:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-announces-positive-data-from-phase-3b-study-of-repatha-in-pediatric-patients 2020-08-31 07:04:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gileads-investigational-antiviral-veklury-receives-us-food-and-drug-administration-emergency 2020-08-31 07:01:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-acquires-rights-to-boxr-car-t-platform-and-products-from-unum-therapeutics 2020-08-31 06:20:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-of-melflufen-for-patients-with-triple-class-refractory-multiple-myeloma 2020-08-30 22:52:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortress-biotech-announces-positive-topline-clinical-efficacy-results-for-cutx-101-copper-histidinate-for-the-treatment-of-menkes-disease 2020-08-28 23:41:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/os-therapies-to-develop-blinkbio-next-generation-antibody-drug-conjugate 2020-08-28 06:47:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-to-collaborate-with-epirium-bio 2020-08-28 06:40:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galecto-inc-receives-us-and-eu-orphan-drug-designations 2020-08-28 06:38:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-fda-approval-of-foundationone-liquid-cdx 2020-08-28 06:35:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-receives-fda-fast-track-designation-for-rp-l401-gene-therapy-for-infantile-malignant-osteopetrosis 2020-08-28 00:37:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/assembly-biosciences-and-arbutus-biopharma-announce-clinical-collaboration-agreement 2020-08-27 23:52:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-blenrep-belantamab-mafodotin-for-the-treatment 2020-08-27 07:22:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-investigational-novel-stamp-inhibitor-asciminib 2020-08-27 07:21:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-receives-approval-for-xofigo-in-china 2020-08-27 07:18:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/3d-cell-culture-systems-in-cancer-organoids-reveal-drug-efficacy 2020-08-27 00:25:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/robopharma-acquired-by-capsa-healthcare-to-broaden-reach-into-new-pharmacy-automation-markets 2020-08-27 00:14:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemomab-receives-european-orphan-drug-designation-for-cm-101-for-the-treatment-of-primary-sclerosing-cholangitis 2020-08-27 00:06:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acadia-pharmaceuticals-acquires-cersci-therapeutics-adds-novel-pain-program-to-portfolio 2020-08-25 23:26:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asalyxa-bio-launches-with-novel-neutrophil-targeting-drug-delivery-platform-technology-and-lead-candidate-asx-100-for-acute-respiratory-distress-syndrome-ards-and-covid-19-patients 2020-08-25 23:23:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peel-therapeutics-developing-cancer-drug-from-plant-toxin 2020-08-25 07:33:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioage-discovers-key-pathway-and-identifies-promising-phase-2-ready-drug 2020-08-25 07:33:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-provides-update-on-phase-3-idhentify-trial-in-patients 2020-08-25 07:32:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-i-clinical-trial-initiated-for-monoclonal-antibody-combination-for-the-prevention-and-treatment-of-covid-19 2020-08-25 07:29:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-and-informed-data-systems-inc-join-forces-to-jointly-develop-digital-health-products 2020-08-25 07:28:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/byondis-initiates-phase-i-study-of-adc-trastuzumab-duocarmazine 2020-08-25 05:28:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eppendorf-ag-records-strong-first-half-year-2020 2020-08-25 04:22:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmasourcescom-to-help-propel-the-chinese-api-export-business 2020-08-25 00:45:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmasources-launches-the-export-driven-event-cphi-p-mec-china-e-trade-season 2020-08-25 00:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terumo-cardiovascular-and-cytosorbents-collaborate-to-commercialize-cytosorb-in-ten-us-hotspot-states-under-emergency-use-authorization-for-covid-19 2020-08-24 23:36:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mc2-therapeutics-announces-collaboration-agreement-with-epi-health 2020-08-24 23:34:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turning-point-therapeutics-granted-fast-track-designation-for-repotrectinib-in-ntrk-positive-tki-pretreated-advanced-solid-tumors 2020-08-24 23:40:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/barhemsys-amisulpride-injection-launched-in-the-us-for-the-treatment 2020-08-24 07:18:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-awards-orphan-drug-designation-odd-to-paxalisib-for-malignant-glioma 2020-08-24 07:16:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/europital-forecast-30-cagr-from-uk-biotech-for-three-years 2020-08-24 06:11:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adlai-nortye-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-an0025-ep4-antagonist-in-combination-with-mercks-keytruda-pembrolizumab-for-advanced-solid-tumors 2020-08-24 00:39:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tiziana-granted-a-patent-on-the-use-of-milciclib-in-combination-with-tyrosine-kinase-inhibitors-for-treatment-of-hepatocellular-carcinoma-and-other-cancers 2020-08-24 00:22:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fordoz-pharma-partners-with-lupin-on-development-of-2-complex-injectable-products 2020-08-21 08:28:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-kesimpta-the-first-and-only-self-administered 2020-08-21 08:27:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-kyproliscombination-regimen-with-darzalex 2020-08-21 08:26:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-approved-in-japan-for-the-treatment-of-extensive-stage-small-cell-lung-cancer 2020-08-21 08:24:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kubota-vision-receives-orphan-products-clinical-trials-grants-to-emixustat-for-stargardt-disease 2020-08-20 23:49:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cipla-and-stempeutics-collaborate-to-launch-stempeucel-cell-therapy 2020-08-20 23:46:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hercules-ahr-inhibitor-hp163-blocks-viral-replication-in-zika-infection-and-potentially-in-covid-19 2020-08-20 06:19:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zosano-pharma-announces-agreement-to-collaborate-with-mitsubishi-tanabe-pharma-corporation 2020-08-20 06:13:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galapagos-announces-that-gilead-received-a-complete-response-letter 2020-08-20 06:12:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-canada-launches-two-new-biosimilars-ziextenzo-and-riximyo 2020-08-20 06:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-and-evotec-expand-collaboration-into-gaucher-disease 2020-08-20 06:00:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-receives-fast-track-disease-designation-from-us 2020-08-20 05:58:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/4d-molecular-therapeutics-announces-first-patient-dosed-in-phase-12-clinical-trial-of-4d-125-by-intravitreal-injection-for-the-treatment-of-x-linked-retinitis-pigmentosa 2020-08-19 23:30:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-to-expand-phase-3-clinical-trial-for-bucillamine-in-covid-19-in-asia-pacific-and-canada 2020-08-19 23:31:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-pharmaceuticals-initiates-phase-1b-study-of-aro-hif2-for-treatment-of-clear-cell-renal-cell-carcinoma 2020-08-19 00:03:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapure-biomanufacturing-signs-manufacturing-deal-with-vbi-vaccines-for-coronavirus-vaccine-candidates 2020-08-18 23:23:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-expands-scheduled-flights-adds-shanghai-to-network 2020-08-18 02:19:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pluristem-and-abu-dhabi-stem-cells-center-sign-mou-to-collaborate-in-the-development-of-cell-therapies-and-regenerative-medicines-for-the-treatment-of-severe-diseases-including-covid-19 2020-08-17 23:45:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dragonfly-therapeutics-and-bristol-myers-squibb-announce-exclusive-global-license-for-dragonflys-il-12-investigational-immunotherapy-program 2020-08-17 23:41:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ns-pharmas-viltepso-viltolarsen-injection-now-fda-approved-in-the-us-for-the-treatment 2020-08-17 01:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-national-medical-products-administration-approves-truvada 2020-08-17 01:23:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-ag-delivers-pharma-vials-to-package-billion-doses-of-covid-19-vaccines 2020-08-17 01:14:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-announces-fda-acceptance-of-new-drug-application-for-umbralisib 2020-08-17 01:01:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-the-bristol-myers-squibb-foundation-commit 2020-08-17 01:00:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-signs-mou-with-attwill-medical-solutions-for-phase-3-clinical-trial-for-bucillamine-in-covid-19 2020-08-16 22:35:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-hbv-patient-dosed-in-phase-iia-clinical-trial-of-asc22-a-subcutaneously-administered-pd-l1-antibody 2020-08-16 22:24:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isofol-enters-licensing-agreement-with-solasia-to-develop-and-commercialize-arfolitixorin-in-japan 2020-08-13 21:19:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prometheus-biosciences-and-dr-falk-pharma-gmbh-announce-global-collaboration-agreement-to-develop-and-commercialize-a-novel-ibd-antibody 2020-08-13 21:17:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytovia-therapeutics-licenses-productivity-boosting-manufacturing-technology-for-its-nk-engager-multifunctional-antibodies-from-proteonic 2020-08-12 22:30:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monopar-announces-plan-to-advance-development-of-novel-triage-test-for-severe-covid-19-utilizing-its-patented-technology 2020-08-12 22:22:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/specialty-label-from-schreiner-medipharm-blinds-vials-for-clinical-trial-conducted-by-csl-behring 2020-08-12 07:01:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyenovia-and-arctic-vision-announce-exclusive-collaboration-and-license-agreement-to-develop-and-commercialize-micropine-and-microline-in-greater-china-and-south-korea 2020-08-11 23:12:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurogene-announces-fda-orphan-drug-designation-for-cln7-batten-disease-gene-therapy 2020-08-11 23:05:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/byondis-initiates-phase-i-study-of-antibody-drug-conjugate-syd1875 2020-08-11 06:11:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dutch-saillant-therapeutics-to-develop-generic-virus-inhibiting-therapy 2020-08-11 06:05:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/secura-bio-signs-agreement-to-acquire-global-rights-to-oncology-drug-copiktra 2020-08-10 22:43:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seelos-therapeutics-receives-fda-may-proceed-notice-to-initiate-a-phase-iibiii-trial-of-sls-005-in-amyotrophic-lateral-sclerosis 2020-08-10 22:38:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-evrysdi-risdiplam-for-treatment-of-spinal-muscular-atrophy 2020-08-10 03:34:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-oral-treatment-for-spinal-muscular-atrophy 2020-08-08 03:52:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-ec-approval-for-new-xolair-indication-to-treat-severe-chronic-rhinosinusitis-with-nasal-polyps 2020-08-08 03:52:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zosano-pharma-announces-partnership-agreement-with-eversana-to-support-the-launch-and-commercialization-of-qtrypta 2020-08-07 23:34:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-completes-enrollment-in-phase-1b-clinical-trial-of-nasoshield-a-single-dose-intranasal-anthrax-vaccine-candidate 2020-08-07 23:24:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immatics-extends-cell-therapy-manufacturing-collaboration-with-uthealth 2020-08-06 22:42:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valsteam-adcas-new-website-is-now-live 2020-08-06 22:32:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sab-biotherapeutics-awarded-356m-from-us-department-of-defense-for-covid-19-and-scaling-rapid-response-antibody-program 2020-08-06 22:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-to-supply-canada-with-their-bnt162-mrna-based-vaccine-candidate 2020-08-06 01:09:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-gsks-blenrep-for-the-treatment 2020-08-06 01:07:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-fda-authorisation-for-the-first-epstein-barr-virus 2020-08-06 01:05:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalyst-clinical-research-announces-merger-with-ce3-inc-to-form-a-market-leading-next-generation-oncology-cro 2020-08-05 22:45:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-update-following-us-fda-approval-of-phase-3-clinical-trial-for-bucillamine-in-covid-19 2020-08-05 22:39:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosight-granted-us-fda-fast-track-designation-for-bst-236-for-the-treatment-of-acute-myeloid-leukemia 2020-08-05 01:58:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pacira-biosciences-announces-fda-acceptance-of-snda 2020-08-05 01:57:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-for-bcx9930-in-pnh 2020-08-05 01:56:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-kymriah-meets-primary-endpoint 2020-08-04 04:31:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-cosentyx-receives-eu-approval-for-first-line-systemic-treatment-in-pediatric-psoriasis 2020-08-04 04:28:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rozlytrek-roches-first-tumour-agnostic-therapy-approved-in-europe 2020-08-04 04:25:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-initiates-phase-3-trial-of-ly-cov555-for-prevention-of-covid-19-at-long-term-care-facilities-in-partnership 2020-08-04 04:23:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tyme-announces-orphan-drug-designation-for-sm-88-as-potential-treatment-for-patients-with-pancreatic-cancer 2020-08-03 22:27:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gtcr-and-tersera-therapeutics-announce-acquisition-of-xermelo 2020-08-03 22:26:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-indication-for-drug-containing-an-active-ingredient-derived-from-cannabis-to-treat-seizures-in-rare-genetic-disease 2020-08-02 22:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/made-in-singapore-cancer-drug-etc-159-advances-further-in-clinical-trials 2020-08-02 22:29:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-us-fda-breakthrough-therapy-designation-granted-for-pevonedistat-for-the-treatment-of-patients-with-higher-risk-myelodysplastic-syndromes-hr-mds 2020-08-01 05:29:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-two-us-regulatory-milestones-for-keytruda-pembrolizumab-in-triple-negative-breast-cancer-tnbc 2020-08-01 05:12:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tagrisso-granted-breakthrough-therapy-designation-in-the-us-for-the-adjuvant-treatment-of-patients-with-stage-ib-iiia-egfr-mutated-lung-cancer 2020-08-01 05:05:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-tecentriq-plus-cotellic-and-zelboraf-for-people-with-advanced-melanoma 2020-08-01 05:04:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revive-therapeutics-announces-us-fda-approval-of-confirmatory-phase-3-clinical-trial-for-bucillamine-in-covid-19 2020-07-31 23:12:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-to-supply-japan-with-120-million-doses-of-their-bnt162-mrna-based-vaccine-candidate 2020-07-31 22:52:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-application-for-additional-indication-of-anti-cancer-agent-lenvima-for-unresectable-thymic-carcinoma-submitted-in-japan 2020-07-31 00:26:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-survey-reveals-biopharma-companies-focus-on-sustainability-in-cold-chain-partnerships 2020-07-30 23:17:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-receives-mhra-approval-to-initiate-phase-i-trial-of-potential-covid-19-antiviral-antibody-treatment-ct-p59-in-the-uk 2020-07-30 22:57:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imara-announces-imr-687-granted-fast-track-designation-and-rare-pediatric-disease-designation-for-treatment-of-beta-thalassemia 2020-07-30 22:38:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-to-mercks-novel-hif-2a-inhibitor 2020-07-30 01:23:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-piqray-approval-in-europe-the-first-and-only-targeted-medicine 2020-07-30 01:19:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-new-ventana-her2-dual-ish-test-as-companion-diagnostic 2020-07-30 01:17:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-gsk-agree-with-the-uk-government-to-supply-up-to-60-million-doses-of-covid-19-vaccine 2020-07-30 01:15:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-achieves-carbon-dioxide-neutral-levels 2020-07-29 23:33:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avacta-and-daewoong-pharmaceutical-expand-partnership-to-include-covid-19-neutralising-affimer-therapy 2020-07-29 22:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regulus-therapeutics-announces-fda-orphan-drug-designation-of-rgls4326-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd 2020-07-29 22:31:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intravacc-and-celonic-to-develop-and-produce-a-novel-covid-19-vaccine 2020-07-29 06:38:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-japan-rescheduled-for-spring-2021-with-digital-solutions-to-be-launched 2020-07-29 00:03:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terns-pharmaceuticals-and-hansoh-pharma-announce-collaboration-and-license-agreement-for-trn-000632-in-greater-china 2020-07-28 22:35:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protara-therapeutics-receives-rare-pediatric-disease-designation-for-tara-002-for-the-treatment-of-lymphatic-malformations 2020-07-28 22:33:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mayne-pharma-launches-chlorzoxazone-tablet-in-the-united-states 2020-07-28 00:38:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-announces-plans-for-joint-investment-to-help-strengthen-future-of-antibiotics-manufacturing-in-europe 2020-07-28 00:33:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lgm-pharma-acquires-pharmaceutical-development-and-manufacturing-unit-of-nexgen-pharma 2020-07-27 22:58:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-choose-lead-mrna-vaccine-candidate-against-covid-19-and-commence-pivotal-phase-23-global-study 2020-07-27 22:52:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-novartis-analysis-shows-wet-amd-patients-achieved-sustained-fluid-control-faster-with-beovu 2020-07-27 04:38:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imfinzi-recommended-for-approval-in-the-eu-by-chmp-for-extensive-stage-small-cell-lung-cancer 2020-07-27 04:36:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calquence-recommended-for-approval-in-the-eu-by-chmp-for-chronic-lymphocytic-leukaemia 2020-07-27 04:35:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carisma-therapeutics-announces-fda-clearance-of-ind-application-for-first-ever-engineered-macrophage-immunotherapy 2020-07-27 03:45:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metvital-inc-announces-collaboration-with-the-national-institute-of-neurological-disorders-and-stroke-part-of-the-nih-in-the-epilepsy-therapy-screening-program-etsp 2020-07-25 00:35:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-cell-based-gene-therapy-for-adult-patients-with-relapsed-or-refractory-mcl 2020-07-25 00:30:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-adakveo-receives-positive-chmp-opinion-for-the-prevention-of-recurrent 2020-07-25 00:07:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-galapagos-announce-positive-european-chmp-opinion-for-jyseleca 2020-07-25 00:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-kites-tecartus-the-first-and-only-car-t-treatment 2020-07-24 23:55:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breztri-aerosphere-approved-in-the-us-for-the-maintenance-treatment-of-copd 2020-07-24 23:53:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vita-therapeutics-receives-orphan-drug-designation-from-fda-for-new-novel-treatment 2020-07-24 05:30:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/covid-19-ema-sets-up-infrastructure-for-real-world-monitoring-of-treatments-and-vaccines 2020-07-24 05:29:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-phase-iii-study-of-jakavi 2020-07-24 05:28:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novavax-and-fujifilm-diosynth-biotechnologies-initiate-large-scale-manufacturing-of-covid-19-vaccine-candidate 2020-07-23 22:52:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/myokardia-announces-receipt-of-breakthrough-therapy-designation-from-fda-for-mavacamten-for-the-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy 2020-07-23 22:49:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cmic-group-establishes-new-biologic-contract-development-and-manufacturing-business 2020-07-23 05:50:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-iii-data-show-roches-port-delivery-system-with-ranibizumab 2020-07-23 05:48:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-secures-exclusive-option-to-acquire-tizona-therapeutics 2020-07-23 05:46:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-announce-an-agreement-with-us-government-for-up-to-600-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2 2020-07-22 22:53:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dragonfly-therapeutics-launches-phase-12-study-of-its-il12-immunotherapy-in-patients-with-advanced-solid-tumors 2020-07-22 22:45:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nhs-study-confirms-ogts-cytosure-constitutional-v3-array-has-significantly-higher-reporting-rate 2020-07-22 03:31:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-present-latest-data-on-pipeline-assets-in-the-area-of-alzheimers-disease 2020-07-22 03:19:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avance-clinical-contracted-for-atossa-therapeutics-at-301-nasal-spray-clinical-study 2020-07-22 03:15:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arctoris-contributes-its-capabilities-and-expertise-to-the-fight-against-covid-19 2020-07-21 22:59:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/irbm-to-collaborate-with-msd-to-develop-peptides-against-coronavirus 2020-07-21 22:32:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seelos-therapeutics-receives-positive-ema-opinion-on-orphan-drug-designation-for-sls-005-trehalose-in-sanfilippo-syndrome 2020-07-21 22:28:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bostongene-and-nec-collaborate-to-analyze-cancer-patients-in-clinical-trials 2020-07-21 00:40:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-orphan-drug-and-rare-pediatric-disease-designations-for-otl-203-for-the-treatment-of-mps-i 2020-07-20 22:46:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-food-and-drug-administration-accepts-karyopharms-supplemental-new-drug-application-for-xpovio 2020-07-20 07:00:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/assembly-biosciences-and-beigene-announce-license-and-collaboration-agreement-in-china 2020-07-20 06:57:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-smartphone-app-for-vital-signs-measurement-of-patients-with-the-novel-coronavirus-infection-experimental-study-project-adopted-as-amed-project 2020-07-20 00:49:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-validates-bristol-myers-squibbs-application-for-car-t-cell-therapy 2020-07-18 07:16:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lillys-mirikizumab-superior-to-cosentyx-in-a-phase-study 2020-07-18 07:07:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-partners-with-pharmapark-to-market-bat2506-in-russia-and-other-cis-countries 2020-07-17 23:28:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-therapeutics-announces-first-patient-dosed-in-pivotal-phase-2-portion-of-lotis-3-clinical-trial-of-loncastuximab-tesirine-lonca-in-combination-with-ibrutinib 2020-07-17 23:24:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-early-breast-cancer-drug-now-approved-in-malaysia 2020-07-17 06:51:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-to-mercks-new-drug-application-for-vericiguat 2020-07-17 06:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/farxiga-granted-fast-track-designation-in-the-us-for-heart-failure 2020-07-17 06:42:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marinomed-biotech-ag-carragelose-effective-against-sars-cov-2-in-cell-culture-assays 2020-07-17 02:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/f-star-therapeutics-merck-kgaa-darmstadt-germany-takes-an-early-option-in-immuno-oncology-collaboration 2020-07-16 22:50:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atossa-therapeutics-contracts-for-clinical-study-of-at-301-nasal-spray-atossas-second-covid-19-therapeutic-development-program 2020-07-16 22:44:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-launches-first-of-its-kind-not-for-profit-portfolio-of-medicines-for-symptomatic-treatment-of-covid-19 2020-07-16 07:11:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brilinta-significantly-reduced-the-rate-of-the-composite-of-stroke-and-death-in-patients 2020-07-16 07:07:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-third-nintedanib-indication-in-pulmonary-fibrosis 2020-07-16 05:49:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tevogen-bio-announces-steps-toward-a-proprietary-t-cell-therapy-for-treatment-of-covid-19-development-of-bivalent-vaccine-for-covid-19-influenza 2020-07-15 22:32:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-and-immuneoncia-sign-multi-product-development-and-manufacturing-agreement 2020-07-15 22:21:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/byondis-initiates-phase-ii-study-of-antibody-drug-conjugate-vic-trastuzumab-duocarmazine-in-advanced-endometrial-cancer 2020-07-15 02:51:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tremfya-guselkumab-approved-by-us-food-and-drug-administration 2020-07-15 02:46:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-announces-fda-advisory-committee-votes-in-favour-of-positive-benefit 2020-07-15 02:32:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-collaborates-with-blueprint-medicines-to-bring-a-new-treatment-to-people-with-ret-altered-cancers 2020-07-15 02:29:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-for-inflazomes-inzomelid-for-the-treatment-of-cryopyrin-associated-periodic-syndromes-caps 2020-07-14 23:20:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-biology-and-kintor-to-collaborate-on-the-use-of-proxalutamide-for-the-treatment-of-covid-19 2020-07-14 23:11:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-announces-first-patient-dosed-in-part-b-of-phase-study 2020-07-14 22:23:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celyad-oncology-announces-fda-clearance-of-ind-application-for-cyad-211 2020-07-14 22:21:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arch-biopartners-engages-global-cro-to-conduct-lsalt-peptide-phase-ii-trial 2020-07-14 22:19:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invivoscribe-launches-new-division-for-drug-development 2020-07-14 22:18:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-initiation-of-new-phase-iii-clinical-study-ahead-3-45-of-ban2401-preclinical-asymptomatic-alzheimers-disease 2020-07-14 00:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-first-patient-treated-in-phase-1-trial-of-rp-l301-gene-therapy-for-pyruvate-kinase-deficiency 2020-07-14 00:03:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-granted-fda-fast-track-designation-for-two-investigational-mrna-based-vaccine-candidates-against-sars-cov-2 2020-07-13 23:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-data-from-phase-iiib-study-reinforces-safety-profile-of-roches-hemlibra-in-people-with-haemophilia-a 2020-07-13 06:38:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-provides-update-on-phase-iii-study-of-tecentriq-in-women-with-advanced-stage-ovarian-cancer 2020-07-13 06:36:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-industry-academia-government-joint-development-agreement 2020-07-13 00:01:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luina-bio-and-xing-technologies-set-to-manufacture-new-and-fast-sars-cov-2-diagnostic-kit 2020-07-12 23:23:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spark-therapeutics-announces-updated-data-on-spk-8011-from-phase-12-clinical-trial-in-hemophilia-a-at-isth-2020-virtual-congress 2020-07-12 22:55:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-expanded-botox-onabotulinumtoxina-label-for-the-treatment-of-pediatric-patients-with-spasticity 2020-07-11 06:59:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-phase-iii-iridium-data-in-lancet-respiratory-medicine 2020-07-11 06:56:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-presents-additional-data-on-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19 2020-07-11 06:52:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hemoshear-therapeutics-achieves-milestone-in-exclusive-drug-discovery-collaboration-with-horizon-therapeutics-in-gout 2020-07-10 23:11:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-opens-its-largest-m-lab-collaboration-center-in-shanghai 2020-07-10 02:59:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/osmotica-pharmaceuticals-plc-receives-fda-approval-for-upneeq 2020-07-10 02:59:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kymera-therapeutics-and-sanofi-enter-into-strategic-partnership-to-advance-novel-protein-degrader-therapies-to-patients 2020-07-10 02:54:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-for-keytruda 2020-07-10 02:06:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-establishes-center-of-excellence-for-integrated-dry-powder-inhaler-product-development-services 2020-07-09 23:58:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/assembly-biosciences-announces-fda-fast-track-designation-granted-to-abi-h2158-for-the-treatment-of-chronic-hepatitis-b-virus-infection 2020-07-09 23:01:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tris-pharma-and-kye-pharmaceuticals-announce-exclusive-license-agreement-to-commercialize-tris-adhd-products-in-canada 2020-07-09 22:36:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brilinta-granted-fda-priority-review-for-the-reduction-of-subsequent-stroke-in-patients-who-had-an-acute-ischemic-stroke-or-transient-ischemic-attack 2020-07-09 04:01:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-manufacturing-and-supply-agreement-for-barda-and-us-department-of-defense-for-regn-cov2-anti-viral-antibody-cocktail 2020-07-09 03:59:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cepi-expands-partnership-with-clover-biopharmaceuticals 2020-07-09 03:53:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-completes-submission-of-biologics-license-application-to-fda-for-aducanumab-as-a-treatment-for-alzheimers-disease 2020-07-09 01:17:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-merck-receive-complete-response-letter-for-lenvima-plus-keytruda 2020-07-09 01:12:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-further-expands-its-development-service-with-new-site-in-austria 2020-07-08 23:53:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-new-drug-application-for-in-house-developed-new-anti-insomnia-drug-dayvigo-accepted-in-hong-kong 2020-07-08 23:47:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/virtual-patient-experience-innovation-summit-2020 2020-07-08 23:44:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reflexion-and-telix-pharmaceuticals-announce-strategic-collaboration-for-treatment-of-high-risk-cancers 2020-07-08 22:40:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/concert-pharmaceuticals-receives-fda-breakthrough-therapy-designation-for-ctp-543-for-the-treatment-of-alopecia-areata 2020-07-08 22:35:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynparza-approved-in-the-eu-for-brca-mutated-metastatic-pancreatic-cancer 2020-07-08 04:47:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-and-medicago-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-candidate-vaccine 2020-07-08 04:45:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viiv-healthcare-announces-superior-efficacy-of-investigational 2020-07-08 04:42:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-receives-ec-approval-for-enerzair-breezhaler 2020-07-08 04:40:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corvus-pharmaceuticals-initiates-clinical-trial-of-novel-immunotherapy 2020-07-07 23:22:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/soundny-presents-a-new-drug-based-alternative-in-fight-against-cancer 2020-07-07 23:20:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-new-analyses-showing-additional-safety-and-efficacy 2020-07-07 23:19:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hibercell-announces-acquisition-of-biothera-pharmaceuticals-imprime-pgg-program 2020-07-07 22:57:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plakous-therapeutics-awarded-17-million-fast-track-sbir-grant-from-nih-to-develop-therapies-for-necrotizing-enterocolitis 2020-07-07 22:54:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aboundbio-licenses-potent-human-antibodies-against-the-sars-cov-2-virus-that-causes-covid-19-to-saudivax-ltd-for-clinical-development 2020-07-07 22:53:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-acquisition-of-fluconazole-tablets 2020-07-06 23:39:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eusa-pharma-announces-fda-approval-for-phase-3-clinical-study-to-study-siltuximab-in-hospitalized-patients-with-covid-19-related-acute-respiratory-distress-syndrome 2020-07-06 23:32:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergent-biosolutions-signs-five-year-agreement 2020-07-06 06:59:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-announces-clinical-trial-collaboration-agreement-with-msd 2020-07-06 06:58:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-and-vetter-team-up-with-joint-goal-to-simplify-processes 2020-07-06 03:43:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-regulation-ltd-partners-with-dynport-vaccine-company-to-advance-its-drug-product 2020-07-06 01:42:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-launch-in-house-developed-new-anti-insomnia-drug-dayvigo-lemborexant-with-indication-for-insomnia-in-japan 2020-07-05 23:47:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-new-fine-granule-formulation-of-anti-epileptic-drug-fycompa-launched-in-japan 2020-07-05 23:41:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytodyn-announces-execution-of-exclusive-agreement-with-american-regent-for-distribution-and-supply-of-leronlimab 2020-07-05 23:42:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/affinity-discovers-potent-antibodies-to-sars-cov-2 2020-07-03 23:07:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-regeneron-provide-update-on-kevzara-sarilumab-phase-us-trial 2020-07-03 05:47:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-announces-european-commission-approval-for-janssens-preventive-ebola-vaccine 2020-07-03 05:44:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-partners-with-dr-reddys-and-global-response-aid-for-deployment 2020-07-03 05:42:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intravacc-to-in-license-cimcures-iboost-technology 2020-07-03 05:40:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liminal-biosciences-joins-covig-plasma-alliance-to-contribute-to-development-of-potential-new-covid-19-therapy 2020-07-02 22:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-hiv-treatment-for-patients-with-limited-treatment-options 2020-07-02 22:27:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/osteolabs-gmbh-provides-further-validation-for-use-of-osteotest-in-osteoporosis 2020-07-02 07:05:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cambrex-increases-flexible-manufacturing-capacity-at-karlskoga-sweden-facility 2020-07-02 03:05:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-ridgeback-bio-announce-closing-of-collaboration-and-licensing-transaction 2020-07-02 02:52:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-biontech-announce-early-positive-data-from-an-ongoing-phase-12-study 2020-07-02 02:53:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-particle-engineering-services 2020-07-01 23:56:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metvital-inc-announces-fda-fast-track-designation-of-anhydrous-enol-oxaloacetate-aeo-for-the-treatment-of-patients-with-newly-diagnosed-glioblastoma-multiforme 2020-07-01 22:22:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isa-pharmaceuticals-receives-us-orphan-drug-designation-for-isa101b-in-hpv16-positive-cervical-cancer 2020-07-01 22:21:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ajinomoto-bio-pharma-services-introduces-ajility-fast-track-platform-for-drug-product-manufacturing 2020-07-01 01:07:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/completion-of-biotech-packaging-center-of-excellence-in-philadelphia-expansions-in-europe 2020-07-01 01:06:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avantor-expands-life-sciences-innovation-center-to-address-bioprocessing-needs-in-protein-science 2020-07-01 01:03:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-daurismo-glasdegib-for-certain-adult-patients 2020-07-01 01:00:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-bavencio-as-first-line-maintenance-treatment-for-patients 2020-07-01 00:57:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selumetinib-granted-orphan-drug-designation-in-japan-for-neurofibromatosis-type-1 2020-07-01 00:52:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncomine-precision-assay-receives-breakthrough-device-designation-by-the-us-fda 2020-07-01 00:49:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allmpus-laboratories-embraces-local-manufacturing-of-pharmaceutical-essentials 2020-07-01 00:42:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marker-therapeutics-announces-new-manufacturing-facility-to-support-clinical-development-of-multitaa-specific-t-cell-therapy-product-candidates 2020-06-30 23:04:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mediwound-announces-submission-of-biologics-license-application-to-the-us-fda-for-nexobrid-for-the-treatment-of-severe-thermal-burns 2020-06-30 23:03:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-orphan-drug-designation-odd-for-prestige-biopharmas-pbp1510-anti-pauf-monoclonal-antibody 2020-06-30 06:10:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-phesgo-fixed-dose-combination-of-perjeta-and-herceptin-for-subcutaneous-injection-for-her2-positive-breast-cancer 2020-06-30 00:27:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roches-enspryng-satralizumab-approved-in-japan 2020-06-30 00:22:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-mercks-keytruda-for-first-line-treatment 2020-06-30 00:19:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-receives-first-regulatory-approval-for-duvroq-daprodustat-in-japan 2020-06-30 00:14:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-met-inhibitor-tabrecta-approved-in-japan 2020-06-30 00:08:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipa-confirms-discovery-of-fully-human-potent-neutralizing-antibodies-targeting-sars-cov-2 2020-06-29 23:00:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revimmune-announces-phase-ii-trial-of-the-t-cell-growth-factor-cyt107-for-covid-19 2020-06-29 22:57:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuneering-enters-collaboration-with-astex-pharmaceuticals-to-identify-novel 2020-06-29 03:48:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oblique-therapeutics-and-targovax-enter-collaboration-to-target-mutant-ras-cancers 2020-06-29 03:45:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rybelsus-approved-in-japan-for-the-treatment-of-type-2-diabetes 2020-06-29 03:44:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avalon-globocare-achieves-milestones-in-advancing-novel-intranasal-and-oral-covid-19-vaccine-candidate 2020-06-27 01:51:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-fintepla-fenfluramine-for-the-treatment-of-seizures-associated-with-dravet-syndromefda-approves-fintepla-fenfluramine-for-the-treatment 2020-06-27 01:50:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-approves-reblozyl-luspatercept-for-the-treatment 2020-06-27 01:40:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-expands-global-rental-network-in-incheon-south-korea 2020-06-27 01:04:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltex-therapeutics-receives-another-fda-approval-phase-ii-clinical-trial-using-mesenchymal-stem-cells-mscs-as-a-prophylactic-against-covid-19 2020-06-26 22:45:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sal-launches-its-pharma-facilities-at-kfia-cargo-village-with-operational-capacity-of-14000-tons-a-year 2020-06-26 03:07:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-improves-speed-and-accuracy-of-non-small-cell-lung-cancer-diagnosis 2020-06-26 01:08:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-sciences-secures-exclusive-option-to-acquire-pionyr-immunotherapeutics 2020-06-26 01:04:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-translate-bio-expand-collaboration-to-develop-mrna-vaccines 2020-06-26 01:01:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stevanato-group-signs-an-agreement-with-the-coalition-for-epidemic-preparedness-innovations-cepi-to-provide-pharma-glass-vials-for-2-billion-doses-of-covid-19-vaccines-under-development 2020-06-25 22:35:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/babson-diagnostics-receives-fda-emergency-use-authorization-for-its-sars-cov-2-igg-antibody-test 2020-06-25 22:31:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-mercks-keytruda-pembrolizumab-for-the-treatment-of-patients-with-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma-cscc-that-is-not-curable-by-surgery-or-radiation 2020-06-25 04:32:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-receives-anda-approval-for-fingolimod-capsules 2020-06-25 04:14:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-becomes-the-first-pharmaceutical-company-in-india-to-receive-regulatory-approval-for-oral-antiviral-favipiravir 2020-06-25 04:14:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/honeywell-expedites-development-and-production-of-vital-vaccines-and-medical-therapies-with-fast-track-automation 2020-06-25 00:20:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-regulators-discuss-data-requirements-for-phase-3-trials-of-covid-19-vaccines 2020-06-25 00:13:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viracta-therapeutics-announces-orphan-drug-designation-granted-for-the-treatment-of-t-cell-lymphoma 2020-06-24 22:52:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kd-pharma-group-and-herbolea-biotech-sign-licensing-agreement-for-use-of-bio-herbolysis-extraction-technology 2020-06-24 22:49:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/frontier-scientific-develops-and-provides-process-to-produce-active-pharmaceutical-ingredient-for-clinical-trial-of-covid-19-therapeutic-investigational-drug-rbt-9 2020-06-23 22:37:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renibus-therapeutics-receives-fda-fast-track-designation-for-rbt-9-treatment-in-covid-19 2020-06-23 22:34:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/esperion-and-daiichi-sankyo-europe-announce-amendment-to-license-and-commercial-collaboration-agreement 2020-06-22 22:54:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-announces-ind-clearance-for-a-phase-2-trial-of-heptcell-immunotherapeutic-for-the-treatment-of-chronic-hepatitis-b 2020-06-22 22:52:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-to-showcase-new-analytical-instruments-at-virtual-conference 2020-06-21 23:20:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terns-pharmaceuticals-launches-phase-2a-clinical-trial-lift-of-tern-101-for-treatment-of-nash 2020-06-21 22:49:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ridgeback-biotherapeutics-announces-launch-of-phase-2-trials-testing-eidd-2801-as-potential-treatment-for-covid-19 2020-06-19 22:55:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/application-of-immtor-plus-sareptas-investigational-gene-therapies-will-be-evaluated-for-duchenne-muscular-dystrophy-and-limb-girdle-muscular-dystrophies 2020-06-18 23:03:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tff-pharmaceuticals-receives-orphan-drug-designation-for-tacrolimus-inhalation-powder 2020-06-18 22:56:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leading-pharma-packaging-companies-commit-to-supply-for-covid-19-fight 2020-06-18 06:52:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-presents-the-maiden-pharma-gmp-gcp-quality-management-2020 2020-06-18 02:10:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ptc-therapeutics-announces-the-initiation-of-a-phase-23-clinical-trial-to-evaluate-ptc299-for-the-treatment-of-covid-19 2020-06-17 22:51:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hepcidin-mimetic-ptg-300-receives-us-fda-orphan-drug-designation-for-the-treatment-of-polycythemia-vera 2020-06-17 22:36:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agex-therapeutics-and-pluristyx-announce-manufacturing-marketing-and-distribution-agreement-to-expand-access-to-clinical-grade-human-pluripotent-stem-cells-for-therapeutic-applications 2020-06-16 22:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trialspark-announces-launch-of-project-covalence-a-clinical-trial-platform-to-rapidly-test-drugs-and-diagnostics-for-covid-19 2020-06-16 22:41:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-signs-agreement-with-astrazeneca-to-manufacture-covid-19-vaccine-candidate 2020-06-15 22:55:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ligand-announces-an-expansion-of-vernalis-collaboration-with-servier-for-research-on-novel-oncology-targets 2020-06-15 22:54:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neoimmunetech-receives-fda-orphan-drug-designation-for-nt-i7-efineptakin-alfa-for-the-treatment-of-progressive-multifocal-leukoencephalopathy 2020-06-15 05:53:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mydecine-innovations-group-inc-signs-partnership-agreement-with-applied-pharmaceutical-innovation 2020-06-12 22:47:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mylan-and-biocon-announce-us-fda-approval-of-semglee-insulin-glargine-injection 2020-06-11 22:40:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sinovac-and-butantan-join-efforts-to-advance-the-clinical-development-of-an-inactivated-vaccine-for-covid-19-to-phase-iii 2020-06-11 22:32:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anthos-therapeutics-partners-with-lonza-to-develop-and-manufacture-abelacimab-maa868-a-unique-dual-factor-xi-xia-inhibitor 2020-06-11 08:33:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellink-and-lonza-join-forces-to-offer-complete-3d-cell-culture-workflows 2020-06-11 08:12:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/melinta-therapeutics-enters-into-agreement-to-acquire-tetraphase-pharmaceuticals 2020-06-10 22:47:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curis-announces-fda-clearance-of-ind-application-for-ci-8993-the-first-in-class-monoclonal-anti-vista-antibody 2020-06-10 22:31:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/latest-data-support-continued-use-of-ace-inhibitors-and-arb-medicines-during-covid-19-pandemic 2020-06-10 05:25:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-support-counter-measures-against-the-spread-of-the-novel-coronavirus-infection-in-africa 2020-06-10 02:59:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/researchers-identify-the-impact-of-bacterial-co-infections-and-antimicrobial-resistance-in-covid-19 2020-06-10 02:56:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cresset-and-inocardia-to-develop-in-silico-cardiac-safety-assay-for-drug-candidate-screening 2020-06-10 02:53:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptive-phage-therapeutics-enters-agreement-with-mayo-clinic-to-commercialize-a-phage-susceptibility-test 2020-06-09 22:48:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/twist-bioscience-partners-with-serimmune-to-identify-sars-cov-2-therapeutic-antibody-candidates 2020-06-09 22:43:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ema-receives-application-for-conditional-authorisation-of-first-covid-19-treatment-in-the-eu 2020-06-09 01:52:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/joonghun-pharmaceutical-of-korea-targets-overseas-markets-for-coronavirus-diagnostic-kits 2020-06-08 23:53:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cleveland-clinic-research-confirms-no-association-between-certain-chronic-disease-medications-and-covid-19 2020-06-08 23:50:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intravacc-and-versatope-sign-research-service-agreement-to-develop-universal-influenza-vaccine-based-on-omv-technology 2020-06-08 23:44:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ai-to-deliver-next-evolution-of-drug-manufacturing-and-supply-chain-efficiency 2020-06-08 23:40:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clean-cold-experts-explore-how-people-in-africa-can-access-covid-19-vaccine 2020-06-08 23:37:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharmas-purehaletm-upper-respiratory-device-launches-with-blairex-laboratories-breathe-free-essentials-brand 2020-06-08 23:31:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teneobio-enters-a-research-collaboration-and-licensing-agreement-to-develop-next-generation-engineered-cell-therapies-with-intellia-therapeutics 2020-06-08 22:37:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/algotherapeutix-announces-orphan-drug-designation-granted-by-fda-for-atx01-in-erythromelalgia 2020-06-08 22:30:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rousselot-introduces-x-pure-gelma-for-translational-medicine 2020-06-08 05:34:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-presents-positive-phase-3-results-from-illuminate-a-study-of-lumasiran-an-investigational-rnai-therapeutic-for-treatment-of-primary-hyperoxaluria-type-1 2020-06-07 22:36:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-harbour-biomed-utrecht-university-and-erasmus-medical-center-announce-collaboration-to-develop-monoclonal-antibody-therapy-to-prevent-and-treat-covid-19 2020-06-05 22:41:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aldeyra-therapeutics-reaches-agreement-with-the-us-food-and-drug-administration-for-the-use-of-rasp-as-an-objective-sign-for-the-treatment-of-dry-eye-disease 2020-06-04 22:57:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synedgen-receives-fda-510k-clearance-for-synvaza-mouth-sore-and-wound-rinse 2020-06-04 22:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/swift-biosciences-and-arbor-biosciences-partner-on-targeted-ngs-workflows-for-coronavirus 2020-06-03 23:09:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-2020-implements-new-informa-allsecure-standard 2020-06-03 22:34:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cordenpharma-moderna-extend-lipid-supply-agreement-for-modernas-coronavirus-vaccine-mrna-1273 2020-06-03 02:18:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/treadwell-therapeutics-announces-us-fda-clearance-of-ind-application-for-phase-12-study-of-hpk1-inhibitor-cfi-402411 2020-06-02 23:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-presents-the-webinar-on-advanced-pharma-tech 2020-06-02 06:42:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytosmart-technologies-announces-the-launch-of-the-cytosmart-lux2-duo-kit 2020-06-02 05:15:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-launches-new-insomnia-drug-dayvigo-lemborexant-civ-in-the-united-states-as-a-treatment-option-for-adults-with-insomnia 2020-06-02 00:34:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aveo-oncology-announces-fda-acceptance-for-filing-of-a-new-drug-application-for-tivozanib-as-a-treatment-of-relapsed-or-refractory-renal-cell-carcinoma 2020-06-02 00:04:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codiak-biosciences-collaborates-with-ragon-institute-to-evaluate-the-exovacc-vaccine-platform-in-sars-cov-2-and-hiv 2020-06-01 23:40:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-announces-positive-preclinical-results-from-its-treatment-against-covid-19-based-on-an-antiviral-antibody-with-proven-reduction-in-healing-times 2020-05-31 23:29:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nabriva-therapeutics-receives-positive-eu-chmp-opinion-for-xenleta-lefamulin-for-the-treatment-of-community-acquired-pneumonia-cap 2020-05-29 23:46:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-receives-positive-chmp-opinion-for-janssens-investigational-preventive-ebola-vaccine-regimen 2020-05-29 23:43:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-expands-emprove-portfolio-with-chromatography-resins 2020-05-29 00:47:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-wins-axia-best-managed-companies-award 2020-05-29 00:45:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/premier-inc-providegx-program-partners-with-hikma-pharmaceuticals-to-secure-the-supply-of-two-drugs-essential-for-covid-19-patient-care 2020-05-28 23:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-drug-to-image-tau-pathology-in-patients-being-evaluated-for-alzheimers-disease 2020-05-28 23:11:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-extends-collaboration-with-genmab-to-us-facility 2020-05-28 00:50:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microbion-corporation-announces-orphan-drug-designation-granted-for-pravibismane-suspension-for-inhalation-by-us-fda 2020-05-27 23:26:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensei-biotherapeutics-completes-acquisition-of-alvaxa-biosciences-a-camelid-antibody-therapeutics-company 2020-05-27 23:25:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protara-therapeutics-receives-fast-track-designation-from-us-fda-for-intravenous-choline-chloride-for-the-treatment-of-intestinal-failure-associated-liver-disease 2020-05-26 23:17:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ceapro-inc-expands-collaborative-research-program-with-mcmaster-university-to-develop-inhalable-therapeutic-for-covid-19 2020-05-26 23:15:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seranovo-enters-into-a-second-license-agreement-with-carna-biosciences-for-development-of-oral-formulation-of-carnas-kinase-inhibitor 2020-05-26 04:26:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-dosed-in-a-phase-1-clinical-trial-of-anti-tigit-monoclonal-antibody-in-china 2020-05-25 23:31:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/algernon-submits-investigational-new-drug-ind-application-with-us-fda-for-multinational-phase-2b3-human-study-to-evaluate-ifenprodil-for-covid-19 2020-05-25 07:57:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zealand-pharma-announces-fda-acceptance-of-new-drug-application-for-the-dasiglucagon-hypopal-rescue-pen-for-treatment-of-severe-hypoglycemia 2020-05-22 23:15:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-advances-royalty-monetization-plan-as-sunovion-pharmaceuticals-apomorphine-sublingual-film-therapy-receives-fda-approval 2020-05-21 23:28:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akari-therapeutics-receives-positive-ema-opinion-on-orphan-designation-for-nomacopan-for-bullous-pemphigoid 2020-05-21 23:18:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boragen-collaborates-with-dole-to-develop-boron-based-treatment-for-major-banana-disease 2020-05-20 23:34:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-octapharma-usa-investigational-new-drug-application-for-severe-covid-19-patients 2020-05-20 23:27:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/airway-therapeutics-and-celonic-group-collaborate-to-produce-at-100-as-promising-new-candidate-for-coronavirus 2020-05-20 21:14:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/archerdx-receives-breakthrough-device-designation-to-detect-ntrk-gene-fusions 2020-05-19 23:40:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vibalogics-announces-collaboration-to-provide-additional-clinical-trial-material 2020-05-19 22:00:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgen-therapeutics-receives-ind-clearance-from-the-us-fda-for-ct041-cldn182-car-t-cells 2020-05-18 23:29:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-launch-new-selbelle-premium-tablets-and-new-selbelle-premium-fine-granules 2020-05-18 00:46:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orexos-partner-gesynta-pharma-announces-positive-results-from-phase-1-study-for-ox-mpi 2020-05-15 23:56:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellphire-announces-orphan-drug-designation-of-thrombosomes-for-treatment-of-acute-radiation-syndrome 2020-05-15 23:21:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/how-to-process-powders-efficiently 2020-05-15 04:47:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-and-nec-demonstrate-high-accuracy-of-ai-based-neoantigen-prediction-for-the-design-of-individualized-cancer-vaccine-tg4050 2020-05-15 03:00:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/predictive-oncology-nasdaq-symbol-poai-is-licensing-and-partnering-this-groundbreaking-nsp10-technology-in-the-race-to-develop-a-vaccine-for-development 2020-05-14 23:33:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuraptive-therapeutics-announces-fda-has-granted-fast-track-designation-to-ntx-001-clinical-development-program-for-treatment-of-patients-with-peripheral-nerve-injuries 2020-05-14 23:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-signs-exclusive-agreement-with-xeris-pharmaceuticals 2020-05-14 01:45:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rhythm-pharmaceuticals-announces-fda-acceptance-of-new-drug-application-for-setmelanotide-for-the-treatment-of-pomc-and-lepr-deficiency-obesities 2020-05-13 23:57:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-clears-agentus-ind-for-allogeneic-inkt-cell-therapy 2020-05-13 23:34:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neutec-aids-in-the-fight-against-covid19-with-automated-tube-fillers 2020-05-13 07:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-new-exome-and-custom-kapa-target-enrichment-portfolio-for-translational-and-clinical-research-applications-in-sequencing 2020-05-12 23:32:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-receives-fda-fast-track-designation-for-mrna-vaccine-mrna-1273-against-novel-coronavirus 2020-05-12 23:19:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acer-therapeutics-to-develop-emetine-as-potential-covid-19-treatment-in-collaboration-with-national-center-for-advancing-translational-sciences-one-of-the-national-institutes-of-health 2020-05-11 23:54:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-and-colorado-center-for-personalized-medicine-announce-major-new-human-genetics-research-collaboration 2020-05-11 23:29:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitachi-chemical-advanced-therapeutics-solutions-and-apceth-biopharma-gmbh-enter-into-strategic-clinical-and-commercial-manufacturing 2020-05-11 06:51:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orexo-acquires-exclusive-us-rights-to-commercialize-deprexis-a-world-leading-digital-therapy-to-help-patients-manage-the-symptoms-of-depression 2020-05-11 06:46:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/7th-emirates-physiotherapy-conference-goes-virtual 2020-05-11 06:39:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanderbilt-university-medical-center-and-idbiologics-ally-in-race-to-develop-breakthrough-medicines-for-covid-19 2020-05-08 23:22:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-fair-asia-2020-postponed-to-9-11-december-2020 2020-05-08 00:10:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-manufacturing-asia-2020-has-been-cancelled 2020-05-08 00:06:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avectas-and-onk-therapeutics-to-develop-off-the-shelf-cancer-therapy 2020-05-07 23:50:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-the-ind-clearance-of-bbt-176-an-egfr-tki-for-nsclc-in-south-korea 2020-05-07 23:31:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/digital-science-reports-that-just-of-global-research-output-relates 2020-05-07 06:15:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-targeted-therapy-to-treat-aggressive-form-of-lung-cancer 2020-05-06 23:35:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-fda-approval-of-met-inhibitor-tabrecta-for-metastatic-non-small-cell-lung-cancer-with-metex14 2020-05-06 23:33:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ajinomoto-bio-pharma-services-announces-manufacturing-partnership-with-cytodyn-for-drug-product-used-in-covid-19-clinical-trials 2020-05-06 00:37:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crescendo-biologics-and-cancer-research-uk-sign-clinical-development-partnership-to-develop-cb213-a-novel-bispecific-humabody-therapeutic 2020-05-06 00:05:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/introducing-samplix-services-pcr-free-single-molecule-target-selection 2020-05-05 06:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/d-flex-a-new-generation-of-manual-injection-pens-from-haselmeier-wins-red-dot-for-outstanding-design-quality 2020-05-05 04:00:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/applied-biomath-llc-announces-collaboration-with-zymeworks 2020-05-04 23:34:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine 2020-05-04 23:14:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/domain-therapeutics-receives-development-milestone-payment-from-merck-kgaa 2020-05-04 23:08:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rescheduled-cphi-south-east-asia-to-now-take-place-in-november 2020-05-04 07:52:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharmas-core-drug-candidate-hqp1351-granted-orphan-drug-designation-by-the-us-fda-for-the-treatment-of-patients-with-chronic-myeloid-leukemia 2020-05-04 05:19:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essa-pharma-announces-fda-allowance-of-the-clinical-investigation-of-epi-7386-in-prostate-cancer 2020-05-01 23:39:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/interphex-announces-new-show-dates 2020-05-01 23:20:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hardy-diagnostics-increases-manufacturing-to-meet-demand-for-covid-19-related-products 2020-04-30 23:57:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-hardy-diagnostics-emergency-use-authorization-eua-for-a-rapid-antibody-test-kit-for-covid-19 2020-04-30 23:55:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/notable-and-mds-foundation-announce-partnership-to-collaborate-on-clinical-mds-trials-and-advance-drug-therapies-for-mds-patients 2020-04-30 23:29:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seelos-therapeutics-receives-orphan-drug-designation-for-sls-005-trehalose-in-sanfilippo-syndrome 2020-04-30 23:28:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/food-beverage-online21food 2020-05-14 01:16:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marker-therapeutics-receives-fda-orphan-drug-designation-for-its-multi-antigen-targeted-t-cell-therapy-for-acute-myeloid-leukemia 2020-04-29 23:40:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuraptive-therapeutics-announces-fda-approval-of-ind-application-for-new-drug-ntx-001-for-treatment-of-patients-with-peripheral-nerve-impairment 2020-04-29 23:37:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteogenix-announces-a-new-human-covid-19-antibody-library-to-accelerate-the-discovery 2020-04-29 07:04:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytosmart-to-donate-100-live-cell-imaging-systems-to-assist-covid-19-researchers 2020-04-29 06:53:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioeclipse-receives-fda-clearance-of-investigational-new-drug-application-for-crx100 2020-04-28 23:33:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbios-bemcentinib-selected-to-be-fast-tracked-as-potential-treatment-for-covid-19-through-new-national-uk-government-clinical-trial-initiative 2020-04-28 23:20:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rome-therapeutics-launches-to-develop-novel-therapies-for-cancer-and-autoimmune-diseases-by-harnessing-the-power-of-the-repeatome 2020-04-27 23:32:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-pharmaceuticals-and-affinia-therapeutics-establish-multi-year-collaboration-to-discover-and-develop-novel-aav-capsids-for-genetic-therapies 2020-04-27 23:29:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calliditas-provides-a-corporate-business-update-in-the-context-of-the-covid-19-pandemic 2020-04-27 05:08:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-expands-distributor-base-worldwide 2020-04-27 00:55:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptvac-teams-up-with-agc-biologics-to-develop-and-produce-covid-19-vaccine 2020-04-26 23:40:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-and-eli-lilly-announce-nmpa-acceptance-of-a-supplemental-new-drug-application-for-sintilimab-in-combination-with-alimta-pemetrexed-and-platinum-as-first-line-therapy 2020-04-24 00:05:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-orphan-drug-designation-to-amidebios-glucagon-analog-for-the-treatment-of-congenital-hyperinsulinism 2020-04-23 23:33:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/interphex-and-chemspec-usa-announce-new-show-dates-for-2020 2020-04-22 23:56:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epimab-biotherapeutics-and-qimr-berghofer-medical-research-institute-announce-research-collaboration-and-license-agreement-on-novel-bispecific-target-combinations 2020-04-22 23:29:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocean-biomedical-announces-groundbreaking-malaria-vaccine-discovery 2020-04-22 23:28:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novelstem-announces-new-research-collaborations-for-stem-cell-technology-platform-in-cancer-immunotherapy-and-covid-19-resistance 2020-04-21 23:47:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-and-navitor-announce-development-and-option-agreement-for-orally-active-mtorc1-activator-nv-5138 2020-04-21 23:43:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-high-performance-is-again-recognized-at-the-2020-cmo-leadership-awards 2020-04-21 08:20:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precisionlife-offers-analytics-and-resource-support-to-covid-19-coronavirus-research-community 2020-04-21 05:37:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-announces-agreement-with-imquest-biosciences-to-expand-coronavirus-testing 2020-04-20 23:58:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcenta-received-ind-clearance-from-fda-for-initiating-clinical-trials-for-its-novel-humanized-claudin-182-monoclonal-antibody-tst001 2020-04-20 23:59:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-targeted-treatment-for-patients-with-cholangiocarcinoma-a-cancer-of-bile-ducts 2020-04-19 23:54:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-new-drug-under-international-collaboration-a-treatment-option-for-patients-with-her2-positive-metastatic-breast-cancer 2020-04-17 23:50:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-and-ubirch-create-secure-blockchain-solution-for-the-successful-fight-against-covid-19 2020-04-17 23:49:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sense-accelerates-instrument-free-molecular-diagnostic-test-for-covid-19 2020-04-17 07:30:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autolus-therapeutics-announces-fda-acceptance-of-ind-application-for-auto1-for-adult-acute-lymphoblastic-leukemia 2020-04-17 00:32:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sab-biotherapeutics-advances-therapeutic-for-covid-19-in-partnership-with-department-of-defense-and-barda 2020-04-17 00:30:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galapagos-and-ryvu-announce-research-collaboration 2020-04-16 01:11:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forma-therapeutics-receives-fda-orphan-drug-designation-for-ft-4202-for-the-treatment-of-sickle-cell-disease 2020-04-16 00:53:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halix-enters-collaboration-with-the-university-of-oxford-for-gmp-manufacturing-of-a-covid-19-vaccine 2020-04-15 07:11:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-covid-19-clinical-trial-tracker-launched-by-cytel 2020-04-15 05:13:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ori-biotech-partners-with-achilles-therapeutics-to-test-novel-cell-therapy-manufacturing-platform 2020-04-15 00:04:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lifemax-receives-fast-track-designation-for-lm-030-for-the-treatment-of-netherton-syndrome 2020-04-14 23:52:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/can-fite-received-approval-for-covid-19-clinical-trial-in-israel-patient-enrollment-and-dosing-to-commence-immediately 2020-04-13 23:50:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blackstone-and-alnylam-enter-into-2-billion-strategic-financing-collaboration-to-accelerate-the-advancement-of-rnai-therapeutics 2020-04-13 23:37:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dec-group-announces-the-acquisition-of-inno4life 2020-04-12 22:44:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tiziana-lifesciences-develops-novel-investigational-treatment-for-patients-infected-with-covid-19-utilizing-direct-delivery-of-anti-interlukin-6-receptor-monoclonal-antibodies 2020-04-09 21:31:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-expands-strategic-collaboration-with-united-therapeutics-corporation-to-covid-19-infection-and-acute-respiratory-distress-syndrome 2020-04-09 21:32:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-expands-passenger-freighter-coverage-as-it-continues-to-deliver-essential-supplies-to-uae-and-the-world 2020-04-09 01:50:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aeglea-biotherapeutics-announces-approval-of-clinical-trial-application-for-its-novel-engineered-human-enzyme-designed-to-treat-homocystinuria-acn00177 2020-04-09 00:12:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/komodo-health-teams-up-with-karyopharm-therapeutics-to-accelerate-new-global-clinical-trial-to-treat-patients-with-covid-19 2020-04-08 23:49:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accelerates-development-of-novel-therapies-for-covid-19 2020-04-08 00:09:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polaryx-therapeutics-receives-ind-approval-from-the-fda-to-study-plx-200-treatment-for-patients-with-juvenile-neuronal-ceroid-lipofuscinosis 2020-04-08 00:07:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/queens-university-leading-cell-therapy-clinical-trial-to-help-improve-outcomes-in-covid-19-patients 2020-04-07 23:44:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thyrocare-has-slashed-down-covid-19-test-pricing 2020-04-07 23:37:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/electronic-patient-record-provider-patientsource-to-offer-slimmed-down-version-of-their-software-in-response-to-coronavirus-pandemic 2020-04-07 10:31:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/who-and-tencent-deepened-collaboration-to-fight-against-covid-19 2020-04-07 05:39:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ogt-delivers-translocation-and-partial-tandem-duplication-detection-with-updates-to-sureseq-ngs-portfolio 2020-04-07 05:17:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hope-biosciences-receives-fda-approval-to-commence-first-stem-cell-clinical-trial-for-protection-against-covid-19 2020-04-06 23:53:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-and-dicerna-form-rnai-therapeutics-collaboration-on-alpha-1-antitrypsin-deficiency-associated-liver-disease-and-complete-cross-license-agreement-for-primary-hyperoxaluria-programs 2020-04-06 23:50:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oxthera-announces-completion-of-recruitment-in-phase-3-ephex-study-with-oxabact-in-patients-with-primary-hyperoxaluria 2020-04-06 06:14:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iveric-bio-announces-fast-track-designation-from-us-fda-for-zimura-for-the-treatment-of-geographic-atrophy-secondary-to-dry-age-related-macular-degeneration 2020-04-03 23:43:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-covid-19-at-home-test-with-social-distancing-ready-for-validation-study 2020-04-03 07:56:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/digital-science-partners-with-zhipuai-to-conduct-data-challenges-and-build-covid-19-information-portal 2020-04-03 04:07:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sab-biotherapeutics-awarded-27m-contract-to-develop-novel-rapid-response-capability-for-us-department-of-defense 2020-04-03 00:14:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-completes-acquisition-of-movantik-from-astrazeneca 2020-04-03 00:05:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/concert-pharmaceuticals-announces-plans-for-ctp-543-phase-3-trials-in-alopecia-areata 2020-04-02 00:21:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ge-announces-completion-of-biopharma-sale-to-danaher-receives-20-billion-net-cash-proceeds 2020-04-02 00:15:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-seikagaku-enter-into-agreement-for-the-co-development 2020-04-01 04:25:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phio-announces-positive-new-data-validating-the-intasyl-immunotherapy-platforms-ability-to-develop-novel-compounds-capable-of-inhibiting-cancer-tumor-growth 2020-03-31 23:53:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vbi-vaccines-announces-collaboration-with-the-national-research-council-of-canada-to-develop-pan-coronavirus-vaccine-candidate-targeting-covid-19-sars-and-mers 2020-03-31 23:50:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/2020-eppendorf-award-for-young-european-investigators-goes-to-randall-platt 2020-03-31 10:08:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-laboratories-and-deciphex-form-a-partnership-to-enhance-drug-discovery-development-with-digital-pathology 2020-03-30 23:37:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ritedose-selects-chargepoint-technologys-transfer-solution-for-biomanufacturing-project 2020-04-01 00:04:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-launches-new-therapeak-sfaav-medium-to-boost-and-optimize-the-production-of-aav-in-sf9-insect-cells 2020-03-30 07:10:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/with-its-cargo-operations-turkish-cargo-maintains-the-air-bridge-built-by-turkish-airlines 2020-03-30 00:49:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-first-patient-outside-us-treated-in-global-kevzara-sarilumab-clinical-trial-program-for-patients-with-severe-covid-19 2020-03-29 23:54:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cg-oncology-announces-license-and-commercialization-agreement-with-kissei-pharmaceutical-co-ltd-for-cg0070-in-japan-and-other-asian-countries 2020-03-27 00:31:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alector-enters-into-a-licensing-agreement-with-innovent-biologics-to-develop-and-commercialize-al008-in-oncology-indications-in-china 2020-03-26 23:53:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-supports-the-development-of-the-first-vaccine-candidate-against-the-novel-coronavirus-to-enter-clinical-trials 2020-03-25 23:16:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisais-discovery-research-on-multikinase-inhibitor-lenvatinib-honored-with-psj-award 2020-03-25 23:12:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunogenesis-contracts-probiogen-for-development-and-large-scale-manufacturing-services 2020-03-25 23:09:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-biopharmaceuticals-completes-submission-of-new-drug-application-to-fda-for-lonafarnib-for-treatment-of-progeria-and-progeroid-laminopathies 2020-03-23 23:39:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cns-pharmaceuticals-signs-agreement-with-wpd-pharmaceuticals-to-develop-drug-candidates-for-a-range-of-viruses-including-coronavirus-for-international-markets 2020-03-23 23:37:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaccitech-and-oxford-university-announce-promising-phase-2a-data-on-prostate-cancer-immunotherapy 2020-03-23 02:44:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-launch-digital-tool-nouknowtm-in-japan 2020-03-22 23:43:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-cro-tapped-for-two-informa-citeline-awards-for-excellence-in-asia-pacific-clinical-trials 2020-03-21 01:45:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/design-therapeutics-launches-with-45-million-to-develop-a-new-class-of-disease-modifying-therapies-for-serious-degenerative-disorders 2020-03-20 23:44:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rescale-partners-with-google-cloud-and-microsoft-azure-to-accelerate-the-race-for-covid-19-vaccine-with-cloud-supercomputers-for-researchers 2020-03-20 00:23:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-for-pediatric-patients-with-any-strain-of-hepatitis-c 2020-03-20 00:09:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocad-started-working-on-mrna-vaccine-against-coronavirus 2020-03-19 02:35:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/entos-pharmaceuticals-is-developing-a-dna-vaccine-against-covid-19-using-its-fusogenix-nanomedicine-platform 2020-03-18 23:59:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axim-biotechnologies-completes-acquisition-of-oncology-research-and-development-company-sapphire-biotech-inc 2020-03-18 23:54:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luina-bio-and-griffith-university-position-to-develop-coronavirus-vaccine 2020-03-18 02:32:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abeona-therapeutics-announces-first-patient-treated-in-pivotal-phase-iii-clinical-trial-evaluating-eb-101-gene-therapy-for-recessive-dystrophic-epidermolysis-bullosa 2020-03-17 23:53:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altasciences-and-amador-bioscience-announce-strategic-collaboration 2020-03-17 23:46:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schreiner-medipharm-and-kit-check-offer-automated-medication-management-for-hospitals 2020-03-17 07:55:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acelrx-pharmaceuticals-to-acquire-tetraphase-pharmaceuticals 2020-03-17 00:12:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-expands-presence-in-greater-china-region-with-cdo-partnership-for-alzheimers-candidate 2020-03-16 23:51:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/coronavirus-drug-development-update-from-nanoviricides 2020-03-16 05:18:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-johnson-announces-collaboration-with-the-beth-israel-deaconess-medical-center 2020-03-15 23:55:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/denovo-biopharma-announces-breakthrough-discovery-of-a-novel-genetic-biomarker-for-db104-for-depression 2020-03-12 23:44:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-fast-track-designation-to-empagliflozin-for-the-treatment-of-chronic-kidney-disease 2020-03-12 23:40:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanderbilt-vaccine-center-acquires-octet-htx-system-to-speed-antibody-screening 2020-03-11 23:45:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-receives-fda-orphan-drug-designation-for-spr720-for-the-treatment-of-nontuberculous-mycobacterial-ntm-infection 2020-03-11 23:42:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-and-kaken-enter-into-license-agreement 2020-03-10 23:46:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cadent-therapeutics-announces-fda-clearance-of-ind-application-and-dosing-of-subjects-of-cad-9303-for-schizophrenia 2020-03-10 23:43:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avrobio-receives-orphan-drug-designation-from-us-fda-for-avrrd04-for-cystinosis 2020-03-10 00:02:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/f2g-receives-us-fda-orphan-drug-designation-for-olorofim 2020-03-09 23:57:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-launches-biostat-str-generation-3-with-biobrain 2020-03-09 05:32:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-announces-launch-of-mulpleo-lusutrombopag-in-the-uk 2020-03-08 23:34:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-for-adults-with-cushings-disease 2020-03-06 23:28:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zydus-announces-worlds-first-drug-for-the-treatment-of-non-cirrhotic-nash 2020-03-06 00:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-biologics-announces-first-patient-dosed-in-the-pivotal-registrational-trial-of-pemigatinib-in-patients-with-advanced-cholangiocarcinoma-in-china 2020-03-05 23:59:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellect-biotechnology-and-canndoc-ltd-to-enter-into-strategic-pharma-grade-cannabis-commercial-deal-for-reduction-in-opioid-usage 2020-03-05 00:00:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zosano-pharma-announces-fda-acceptance-of-505b2-new-drug-application-for-qtrypta-for-the-acute-treatment-of-migraine 2020-03-04 23:57:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biofourmis-ai-powered-remote-monitoring-platform-to-provide-new-insights-to-fight-covid-19 2020-03-04 05:39:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emerald-health-pharmaceuticals-receives-fast-track-designation-from-us-fda-for-ehp-101-in-the-treatment-of-systemic-sclerosis 2020-03-03 23:40:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ayala-pharmaceuticals-granted-us-fda-fast-track-designation-for-al101-for-the-treatment-of-recurrent-or-metastatic-adenoid-cystic-carcinoma 2020-03-03 23:36:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mimetas-to-launch-assay-ready-product-line-for-organ-on-a-chip 2020-03-03 07:47:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyevance-pharmaceuticals-launches-tobradex-st-in-the-united-states 2020-03-03 00:25:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-therapy-for-patients-with-previously-treated-multiple-myeloma 2020-03-02 23:50:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-enterprise-level-chromatography-data-system-software-enhances-laboratory-efficiency-compliance-and-standardization 2020-03-02 07:58:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-advanced-liquid-chromatography-system-delivers-productivity-precision-and-compliance-in-routine-analyses 2020-03-02 07:56:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novus-therapeutics-completes-enrollment-of-phase-2a-trial-of-op0201 2020-03-02 06:15:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altimmune-completes-first-development-milestone-toward-a-single-dose-intranasal-covid-19-vaccine 2020-02-28 23:34:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tetra-bio-pharma-enters-into-co-development-agreement-with-makscientific 2020-02-27 23:37:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hikma-and-glenmark-pharmaceuticals-enter-into-exclusive-licensing-agreement-for-commercialising-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us 2020-02-27 23:35:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/translate-bio-receives-fda-fast-track-designation-for-mrt5005-for-the-treatment-of-cystic-fibrosis 2020-02-26 23:37:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-announces-approval-in-brazil-of-onpattro-for-the-treatment-of-hereditary-attr-amyloidosis-with-polyneuropathy 2020-02-26 23:32:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oliver-healthcare-packaging-strengthens-presence-in-southeast-asia 2020-02-26 00:26:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncologie-inc-announces-collaboration-with-moffitt-cancer-center-to-advance-the-development-of-precision-medicine 2020-02-26 00:23:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunos-therapeutics-selects-probiogen-for-development-and-large-scale-manufacturing-services 2020-02-25 03:34:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-fuji-yakuhin-conclude-license-agreement-concerning-the-development 2020-02-25 03:26:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-continued-its-steady-growth-in-2019 2020-11-16 05:35:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perrigo-and-catalent-announce-fda-approval-of-perrigos-ab-rated-generic-version-of-proair-hfa 2020-02-24 23:41:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-presents-the-maiden-pharma-gmp-gcp-quality-management-2020 2020-02-24 07:17:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-introduces-biopat-spectro-to-enable-raman-spectroscopy-capability-and-qbd-with-its-ambr-and-biostat-str-platforms 2020-02-24 06:31:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/erytech-enters-into-strategic-supply-partnership-with-the-german-red-cross-blood-donor-service 2020-02-20 23:34:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baudax-bio-announces-fda-approval-of-anjeso-for-the-management-of-moderate-to-severe-pain 2020-02-20 23:24:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/premier-inc-providegx-program-partners-with-pfizer-inc 2020-02-19 23:51:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytosorbents-enters-agreement-with-china-medical-system-holdings-limited-to-bring-cytosorb-to-mainland-china-to-treat-critically-ill-patients-with-covid-19-coronavirus-infection 2020-02-19 23:49:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dnx-biopharmaceuticals-announces-collaboration-with-lung-cancer-initiative-at-johnson-johnson 2020-02-19 00:36:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/good-laboratory-practices-software-upgrade-for-biotage-extrahera 2020-02-19 00:34:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/s2-genomics-and-the-riken-center-for-integrative-medical-sciences-collaborate-on-single-cell-genomics-on-solid-tissues 2020-02-18 23:52:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/monopar-therapeutics-receives-orphan-drug-designation-from-the-european-commission-for-camsirubicin-in-the-treatment-of-soft-tissue-sarcoma 2020-02-18 23:24:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-gsks-voltaren-arthritis-pain-for-over-the-counter-use-in-the-united-states 2020-02-17 23:38:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inceptua-appoints-new-head-of-asia-pacific-clinical-trial-services 2020-02-17 07:24:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/promedior-announces-completion-of-acquisition-by-roche 2020-02-14 03:32:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/m8-pharmaceuticals-and-daewoong-pharmaceuticals-signed-an-exclusive-licensing-agreement-for-fexuprazan-in-mexico 2020-02-13 00:39:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prevail-therapeutics-pr001-receives-orphan-drug-designation-and-rare-pediatric-disease-designation-from-fda 2020-02-12 23:21:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elicio-therapeutics-and-natera-to-collaborate-in-phase-iii-pancreatic-cancer-study-of-eli-002 2020-02-11 23:32:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fibrogen-announces-us-fda-acceptance-of-new-drug-application-for-roxadustat-for-the-treatment-of-anemia-of-chronic-kidney-disease 2020-02-11 23:29:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aim-immunotech-files-three-provisional-patent-applications-surrounding-ampligenr 2020-02-11 06:41:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-completes-acquisition-of-masthercell 2020-02-10 23:51:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-southeast-asia-report-executives-call-for-track-and-trace-schemes-in-southeast-asia 2020-02-10 07:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-provides-topline-results-from-investigator-led-phase-iiiii-trial-with-gantenerumab-in-rare-inherited-form-of-alzheimers-disease 2020-02-10 04:17:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurosense-therapeutics-receives-orphan-drug-designation-for-amyotrophic-lateral-sclerosis-als-drug-and-announces-initiation-of-two-clinical-studies-in-als 2020-02-06 23:48:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-southeast-asia-report-executives-call-for-track-and-trace-schemesin-southeast-asia 2020-02-07 07:52:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-to-seek-accelerated-fda-approval-and-plans-for-pivotal-phase-2-aml-trial 2020-02-05 23:22:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-announces-fda-clearance-of-ind-application-for-bxcl501-for-the-treatment-of-opioid-withdrawal-symptoms 2020-02-05 23:19:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cns-pharmaceuticals-announces-completion-of-gmp-manufacturing 2020-02-04 23:33:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-expanded-collaboration-with-hhs-to-develop-antibody-treatments-for-new-coronavirus 2020-02-04 23:32:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-medias-3rd-annual-pharma-project-portfolio-management-summit-2020 2020-02-04 03:01:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-presents-pharma-authors-roundtable-at-jw-marriott 2020-02-04 01:56:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anavex-life-sciences-announces-fast-track-designation-granted-by-us-fda-for-anavex2-73-blarcamesine-clinical-development-program-for-the-treatment-of-rett-syndrome 2020-02-04 00:01:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/resverlogix-receives-us-fda-breakthrough-therapy-designation-for-apabetalone 2020-02-03 23:39:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-positive-top-line-results-from-ajovy-fremanezumab-clinical-trials-in-japan 2020-02-03 06:39:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-drug-for-treatment-of-peanut-allergy-for-children 2020-01-31 23:24:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ogt-launches-breakthrough-cytosure-ngs-panel-for-constitutional-cytogenetics 2020-01-31 01:41:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-aligns-its-development-service-laboratory-portfolio-under-one-roof 2020-01-31 00:09:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pulmatrix-receives-fast-track-designation-for-pulmazole-for-the-treatment-of-asthma-abpa 2020-01-30 23:40:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compugen-further-expands-intellectual-property-portfolio 2020-01-29 23:56:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/predictive-technology-group-and-atrin-pharmaceuticals-announce-molecular-diagnostic-oncology-development-collaboration 2020-01-28 23:47:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saga-diagnostics-extends-its-collaboration-with-servier-to-use-ultrasensitive-sagasafe 2020-01-28 23:10:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ningbo-newbay-medical-technology-co-ltd-announces-a-license-agreement-with-genentech 2020-01-27 23:43:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-mercks-dificid-fidaxomicin-to-treat-clostridioides-difficile-in-children-aged-six-months-and-older 2020-01-27 23:42:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-advances-rnai-based-prophylactics-and-therapeutics-to-battle-sari-caused-by-2019-ncov 2020-01-27 00:02:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-cns-specialist-neuraxpharm-strengthens-expansion-into-austrian-market-with-acquisition-of-easypharm 2020-01-24 00:14:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evoke-pharma-enters-commercialization-agreement-with-eversana-life-sciences-for-gimoti 2020-01-24 00:13:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-submits-new-drug-application-for-jzp-258-for-cataplexy-and-excessive-daytime-sleepiness-associated-with-narcolepsy 2020-01-22 23:38:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aruvant-receives-orphan-drug-designation-for-aru-1801-for-the-treatment-of-sickle-cell-disease 2020-01-22 23:28:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/denovo-biopharma-enters-into-option-agreement-with-rumpus-therapeutics-for-selected-db102-enzastaurin-clinical-indications 2020-01-21 23:26:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-granted-us-fda-orphan-drug-designation-for-the-treatment-of-gastric-cancer-for-its-antibody-drug-conjugate-adc-targeted-cancer-therapy-obi-999 2020-01-21 23:25:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discover-the-latest-information-and-seize-market-opportunities-in-the-annual-event-of-the-cro-cmo-industry 2020-01-21 03:03:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fdf-china-to-be-held-in-june-to-boost-chinese-pharmaceutical-enterprises 2020-01-21 03:46:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/continuing-the-resplendence-with-20-years-glory-cphi-china-welcomes-the-golden-year-of-chinese-pharma 2020-01-21 03:40:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/focusing-on-cutting-edge-biopharmaceutical-technologies-boosting-the-industry-to-achieve-innovation-and-development-biolive-china-2020-is-ready 2020-01-21 03:34:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hub-of-global-pharmaceutical-packaging-solutions-in-the-asia-pacific-region-innopack-china-gathering-innovative-forces 2020-01-21 03:28:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/at-it-china-2020-to-be-held-alongside-cphi-p-mec-china-2020-will-showcase-intelligent-pharma-high-tech-solutions 2020-01-21 03:24:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/15-years-of-p-mec-china-driving-global-pharma-technology-forward-in-china 2020-01-21 03:17:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tennor-therapeutics-received-fda-orphan-drug-designation 2020-01-20 23:25:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotheryx-announces-the-initiation-of-patient-dosing-in-a-first-in-man-phase-1-clinical-trial-of-btx-a51-a-multi-kinase-inhibitor 2020-01-17 23:24:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-completes-acquisition-of-arqule 2020-01-16 23:46:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fortress-biotech-announces-rare-pediatric-disease-designation-for-cutx-101-for-the-treatment-of-menkes-disease 2020-01-16 23:40:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bosch-packaging-technology-is-now-syntegon 2020-01-16 06:13:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-lava-therapeutics-sign-cell-line-development-and-gmp-manufacturing-agreement 2020-01-16 01:15:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/personal-genome-diagnostics-and-eisai-co-ltd-collaborate-to-develop-comprehensive-liquid-biopsy-biomarker-discovery-solution 2020-01-15 23:34:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-completes-acquisition-of-audentes-therapeutics 2020-01-15 23:31:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apceth-starts-commercial-manufacturing-of-zynteglo 2020-01-13 05:39:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brickell-bios-development-partner-kaken-pharmaceutical-submits-new-drug-application-for-sofpironium-bromide-in-japan-for-primary-axillary-hyperhidrosis 2020-01-13 00:00:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/presage-receives-fda-clearance-of-first-ind-application-for-trial-to-evaluate-investigational-oncology-agents-with-civo-technology 2020-01-09 23:38:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-partners-with-enleofen-to-develop-first-in-class-anti-il-11-therapies-for-a-range-of-fibrotic-diseases 2020-01-09 23:36:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-starts-new-research-program-in-autoimmune-diseases-with-merck 2020-01-09 04:38:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altavant-sciences-acquires-onspira-therapeutics-adding-a-potentially-life-saving-treatment-for-post-lung-transplant-patients-to-the-altavant-pipeline 2020-01-08 23:38:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tyme-announces-first-patient-dosed-in-tyme-88-panc-pivotal-trial-to-evaluate-sm-88-as-oral-treatment-for-patients-with-metastatic-pancreatic-cancer 2020-01-08 23:37:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-inks-next-commercial-glymaxx-license-with-roche 2020-01-08 04:04:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tyme-technologies-and-eagle-pharmaceuticals-announce-strategic-collaboration-to-advance-innovative-oral-sm-88-for-the-treatment-of-patients-with-cancer 2020-01-07 23:41:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/curevac-announces-positive-results-in-low-dose-1-ug-rabies-vaccine-clinical-phase-1-study 2020-01-07 23:37:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-and-nec-start-two-clinical-trials-with-tg4050 2020-01-07 01:30:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/velabs-therapeutics-receives-exclusive-licence-from-alytas-therapeutics 2020-01-07 01:27:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yisheng-biopharma-and-tavotek-biotherapeutics-announce-strategic-research-alliance 2020-01-06 23:49:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytovia-therapeutics-and-the-university-of-california-san-francisco-enter-into-a-partnership-to-develop-precision-gene-edited-car-nk-cell-therapy 2020-01-06 23:47:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precigen-receives-fda-orphan-drug-designation-for-prgn-3006-ultracar-t-in-patients-with-acute-myeloid-leukemia-aml 2020-01-06 23:46:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mediwound-continues-nexobrids-global-expansion-through-a-new-distribution-agreement-in-australia-new-zealand-and-singapore-with-balance-medical 2020-01-02 23:43:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arena-pharmaceuticals-and-beacon-discovery-expand-strategic-relationship 2020-01-02 23:18:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-congratulates-oncoimmune-on-fda-clearance-of-ind-application-for-next-generation-anti-ctla-4-antibody-onc-392 2020-01-02 04:07:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/urovant-sciences-announces-submission-of-new-drug-application-for-vibegron-for-the-treatment-of-overactive-bladder 2019-12-31 00:18:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-biopharmaceuticals-initiates-phase-study-of-etanercept-biosimilar-candidate 2019-12-30 23:20:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-launched-sal-for-ground-handling-and-logistics-services-at-saudi-airports 2019-12-29 23:45:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avita-medical-receives-us-fda-investigational-device-exemption-approval-of-clinical-feasibility-study-to-evaluate-recell-system-for-vitiligo 2019-12-29 23:37:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-china-nmpa-clearance-of-ind-for-bbt-401-a-pellino-1-inhibitor-for-uc 2019-12-27 00:00:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharma-submits-new-drug-application-in-the-us-for-its-antidepressant-drug-ly03005 2019-12-27 00:02:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-eisai-enter-into-agreement-in-japan 2019-12-24 05:02:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fibrogen-submits-new-drug-application-to-the-us-fda-for-roxadustat-in-patients-with-anemia-of-chronic-kidney-disease 2019-12-23 23:40:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phathom-pharmaceuticals-announces-initiation-of-pivotal-phase-3-clinical-trial-for-vonoprazan-in-helicobacter-pylori-h-pylori-infection 2019-12-23 23:32:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polaryx-therapeutics-submits-investigational-new-drug-application 2019-12-23 03:31:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-option-for-patients-with-her2-positive-breast-cancer-who-have-progressed-on-available-therapies 2019-12-20 23:44:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-type-of-therapy-to-treat-advanced-urothelial-cancer 2019-12-19 23:59:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neximmune-receives-ind-clearance-for-phase-12-trial-in-relapsed-refractory-multiple-myeloma 2019-12-19 23:39:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agenus-commences-combination-trial-of-its-next-gen-ctla-4-with-its-pd-1-antibody 2019-12-19 23:31:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-and-the-german-research-center-for-artificial-intelligence-launch-joint-research-laboratory 2019-12-19 04:37:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mc2-therapeutics-announces-positive-top-line-results-from-eu-phase-3 2019-12-19 01:39:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chondrial-therapeutics-announces-dosing-of-first-patients-in-phase-1-clinical-program-of-cti-1601-for-treatment-of-friedreichs-ataxia 2019-12-18 23:59:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/angion-initiates-dosing-in-phase-1-clinical-trial-evaluating-ang-3070-a-dual-kinase-inhibitor-for-the-treatment-of-fibrotic-diseases 2019-12-19 07:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaccitech-oncology-limited-enters-collaboration-with-cancer-research-uk 2019-12-18 02:54:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/armgo-pharma-inc-announces-clinical-trial-of-arm210s48168-for-the-treatment-of-ryanodine-receptor-type-1-related-myopathies 2019-12-17 23:57:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/diamedica-therapeutics-announces-first-patient-dosed-in-redux-phase-ii-clinical-trial-of-dm199-for-the-treatment-of-chronic-kidney-disease 2019-12-17 23:56:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-presents-pharma-authors-round-table 2019-12-17 06:13:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mea-clinical-laboratory-services-market-to-top-us14-billion-by-2023 2019-12-17 06:08:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-and-somaserve-announce-comprehensive-partnership 2019-12-17 03:40:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-therapeutics-announces-plan-to-acquire-aletheia-therapeutics-to-create-a-new-precision-oncology-company 2019-12-16 23:55:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salarius-pharmaceuticals-receives-fda-fast-track-designation-for-lead-drug-candidate-seclidemstat-in-relapsed-or-refractory-ewing-sarcoma 2019-12-16 23:50:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-medias-organizes-the-2nd-edition-remarkable-women-camaraderie-2019 2019-12-16 04:09:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-receives-positive-chmp-opinion-for-vyndaqel-for-use-in-patients 2019-12-15 23:39:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-accelerated-approval-to-first-targeted-treatment-for-rare-duchenne-muscular-dystrophy-mutation 2019-12-13 00:04:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-xeljanz-xr-extended-release-tablets 2019-12-12 23:58:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zeta-engineering-for-lonzas-mega-project-ibextm-solutions 2019-12-12 07:45:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mihas-2020-to-promote-the-values-of-sustainability-among-halal-based-businesses 2019-12-12 00:29:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-and-kiniksa-pharmaceuticals-announce-clinical-collaboration 2019-12-11 23:51:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-fda-filing-acceptance-of-xolair-for-treatment-of-nasal-polyps 2019-12-11 23:45:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zealand-pharma-partner-beta-bionics-receives-fda-breakthrough-device-designation 2019-12-10 23:49:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dermira-receives-fast-track-designation-from-fda-for-lebrikizumab 2019-12-10 23:43:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-occupational-health-management-excels-again-in-employee-wellness-initiatives 2019-12-10 08:04:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metp-pharma-receives-us-patent-for-drug-therapy 2019-12-09 23:40:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quva-pharma-launches-cardioplegia-offering-through-compounding-agreement 2019-12-09 23:39:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sangamo-and-pfizer-announce-updated-phase-12-results-showing-sustained-increased-factor-viii-activity-through-44-weeks-following-sb-525-gene-therapy-treatment 2019-12-08 23:48:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medpharm-the-leader-in-topical-and-transdermal-drug-delivery 2019-12-06 01:43:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galectin-therapeutics-plans-adaptively-designed-phase-3-nash-rx-clinical-trial-in-nash-cirrhosis 2019-12-06 00:04:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alector-announces-fda-fast-track-designation-granted-to-al001-for-the-treatment-of-patients-with-frontotemporal-dementia 2019-12-05 23:48:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schreiner-medipharm-and-pragmatic-announce-strategic-partnership 2019-12-05 05:14:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-to-present-latest-data-on-alzheimers-disease 2019-12-05 02:57:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergency-medicine-conference-to-kick-off-in-abu-dhabi-this-week 2019-12-05 01:27:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tetra-bio-pharma-receives-fda-orphan-drug-designation-for-hepatocellular-carcinoma 2019-12-04 23:51:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adastra-pharmaceuticals-announces-fda-and-ema-orphan-drug-designation-has-been-granted-for-zotiraciclib-in-the-treatment-of-glioma 2019-12-04 23:33:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-announces-collaboration-with-bergenbio-on-the-development-of-fda-fast-track-designated-leukemia-treatment 2019-12-03 23:26:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atreca-announces-fda-clearance-of-investigational-new-drug-application-for-atrc-101 2019-12-03 23:24:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samyang-biopharm-usa-inc-and-cancure-llc-announce-global-strategic-collaboration-to-advance-novel-immuno-oncology-therapeutic 2019-12-02 23:33:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-life-science-inc-announces-fda-acceptance-of-ind-application-for-anti-epileptic-drug-candidate-skl24741 2019-12-02 23:32:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-reaches-milestone-in-respiratory-disease-research-collaboration-with-boehringer-ingelheim 2019-12-02 04:37:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-presents-co-developed-cancer-fighting-tyvytr-sintilimab-injection-at-ciie-2019-with-eli-lilly 2019-12-02 00:05:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-cns-specialist-neuraxpharm-expands-southern-european-presence-with-expansion-into-portugal 2019-11-28 23:40:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-announces-first-patient-dosed-in-phase-clinical-trial-of-anti-pd 2019-11-28 05:17:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imcd-further-expands-global-network-with-the-opening-of-three-pharma-technical-centres-in-asia-pacific 2019-11-27 06:29:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/high-purity-new-england-launches-single-use-mixing-system 2019-11-27 04:14:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knight-and-therapeuticsmd-announce-filing-of-new-drug-submission-for-bijuva-in-canada 2019-11-26 23:59:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imbrium-therapeutics-lp-and-spinethera-inc-announce-first-patient-dosed-in-phase-12-clinical-study 2019-11-26 23:57:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chi-med-announces-surufatinib-granted-fda-orphan-drug-designation-for-pancreatic-neuroendocrine-tumors 2019-11-25 23:52:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sk-life-science-inc-receives-us-fda-approval-for-cenobamate-tablets-for-the-treatment-of-partial-onset-seizures-in-adults-with-epilepsy 2019-11-25 23:31:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-expands-the-pharma-corridor-in-its-wide-flight-network 2019-11-25 06:29:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vaccitech-provides-update-on-clinical-progress-for-its-two-phase-2-universal-influenza-studies 2019-11-25 03:00:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glaukos-completes-acquisition-of-avedro-inc 2019-11-22 00:00:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proqr-receives-orphan-drug-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa 2019-11-21 23:53:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mc2-therapeutics-announces-fda-acceptance-of-its-new-drug-application-for-wynzora-cream-for-treatment-of-plaque-psoriasis 2019-11-21 06:17:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kiniksa-announces-breakthrough-therapy-designation-for-rilonacept-for-the-treatment-of-recurrent-pericarditis 2019-11-20 23:59:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-announces-approval-of-givlaari-by-the-us-food-and-drug-administration-fda 2019-11-20 23:37:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sangamo-announces-uk-authorization-of-a-phase-12-clinical-trial-evaluating-the-car-treg-cell-therapy-tx200-for-kidney-transplantation 2019-11-20 04:58:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/newron-receives-fda-rare-pediatric-disease-designation-for-sarizotan-for-the-treatment-of-rett-syndrome 2019-11-19 23:51:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-expanding-and-untouched-south-east-asia-pharmaceutical-market 2019-11-19 23:44:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-pfizers-biosimilar-abrilada-adalimumab-afzb-for-multiple-inflammatory-conditions 2019-11-19 00:02:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/levo-therapeutics-receives-fast-track-designation-from-fda-for-intranasal-carbetocin-for-the-treatment-of-prader-willi-syndrome 2019-11-18 23:35:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/securecell-introduces-sephara-novel-silicon-based-in-situ-filtration-membrane 2019-11-18 02:51:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/3sbio-selects-verseaus-psgl-1-targeted-antibody-vtx-0811 2019-11-17 23:40:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-of-its-kind-soliqua-treatment-launched-in-singapore-to-benefit-adults 2019-11-15 23:36:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dubai-hosts-the-congress-of-the-international-society-for-organ-donation-and-procurement-isodp 2019-11-15 23:24:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eastgate-biotech-expands-pipeline-to-alzheimers-disease-using-its-alternative-insulin-delivery-platform 2019-11-14 23:53:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-biopharma-receives-ind-approval-from-nmpa-to-initiate-clinical-trials-for-its-anti-gm-csf-monoclonal-antibody-tjm2-in-china 2019-11-14 23:36:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-licenses-riluzole-oral-film-to-zambon-for-development-and-commercialization-in-the-eu-for-patients-with-als 2019-11-13 23:50:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapix-biosciences-announces-positive-topline-results-from-phase-iia-clinical-trial-of-thx-110-for-obstructive-sleep-apnea-program 2019-11-13 23:47:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medpharm-announced-as-a-winner-at-cphi-pharma-awards-2019 2019-11-13 03:44:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-announces-fda-approval-of-ind-for-its-stat3-inhibitor-in-emory-university-clinical-trial 2019-11-13 00:01:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/x4-pharmaceuticals-receives-breakthrough-therapy-designation-from-the-fda-for-mavorixafor-for-the-treatment-of-whim-syndrome 2019-11-12 23:52:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/directedluck-transposase-for-efficient-gene-delivery 2019-11-12 03:38:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supernus-submits-new-drug-application-for-spn-812-for-the-treatment-of-adhd 2019-11-11 23:38:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nec-and-vaximm-announce-collaboration-to-advance-personalized-neoantigen-cancer-vaccines 2019-11-11 23:35:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gw-pharmaceuticals-receives-positive-nice-recommendation-for-epidyolex-cannabidiol-oral-solution 2019-11-11 03:06:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurogen-brain-and-spine-institutes-stem-cell-therapy-combined-with-neurorehabilitation-offers-hope-for-intellectual-disability 2019-11-08 05:11:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-and-brickbio-announce-partnership-to-incorporate-conjugation-ready-sites-into-recombinant-antibodies 2019-11-08 01:22:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-enters-exclusive-china-distribution-license-agreement-for-octreotide-long-acting-injectable-lai-microsphere-for-neuroendocrine-cancers-and-acromegaly 2019-11-08 00:00:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/triumvira-immunologics-announces-fast-track-designation-for-its-first-tac-t-cell-therapeutic-product-candidate-tac01-cd19 2019-11-07 23:55:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-exercises-second-target-option-under-existing-collaboration-with-nbe-therapeutics 2019-11-07 06:25:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phillips-medisize-announced-as-winner-of-cphi-pharma-award-for-drug-delivery-devices 2019-11-07 04:24:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teneobios-lead-candidate-tnb-383b-receives-orphan-drug-designation-from-the-fda-for-the-treatment-of-multiple-myeloma 2019-11-06 23:42:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncology-pharma-and-ribera-solutions-signed-a-licensing-agreement-for-the-use-of-riberas-clinical-trials-platform-connect2med 2019-11-06 23:37:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/autolus-therapeutics-receives-fda-orphan-drug-designation-for-auto1-for-treatment-of-acute-lymphoblastic-leukemia 2019-11-05 23:34:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-unveils-new-dengue-vaccine-manufacturing-plant-in-germany 2019-11-05 23:29:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scirhom-initiates-first-in-class-antibody-development-program-to-treat-major-autoimmune-diseases 2019-11-05 03:25:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioagilytix-announces-acquisition-of-boston-based-clinical-research-organization-cambridge-biomedical 2019-11-04 23:56:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ichnos-sciences-announces-completion-of-enrollment-of-phase-2b-trials 2019-11-04 23:15:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/octapharma-announces-publication-of-fibryga-for-the-treatment-of-acquired-fibrinogen-deficiency-in-patients-undergoing-cardiac-surgery 2019-11-04 05:07:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invenra-announces-expansion-of-collaboration-with-exelixis 2019-11-01 23:45:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dicerna-enters-agreement-with-roche-to-develop-and-commercialize-dcr-hbvs 2019-11-01 00:00:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pinteon-therapeutics-launches-phase-trial-of-novel-tau-antibody-that-targets-potent-driver 2019-10-31 23:58:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujitsu-launches-japans-first-system-for-automatically-generating-electronic-submission-data 2019-10-30 23:20:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-provides-greater-flexibility-in-secondary-packaging-through-collaborative-work 2019-10-31 05:20:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seranovo-enters-into-license-agreement-with-carna-biosciences-for-development 2019-10-30 07:47:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/galimedix-therapeutics-incs-gal-101-gains-from-target-validation-by-positive-phase-3-results-of-biogens-aducanumab 2019-10-29 23:39:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terns-pharmaceuticals-receives-fast-track-designation-from-the-fda-for-tern-101-an-fxr-agonist-for-the-treatment-of-nash 2019-10-29 23:30:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sfa-therapeutics-inc-receives-an-fda-orphan-drug-designation-odd-for-sfa001-in-the-treatment-of-hepatocellular-carcinoma-hcc 2019-10-28 23:58:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mirum-pharmaceuticals-announces-breakthrough-therapy-designation-for-maralixibat-for-the-treatment-of-pruritus-associated-with-alagille-syndrome 2019-10-28 23:52:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-completes-alzheimers-disease-research-project 2019-10-28 07:27:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sundial-and-crescita-sign-exclusive-partnership-to-develop-cannabis-and-hemp-topicals 2019-10-28 07:24:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/natural-extracts-innovated-transformed-and-diversely-laid-out 2019-10-24 23:57:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flypharma-europe-2019-latest-supply-chain-challenges-and-industry-best-practices 2019-10-24 23:23:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomica-to-collaborate-with-weizmann-institute-of-science-to-develop-a-selective-treatment-against-antibiotic-resistant-bacteria 2019-10-24 00:04:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knight-therapeutics-and-sifi-spa-announce-approval-of-netildex-in-canada 2019-10-23 23:26:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-launches-navify-guidelines-app-to-help-clinicians-easily-access-personalise 2019-10-22 23:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-clearance-of-ind-for-rp-l301-gene-therapy-for-pyruvate-kinase-deficiency 2019-10-22 23:42:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbio-receives-fda-approval-of-fast-track-designation-for-bemcentinib 2019-10-22 23:37:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-grand-opening-of-novo-nordisk-pharmatech-as-new-branch-office-in-singapore 2019-10-22 04:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-received-the-customer-satisfaction-management-certificate-iso-10002 2019-10-22 03:58:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/in-recognition-of-its-conformity-with-handling-and-storing-standards-saudia-cargo-receives-eu-gdp-certificate-from-sgs 2019-10-21 23:48:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alkermes-announces-clinical-collaboration-with-fred-hutchinson-cancer-research-center 2019-10-21 23:45:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/movilitas-announces-featured-speakers-for-track-and-trace-conference-in-kuala-lumpur 2019-10-21 07:38:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-launches-new-sartocheck-5-plus-filter-tester 2019-10-21 07:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moberg-pharma-and-dongkoo-sign-agreement-for-mob-015-in-the-republic-of-korea 2019-10-21 00:02:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-receives-chmp-positive-opinion-for-upadacitinib-for-the-treatment-of-adults 2019-10-18 23:26:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-announces-fda-approval-of-xofluza-baloxavir-marboxil-for-people-at-high-risk-of-developing-influenza-related-complications 2019-10-17 23:51:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-for-neurens-nnz-2591 2019-10-17 23:25:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/credence-medsystems-awarded-grant-to-develop-its-dual-chamber-drug-delivery-device-for-the-global-health-setting 2019-10-16 23:32:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptate-biotherapeutics-formed-to-develop-antibody-based-therapies-that-modulate-gamma-delta-t-cells 2019-10-16 23:27:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/replimune-provides-update-on-rp1-clinical-development-program-in-cutaneous-squamous-cell-carcinoma 2019-10-15 23:25:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proqr-receives-rare-pediatric-disease-designation-from-fda-for-sepofarsen-for-the-treatment-of-lca10 2019-10-15 23:14:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultragenyx-announces-fda-accepts-new-drug-application-for-ux007-triheptanoin-for-treatment-of-long-chain-fatty-acid-oxidation-disorders 2019-10-14 23:31:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-biopharma-and-morphosys-announce-ind-clearance-to-initiate-clinical-trials-of-tj202mor202-for-the-treatment-of-multiple-myeloma-in-mainland-china 2019-10-14 23:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turn-therapeutics-announces-fda-clearance-of-protego-antimicrobial-wound-dressing 2019-10-13 23:35:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chanticleer-holdings-announces-merger-agreement-with-sonnet-biotherapeutics-to-advance-pipeline-of-novel-immune-therapeutics 2019-10-10 23:04:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orasis-pharmaceuticals-announces-csf-1-eye-drop-successfully-met-primary-endpoint-in-phase-2b-clinical-study-in-presbyopia 2019-10-10 23:01:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zelda-to-merge-with-us-based-ilera-therapeutics-to-create-a-leading-global-therapeutic-medicinal-cannabis-company 2019-10-09 22:29:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-scenesse-for-genetic-disorder 2019-10-09 22:13:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/onl-therapeutics-announces-first-in-human-clinical-study-with-onl1204 2019-10-08 23:49:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hoth-therapeutics-successfully-completes-phase-i-of-in-life-dose-escalation-study-for-treating-eczema 2019-10-08 23:48:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-announces-enhanced-collaboration-with-summit-pharmaceuticals-international-corporation-to-expand-japanese-operation-base 2019-10-03 23:56:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicasafe-announces-partnership-with-amneal-pharmaceuticals 2019-10-03 23:42:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-announces-us-fda-breakthrough-therapy-designation-granted-for-niraparib-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer 2019-10-03 23:29:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirio-group-introduces-one-stop-platform-for-plant-based-nutraceuticals-at-supplyside-west 2019-10-03 01:11:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mc10-inc-announces-collaboration-with-university-of-rochester-development-novel-digital-biomarkers-for-central-nervous-system-diseases 2019-10-02 23:44:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athira-pharma-announces-completion-of-phase-1b-clinical-trial-of-ndx-1017-in-alzheimers-patients 2019-10-02 23:41:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-and-ribometrix-establish-strategic-collaboration-to-discover-and-develop-rna-targeted-small-molecule-therapeutics 2019-09-30 23:44:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-rituxan-rituximab-in-children-with-two-rare-blood-vessel-disorders 2019-09-30 23:42:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-nichi-iko-enter-into-collaboration-agreement 2019-09-30 00:11:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sysmex-inostics-launches-two-ngs-based-liquid-biopsy-panels 2019-09-30 00:10:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ensysce-biosciences-receives-multi-year-nih-heal-grant-to-develop-a-novel-opioid-use-disorder-oud-medication 2019-09-27 00:18:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knopp-biosciences-receives-nih-heal-grant-to-discover-and-advance-non-opiate-treatment-of-chronic-pain 2019-09-27 00:03:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tyme-launches-pivotal-stage-of-tyme-88-panc-trial-to-evaluate-sm-88-for-third-line-treatment-of-patients-with-metastatic-pancreatic-cancer 2019-09-26 01:17:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/achillion-receives-breakthrough-therapy-designation-from-fda-for-danicopan-for-treatment-of-paroxysmal-nocturnal-hemoglobinuria 2019-09-25 23:34:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nst-doses-first-patient-in-phase-2b-clinical-study-of-icosabutate-in-nash 2019-09-25 06:14:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theraly-fibrosis-granted-us-orphan-drug-designation-for-tly012-for-chronic-pancreatitis 2019-09-24 23:34:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aldeyra-therapeutics-receives-fast-track-designation-for-adx-2191-for-the-prevention-of-proliferative-vitreoretinopathy 2019-09-24 23:33:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xynomic-pharma-receives-fast-track-designation-from-the-us-fda-for-abexinostat-as-4l-therapy-treating-follicular-lymphoma 2019-09-23 23:31:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annexon-biosciences-announces-fda-fast-track-designation-for-novel-c1q-inhibitor-anx005-for-the-treatment-of-guillain-barre-syndrome 2019-09-23 23:30:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomed-x-successfully-completes-collaboration-on-development-of-nanomaterial-based-biosensors-for-near-patient-testing 2019-09-23 03:09:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brazilian-federal-council-of-pharmacy-takes-home-international-award-for-best-national-pharmacy-health-campaign 2019-09-23 00:09:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xbiotech-announces-granting-of-canadian-patent-for-treatment-of-dermatological-pathologies 2019-09-22 23:36:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-reneo-pharmaceuticals-for-ren001-for-treatment-of-fatty-acid-oxidation-disorders 2019-09-20 23:16:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/auo-pharmaceuticals-announces-positive-results-for-chinas-phase-iii-clinical-trial-of-new-antibacterial-drug-contezolid-for-complex-skin-and-soft-tissue-infections 2019-09-19 23:51:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lineage-cell-therapeutics-receives-ce-mark-approval-for-renevia 2019-09-19 23:39:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ocugen-granted-fda-orphan-drug-designation-for-ocu400-nr2e3-gene-therapy-for-the-treatment-of-cep290-mutation-associated-retinal-disease 2019-09-18 23:35:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-for-spi-1005-in-the-treatment-of-menieres-disease 2019-09-18 23:32:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-for-roches-gazyva-obinutuzumab-in-lupus-nephritis 2019-09-17 23:57:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mylan-expands-oncology-portfolio-with-launch-of-generic-faslodex-injection-a-treatment-for-advanced-breast-cancer 2019-09-17 23:45:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-and-mundipharma-china-pharmaceutical-jointly-announce-approval-of-the-oral-formulation-of-akynzeo-in-china 2019-09-16 23:39:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-receives-orphan-drug-designation-for-gbr-1342-a-bispecific-antibody-candidate-under-evaluation-for-the-treatment-of-multiple-myeloma 2019-09-16 23:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-biogen-to-discontinue-phase-clinical-studies-of-bace-inhibitor 2019-09-15 23:57:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phillips-medisize-enters-agreement-with-global-pharmaceutical-company-to-acquire-exclusive-ownership-of-patents 2019-09-13 01:34:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aytu-bioscience-announces-definitive-agreement-to-acquire-innovus-pharmaceuticals 2019-09-12 23:51:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orion-biotechnology-to-initiate-clinical-trials-of-its-innovative-microbicide-gel-for-hiv-prevention 2019-09-12 23:41:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-announces-initiation-of-phase-i-clinical-study-in-china-of-kx2-361-oral-by-partner-guangzhou-xiangxue-pharmaceutical 2019-09-11 23:28:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-launch-of-vancomycin-hydrochloride 2019-09-11 23:23:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atomwise-and-oncostatyx-announce-joint-venture-to-develop-small-molecule-inhibitors-of-oncology-target-kdm5b 2019-09-10 23:29:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellcentric-starts-dosing-patients-in-blood-cancer-trial-expanding-clinical-testing-of-ccs1477 2019-09-10 23:23:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/drivers-behind-saudi-arabias-forecast-market-explored-ahead-of-cphi-mea 2019-09-10 05:35:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-licenses-glymaxx-technology-to-bayer 2019-09-10 03:04:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proqr-receives-fast-track-designation-from-fda-for-qr-1123-for-autosomal-dominant-retinitis-pigmentosa 2019-09-09 23:49:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-states-orphan-drug-designation-for-treatment-of-soft-tissue-sarcomas-granted-to-spear-t-cells-targeting-mage-a4 2019-09-09 23:47:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-organizes-its-2nd-annual-pharma-manufacturing-automation-convention 2019-09-09 03:53:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-treatment-for-patients-with-rare-type-of-lung-disease 2019-09-06 23:41:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saladax-develops-the-first-ever-rapid-antipsychotic-screening-test-using-a-single-drop-of-blood-to-help-psychiatrists-treat-schizophrenia 2019-09-06 00:20:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-announces-approval-of-generic-version-of-amicar 2019-09-06 00:21:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ra-pharmaceuticals-receives-orphan-drug-designation-from-the-us-fda-for-zilucoplan-for-the-treatment-of-myasthenia-gravis 2019-09-04 23:24:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/idera-pharmaceuticals-announces-immuno-oncology-clinical-research-collaboration-with-abbvie 2019-09-04 23:21:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-receives-fda-orphan-drug-designation-for-bxcl701-for-the-treatment-of-acute-myeloid-leukemia 2019-09-04 23:19:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-medias-maiden-pharma-brand-protection-packaging-2019 2019-09-04 03:10:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-to-acquire-semma-therapeutics-with-a-goal-of-developing-curative-cell-based-treatments-for-type-1-diabetes 2019-09-03 23:33:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genetx-and-ultragenyx-announce-orphan-drug-designation-and-rare-pediatric-disease-designation-for-gtx-102 2019-09-03 23:31:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-pharmaceuticals-provides-perspective-on-positive-complete-results-from-orion-11-phase-3-study-of-inclisiran 2019-09-02 23:38:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-signs-exclusive-distribution-agreement-with-cheplapharm-to-distribute-etopophos-and-vepesid-in-australia-and-new-zealand 2019-09-02 23:31:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akari-therapeutics-nomacopan-granted-us-orphan-drug-designation 2019-08-30 23:27:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-ofatumumab-demonstrates-superiority-versus-aubagio 2019-08-30 00:16:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/springworks-therapeutics-receives-breakthrough-therapy-designation-for-nirogacestat-for-the-treatment-of-adult-patients-with-progressive-unresectable-recurrent-or-refractory-desmoid-tumors 2019-08-29 23:17:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phillips-medisize-highlights-innovations-in-drug-delivery-and-digital-health 2019-08-29 01:33:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-shinkei-therapeutics-investigational-new-drug-application-for-mr-301-for-traumatic-brain-injury 2019-08-28 23:30:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/esco-ventures-announces-the-launch-of-carmine-therapeutics-a-company-pioneering-red-blood-cell 2019-08-28 23:26:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adaptimmune-and-noile-immune-announce-agreement-to-develop-spear-t-cell-products-expressing-il-7-and-ccl19-as-a-next-generation-treatment-for-cancer-patients 2019-08-27 23:24:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sigilon-therapeutics-receives-orphan-drug-designation-for-sig-001-for-the-treatment-of-hemophilia-a 2019-08-27 23:20:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/velabs-therapeutics-enters-into-a-screening-cooperation-with-chiome-bioscience 2019-08-27 02:54:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-fill-solutions-receives-open-ended-gmp-certification-by-the-austrian-authority-ages 2019-08-27 02:52:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discgenics-receives-fda-fast-track-designation-for-cell-therapy-for-disc-degeneration 2019-08-26 23:34:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-receives-us-fda-approval-for-taltz-for-the-treatment-of-active-ankylosing-spondylitis 2019-08-26 23:31:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gilead-and-galapagos-complete-closing-of-their-transformative-research 2019-08-25 23:52:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/themis-bioscience-announces-exclusive-license-agreement-and-research-collaboration-with-msd-to-develop-vaccine-candidates 2019-08-22 23:48:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seelos-therapeutics-announces-fda-acceptance-of-ind-application-for-sls-005-for-mucopolysaccharidosis-type-iii 2019-08-22 23:38:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rfxcel-will-exhibit-at-cphi-middle-east-africa-the-largest-pharmaceutical-event-in-the-region 2019-08-22 03:35:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rozlytrek-entrectinib-fda-approved-for-hard-to-treat-ntrk-fusion-positive-tumors-available-at-biologics-by-mckesson 2019-08-21 23:29:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cmab-and-kintor-announce-a-new-comprehensive-collaboration-to-develop-and-manufacture-the-alk-1-monoclonal-antibody 2019-08-21 23:28:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-announces-fda-breakthrough-therapy-designation-for-peginterferon-lambda-for-treatment-of-hepatitis-delta-virus-infection 2019-08-20 23:29:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/q-biomed-and-collaborator-chemveda-life-sciences-announce-potential-chemotherapeutic-breakthrough-in-liver-cancer 2019-08-20 23:27:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/switzerland-overtakes-germany-as-europes-biggest-drug-delivery-innovator 2019-08-20 03:00:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/okyo-pharma-announces-collaboration-with-prof-pedram-hamrah-to-evaluate-proprietary-lead-compounds-as-non-opioid-analgesics-targeting-g-protein-coupled-receptors 2019-08-20 00:01:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nabriva-therapeutics-receives-us-fda-approval-of-xenleta-to-treat-community-acquired-bacteria-pneumonia 2019-08-19 23:25:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-roches-rozlytrektm-for-people-with-ros1-positive-metastatic-non-small-cell-lung-cancer 2019-08-16 23:27:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ultragenyx-announces-partnership-with-genetx-to-advance-treatment-for-angelman-syndrome 2019-08-15 23:49:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-third-oncology-drug-that-targets-a-key-genetic-driver-of-cancer-rather-than-a-specific-type-of-tumor 2019-08-15 23:21:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genecentric-and-collaborators-at-washington-university-advance-academic-industry-head-and-neck-cancer-partnership-under-nci-grant 2019-08-13 23:50:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-techne-and-cygnus-technologies-announce-partnership-for-3g-cho-hcp-assay 2019-08-13 23:47:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terns-pharmaceuticals-announces-positive-interim-results-from-ongoing-phase-1-clinical-trial-of-tern-201-a-ssao-inhibitor-in-development-for-nash 2019-08-13 23:47:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/windtree-announces-fda-fast-track-designation-for-istaroxime 2019-08-13 23:46:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ac-immune-announces-research-collaboration-with-university-of-pennsylvania-focusing-on-pathogenic-protein-tdp-43-in-neurodegenerative-diseases 2019-08-12 23:27:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-md-anderson-form-unique-virtual-research-and-development-center-to-rapidly-advance-new-cancer-therapies 2019-08-12 23:27:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-announces-launch-of-evomela-melphalan-for-injection-in-china 2019-08-12 23:25:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halix-starts-operational-production-with-new-cgmp-facility-in-q4-2019 2019-08-09 03:10:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dynacure-receives-orphan-drug-designation-from-the-us-fda-for-dyn101-an-antisense-medicine 2019-08-09 00:01:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-launches-new-services-for-mammalian-cell-bank-manufacturing 2019-08-08 05:06:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aevi-genomic-medicine-enters-into-license-agreement-with-astrazeneca-for-anti-il-18-antibody 2019-08-07 23:55:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turalio-fda-approved-treatment-of-tgct-available-at-biologics-by-mckesson 2019-08-07 23:43:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zenith-epigenetics-and-china-based-newsoara-biopharma-announce-licensing-agreement-for-zen-3694 2019-08-06 23:41:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stoke-therapeutics-granted-fda-orphan-drug-designation-for-stk-001-an-investigational-new-treatment-for-dravet-syndrome 2019-08-06 23:31:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eloxx-pharmaceuticals-announces-initiation-of-phase-2-clinical-trial-for-elx-02-in-cystinosis 2019-08-05 23:41:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytena-gmbh-announces-that-it-has-been-entered-into-an-agreement-to-be-acquired-by-cellink 2019-08-05 23:16:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-mea-expert-growing-domestic-manufacturing-is-creating-new-opportunities 2019-08-05 07:03:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/poxel-initiates-pharmacokinetic-pharmacodynamic-study-as-part-of-the-phase-2a-clinical-program-for-pxl770 2019-08-05 01:21:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-therapy-for-rare-joint-tumor 2019-08-02 23:34:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-announces-fda-acceptance-of-new-drug-application-for-et-105 2019-08-01 23:41:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/momenta-pharmaceuticals-launches-phase-23-trial-of-m281-for-the-treatment-of-warm-autoimmune-hemolytic-anemia-and-is-granted-fda-fast-track-designation 2019-08-01 23:31:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-korea-data-shows-an-increase-in-overall-competitiveness 2019-08-01 00:01:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-biologics-and-ucb-sign-third-drug-manufacturing-deal 2019-07-31 23:56:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omeros-and-lonza-enter-long-term-manufacturing-agreement-for-commercial-supply-of-narsoplimab 2019-07-31 23:52:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xynomic-received-china-approval-to-start-2-pivotal-lymphoma-clinical-trials 2019-07-31 00:08:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-approves-darolutamide-a-new-treatment-for-men-with-non-metastatic-castration-resistant-prostate-cancer-nmcrpc 2019-07-30 23:42:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/canbridge-pharmaceuticals-submits-new-drug-application-for-hunterase-for-the-treatment-of-hunter-syndrome-in-china 2019-07-29 23:58:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-fda-regenerative-medicine-advanced-therapy-rmat-designation-granted-for-otl-103-for-the-treatment-of-wiskott-aldrich-syndrome 2019-07-29 23:43:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alexion-receives-positive-chmp-opinion-for-soliris-eculizumab-for-the-treatment-of-nmosd 2019-07-28 23:42:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mustang-bio-receives-orphan-drug-designation-for-mb-102-for-the-treatment-of-acute-myeloid-leukemia 2019-07-26 00:07:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermalreveals-2019-biopharma-cold-chain-logistics-survey 2019-07-26 00:07:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arena-pharmaceuticals-announces-first-subject-dosed-in-captivate-phase-2-trial-evaluating-olorinab-in-abdominal-pain-associated-with-irritable-bowel-syndrome 2019-07-25 23:51:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dubai-to-host-dubai-conference-exhibition-this-november 2019-07-25 01:29:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kura-oncologys-menin-mll-inhibitor-ko-539-receives-orphan-drug-designation-from-fda-for-treatment-of-acute-myeloid-leukemia 2019-07-24 23:38:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-samsung-bioepis-hadlima 2019-07-24 23:24:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fps-will-attend-next-events 2019-07-24 04:01:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/achieve-life-sciences-extends-collaboration-with-the-national-institutes-of-health-to-advance-the-development-of-cytisinicline-for-smoking-cessation 2019-07-23 23:47:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/la-jolla-pharmaceutical-company-receives-orphan-designation-from-fda-for-ljpc-0118 2019-07-23 23:41:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jounce-therapeutics-announces-update-on-strategic-collaboration-with-celgene-corporation 2019-07-23 23:34:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmacyte-biotech-and-uts-creating-advanced-version-of-melligen-cells-to-treat-diabetes 2019-07-22 23:33:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apic-bios-apb-102-receives-orphan-drug-designation-from-the-fda-for-the-treatment-of-genetic-sod1-als 2019-07-22 23:20:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/huge-cphi-p-mec-china-a-direct-result-of-surging-manufacturing 2019-07-22 06:53:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-receives-approval-in-china-to-initiate-ivosidenib-phase-i-bridging-registrational-study-for-the-treatment-of-idh1-mutant-relapsed-or-refractory-aml 2019-07-21 23:23:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-receives-approval-to-start-clinical-trial-of-tg6002-in-uk-patients-with-colorectal-cancer-with-liver-metastases 2019-07-19 23:33:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pear-therapeutics-announces-fda-submission-for-somryst-a-prescription-digital-therapeutic-for-the-treatment-of-adults-with-chronic-insomnia-and-depression 2019-07-18 23:47:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spring-bank-announces-research-agreement-with-the-national-institute-of-allergy-and-infectious-diseases-to-evaluate-hbv-antisense-oligonucleotide-compounds 2019-07-18 23:36:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jet-milling-industrialization-of-sticky-active-pharmaceutical-ingredient-using-quality-by-design-approach 2019-07-18 06:10:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aum-biosciences-expands-pipeline-with-global-license-for-first-in-class-targeted-cancer-therapy 2019-07-17 23:35:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-for-complicated-urinary-tract-and-complicated-intra-abdominal-infections 2019-07-17 23:22:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eminence-business-media-organizes-its-maiden-pharma-brand-protection-packaging-2019 2019-07-17 07:31:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sosei-heptares-enters-into-multi-target-research-collaboration-and-license-agreement-with-genentech 2019-07-16 23:44:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-pharmaceuticals-receives-orphan-drug-designation-for-aro-ang3 2019-07-16 23:40:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inscopix-announces-research-collaboration-to-pursue-new-approach-for-development-of-therapies-for-chronic-pain 2019-07-15 23:43:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dicerna-receives-breakthrough-therapy-designation-for-dcr-phxc-for-treatment-of-primary-hyperoxaluria-type-1 2019-07-15 23:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-state-of-the-art-cleanroom-completed-by-whp-for-adc-bio 2019-07-15 06:14:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascentage-pharma-announces-first-patient-dosed-in-phase-clinical-trial 2019-07-14 23:22:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eip-pharma-initiates-new-study-with-neflamapimod-for-the-treatment-of-cognitive-deficits 2019-07-14 23:21:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensorion-receives-fda-ind-approval-for-arazasetron 2019-07-12 01:26:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/h2-pharma-and-cheplapharm-announce-launch-of-etopophos-injection 2019-07-11 23:25:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-initiates-first-in-human-clinical-trial-with-il-15-superagonist-so-c101 2019-07-11 04:43:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cara-therapeutics-announces-initiation-of-phase-2-trial-of-oral-korsuva-for-pruritus-in-patients-with-atopic-dermatitis 2019-07-10 23:49:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurocrine-biosciences-announces-fda-acceptance-of-new-drug-application-for-opicapone-as-an-adjunctive-treatment-for-patients-with-parkinsons-disease 2019-07-10 23:21:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trend-barometer-chemspec-europe-2019-closes-with-record-invisitor-numbers-and-exhibition-space 2019-07-10 03:56:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellectar-receives-fda-fast-track-designation-for-clr-131-in-diffuse-large-b-cell-lymphoma 2019-07-09 23:28:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celsius-therapeutics-signs-collaboration-agreement-with-janssen-to-identify-response-biomarkers-for-ulcerative-colitis 2019-07-09 23:23:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-announces-first-patient-dosed-in-china-with-avapritinib-in-global-phase-iii-clinical-trial-in-advanced-gist 2019-07-09 23:22:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-multi-tear-closure-label-from-schreiner-medipharm 2019-07-09 07:55:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sungen-pharma-pharmaceuticals-receives-fdas-sixth-anda-approval 2019-07-08 23:46:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adma-biologics-receives-fda-approval-for-license-transfers-for-bivigam-and-nabi-hb 2019-07-08 23:44:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-releases-positive-results-from-phase-i-study-of-hd204-biosimilar-candidate-to-bevacizumab 2019-07-08 06:51:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-and-pharmapark-announce-license-and-supply-agreement-to-commercialize-prestiges-trastuzumab-biosimilar 2019-07-08 01:50:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sangamo-and-pfizer-announce-updated-phase-12-results-for-sb-525-investigational-hemophilia-a-gene-therapy-showing-sustained-increased-factor-viii-levels 2019-07-07 23:43:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sangamo-and-pfizer-announce-updated-phase-12-results-for-sb-525-investigational-hemophilia-a-gene-therapy-showing-sustained-increased-factor-viii-levels 2019-07-05 23:28:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aaf-filtration-solutions-provide-the-highest-levels-of-protection-for-cleanrooms 2019-07-04 23:18:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/grifols-selected-to-build-its-first-intravenous-solutions-manufacturing-line-in-africa 2019-07-04 01:20:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alten-calsoft-in-partnership-with-clinlogix-launches-blockchain-for-clinical-trials 2019-07-04 00:25:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-treatment-for-refractory-multiple-myeloma 2019-07-04 00:22:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/confo-therapeutics-and-dynabind-announce-drug-discovery-collaboration-to-identify-novel-gpcr-modulating-compounds 2019-07-03 01:35:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-acquire-sterile-fill-and-finish-facility-from-novartis 2019-07-03 01:07:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viriom-signed-licensing-agreement-for-indonesia-with-pt-lloyd-pharma 2019-07-02 23:28:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calithera-biosciences-initiates-phase-12-trial-of-telaglenastat-in-combination-with-pfizers-cdk46-inhibitor-palbociclib 2019-07-02 23:23:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-pharmaceuticals-and-pi-medical-sign-distribution-agreement-for-the-netherlands 2019-07-01 23:34:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amicus-therapeutics-and-brammer-bio-a-part-of-thermo-fisher-scientific-enter-strategic-gene-therapy-development-and-manufacturing-collaboration 2019-07-01 23:32:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wize-pharma-completes-milestone-for-joint-venture-with-cannabics-pharmaceuticals-companies-to-develop-cannabinoid-ophthalmic-treatments 2019-06-30 23:37:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomatrix-specialty-pharmacy-expands-expertise-in-oncology-and-rare-and-ultra-rare-diseases 2019-06-27 23:37:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcturus-therapeutics-receives-orphan-drug-designation-from-the-us-fda-for-arct-810-for-treatment-of-ornithine-transcarbamylase-deficiency 2019-06-27 23:30:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hilleman-laboratories-licenses-oral-cholera-vaccine-hillchol-to-bharat-biotech 2019-06-27 23:13:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-ambr-250-modular-bioreactor-vessel-launched-for-cell-and-gene-therapy-applications 2019-06-27 06:22:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essity-integrates-bsn-medical-india-into-essity-organization 2019-06-27 06:18:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/translate-bio-announces-fda-clearance-to-proceed-with-a-single-ascending-dose-sad-phase-12-clinical-trial 2019-06-26 23:41:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/yisheng-biopharma-receives-ind-clearance-from-china-nmpa-to-initiate-clinical-trial-of-ys-on-001 2019-06-26 23:27:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapores-drug-development-efforts-given-additional-momentum-with-national-platforms 2019-06-26 07:50:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sound-pharmaceuticals-announces-positive-topline-results-from-the-spi-1005-phase-2b-menieres-disease-clinical-trial 2019-06-25 23:47:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/windmil-therapeutics-announces-fda-clearance-of-investigational-new-drug-in-non-small-cell-lung-cancer 2019-06-25 23:35:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-series-reporting-successful-first-half-to-2019 2019-06-25 03:19:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/minerva-biotechnologies-announces-fda-acceptance-of-ind-application-for-humnc2-car44-t-cells-to-treat-metastatic-breast-cancer 2019-06-25 01:56:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-new-drug-application-for-vyleesi 2019-06-25 01:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-reports-positive-top-line-phase-iii-results-for-tuznue 2019-06-24 03:54:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-broadens-partnership-with-accord-healthcare-to-supply-and-distribute-cardioxane-and-savene-in-poland 2019-06-24 00:38:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-launches-enhanced-integrated-functional-service-provider-model-to-drive-delivery 2019-06-24 00:07:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orion-biotechnology-reports-additional-positive-preclinical-data-for-ob-002-in-the-treatment-of-colorectal-cancer 2019-06-21 00:07:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gamida-cell-and-lonza-establish-commercial-manufacturing-agreement-for-omidubicel 2019-06-20 00:07:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/melinta-therapeutics-announces-us-fda-acceptance-of-supplemental-new-drug-application-for-baxdela-for-the-treatment-of-community-acquired-bacterial-pneumonia 2019-06-20 00:03:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/carsgen-therapeutics-receives-ind-clearance-for-bcma-car-t-cells-from-the-us-fda 2019-06-19 23:40:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/denovo-biopharma-receives-global-rights-to-a-novel-late-stage-drug-for-alzheimers-disease-from-orion-corporation-for-development-as-a-personalized-medicine 2019-06-18 23:21:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/concept-life-sciences-opens-new-facility-to-offer-complete-pharmaceutical-manufacturing-support-services 2019-06-18 23:04:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/digital-science-joins-research4life-initiative-as-a-publishing-partner 2019-06-18 05:44:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xeris-pharmaceuticals-announces-additional-positive-outcomes-from-global-phase-clinical-trial 2019-06-17 23:17:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-2-trial-shows-efficacy-of-cytuvaxs-adjuvant-platform-technology 2019-06-17 23:05:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/liquid-addition-a-revolutionary-development-in-ibc-blending 2019-06-14 23:39:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/upsher-smith-laboratories-enters-into-agreement-to-acquire-tosymra-and-zembrace-symtouch 2019-06-14 23:18:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcellera-announces-therapeutic-antibody-discovery-collaboration-with-gilead-in-infectious-disease 2019-06-13 23:50:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/terns-pharmaceuticals-and-shanghai-tuosheng-biotechnology-co-ltd-initiated-the-first-phase-trial-of-tern-101 2019-06-13 23:49:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinical-inks-jonathan-andrus-invited-to-speak-at-the-duke-margolis-center 2019-06-13 06:36:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nucana-receives-orphan-drug-designation-from-the-us-food-and-drug-administration-for-acelarin 2019-06-12 23:40:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/macrogen-announces-strategic-investment-in-australian-microbiome-company-microba 2019-06-12 23:36:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioventus-and-mtf-biologics-work-together-to-develop-the-next-generation-of-placental-tissue-products-for-knee-osteoarthritis 2019-06-11 23:41:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metvital-inc-announces-fda-clearance-of-investigational-new-drug-ind-application-for-aeo-for-phase-2-testing-for-glioblastoma-multiforme 2019-06-11 23:33:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncternal-therapeutics-completes-reverse-merger-with-gtx-inc 2019-06-11 00:07:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-chemoimmunotherapy-regimen-for-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma 2019-06-11 00:02:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acucela-receives-orphan-designation-from-the-ema-for-emixustat-for-the-treatment-of-stargardt-disease 2019-06-09 23:26:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioventus-will-develop-with-mtf-biologics-a-next-generation-placental-tissue-product-for-knee-osteoarthritis 2019-06-06 23:29:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-reaches-mutual-agreement-with-innovus-pharma-to-terminate-distribution-and-license-agreement 2019-06-06 23:21:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phoenix-molecular-designs-and-wuxi-sta-reach-drug-supply-milestone-to-support-phase-study 2019-06-06 07:31:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/origenis-gmbh-announces-research-collaboration-with-us-cancer-center 2019-06-05 23:57:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomarin-announces-approval-of-vimizim-elosulfase-alfa-in-china-for-treatment-of-morquio-a-syndrome 2019-06-05 23:37:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-repeatedly-increases-production-capacity-for-pharmaceutical-tubing-in-india 2019-06-04 03:03:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apceth-will-operate-as-the-commercial-manufacturer-in-europe-for-zynteglo 2019-06-04 00:39:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ironwood-pharmaceuticals-and-allergan-initiate-patient-dosing-in-phase-clinical-trial 2019-06-04 00:36:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zenith-technologies-sees-400-china-growth-in-latest-asia-success 2019-06-03 03:00:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotios-dcvacluca-significantly-improves-survival-in-patients-with-stage-iv-non-small-cell-lung-cancer 2019-06-03 00:37:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iovance-biotherapeutics-expands-partnership-with-wuxi-advanced-therapies-business 2019-06-03 00:23:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-participates-in-air-cargo-europe-2019 2019-05-31 06:11:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lantheus-announces-strategic-collaboration-with-nanomab-to-provide-a-novel-biomarker-for-clinical-development-and-management-of-immuno-oncology-therapies 2019-05-30 23:34:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-signs-license-agreement-to-nasal-technology-with-university-of-texas-at-austin 2019-05-30 23:29:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-joins-with-community-oncology-networks-for-new-research-collaboration 2019-05-29 23:29:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-gubra-announce-new-collaboration-to-develop-anti-obesity-peptide-poly-agonists 2019-05-29 23:27:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-china-opens-with-analysis-pointing-to-a-surge-in-growth-in-2019 2019-05-29 07:54:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sygnature-discovery-and-renasci-strengthen-in-vivo-pharmacology-service-offering 2019-05-29 06:09:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/msn-labs-novadoz-pharmaceuticals-receives-consecutive-fda-approvals 2019-05-28 23:02:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-works-towards-a-sustainable-energy-supply 2019-05-28 22:45:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-medicines-agency-accepts-marketing-authorisation-application-for-prestige-biopharmas-trastuzumab-biosimilar-hd201-for-review 2019-05-28 04:20:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-the-novottf-100ltm-system-in-combination-with-chemotherapy-for-the-treatment-of-malignant-pleural-mesothelioma 2019-05-24 00:02:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-expands-pipeline-with-mid-stage-biologic-candidate-tnx-1300-for-cocaine-intoxication 2019-05-23 23:48:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-abcuro-signed-glymaxx-improved-cell-line-development-and-gmp-production-agreement 2019-05-23 02:53:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agile-therapeutics-announces-fda-acceptance-of-the-nda-resubmission-of-twirla 2019-05-22 23:36:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kalytera-announces-engagement-of-echelon-wealth-partners-to-assist-with-review-of-potential-out-license-opportunities 2019-05-22 23:30:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avalon-globocare-partners-with-mit-to-develop-innovative-ai-enhanced-protein-design-technology-in-cellular-therapy 2019-05-21 23:51:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santhera-starts-collaboration-in-gene-therapy-research-for-congenital-muscular-dystrophy-with-the-biozentrum-university-of-basel 2019-05-21 23:34:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/springworks-therapeutics-announces-initiation-of-phase-3-trial-defi-of-nirogacestat-in-adult-patients-with-desmoid-tumors 2019-05-20 23:32:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioxcel-therapeutics-achieved-targeted-exposures-of-bxcl501-designed-for-non-invasive-acute-treatment-of-agitation-in-neuropsychiatric-diseases 2019-05-20 23:21:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemspec-europe-2019-gathers-impressive-array-of-industry-experts-under-one-roof 2019-05-17 06:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-chooses-synpromics-novel-inducible-promoter-platform-to-manufacture-biopharmaceuticals 2019-05-17 06:45:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/altasciences-and-wuxi-apptec-enter-into-collaboration-for-wind-projects 2019-05-17 00:16:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/scintomics-and-1717-life-science-ventures-form-joint-venture-pentixapharm 2019-05-16 23:17:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/visit-asias-leading-exhibition-for-pharma-rd-and-manufacturing-technologies 2019-05-16 00:23:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/x4-pharmaceuticals-and-the-leukemia-lymphoma-society-announce-collaboration-to-advance-development-of-mavorixafor 2019-05-15 23:34:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matinas-biopharma-announces-a-research-collaboration-with-viiv-healthcare 2019-05-15 23:26:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-vaccitech-sign-license-agreement-for-probiogens-technology-platform 2019-05-15 03:04:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-japan-tokyo-expands-its-scale 2019-05-14 23:56:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmscript-expands-into-tennessee-with-acquisition-of-rx-med 2019-05-14 23:54:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/progenics-pharmaceuticals-and-rotop-pharmaka-gmbh-announce-european-collaboration 2019-05-14 23:37:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transgene-receives-fda-investigational-new-drug-indication-to-initiate-clinical-development-of-tg4050-the-first-individualized-immunotherapy 2019-05-13 23:48:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/poseida-therapeutics-receives-us-fda-orphan-drug-designation-for-p-bcma-101 2019-05-13 23:17:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-the-launch-of-a-generic-version-of-delzicol-delayed-release-capsules 2019-05-12 23:23:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/olix-pharmaceuticals-expands-ocular-disease-pipeline 2019-05-10 00:03:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-enters-into-licensing-agreement-with-medac-concerning-anti-rheumatic-agent-methotrexate-subcutaneous-injection-in-japan 2019-05-09 23:59:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-commences-venture-investment-business-aimed-at-accelerating-innovation-in-drug-creation 2019-05-09 03:11:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-and-mundipharma-china-pharmaceutical-together-announce-the-launch-of-aloxi-iv 2019-05-09 03:07:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-introduces-new-simca-software-for-multivariate-data-analytics 2019-05-09 01:43:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-strengthen-its-presence-in-china-india-resuming-freighter-flights 2019-05-05 23:42:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/presage-announces-collaboration-with-celgene-to-investigate-novel-agents 2019-05-02 23:41:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-therapeutics-expands-specialty-portfolio-with-otiprio-co-promotion-agreement-in-the-us 2019-05-02 23:38:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-launches-new-ambr-15-cell-culture-microbioreactor-system 2019-05-02 07:21:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amal-therapeutics-enters-clinical-collaboration-with-boehringer-ingelheim-to-evaluate-atp128-in-combination-with-bi754091 2019-05-02 03:21:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tetra-bio-pharma-closes-the-acquisition-of-panag-pharma 2019-05-01 23:35:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncbiomune-announces-agreement-with-cato-bioventures-as-a-strategic-investor-in-support-of-cd71-targeted-therapy 2019-05-01 23:31:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-buys-out-purdue-rights-to-end-collaboration 2019-05-01 23:19:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/manufacturing-growth-sees-surging-demand-at-cphi-south-east-asia 2019-05-01 06:12:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-purdue-pharma-announce-buy-out-of-purdues-rights-in-worldwide-collaboration 2019-04-30 23:38:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/caprion-biosciences-acquires-serametrix-corporation 2019-04-30 23:36:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iktos-announces-research-collaboration-with-janssen-to-utilize-iktos-artificial-intelligence-technology-to-increase-speed-efficiency-of-small-molecule-drug-discovery 2019-04-29 23:40:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/geisinger-partners-with-rx-savings-solutions-to-offer-members-innovative-savings-on-prescription-drugs 2019-04-29 23:38:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-praluent-to-prevent-heart-attack-stroke-and-unstable-angina-requiring-hospitalization 2019-04-28 23:39:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precigen-opens-gene-and-cell-therapy-manufacturing-facility-in-germantown-maryland 2019-04-25 23:47:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aurora-bolsters-anandias-testing-capabilities-through-acquisition-of-chemi-pharmaceutical 2019-04-25 23:38:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/garhwal-central-university-received-first-indian-patent 2019-04-26 06:44:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/la-jolla-pharmaceutical-company-announces-us-fdas-grant-of-breakthrough-therapy-designation 2019-04-24 23:33:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/velabs-therapeutics-to-cooperate-with-chiome-bioscience-in-the-field-of-gpcr-specific-functional-antibody-screening 2019-04-24 01:43:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/macrogen-and-exosome-plus-sign-mou-for-joint-development-of-exosome-based-diagnostic-and-therapeutic-agents 2019-04-23 23:55:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epimab-biotherapeutics-is-granted-us-patent-on-core-bispecific-antibody-technology 2019-04-23 23:54:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vineti-and-marker-therapeutics-announce-strategic-partnership-to-support-diverse-cell-therapy-portfolio 2019-04-22 23:32:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-announces-that-breakthrough-therapy-designation-remains-in-effect-for-tonmya-for-the-treatment-of-posttraumatic-stress-disorder 2019-04-22 23:32:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moleculin-receives-fda-approval-of-fast-track-designation-for-annamycin 2019-04-20 03:44:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/osiris-therapeutics-inc-announces-closing-of-acquisition-by-smith-nephew-plc daily 0.1 https://demo.pharmafocusasia.com/pressreleases/labcorp-and-envigo-sign-innovative-agreement-to-expand-covances-nonclinical-drug-development-capabilities daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stealth-biotherapeutics-announces-positive-results-for-elamipretide- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-biopharma-and-wuxi-biologics-announce-long-term-strategic-manufacturing-partnership daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tg-therapeutics-receives-orphan-drug-designation-for-umbralisib daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pulmatrix-and-cipla-technologies-llc-enter-into-definitive-agreement 2019-04-15 23:53:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knight-therapeutics-announces-canadian-expansion-of-probuphine-subcutaneous-implant daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tetra-bio-pharma-and-ovensa-will-engage-in-a-collaboration-to-tackle-brain-cancer 2019-04-12 00:27:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celularity-enters-lease-to-develop-advanced-cell-manufacturing-and-research-facility daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-continued-its-growth-in-a-shrinking-air-cargo-market 2019-04-11 05:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-and-kaken-enter-into-license-agreement daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shionogi-announces-licensing-of-symproic daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ra-pharmaceuticals-announces-completion-of-end-of-phase-interactions-with-fda daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reneuron-partners-with-fosun-pharma-in-china daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genedesign-joins-ajinomoto-bio-pharma-services daily 0.1 https://demo.pharmafocusasia.com/pressreleases/audentes-therapeutics-announces-expansion-of-aav-technology-platform-and-pipeline-with-new-development-programs daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-therapeutics-announces-completion-of-merger-with-helomics-holding-corporation daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puma-biotechnology-expands-cohorts-in-phase-ii-summit-trial-of-neratinib-in-cancer-patients-with-tumors daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anges-obtains-conditional-approval-in-japan-for-hgf-gene-therapy daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spotlight-on-sustainable-endotoxin-testing-to-support-horseshoe-crab-conservation daily 0.1 https://demo.pharmafocusasia.com/pressreleases/csc-pharmaceuticals-announces-the-launch-of-the-innovative-migraine-and-pain-treatment-developed daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qiagen-and-labcorp-launch-collaboration-to-provide-day-one-access-for-patients-to-innovative-companion-diagnostics daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trillium-therapeutics-expands-immuno-oncology-pipeline-with-sting-agonist-program daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-and-molecular-partners-announce-topline-safety-results-from-maple-study-of-abicipar-pegol daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-starts-to-operate-at-istanbul-airport-its-new-hub 2019-04-02 04:35:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-with-purchase-of-advanced-biologics-therapy-manufacturing-campus- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-announces-agreement-with-zentiva-to-divest-creo-pharma daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-announces-the-nda-submission-for-fda-approval-of-lmis-mg daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-receives-fda-fast-track-designation-for-spr- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discovery-life-sciences-expands-scientific-capabilities daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mitsubishi-tanabe-pharma-america-announces-collaboration-with-massachusetts-general-hospital daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antares-pharma-announces-receipt-of-orphan-drug-designation-for-the-treatment-of-ectopic-pregnancy-with-methotrexate daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novel-first-in-class-flip-inhibitors-for-the-treatment-of-cancer daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteonic-biotechnology-licenses-protein-production-technology-to-bayer daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bcg-digital-ventures-and-sartorius-help-launch-the-worlds-first-voice-powered-digital-assistant-for-scientists 2019-03-28 03:18:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tasly-pharmaceutical-group-taps-shuwen-biotech-for-companion-diagnostic-services daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leo-pharma-chooses-veeva-development-cloud-to-accelerate-drug-development daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-receives-fda-breakthrough-therapy-designation-for-axs-for-the-treatment-of-major-depressive-disorder daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enamine-extends-multi-year-drug-discovery-collaboration-with-lundbeck daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanosurface-biomedical-launches-new-drug-screening-platform- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breath-therapeutics-announces-initiation-of-global-phase-trials-for-the-treatment- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biofrontera-inc-usa-acquires-cutanea-life-sciences-inc-usa daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerveau-technologies-inc-signs-research-agreement-with-eisai-inc-for-novel-tau-imaging-agent daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bluebird-bio-opens-state-of-the-art-gene-and-cell-therapy-manufacturing-facility daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzprotect-starts-collaboration-with-parexel-biotech daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-eisai-to-discontinue-phase-engage-and-emerge-trials daily 0.1 https://demo.pharmafocusasia.com/pressreleases/primex-pharmaceuticals-and-nordic-group-sign-a-strategic-partnership-to-commercialise-ozalin daily 0.1 https://demo.pharmafocusasia.com/pressreleases/knopp-biosciences-collaborates-with-leading-british-researchers- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lead-pharma-announces-start-of-phase-clinical-trials daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valoremrx-collaborates-with-kroger-specialty-pharmacy-to-improve-access-and-patient-care daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alexion-and-zealand-pharma-announce-collaboration-to-discover-and-develop-peptide-therapies daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-sponsored-the-carriage-of-historical-artifacts 2019-03-20 07:44:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/domainex-and-spirochem-enter-a-fragment-drug-discovery-partnership daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crinetics-pharmaceuticals-doses-first-patients-in-phase-clinical-trials-of-crn-for-acromegaly 2019-04-17 07:29:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abzena-and-lipum-ab-sign-integrated-cmc-agreement-to-produce-a-novel-biologic- 2019-04-17 07:29:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotios-dcvac-ovca-significantly-improves-survival-in-patients-with-recurrent-ovarian-cancer 2019-04-17 07:29:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharmas-bidose-nasal-drug-delivery-device-approved-by-us-fda 2019-04-17 07:29:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/highlighting-advantages-of-the-whole-industry-chain-layout 2019-04-17 07:29:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmapack-success-points-to-sizeable-growth-potential-for-global-drug-delivery-and-packaging 2019-04-17 07:28:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharmas-bidose-nasal-drug-delivery-device-approved-by-u-s-fda- 2019-04-17 07:28:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-national-biotec-group-and-immunobiology-ltd-enter-licensing-agreement- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellesce-announces-license-agreement-with-hubrecht-organoid-technology-for-the-expansion 2019-04-17 07:28:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xynomic-pharma-achieves-important-regulatory-milestones-in-china-and-eu- 2019-04-17 07:28:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pii-to-manufacture-fda-approved-busulfan-injection-drug-product 2019-04-17 07:28:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iktos-announces-collaboration-with-merck-kgaa-darmstadt-germany 2019-04-17 07:28:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adamis-pharmaceuticals-announces-fda-acceptance-for-review-of-the-new-drug-application-of-its-higher-dose-naloxone-injection-product-candidate 2019-04-17 07:28:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hematogenix-introduces-the-fda-approved-immuno-oncological-diagnostic-adjunctive-diagnostic-test 2019-04-17 07:28:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sungen-pharma-and-athenex-pharmaceutical-division-announce-busulfan-injection-product-launch 2019-04-17 07:28:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyd-pharma-develops-new-deuterium-depleted-drugs 2019-04-17 07:28:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fidia-pharma-usa-announces-expansion-into-regenerative-medicine-markets 2019-04-17 07:28:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstone-received-ind-approval-in-china-for-hdac-inhibitor-cs- 2019-04-17 07:28:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigo-launches-pathway-an-optimized-safety-assessment-solution-to-enable-first-in-human-clinical-trials 2019-04-17 07:28:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-imbrium-therapeutics-announce-us-fda-filing-acceptance-of-new-drug-application 2019-04-17 07:28:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/third-sartorius-research-xchange-forum-focuses-on-car-t-cell-therapy 2019-04-17 07:28:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genentech-submits-supplemental-new-drug-application-to-fda daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aprecia-and-cmic-a-leading-cdmo-in-japan-have-established-an-agreement 2019-04-17 07:28:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/concert-pharmaceuticals-announces-initiation-of-open-label-trial-to-evaluate-once-daily-vs-twice-daily-dosing-of-ctp- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antolrx-announces-pfizer-exercises-option-to-license-immune-tolerance-therapy 2019-04-17 07:28:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adult-stem-cell-derived-kidney-on-a-chip-in-nature-biotechnology 2019-04-17 07:28:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyrus-biotechnology-announces-release-of-antibody-structure-prediction-software 2019-04-17 07:28:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iksuda-therapeutics-and-femtogenix-sign-license-agreement 2019-04-17 07:28:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-announces-final-approval-of-its-anda-for-imatinib-mesylate-tablets 2019-04-17 07:28:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agc-completes-the-acquisition-of-the-spanish-manufacturer-of-synthetic-active-drugs daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novago-therapeutics-raises-to-develop-regenerative-anti-nogo-therapy-for-stroke 2019-04-17 07:28:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupus-therapeutics-partners-with-takeda-on-phase-trial 2019-04-17 07:28:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovus-pharma-announces-the-approval-of-its-diabasens-product-in-canada-indicated 2019-04-17 07:28:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/halozyme-announces-fda-approval-of-herceptin-hylecta 2019-04-17 07:28:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfenex-and-alvogen-expand-development-and-commercialization-collaboration daily 0.1 https://demo.pharmafocusasia.com/pressreleases/confo-therapeutics-forms-scientific-advisory-board-as-it-accelerates-development 2019-04-17 07:27:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-opens-dublin-network-station-service-center 2019-04-17 07:27:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inflarx-receives-approval-to-initiate-phase-iia-clinical-trial 2019-04-17 07:27:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-announces-final-approval-of-its-anda-for-exemestane-tablets 2019-04-17 07:27:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medlab-asia-pacific-bringing-intelligence-and-innovation-together 2019-04-17 07:27:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cac-and-rfxcel-announce-partnership-agreement-for-pharmaceutical-traceability 2019-04-17 07:27:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-biologics-formulation-development-and-drug-delivery-forum 2019-04-17 07:27:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-portfolio-management-strategies-for-biosimilars-generics 2019-04-17 07:27:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aslan-pharmaceuticals-to-partner-with-biogenetics-on-commercialisation 2019-04-17 07:27:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/blackstone-life-sciences-and-novartis-launch-anthos-therapeutics-to-develop-innovative-medicines 2019-04-17 07:27:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nex-china-takes-the-express-for-healthy-food-together-with-natural-extract-enterprises 2019-04-17 07:27:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seize-the-strategic-market-of-the-livestock-industry 2019-04-17 07:27:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revolutionary-technology-and-innovation-to-debut-at-interphex 2019-04-17 07:27:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abl-bio-expands-strategic-collaboration-with-wuxi-biologics-and-licenses-wuxibody-platform daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anixa-biosciences-announces-partnership-with-researchdx-for-launch- 2019-04-17 07:27:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-grants-orphan-drug-designation-for-etoposide-toniribate-in-relapsed-refractory-biliary-tract-cancer 2019-04-17 07:27:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/anixa-biosciences-extends-collaborative-research-agreement-with-the-wistar-institute-and-leading-myeloid-derived-suppressor-cell-researcher daily 0.1 https://demo.pharmafocusasia.com/pressreleases/opiant-pharmaceuticals-announces-top-line-results-from-phase-clinical-trial 2019-04-17 07:27:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arca-biopharma-announces-fda-agreement-for-a-single-phase-clinical-trial-to-support-approval- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/satsuma-pharmaceuticals-provides-corporate-update-and-prepares-to-advance-lead-product-candidate daily 0.1 https://demo.pharmafocusasia.com/pressreleases/calypso-biotech-bv-secures-million-eur-in-series-a-financing daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alzprotect-on-track-for-phase-entry-in-for-its-drug-candidate-azp- 2019-04-17 07:27:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gamida-cell-announces-agreement-with-editas-medicine- 2019-04-17 07:27:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ars-pharmaceuticals-announces-fda-fast-track-designation-for-ars-intranasal-epinephrine-spray 2019-04-17 07:27:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-to-roche-s-personalised-medicine-entrectinib 2019-04-17 07:27:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bayer-to-obtain-full-rights-to-global-development-and-commercialization-of-oncology-compounds-vitrakvi 2019-04-17 07:27:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leiters-and-mobius-therapeutics-enter-into-national-sales 2019-04-17 07:27:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rdd-pharma-receives-fast-track-designation-from-fda-for-rdd-for-treatment-of-fecal-incontinence 2019-04-17 07:27:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/moderna-announces-positive-interim-phase-data-for-first-combination-vaccine 2019-04-17 07:27:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-to-initiate-phase-clinical-development-of-xl- 2019-04-17 07:27:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/haselmeier-acquires-drug-manufacturing-license-and-now-offers-assembly 2019-04-17 07:27:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zylo-and-ferndale-enter-into-exclusive-development-and-supply-agreement 2019-04-17 07:27:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-and-c-bridge-capital-team-up-to-develop-and-commercialize-next-generation-biosimilars 2019-04-17 07:27:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aussie-group-and-us-vitruvias-therapeutics-inc-sign-semi-solid-formulation-cooperation-agreement 2019-04-17 07:26:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eton-pharmaceuticals-enters-into-license-agreement 2019-04-17 07:26:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/andrew-alliance-and-sartorius-collaborate 2019-04-17 07:26:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antidote-therapeutics-announces-collaboration-with-national-cancer-institute-to-develop-ati- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/frazier-healthcare-partners-launches-recida-therapeutics-to-develop-novel-therapeutics 2019-04-17 07:26:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellmid-significant-new-findings-published-on-midkine 2019-04-17 07:26:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seqens-new-name-for-a-global-leader-in-pharmaceutical-synthesis-and-specialty-ingredients 2019-04-17 07:26:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eyenovia-announces-fda-acceptance-of-ind-application-for-micropine 2019-04-17 07:26:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-kgaa-darmstadt-germany-to-expand-us-biopharmaceutical-r-d-facility 2019-04-17 07:26:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/matcon-supports-evesham-vale-community-charity 2019-04-17 07:26:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/entasis-therapeutics-receives-positive-feedback-from-fda-end-of-phase-meeting 2019-04-17 07:26:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apellis-apl-receives-orphan-drug-designation-from-the-fda-for-the-treatment-of-autoimmune-hemolytic-anemia 2019-04-17 07:26:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-therapeutics-announces-fda-acceptance-of-ind-application-for-spr- 2019-04-17 07:26:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolinerx-receives-orphan-drug-designation-from-the-fda 2019-04-17 07:26:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-purdue-pharma-present-efficacy-and-safety-data-from-second-pivotal-phase-study 2019-04-17 07:26:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cti-biopharma-receives-results-of-the-chmp-oral-explanation-for-pacritinib-in-the-treatment-of-myelofibrosis- 2019-04-17 07:26:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenxbio-receives-rare-pediatric-disease-designation-for-rgx-gene-therapy-for-the-treatment 2019-04-17 07:26:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/particle-sciences-partners-with-encube-ethicals-to-develop-novel-vaginal-rings 2019-04-17 07:26:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitachi-chemical-co-ltd-to-acquire-apceth-biopharma-gmbh 2019-04-17 07:26:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eureka-therapeutics-announces-us-fda-clearance-of-ind-application-for-phase-trial-of-et-artemis-t-cell-therapy 2019-01-30 23:33:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/brainsway-receives-pmda-approval-in-japan- 2019-04-17 07:26:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapore-edevelopment-subsidiary-global-biolifes-f-antimicrobial-fragrance 2019-04-17 07:26:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-lilly-announce-top-line-results-from-second-phase-study-of-tanezumab 2019-04-17 07:26:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lambda-therapeutic-research-expands-global-footprint-in-the-u-s-by-acquiring-novum-pharmaceutical-research-services 2019-04-17 07:26:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kowa-pharmaceuticals-america-inc-enters-into-co-promotion-agreement-with-allergan 2019-04-17 07:26:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-biologics-manufacturing-korea 2019-04-17 07:26:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centerline-biomedical-announces-fda-submission-for-iops-system 2019-04-17 07:26:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-announces-closing-of-license-agreement-with-arena-pharmaceuticals 2019-04-17 07:26:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rigel-pharmaceuticals-enters-collaboration-and-license-agreement-with-grifols-s-a 2019-04-17 07:25:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-combined-diagnostic-and-antimicrobial-susceptibility-test-enables 2019-04-17 07:25:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/telix-group-expands-prostate-imaging-capability-through-inin-technology-partnership 2019-04-17 07:25:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cognate-bioservices-and-astero-bio-corporation-announce-collaboration 2019-04-17 07:25:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-offers-services-for-characterization-of-new-biological-entities 2019-04-17 07:25:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-and-the-loulou-foundation-partner-to-develop-key-research-tools 2019-04-17 07:25:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-biopharma-receives-u-s-fda-ind-clearance-for-proprietary-cd-antibody-tjd- 2019-04-17 07:25:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-announces-publication-by-san-raffaele-telethon-institute-for-gene-therapy daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crispr-therapeutics-and-probiogen-sign-collaboration-and-license-agreement 2019-04-17 07:25:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taiwanj-pharmaceuticals-announces-positive-results-from-phase-orphan-drug-designation-study 2019-04-17 07:25:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-introduces-biostat-rm-tx-with-flexsafe-rm-tx 2019-04-17 07:25:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kura-oncology-reports-clinical-activity-of-tipifarnib 2019-04-17 07:25:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-provides-update-on-phase-study-of-ibrutinib-in-metastatic-pancreatic-cancer 2019-04-17 07:25:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/promentis-pharmaceuticals-announces-commencement-of-phase-studies- 2019-04-17 07:25:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-biopharmaceuticals-china-expands 2019-04-17 07:25:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lack-of-regional-research-into-precision-medicine-may-hinder-targeted-therapies 2019-04-17 07:25:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/middle-east-ivf-market-worth-as-infertility-rates-rise 2019-04-17 07:25:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therachon-is-granted-orphan-drug-designation-by-us-fda-for-apraglutide 2019-04-17 07:25:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bluerock-therapeutics-establishes-key-partnerships-with-leading-experts 2019-04-17 07:25:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/menlo-therapeutics-serlopitant-granted-breakthrough-therapy-designation-by-fda 2019-04-17 07:25:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ironwood-pharmaceuticals-announces-approval-of-linzess-in-china 2019-04-17 07:25:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evenity-receives-approval-in-japan-for-the-treatment-of-osteoporosis 2019-04-17 07:25:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinese-api-market-growing-strongly-cphi-china-assisting-enterprises-with-the-transformation 2019-04-17 07:25:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-extends-exclusive-european-clinical-trial-sourcing 2019-04-17 07:25:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aphria-completes-acquisition-of-cc-pharma-leading-german-pharmaceutical-and-medical-cannabis-distributor 2019-04-17 07:25:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagonist-therapeutics-initiates-phase-trial-of-novel-hepcidin-mimetic-ptg- 2019-04-17 07:25:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-and-pear-therapeutics-announce-us-launch-of-reset-otm 2019-04-17 07:25:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-introduces-new-dedicated-division-to-help-emerging-biotech-companies 2019-04-17 07:25:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/decibel-therapeutics-and-cocoon-biotech-announce-collaboration-to-develop-proprietary-formulations 2019-04-17 07:25:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sublimity-therapeutics-receives-investigational-new-drug-clearance 2019-04-17 07:25:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/velabs-therapeutics-to-cooperate-with-biomed-x-in-the-field-of-immunology 2019-04-17 07:25:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oculis-expands-portfolio-with-the-in-licensing-of-a-novel-phase-ii-stage-anti-tnf-alpha-antibody-fragment 2019-04-17 07:24:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-the-legal-approval-of-the-settlement-agreement-for-the-acquisition-of-shire-plc 2019-04-17 07:24:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ablexis-announces-licensing-agreement-with-corvidia-therapeutics 2019-04-17 07:24:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-announces-multiple-collaborations-in-cell-therapies- 2019-04-17 07:24:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-completes-acquisition-of-us-manufacturing-site 2019-04-17 07:24:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amunix-announces-licensing-agreement-with-merck-for-protia-immune-activator-platform 2019-04-17 07:24:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-initiates-a-collaborative-partnership-with-science- 2019-04-17 07:24:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/banner-receives-fda-tentative-approval-for-bafiertam-for-the-treatment-of-relapsing-forms-of-multiple-sclerosis 2019-04-17 07:24:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sol-global-announces-investment-in-and-strategic-partnership-with-european-medical-cannabis 2019-04-17 07:24:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-designation-for-heron-therapeutics-nda-for-htx- 2019-04-17 07:24:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharma-announces-innovative-drug-risperidone-extended-release-microspheres 2019-04-17 07:24:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polarityte-registers-osteote-with-us-food-and-drug-administration 2019-04-17 07:24:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-kaisha-brings-new-portfolio-of-highly-customizable-prefillable-glass-syringes 2019-04-17 07:24:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-a-successful-activation-of-u-s-clinical-trial-sites 2019-04-17 07:24:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tracon-pharmaceuticals-announces-submission-of-ind-application-for-tj- 2019-04-17 07:24:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/special-event-organized-by-turkish-cargo-for-iata-ceiv-pharma-workshop 2019-04-17 07:24:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-and-thermo-fisher-scientific-collaborate-for-biopharmaceutical 2019-04-17 07:24:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinnn-group-grants-exclusive-licensing-rights-to-menarini-for-pracinostat 2019-04-17 07:24:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-receives-u-s-fda-ind-approval 2019-04-17 07:24:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-extends-its-services-to-calicut-international-airport 2018-12-24 02:55:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gritstone-oncology-announces-fda-fast-track-designation-for-granite- 2019-04-17 07:24:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apexigen-announces-clinical-collaboration-on-a-new-phase-trial-for-apx-m-in-sarcoma 2019-04-17 07:24:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-se-to-purchase-us-manufacturing-site-from-shire-plc 2019-04-17 07:24:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orgenesis-announces-collaboration-with-mangogen-pharma-for-advanced-gene-delivery-platform 2019-04-17 07:24:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kyn-therapeutics-announces-initiation-of-phase-b-clinical-studies 2019-04-17 07:24:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lakepharma-announces-its-cgmp-microbiomanufacturing-center-is-now-operational 2019-04-17 07:24:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tilray-signs-a-global-collaboration-agreement-with-a-leading-pharmaceutical-company 2018-12-18 23:43:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-h-biomedicine-announce-research-collaboration- 2019-04-17 07:24:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-announces-breakthrough-therapy-designation-granted-by-fda-for-lonafarnib- 2019-04-17 07:23:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridge-biotherapeutics-announces-fda-clearance-of-ind- 2019-04-17 07:23:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-and-sirion-biotech-announce-licensing-agreement 2019-04-17 07:23:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-partners-with-cipla-ltd-to-market-key-cancer-biosimilar 2019-04-17 07:23:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dragonfly-therapeutics-announces-celgene-in-license-of-first-two-trinket-immunotherapy-drug-candidates 2019-04-17 07:23:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-the-build-out-of-new-gene-therapy-manufacturing-facility 2019-04-17 07:23:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rodin-therapeutics-announces-initiation-of-phase-clinical-trial- 2019-04-17 07:23:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomx-enters-collaboration-with-johnson-johnson-innovation- 2019-04-17 07:23:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-and-magellan-rx-management-collaborate-to-improve-patient-care-for-chronic-difficult-to-treat-conditions 2019-04-17 07:23:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-achieves-breakthrough-titer-of-gl-in-cell-culture-productivity 2019-04-17 07:23:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/batavia-biosciences-partners-with-iavi 2019-04-17 07:23:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-expands-global-network-with-launch-of-services-to-barcelona 2019-04-17 07:23:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tissue-regeneration-therapeutics-and-roosterbio-inc-form-strategic-alliance 2019-04-17 07:23:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-genoway-enter-into-a-strategic-alliance 2019-04-17 07:23:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fimbrion-and-gsk-discover-a-possible-novel-drug-for-the-treatment-of-urinary-infections 2019-04-17 07:23:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dendreon-signs-long-term-lease-agreement 2019-04-17 07:23:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iterion-therapeutics-initiates-phase-i-clinical-study-of-tegavivint- 2019-04-17 07:23:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viracta-and-salubris-announce-equity-financing-and-partnership-to-bring-novel-treatment 2019-04-17 07:23:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovent-receives-an-approval-from-the-us-fda-to-initiate-clinical-trials-for-its-anti-ox-monoclonal-antibody-ibi- 2019-04-17 07:23:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tilray-announces-new-subsidiary-tilray-latin-america 2019-04-17 07:23:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-biopharmaceuticals-announces-fda-acceptance-of-ind-application-for-lonafarnib- 2019-04-17 07:23:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/x-pharmaceuticals-presents-additional-positive-phase-results daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qiagen-and-neogenomics-collaborate-to-offer-cancer-patients-day-one-access 2019-04-17 07:23:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zambon-announces-approval-and-artg-listing-of-safinamide-in-australia- 2019-04-17 07:23:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-announces-licensing-agreement-with-pharmaessentia-for-rights-to-oradoxel- 2019-04-17 07:23:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/als-organizations-collaborate-to-advance-new-therapeutic-into-trials 2019-04-17 07:23:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-abl-bio-enter-an-exclusive-development-and-clinical-manufacturing-partnership 2019-04-17 07:23:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-treatment-for-lambert-eaton-myasthenic-syndrome 2019-04-17 07:23:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-biosciences-receives-fda-authorization-to-initiate-clinical-study 2019-04-17 07:23:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sygnature-discovery-establishes-us-office-in-cambridge 2019-04-17 07:22:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/accenture-expands-platform-for-drug-discovery-and-innovation 2019-04-17 07:22:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regenxbio-and-rocket-pharmaceuticals-announce-new-license-agreement 2019-04-17 07:22:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-regulation-announces-positive-results-from-phase-clinical-trial 2019-04-17 07:22:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-announces-presentations-on-cdk-inhibitor-sel 2019-04-17 07:22:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-granted-fda-orphan-drug-designation 2019-04-17 07:22:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theravance-biopharma-announces-first-patient-dosed-in-phase-study 2019-04-17 07:22:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pliant-therapeutics-receives-fda-orphan-drug-designation 2019-04-17 07:22:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sandoz-and-pear-therapeutics-announce-launch-of-reset 2019-04-17 07:22:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-clearance-of-ind 2019-04-17 07:22:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/restoring-sight-clinical-progress-towards-australias-bionic-eye 2019-04-17 07:22:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-novartis-drug-promacta 2019-04-17 07:22:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recordati-rare-diseases-canada-inc-announces-the-canadian-launch-of-panhematin 2019-04-17 07:22:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arena-pharmaceuticals-and-united-therapeutics-announce-global-license-agreement-for-ralinepag 2019-04-17 07:22:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elpis-biomed-wins-cambridge-start-up-of-the-year 2019-04-17 07:22:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vyera-pharmaceuticals-receives-fda-clearance-to-initiate-a-phase-study- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arix-bioscience-plc-pharmaxis-releases-positive-results-of-phase-clinical-trial 2019-04-17 07:22:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonzas-global-subject-matter-expert-for-endotoxin-detection-appointed-chair 2019-04-17 07:22:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fervent-pharmaceuticals-completes-clinical-trial-for-promising-new-post-menopausal-therapy-treating-vasomotor-symptoms 2019-04-17 07:22:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-rgx-gene-therapy-for-the-treatment-of-cln-form-of-batten-disease 2019-04-17 07:22:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurorx-receives-fda-breakthrough-therapy-designation 2019-04-17 07:22:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardelyx-announces-fda-acceptance-of-the-filing-of-its-new-drug-application daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theravance-biopharma-highlights-expanded-copd-indication-for-trelegy-ellipta-in-europe 2019-04-17 07:22:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nmpa-accepts-biosimilar-new-drug-application-for-ibi- 2019-04-17 07:22:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders 2019-04-17 07:22:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/t-pharmaceuticals-wins-prestigious-falling-walls-venture-award-for-its-bacterial-cancer-therapy 2019-04-17 07:22:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/generon-receives-investigative-new-drug-approval-from-china 2019-04-17 07:22:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-strengthens-global-commercial-leadership-team 2019-04-17 07:22:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-drug-using-the-recombinant-factor-c-assay 2019-04-17 07:22:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/voyageur-minerals-signs-joint-venture-with-chief-medical-supply-to-begin-manufacturing-barium-contrast-pharmaceutical-products 2019-04-17 07:22:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascendis-pharma-announces-formation-of-visen-pharmaceuticals 2019-04-17 07:22:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/verastem-oncology-announces-collaboration-with-the-leukemia-lymphoma-society daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rocket-pharmaceuticals-announces-fda-clearance-of-ind-application 2019-04-17 07:21:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-announces-successful-bispecific-glymaxx-development-project-for-zymeworks 2019-04-17 07:21:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zpredicta-collaborates-with-science-exchange 2019-04-17 07:21:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-introduces-biocontinuum-platform-for-advanced-process-optimization- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xellia-pharmaceuticals-announces-the-launch-of-first-us-market-product 2019-04-17 07:21:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-and-genexine-announce-china-ind-approval-for-innovative-immunotherapy 2019-04-17 07:21:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agilent-introduces-groundbreaking-uv-vis-spectrophotometer 2019-04-17 07:21:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ers-genomics-licenses-crispr-gene-editing-technology daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-achieves-next-expansion-milestone-in-biologics-production-in-the-us daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-receives-eu-funding-as-part-of-consortium-to-advance-neurodegenerative 2019-04-17 07:21:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-announces-expansion-of-natesto-agreement-with-medac 2019-04-17 07:21:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heron-announces-fda-submission-of-htx-nda-for-postoperative-pain-management 2019-04-17 07:21:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-to-present-new-data-from-its-oncology-programs-at-the-upcoming-sitc 2019-04-17 07:21:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/temperature-controlled-logistics-returns-with-a-top-schedule 2019-04-17 07:21:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analytica-vietnam-attracts-more-exhibitors-than-ever 2018-10-30 23:51:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schrodinger-and-wuxi-apptec-announce-the-launch-of-faxian-therapeutics 2019-04-17 07:21:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alligator-bioscience-expands-pipeline-preclinical-development-initiated 2019-04-17 07:21:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tesaro-announces-achievement-of-zejula-prostate-cancer-development-milestones-by-janssen 2019-04-17 07:21:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-announces-fda-approval-of-eribulin-ora-research-drugs-for-clinical-trials 2019-04-17 07:21:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nordic-nanovector-announces-opening-of-first-us-site-for-paradigme-trial-of-betalutin 2019-04-17 07:21:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampels-system-for-drug-repositioning-confirmed 2019-04-17 07:21:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/noviosense-announces-positive-results- 2019-04-17 07:21:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elpis-biomed-human-cell-models-could-potentially-replace-animal-experiments-in-drug-discovery 2019-04-17 07:21:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schreiner-medipharm-develops-protective-label-for-raumedics-dosing-syringe 2019-04-17 07:21:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cristal-therapeutics-initiates-phase-clinical-trial-of-innovative-cripec-nanomedicine-drug 2019-04-17 07:21:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapix-biosciences-signs-binding-loi-to-be-acquired-by-fsd-pharma 2019-04-17 07:21:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agena-and-darui-biotechnology-announce-china-fda-clearance-of-massarray-technology 2019-04-17 07:21:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-new-webinar-electronic-batch-records 2019-04-17 07:21:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-further-expands-secondary-packaging 2019-04-17 07:21:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/precision-nanosystems-announces-manufacturing-collaboration-agreement-with-ajinomoto-bio-pharma-services- 2019-04-17 07:21:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/compass-pathways-receives-fda-breakthrough-therapy-designation- 2019-04-17 07:20:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-pharma-set-for-strong-year-with-record-countries-and-attendees-at-cphi-worldwide daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-reveal-next-generation-electronic-batch-record-execution-platform 2019-04-17 07:20:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/consortiatx-awarded-exclusive-license-for-food-allergy-microbial-therapy 2019-04-17 07:20:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/owc-pharmaceutical-research-corp-successfully-tests-unique-innovative-delivery-formulation-aimed 2019-04-17 07:20:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncomed-announces-interim-phase-b-results 2019-04-17 07:20:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amneal-announces-the-approval-and-launch-of-generic-isoproterenol-hydrochloride-injection-usp 2019-04-17 07:20:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apceth-biopharma-presents-positive-data-demonstrating-efficacy 2019-04-17 07:20:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boost-for-make-in-india-schott-tubing-india-to-further-invest 2019-04-17 07:20:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/axsome-therapeutics-receives-fda-orphan-drug-designation 2019-04-17 07:20:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/proteostasis-therapeutics-announces-positive-preliminary-results 2019-04-17 07:20:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kala-pharmaceuticals-submits-new-drug-application-to-u-s-food-and-drug-administration 2019-04-17 07:20:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/-jhl-biotech-announces-china-approves-phase-i-and-phase-iii-clinical-trial-application- 2019-04-17 07:20:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-and-cns-deal-expands-cro-services-for-biopharma-clients-across-asia-pacific 2019-04-17 07:20:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-announces-plan-to-initiate-rolling-submission-of-a-new-drug-application- 2019-04-17 07:20:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptilogics-receives-regulatory-approval-to-initiate-first-in-human-safety-study 2019-04-17 07:20:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maat-pharma-announces-first-patient-dosed-in-phase-clinical-trial daily 0.1 https://demo.pharmafocusasia.com/pressreleases/promis-neurosciences-identifies-novel-antibody-drug-candidates-for-parkinsons-disease 2019-04-17 07:20:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/synspira-receives-u-s-fda-orphan-designation 2019-04-17 07:20:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/europes-bio-capacity-forecast-to-overtake-the-usa 2019-04-17 07:20:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rfxcel-extends-track-trace-solutions-to-food-beverage 2019-04-17 07:20:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aum-lifetech-chop-and-penn-partnering 2019-04-17 07:20:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antibe-therapeutics-receives-approval 2019-04-17 07:20:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-includes-stansted-the-third-busiest-airport-in-england 2019-04-17 07:20:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-new-webinar-streamlining-your-qc-testing 2019-04-17 07:20:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spi-pharma-launches-mannogem-xl-mannitol-enabling-production- 2019-04-17 07:20:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iavi-announces-clinical-trial-of-next-generation-hiv-vaccine-candidate-designed-to-induce-antibodies-to-block-hiv-infection 2019-04-17 07:20:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cocrystal-pharma-announces-clinical-trial-agreement-for-investigator-initiated-phase-a-study-in-hong-kong daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-novel-chemiflex-raw-materials-program-solves-regulatory-compliance-challenges 2019-04-17 07:19:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tfs-collaboration-with-lobsor-pharmaceuticals-ab-on-the-development-of-lecigon 2019-04-17 07:19:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-announces-fda-and-ema-filing-acceptance-of-siponimod 2018-10-08 03:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/u-s-food-and-drug-administration-accepts-karyopharms-new-drug-application 2019-04-17 07:19:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-launches-of-xcelerate-integrated-solutions 2019-04-17 07:19:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apceth-to-manufacture-first-potential-one-time-gene-therapy 2018-10-05 06:26:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-annual-report-warns-pharma-manufacturers-that-dont-invest daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmadule-morimatsu-wins-basic-design-order 2019-04-17 07:19:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c-pharma-brings-reliable-cannabidiol-api-source daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-hemlibra-receives-regulatory-approval-from-u-s-fda 2019-04-17 07:19:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclacel-pharmaceuticals-and-md-anderson-cancer-center-announce-strategic-alliance 2019-04-17 07:19:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-receives-ema-prime-designation-for-otl 2019-04-17 07:19:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metp-pharma-introduces-nascum-plus 2019-04-17 07:19:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/centogene-and-denali-therapeutics-announce-strategic-collaboration 2019-04-17 07:19:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag- 2019-04-17 07:19:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/canbridge-pharmaceutical-submits-new-drug-application 2019-04-17 07:19:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/go-therapeutics-enters-into-a-license-agreement-with-roche 2019-04-17 07:19:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-flash-purification-system-and-columns-from-biotage 2019-04-17 07:19:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qatar-airways-cargo-rolled-out-the-red-carpet-for-eight-year-old-erics-epic-journey 2019-04-17 07:19:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynch-biologics-completes-acquisition-of-gem-s 2019-04-17 07:19:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolive-report-forecast-bioconjugation-expertise-and-increased-productivity 2019-04-17 07:19:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-strategic-project-portfolio-management-for-pharma 2019-04-17 07:19:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagonist-therapeutics-announces-fast-track-designation 2019-04-17 07:19:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emerald-health-pharmaceuticals-initiates-phase-i-clinical-study- 2019-04-17 07:19:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nutriband-inc-signs-acquisition-agreement-of-carmel-biosciences- 2019-04-17 07:19:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/i-mab-biopharma-expands-strategic-collaboration-with-wuxi-biologics 2019-04-17 07:19:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nec-laboratories-europe-gmbh-and-protagen-ag-collaborate daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmadule-morimatsu-wins-european-design-order-for-a-modular-ff-facility 2019-04-17 07:19:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-grants-award-for-novel-idea-at-the-open-innovation-challenge 2019-04-17 07:19:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siteone-therapeutics-receives-nih-grant-to-support-the-development-of-novel-therapeutics 2019-04-17 07:19:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/portola-pharmaceuticals-receives-fda-orphan-drug-designation-for-cerdulatinib 2019-04-17 07:18:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genecentric-therapeutics-licenses-pancreatic-cancer-subtyping-technology- 2019-04-17 07:18:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lumos-pharma-acquires-candidate-for-oral-treatment-of-growth-hormone-deficiency 2019-04-17 07:18:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-announces-latest-mass-spectrometry-solution 2019-04-17 07:18:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-receives-favorable-opinion-from-the-chmp-for-alunbrig daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aivita-biomedical-announces-treatment-of-first-patient-in-phase-ovarian-cancer-trial 2019-04-17 07:18:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-to-launch-global-customer-solution-centers 2019-04-17 07:18:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/athenex-and-partner-hanmi-pharmaceutical-announce-strategies 2019-04-17 07:18:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oceasoft-launches-cobalt-x 2019-04-17 07:18:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmacyte-biotech-successfully-completes-final-pre-production-run 2019-04-17 07:18:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-submits-new-drug-application-to-u-s-fda-seeking-approval-of-erdafitinib 2019-04-17 07:18:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-annual-report-warns-trade-and-patent-changes-could-increase-healthcare 2019-04-17 07:18:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurimmune-achieves-milestone-in-collaboration-with-ono-pharmaceutical 2019-04-17 07:18:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampliphi-biosciences-announces-positive-fda-feedback 2019-04-17 07:18:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-fda-approval-of-ajovy 2019-04-17 07:18:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shuwen-biotechs-pd-l-detection-kit-validated-in-clinical-trials-of-leading-drugs 2019-04-17 07:18:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cannabics-pharmaceuticals-receives-positive-results 2019-04-17 07:18:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-acquires-pirana 2019-04-17 07:18:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mihas-welcomes-halal-brands-from-around-the-world-to-kuala-lumpur 2019-04-17 07:18:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antares-vision-india-new-joint-venture-with-jisl 2019-04-17 07:18:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/etihad-cargo-increases-focus-on-cold-chain-industry-with-freshfoward-product 2019-04-17 07:18:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-keeps-enhancing-its-competence-in-international-air-cargo-transportation 2019-04-17 07:18:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-and-sparc-announce-us-fda-approval-of-xelpros 2019-04-17 07:18:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/newly-formed-pmi-biopharma-solutions-announces-launch-of-research-lab-and-manufacturing-facilities-tailored 2019-04-17 07:18:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fluidic-analytics-redefines-protein-analysis-with-the-global-launch-of-the-fluidity-one-system 2019-04-17 07:18:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-advances-patient-centric-drug-development 2019-04-17 07:18:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation 2019-04-17 07:18:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/technology-and-innovation-drives-the-success-of-medical-fair-asia 2019-04-17 07:18:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovents-anti-cd-antibody-ibi-receives-ind-approval-in-china 2019-04-17 07:18:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cyclenium-pharma-and-haplogen-bioscience-announce-granting-of-eureka-label-and-funding 2019-04-17 07:18:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/qatar-airways-cargo-charters-life-saving-medications-to-brasilia 2019-04-17 07:17:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xspray-pharma-announces-positive-clinical-data-for-its-lead-product-candidate-hynap-dasa 2019-04-17 07:17:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pvp-biologics-announces-first-in-human-clinical-trials 2019-04-17 07:17:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-partner-hutchison-medipharma 2019-04-17 07:17:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-partner-hutchison-medipharma-receives-approval-of-fruquintinib-capsules 2019-04-17 07:17:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advicenne-announces-fda-clearance-of-ind 2019-04-17 07:17:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/checkmate-pharmaceuticals-announces-strategic-collaboration-with-merck-kgaa-darmstadt-germany-and-pfizer 2019-04-17 07:17:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thrombolytic-science-initiates-phase-clinical-trial-of-its-novel-treatment-regimen 2019-04-17 07:17:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advaxis-licenses-adxs-her-to-os-therapies-for-evaluation-in-the-treatment-of-osteosarcoma 2019-04-17 07:17:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-and-repligen-corporation-partner 2019-04-17 07:17:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-wins-military-contract-to-develop-regenerative-medicines-for-the-battlefield 2019-04-17 07:17:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cablivi-approved-in-europe-for-adults 2019-04-17 07:17:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-announces-acceptance-of-new-drug-application 2019-04-17 07:17:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/actelion-applies-for-ema-approval-of-opsumit-for-the-treatment 2019-04-17 07:17:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-corporation-completes-acquisition-of-steadymed-ltd- 2019-04-17 07:17:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-healthcare-and-medtech-innovations-take-centre-stage-at-asias-leading-exhibitions 2018-08-30 05:35:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-and-ppf-complete-acquisition-of-cytune-pharma 2019-04-17 07:17:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adverum-biotechnologies-announces-ind-active-for-advm- 2019-04-17 07:17:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-annouces-first-subject-dosed-in-phase-trial-evaluating-inp- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gt-biopharma-announces-initiation-of-oxs- 2019-04-17 07:17:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiragtx-announces-aav-cnga-granted-rare-pediatric-disease-designation 2019-04-17 07:17:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/beigene-announces-acceptance-of-its-first-new-drug-application-for-zanubrutinib 2019-04-17 07:17:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptilogics-completes-successful-pre-ind-meeting-with-the-food-and-drug-administration 2019-04-17 07:17:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orgenesis-announces-collaboration-with-ben-gurion-university- 2019-04-17 07:17:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kala-pharmaceuticals-announces-fda-approval-of-inveltys 2019-04-17 07:17:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-announces-first-patient-dosed 2019-04-17 07:17:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-and-astellas-amend-clinical-research-protocols-for-two-phase-trials- 2019-04-17 07:17:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-thera-solutions-announces-china-national-drug-administration-acceptance-of-biologics-license-application-for-proposed-biosimilar 2019-04-17 07:17:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c-cit-sensors-single-use-cell-culture-in-situ-technologies daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapores-first-clinical-trial-approval-for-t-cell-engineered-immunotherapy 2019-04-17 07:17:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-merck-announce-fda-approval-of-lenvima-capsules 2019-04-17 07:16:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/middle-east-and-africa-pharma-economy daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rafael-pharmaceuticals-receives-fda-orphan-drug-designation-of-cpi- 2019-04-17 07:16:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antares-pharma-announces-fda-approval-of-generic-epipen-utilizing-vibex-auto-injector 2019-04-17 07:16:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rfxcel-enhances-pharmaceutical-track-and-trace-solution-for-russia 2019-04-17 07:16:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/martin-pharmaceuticals-livantra-receives-fda-orphan-drug-designation- 2019-04-17 07:16:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ortho-dermatologics-resubmits-u-s-new-drug-application- 2019-04-17 07:16:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sutro-and-the-leukemia-lymphoma-society-partner 2019-04-17 07:16:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/haisco-pharmaceutical-group-will-invest-million-dollars 2019-04-17 07:16:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samsung-bioepis-to-initiate-phase-clinical-trial-of-sb-ulinastatin-fc-fusion-protein 2019-04-17 07:16:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/castle-creek-pharmaceuticals-receives-fda-fast-track-designation 2019-04-17 07:16:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/health-canada-gives-green-light-to-tetra-bio-pharmas-cannabis-vs-fentanyl-trial 2019-04-17 07:16:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perrigo-announces-plan-to-separate-prescription-pharmaceuticals-business 2019-04-17 07:16:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-generic-drug-under-new-pathway-aimed-at-enhancing-market-competition-for-sole-source-drugs 2019-04-17 07:16:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pivot-acquires-rights-to-patented-solumer-oral-drug-delivery-technology-ideal 2019-04-17 07:16:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-announces-fda-acceptance- 2019-04-17 07:16:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pliant-therapeutics-receives-fda-orphan-drug-designation-for-lead-program 2019-04-17 07:16:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-the-uk-cystic-fibrosis-gene-therapy-consortium-imperial-innovations-and-oxford-biomedica-announce-new-partnership- 2018-08-06 00:55:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lenalidomina-an-oral-drug-to-treat-relapsed-multiple-myeloma-is-now-available-in-brazil 2019-04-17 07:16:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/armagen-receives-u-s-orphan-drug-designation-for-agt- 2019-04-17 07:16:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-and-innocore-pharmaceuticals-to-improve-patient-compliance 2019-04-17 07:16:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intas-pharmaceuticals-to-be-the-first-to-launch-pegfilgrastim-biosimilar 2019-04-17 07:16:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellectar-and-orano-med-announce-collaboration-to-develop-new-phospholipid-drug-conjugate 2019-04-17 07:16:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trovagene-receives-positive-opinion-for-orphan-drug-designation 2019-04-17 07:16:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/united-therapeutics-announces-fda-approval-of-the-implantable-system 2019-04-17 07:16:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leo-pharma-to-expand-its-lead-in-medical-dermatology-with-acquisition-of-bayer 2019-04-17 07:16:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fps-workshops-containment-micronization 2019-04-17 07:16:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-extends-and-expands-research-collaboration-and-license-agreement 2019-04-17 07:16:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advaxis-announces-fda-allowance-of-ind-application 2019-04-17 07:16:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-enters-worldwide-licensing-agreement-with-glycotope 2019-04-17 07:15:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/propanc-biopharma-enters-national-phase-for-two-key-patents 2019-04-17 07:15:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-stas-jinshan-site-passes-fourth-us-fda-inspection 2019-04-17 07:15:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omeros-oms-receives-european-orphan-drug-designation-positive-opinion 2019-04-17 07:15:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/convelo-therapeutics-to-develop-new-regenerative-medicines 2019-04-17 07:15:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oramed-granted-japanese-patent-for-glp-analog-capsule 2019-04-17 07:15:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apellis-pharmaceuticals-apl-receives-fast-track-designation-from-fda-for-the-treatment-of-patients-with-geographic-atrophy 2019-04-17 07:15:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/windtree-announces-completion-of-new-design-development 2019-04-17 07:15:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmacyte-biotech-successfully-completes-another-study- 2019-04-17 07:15:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/azafaros-bv-secures-seed-funding-to-develop-new-treatments 2019-04-17 07:15:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puretech-health-announces-collaboration-with-roche 2019-04-17 07:15:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corbus-pharmaceuticals-receives-fda-orphan-drug-designation 2019-04-17 07:15:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-and-antengene-sign-development-and-manufacturing-agreement 2019-04-17 07:15:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotech-company-marinomed-successfully-tests-new-combination-drug 2019-04-17 07:15:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hyleukin-selected-as-a-korea-drug-development-fund-project 2019-04-17 07:15:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gt-biopharma-inc-announces-agreement-with-a-major-pharmaceutical-company- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-and-gadeta-announce-strategic-collaboration 2019-04-17 07:15:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gamida-cell-receives-orphan-drug-designation-from-the-fda 2019-04-17 07:15:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-cancer-drug-through-new-oncology-review-pilot-that-enables-greater-development-efficiency 2019-04-17 07:15:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovation-pharmaceuticals-signs-drug-product-manufacturing-contract-with-corerx-to-formulate-and-package-brilacidin-for-oral-mucositis-in-sachet-form 2019-04-17 07:15:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avondale-pharmaceuticals-llc-signs-development-agreement-with-oxford-pharmaceuticals-llc 2019-04-17 07:15:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leon-nanodrugs-supports-takeda-in-feasibility-assessment 2019-04-17 07:15:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spero-awarded-up-to-million-by-barda-and-dtra 2019-04-17 07:15:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tonix-pharmaceuticals-receives-fast-track-designation-from-the-u-s-fda-for-tnx-sl 2019-04-17 07:15:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-pct-assay-cleared-for-expanded-use-important-tool-in-antibiotic-resistance-crisis 2019-04-17 07:15:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/landos-biopharma-initiates-phase-clinical-trial-of-bt-an-oral-lancl-agonist-for-treatment-of-ibd 2019-04-17 07:15:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immatics-enters-into-strategic-partnership-with-genmab 2019-04-17 07:15:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akcea-and-ionis-announce-approval-of-tegsedi 2019-04-17 07:15:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biosight-launches-a-phase-b-clinical-trial-of-bst-as-a-first-line-treatment-of-acute-myeloid-leukemia 2019-04-17 07:15:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/-d-molecular-therapeutics-and-medimmune-collaborate-to-design-develop-and-commercialize-aav-gene-therapy-for-chronic-lung-disease 2019-04-17 07:15:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/recursion-receives-fda-clearance-of-investigational-new-drug-application-to-initiate-first-clinical-trial 2019-04-17 07:14:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-pionyr-immunotherapeutics-initiate-second-immuno-oncology-contract 2019-04-17 07:14:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-immune-pharmaceuticals-announce-late-phase-development-and-manufacturing-partnership 2019-04-17 07:14:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/citius-provides-clinical-update-and-progress-of-the-mino-lok-phase-trial 2019-04-17 07:14:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/korea-finished-drug-market-growth-driven-by-generics 2019-04-17 07:14:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intelgenx-receives-cipo-notice-of-allowance-for-loxapine-versafilm-patent 2019-04-17 07:14:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jhl-biotech-announces-china-approves-clinical-trial-rituximab-biosimilar-to-treat-non-hodgkin-lymphoma 2019-04-17 07:14:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioarctic-announces-positive-topline-results-of-ban-phase-b-at-months-in-early-alzheimers-disease 2019-04-17 07:14:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-extends-one-stop-shop-service 2019-04-17 07:14:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/elite-pharmaceuticals-receives-fda-approval-for-generic-percocet-tablets 2019-04-17 07:14:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-signs-agreement-to-acquire-juniper-pharmaceuticals-inc- 2019-04-17 07:14:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-launches-new-bioscience-website 2019-04-17 07:14:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trigr-therapeutics-and-abl-bio-announce-global-oncology-collaboration 2019-04-17 07:14:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-merck-collaboration-produces-new-antibody-for-immuno-oncology-research 2019-04-17 07:14:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cannabics-pharmaceuticals-enters-a-memorandum-of-understanding-with-clinical-stage-biopharmaceutical-company-focused-on-the-treatment-of-ophthalmic-disorders 2019-04-17 07:14:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolive-report-predicts-pat-nirs-continuous-bioprocessing 2019-04-17 07:14:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioaxone-biosciences-awarded-million-phase-sbir-funding-for-continued-development-of-sd-rxrna-drug-candidate-for-the-treatment-of-spinal-cord-injury daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cocrystal-pharma-commences-enrollment-and-initiates-patient-dosing-in-phase-a-study-evaluating-cc-for-the-treatment-of-hcv 2019-04-17 07:14:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prestige-biopharma-and-alvogen-announce-license-and-supply-agreement 2019-04-17 07:14:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/relmada-therapeutics-inc-announces-first-patient-dosed-in-phase-study-of-rel-in-patients-with-major-depressive-disorder 2019-04-17 07:14:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-launch-of-cholestyramine-for-oral-suspension-usp 2019-04-17 07:14:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saladax-signs-licensing-agreement-with-janssen-for-antipsychotic-drug-testing-patents 2019-04-17 07:14:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enteris-biopharma-announces-positive-results-from-expanded-phase-a-clinical-trial-of-ovarest-oral-leuprolide-tablet-for-endometriosis 2019-04-17 07:14:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apcer-life-sciences-and-arisglobal-jointly-launch-integrated-pharmacovigilance 2019-04-17 07:14:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-nouscom-sign-license-agreement-for-probiogens-technology-platform 2019-04-17 07:14:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-leads-gene-therapy-manufacturing-consortium 2019-04-17 07:14:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/positive-outcome-data-of-large-randomized-controlled-trial 2019-04-17 07:14:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/c-pharma-buys-out-joint-venture-partner daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomontr-labs-announces-laboratory-service-agreement-with-viiv-healthcare 2019-04-17 07:14:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merrimack-announces-top-line-results-from-randomized-phase-trial-of-mm-in-front-line-metastatic-pancreatic-cancer 2019-04-17 07:14:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revance-doses-first-patient-in-aspen-phase-clinical-program-of-rt-injectable-for-the-treatment-of-cervical-dystonia 2019-04-17 07:14:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acg-films-foils-becomes-indias-first-complete-packaging-solution 2019-04-17 07:14:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapore-polytechnic-and-shimadzu-join-hands 2019-04-17 07:14:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cellgenix-completed-first-step-of-facility-expansion-to-stay-on-top-of-the-increasing-demands 2019-04-17 07:13:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alligator-bioscience-s-ator-strongly-activates-both-t-cells-and-nk-cells-important-for-the-effective-eradication-of-tumor-cells 2019-04-17 07:13:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alchem-international-granted-cos-by-edqm-for-innovative-production-process-to-resolve-stability-challenge-for-micronized-digoxin 2019-04-17 07:13:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/luye-pharma-bolsters-its-global-analgesics-portfolio-with-china-class-new-compound-ly-to-start-phase-i-clinical-trials 2019-04-17 07:13:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-expands-rna-cells-to-ct-kits 2018-06-19 01:25:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-signs-mou-with-cmuh-taiwan-to-offer-enhanced-services-for-global-trials 2019-04-17 07:13:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-signs-exclusive-supply-distribution-agreement-with-lukare 2019-04-17 07:13:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-first-cdmo-to-support-the-approval-of-an-innovative-drug-in-china 2019-04-17 07:13:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders 2019-04-17 07:13:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovion-announces-fda-acceptance-of-new-drug-application 2019-04-17 07:13:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-and-siemens-sign-long-term-cooperation-agreement 2019-04-17 07:13:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arcus-biosciences-announces-fda-clearance-of-inds daily 0.1 https://demo.pharmafocusasia.com/pressreleases/translate-bio-announces-agreement-with-sanofi-pasteur 2019-04-17 07:13:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/attendance-rise-sees-cphi-p-mec-india-move-to-indian-capital 2019-04-17 07:13:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-strikes-out-on-new-pathways-to-further-develop-the-injection-process 2019-04-17 07:13:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saudia-cargo-launches-state-of-the-art-pharmaceutical-cold-storage-facility-at-kaia 2019-04-17 07:13:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tricida-announces-positive-pivotal-phase-clinical-trial-results 2019-04-17 07:13:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/process-innovation-needs-to-be-undertaken-in-early-rd 2019-04-17 07:13:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chinas-domestic-pharma-industry-driving-huge-machinery-influx-at-pmec-china 2019-04-17 07:13:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-hemlibra-receives-priority-review-status-from-us-fda-for-hemophilia 2019-04-17 07:13:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-clinical-trials-of-dcvac-show-significant-benefit 2019-04-17 07:13:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genea-biocells-announces-fda-orphan-drug-designation 2019-04-17 07:13:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-licensing-agreement-with-celsius-therapeutics 2019-04-17 07:13:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabplex-usa-announces-the-opening-of-its-process-development-center-of-excellence 2019-04-17 07:13:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptar-pharma-and-propeller-health-partner 2019-04-17 07:13:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zai-lab-and-crescendo-biologics-enter-exclusive-worldwide-license-agreement 2019-04-17 07:13:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-completes-resubmission-for-biosimilar-candidate-to-fda-for-review 2019-04-17 07:13:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trioxbio-announces-fast-track-designation-granted-by-us-fda-to-raviten 2019-04-17 07:13:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-report-predicts-new-finished-product-manufacturing-hub 2019-04-17 07:13:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerenis-therapeutics-and-university-of-north-texas-health-science-center-announce-strategic-initiative 2019-04-17 07:13:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shuwen-biotech-and-bliss-biopharmaceutical-partner 2019-04-17 07:12:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/welldynerx-minimized-advancing-drug-costs 2019-04-17 07:12:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cargo-airline-of-the-year-award-to-turkish-cargo 2019-04-17 07:12:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stellar-achieves-robust-viral-clearance-for-manufacturing-process 2019-04-17 07:12:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tanner-pharma-group-signs-distribution-agreement-for-partner-therapeutics 2019-04-17 07:12:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-announces-further-development-milestone-for-use-of-its-glymaxx-cancer 2019-04-17 07:12:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-starts-phase-trial-of-dcvac-in-combination 2019-04-17 07:12:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lunaphore-and-vitro-sign-collaboration-agreement 2019-04-17 07:12:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dont-let-static-charges-or-air-drafts-disrupt-weighing-accuracy 2019-04-17 07:12:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendia-and-angsana-to-provide-breast-cancer-risk-of-recurrence-testing-with-mammaprint 2019-04-17 07:12:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-for-tafamidis 2019-04-17 07:12:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-and-lundbeck-to-start-third-phase-trial-in-june daily 0.1 https://demo.pharmafocusasia.com/pressreleases/peptide-display-company-orbit-discovery-closes-series-financing 2019-04-17 07:12:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-announces-usfda-approval-of-yonsa 2019-04-17 07:12:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-begins-phase-study-to-evaluate-respiratory-syncytial-virus-vaccine 2019-04-17 07:12:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-and-mitsubishi-tanabe-initiate-european-managed-access-program 2019-04-17 07:12:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-pharmaceuticals-presents-new-preclinical-data 2019-04-17 07:12:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-asian-study-shows-one-hour-diagnosis-of-heart-attacks-in-patients 2019-04-17 07:12:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gc-pharma-to-establish-curevo-seattle-based-new-company 2019-04-17 07:12:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/correvio-announces-enrollment-of-first-patient-in-phase-study-evaluating-brinavess-in-china 2019-04-17 07:12:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chargepoint-technology-launches-first-of-its-kind-smart-monitoring-technology 2019-04-17 07:12:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/internationalisation-and-regulatory-reform-driving-growth-and-investment-at-cphi-china 2019-04-17 07:12:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shuwen-debuts-its-codar-arms-pcr-liquid-biopsy-technology 2019-04-17 07:12:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iconic-therapeutics-initiates-second-phase-study 2019-04-17 07:12:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-insights-into-hookipas-therat-replicating-viral-vector-platform-published-in-immunity 2019-04-17 07:12:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendias-mammaprint-and-blueprint-breast-cancer-tests-selected-by-unicancer-for-french-patients 2019-04-17 07:12:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/entasis-therapeutics-initiates-clinical-studies 2019-04-17 07:12:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergex-awarded-innovate-uk-grant-to-progress-its-universal-and-pandemic-flu-vaccine 2019-04-17 07:12:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/risk-management-planning-signal-management-in-pharmacovigilance 2019-04-17 07:12:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aravive-biologics-achieves-proof-of-mechanism-for-novel-pathway-inhibitor 2019-04-17 07:12:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-uv-monitor-kit-for-large-scale-purification 2019-04-17 07:12:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sellas-life-sciences-receives-fda-orphan-drug-designation-for-galinpepimuts 2019-04-17 07:11:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eurofins-expands-its-leadership-in-biopharmaceutical-services 2019-04-17 07:11:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celonic-ag-appoints-soenke-brunswieck-as-vice-president-cell-gene-therapy 2019-04-17 07:11:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indias-leading-event-on-redefining-logistics-is-back-in-june 2019-04-17 07:11:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-changzhou-site-passes-first-us-fda-inspection 2019-04-17 07:11:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salix-receives-fda-approval-for-plenvu 2019-04-17 07:11:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abcam-and-shuwen-biotech-sign-strategic-mou-to-establish-global-alliance 2019-04-17 07:11:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-priority-review-to-genentechs-cancer-immunotherapy-tecentriq daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-swiss-biotech-association-honors-major-industry-achievements 2019-04-17 07:11:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alkermes-to-host-webcast-and-conference-call-to-discuss-alks-development-program 2019-04-17 07:11:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/haselmeier-and-common-sensing-enter-medicine-collaboration 2019-04-17 07:11:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-otl-receives-rare-pediatric-disease-designation 2019-04-17 07:11:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immusoft-granted-orphan-drug-designation-for-treatment-of-rare-childhood-disease 2019-04-17 07:11:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cdrd-and-pfizer-canada-partner-to-establish-the-cdrd-life-sciences-executive-institute 2019-04-17 07:11:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acceleron-receives-fda-fast-track-designation 2019-04-17 07:11:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-and-ironwood-launch-interactive-digital-destination daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-neurimmune-announce-option-exercise-for-alzheimers-disease 2019-04-17 07:11:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mologic-signs-agreements-with-medisur-and-peripal daily 0.1 https://demo.pharmafocusasia.com/pressreleases/karyopharm-announces-positive-top-line-data-from-phase-storm-study-evaluating-selinexor 2019-04-17 07:11:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schreiner-medipharm-equips-syringes-for-pfizer-epoetin-product 2019-04-17 07:11:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lyndra-inc-and-global-drug-commercialization-center-announce-joint-venture 2019-04-17 07:11:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-to-build-new-rd-center-in-shanghai 2019-04-17 07:11:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/endo-to-acquire-somerset-therapeutics 2019-04-17 07:11:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/drying-time-reduced-by-nearly-four-hours-with-halogen-moisture-analysis 2019-04-17 07:11:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurimmune-appoints-fabian-buller-as-chief-business-officer 2019-04-17 07:11:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-fast-track-designation-for-orphomeds-for-treatment-of-ibs-d 2019-04-17 07:11:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novaliq-to-present-scientific-and-clinical-research daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aldeyra-therapeutics-announces-first-patient-enrolled-in-allergic-conjunctivitis-phase-clinical-trial 2019-04-17 07:11:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-expands-us-presence-with-new-corporate-office-in-boston 2019-04-17 07:11:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rapid-detection-of-pathogen-and-antibiotic-resistance-with-dnaes 2019-04-17 07:11:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amerigen-and-dipharma-announce-us-fda-approval-for-generic-miglustat-capsules 2019-04-17 07:11:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/noramco-and-spi-pharma-sign-agreement 2019-04-17 07:11:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/porton-pharma-solutions-and-codexis-launch-global-partnership 2019-04-17 07:10:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/creation-of-inceptua-clinical-trial-services-marks-new-era-for-the-company 2019-04-17 07:10:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phenomenex-introduces-biozen-series-for-characterization-of-biotherapeutics 2019-04-17 07:10:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iterum-therapeutics-presents-data-on-prevalence-of-resistant-infections 2019-04-17 07:10:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-vertical-diffusion-cell-from-copley-scientific-extends-options 2019-04-17 07:10:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-and-healthprize-expand-successful-digital-patient-support-program 2019-04-17 07:10:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-introduces-mini-microcarrier-bioreactor 2019-04-17 07:10:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helperby-therapeutics-announces-phase-results-demonstrating-multiple-benefits 2018-04-19 06:33:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/obi-pharma-announces-fda-clearance-of-obi-ind-application 2019-04-17 07:10:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-expands-site-in-the-us-for-drug-development-testing-services 2019-04-17 07:10:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/specialised-conferences-to-give-latest-insights-into-rd-findings 2019-04-17 07:10:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-welcomes-illinois-governor-bruce-rauner-to-its-german-facilities 2019-04-17 07:10:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phoenix-molecular-designs-collaboration-with-wuxi-sta 2019-04-17 07:10:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-signs-second-contract-development-agreement-with-tizona-therapeutics 2019-04-17 07:10:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wacker-strengthens-its-pharmaceutical-protein-business-and-buys-dutch-biotechnology-plant 2019-04-17 07:10:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-introduces-new-single-use-technologies-to-advance-flexible-manufacturing 2019-04-17 07:10:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-hemlibra-receives-breakthrough-therapy-designation-from-us-fda 2019-04-17 07:10:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-and-penn-state-university-announce-partnership 2019-04-17 07:10:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alnylam-presents-new-positive-clinical-results-for-givosiran 2019-04-17 07:10:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncology-company-hercules-pharmaceuticals-to-present-ahr-inhibitor-efficacy-results 2019-04-17 07:10:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dnae-to-present-new-data-and-preview-its-blood-to-result-test 2019-04-17 07:10:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cirius-therapeutics-preclinical-data-demonstrates-potential-for-lead-drug 2019-04-17 07:10:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-acquires-analytica-laser-leader-in-market-access 2019-04-17 07:10:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-helps-accelerate-global-access-to-affordable-vaccines 2019-04-17 07:10:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/potential-of-icosabutate-as-a-novel-approach-to-the-treatment-of-nash-highlighted daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio 2019-04-17 07:10:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-partners-with-karolinska-institutet-to-validate-calscreener 2019-04-17 07:10:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mimetas-secures-series-b-financing 2019-04-17 07:10:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-announces-rhode-island-will-be-location-of-first-us-next-generation-biomanufacturing-plant 2019-04-17 07:10:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fimecs-concludes-licensing-agreement-with-takeda 2019-04-17 07:10:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/copley-scientific-introduces-new-test-equipment-for-generic-product-development-at-rdd 2019-04-17 07:09:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gustave-roussy-and-protagen-ag-collaborate 2019-04-17 07:09:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanced-ultra-high-performance-liquid-chromatography-systems 2019-04-17 07:09:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advances-in-gas-chromatography-mass-spectrometry-systems-revolutionize-routine-analysis 2019-04-17 07:09:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-high-pressure-ion-chromatography-system-designed-to-deliver-heightened-performance 2019-04-17 07:09:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanced-laboratory-management-system-now-available-on-a-global-scale 2019-04-17 07:09:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhanced-icp-ms-triple-quadrupole-technology-for-ultra-trace-analysis 2019-04-17 07:09:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protalex-initiates-fourth-cohort-dosing-of-phase-study-of-prtx-in-immune-thrombocytopenia 2019-04-17 07:09:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-south-east-asia-strengthens-asean-integration-by-opening-thailand-edition 2019-04-17 07:09:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensorion-to-present-data-in-two-oral-sessions 2019-04-17 07:09:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-to-present-new-data-from-its-oncology-programs 2019-04-17 07:09:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ubiquigent-and-forma-therapeutics-enter-an-exclusive-rd-collaboration 2019-04-17 07:09:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tenax-therapeutics-announces-results-of-pre-ind-meeting-with-fda 2019-04-17 07:09:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reform-biologics-and-kbi-biopharma-announce-strategic-partnership 2019-04-17 07:09:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tfs-international-to-strengthen-strategic-planning-capabilities-with-citeline-deal 2019-04-17 07:09:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/iontas-and-igem-therapeutics-collaborate-to-identify-novel-ige-antibodies 2019-04-17 07:09:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-laboratories-completes-the-acquisition-of-mpi-research 2019-04-17 07:09:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puma-biotechnology-and-pint-pharma-enter-into-exclusive-licensing-agreement 2019-04-17 07:09:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tfs-international-appoints-dr-andrew-copestake-as-chief-commercial-officer 2019-04-17 07:09:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-first-therapy-for-patients-with-mrd-positive-all 2019-04-17 07:09:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-and-its-us-subsidiary-promius-pharma-announce-the-filing-of-an-nda 2019-04-17 07:09:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovion-submits-new-drug-application-to-the-fda-for-apomorphine-sublingual-film daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-showcases-new-innovations-at-interphex 2019-04-17 07:09:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/do-you-know-your-lean-lab-terminology 2019-04-17 07:09:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novaquest-capital-management-acquires-cutispharma 2019-04-17 07:09:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mylan-and-biocon-receive-approvals-from-the-european-commission-and-tga daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-new-webinar-integrating-devices-into-quality-systems 2019-04-17 07:09:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-p-mec-china-build-lucrative-pharma-business-partnerships-in-china 2019-04-17 07:09:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotime-announces-cash-sale-of-ascendance-biotechnology 2019-04-17 07:08:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/imprimis-pharmaceuticals-issued-composition-patent-for-non-opioid-conscious-sedation-formulation 2019-04-17 07:08:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/smithers-rapra-announce-inaugural-extractables-and-leachables-china 2019-04-17 07:08:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolive-to-introduce-global-biopharma-country-ranking 2019-04-17 07:08:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/forma-therapeutics-collaborates-with-arpeggio-biosciences 2019-04-17 07:08:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oragenics-completes-enrollment-for-the-interim-analysis 2019-04-17 07:08:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-drug-tasigna-approved-by-fda-to-treat-children-with-rare-form-of-leukemia 2019-04-17 07:08:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-wins-ipse-facility-of-the-year-award 2019-04-17 07:08:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nohla-therapeutics-selects-advanced-therapies-business-unit-of-wuxi-apptec 2019-04-17 07:08:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chemspec-europe-introduction-of-partnering-programme-adds-new-level-of-networking 2019-04-17 07:08:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigo-expands-livermore-surgical-facilities 2019-04-17 07:08:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-carried-live-fish-to-oman-from-izmir 2019-04-17 07:08:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-strengthens-executive-leadership-team 2019-04-17 07:08:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendia-announces-ce-mark-for-ngs-based-mammaprint-blueprint-kit-enhancing-access 2019-04-17 07:08:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-kaisha-and-vanrx-pharmasystems-announce-product-compatibility 2019-04-17 07:08:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pricing-system-reform-and-generics-trend-apparent-at-cphi-japan 2019-04-17 07:08:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amplyx-pharmaceuticals-receives-fourth-qualified-infectious-disease-product-designation 2019-04-17 07:08:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-supports-abl-europe-in-successful-completion 2019-04-17 07:08:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/watson-marlow-fluid-technology-group-presenting-complete-bioprocessing-fluid-path 2019-04-17 07:08:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medisca-signs-out-licensing-agreement-with-torrey-hills-technologies 2019-04-17 07:08:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-launches-new-ambr-high-throughput-bioreactor-system 2019-04-17 07:08:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xchem-announces-licensing-of-two-discovery-programs-to-abbvie 2019-04-17 07:08:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intec-pharma-partners-with-lts 2019-04-17 07:08:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-begins-dosing-in-phase-study-of-aro-aat 2019-04-17 07:08:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biopharma-and-leukocare-demonstrate-success-of-strategic-alliance 2019-04-17 07:08:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-scientific-founder-donald-kohn-recognized-with-award 2019-04-17 07:08:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-operating-model-for-alliance-management 2019-04-17 07:08:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapeuticsmd-announces-fda-acceptance-of-new-drug-application 2019-04-17 07:08:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-surface-oncology-sign-second-antibody-manufacturing-program 2019-04-17 07:08:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/personalised-medicines-intelligent-packaging-and-fda-deadlines-seen-as-major-trends-for-pharma-packaging 2019-04-17 07:08:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/navitor-pharmaceuticals-to-present-at-cowen-and-company-healthcare-conference 2019-04-17 07:08:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-to-present-at-the-cowen-and-company-annual-healthcare-conference 2019-04-17 07:08:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cdmo-pfizer-centreone-launches-enviero-green-chemistry-progesterone-api 2019-04-17 07:07:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/world-class-speakers-announced-for-lonzas-global-endotoxin-testing-summit 2019-04-17 07:07:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-named-company-of-the-year-by-selectscience 2019-04-17 07:07:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/meiragtx-receives-ema-prime-designation-for-achromatopsia-gene-therapy-candidate 2019-04-17 07:07:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ionis-htt-rx-top-line-data-demonstrate 2019-04-17 07:07:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/international-investor-influx-in-south-east-asia 2019-04-17 07:07:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pear-therapeutics-to-collaborate-with-novartis 2019-04-17 07:07:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/project-pharmaceutics-expands-facilities-for-formulation-and-lyophilization-process daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catalent-completes-expansion-at-singapore-clinical-supply-facility 2019-04-17 07:07:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanced-ultra-high-performance-liquid-chromatography-systems-enhance-lab-productivity 2019-04-17 07:07:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advances-in-gas-chromatography-mass-spectrometry-systems-revolutionize-routine-analysis 2019-04-17 07:07:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biopharmaspec-launches-new-host-cell-protein-detection-service 2019-04-17 07:07:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-high-pressure-ion-chromatography-system-designed-to-deliver-heightened-performance 2019-04-17 07:07:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advanced-laboratory-management-system-now-available-on-a-global-scale 2019-04-17 07:07:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enhanced-icp-ms-triple-quadrupole-technology-for-ultra-trace-analysis 2019-04-17 07:07:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovative-precision-weighing-solutions-offer-top-speed-and-accuracy-in-tough-environments 2019-04-17 07:07:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clintec-international-expands-capabilities-with-the-accreditation-of-the-latest-generation 2019-04-17 07:07:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akzonobel-specialty-chemicals-expands-offering-of-kromasil-products 2019-04-17 07:07:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/russian-infliximab-biosimilar-has-been-proved-equivalent-to-remicade 2019-04-17 07:07:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/giapreza-significantly-improved-survival-of-patients 2019-04-17 07:07:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amgen-receives-positive-opinion-expanding-use-of-xgeva daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-carried-thousand-tons-of-cut-roses-to-holland-with-its-wide-body-cargo-aircrafts 2019-04-17 07:07:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/customized-solutions-for-containment-and-micronization 2019-04-17 07:07:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-initiates-phase-study 2019-04-17 07:07:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-and-regulus-announce-microrna-development-collaboration 2019-04-17 07:07:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vertex-initiates-first-phase-study daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dcc-vital-selects-rfxcel-for-eu-fmd-compliance 2019-04-17 07:07:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wize-pharma-receives-irb-approval-of-phase-study-protocol daily 0.1 https://demo.pharmafocusasia.com/pressreleases/global-chromatography-market 2019-04-17 07:07:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evolus-announces-presentation-of-phase-european-canadian-comparative-data 2019-04-17 07:06:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-announces-successful-completion-of-book-building 2019-04-17 07:06:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-is-winner-of-the-fraunhofer-clean-manufacturing-award-clean 2019-04-17 07:06:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanner-and-amiko-partner-to-develop-digital-solutions 2019-04-17 07:06:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-launches-version-its-industry-leading-drug-discovery-informatics-platform 2019-04-17 07:06:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-to-present-at-the-rbc-capital-markets 2019-04-17 07:06:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mologen-signs-license-deal-for-china 2019-04-17 07:06:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chi-med-completes-enrollment-of-patients-in-pivotal-phase-faluca-trial 2019-04-17 07:06:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-cell-culture-portfolio-with-quasi-vivo-system 2019-04-17 07:06:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-bio-developing-downstream-bioconjugation-process 2019-04-17 07:06:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/salix-provides-update-on-fda-submission-for-plenvu 2019-04-17 07:06:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zytiga-plus-prednisone-approved 2019-04-17 07:06:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enamine-and-biosolveit-launch-the-worlds-largest-searchable-chemical-space 2019-04-17 07:06:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shaanxi-aoxing-pharmaceutical-renewed-its-gmp-certification 2019-04-17 07:06:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/probiogen-and-teva-sign-license-agreement-on-human-artificial-lymph-node-technology 2019-04-17 07:06:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-expands-staff-for-clinical-market-growth-and-horizon-funded-validation daily 0.1 https://demo.pharmafocusasia.com/pressreleases/siemens-and-perceptive-engineering-combining-software-solutions 2019-04-17 07:06:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mallinckrodt-to-present-at-raymond-james-annual-institutional-investors-conference 2019-04-17 07:06:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-appoints-steffen-heeger-as-chief-medical-officer 2019-04-17 07:06:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-clears-oricula-therapeutics-investigational-new-drug-application 2019-04-17 07:06:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-appoints-dr-harry-malech-to-scientific-advisory-board 2019-04-17 07:06:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-present-latest-research-into-more-physiologically-relevant 2019-04-17 07:06:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clene-nanomedicine-announces-preclinical-results-of-a-novel-gold-nanocrystal 2019-04-17 07:06:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-introduces-south-koreas-pharma-and-biotech-community-to-meet-company-management 2019-04-17 07:06:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmabcine-enters-collaboration-with-msd-focused-on-clinical-evaluation daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puma-biotechnology-and-canbridge-life-sciences-enter-into-exclusive-licensing-agreement 2019-04-17 07:06:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharm-connect-helps-you-to-raise-your-presence-in-central-and-eastern-europe 2019-04-17 07:06:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/purdue-pharma-l-p-awards-grants-to-further-research-on-the-assessment-of-chronic-pain 2019-04-17 07:06:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strides-shasun-receives-usfda-approval-for-piroxicam-capsules daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovus-pharma-apeaz-drug-for-arthritis-pain-relief-approved-for-commercialization-in-canada 2019-04-17 07:06:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/puma-biotechnology-and-medison-pharma-enter-into-exclusive-licensing-agreement 2019-04-17 07:06:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-and-aravive-biologics-to-form-strategic-manufacturing-collaboration 2019-04-17 07:06:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theravance-biopharma-and-mylan-announce-fda-acceptance-of-new-drug-application-for-revefenacin-td- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zz-biotech-announces-preliminary-phase-stroke-trial-results 2019-04-17 07:05:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/preliminary-data-from-firefish-trial-in-type-sma-infants 2019-04-17 07:05:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/araclon-biotech-partners-with-tfs-international-for-their-alzheimers-phase-trial 2019-04-17 07:05:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-manufacturing-asia 2019-04-17 07:05:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clover-biopharmaceuticals-selects-ges-flexfactory-biomanufacturing-platform 2019-04-17 07:05:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-approval-to-shire-for-technology-transfer-of-cinryze-drug 2019-04-17 07:05:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fujifilm-announces-the-opening-of-its-flexible-manufacturing-facility 2019-04-17 07:05:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-keeps-protecting-the-wildlife 2019-04-17 07:05:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-launches-miami-flights-offering-wide-body-cargo-aircraft 2019-04-17 07:05:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-receives-orphan-designation-from-the-european-commission-for-gilteritinib 2019-04-17 07:05:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/free-anti-static-white-paper-and-receive-free-anti-static-kit 2018-01-24 05:57:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kbi-biopharma-acquires-elion-labs 2019-04-17 07:05:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-approval-of-dupixent-in-japan 2019-04-17 07:05:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/braeburn-receives-complete-response-letter-for-cam-injectable-buprenorphine-depot 2019-04-17 07:05:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adlai-nortye-enters-into-global-licensing-agreement-with-eisai-for-ep-antagonist 2019-04-17 07:05:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquestive-therapeutics-announces-us-fda-filing-acceptance-of-new-drug-application 2019-04-17 07:05:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ziath-to-showcase-new-low-profile-barcode-scanner 2019-04-17 07:05:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avion-pharmaceuticals-announces-approval-of-first-nda-in-the-oral-contraceptive-category 2019-04-17 07:05:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/futuragenes-exclusive-license-for-rnai-technology-in-eucalyptus 2019-04-17 07:05:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-strategic-alliance-management-for-pharma-2018 2019-04-17 07:05:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-appoints-frank-thomas-as-chief-financial-officer 2019-04-17 07:05:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tenax-therapeutics-announces-plan-to-develop-levosimendan 2019-04-17 07:05:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovus-pharma-hemorrhoid-drug-xyralid-receives-approval-in-canada 2019-04-17 07:05:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/japanese-pharma-no-longer-lost-in-translation 2019-04-17 07:05:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/batavia-biosciences-teams-up-with-international-consortium-to-support-polio-eradication 2019-04-17 07:05:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nitto-avecia-pharma-services-appoints-raymond-kaczmarek-as-president 2019-04-17 07:05:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-fda-approves-new-once-weekly-bydureon 2019-04-17 07:05:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-manufacturing-asia 2019-04-17 07:05:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/renova-therapeutics-to-present-key-components-of-flourish-gene-therapy-trial 2019-04-17 07:05:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-group-and-mei-pharma-announce-that-pracinostat-has-received-orphan-drug-designation daily 0.1 https://demo.pharmafocusasia.com/pressreleases/syndax-pharmaceuticals-announces-clinical-collaboration-to-evaluate-entinostat 2019-04-17 07:05:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avadel-pharmaceuticals-receives-orphan-drug-designation-from-fda-for-ft-for-the-treatment-of-narcolepsy 2019-04-17 07:05:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tfs-international-appoints-new-chief-executive-officer 2019-04-17 07:04:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-merck-receive-breakthrough-therapy-designation 2019-04-17 07:04:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bergenbio-meets-first-efficacy-endpoint-in-phase-trial-with-selective-axl-inhibitor 2019-04-17 07:04:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evelo-biosciences-announces-issuance-of-us-patent-supporting-oncology-trials 2019-04-17 07:04:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wacker-obtains-fda-approval-to-manufacture-the-drug-substance-in-retavase 2019-04-17 07:04:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-and-sanofi-to-accelerate-and-expand-investment-for-cemiplimab 2019-04-17 07:04:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/supporting-excellence-in-science-at-the-winter-conference-on-plasma-spectrochemistry 2019-04-17 07:04:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/semnur-pharmaceuticals-begins-pivotal-phase-trial 2019-04-17 07:04:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/harbour-biomed-announces-licensing-agreement-with-beigene 2019-04-17 07:04:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rebiotix-and-corebiome-collaborate-on-evaluating-microbiomes-of-patients-treated-with-microbiota-restoration-therapy 2019-04-17 07:04:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mallinckrodt-completes-stannsoporfin-new-drug-application-filing 2019-04-17 07:04:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-biopharmaceuticals-completes-enrollment-of-phase-ultra-study 2019-04-17 07:04:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abzena-selects-sartorius-stedim-biotech-to-equip-its-us-based-development 2019-04-17 07:04:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/venatorx-pharmaceuticals-receives-fdas-qidp-and-fast-track-designations 2019-04-17 07:04:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/momenta-and-mylan-announce-development-strategy 2019-04-17 07:04:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bio-techne-acquires-atlanta-biologicals 2019-04-17 07:04:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nuvo-pharmaceuticals-acquires-global-product-rights-and-existing-royalty-streams 2019-04-17 07:04:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cstones-anti-ctla-antibody-cs-filed-for-clinical-trial-approval-in-australia 2019-04-17 07:04:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-menopause-therapy-from-fervent-pharmaceuticals-to-begin-clinical-trial 2019-04-17 07:04:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arrowhead-pharmaceuticals-appoints-william-waddill-to-board-of-directors 2019-04-17 07:04:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delmar-pharmaceuticals-announces-fast-track-designation-for-val-in-recurrent-glioblastoma 2019-04-17 07:04:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-receives-notice-of-deficiency-from-health-canada-for-gynoflor 2019-04-17 07:04:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-to-present-at-the-annual-jp-morgan-healthcare-conference 2019-04-17 07:04:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-enters-worldwide-collaboration-and-license-agreement-with-chinese-company-legend-biotech- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-for-avelumab-in-combination-with-inlyta-in-advanced-renal-cell-carcinoma 2019-04-17 07:04:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-precision-balances-speed-up-lab-processes-for-easier 2019-04-17 07:04:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-enters-into-licensing-agreement-with-viramal 2019-04-17 07:04:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evox-therapeutics-to-collaborate-with-boehringer-ingelheim 2019-04-17 07:04:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-series-b-financing-to-advance-transformative-gene-therapy-pipeline 2019-04-17 07:04:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/avista-pharma-solutions-expands-drug-product-cgmp-manufacturing 2019-04-17 07:04:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-ionis-enter-into-new-collaboration 2019-04-17 07:04:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/major-changes-for-bio-supply-forecast 2019-04-17 07:03:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-p-mec-india-expo-catapults-the-pharma-sector-to-new-heights daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delsitech-ltd-and-c-tri-co-ltd-sign-collaboration-agreement 2019-04-17 07:03:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stealth-biotherapeutics-granted-fast-track-designation-for-elamipretide 2019-04-17 07:03:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/horizon-discovery-enters-into-agreement-with-roche-diagnostics 2019-04-17 07:03:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spectrum-pharmaceuticals-announces-leadership-changes 2019-04-17 07:03:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/b-b-exhibition-cosmetic-ingredient-technology-exhibition-in-korea 2019-04-17 07:03:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-best-gateway-into-the-dynamic-korean-pharma-bio-pharma-market 2019-04-17 07:03:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/swedish-cell-therapy-candidate-cellprotect-has-received-orphan-drug-designation 2019-04-17 07:03:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-and-genethon-announce-gene-therapy-alliance 2019-04-17 07:03:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medimetriks-pharmaceuticals-receives-fda-approval-for-xepi-cream 2019-04-17 07:03:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-zytoprotecs-novel-dialysis-fluid 2019-04-17 07:03:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thrombolytic-science-announces-the-appointment-of-annalisa-jenkins 2019-04-17 07:03:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zuellig-pharma-partners-with-the-vietnamese-government 2019-04-17 07:03:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-enters-into-research-collaboration-with-crtd 2019-04-17 07:03:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xchem-and-abilita-bio-announce-joint-research-collaboration 2019-04-17 07:03:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tremeau-and-fda-agree-on-phase-plan-for-rofecoxib 2019-04-17 07:03:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/omeros-corporation-announces-fda-approval-of-omidria-for-use-in-pediatric-patients 2019-04-17 07:03:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/key-studies-presented-at-the-san-antonio-breast-cancer-symposium daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitto-kaufmann-and-eliana-clark-of-biogen-to-deliver-plenary-keynote-presentations daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogenes-establishes-scientific-advisory-board 2019-04-17 07:03:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/northsea-therapeutics-secures-funding-for-clinical-development-of-promising-nash-drug 2019-04-17 07:03:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/polaryx-therapeutics-receives-orphan-drug-designation-from-the-us-fda 2019-04-17 07:03:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardelyx-announces-license-agreement-with-shanghai-fosun-pharmaceutical-industrial-development 2019-04-17 07:03:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-scapho-shows-pioneering-data-in-preventing-ankylosing 2019-04-17 07:03:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/schott-kaisha-announces-path-breaking-innovation-in-pharma-packaging 2019-04-17 07:03:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kite-announces-long-term-data-from-pivotal-zuma-study-of-yescarta 2019-04-17 07:03:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-showcase-its-latest-solutions-for-enhanced-qc-testing 2019-04-17 07:03:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pieris-pharmaceuticals-announces-ethics-and-regulatory-clearance-to-begin-clinical-testing-of-inhaled-respiratory-program 2019-04-17 07:03:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-receives-approval-updated-registration-for-mavenclad-cladribine-tablets-in-australia 2019-04-17 07:02:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sartorius-stedim-biotech-launches-new-versions-of-data-analytics-software-solutions 2019-04-17 07:02:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendia-and-uz-leuven-partner-to-co-validate-mammaprint-blueprint-breast-cancer-risk daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cytrx-corporation-announces-filing-of-key-provisional-patent-applications 2019-04-17 07:02:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-receives-corporate-health-awards-recognition-of-excellence 2019-04-17 07:02:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-bio-signs-construction-agreement-with-sector-specialists-whp 2019-04-17 07:02:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmacyte-biotech-announces-production-of-master-cell-bank 2019-04-17 07:02:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-announces-the-results-of-a-series-of-phase-clinical-trials 2019-04-17 07:02:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-and-anthony-nolan-to-partner-in-clinical-trials 2019-04-17 07:02:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendia-collaborates-with-prestigious-cancer-center 2019-04-17 07:02:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/foresee-pharmaceuticals-announces-results-from-phase-clinical-studies 2019-04-17 07:02:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-pharmaceutical-announces-final-approval 2019-04-17 07:02:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emergency-medicine-conference-to-kick-off-in-dubai-this-week 2019-04-17 07:02:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-and-translational-sciences-conclude-agreement 2019-04-17 07:02:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sta-pharmaceutical-sees-rapid-growth-in-mah-programs-in-china 2019-04-17 07:02:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-data-at-the-san-antonio-breast-cancer-symposium-demonstrate-the-value-of-mammaprint 2017-12-01 05:01:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/solid-biosciences-initiates-clinical-trial 2019-04-17 07:02:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-enters-into-agreement-to-develop-and-commercialize-cresemba 2019-04-17 07:02:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/selvita-promotes-edyta-jaworska-to-the-management-board 2019-04-17 07:02:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/second-sartorius-research-xchange-forum-focuses-on-regenerative-medicine 2019-04-17 07:02:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-expansion-of-technical-operations 2019-04-17 07:02:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/therapeuticsmd-announces-resubmission-of-new-drug-application 2019-04-17 07:02:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agendia-s-mammaprint-breast-cancertest-obtains-final-payment-determination-from-cms-for-cpt-code 2017-11-29 02:39:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ardelyx-and-kyowa-hakko-kirin-announce-license-agreement-for-cardiorenal-diseases-in-japan 2019-04-17 07:02:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phaserx-receives-positive-opinion-for-orphan-drug-designation-for-prx-asl 2019-04-17 07:02:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-broadens-its-phase-clinical-trial-program-in-ovarian-cancer 2019-04-17 07:02:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-completes-enrollment-in-second-pivotal-phase-clinical-trial 2019-04-17 07:02:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hitgen-and-boehringer-ingelheim-enter-dna-encoded-library 2019-04-17 07:02:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sphere-fluidics-and-geneva-biotech-receive-eurostars-genome-editing-grant 2019-04-17 07:02:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/owlstone-medicals-breath-biopsy-platform-integrated-into-gsks-phase-clinical-trial daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-extension-of-its-collaboration 2019-04-17 07:02:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharming-submits-supplemental-biologics-license-application-to-fda-for-ruconest 2019-04-17 07:02:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innate-pharma-provides-an-update-on-lirilumab 2019-04-17 07:02:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mundipharma-and-apr-applied-pharma-research-sa-announce-a-new-alliance daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lead-pharma-achieves-third-milestone-in-sanofi-collaboration 2019-04-17 07:01:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/koreas-leading-and-largest-dedicated-international-process-packaging-exhibition 2017-11-22 03:17:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/koreas-leading-and-largest-dedicated-chemical-engineering-and-process-exhibition 2019-04-17 07:01:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sumitomo-dainippon-pharma-and-angelini-announce-partnership 2019-04-17 07:01:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/palatin-technologies-agreement-with-kwangdong-pharmaceutical 2019-04-17 07:01:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-secures-horizon-phase-grant-for-clinical-validation 2019-04-17 07:01:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm 2019-04-17 07:01:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/revance-announces-orphan-drug-designation 2019-04-17 07:01:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/leon-nanodrugs-congratulates-its-partner-mjr-pharmjet 2019-04-17 07:01:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-receives-agreement-from-fda-on-initial-pediatric-study daily 0.1 https://demo.pharmafocusasia.com/pressreleases/successful-first-in-human-testing-of-implandatas-next-generation-eyemate 2019-04-17 07:01:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-set-for-prosperous-attend-cphi-worldwide 2019-04-17 07:01:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-hemlibra-receives-the-worlds-first-regulatory-approval 2019-04-17 07:01:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/poor-aggregation-will-see-adc-targets-fail-or-face-long-delays 2017-11-17 01:21:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pertinax-pharma-appoints-nigel-brooksby-as-chairman 2019-04-17 07:01:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-treatments-to-solve-global-antibiotic-crisis 2019-04-17 07:01:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pin-pharma-announces-initiation-of-its-first-phase-study 2019-04-17 07:01:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eusa-pharma-and-aveo-oncology-announce-the-first-commercial-launch-of-fotivda 2019-04-17 07:01:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trinity-partners-reveals-findings-on-fda-approved-novel-drug 2019-04-17 07:01:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-announces-the-launch-of-clofarabine-injection 2019-04-17 07:01:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ema-grants-orphan-drug-designation-to-debiopharm-international 2019-04-17 07:01:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kadmon-initiates-phase-placebo-controlled-clinical-trial 2019-04-17 07:01:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/where-healthcare-meets-technology-medical-fair-asia 2019-04-17 07:01:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antikor-advances-breakthrough-fragment-drug-conjugate-technology 2019-04-17 07:01:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-global-pharma-index 2019-04-17 07:01:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novaliq-announces-first-patient-randomized-in-its-essence-phase-trial daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-expands-its-footprint-in-asia-pacific-region 2019-04-17 07:01:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-last-patient-enrolled-in-the-phase-study 2019-04-17 07:01:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neogenomics-europe-sa-opens-its-doors-in-rolle 2019-04-17 07:01:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/millendo-therapeutics-announces-positive-topline-phase-results 2019-04-17 07:00:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerenis-therapeutics-acquires-lypro-biosciences-expanding-its-hdl-strategy 2019-04-17 07:00:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pique-therapeutics-announces-positive-results-in-phase-clinical-trial 2019-04-17 07:00:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-and-portal-instruments-announce-collaboration 2019-04-17 07:00:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/artemis-therapeutics-receives-orphan-drug-designation 2019-04-17 07:00:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-announces-new-offering-of-silensomes-hlm 2019-04-17 07:00:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sotio-completes-enrolment-of-phase-viable-study 2019-04-17 07:00:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invitria-announces-new-media-formulation-service 2019-04-17 07:00:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quark-pharmaceuticals-presents-results-from-positive-phase-study daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celonic-acquires-glycotopes-bio-manufacturing-facility 2019-04-17 07:00:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenetic-biosciences-enters-into-sublicense-agreement-with-baxalta 2019-04-17 07:00:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-completion-of-plan-b-one-step-divestiture 2019-04-17 07:00:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-and-intelgenx-submit-new-drug-application 2019-04-17 07:00:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/columbia-asia-expands-in-india 2019-04-17 07:00:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crf-healths-trialmax-touch-solution-selected-for-landmark-global-oncology-study 2017-11-02 01:09:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mitosol-s-orphan-drug-designation-is-expanded-for-all-glaucoma-surgery- daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medicure-acquires-exclusive-license-to-sell-prexxartan-in-the-u-s- 2019-04-17 07:00:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pdl-biopharma-announces-settlement-agreement-with-valeant 2019-04-17 07:00:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-and-glycotope-announce-option-agreement 2019-04-17 07:00:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/indias-generics-exports-expanding-per-year 2019-04-17 07:00:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-dedicated-biopharma-event-launches-alongside-cphi-worldwide 2019-04-17 07:00:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-receives-tentative-fda-approval-for-pemfexy 2019-04-17 07:00:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lin-bioscience-receives-us-fda-orphan-drug-status 2019-04-17 07:00:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/saltigo-at-cphi 2019-04-17 07:00:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prometic-receives-fast-track-designation 2019-04-17 07:00:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apexigen-announces-new-collaboration-with-ucsf 2019-04-17 07:00:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/latest-moda-software-release-from-lonza 2019-04-17 07:00:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medivir-receives-fda-fast-track-designation 2019-04-17 07:00:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bracket-acquires-mprove-health-to-radically-advance-patient-engagement 2019-04-17 07:00:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-soliris-for-the-treatment-of-patients 2019-04-17 06:59:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biogen-and-eisai-expand-existing-collaboration-agreement 2019-04-17 06:59:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-unrivalled-capabilities-take-gc-ms-to-the-next-level-of-performance 2019-04-17 06:59:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/albumedix-establishes-scientific-advisory-board 2019-04-17 06:59:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/strong-cresemba-sales-in-the-united-states 2019-04-17 06:59:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-report-states-the-current-drugs-pipeline 2019-04-17 06:59:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sta-pharmaceutical-to-open-new-transition-metal-catalysis-center 2019-04-17 06:59:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/discover-the-latest-thinking-on-lean-handling-of-powders-granules-and-tablets 2019-04-17 06:59:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-to-expand-its-secondary-packaging-service-capacity 2019-04-17 06:59:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/reviva-pharmaceuticals-announces-successful-completion-of-pre-ind-meeting-with-fda 2019-04-17 06:59:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-and-gsk-sign-collaboration-agreement 2019-04-17 06:59:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanology-announces-first-patient-enrolled-in-phase-clinical-trial 2019-04-17 06:59:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunogen-announces-investigational-new-drug-application 2019-04-17 06:59:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chimed-reports-preliminary-phase-data-on-fruquintinib 2019-04-17 06:59:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-report-highlights-unpredictability-in-cdmo-growth 2019-04-17 06:59:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-announces-settlement-on-restasis-patent-litigation-with-innopharma 2019-04-17 06:59:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-joins-phrma-to-continue-advancing-research-and-innovation 2019-04-17 06:59:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biopharmx-collaborates-with-wellman-center 2019-04-17 06:59:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigo-appointment-of-new-business-lead-consultant-further-strengthens 2019-04-17 06:59:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-announces-large-scale-expansion 2019-04-17 06:59:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pertinax-pharma-launches-patented-chlorhexidine-technology daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nanology-announces-first-patient-enrolled-for-ovarian-cancer daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-accepts-supplemental-biologics-license-application-for-prolia daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-kadmons-for-the-treatment-of-cgvhd 2019-04-17 06:59:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aerie-pharmaceuticals-announces-drug-delivery-asset-acquisition 2019-04-17 06:59:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regulatory-approval-in-europe-granted-for-synthons-glatiramer-acetate 2019-04-17 06:59:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biotechnologie-gmbh-announces-transition-into-european-corporation 2019-04-17 06:59:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acadia-pharmaceuticals-initiates-phase-study-of-pimavanserin 2019-04-17 06:59:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/albumedix-oslo-university-hospital-and-university-strategic-research-collaboration 2019-04-17 06:59:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-to-support-international-medical-corps-uk 2019-04-17 06:59:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-positive-top-line-results-from-phase-study-of-bekinda 2019-04-17 06:58:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-and-biotoscana-sign-exclusive-licensing-agreement 2019-04-17 06:58:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-new-webinar 2019-04-17 06:58:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-accelerates-rhb-phase-study 2019-04-17 06:58:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-reports-negative-topline-data-from-spinocerebellar-ataxia 2019-04-17 06:58:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mallinckrodt-licenses-inhaled-xenon-gas-therapy-development-product 2019-04-17 06:58:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taxis-pharmaceuticals-to-present-pipeline-update 2019-04-17 06:58:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-gains-ce-label-expansion-for-pd-l-testing 2019-04-17 06:58:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immatics-initiates-the-first-phase-clinical-trial 2019-04-17 06:58:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-lays-the-foundation-for-state-of-the-art-administration-building 2019-04-17 06:58:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/castle-creek-pharmaceuticals-announces-first-iga-scale 2019-04-17 06:58:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-and-sanofi-announce-approval-of-dupixent 2019-04-17 06:58:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pall-life-sciences-introduces-new-continuous-and-single-use-technologies daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quva-pharma-announces-fda-registration-of-its-new-jersey-facility 2019-04-17 06:58:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/systech-international-and-innolife-launch-pharmaceutical-serialization-solution 2019-04-17 06:58:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lanxess-india-continues-with-its-csr-thrust-in-nagda 2019-04-17 06:58:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sound-pharmaceuticals-initiates-stop-ototoxicity-study-in-cystic-fibrosis 2019-04-17 06:58:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sonnet-biotherapeutics-to-present-data-on-bispecific-platform 2019-04-17 06:58:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-fair-thailand-sets-record-again 2019-04-17 06:58:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/domestic-companies-predict-growth-in-the-south-korean-pharma-market 2019-04-17 06:58:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/adc-bio-to-invest-on-bioconjugation-facility 2019-04-17 06:58:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abbvie-and-bristol-myers-squibb-announce-clinical-research-collaboration 2019-04-17 06:58:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alligator-bioscience-to-present-adc-intratumoral-clinical-phase-study 2019-04-17 06:58:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cbre-ne-announces-corbus-pharmaceuticals-triples-its-footprint 2019-04-17 06:58:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delmar-pharmaceuticals-announces-issuance-of-new-patent 2019-04-17 06:58:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/agenebio-receives-nih-grant 2019-04-17 06:58:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aplagon-partners-with-cadila-pharmaceuticals daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-introduces-the-new-cytosmart-system-for-live-cell-imaging 2019-04-17 06:58:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delmar-pharmaceuticals-receives-ind-allowance-from-fda 2019-04-17 06:58:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-international-receives-shareholder-approval 2019-04-17 06:58:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-laboratory-freezers-earn-us-epa-energy-star-rating 2019-04-17 06:57:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/-us-fda-approves-ipsens-somatuline-depot-injection 2017-09-18 01:08:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohaven-and-alzheimers-disease-cooperative-study-collaboration daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pear-therapeutics-obtains-fda-clearance 2019-04-17 06:57:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transcelerate-biopharma-grows-industry-collaboration 2019-04-17 06:57:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/onxeo-grants-exclusive-worldwide-license-of-validive 2019-04-17 06:57:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotechs-ramp-up-clinical-trial-programs 2019-04-17 06:57:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dfb-pharmaceuticals-forms-nanology-for-clinical-development 2019-04-17 06:57:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/humanetics-awarded-patent-for-drug 2019-04-17 06:57:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/successful-industrial-gmp-manufacturing-of-riboxxim 2019-04-17 06:57:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-presents-new-data-solid-tumors-at-esmo daily 0.1 https://demo.pharmafocusasia.com/pressreleases/onxeo-announces-top-line-results-from-relive daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lanxess-accelerates-profitable-growth 2019-04-17 06:57:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-and-sanofi-announce-cemiplimab-received-fda 2019-04-17 06:57:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-takes-steps-to-streamline-business 2019-04-17 06:57:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/trakcel-announces-partnership-with-cell-and-gene-therapy-catapult 2017-09-08 00:43:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pulmatrix-licenses-inhaled-copd-drug-pur-to-vectura-group 2019-04-17 06:57:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clintec-expands-uk-headquarters 2019-04-17 06:57:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-announces-fda-orphan-drug-designation 2019-04-17 06:57:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novacap-start-production-sodium-bicarbonate-plant 2019-04-17 06:57:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/u-s-fda-approves-chemo-group-s-benznidazole-to-treat-children-with-chagas-disease 2019-04-17 06:57:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovion-submits-new-drug-application-for-dasotraline 2019-04-17 06:57:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bim-technology-assists-in-the-latest-monobloc-cleanroom-installation 2019-04-17 06:57:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/isct-revises-cell-and-gene-therapy-industry 2019-04-17 06:57:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/prometic-receives-rare-pediatric-disease-designation-from-u-s-fda 2019-04-17 06:57:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-receives-fda-approval-for-cyltezo 2017-08-30 01:26:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lumosa-therapeutics-partners-with-camargo-pharmaceutical-services 2019-04-17 06:57:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bristol-myers-squibb-and-daiichi-sankyo-announce-research-collaboration 2019-04-17 06:57:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/worldwide-clinical-trials-experts-to-advance-dialogue 2019-04-17 06:57:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/boehringer-ingelheim-initiates-phase-study 2019-04-17 06:57:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-somru-bioscience-radiant-pharmaceuticals-joint-venture 2019-04-17 06:57:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roquette-continues-momentum-with-pharmaceutical-investments 2019-04-17 06:57:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/epygenix-therapeutics-receives-us-fda-orphan-drug-designation 2019-04-17 06:56:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teikoku-pharma-usa-announces-positive-topline-results 2017-08-23 00:51:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jupiter-orphan-therapeutics-receives-orphan-drug-designation 2019-04-17 06:56:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-received-designation 2019-04-17 06:56:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cmed-to-demonstrate-the-capture-visualization-and-real-time-analysis-of-clinical-data daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-and-medicines-for-malaria-venture-launch-patient-trial-in-africa 2019-04-17 06:56:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/european-commission-grants-new-indication-for-soliris 2019-04-17 06:56:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolinerx-announces-regulatory-submission-of-phase-registrational-study 2019-04-17 06:56:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-us-commercialization-agreement 2019-04-17 06:56:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ligand-to-receive-from-wuxi-biologics-for-licensing-clinical-stage 2019-04-17 06:56:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ficci-and-kantar-imrb-launch-healthcare-consumer-report daily 0.1 https://demo.pharmafocusasia.com/pressreleases/edition-of-ficci-heal-gets-under-way 2019-04-17 06:56:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmadule-morimatsu-poised-to-benefit-from-pharma 2019-04-17 06:56:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-global-systems-director-appointed-at-matcon-ltd 2019-04-17 06:56:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/perrigo-announces-fda-final-approval 2019-04-17 06:56:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mimetas-develops-high-throughput-gut-on-chip-technology 2019-04-17 06:56:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ficci-heal-to-unveil-patients-expectations 2019-04-17 06:56:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lanxess-continues-to-expect-record-earnings 2019-04-17 06:56:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/singapore-edevelopments-global-biolife-and-us-based-chemia-corporation 2019-04-17 06:56:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/alexion-receives-three-new-us-patents-for-soliris 2019-04-17 06:56:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-expands-support-for-researchers 2019-04-17 06:56:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orig-partners-with-baltimore-ravens 2019-04-17 06:56:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-introduces-externalization-technology 2019-04-17 06:56:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inventiva-odiparcil-awarded-orphan-drug-designation 2019-04-17 06:56:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-india-report-identifies-two-tier-manufacturing-market 2019-04-17 06:56:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/the-great-hall-of-china-double-digit-growth-at-cphi-china 2019-04-17 06:56:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/can-fite-completes-patient-enrolment-for-its-phase-study 2019-04-17 06:56:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-apptec-immunotherapy-report 2019-04-17 06:56:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mylan-launches-avonza-in-india 2019-04-17 06:56:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oasmia-pharmaceutical-receives-market-approval 2019-04-17 06:56:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-fda-approval-of-qvar-redihaler 2019-04-17 06:56:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cycle-pharmaceuticals-partners-with-cardinal 2019-04-17 06:55:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-announces-positive-results 2019-04-17 06:55:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inc-research-and-inventiv-health-announce-merger 2019-04-17 06:55:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intec-pharma-reports-clinical-results-from-phase-trial 2019-04-17 06:55:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/helsinn-group-and-mei-pharma-announce-first-patient-dosed-in-pivotal-phase-study daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antibe-therapeutics-receives-approval-to-initiate-phase-clinical-trial 2019-04-17 06:55:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flex-pharma-initiates-als-phase-trial-in-us 2019-04-17 06:55:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acelrx-pharmaceuticals-reports-successful-outcome-of-zalviso-phase-study 2019-04-17 06:55:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ubm-and-restec-discontinue-russia-partnership 2019-04-17 06:55:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-unanimous-positive-dsmb-recommendation 2019-04-17 06:55:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-lab-grade-undercounter-refrigerators 2019-04-17 06:55:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovus-pharma-files-its-product-license-application-in-canada 2019-04-17 06:55:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxis-pharmaceutical-development-services-division 2019-04-17 06:55:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ttp-introduces-formajet-liquid-handling-platform 2019-04-17 06:55:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-generic-epiduo-in-the-united-states 2019-04-17 06:55:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/themis-bioscience-starts-phase-clinical-study-in-endemic-area 2019-04-17 06:55:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/infinity-amends-delta-gamma-agreement-with-takeda-oncology 2019-04-17 06:55:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samumed-successfully-completed-phase-study 2019-04-17 06:55:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/steriline-to-unveil-new-features-of-its-novel-robotic-pulsed-light-sterilizer 2019-04-17 06:55:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teklad-diets-recertified-to-new-iso-standard daily 0.1 https://demo.pharmafocusasia.com/pressreleases/innovus-pharma-expands-exclusive-license-and-distribution-agreement 2019-04-17 06:55:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-workflow-is-first-end-to-end-solution-for-drug-implant-production 2019-04-17 06:55:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-calorimetry-based-phenotype-assays daily 0.1 https://demo.pharmafocusasia.com/pressreleases/som-biotech-expands-to-the-united-states 2019-04-17 06:55:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/janssen-announces-phase-pivotal-study-results 2019-04-17 06:55:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-announces-that-has-received-rare-paediatric-disease-designation 2019-04-17 06:55:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antabio-awarded-from-carb-x-to-accelerate-the-development daily 0.1 https://demo.pharmafocusasia.com/pressreleases/delmar-pharmaceuticals-receives-approval 2019-04-17 06:55:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/johnson-announces-encouraging-clinical-data 2019-04-17 06:55:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/corning-and-gerresheimer-collaborate 2019-04-17 06:55:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gsk-receives-fda-approval-for-new-self-injectable-formulation 2019-04-17 06:55:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/samumed-successfully-completes-phase-study 2019-04-17 06:55:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-launches-new-site-management-organisation-business 2019-04-17 06:54:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merck-announces-us-fda-grants-tentative-approval 2019-04-17 06:54:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/philogen-agreement-with-boehringer-ingelheim 2019-04-17 06:54:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/data-integrity-for-endotoxin-testing 2019-04-17 06:54:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intec-pharma-granted-patent-in-hong-kong 2019-04-17 06:54:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ra-pharmaceuticals-announces-publication-of-positive-preclinical-data 2019-04-17 06:54:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/south-korean-pharma-rapidly-becoming-manufacturing-export-hub 2019-04-17 06:54:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/high-point-clinical-trials-center-unveils-community-screening-outreach-rv 2019-04-17 06:54:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-thermo-scientific-samco-leakproof-vials 2019-04-17 06:54:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/gerresheimer-will-launch-an-innovative-syringe-safety-solution 2019-04-17 06:54:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vuv-analytics-announces-the-launch-of-novel-method 2019-04-17 06:54:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cardiome-announces-health-canada-approval-of-aggrastat 2019-04-17 06:54:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/codon-ag-achieves-remarkable-outcome 2019-04-17 06:54:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-expected-timeline-for-dsmb-meeting daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aytu-bioscience-expands-mioxsys-distribution-network 2019-04-17 06:54:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mallinckrodt-phase-terlipressin-trial-achieves-its-enrollment-target 2019-04-17 06:54:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cannabics-pharmaceuticals-collaboration-agreement-with-simfo-gmbh 2019-04-17 06:54:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-orphan-drug-designation-to-mallinckrodt-development-product 2019-04-17 06:54:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oramed-announces-end-of-phase-meeting-with-fda 2019-04-17 06:54:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/daiichi-sankyo-max-planck-innovation-and-lead-discovery-center-research-collaboration 2019-04-17 06:54:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merus-labs-international-shareholders-approve-plan-of-arrangement-with-norgine 2019-04-17 06:54:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biolinerx-announces-initiation-of-phase-trial 2019-04-17 06:54:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific-and-sri-international-collaborate 2019-04-17 06:54:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/solasia-announces-approval-of-episil-in-japan 2019-04-17 06:54:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biohavens-bhv-receives-orphan-drug-designation 2019-04-17 06:54:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-and-purdue-university-announce-strategic-research-collaboration 2019-04-17 06:54:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocads-rituximab-biosimilar-to-receive-ma-soon-in-india 2019-04-17 06:54:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/breckenridge-announces-final-approval-for-omeprazole-delayed-release-capsules 2019-04-17 06:54:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/array-biopharma-submits-new-drug-applications 2019-04-17 06:54:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/advicenne-receives-orphan-drug-designation-from-the-eu 2019-04-17 06:53:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/spherix-announces-closing-of-the-deal-with-hoth-therapeutics 2019-04-17 06:53:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merus-labs-international-and-norgine-bv-receive-spanish-anti-trust-approval 2019-04-17 06:53:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/horizon-discovery-announces-inclusion-of-its-reference-standards daily 0.1 https://demo.pharmafocusasia.com/pressreleases/preliminary-phase-data-from-spinal-muscular-atrophy-program 2019-04-17 06:53:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomarin-submits-pegvaliase-biologics-license-application 2019-04-17 06:53:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/celltrion-and-teva-announce-us-fda-acceptance-of-biologics-license 2019-04-17 06:53:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/apellis-pharmaceuticals-announces-positive-data-from-apl-studies 2019-04-17 06:53:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/heptares-enters-new-research-and-drug-discovery-collaboration 2019-04-17 06:53:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-expands-harmony-prenatal-test 2019-04-17 06:53:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-expands-ipsc-drug-discovery-leadership 2019-04-17 06:53:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mitoconix-bio-raises-series-funding 2019-04-17 06:53:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-and-be-collaborate-to-develop-low-cost-vaccines 2019-04-17 06:53:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-announces-leadership-promotions-in-marketing-strategy 2019-04-17 06:53:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kitov-updates-on-kit-new-drug-application 2019-04-17 06:53:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novotech-signs-central-lab-services-agreement 2019-04-17 06:53:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampio-injects-first-patient-in-final-pivotal-clinical-trial 2019-04-17 06:53:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-combination-targeted-therapy-tafinlar-mekinist-receives-fda-approval 2019-04-17 06:53:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protea-introduces-new-molecular-imaging-technology 2019-04-17 06:53:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eli-lilly-and-company-unveils-expanded-biotechnology-center 2019-04-17 06:53:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-launch-of-diphenoxylate-hcl 2019-04-17 06:53:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-licenses-small-molecule-oncology-compound 2019-04-17 06:53:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seattle-genetics-discontinues-phase-cascade-trial 2019-04-17 06:53:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-single-quadrupole-mass-spectrometer 2019-04-17 06:53:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ipsen-announces-fda-approval-of-dysport 2019-04-17 06:53:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rasrx-receives-orphan-drug-designation-from-fda 2019-04-17 06:53:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-pharmaceuticals-signs-agreement-to-regain-worldwide-rights-for-ceplene 2019-04-17 06:53:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/baxter-announces-agreement-with-dorizoe-lifesciences 2019-04-17 06:53:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evolving-pharmaceutical-ecosystem-transforms-clinical-trials 2019-04-17 06:53:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-has-started-promoting-donnatal 2019-04-17 06:53:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/inmed-announces-agreement-to-advance-topical-formulation 2019-04-17 06:52:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/crispr-therapeutics-and-masthercell-sa-sign-service-agreement 2019-04-17 06:52:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/rentschler-biotechnologie-and-rentschler-fill-solutions-announce-strategic-partnership 2019-04-17 06:52:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/teva-announces-launch-of-generic-zetia-in-the-united-states 2019-04-17 06:52:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-immobilized-lux-chiral-lc-sfc-selector-from-phenomenex 2019-04-17 06:52:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lexicon-pharmaceuticals-reports-positive-top-line-results 2019-04-17 06:52:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/top-safety-accreditation-for-connect-cleanrooms 2019-04-17 06:52:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aptuit-announces-strategic-provider-agreement 2019-04-17 06:52:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciclone-enters-into-definitive-merger-agreement 2019-04-17 06:52:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mundipharma-announces-worlds-first-launch-of-mundesine-treatment 2019-04-17 06:52:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/launch-of-pain-treatment-lyrica-od-tablet-formulation 2019-04-17 06:52:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/egalet-partners-with-ascend-therapeutics-to-co-promote-sprix-nasal-spray 2019-04-17 06:52:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aralez-announces-national-us-commercial-launch-of-zontivity 2019-04-17 06:52:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stratpharma-brings-stratpharma-ags-innovative-wound-care-products 2019-04-17 06:52:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nih-and-themis-bioscience-announce-the-initiation-of-clinical-trial 2019-04-17 06:52:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essa-pharma-presents-data-from-phase-trial 2019-04-17 06:52:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/connect-cleanrooms-support-preclinical-and-clinical-trials 2019-04-17 06:52:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atum-and-horizon-discovery-announce-collaboration 2019-04-17 06:52:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ventaleon-gmbh-initiates-challenge-trial 2019-04-17 06:52:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fstar-expands-its-relationship-with-merck 2019-04-17 06:52:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/roche-announces-fda-approval-of-companion-diagnostic 2019-04-17 06:52:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nexus-pharmaceuticals-receives-fda-approval 2019-04-17 06:52:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/successful-aaalac-accreditation-for-envigo-facilities 2019-04-17 06:52:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ralexar-therapeutics-initiates-phase-study 2019-04-17 06:52:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-and-microdermics-enter-into-strategic-cooperation-agreement 2019-04-17 06:52:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-makes-strong-impression-on-air-cargo-europe 2019-04-17 06:52:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/amo-pharma-announces-fda-fast-track-designation 2019-04-17 06:52:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orchard-therapeutics-agreement-with-pct-cell-therapy-services 2019-04-17 06:52:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/optibrium-imperial-college-and-dndi-collaborate 2019-04-17 06:52:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/seafood-expo-brussels 2019-04-17 06:51:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/first-in-turkish-cargo 2019-04-17 06:51:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-attended-logipharma 2019-04-17 06:51:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo-barselona-pharmaday 2019-04-17 06:51:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taigen-biotechnology-announces-submission-of-new-drug-application 2019-04-17 06:51:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nls-pharma-announces-new-information-in-support-of-the-mechanism 2019-04-17 06:51:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lupin-pharmaceuticals-announces-nationwide-recall daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermi-receives-clearance-to-market-thermirf 2019-04-17 06:51:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurana-pharmaceuticals-receives-notice-of-allowance-of-patents 2019-04-17 06:51:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ogt-pushes-forward-hybridisation-based-targeted-sequencing daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biocad-joins-the-eu 2019-04-17 06:51:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-sta-cfda-and-jinshan-government-to-cohost-marketing-authorization 2019-04-17 06:51:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sun-pharma-announces-us-fda-filing-acceptance 2019-04-17 06:51:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/intellipharmaceutics-reports-on-launch-of-additional-strengths 2019-04-17 06:51:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/bioverativ-to-acquire-true-north-therapeutics 2019-04-17 06:51:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ironshore-pharmaceuticals-presents-pivotal-trial-data 2019-04-17 06:51:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emed-partners-with-global-pharma-leaders-in-new-fda-clearance 2019-04-17 06:51:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurovive-to-continue-neurostat-clinical-development 2019-04-17 06:51:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/evotec-receives-preclinical-milestone 2019-04-17 06:51:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/arena-pharmaceuticals-to-host-key-opinion-leader-event 2019-04-17 06:51:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nemaura-pharma-memspatch-addresses-diabetics-fear-of-needle-puncture-pain 2019-04-17 06:51:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/atum-licenses-gene-design-software-to-thermo-fisher-scientific 2019-04-17 06:51:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pelican-biothermal-unveils-new-series-universal-system 2019-04-17 06:51:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/kemwell-biopharma-supplies-biologics-drug-phase-clinical-trials 2019-04-17 06:51:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/essa-pharma-announces-data-from-phase-trial 2019-04-17 06:51:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/abon-received-approval-from-the-us-fda 2019-04-17 06:51:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ionis-pharmaceuticals-announces-phase-neuro-ttr-study 2019-04-17 06:51:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glenmark-pharmaceuticals-to-initiate-clinical-study 2019-04-17 06:51:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-to-launch-global-pharma-market-ranking-index 2019-04-17 06:51:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/positive-data-from-phase-us-blue-light-cystoscopy 2019-04-17 06:50:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lilly-announces-positive-results-for-three-phase-studies 2019-04-17 06:50:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/marketing-approval-for-childrens-cancer-immunotherapy-in-the-eu 2019-04-17 06:50:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-phenotype-assays-needed-for-antibiotic-resistance 2019-04-17 06:50:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milestone-pharmaceuticals-announces-etripamil-phase-clinical-program-success 2019-04-17 06:50:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-and-onxeo-initiate-managed-access-programme 2019-04-17 06:50:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/savara-announces-expedited-us-molgradex-development-strategy 2019-04-17 06:50:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clintec-secures-queens-award-for-enterprise 2017-05-10 03:51:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oramed-granted-canadian-patent-for-glp-analog-capsule 2019-04-17 06:50:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/santalis-pharmaceuticals-enrolls-first-us-subject-into-phase-clinical-study 2019-04-17 06:50:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-thermo-scientific-refrigerated-incubators 2019-04-17 06:50:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-launch-of-pindolol-tablets 2019-04-17 06:50:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/embera-neurotherapeutics-announces-positive-topline-data 2019-04-17 06:50:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dauntless-pharmaceuticals-announces-positive-data-from-phase-study 2019-04-17 06:50:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/quest-pharmatech-expands-its-consumer-health-product-pipeline 2019-04-17 06:50:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/international-pharma-at-cphi-china 2019-04-17 06:50:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eiger-announces-us-ind-filing-of-pegylated-interferon-lambda 2019-04-17 06:50:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/owc-pharmaceutical-research-announces-update 2019-04-17 06:50:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/camurus-and-braeburn-pharmaceuticals-announce-positive-top-line-results 2019-04-17 06:50:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/otsuka-and-lundbeck-announce-results 2019-04-17 06:50:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/transasia-bio-medicals-acquisition-of-calbiotech-group 2019-04-17 06:50:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ampio-initiates-pivotal-trial-of-ampion 2019-04-17 06:50:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cantex-pharmaceuticals-announces-initiation-of-phase-clinical-development 2019-04-17 06:50:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-approves-radius-healths-tymlos-a-bone-building-agent-for-the-treatment daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aeterna-zentaris-to-announce-top-line-results 2019-04-17 06:50:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-webinar 2019-04-17 06:50:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/takeda-and-harrington-discovery-institute-announce-collaboration 2019-04-17 06:50:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piqur-receives-ema-orphan-drug-designation 2019-04-17 06:50:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/dr-reddys-laboratories-announces-the-launch-of-ezetimibe 2017-04-27 04:33:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-clears-flex-pharmas-to-commence-us-phase-trial 2019-04-17 06:50:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impax-announces-fda-approval-of-vytorin 2019-04-17 06:50:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-japan-japanese-pharma-companies-predict 2019-04-17 06:49:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-expert-calls-for-anda-approvals 2019-04-17 06:49:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aquinnah-pharmaceuticals-receives-investment 2019-04-17 06:49:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanofi-and-regeneron-announce-fda-approval 2019-04-17 06:49:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/enamine-to-collaborate-with-embl 2019-04-17 06:49:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clinigen-and-onxeo-initiate-managed-access-programme 2019-04-17 06:49:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sillajen-and-transgene-announce-the-enrollment daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-announces-enrollment-of-last-patient 2019-04-17 06:49:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immune-pharmaceuticals-signs-letter-of-intent-with-pint-pharma 2019-04-17 06:49:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-unveils-agenda-for-annual-global-endotoxin-testing-summit 2019-04-17 06:49:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ani-pharmaceuticals-announces-launch-of-indapamide-tablets 2019-04-17 06:49:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eisai-announces-continued-support 2019-04-17 06:49:39 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-and-kings-college-london-collaborate daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-confirms-prometics-pbi-ipf-clinical-trial-design 2019-04-17 06:49:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regen-biopharma-identifies-three-new-series-of-compounds 2019-04-17 06:49:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/novartis-car-t-cell-therapy-receives-fda-breakthrough-therapy 2019-04-17 06:49:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncomeds-phase-trial 2019-04-17 06:49:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/china-pharmaceutical-packaging-industry-report 2019-04-17 06:49:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/casi-pharmaceuticals-reports-on-enrollment-status 2019-04-17 06:49:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vanda-pharmaceuticals-to-announce-first-quarter-financial-results 2019-04-17 06:49:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-to-produce-red-blood-cell-substitute daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-fair-thailand 2019-04-17 06:49:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sonoma-pharmaceuticals-receives-united-arab-emirates-regulatory-approvals 2019-04-17 06:49:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regen-biopharma-sees-success-in-pre-clinical 2019-04-17 06:49:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/hi-tech-pharmaceuticals-expands 2019-04-17 06:49:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exova-acquires-sl-pharma-labs-incorporated 2019-04-17 06:49:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lonza-to-host-new-webinar 2017-04-12 04:57:41 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oncomed-pharmaceuticals-announces-bayer-terminates-its-option 2019-04-17 06:49:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valeo-pharma-and-zambon-form-partnership 2019-04-17 06:49:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antibacterial-therapies-drug-development-pipeline 2019-04-17 06:49:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chugais-alecensa-met-its-primary-endpoint 2019-04-17 06:49:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/orphan-drugs-market 2019-04-17 06:49:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regeneron-announces-evinacumab-received-fda-designation 2019-04-17 06:49:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xtl-biopharmaceuticals-unveils-expanded-hcdr-preclinical-data 2019-04-17 06:49:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tolero-pharmaceuticals-presents-preclinical-data 2019-04-17 06:48:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lakewood-amedex-advances-novel-bisphosphocin 2019-04-17 06:48:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/redhill-biopharma-receives-fda-orphan-drug-designation 2019-04-17 06:48:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/audentes-therapeutics-announces-fda-clearance 2019-04-17 06:48:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/morphotek-launches-antibody-drug-conjugate-services-business 2019-04-17 06:48:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigo-launches-double-knockout-mouse-model daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomedicine-to-present-data-on-emerging-pipeline-compounds 2019-04-17 06:48:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/genprex-reports-new-pre-clinical-data 2019-04-17 06:48:45 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incyte-and-merck-provide-additional-details 2019-04-17 06:48:43 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/parexel-launches-patient-sensor-solution 2019-04-17 06:48:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/merrimack-stockholders-approve-sale-to-ipsen 2019-04-17 06:48:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-claudia-roth-appointed-fraunhofer-advisory-board 2019-04-17 06:48:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/wuxi-biologics-receives-asia-pacific-best-bioprocessing-excellence-award 2019-04-17 06:48:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sciex-announces-new-biotransformation-solutions 2019-04-17 06:48:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-signs-stem-cell-research-collaborations daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eusa-pharma-and-apeiron-biologics-receive-positive-chmp-opinion 2019-04-17 06:48:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xenetic-biosciences-provides-update-on-patent-portfolio-development 2019-04-17 06:48:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/make-sure-your-balance 2019-04-17 06:48:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/maintain-quality-while-improving-productivity 2019-04-17 06:48:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/taking-mass-calibration-to-new-limits 2019-04-17 06:48:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/keep-your-cookies-crunchy 2019-04-17 06:48:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/free-tips-help-keep-test-weights-accurate 2019-04-17 06:48:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pfizer-receives-positive-chmp-opinion-for-trumenba 2019-04-17 06:48:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/datwyler-for-the-future 2019-04-17 06:48:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/argentum-patent-on-ucbs-vimpat 2019-04-17 06:48:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ignyta-announces-exploration-of-strategic-options 2019-04-17 06:48:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/shire-receives-fda-fast-track-designation 2019-04-17 06:48:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/piramal-pharma-solutions-augments-integrated-capabilities 2019-04-17 06:48:05 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/milliporesigma-introduces-mobius-myway-portfolio 2019-04-17 06:48:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/xchem-and-ono-drug-discovery-collaboration 2019-04-17 06:48:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/turkish-cargo 2019-04-17 06:47:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cerulean-pharma-and-dare-bioscience-enter-agreement 2019-04-17 06:47:57 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ferring-and-cdi-sign-agreement 2019-04-17 06:47:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/analyses-of-pcsk-inhibitor-prescription-rejection 2019-04-17 06:47:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/thermo-fisher-scientific 2019-04-17 06:47:52 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/asana-biosciences-announces-fda-acceptance 2019-04-17 06:47:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-south-east-asia 2019-04-17 06:47:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/growing-market-for-generics-cphi-japan 2019-04-17 06:47:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fps-multimilling-platform 2019-04-17 06:47:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/catabasis-pharmaceuticals-to-present-conference 2019-04-17 06:47:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vtesse-completes-enrollment 2019-04-17 06:47:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigo-expands-rd-capabilities 2019-04-17 06:47:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/allergan-and-editas-medicine-enter-into-strategic-r-d-alliance 2019-04-17 06:47:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/incj-takeda-and-medipal-holdings-partner 2019-04-17 06:47:35 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/metriopharm-announces-positive-top-line-results-from-phase-study 2019-04-17 06:47:33 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/stellar-biotechnologies-and-matrivax-sign-agreement 2019-04-17 06:47:31 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lsk-biopharma-announces-enrollment-of-first-patient 2019-04-17 06:47:29 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotime-expands-opregen-clinical-trial 2019-04-17 06:47:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immunogen-presents-phase-biopsy-expansion 2019-04-17 06:47:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sensorion-receives-european-authorization 2019-04-17 06:47:24 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mersana-adds-to-antibody-drug-conjugate 2019-04-17 06:47:22 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/horizon-discovery-partnership-amplycell 2019-04-17 06:47:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medgenome-launches-oncotrack daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmajet-partners-with-serum-institute 2019-04-17 06:47:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/glycomimetics-completes-enrollment 2019-04-17 06:47:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-china-to-launch-china-pharma-week 2019-04-17 06:47:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/deciphera-pharmaceuticals-initiates-phase-clinical-trial 2019-04-17 06:47:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/akcea-and-ionis-announce-positive-results-from-pivotal-study 2019-04-17 06:47:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/oral-otezla-demonstrated-significant-improvement daily 0.1 https://demo.pharmafocusasia.com/pressreleases/valerion-therapeutics-new-mechanism daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regen-biopharma-licenses-nrf-technology 2019-04-17 06:46:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ppd-awarded-national-institutes-of-health-contract 2019-04-17 06:46:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acerus-files-new-drug-submission 2019-04-17 06:46:54 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/jazz-pharmaceuticals-announces-participation 2019-04-17 06:46:50 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/zogenix-receives-orphan-drug-designation 2019-04-17 06:46:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-expands-in-middle-east-africa 2019-04-17 06:46:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/annual-strategic-alliance-management-for-pharma 2019-04-17 06:46:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/astellas-and-affinivax-announce-worldwide-partnership 2019-04-17 06:46:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ppd-introduces-rare-disease 2019-04-17 06:46:38 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/invenra-and-qimr-berghofer-medical-research-institute-enter-collaboration 2019-04-17 06:46:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/microport-commences-local-commercial-operations 2019-04-17 06:46:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/titan-pharmaceuticals-receives-fda-communication 2019-04-17 06:46:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovion-announces-positive-topline-results 2019-04-17 06:46:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mercks-letermovir-an-investigational-antiviral-medicine daily 0.1 https://demo.pharmafocusasia.com/pressreleases/antibe-therapeutics-enters-into-regional-licensing-deal 2019-04-17 06:46:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acticor-biotech-has-selected-its-contract-research-organisation 2019-04-17 06:46:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fusion-pharmaceuticals-launches-with-series-a-financing 2019-04-17 06:46:20 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lannett-provides-further-update 2019-04-17 06:46:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pmv-pharma-secures-in-series-b-financing 2019-04-17 06:46:15 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cohbar-announces-positive-results 2019-04-17 06:46:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/eagle-pharmaceuticals-new-patents 2019-04-17 06:46:09 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lysogene-receives-orphan-drug-designation 2019-04-17 06:46:07 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/envigos-fully-validated-highly-sensitive-method daily 0.1 https://demo.pharmafocusasia.com/pressreleases/modus-therapeutics-raises-to-support-development 2019-04-17 06:46:03 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/immuron-completes-phase-nash-clinical-trial 2019-04-17 06:46:02 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/russian-government-growth-at-cphi-russia 2019-04-17 06:46:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lynparza-olaparib-meets-primary-endpoint daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exelixis-announces-phase-trial-results daily 0.1 https://demo.pharmafocusasia.com/pressreleases/drug-discovery-and-development 2019-04-17 06:45:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ionis-and-akcea-close-on-strategic-collaboration 2017-02-16 23:51:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ascendis-pharma-as-announces-publication 2017-02-16 23:46:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/us-fda-expands-approval daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-south-east-asia 2019-04-17 06:45:48 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sanarias-pfspzcvac-vaccine 2019-04-17 06:45:46 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmapack-europe 2019-04-17 06:45:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/clintec-marks-global-clinical-research 2019-04-17 06:45:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/theratechnologies-announces-new-data daily 0.1 https://demo.pharmafocusasia.com/pressreleases/chi-med-and-astrazeneca-present-savolitinib daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mabvax-therapeutics-studies-lead-investigational-drug 2019-04-17 06:45:37 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/armetheon-announces-issuance-of-new-us-patent 2019-04-17 06:45:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/ts-international-conference 2019-04-17 06:45:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/provectus-biopharmaceuticals 2019-04-17 06:45:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/newfound-effect-of-cancer-drug-may-expand-its-use 2019-04-17 06:45:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/replicel-announces-european-patents 2019-04-17 06:45:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acorda-announces-positive-clinical-trial-results 2019-04-17 06:45:26 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurocrine-and-bial-announce-agreement 2019-04-17 06:45:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/phase-compass-study-of-xarelto daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neuraltus-pharmaceuticals 2019-04-17 06:45:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/impel-neuropharma-partners 2019-04-17 06:45:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/nemaura-pharma-secures-funding 2019-04-17 06:45:18 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/plasticell-stem-cell-therapy 2019-04-17 06:45:16 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-comprehensive-lc-ms-workflow 2019-04-17 06:45:14 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sirnaomics-initiates-a-clinical-phase 2019-04-17 06:45:12 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/fda-grants-cellectis-ind-approval daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biotime-expands-ophthalmology-portfolio daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charleston-laboratories-inc-and-daiichi-sankyo-inc daily 0.1 https://demo.pharmafocusasia.com/pressreleases/palatin-technologies-announces daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-hepatitis-c-drugs 2019-04-17 06:45:01 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagen-ag-join-us-national-cancer-institute 2019-04-17 06:44:59 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharmapack-europe-award-winners daily 0.1 https://demo.pharmafocusasia.com/pressreleases/regen-biopharma-begins-optimization 2019-04-17 06:44:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/biomarin-receives-access-to-priority-medicines 2019-04-17 06:44:53 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/optinose-announces-fda-acceptance 2019-04-17 06:44:51 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/certara-releases-new-version 2019-04-17 06:44:49 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/neurotrope-completes-licensing-agreement 2019-04-17 06:44:47 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/charles-river-laboratories 2019-04-17 06:44:44 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-istanbul 2019-04-17 06:44:42 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/sunovions-latuda-receives-fda-approval 2019-04-17 06:44:40 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/aurinia-selects-worldwide-clinical-trials 2019-04-17 06:44:36 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/director-appointed-at-matcon 2019-04-17 06:44:34 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetter-starts-operations 2019-04-17 06:44:32 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mikron-automation-expands 2019-04-17 06:44:30 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/acucela-initiates-phase-study 2019-04-17 06:44:28 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/purdue-pharma-and-commonwealth-of-virginia-partner 2019-04-17 06:44:27 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/medical-fair-thailand 2019-04-17 06:44:25 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/summit-on-healthcare-industry 2019-04-17 06:44:23 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/onxeo-completes-enrollment-in-phase-study 2019-04-17 06:44:21 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/viracyte-receives-orphan-drug-designation 2019-04-17 06:44:19 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/flex-pharma-focuses-on-phase-clinical-programs 2019-04-17 06:44:17 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/emirates-otorhinolaryngology-audiology-and-communication-disorders-congress daily 0.1 https://demo.pharmafocusasia.com/pressreleases/cphi-worldwide-experts-make-pharma-predictions 2019-04-17 06:44:13 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/west-introduces-verux-pharmaceutical-packaging-components 2019-04-17 06:44:11 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/mab-facility-to-pharmadule-morimatsu 2019-04-17 06:44:10 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/symcel-and-colzyx-partner 2019-04-17 06:44:08 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/pharma-innovation-technology-summit 2019-04-17 06:44:06 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/lillys-ramucirumab-is-available-in-singapore 2019-04-17 06:44:04 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/international-executives-forecast-growth-in-india daily 0.1 https://demo.pharmafocusasia.com/pressreleases/protagen-launches-navigaid-assay-to-support-clinical-drug-development 2019-04-17 06:44:00 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/vetters-skokie-site-successfully-manufactures-batches-on-new-clinical-syringe-filling-line 2019-04-17 06:43:58 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/exploring-the-world-of-biomolecules 2019-04-17 06:43:56 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/tech-trends-and-turns-of-structural-biology 2019-04-17 06:43:55 daily 0.1 https://demo.pharmafocusasia.com/pressreleases/new-cool-methods-and-hot-new-structures 2019-04-17 06:43:53 daily 0.1